Avian Influenza Social Media Toolkit | Bird Flu | CDC Skip directly to site content Skip directly to search An official website of the United States government Here's how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. Avian Influenza (Bird Flu) Explore Topics Search Search Clear Input For Everyone Current Situation Monitoring Current Situation About Bird Flu in Animals and People Prevention Backyard Flock Owners: Protect Yourself from Bird Flu Avian Influenza Social Media Toolkit H5N1 Informational Videos View all Health Care Providers Case Definitions for Investigations of Human Infection with Avian Influenza A Viruses in the United States Clinical Overview Interim Guidance on the Use of Antiviral Medications for Treatment of Human Infections with Novel Influenza A Viruses Associated with Severe Human Disease Clinical Testing and Diagnosis Interim Guidance on Influenza Antiviral Chemoprophylaxis of Persons Exposed to Birds with Avian Influenza A Viruses Associated with Severe Human Disease or with the Potential to Cause Severe Human Disease Infection Control Guidance Considerations for Veterinarians: Evaluating and Handling of Cats Potentially Exposed to Highly Pathogenic Avian Influenza A(H5N1) Virus in Cats Conversation Tips: Unpasteurized (Raw Milk) View all Public Health H5N1 Bird Flu: Current Situation Summary Public Health Strategies for Bird Flu Interim Guidance on Specimen Collection and Testing for Patients with Suspected Infection with Novel Influenza A Viruses Associated with Severe Disease or with the Potential to Cause Severe Disease in Humans Interim Guidance for Follow-up of Close Contacts of Persons Infected with Novel Influenza A Viruses and Use of Antiviral Medications for Chemoprophylaxis H5N1 Technical Report Report: Highly Pathogenic Avian Influenza View all Related Topics: Seasonal Flu | Swine Flu | Flu in Animals | Flu Vaccines Work | Flu Forecasting | Flu Burden View All search close search search Bird Flu Menu Close search For Everyone Current Situation Monitoring Current Situation About Bird Flu in Animals and People Prevention Backyard Flock Owners: Protect Yourself from Bird Flu Avian Influenza Social Media Toolkit H5N1 Informational Videos View All Home Health Care Providers Case Definitions for Investigations of Human Infection with Avian Influenza A Viruses in the United States Clinical Overview Interim Guidance on the Use of Antiviral Medications for Treatment of Human Infections with Novel Influenza A Viruses Associated with Severe Human Disease Clinical Testing and Diagnosis Interim Guidance on Influenza Antiviral Chemoprophylaxis of Persons Exposed to Birds with Avian Influenza A Viruses Associated with Severe Human Disease or with the Potential to Cause Severe Human Disease Infection Control Guidance Considerations for Veterinarians: Evaluating and Handling of Cats Potentially Exposed to Highly Pathogenic Avian Influenza A(H5N1) Virus in Cats Conversation Tips: Unpasteurized (Raw Milk) View All Public Health H5N1 Bird Flu: Current Situation Summary Public Health Strategies for Bird Flu Interim Guidance on Specimen Collection and Testing for Patients with Suspected Infection with Novel Influenza A Viruses Associated with Severe Disease or with the Potential to Cause Severe Disease in Humans Interim Guidance for Follow-up of Close Contacts of Persons Infected with Novel Influenza A Viruses and Use of Antiviral Medications for Chemoprophylaxis H5N1 Technical Report Report: Highly Pathogenic Avian Influenza View All Related Topics Seasonal Flu Swine Flu Flu in Animals Flu Vaccines Work Flu Forecasting Flu Burden View All Bird Flu Current Situation Monitoring Current Situation About Bird Flu in Animals and People Prevention Backyard Flock Owners: Protect Yourself from Bird Flu Avian Influenza Social Media Toolkit H5N1 Informational Videos View All August 2, 2024 EspaÃ±ol Avian Influenza Social Media Toolkit Purpose CDC’s avian influenza (bird flu) social media toolkit is available to assist partners in communicating about bird flu prevention. This digital toolkit includes sample social media copy and associated graphics available for download. People with exposure to infected or potentially infected cows Twitter Sample Messages – English Farm workers: If you work with dairy cows or other animals that could be infected with bird flu, take action to reduce your risk of infection. Read more here: https://www.cdc.gov/bird-flu/media/pdfs/2024/09/H5-Wear-personal-protective-equipment-09192024-FINAL-CLEAN.pdf View LargerDownload Protect Yourself From H5N1 Bird Flu Wear Personal protective equipment Wondering how #H5N1 bird flu is spreading in dairy cows? This graphic illustrates what is currently known about how spread is happening. Find out more about the current H5N1 bird flu situation: H5 Bird Flu: Current Situation View LargerDownload H5N1 Bird Flu in Dairy Cows: How is it Spreading? This graphic illustrates what is currently known about how spread is happening. H5N1 bird flu is spreading in some farm animals like poultry and cows. Though rare, it can infect people. If you are around poultry, dairy cows or raw, unpasteurized milk, seek medical care if you get symptoms of bird flu: Fever Cough Sore Throat Muscle Aches Shortness of Breath Eye Redness Find out more about the signs of bird flu at https://bit.ly/3R7bYs2 View LargerDownload If you have signs of bird flu, fever, cough/sore throat, muscle aches, shortness of breath, eye redness, seek medical care.” Icons of a thermometer, person coughing, a muscle aching, a person experiencing shortness of breath, and eye redness get medical careShow More #H5N1 #birdflu is spreading in some farm animals like poultry and cows. Though rare, bird flu can infect people who are around these animals. Use protective gear when working with poultry, dairy cows or other animals that could be infected: Coveralls NIOSH® Approved respirator Goggles or eye protection Head cover Boots Gloves Learn the steps to stay safe at the link:https://bit.ly/3X3eIu7 View LargerDownload If you work with animals, use: coveralls, respirator, eye protection, head cover, boots/gloves to help protect yourself from bird flu.” Icons of coveralls, a NIOSH® approved respirator, goggles, a head cover and boots and gloves to help protect yourself from bird fluShow More Twitter Sample Message – Spanish Trabajadores de granja: si trabajan con vacas lecheras u otros animales que podrían tener influenza aviar, hay medidas que pueden tomar para reducir su riesgo de infectarse. Lean más aquí: Protéjase para no enfermarse si trabaja con ganado View LargerDownload Trabajadores de granja: si trabajan con vacas lecheras u otros animales que podrían tener influenza aviar, hay medidas que pueden tomar para reducir su riesgo de infectarse. La influenza aviar H5N1 se está propagando en animales como las aves de corral y las vacas, y puede infectar a las personas. Busca atención médica si tienes síntomas de influenza aviar: Fiebre Tos Dolor de garganta Dolores musculares Dificultad para respirar Enrojecimiento de los ojos Ve los signos de la influenza aviar en https://bit.ly/3LhZ8nH View LargerDownload Si tienes signos de influenza aviar, fiebre, tos/dolor de garganta, dolores en los músculos, dificultad para respirar, enrojecimiento de los ojos, busca atención médica La influenza aviar H5N1 se está propagando en animales como las aves de corral y las vacas. La influenza aviar puede infectar a las personas cerca de ellos. Usa protección cerca de animales que podrían estar infectados: Overoles Respirador aprobado por NIOSH® Gafas o protección para ojos Cubierta para cabeza Botas Guantes Ve cómo reducir tu riesgo: https://bit.ly/4cAhJH6 View LargerDownload Si trabajas con animales, usa overoles, respirador, protección para los ojos, cubierta para la cabeza, botas/guantes para ayudar a protegerte de la influenza aviar". Junto a su descripción se muestran los íconos de overoles, un respirador aprobado por NIOSH®, gafas protectoras, una cubierta para la cabeza y botas y guantes.Show More Facebook Sample Message – English If you work with dairy cows or other animals that could be infected with H5N1 bird flu, find out how to reduce your risk of infection. CDC has information for farm workers exposed to H5N1 bird flu in dairy cows or other animals. https://www.cdc.gov/bird-flu/prevention/farm-workers.html View LargerDownload CDC has information for farm workers exposed to H5N1 bird flu in dairy cows or other animals. H5N1 bird flu is spreading in poultry and cows. It's rare, but people can become infected too. Be careful working with animals that could be infected. Find out what precautions you can take to work safely around animals at https://bit.ly/3R7bYs2 View LargerDownload If you work with dairy cows, poultry, raw/unpasteurized milk, or wild animals protect yourself from bird flu. Facebook Sample Message – Spanish Si trabajan con vacas lecheras u otros animales que podrían tener la #InfluenzaAviar H5N1, tomen medidas para protegerse del riesgo de infectarse. Los CDC tienen información para trabajadores de granja expuestos al H5N1 en vacas lecheras u otros animales. Información para trabajadores de granjas expuestos a la influenza aviar H5N1 en vacas lecheras u otros animales en los EE. UU. View LargerDownload Información para trabajadores de granjas expuestos a la influenza aviar H5N1 en vacas lecheras u otros animales en los EE. UU. La influenza aviar está propagándose en aves de corral y vacas. Las personas también pueden infectarse. Cuídate al trabajar con animales que podrían estar infectados. Toma estas precauciones al trabajar cerca de animales: https://bit.ly/4cAhJH6 View LargerDownload Si trabajas con vacas lecheras, aves de corral, leche cruda/sin pasteurizar o animales silvestres, protégete de la influenza aviar Instagram Sample Message – English Wondering how #H5N1 bird flu is spreading in dairy cows? While the current risk to most people from H5N1 bird flu is low, people who have contact with infected or potentially infected animals are at higher risk and should take actions to protect themselves. Link in bio to stay up to date on the current H5N1 bird flu situation.#PublicHealth #BirdFlu #H5N1Link: https://www.cdc.gov/bird-flu/spotlights/bird-flu-update-052424.html View LargerDownload While the current risk to most people from H5N1 bird flu is low, people who have contact with infected or potentially infected animals are at higher risk and should take actions to protect themselves. Instagram Sample Message – Spanish ¿Te estás preguntando cómo el virus #H5N1 de la influenza aviar se está propagando en vacas lecheras? Si bien el riesgo actual de contraer el H5N1 de la influenza aviar es bajo para la mayoría de las personas, las que tienen contacto con animales infectados o posiblemente infectados están en mayor riesgo y deben tomar medidas para protegerse. Ve el enlace en la biografía para mantenerte al día sobre la situación actual de la influenza aviar H5N1. #SaludPública #InfluenzaAviar #H5N1 Actualización de los CDC sobre la respuesta a la influenza aviar A(H5N1), 24 de mayo, 2024 | Influenza (gripe) aviar View LargerDownload Si bien el riesgo actual de contraer el H5N1 de la influenza aviar es bajo para la mayoría de las personas, las que tienen contacto con animales infectados o posiblemente infectados están en mayor riesgo y deben tomar medidas para protegerse. LinkedIn Sample Messages – English Farm workers: When in contact with infected or potentially infected dairy cows, raw milk, other animals, or surfaces and other items that might be contaminated with #H5N1 bird flu virus, take action to reduce your risk of infection. View LargerDownload When in contact with infected or potentially infected dairy cows, raw milk, other animals, or surfaces and other items that might be contaminated with #H5N1 bird flu virus, take action to reduce your risk of infection. Wear personal protective equipment and learn how to put on and remove it safely. CDC recommends farm workers monitor their health for 10 days after their most recent exposure and contact their local health department if they get symptoms. Symptoms can include: Fever (Temperature of 100°F [37.8°C] or greater) or feeling feverish/chills* Cough Sore throat Difficulty breathing/shortness of breath Eye tearing, redness, or irritation Headaches Runny or stuffy nose Muscle or body aches Protect yourself by following these recommendations:https://www.cdc.gov/bird-flu/prevention/farm-workers.html There is currently a multistate outbreak of #H5N1 bird flu in dairy cows and poultry. CDC recommends protective measures for workers who are exposed to infected or potentially infected animals. LinkedIn Sample Messages – Spanish Trabajadores de granja: Cuando estén en contacto con vacas lecheras, leche cruda y otros animales infectados o posiblemente infectados, o con superficies y otros objetos que podrían estar contaminados con el virus #H5N1 de la influenza aviar, tomen medidas para reducir su riesgo de infectarse. View LargerDownload Protéjanse al seguir estas recomendaciones: Información para trabajadores de granjas expuestos a la influenza aviar H5N1 en vacas lecheras u otros animales en los EE. UU. Usen equipo de protección personal y sepan cómo ponérselo y quitárselo de manera segura. Los CDC recomiendan que los trabajadores de granja vigilen su salud durante 10 días después de su exposición más reciente y que contacten a su departamento de salud local si presentan síntomas. Los síntomas pueden incluir: Fiebre (temperatura de 100 °F [37.8 °C] o mayor) o sentirse afiebrado, o tener escalofríos* Tos Dolor de garganta Dificultad para respirar Ojos llorosos, enrojecidos o irritados Dolor de cabeza Moqueo o congestión nasal Dolores en los músculos o el cuerpo Protéjanse al seguir estas recomendaciones: Información para trabajadores de granjas expuestos a la influenza aviar H5N1 en vacas lecheras u otros animales en los EE. UU. Actualmente, hay un brote multiestatal de influenza aviar #H5N1 en vacas lecheras y aves de corral. Los CDC recomiendan medidas de protección para trabajadores que podrían estar expuestos a animales infectados o posiblemente infectados. View LargerDownload Protéjase del virus H5N1 si trabaja con animales de granjaEl H5N1 es un virus de la influenza aviar que podría enfermarlo. Recomendaciones provisionales actualizadas para la protección de los trabajadores y el uso del equipo de protección personal (EPP) para disminuir la exposición a los nuevos virus de la influenza aviar tipo A asociados a enfermedades en los seres humanos | Influenza (gripe) aviar People with exposure to infected birds Share the below prevention messages online or on social media. Twitter Sample Messages – English Per CDC, H5 #birdflu virus infections in US wild birds/poultry pose a low risk to the public. People very rarely get sick with bird flu, but those with work or recreational exposures to infected birds/poultry should take precautions:https://www.cdc.gov/bird-flu/prevention/ If you work with poultry infected with H5 bird flu virus, you are at higher risk of getting sick w/ bird flu yourself. CDC recommends poultry workers take precautions, including proper use of personal protective equipment to minimize your exposure risk. https://www.cdc.gov/bird-flu/prevention/ View LargerDownload If you work with poultry infected with H5 bird flu virus, you are at higher risk of getting sick w/ bird flu yourself. CDC recommends poultry workers take precautions, including proper use of personal protective equipment to minimize your exposure risk.Show More Twitter Sample Messages – Spanish CDC: las infecciones de influenza aviar reportadas en aves de corral y silvestres en EE. UU. presentan un riesgo bajo para el público. Es raro que las personas se enfermen, pero las que tengan más exposición a aves infectadas deberían tomar precauciones:https://espanol.cdc.gov/bird-flu/prevention/ Hay brotes actuales de influenza aviar en aves de corral y silvestres en los EE. UU. Si trabajas con aves infectadas, tienes un riesgo mayor de exposición a la influenza aviar. Los CDC recomiendan que los trabajadores avícolas tomen precauciones: https://espanol.cdc.gov/bird-flu/prevention/ People with backyard poultry Share the below prevention messages online or on social media. Twitter Sample Message #DYK there are ongoing outbreaks of H5 bird flu in US birds? If you have backyard poultry, learn how to protect them and yourself against bird flu. While human infections are rare, CDC recommends precautions for people w/ exposure to infected birds: https://www.cdc.gov/bird-flu/prevention/ View LargerDownload If you have backyard poultry, learn how to protect them and yourself against bird flu. Facebook Sample Message Did you know there are ongoing outbreaks of H5 bird flu in wild birds and poultry in the United States? CDC recommends people with exposure to infected birds take precautions to avoid bird flu virus infection, even though human infections are rare. If you have a backyard poultry flock, protect your poultry and yourself against bird flu. Instagram Sample Message Did you know there are ongoing outbreaks of H5 bird flu in wild birds and poultry in the United States? CDC recommends people in contact with infected birds take precautions to avoid bird flu virus infection, even though human infections are rare. If you have a backyard poultry flock, protect your poultry and yourself against bird flu. https://www.cdc.gov/bird-flu/prevention/ #FightFlu #PublicHealth View LargerDownload CDC recommends people in contact with infected birds take precautions to avoid bird flu virus infection, even though human infections are rare. Print resources Bird Flu Print Materials and Tools‎ CDC has avian influenza (bird flu) materials and tools to help educate and inform the public about bird flu, including fact sheets, posters, and infographics. These resources aim to promote awareness and understanding of bird flu prevention, protection, and transmission. Access more bird flu resources On This Page People with exposure to infected or potentially infected cows People with exposure to infected birds People with backyard poultry Print resources August 2, 2024 Sources Print Share Facebook LinkedIn Twitter Syndicate Content Source: National Center for Immunization and Respiratory Diseases (NCIRD) Bird Flu Avian influenza or bird flu refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. View All For Everyone Current Situation Monitoring Current Situation About Bird Flu in Animals and People Prevention Backyard Flock Owners: Protect Yourself from Bird Flu Avian Influenza Social Media Toolkit H5N1 Informational Videos View all Health Care Providers Case Definitions for Investigations of Human Infection with Avian Influenza A Viruses in the United States Clinical Overview Interim Guidance on the Use of Antiviral Medications for Treatment of Human Infections with Novel Influenza A Viruses Associated with Severe Human Disease View All Public Health H5N1 Bird Flu: Current Situation Summary Public Health Strategies for Bird Flu Interim Guidance on Specimen Collection and Testing for Patients with Suspected Infection with Novel Influenza A Viruses Associated with Severe Disease or with the Potential to Cause Severe Disease in Humans View All Sign up for Email Updates Contact Us Contact Us Call 800-232-4636 Contact CDC About CDC About CDC Organization Budget & Funding Careers & Jobs Policies Accessibility External Links Privacy Web Policies FOIA OIG No Fear Act Nondiscrimination Vulnerability Disclosure Policy Languages Languages EspaÃ±ol Language Assistance EspaÃ±ol ç¹é«ä¸­æ Tiáº¿ng Viá»t íêµ­ì´ Tagalog Ð ÑÑÑÐºÐ¸Ð¹ Ø§ÙØ¹Ø±Ø¨ÙØ© KreyÃ²l Ayisyen FranÃ§ais Polski PortuguÃªs Italiano Deutsch æ¥æ¬èª ÙØ§Ø±Ø³Û English Archive CDC Archive Public Health Publications Contact Us Contact Us Call 800-232-4636 Contact CDC About CDC Organization Budget & Funding Careers & Jobs About CDC Policies Accessibility External Links Privacy Web Policies FOIA OIG No Fear Act Nondiscrimination Vulnerability Disclosure Policy Languages Languages EspaÃ±ol Language Assistance EspaÃ±ol ç¹é«ä¸­æ Tiáº¿ng Viá»t íêµ­ì´ Tagalog Ð ÑÑÑÐºÐ¸Ð¹ Ø§ÙØ¹Ø±Ø¨ÙØ© KreyÃ²l Ayisyen FranÃ§ais Polski PortuguÃªs Italiano Deutsch æ¥æ¬èª ÙØ§Ø±Ø³Û English Archive CDC Archive Public Health Publications HHS.gov USA.govNew initiative launched to advance mRNA vaccine development against human avian influenza (H5N1) Skip to main content World Health Organization Global Regions World Health Organization WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. Select language Select language English العربية 中文 Français Русский Español Português Donate Donate Home Health Topics All topicsABCDEFGHIJKLMNOPQRSTUVWXYZ Resources Fact sheets Facts in pictures Multimedia Podcasts Publications Questions and answers Tools and toolkits Popular Dengue Endometriosis Excessive heat Herpes Mental disorders Mpox Countries All countriesABCDEFGHIJKLMNOPQRSTUVWXYZ Regions Africa Americas Europe Eastern Mediterranean South-East Asia Western Pacific WHO in countries Data by country Country presence Country strengthening Country cooperation strategies Newsroom All news News releases Statements Campaigns Events Feature stories Press conferences Speeches Commentaries Photo library Headlines Emergencies Focus on Cholera Coronavirus disease (COVID-19) Greater Horn of Africa Israel and occupied Palestinian territory Mpox Sudan Ukraine Latest Disease Outbreak News Situation reports Weekly Epidemiological Record WHO in emergencies Surveillance Operations Research Funding Partners Health emergency appeal International Health Regulations Independent Oversight and Advisory Committee Data Dashboards Triple Billion Progress Health Inequality Monitor Delivery for impact COVID-19 dashboard Data collection Classifications SCORE Surveys Civil registration and vital statistics Routine health information systems Harmonized health facility assessment GIS centre for health Reports World Health Statistics UHC global monitoring report About WHO About WHO Partnerships Committees and advisory groups Collaborating centres Technical teams Organizational structure Who we are Our work Activities Initiatives General Programme of Work WHO Academy Funding Investment in WHO WHO Foundation Accountability External audit Financial statements Internal audit and investigations Programme Budget Results reports Governance Governing bodies World Health Assembly Executive Board Member States Portal Home/ News/ item/ New initiative launched to advance mRNA vaccine development against human avian influenza (H5N1) Medicines Patent Pool / Rodger Bosch A laboratory technician at work at Afrigen in Cape Town, South Africa © Credits New initiative launched to advance mRNA vaccine development against human avian influenza (H5N1) 29 July 2024 Joint News Release Geneva, Switzerland Reading time: A new project aiming to accelerate the development and accessibility of human avian influenza (H5N1) messenger RNA (mRNA) vaccine candidates for manufacturers in low- and middle-income countries has been launched today. The Argentinian manufacturer Sinergium Biotech will lead this effort leveraging the World Health Organization (WHO) and the Medicines Patent Pool (MPP) mRNA Technology Transfer Programme.The mRNA Technology Transfer Programme, jointly developed by WHO and MPP, was launched in July 2021 with the aim to build capacity in low- and middle-income countries (LMICs) for the development and production of mRNA-based vaccines. Sinergium Biotech, a partner in the mRNA Technology Transfer Programme, has developed candidate H5N1 vaccines and aims to establish proof-of-concept in preclinical models. Once the preclinical data package is concluded, the technology, materials, and expertise will be shared with other manufacturing partners, aiding the acceleration of the development of H5N1 vaccine candidates, and bolstering pandemic preparedness efforts. "This initiative exemplifies why WHO established the mRNA Technology Transfer Programme – to foster greater research, development and production in low- and middle-income countries, so that when the next pandemic arrives, the world will be better prepared to mount a more effective and more equitable response," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General."When we created the mRNA Technology Transfer Programme with WHO, our goal was to enable low- and middle-income countries to lead development efforts, foster collaboration, share resources, and disseminate knowledge,” said Charles Gore, Executive Director of MPP. “This project embodies our vision and demonstrates a strong commitment to future pandemic preparedness and response."Avian influenza viruses are a significant public health risk due to their widespread circulation in animals and potential to cause a future pandemic. This development supplements ongoing work under the Pandemic Influenza Preparedness Framework to improve and strengthen the sharing of influenza viruses with human pandemic potential and increasing LMIC access to vaccines.“This announcement underscores the importance of not only geographically diversifying the innovation and production of health technologies including and recognizing the capacities in Latin American and the Caribbean, but also the importance of early planning for access and the sharing of knowledge and technologies during the research and development processes," said Dr Jarbas Barbosa, Director of the Pan American Health Organization. Dr Alejandro Gil, Chief Executive Officer of Sinergium, said, "Sinergium’s enhanced capacity and readiness to apply our expertise to H5N1 will play a vital role in this effort towards global pandemic preparedness. I would also like to thank PAHO who have also been instrumental through the strong support it offers to regional manufacturers in the Americas. We are excited to tackle this public health challenge and our R&D team will continue to work closely with the Programme Partners."Since its inception, the mRNA Technology Transfer Programme has developed and implemented a platform that was used to establish the immunogenicity, efficacy, and safety of a COVID-19 vaccine candidate in preclinical animal models. Afrigen is the centre where the platform was created and is being validated and this technology is now being transferred to manufacturing partners to adapt and enhance it for other critical disease targets. The progress made by the mRNA Technology Transfer Programme is a vital part of WHO and MPP’s efforts to improve the availability, access, and use of mRNA vaccines for better vaccine equity globally. Media Contacts WHO Media Team World Health Organization Email: mediainquiries@who.int Related The mRNA vaccine technology transfer hubWHO's work on avian and other zoonotic influenzaQuestions and answers: Avian influenza Fact sheets Influenza (Avian and other zoonotic) 3 October 2023 Regions Africa Americas Eastern Mediterranean Europe South-East Asia Western Pacific Policies Cybersecurity Ethics Information disclosure Permissions and licensing Preventing sexual exploitation Terms of use About us Careers Frequently asked questions Library Newsletters Procurement Publications Contact us Report misconduct Privacy policy © 2024 WHOMachine learning approaches for influenza A virus risk assessment identifies predictive correlates using ferret model in vivo data | Communications Biology Skip to main content Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement View all journals Search Log in Explore content About the journal Publish with us Sign up for alerts RSS feed nature communications biology articles article Machine learning approaches for influenza A virus risk assessment identifies predictive correlates using ferret model in vivo data Download PDF Download PDF Article Open access Published: 01 August 2024 Machine learning approaches for influenza A virus risk assessment identifies predictive correlates using ferret model in vivo data Troy J. Kieran ORCID: orcid.org/0000-0002-3711-07271, Xiangjie Sun ORCID: orcid.org/0000-0002-9872-13371, Taronna R. Maines ORCID: orcid.org/0000-0002-4097-67241 & …Jessica A. Belser ORCID: orcid.org/0000-0002-0755-73681 Show authors Communications Biology volume 7, Article number: 927 (2024) Cite this article 1044 Accesses 1 Citations 6 Altmetric Metrics details Subjects Influenza virusMachine learning AbstractIn vivo assessments of influenza A virus (IAV) pathogenicity and transmissibility in ferrets represent a crucial component of many pandemic risk assessment rubrics, but few systematic efforts to identify which data from in vivo experimentation are most useful for predicting pathogenesis and transmission outcomes have been conducted. To this aim, we aggregated viral and molecular data from 125 contemporary IAV (H1, H2, H3, H5, H7, and H9 subtypes) evaluated in ferrets under a consistent protocol. Three overarching predictive classification outcomes (lethality, morbidity, transmissibility) were constructed using machine learning (ML) techniques, employing datasets emphasizing virological and clinical parameters from inoculated ferrets, limited to viral sequence-based information, or combining both data types. Among 11 different ML algorithms tested and assessed, gradient boosting machines and random forest algorithms yielded the highest performance, with models for lethality and transmission consistently better performing than models predicting morbidity. Comparisons of feature selection among models was performed, and highest performing models were validated with results from external risk assessment studies. Our findings show that ML algorithms can be used to summarize complex in vivo experimental work into succinct summaries that inform and enhance risk assessment criteria for pandemic preparedness that take in vivo data into account. Similar content being viewed by others An aggregated dataset of serial morbidity and titer measurements from influenza A virus-infected ferrets Article Open access 17 May 2024 Early prognosis of respiratory virus shedding in humans Article Open access 25 August 2021 Forecasting COVID-19 spreading through an ensemble of classical and machine learning models: Spain’s case study Article Open access 25 April 2023 IntroductionMachine learning (ML), a subset of artificial intelligence, has attracted significant interest for its transformative potential across industries, including infectious disease risk assessment1,2. By analyzing vast amounts of data and identifying complex patterns, ML algorithms can provide valuable insights and predictions across biological and microbiological research3,4. These algorithms allow computers to learn and make predictions from data, enhancing performance by recognizing patterns and relationships, which can be particularly valuable in tasks such as disease diagnosis and risk assessment through the analysis of large datasets5. In the case of influenza A viruses (IAV), ML algorithms can predict host susceptibility and transmission dynamics by considering factors such as genetics, host characteristics, and environmental parameters6,7, enabling the identification of critical determinants that influence host-virus interactions. However, while selected studies have trained and tested models to predict outcomes of in vivo experimentation with IAV8,9,10,11, few efforts have been conducted to date that formally include data from in vivo experimentation in model training datasets12, and only infrequently have included viral titer-based or clinical parameters from experimentally inoculated animals13.The CDC and WHO have established public health risk assessment tools which aid pandemic preparedness efforts, and are informed in part by data generated in vivo14,15. These multi-attribute, additive rubrics provide quantitative approaches to assess the relative impact and emergence of newly identified IAV, to inform resource allocation, development of candidate vaccine viruses, and other public health decisions. However, these tools are not predictive. There is a need for studies to identify not only viral properties and molecular determinants which contribute to key infection outcomes (notably disease severity and transmissibility)16,17,18, but to further assess the relative ability of quantifiable datapoints to predict these outcomes on a more rapid timeframe after viral isolation. While ML algorithms have been employed in the context of IAV risk assessment activities, including in healthcare settings19, poultry farms20, and surveillance of wild bird populations21, studies specifically employing both in vivo and viral metadata which formally contribute to risk assessment rubrics evaluating the emergence and spread of pre-pandemic IAV have not been conducted to date.Ferrets are frequently employed to inform IAV pandemic risk assessment rubrics as, unlike other small mammalian models, this species permits the coincident study of IAV pathogenesis and transmission22. Many laboratories worldwide employ ferrets to study these multifactorial traits, but heterogeneity in experimental designs and other confounders limits the capacity to perform meta-analyses from data collected across different institutions23,24. Furthermore, the relatively small sample size of ferret experiments (e.g., n = 3 or 4 transmission pairs per virus tested) precludes robust statistical analyses from most studies in isolation25,26. For these reasons, despite the critical role played by this species, there have been comparatively few studies performed that examine trends in aggregated in vivo-generated data16,17,18,27,28,29; these analyses have been generally limited to statistical assessments and linear models, with few predictive modeling studies performed.To this aim, we aggregated ferret pathogenesis and transmission data collected for risk assessment purposes over a 25-year span, to evaluate which ML algorithms are best suited for in vivo-generated data, and which phenotypic outcomes from in vivo experimentation are most accurately predicted via ML. Once high-performing classification models for lethality and transmission outcomes were established, we tested these models with externally generated risk assessment data from the published literature to validate classification outcomes. Collectively, our findings support that ML algorithms can permit identification of features generated from in vivo experimentation which have high predictive value and can ascertain which molecular features most faithfully predict mammalian phenotypic outcomes in the absence of in vivo experimentation.ResultsSource data and supervised classification models testedFerrets (n = 717) were inoculated with an extensive panel of 125 unique influenza A viruses (Supplemental Table 1) by standard high-dose intranasal instillation, with multiple virological and clinical parameters captured post-inoculation as specified in the methods. Informed by these data, three overarching supervised classification models (lethality, morbidity, and transmissibility) were developed to classify and predict, on a per-ferret basis, a binary outcome (yeso for lethality, yeso for high weight loss, ≥50%/<50% for transmission in a respiratory droplet setting) from aggregated ferret data (Fig. 1). Each classification model was trained on three different source data types emulative of information generated during standard risk assessment activities (see Table 1 for key features included in models and rationale for inclusion). The standard data type included viral titer and clinical symptoms obtained from virus-inoculated ferrets, sequence-predicted receptor-binding preference and polymerase activity, with limited other metadata. The molecular only data type included no data from virus-inoculated ferrets and was informed solely by sequence-based and other viral metadata available prior to in vivo experimentation. A combined data type pooled all available data parameters from both standard and molecular data sets. Details of all 9 models evaluated are presented in Table 2.Fig. 1: Analysis workflow for generation of models employing machine learning algorithms.IAV metadata and results from in vivo experimentation are collected from pathogenicity (to inform lethality and morbidity classifications, top left depiction) and respiratory droplet transmissibility (to inform transmission classification, top right depiction) experiments in ferrets. Extensive data preprocessing was conducted to train numerous supervised classification models (encapsulating 11 different ML algorithms) and assess relative model performance. Final model selection led to additional model training and tuning, with all chosen models tested with both internally generated data and several external datasets for validation purposes. Illustrations in this figure were generated by the US Centers for Disease Control and Prevention.Full size imageTable 1 Summary of key features used to train classification models on different outcome variablesFull size tableTable 2 Description of supervised classification models trained and tested in this studyFull size tableIterative testing of disparate machine learning algorithmsML algorithms can vary in the relative weight they give different parameters, leading to variability in outcomes and overall performance metrics. Due to a paucity of previously assessed models employing in vivo data in the context of viral infection, and a systemic lack of head-to-head comparisons of ML performance metrics when employing virological data, we chose to test a panel of 11 different ML algorithms spanning several different ML families (see methods) against all 9 model iterations described above. For each of the 11 ML algorithms tested, multiple iterations of feature selection were tested (Supplementary Data 1), with final model selection informed by assessing 14 performance metrics (area under the curve [AUC], accuracy, balanced accuracy, detection rate, F1, kappa, negative prediction value, positive prediction value, precision, recall, sensitivity, specificity, logarithmic loss, precision-recall AUC), with a focus on balanced accuracy, sensitivity, specificity, and F1 score. A full scope of all metrics calculated, for each feature iteration, for each model, are presented in Supplementary Data 2–7. An example is provided in Fig. 2 showing one performance metric (balanced accuracy) for 4 of the 11 ML algorithms across each iteration of features tested (Supplementary Data 1) for the L1 model (lethality standard). Employing these metrics for all 9 models evaluated, we found a range of variability between the ML algorithm employed and selected features informing each model. However, these assessments identified a consistent trend of top performing (gbm, nnet, rf, ranger) and low performing (glm, rpart) algorithms independent of the outcome metric assessed. Based on these metrics, a final algorithm of gradient boosting (gbm) was selected for lethality and morbidity models, while random forest (rf) was selected for transmission models. The top three features for each final model are presented in Table 2 and discussed in more detail below. Subsequent refinement of all classification models was performed with hyperparameter tuning (Supplementary Data 8) using the sample metrics for finalized model selection.Fig. 2: Comparison of lethality standard model balanced accuracy and feature selection iterations.A Heat map depicting balanced accuracy performance metrics of four ML algorithms (support vector machine (svm), decision trees (rpart), random forest (rf), and gradient boosting (gbm)) for the lethality standard (L1) model employing different feature selection. Values range from 0 (worst, green) to 1 (best, purple). B Feature inclusion for ML algorithms shown. Purple, feature inclusion; green, feature exclusion. All L1 models include AUC_6, MBAA, RBS, and PA features (not shown). Origin_orig: Virus host origin (human, variant, avian, swine, canine), based on lineage (not species of isolation). Origin: Binary virus host origin (avian or mammalian, see methods for definition). Temp: peak rise in pre-inoculation temperature (in degrees C) over 14 days p.i. (temp) or over first 5 days p.i. only (temp_5). slope1,3: measurement of virus growth or decay in NW specimens between days 1 and 3 p.i. peak_inoc: peak NW titer over days 1–6 p.i. HA: IAV HA subtype only. Subtype: IAV HA and NA subtypes combined. Feature definitions are also shown and provided in Supplemental Fig. 1 and Supplementary Data 1. Full scope of all model metrics and feature selections for models described in Table 2 are reported in Supplementary Data 2–7.Full size imageAssessments of final model performance and comparisonOnce final algorithm selection was determined, we next examined in depth the relative performance of all 9 models (lethality, morbidity, and transmissibility, with standard, molecular or combined data types), with a focus on balanced accuracy, sensitivity, specificity, and F1 score metrics. Balanced accuracy was >0.9 among lethality classification models employing a tuned gradient boosting ML algorithm, with the standard (L1) model consistently showing the highest balanced accuracy (0.9314) followed closely by the combined (L1M) and molecular (LM) models (Fig. 3, Supplementary Data 2, 3), demonstrating that all models independent of training data type could accurately categorize both positive (no lethality) and negative (yes lethality) cases among our internal data test sets. Sensitivity values were also >0.92 across all lethality models, emphasizing model competence in correctly recognizing true positive outcomes. Specificity values exhibited greater variability between lethality models but still demonstrated the ability of all lethality models to accurately classify negative events with values of 0.9394 (L1), 0.8788 (LM1), and 0.8485 (LM). The F1 score, a metric that balances recall and precision, was >0.95 across all models, further supporting that all lethality models could correctly balance detection of positive events with a reduction in false positives independent of the data type employed for training.Fig. 3: Performance metrics for lethality, morbidity, and transmission classification models.Heat map depicting 9 performance metrics and the probability of prediction threshold determined for 9 models including standard data (L1, M1, T1), molecular only (LM, MM, TM), and combined data types (L1M, M1M, T1M). All 9 model iterations are presented in Table 2. Values range from -1 (no agreement) to 1 (agreement) (MCC, Kappa) or 0 (worst, green) to 1 (best, purple) (all other metrics).Full size imageWhile the lethality models were found to be generally robust, models assessing morbidity (as measured by maximum weight loss of virus-inoculated ferrets) underperformed. For morbidity, the standard (M1) model was evaluated using the random forest algorithm of a stack of the top individually performing models (neural net, ranger, and gradient boosting), while molecular (MM) and combined (M1M) models employed a tuned gradient boosting algorithm (Supplementary Data 8). Balanced accuracy was consistently very similar across all three morbidity models (0.7492-0.7666) (Fig. 3, Supplementary Data 4, 5). Specificity and sensitivity values were consistent and balanced for M1 (0.75, 0.7485) and M1M (0.7692, 0.7362) respectively, while model MM had more specificity (0.8462) at the cost of sensitivity (0.6871), resulting in consistent balanced accuracy as shown above. The F1 score followed a similar pattern with values ranging from 0.7915 (MM) to 0.8188 (M1). While the stacked model algorithms were the best performing, improvement over the top individually performing algorithms for morbidity was negligible.For virus transmission by respiratory droplets, standard (T1), molecular (TM), and combined (T1M) models were finalized using a tuned random forest algorithm (Supplementary Data 8), but several others (such as ranger, gradient boosting, and neural net) were comparable competitors. Similar to lethality classification models, all transmission models were very predictive when tested with internally generated data, with balanced accuracy >0.95 for all three models (Fig. 3, Supplementary Data 6, 7). All models possessed maximum specificity, with very high sensitivity values of 0.9726 (T1M), 0.9577 (T1), and 0.9178 (TM). This pattern was similar, with maximum precision and high recall values, resulting in consistently high F1 scores >0.95 independent of the data type employed for model training.To further compare relative model performance, we employed Matthew’s Correlation Coefficient (MCC), a metric that considers true negatives and positives, and false negatives and positives, producing a high score if only good predictive rates are found for each category. The MCC score ranges from −1 (complete misclassification) to 1 (perfect classification), with zero values being random classification. In agreement with other performance metrics discussed above, MCC supported that transmission classification models were the most accurate, followed by lethality, then morbidity models which performed comparatively poorly (Fig. 3). All three transmission models had MCC values > 0.9. Lethality models had lower MCC values relative to transmission models (ranging from 0.7424 to 0.8114), with the combined L1M model more accurate than either standard (L1) or molecular only (LM) models alone. In contrast, morbidity models were not very accurate, with MCC values < 0.5 (0.4416–0.4598) for models trained on any data type.In conclusion, transmission classification models had the overall highest performance metrics and were very accurate in predictive outcomes when employing internally generated data. Lethality classification models offered similarly high performance with reasonable predictive ability. In contrast, morbidity classification models offered minimal predictive capabilities. Within each classification model, the combined standard and molecular data type models offered the highest predictive value for transmission (T1M) and lethality (L1M), illustrating the usefulness of combining these two types of data for training of ML algorithms.Feature importance for each modelWe next examined in more detail the specific features of each model. As shown in Fig. 4A, all three classification models employing the standard data type (L1, M1, T1) shared several common features (area under the curve days 1–6 [AUC_6], hemagglutinin [HA], polymerase activity [PA], receptor binding preference [RBS], all features defined in Supplementary Data 1), with variability among other features present depending on the classification. Both L1 and M1 models included the absence or presence of a multi-basic amino acid HA cleavage site (MBAA) and a temperature input; in contrast, T1 included features (Origin, slope1,3) not present in highest-performing lethality or morbidity models. RBS, PA, HA, and Origin were included in all combined data type models regardless of classification, further highlighting the critical and multifactorial role many of these features contribute to viral pathogenicity and transmissibility outcomes.Fig. 4: Variability in feature selection among different models employing standard data type.A Feature inclusion (purple) or exclusion (green) for lethality (L1), morbidity (M1), and transmission (T1) models employing the standard data type. Individual feature definitions are provided in Supplementary Data 1. B Relative ranked importance of top numeric features included in L1, M1, and T1 models. C Relative ranked importance of human (H), dual (D), or avian (A) predicted receptor binding preference in L1, M1, and T1 models. Relative ranked performance among features of all models is shown in Supplementary Data 9–14, Supplementary Data 10, 12, and 14 contain ranked importance results for models trained with molecular datasets. Relative ranked importance values are set to 100 for the most important feature and scaled to relative importance for remaining features independently within each model. For each model in (B, C) features are consistently scaled but separated out for visual purposes.Full size imageAmong lethality models, standard and combined models had comparable features, with weight loss followed by MBAA the highest ranked features for both L1 and L1M (Table 2, Fig. 4B) (Supplementary Data 9, 10). In contrast, while included in the highest-performing models, predicted receptor binding preference and HA subtype had minimal contributing impact. Highest importance features of the LM molecular model were HA positions 214 V, 160 T, and 496 R (H3 HA numbering throughout).Morbidity models also showed similar features of importance across the standard and combined models (Supplementary Data 11, 12). Both M1 and M1M models shared area under the curve of days 1–6 (AUC_6), temperature (temp_5), and MBAA as the three features of highest importance (Table 2). Receptor binding preference, polymerase activity, and HA subtype were less impactful, but notably important. Molecular position HA-227S had the highest importance in the MM molecular only model and was moderately important in the combined model; positions HA-196Q and PB2-627K were also highly ranked features across both molecular and combined models. Like the L1M model, in the combined M1M model, the highest ranked features were derived from in vivo experimentation (AUC_6, temp_5) and not sequential data.With the transmission standard model (T1), day 1–6 titer area under the curve showed the highest importance, followed by slope1,3, H5 subtype, and RBS (Table 2, Fig. 4B); polymerase activity (PA) had minimal influence (Supplementary Data 13–14). For the TM molecular only model, PB2-627E, HA-138A, and HA-21S had the strongest impact. Interestingly, unlike L1M and M1M combined models, the most impactful features of the combined T1M model were derived from molecular-based and not in vivo-derived data (Table 2).Assessments of relative ranked importance between the three classification models employing similar data types further highlights the variable strength ML algorithms consider different features. AUC_6 was among the top three ranked features across all standard data type classification models but was substantially less critical in the lethality model (L1) than either M1 or T1, where wt_loss was the most important feature (Fig. 4B). Interestingly, among categorical features such as predicted receptor binding preference, models differentially weighted specific variables within a feature (Fig. 4C). For example, while both M1 and T1 models had RBS as a comparable weighted feature across both models (with categorical responses of avian, human, or dual predicted binding), avian binding was highest ranked in the morbidity standard model among the three responses yet lowest ranked in the transmission standard model. Collectively, close attention to which features are included/excluded from different classification models sourced from different data types, as well as the relative ranked importance of features within each model, provides valuable context towards understanding the drivers of the phenotypic outcomes predicted by these ML algorithms.Validation of model predictive metrics on simulated and externally generated in vivo dataThe findings discussed above support that the lethality and transmission models had high performance metrics trained from our primary dataset of in vivo experimentally-generated data, but it was unknown if this high performance would be maintained when testing data was generated under conditions that diverged from the training data. We first evaluated the performance of models informed by in vivo data metrics (standard lethality and morbidity), by testing data generated from ferret inoculations with two H1N1 IAV from 11 different laboratories (n = 88)24, or from simulated values based upon our primary dataset (Table 2) (see methods). Overall, performance metrics from the H1N1 (L1-H1N1) and simulated (L1-sim) data were generally comparable to those obtained with our primary dataset, with a noticeable consistency in some and a decrease in other model metrics (Fig. 5). For L1-H1N1, balanced accuracy (0.821) was less than L1 (0.9314), while sensitivity (0.9753) and F1 (0.9814) were higher than the L1 model (0.9235 and 0.9548, respectively). However, specificity (0.6667) had a noticeable drop, also impacting the MCC (0.5594). Metrics for L1-sim were not too dissimilar from L1 but with an increase in specificity (0.7264) and MCC (0.645), and a decrease in sensitivity (0.9061) and F1 (0.8927).Fig. 5: Performance metrics for models tested with externally generated data.Heat map depicting 9 performance metrics and the probability of prediction threshold determined for models including standard data (L1, M1) and molecular only data (LM, TM) from three externally generated datasets (H1N1, sim, pub) as described in Table 2 and the methods. Values range from -1 to 1 (MCC, Kappa) or 0 (worst, green) to 1 (best, purple) (all other metrics).Full size imageConsistent with other morbidity models, both the H1N1 (M1-H1N1) and simulated (M1-sim) data performed poorly and consistently worse than the M1 model tested with the primary dataset across metrics (Fig. 5). The simulated data, while not very accurate (0.227) performed better over the H1N1 data which was a random prediction (0.0803). These results support that our well performing lethality L1 model (which includes features derived from in vivo experimentation) maintained high performance metrics when data were generated under a consistent protocol in-house or when certain inclusion criteria were met between laboratories providing data, despite limitations in the H1N1 dataset due to limited sample size and viral diversity (Table 2); use of simulated data provided a secondary validation approach to overcome these limitations, despite being inherently unrealistic compared to the primary dataset presented here.To rigorously evaluate the performance of models informed by molecular features alone (lethality LM, and transmission TM models), we tested these models for lethality (LM-pub) and transmission (TM-pub) with a dataset of previously published data sourced from 68 publications external to our group that employed comparable experimental conditions as our primary dataset (Supplementary Data 18). Strikingly, results from the LM-pub model, tested on ferret lethality outcomes following in vivo experimentation by external research groups only, performed comparably well to all lethality models tested with our primary dataset (Fig. 5). We found comparable high balanced accuracy between LM-pub and LM models (0.888 and 0.9051, respectively) consisting of near equal sensitivity (0.9036 and 0.9617, respectively) and specificity (0.8723 and 0.8485, respectively). The outcome between LM-pub and LM also had a high F1 (0.9417 and 0.967) and a slightly diminished MCC (0.6283 and 0.7424) driven by higher false positives. In contrast, the TM-pub model performed poorly (balanced accuracy, 0.4453) and showed a near random prediction with a slight misclassification bias (MCC, −0.1097) for classification outcomes, suggesting that the TM did not perform well with independent data, likely due to model overfitting on the internal training data. Collectively, we found that our LM, but not TM model, maintained high predictive accuracy with externally generated data from a variety of independent laboratories, underscoring the importance of including external data sets when validating ML models.DiscussionApplication of ML approaches in public health settings has escalated in recent years, with increasing use of these algorithms to study a diversity of zoonotic pathogens, including respiratory viruses such as IAV and SARS-CoV-230. In this vein, numerous studies have employed ML models to assess considerations regarding pandemic risk of IAV31,32,33. However, these approaches to date have typically employed molecular sequence data and/or epidemiologic data in their assessments. As in vivo models are employed in IAV pandemic risk assessment rubrics14,15, we sought to determine the predictive utility of in vivo data generated for this purpose in a ML context. Our study examined three model outcome variables (lethality, morbidity, and transmission), chosen to represent the most key questions addressed by in vivo experimentation using the ferret model in this setting. While using ML approaches to predict phenotypic outcomes itself is not novel, no studies to date have attempted to assess virus transmissibility phenotypic outcomes, nor validated successful ML approaches of lethal outcome with wholly independent data culled from the published literature. We found that ML approaches can offer high predictive value when informed by diverse in vivo-generated data but vary widely in performance metrics and applicability for wider use depending on the classification outcome chosen. Predicated on the exploratory analyses which underlie the choice of parameters selected for inclusion in our ML algorithms17, we show the informative role feature selection may contribute towards identifying the most critical values obtained from in vivo risk assessment work. Ultimately, this work provides additional understanding regarding the biological processes governing key phenotypic outcomes of mammalian IAV infection, and supports that inclusion of in vivo-derived parameters may offer refinements and advantages in strengthening the predictive nature of ML approaches in the context of IAV pandemic preparedness.There are a diversity of supervised classification ML algorithms available for use. We chose 11 models to represent examples of some of the most frequently employed algorithms which employ different strategies for outcome classification4. Interestingly, we observed high consistency among our individual top performing and low performing models among the lethality, morbidity, and transmission classification models developed, likely because all models employed similar testingraining source datasets. While an in-depth assessment of subtle differences between the ML algorithms employed lies outside of this study, it is interesting that models based on recursive partitioning & regression trees and a flexible linear regression model were low performing, whereas ensemble learning methods (gradient boosting, random forest) were among the highest performing, with our in vivo-generated datasets. Similarities in our top performing models with the top performers from recent studies assessing phenotypic predictors from IAV genotypic data6,34 is of particular note; it will be interesting to see if future studies employing in vivo-derived pathogenicity and transmissibility data are similarly best suited for analysis using these families of algorithms. Data generated from the ferret model has been used in ML settings previously to predict gastrointestinal states (employing k-nearest neighbor and support vector machine)35, or to predict phenotypic brain injury (employing an unsupervised method called k-means clustering)36; neither study investigated phenotypic outcomes following viral challenge. Of note, Einav and Ma12 developed a ML framework of regression random forests that used hemagglutinin titers (generated in part from influenza virus-inoculated ferrets) to predict influenza virus antibody-serum interactions, but did not include additional phenotypic features from in vivo experimentation. They found high predictability between datasets with different methodologies, illustrating the utility of ML to extrapolate unknown data from disparate information, and a framework that could be applied to other features and predictive outcomes.Most studies employing ML algorithms to assess predictive phenotypic traits following IAV infection have employed molecular data only or been limited to within-host classification outcomes6,8,9. A recent study by Jhutty et al. incorporated serially-collected viral load, hematology analyses, and lung cytokine values from IAV-infected mice as inputs to forecast in vivo IAV infection parameters from blood sample data, employing five regression ML algorithms, include a few used herein13. However, this study employed one IAV strain only, and conducted independent model validation employing more recent data collection with identical conditions to the testing dataset. Our study is novel in that we tested three phenotypic within-host and between-host outcomes, and generated models trained on primarily molecular, primarily in vivo-generated, or combined data types for each phenotypic outcome. This approach permits head-to-head comparison of feature inclusion and ranked importance across models. Interestingly, while feature selection did vary to some extent, commonalities in highest-performing features were present across many models (Table 2). This is in agreement with previous analyses from our group supporting correlation of many of these metrics (such as AUC_6) with key molecular and/or phenotypic outcomes within an infected ferret host17. Additional ML-based studies which identify specific features captured during mammalian risk assessment activities are warranted so that data from these experiments can be most appropriately interpreted in these settings.Comparison of feature inclusion and relative ranked importance of features retained in finalized models represents a novel approach towards assessing the relative contribution of different discrete data points frequently employed in research-based pandemic risk assessment activities. Viral shedding in NW specimens represents a standard approach to assess within-host viral fitness in the upper respiratory tract of ferrets; our finding that area under the curve days 1–6 (AUC_6) was not only consistently present in high-performing models but also among the highest-ranked feature in these final models when present, supports the capacity of this summary metric (and not other discrete summary metrics of NW viral titer, such as peak titer) to contribute meaningful information to risk assessments of both pathogenicity and transmissibility. Furthermore, the high utility of AUC_6 as a feature across all models supports that IAV capable of sustaining high titers in the mammalian upper respiratory tract for an extended duration of time contributes to both disease severity outcomes (e.g., extended damage of epithelial cells leading to increased inflammatory processes in respiratory tract tissues37) and transmission outcomes (e.g., increased shedding of virus into the environment38). Similarly, a binary feature specifying HPAI viruses bearing a multibasic amino acid cleavage site (MBAA) was found to be a highly ranked feature in both the standard lethality (L1) and morbidity (M1) models, likely owing to the presence of this molecular signature to facilitate viral spread to extrapulmonary tissues in mammals (see Table 2). Interestingly, while predicted receptor binding preference (RBS) and predicted polymerase activity (PA) were included in the highest-performing L1, M1, and T1 (transmission) standard models, in agreement with the critical role these properties contribute to mammalian adaptation (see Table 1 for inclusion rationale), they were not among the highest ranked features of these models (Table 2), likely supporting the multifactorial role multiple gene segments ultimately contribute to both disease severity and transmission outcomes39. Nonetheless, differences in relative ranked importance among how different models weigh different parameters were observed (e.g., the M1 model ranking an avian predicted binding preference above human- or dual-binders, whereas the T1 model ranks human- and dual-binders higher than an avian predicted binding preference, Fig. 4C); compared to viruses with predicted binding to α2-6 linked sialic acids, IAV with predicted binding to α2-3 linked sialic acids are more frequently associated with severe disease outcomes in ferrets40, and less frequently associated with transmission outcomes41, supporting that classification models for these distinct phenotypic outcomes would differentially weigh these features. However, the predictive (and not explanatory) nature of ML means concurrent exploratory analyses are needed to rigorously assess statistical and/or correlative links between individual features and other biologic metrics pertinent to each classification outcome examined. Correlative features of this data have been explored previously17 which informed aspects of this current work. Collectively, the parameters present in final models do appear to be governed by biological sense, and even in underperforming models, offer value in understanding the relative weight and predictive ability of different virological, clinical, and molecular parameters.We consistently observed that lethality classification models performed better than morbidity models, tested with either internally or externally generated data. It should be noted that lethal events included in this source dataset are all-cause and inclusive of animals which reached humane endpoints for multiple reasons (primarily but not exclusively due to severe weight loss and development of neurological symptoms). As such, it is possible that additional refinement of this binary classification to delineate specific causes of mortality more clearly could further improve the model performance. In contrast, it is challenging to identify enhanced refinement of causes of weight loss during the acute phase of infection due to the complex and multifactorial viral-host interactions that contribute to the magnitude of this clinical sign. However, it could be possible that a different quantifiable metric capturing disease severity beyond peak weight loss (such as rapidity of weight loss, weight loss during a defined period of time post-inoculation, AUC-based and not peak measures of weight loss, etc)42 could offer higher predictive value for this parameter. Moreover, the morbidity model could not incorporate lethal outcome as a feature due to concerns about data integrity. This is because defined weight loss thresholds play a significant role in establishing humane endpoint criteria, being correlated with an impact on morbidity42. Including lethality as a variable would essentially create a model reciprocal to the ones where weight loss is the primary predictor. Inclusion of additional in vivo-generated parameters (such as lethargy)43 in morbidity ML models could yield added benefit.While lethality classification models exhibited robust performance metrics against wholly independent, previously published testing data, the high-performance metrics of the transmission classification model employing the primary dataset was not maintained in our validation assessments. The poor performance of transmission classification models with independent data nonetheless contributes important information towards continued development of ML approaches in this area, especially when contextualized alongside high performing models. Our work was limited to evaluation of supervised, classification models; additional investigation of the utility of other model approaches to predict transmission outcomes (such as supervised regression models on continuous features or unsupervised clustering methods to group by similarity)3,4 could provide added benefit. Furthermore, both morbidity and transmission models employed key features (Fig. 2B) that were captured as categorical (and not continuous) values; there is an ongoing need to investigate the most effective ways to capture in vivo datapoints into discrete responses in the context of ML work17. Molecular data incorporated in all models in this study was limited to key positions in the HA and PB2 genes (Table 1); it is possible that these features sufficiently captured key determinants governing lethality, but not transmission, classification outcomes. Meta-analyses of results from ferret respiratory droplet transmission experiments have provided meaningful predictive information44, highlighting the potential of this data type to be employed in other data science applications. Despite the failure of the TM-pub model to maintain the high-performance metrics of TM, this work nonetheless supports the need for continued model development in this area.Several limitations in the source datasets were present. Predicted receptor binding preference and predicted polymerase activity were features included across all highest-performing models (albeit at different ranked importance), which speaks to the role these molecular correlates of virulence and transmissibility contribute to IAV host range and mammalian infection. These categorical variables were employed to summarize underlying sequence data due to the need to consider multiple amino acid residues in these features (which, in the case of receptor binding, differ between virus subtypes included in our analysis). However, these parameters were not independently confirmed in laboratory experiments, which can deviate from predicted sequence identity45. Inclusion of a variable encapsulating host origin of each IAV in the study provided an additional feature for which predictive importance could be assessed in our phenotypic classification models. However, considering the diversity of routes the heterogeneous IAV isolates included in the primary dataset crossed species barriers prior to virus isolation and characterization46, further research is warranted to investigate the relative role phenotypic outcomes are modulated in mammals following infection with viruses originating from different hosts. Infectious virus in NW specimens was captured with two different titration methods (EID50 and PFU), due to IAV strain-specific replicative capacities. While the in vivo experimental inoculation and sampling conditions employed in the source data are reflective of conditions frequently employed in risk assessment settings24, the predictive values and key features identified by these models could vary under different protocols (e.g., virus dose, route, and volume of inoculation, and ferret age, sex, and weight)47,48,49. Limitations of ML learning in this study include the need to impute missing values and remove features that had too many gaps, making accurate assessment difficult. While not a limitation in terms of model outcomes, ML models require the same features as inputs for which the model was trained. In our case, molecular diversity was greater in our training set compared to the external validation datasets, which requires the manual addition of dummy features to fill in these gaps. Inclusion of numerous zoonotic IAV with greater genetic diversity in our testing and training datasets, compared to studies limited to human IAV only, represents an additional challenge for establishment of robust ML frameworks11. We tested several different ML algorithms and many iterations of features; however, our efforts were not exhaustive, leaving room for model improvements and additional insights.Our development of three classification models stemming from generally similar training data, yielding three different performance outcomes, illustrates that modeling different phenotypic outcomes informed by in vivo data does not represent a one-size-fits-all approach, and emphasizes the necessity of validating ML performance against independent, real-world data. It should be noted that the models presented here are specific to data obtained in experimentally inoculated ferrets, and results cannot be directly extrapolated to phenotypic outcomes following IAV infection in a different laboratory model species (e.g., mice) or humans. That said, these models nonetheless provide a first step towards greater biological insight and understanding of contributing features to these outcomes that may be retained across scales, and offer immediate benefit towards refining existing ferret studies conducted for the purposes of IAV pandemic risk assessment. Collectively, this study supports that ML algorithms can extract meaningful information from previously conducted work in vivo and offers areas of future refinement to risk assessment studies employing in vivo-generated data, in line with other recent efforts in the field to incorporate novel analytical frameworks into risk assessment activities50. Furthermore, this work offers a framework to investigate additional experimental classification outcomes frequently captured in ferret studies (such as viral spread in respiratory tract tissues) and virological metadata (such as NA subtype and full protein sequences) not explicitly assessed here. Inclusion of metagenomic data from virus-infected animals51 represents an additional area for which use of ML algorithms have shown utility (when employing human specimens) in predicting clinical outcomes52 and could offer added benefit to existing laboratory workflows. As IAV continue to pose a persistent threat to public health, our work highlights that analysis approaches leveraging laboratory data generated for the purposes of risk assessment to improve pandemic risk assessment rubrics are needed and can provide meaningful benefit to the field.MethodsPrimary datasetMale ferrets (Mustela putorius furo, Triple F Farms, Sayre, PA) were 5–12 months of age and serologically negative to circulating influenza A and B viruses prior to use. Animals were inoculated with 105 to 107 infectious units of IAV intranasally in a 1 ml volume (minimum n = 3 ferrets per virus), and housed inside a HEPA-filtered Duo-Flo BioClean mobile environmental enclosure (Lab Products) for the duration of each experiment. Daily temperature and weight measurements were collected from ferrets post-inoculation (p.i.) as previously described53; any animal that lost >25% preinoculation body weight or exhibited signs of neurological involvement was humanely euthanized. Nasal wash (NW) specimens were collected on alternate days p.i. from all ferrets starting day 1 p.i. (85% of all ferrets) or day 2 p.i. and immediately frozen at −80 °C until titration. Viral stock employed for animal inoculations were propagated, and specimen titrations were performed, in either 10–11 day old embryonated hen’s eggs to determine a 50% egg infectious dose (EID50) or MDCK cells to determine a plaque forming units titer (PFU) as specified in Supplemental Table 154. All viral titers are reported per milliliter and titration limits of detection were 101.5 EID50/ml or 10 PFU/ml. All animal work was approved by CDC’s Institutional Animal Care and Use Committee and conducted in an Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International-accredited animal facility. Experiments were conducted at either BSL2 or BSL3 containment, including enhancements, as required by the U.S. Department of Agriculture and the Federal Select Agent Program55. We have complied with all relevant ethical regulations for animal use.Data were aggregated from experiments conducted over approximately 25 years and (with few exceptions) have been published previously (see Supplemental Table 1) and described17,42, with source data available at data.cdc.gov56. Maximum rise in temperature over preinoculation baseline (temperature range 37–40 °C) between days 1–5 p.i. (temp_5) or days 1-14 p.i. (temp) was reported as a rise in °C. Maximum weight loss below preinoculation baseline (reported as a normalized percentage of weight change), observed over the 14-day experimental period was determined for each animal42. Virus transmissibility of wild-type viruses by respiratory droplets was assessed using a strict 1:1 donor:contact ratio on a subset of viruses (96 out of 125, 76.8%) as described previously57, with successful transmission defined as both detection of infectious virus and seroconversion to homologous virus in contact animals. Additionally, viruses that exhibited 0% transmissibility in the presence of direct contact were identified as 0% transmissibility by respiratory droplets in this study. All viral titers in this study are presented as log10 titer, and all calculations were performed with the log10 of the measured virus titer and not the virus titer itself, in agreement with previous work58.Host origin of each virus was identified as avian or mammalian (inclusive of human, swine, and canine) based on virus lineage, not species of isolation. Avian-origin viruses were identified as highly pathogenic avian influenza (HPAI) and possessing a multibasic amino acid (MBAA) HA cleavage site, or not (see Supplemental Table 1). In all ML datasets, HA and PB2 sequences were obtained from the Global Initiative on Sharing All Influenza Data (GISAID) or NCBI Influenza Virus Resource and HAs were aligned with A/Aichi/2/1968 (H3N2) HA sequence; viral stocks employed for ferret inoculation were routinely sequenced to confirm identity with consensus as is specified in study-specific references in Supplemental Table 1. 33 HA and 5 PB2 amino acids were selected due to known roles in host adaptation, receptor binding preference, and polymerase activity39,59. Predicted receptor binding profile was defined based on hemagglutinin (HA) amino acid residues as avian (190E, 225 G [H1 only], 226Q, 228 G [all other subtypes]), human (190D/N, 225D [H1 only], 226 L/V/I, 228 S [H2, H3 only]), or dual (190D/E/A, 225 G/D/N/E [H1 only], 226 L, 228 G [all other subtypes]), with few exceptions (see Supplemental Table 1). Predicted polymerase activity was defined based on polymerase basic 2 (PB2) amino acid residues as human origin (the presence of at least one of 590 S/591 R, 627 K, or 701 N) or avian origin (not meeting these criteria).Ferrets (n = 717) were inoculated with an expansive panel of 125 influenza A viruses by standard high-dose intranasal administration, as previously described17 and specified in Supplemental Table 1. Animals were inoculated with H1 (n = 213 ferrets, 29.71%), H2 (51, 7.11%), H3 (123, 17.15%), H5 (156, 21.76%), H7 (149, 20.78%), and H9 (25, 3.48%) hemagglutinin subtype viruses. Strains in this study were inclusive of both avian (n = 378 ferrets, 52.72%) and mammalian (n = 339, 47.28%) origins and encapsulated viruses derived from wild bird surveillance, gallinaceous poultry outbreaks, and confirmed human infections; avian-origin viruses were classified as highly pathogenic avian influenza (HPAI) (n = 207 ferrets, 54.76%) or low pathogenicity (171, 45.24%). All ferrets in the study were productively infected with virus, as determined by the presence of infectious virus in serially collected nasal wash (NW) specimens. Animals were observed daily for 14 days post-inoculation unless they met criteria for humane euthanasia and did not survive the observation period (102 ferrets, 14.22%). Overview of the ML analysis workflow employed is presented in Fig. 1.Statistics and reproducibilityData were collected from a minimum of three ferrets per virus, per treatment group as detailed in the Primary Dataset section above. Sample sizes and replicates are detailed in Table 2 and Supplementary Data files. Specific analyses are presented in relevant methods sections below.Data preprocessing and partitioningAll analyses were conducting using R v4.2.160 using the additional packages tidyverse v1.3.261, ggplot2 v3.4.062, funModeling v1.9.463, and caretEnsemble v2.0.164 beyond those cited below. Data were imported into R in CSV format and cleaned and processed to make each column a feature, and each row an observation. A binary column for respiratory transmission was created as yes when respiratory titer and serology were both yes, else it was no. This was then converted to numeric (1, 0) and a proportion of transmission on a per virus basis was calculated. Viruses with ≥50% transmission among ferrets were scored as yes, else no. Weight loss categories were chosen from weight loss values as less than 5% change being ‘none’, then the remaining being equally divided into thirds for low (5–9.5%), medium (9.5–14.5%), and high (14.5–27.6%); weight loss ≥15% is frequently detected in ferrets with elevated disease severity, with these animals more likely to continue to lose weight and reach humane endpoints relative to ferrets in low or medium weight loss categories which more frequently regain weight by the end of the observation period42. The growth or decay rates of ferret NW titer between days 1 and 3 p.i. (termed slope1,3) was computed by subtracting the log10 of day 3 titer from the log10 of day 1 titer on a per ferret basis, and dividing by 48 h, as previously described58.Missing data values were filled in for weight loss and temperature with the median value on a per virus per unit basis. Nasal wash titer values for non-standard collection days (2,4,6,8 p.i.) were imputed as the mean of the standard collection days (1,3,5,7,9 p.i.) immediately preceding and following. Missing values for lung titers that were tested were imputed with the respective limit of detection (LOD) for titration matrix (1.5 for egg, 1 for cell). Peak NW titers for each ferret (detected between days 1–5 p.i.) were determined, and area under the curve (AUC) from serially collected NW specimens (between days 1–9 p.i.) per virus and per titration units. As some viruses were associated with lethal outcomes in ferrets, NW specimens from at least two ferrets per sampling timepoint were required to conduct the AUC, otherwise the virus was excluded from analysis. We used the AUC function in DescTools v0.99.4765 to calculate using the trapezoid method with 1000 bootstraps to obtain percentile confidence intervals at 95%.Missing molecular amino acid signatures were filled in with the dummy variable ‘Z’. Non-numeric predictor variables were one-hot encoded using the R package fastDummies v1.6.366 and the data set was split using rsample v1.1.167 into training (70%) and testing (30%) data sets. Training and testing data were inspected to ensure outcome variable balance/proportion was consistent with the full dataset. The R package caret v6.0.9368 was used to perform ML using the trainControl function with repeated cross validation of 10 folds and 2 repeats (total of 20x) saving results as a twoClassSummary on the trainingesting split data. Additionally, the training data utilized the preProcess option in the train function to scale and center the data, while removing near zero variables for ML algorithms to function properly.Inputs and outputs—feature selectionWe examined three overarching classification models to classify and predict a binary outcome (Table 1). Lethality, to predict mortality as a yes or no, defined as a ferret not surviving the 14-day experimental period for any reason. Morbidity, determined as a measure of high proportion body weight lost (≥14.5%) or not. Transmission, to predict a ferret likely to transmit in a respiratory droplet transmission model (≥ or <50% transmission as yes or no), defined as a contact animal seroconverting to homologous virus with infectious virus detected in at least one collected NW specimen post-contact. Predictive outcomes are made on a per ferret basis for all models, however, for transmission outcome designation was based on a per virus basis, i.e., (≥ or <50% transmission).For each model, three sub-models were tested employing different sets of input data (Tables 1 and 2, Supplementary Data 1): either molecular data alone consisting of 33 HA and 4 PB2 amino acid features, in vivo-derived data with limited key molecular data (standard) consisting of 7 numeric clinical features and 7 categorical viral features, and a combined model employing all molecular and in vivo-derived parameters. As a starting point we used backwards feature selection with the caret function rfe in R. However, we largely relied upon biological subject matter expertise (supported by the published literature) in selection of initial model features, and model performance evaluation to refine (add or subtract) certain features (Supplementary Data 1). For area under the curve (AUC), in addition to initial ML feature testing, we evaluated the various AUC inclusive days with predictive power scores using the R package ppsr v0.0.269 showing AUC of days 1–6 to be the most predictive for lethality and morbidity models (Supplementary Data 15) which become the constant AUC feature used.Models tested and evaluationFor each model we tested eleven ML algorithms: generalized linear model (glm), logistic regression GLM (glmnet), Bayesian GLM (bayesglm), boosted logistic regression (BlogReg), k-nearest neighbor (knn), neural network (nnet), stochastic gradient boosting (gbm), recursive partitioning and regression decision tree (rpart), support vector machine with radial basis function kernel (svm), and two random forest methods (rf, ranger). In certain instances where model performance was suboptimal, we used the caretStack function with the rf method to generate stacked or ensemble models from the top few performing models.Model results were evaluated by examining a series of metrics with balanced accuracy being the primary focus, but all metrics were examined for consistency in high performance when choosing a top model as a quality control check. We also looked at the underlining metrics to balanced accuracy by examining sensitivity and specificity. In cases where two models had similar balanced accuracy, we chose models that were more equal in sensitivity and specificity than one exhibiting more skew. Sensitivity is the true positive rate, or percentage of positive cases the model can detect correctly. Specificity is the true negative rate, or the percentage of negative cases the model can detect accurately. Balanced accuracy is the average of sensitivity and specificity. When balanced accuracy was similar between two models, sensitivity and specificity would be examined more closely to identify reasonable balance, by selecting models with a little less sensitivity if the specificity could be increased. This is because in our models the ‘positive’ case was the more abundant variable (i.e., no) and ‘negative’ case was the minority, which was the case of most interest (see Obs. In Table 2 for class imbalance). However, initial examination and testing of the data with resampling methods (SMOTE70 and ROSE71) did not enhance performance with artificial rebalancing and therefore did not warrant inclusion. Furthermore, as overall models perform well without, balancing was not necessary with these data.When a final algorithm and set of features for a model had been determined via model selection it was further optimized via hyperparameter tuning using balanced accuracy to establish the final model. In addition to the standard metrics, we also examined Matthew’s Correlation Coefficient (MCC) as a post-assessment for final model evaluation, which is a balanced and symmetric measure of all four confusion matrix categories (i.e., true and false, positives and negatives) which examines the correlation between observed and predicted values. MCC range is from −1 (complete misclassification) to 1 (perfect classification). Zero values mean random chance.We used the varImp function from the caret package to compile relative ranked importance of variables. Tree based models calculate variable importance based on how often a particular predictor is selected for splitting and how much it improves the purity or homogeneity of the resulting subsets. None tree based measure (e.g., nnet) utilize other methods such as permutation importance or partial dependence plots. Importance scores were scaled from 0 to 100 with the most frequently important variable set at 100. This method provides a relative rank of importance within a model and numeric values are not meant to be compared across different models.Model validation with externally generated dataA simulated dataset was generated from parameters in the primary dataset after missing data imputation. Focusing on the features that were important in the various models tested, we grouped the primary data set by hemagglutinin subtype (HA), high pathogenic avian influenza multi-basic amino acid (MBAA), lethality, and predicted receptor binding/polymerase activity (RBS/PA). We then calculated the mean and standard deviation using the summarize function in dplyr v1.0.1072. A few group values were manually converted from zero or NA to fill in gaps (Supplementary Data 16). We used this information along with categorical features to set up variable definitions, then used the simstudy package v0.6.073 to simulate the data by group. All group combinations were combined into a single data frame, representative of the primary dataset features of interest. This was performed to create a lethality-severity simulated dataset with 2900 observations, equally balanced with 100 observations per group (Supplementary Data 17).All raw data informing the H1N1 dataset (employing a low pathogenic avian influenza virus and a 2009 pandemic-derived virus) was published previously24. Ferrets were inoculated with 500 µl of each virus at a challenge dose of 106 PFU. Results from 11 independent groups are captured (CDC was one of the 11 groups, but data from this study is not included in the internally generated datasets shown in Supplementary Table 1). Studies included in the aggregated dataset employed for external validation of lethality (LM) and transmission (TM) molecular models met the following criteria: source publications were PubMed-indexed, ferrets were healthy and serologically naïve to circulating IAV prior to inoculation, inoculation was performed with a high (≥105–107 infectious units) dose of wild-type IAV delivered intranasally in a 0.5–1 ml volume, and sequence data matching the virus strain name was publicly available (NCBI or GISAID) (Supplementary Data 18). Lethality and transmission outcome were aggregated on a per-ferret basis. Lethality was all-cause based on the specific humane endpoint criteria of the research group conducting the work, which may vary between institutions. For transmission studies, transmission was defined as both detection of infectious virus in contact animals and seroconversion to homologous virus (which may differ to how source publications reported transmission events), in a respiratory droplet setting with or without directional airflow, and only included transmission outcomes when a strict 1:1 donor:contact ratio was employed.Reporting summaryFurther information on research design is available in the Nature Portfolio Reporting Summary linked to this article. Data availability Data is available from data.cdc.gov under the title “An aggregated dataset of serially collected influenza A virus morbidity and titer measurements from virus-infected ferrets”. A companion data descriptor providing more data is published56. Supplementary Data files 1-18 are presented. Supplementary Data 1: Table of features tested in each iteration of model testing. Includes the classification model (lethality, morbidity, transmission), the type of dataset used for testing (standard, combined, molecular), the outcome being classified. Descriptors of each feature are provided below. Supplementary Data 2: Table of all 14 evaluation metrics, for all 11 machine learning algorithms tested, for each iterative test of lethality classification models on the internal standard dataset. Supplementary Data 3: Table of all 14 evaluation metrics, for all 11 machine learning algorithms tested, for each iterative test of lethality classification models on the internal molecular only and combined datasets. Supplementary Data 4: Table of all 14 evaluation metrics, for all 11 machine learning algorithms tested, for each iterative test of morbidity classification models on the internal standard dataset. Supplementary Data 5: Table of all 14 evaluation metrics, for all 11 machine learning algorithms tested, for each iterative test of morbidity classification models on the internal molecular only and combined datasets. Supplementary Data 6: Table of all 14 evaluation metrics, for all 11 machine learning algorithms tested, for each iterative test of transmission classification models on the internal standard dataset. Supplementary Data 7: Table of all 14 evaluation metrics, for all 11 machine learning algorithms tested, for each iterative test of transmission classification models on the internal molecular only and combined datasets. Supplementary Data 8: Table of final model parameters used for each top model showing the machine learning algorithm, and the relevant parameters that were tuned with the final value for each. Supplementary Data 9: Table of feature importance for each iterative test of lethality classification models on the internal standard dataset. The top importance value is scaled to 100 and remaining features are relatively ranked accordingly. Supplementary Data 10: Table of feature importance for each iterative test of lethality classification models on the internal molecular only and combined datasets. The top importance value is scaled to 100 and remaining features are relatively ranked accordingly. Supplementary Data 11: Table of feature importance for each iterative test of morbidity classification models on the internal standard dataset. The top importance value is scaled to 100 and remaining features are relatively ranked accordingly. Supplementary Data 12: Table of feature importance for each iterative test of morbidity classification models on the internal molecular only and combined datasets. The top importance value is scaled to 100 and remaining features are relatively ranked accordingly. Supplementary Data 13: Table of feature importance for each iterative test of transmission classification models on the internal standard dataset. The top importance value is scaled to 100 and remaining features are relatively ranked accordingly. Supplementary Data 14: Table of feature importance for each iterative test of transmission classification models on the internal molecular only and combined datasets. The top importance value is scaled to 100 and remaining features are relatively ranked accordingly. Supplementary Data 15: Table of predictive power scores for selected features against the outcome variable (y). Supplementary Data 16: Table of summary statistics from the internal dataset grouped by HA, MBAA, RBA-PBS combination, and lethality outcome used to create simulated dataset. The mean (m), standard deviation (sd), skew (sk), and kurtosis (kr) are shown for the features wt_loss, tem5, and AUC_6. Supplementary Data 17: Table of the 2900 simulated data observations. Supplementary Data 18: Table of influenza A viruses from published literature as an external validation dataset to test the molecular only based models for lethality and transmission. Includes virus metadata, and source references with number of observations used for lethality and transmission classification models. Code availability R code used for machine learning analyses and figures is available on Github (https://github.com/CDCgov/machine-learning-influenza-ferret-model). ReferencesChiu, H. R. et al. Machine learning for emerging infectious disease field responses. Sci. Rep. 12, 328 (2022).Article CAS PubMed PubMed Central Google Scholar Keshavamurthy, R., Dixon, S., Pazdernik, K. T. & Charles, L. E. Predicting infectious disease for biopreparedness and response: a systematic review of machine learning and deep learning approaches. One Health 15, 100439 (2022).Article PubMed PubMed Central Google Scholar Goodswen, S. J. et al. Machine learning and applications in microbiology. FEMS Microbiol. Rev. 45, fuab015 (2021).Greener, J. G., Kandathil, S. M., Moffat, L. & Jones, D. T. A guide to machine learning for biologists. Nat. Rev. Mol. Cell Biol. 23, 40–55 (2022).Article CAS PubMed Google Scholar Ansicar, F., Thomas, A. M., Passerini, A., Waldron, L. & Segata, N. Machine learning for microbiologists. Nat. Rev. Microbiol. 22, 191–205 (2023).Borkenhagen, L. K., Allen, M. W. & Runstadler, J. A. Influenza virus genotype to phenotype predictions through machine learning: a systematic review. Emerg. Microbes Infect. 10, 1896–1907 (2021).Article PubMed PubMed Central Google Scholar Yin, R. et al. ViPal: a framework for virulence prediction of influenza viruses with prior viral knowledge using genomic sequences. J. Biomed. Inf. 142, 104388 (2023).Article Google Scholar Peng, Y. et al. Identification of genome-wide nucleotide sites associated with mammalian virulence in influenza A viruses. Biosaf. Health 2, 32–38 (2020).Article Google Scholar Ivan, F. X. & Kwoh, C. K. Rule-based meta-analysis reveals the major role of PB2 in influencing influenza A virus virulence in mice. BMC Genom. 20, 973 (2019).Article CAS Google Scholar Sun, Y. et al. Computational predicting the human infectivity of H7N9 influenza viruses isolated from avian hosts. Transbound. Emerg. Dis. 68, 846–856 (2021).Article CAS PubMed Google Scholar Zeller, M. A. et al. Machine Learning Prediction And Experimental Validation Of Antigenic Drift in H3 influenza A viruses in swine. mSphere 6, 10–1128 (2021).Einav, T. & Ma, R. Using interpretable machine learning to extend heterogeneous antibody-virus datasets. Cell Rep. Methods 3, 100540 (2023).Article PubMed PubMed Central Google Scholar Jhutty, S. S. et al. Predicting influenza A virus infection in the lung from hematological data with machine learning. mSystems 7, e0045922 (2022).Article PubMed Google Scholar Burke, S. A. & Trock, S. C. Use of influenza risk assessment tool for prepandemic preparedness. Emerg. Infect. Dis. 24, 471–477 (2018).Article PubMed PubMed Central Google Scholar WHO. Tool for Influenza Pandemic Risk Assessment (TIPRA) 2nd Edn (WHO, 2020).Danzy, S., Lowen, A. C. & Steel, J. A quantitative approach to assess influenza A virus fitness and transmission in guinea pigs. J. Virol. 95, e02320–e02320 (2021).Article CAS PubMed PubMed Central Google Scholar Kieran, T. J., Sun, X., Maines, T. R., Beauchemin, C. A. A. & Belser, J. A. Exploring associations between viral titer measurements and disease outcomes in ferrets inoculated with 125 contemporary influenza A viruses J. Virol. 98, e01661–23 (2024).Lycett, S. J. et al. Detection of mammalian virulence determinants in highly pathogenic avian influenza H5N1 viruses: multivariate analysis of published data. J. Virol. 83, 9901–9910 (2009).Article CAS PubMed PubMed Central Google Scholar Wolk, D. M. et al. Prediction of influenza complications: development and validation of a machine learning prediction model to improve and expand the identification of vaccine-hesitant patients at risk of severe influenza complications. J. Clin. Med. 11, 4342 (2022).Article PubMed PubMed Central Google Scholar Yoo, D. S. et al. Machine learning-driven dynamic risk prediction for highly pathogenic avian influenza at poultry farms in Republic of Korea: daily risk estimation for individual premises. Transbound. Emerg. Dis. 69, 2667–2681 (2022).Article PubMed Google Scholar Herrick, K. A., Huettmann, F. & Lindgren, M. A. A global model of avian influenza prediction in wild birds: the importance of northern regions. Vet. Res. 44, 42 (2013).Article PubMed PubMed Central Google Scholar Belser, J. A., Katz, J. M. & Tumpey, T. M. The ferret as a model organism to study influenza A virus infection. Dis. Model Mech. 4, 575–579 (2011).Article CAS PubMed PubMed Central Google Scholar Belser, J. A. et al. Ferrets as models for influenza virus transmission studies and pandemic risk assessments. Emerg. Infect. Dis. 24, 965–971 (2018).Article PubMed PubMed Central Google Scholar Belser, J. A. et al. Robustness of the ferret model for influenza risk assessment studies: a cross-laboratory exercise. mBio 13, e0117422 (2022).Article PubMed Google Scholar Belser, J. A., Maines, T. R., Katz, J. M. & Tumpey, T. M. Considerations regarding appropriate sample size for conducting ferret transmission experiments. Future Microbiol. 8, 961–965 (2013).Article CAS PubMed Google Scholar Nishiura, H., Yen, H. L. & Cowling, B. J. Sample size considerations for one-to-one animal transmission studies of the influenza A viruses. PLoS ONE 8, e55358 (2013).Article CAS PubMed PubMed Central Google Scholar Stark, G. V. et al. Clinical profiles associated with influenza disease in the ferret model. PLoS ONE 8, e58337 (2013).Article CAS PubMed PubMed Central Google Scholar Huang, S. S. et al. Comparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B infections depict distinct clinical pictures in ferrets. PLoS ONE 6, e27512 (2011).Article CAS PubMed PubMed Central Google Scholar Zuk, T., Rakowski, F. & Radomski, J. P. A model of influenza virus spread as a function of temperature and humidity. Comput. Biol. Chem. 33, 176–180 (2009).Article CAS PubMed Google Scholar Pillai, N., Ramkumar, M. & Nanduri, B. Artificial intelligence models for zoonotic pathogens: a survey. Microorganisms 10, 1911 (2022).Article PubMed PubMed Central Google Scholar Li, J. et al. Machine learning methods for predicting human-adaptive influenza a viruses based on viral nucleotide compositions. Mol. Biol. Evol. 37, 1224–1236 (2020).Article CAS PubMed Google Scholar Du, L. & Pang, Y. A novel data-driven methodology for influenza outbreak detection and prediction. Sci. Rep. 11, 13275 (2021).Article CAS PubMed PubMed Central Google Scholar Eng, C. L., Tong, J. C. & Tan, T. W. Predicting host tropism of influenza A virus proteins using random forest. BMC Med. Genom. 7 Suppl 3, S1 (2014).Article Google Scholar Marquez, E., Barron-Palma, E. V., Rodriguez, K., Savage, J. & Sanchez-Sandoval, A. L. Supervised machine learning methods for seasonal influenza diagnosis. Diagnostics 13, 3352 (2023).Article PubMed PubMed Central Google Scholar Nanivadekar, A. C. et al. Machine learning prediction of emesis and gastrointestinal state in ferrets. PLoS ONE 14, e0223279 (2019).Article CAS PubMed PubMed Central Google Scholar Wood, T. R. et al. A ferret brain slice model of oxygen-glucose deprivation captures regional responses to perinatal injury and treatment associated with specific microglial phenotypes. Bioeng. Transl. Med. 7, e10265 (2022).Article CAS PubMed Google Scholar Mifsud, E. J., Kuba, M. & Barr, I. G. Innate immune responses to influenza virus infections in the upper respiratory tract. Viruses 13, 2090 (2021).Article CAS PubMed PubMed Central Google Scholar Pulit-Penaloza, J. A. et al. Kinetics and magnitude of viral RNA shedding as indicators for Influenza A virus transmissibility in ferrets. Commun. Biol. 6, 90 (2023).Article CAS PubMed PubMed Central Google Scholar Suttie, A. et al. Inventory of molecular markers affecting biological characteristics of avian influenza A viruses. Virus Genes 55, 739–768 (2019).Article CAS PubMed PubMed Central Google Scholar de Graaf, M. & Fouchier, R. A. Role of receptor binding specificity in influenza A virus transmission and pathogenesis. EMBO J. 33, 823–841 (2014).Article PubMed PubMed Central Google Scholar Belser, J. A., Maines, T. R., Tumpey, T. M. & Katz, J. M. Influenza A virus transmission: contributing factors and clinical implications. Expert Rev. Mol. Med. 12, e39 (2010).Article PubMed Google Scholar Belser, J. A. et al. Key considerations to improve the normalization, interpretation and reproducibility of morbidity data in mammalian models of viral disease. Dis. Model Mech. 17, dmm050511 (2024).Reuman, P. D., Keely, S. & Schiff, G. M. Assessment of signs of influenza illness in the ferret model. J. Virol. Methods 24, 27–34 (1989).Article CAS PubMed Google Scholar Buhnerkempe, M. G. et al. Mapping influenza transmission in the ferret model to transmission in humans. Elife 4, e07969 (2015).Article PubMed PubMed Central Google Scholar Pulit-Penaloza, J. A., Belser, J. A., Tumpey, T. M. & Maines, T. R. Sowing the seeds of a pandemic? Mammalian pathogenicity and transmissibility of H1 variant influenza viruses from the swine reservoir. Trop. Med. Infect. Dis. 4, 41 (2019).Article PubMed PubMed Central Google Scholar Long, J. S., Mistry, B., Haslam, S. M. & Barclay, W. S. Host and viral determinants of influenza A virus species specificity. Nat. Rev. Microbiol. 17, 67–81 (2019).Article CAS PubMed Google Scholar Moore, I. N. et al. Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume. J. Virol. 88, 13879–13891 (2014).Article PubMed PubMed Central Google Scholar Bissel, S. J. et al. Age-related pathology associated with H1N1 A/California/07/2009 influenza virus infection. Am. J. Pathol. 189, 2389–2399 (2019).Article PubMed PubMed Central Google Scholar Meliopoulos, V et al. Diet-induced obesity affects influenza disease severity and transmission dynamics in ferrets. Sci. Adv. 10, eadk9137 (2024).Chokkakula, S. et al. Mammalian adaptation risk in HPAI H5N8: a comprehensive model bridging experimental data with mathematical insights. Emerg. Microbes Infect. 13, 2339949 (2024).Article PubMed PubMed Central Google Scholar Kaul, D. et al. Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection. Nat. Commun. 11, 2537 (2020).Article CAS PubMed PubMed Central Google Scholar Thomas, A. M. et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat. Med. 25, 667–678 (2019).Article CAS PubMed PubMed Central Google Scholar Maines, T. R. et al. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J. Virol. 79, 11788–11800 (2005).Article CAS PubMed PubMed Central Google Scholar Szretter, K. J., Balish, A. L. & Katz, J. M. Influenza: propagation, quantification, and storage. Curr. Protoc. Microbiol. 29, 15G 11 (2006). Google Scholar Meecham, P. J. Biosafety in Microbiological and Biomedical Laboratories, HHS Publication No. (CDC) 300859, 6th edn (US Department of Health and Human Services, 2020).Kieran, T. J. et al. An aggregated dataset of serial morbidity and titer measurements from influenza A virus-infected ferrets. Sci. Data 11, 510 (2024).Maines, T. R. et al. Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc. Natl Acad. Sci. USA 103, 12121–12126 (2006).Article CAS PubMed PubMed Central Google Scholar Creager, H. M. et al. Utility of human in vitro data in risk assessments of Influenza a virus using the ferret model. J. Virol. 97, e0153622 (2023).Article PubMed Google Scholar Burke, D. F. & Smith, D. J. A recommended numbering scheme for influenza A HA subtypes. PLoS ONE 9, e112302 (2014).Article PubMed PubMed Central Google Scholar R Core Team. R: A language and environment for statistical computing (R Foundation for Statistical Computing, 2022).Wickham, H. et al. Welcome to the tidyverse. J. Open Source Softw. 4, 1686 (2019).Article Google Scholar Wickham, H. ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag (2016).Casas, P. funModeling: Exploratory Data Analysis and Data Preparation Tool-Box (R package). 1.9.4 edn (2020).Deane-Mayer, Z. A., Knowles, J. E. caretEnsemble: Ensembles of Caret Models (R package). 2.0.1 edn (2019).Signorell, A. DescTools: Tools for descriptive statistics. (2022).Kaplan, J. fastDummies: Fast Creation of Dummy (Binary) Columns and Rows from Categorical Variables (R package). 1.6.3 edn (2020).Frick, H. et al. rsample: General Resampling Infrastructure (R package). 1.1.1 edn (2022).Kuhn, M. caret: Classification and Regression Training (R package). 6.0.93 edn (2022).van der Laken, P. ppsr: Predictive Power Score (R package). 0.0.2 edn (2021).Chawla, N. V., Bowyer, K. W., Hall, L. O., Kegelmeyer, W. P. SMOTE: Synthetic Minority Over-sampling Technique. J. Artif. Intell. Res. 16, 321–357 (2002).Menardi, G. & Torelli, N. Training and assessin classification rules with imbalanced data. Data Min. Knowl. Disc 28, 92–122 (2014).Article Google Scholar Wickham, H., Francois, R. H. L., Muller. K., Vaughan, D. dplyr: A Grammar of Data Manipulation (R package). 1.1.2 edn (2022).Goldfeld, K. & Wujciak-Jens, J. simstudy: Illuminating research methods through data generation. J. Open Sour. Softw. 5, 2763 (2020).Article Google Scholar Steinhauer, D. A. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258, 1–20 (1999).Article CAS PubMed Google Scholar Lau, L. L. et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J. Infect. Dis. 201, 1509–1516 (2010).Article PubMed Google Scholar Download referencesAcknowledgementsWe thank the international influenza community for facilitating access to many of the viruses employed in this study. The authors thank Alissa Eckert for graphical support, Jeff Colombe and Steffani Silva for helpful discussions, and the Data Science Upskilling program at the Centers for Disease Control and Prevention (CDC) for training support. This project was supported in part by an appointment to the Research Participation Program at the CDC administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the CDC (T.J.K.). The findings and conclusions are those of the authors and do not necessarily reflect the official position of the CDC or the Agency for Toxic Substances and Disease Registry (ATSDR).Author informationAuthors and AffiliationsInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USATroy J. Kieran, Xiangjie Sun, Taronna R. Maines & Jessica A. BelserAuthorsTroy J. KieranView author publicationsYou can also search for this author in PubMed Google ScholarXiangjie SunView author publicationsYou can also search for this author in PubMed Google ScholarTaronna R. MainesView author publicationsYou can also search for this author in PubMed Google ScholarJessica A. BelserView author publicationsYou can also search for this author in PubMed Google ScholarContributionsT.J.K. and J.A.B. conceived and designed the study, and wrote the manuscript. T.J.K. performed the analysis work with initial datasets generated by X.S. and J.A.B. conducted under protocols designed by T.R.M. T.J.K., X.S., and J.A.B. analyzed the data. All authors read and approved the final manuscript.Corresponding authorsCorrespondence to Troy J. Kieran or Jessica A. Belser.Ethics declarations Competing interests The authors declare no competing interests. Peer review Peer review information Communications Biology thanks the anonymous reviewers for their contribution to the peer review of this work. Primary Handling Editor: Johannes Stortz. Additional informationPublisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Supplementary informationSupplementary InformationDescription of Additional Supplementary FilesSupplementary Data 1-18Reporting SummaryRights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Reprints and permissionsAbout this articleCite this articleKieran, T.J., Sun, X., Maines, T.R. et al. Machine learning approaches for influenza A virus risk assessment identifies predictive correlates using ferret model in vivo data. Commun Biol 7, 927 (2024). https://doi.org/10.1038/s42003-024-06629-0Download citationReceived: 16 January 2024Accepted: 24 July 2024Published: 01 August 2024DOI: https://doi.org/10.1038/s42003-024-06629-0Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative Download PDF Advertisement Explore content Research articles Reviews & Analysis News & Comment Collections Follow us on Twitter Sign up for alerts RSS feed About the journal Journal Information Open Access Fees and Funding Journal Metrics Editors Editorial Board Calls for Papers Referees Contact Editorial policies Aims & Scope Publish with us For authors Language editing services Submit manuscript Search Search articles by subject, keyword or author Show results from All journals This journal Search Advanced search Quick links Explore articles by subject Find a job Guide to authors Editorial policies Communications Biology (Commun Biol) ISSN 2399-3642 (online) nature.com sitemap About Nature Portfolio About us Press releases Press office Contact us Discover content Journals A-Z Articles by subject protocols.io Nature Index Publishing policies Nature portfolio policies Open access Author & Researcher services Reprints & permissions Research data Language editing Scientific editing Nature Masterclasses Research Solutions Libraries & institutions Librarian service & tools Librarian portal Open research Recommend to library Advertising & partnerships Advertising Partnerships & Services Media kits Branded content Professional development Nature Careers Nature Conferences Regional websites Nature Africa Nature China Nature India Nature Italy Nature Japan Nature Middle East Privacy Policy Use of cookies Your privacy choices/Manage cookies Legal notice Accessibility statement Terms & Conditions Your US state privacy rights © 2024 Springer Nature Limited Close banner Close Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily. Email address Sign up I agree my information will be processed in accordance with the Nature and Springer Nature Limited Privacy Policy. Close banner Close Get the most important science stories of the day, free in your inbox. Sign up for Nature BriefingObesity Alters the Course of Influenza Infections | TS Digest | The ScientistSubscribeMenuLoginLoginSubscribeNews & OpinionPublicationsAN INTERACTIVE EXPERIENCECurrent IssueNovember 2024, Issue 1 View This IssueArchivesFeaturesQuarterly MagazineCurrent IssueSeptember 2024 View This IssueArchivesFeaturesCategoriesBiochemistryCancerCell BiologyCommunityDrug DevelopmentEnvironmentEvolutionGeneticsImmunologyMicrobiologyNeurosciencePhysiologyPublic HealthZoologyTS UniversityScientific ServicesBrush Up SummariesTechnique TalksJournal ClubTS SciCommMultimediaCrossword PuzzleseBooksInfographicsPodcastsResearch Products BlogResearch ArticlesScience SnapshotSlideshowsVideosWords for NerdsInnovation SpotlightWebinarsArticleObesity Alters the Course of Influenza InfectionsResearchers explored the effects of obesity on the lung microenvironment in ferrets, searching for new therapeutic targets to protect vulnerable populations.Hannah Thomasy, PhDHannah Thomasy, PhDHannah joined The Scientist as an assistant editor in 2023. She earned her PhD in neuroscience from the University of Washington in 2017 and completed the Dalla Lana Fellowship in Global Journalism in 2020.View full profile.Learn about our editorial policies.Aug 1, 2024 | 2 min readShareImage Credit:Harald SchmidtFrom aiding in the construction of Fermilab to serving as valuable models of cystic fibrosis, ferrets have been on the frontlines of many scientific endeavors. Now, researchers have turned to ferrets to investigate the impact of obesity on influenza dynamics, both within and between individuals. In a new study in Science Advances, researchers identified differences in symptom severity and lung gene expression between normal weight and obese ferrets, providing clues about the mechanisms by which body composition might influence antiviral responses.1 Stacey Schultz-Cherry studies host-virus interactions with the aim of informing new strategies for protecting high-risk populations.St. Jude Children’s Research Hospital“We got interested in this because of the 2009 swine flu pandemic, where we saw for the first time, at least epidemiologically, that people who were overweight or obese were more likely to get severe disease,” said lead author Stacey Schultz-Cherry, who studies host-microbe interactions at St. Jude Children's Research Hospital.Schultz-Cherry’s team found that, in accordance with increased H1N1 symptom severity, obese ferrets had significantly higher viral titers in their lungs than their normal weight counterparts. Even before infection, lung tissues from obese animals showed increased expression of genes related to cell death and inflammation. During infection, obese ferrets upregulated some inflammatory factors, including interleukin-1, while downregulating some genes associated with antiviral response and lung tissue repair. Understanding how immune responses may be dysregulated in obesity is crucial for developing therapeutics to protect this high-risk group, said Schultz-Cherry. “I think it's very naive on our part to assume that people are just going lose weight… So how can we do science that is modern, that really reflects our current population?”“This is a great study,” said Aubree Gordon, an influenza researcher at the University of Michigan who was not involved in the study. “Influenza in obese individuals is a substantial problem…having an obese ferret model is incredibly useful for understanding the mechanisms of what’s happening, and hopefully once we understand the mechanism we can get better treatments.”ReferenceMeliopoulos V, et al. Sci Adv. 2024;10(19):eadk9137.This exclusive article was first published in TS DigestThis IssueAugust 2024, Issue 1From Lab to Likes: Socializing Science Through HumorOded Rechavi shares research and relatable science memes at the touch of his fingertips.View This IssuePreviously undetected H5N1 avian flu cases in farmworkers revealed in new report | CIDRAP Skip to main content University of Minnesota Main navigationMain content University of Minnesotahttp:/win-cities.umn.edu/612-625-5000 Go to the U of M home page Main navigation News Antimicrobial Resistance COVID-19 Chronic Wasting Disease Influenza Mpox All Topics A-Z Resilient Drug Supply Influenza Vaccines Roadmap CIDRAP Leadership Forum Roadmap Development Coronavirus Vaccines Roadmap . . Topics & Projects Antimicrobial Stewardship Chronic Wasting Disease Osterholm Update Podcasts Newsletters About CIDRAP CIDRAP in the News Our Staff Our Director Osterholm in the Press Shop Merchandise Contact Us About Search CLOSE Search Support Menu Previously undetected H5N1 avian flu cases in farmworkers revealed in new report Jim Wappes Avian Influenza (Bird Flu) shironosov / iStock Share Copied to clipboard A team of US researchers has revealed evidence of highly pathogenic H5N1 avian flu infections in two Texas farmworkers not previously confirmed to have the disease, and the investigators also cultured infectious H5N1 virus from milk and cattle samples taken from two Texas dairy farms that previously had H5N1 outbreaks.The research, led by scientists with the University of Texas Medical Branch (UTMB) at Galveston, was published yesterday on the preprint server medRxiv, meaning that it has not yet been peer-reviewed. It comes as the US Department of Agriculture (USDA) confirmed two more dairy farms affected by H5N1 in cows, as well as newly infected mammalian species.Two of 14 workers test positive"Knowing that we had a research proposal to study livestock farms for evidence of novel respiratory viruses," the authors wrote, "we were invited by farm owners to study two dairy farms in Texas as they were recovering from incursions of avian influenza A H5N1 virus in their cattle. The identity and locations of two dairy farms (Farm A and B) are protected through nondisclosure agreements."The investigators visited Farm A on April 3 and Farm B on April 4. They had previously studied specimens from Farm A, but this was their first visit to the other farm. Farm A housed 7,200 dairy cows and employed 180 workers. Farm B had 8,200 dairy cattle as well as beef cattle, but the two types were housed separately. It employed 45 farmworkers.We were invited by farm owners to study two dairy farms in Texas as they were recovering from incursions of avian influenza A H5N1 virus.In the 30 days before the researchers visited the farms, both locales reported sick cattle showing signs of respiratory disease, including coughing, nasal discharge, difficulty breathing, and fever. About 5% of the Farm A herd was sick, compared with 14% on Farm B. Farm B also reported that 15 to 20 of roughly 40 feral cats on the property had died after they exhibited influenza-like symptoms. The research team enrolled 17 adult farm workers in the study, 10 from Farm A and 7 from Farm B. Twelve were men and 15 were Latino. All agreed to nasopharyngeal swab collection, but 3 workers on Farm B declined blood draws for sera specimens.All 17 nasopharyngeal swabs collected from the farm workers were negative by molecular assays for influenza A viruses and coronaviruses. Microneutralization assays conducted on the 14 farm workers' sera samples demonstrated that 2 workers, both from Farm A, had antibodies to influenza A H5N1 virus, indicating a previous infection.These workers, both of whom had recent respiratory symptoms, are not included in the US total of 13 human cases of H5 avian flu confirmed since April. Four of these infections are associated with exposure to sick dairy cows, and 9 are tied to H5N1-infected poultry.I am very confident there are more people being infected than we know about.One of the two Farm A workers who tested positive for H5N1 antibodies reported no respiratory illness in the previous year but had a cough and was taking cough medicine at the time of the study. The second employee worked in the Farm A cafeteria and had just recovered from a respiratory illness."I am very confident there are more people being infected than we know about," senior author Gregory Gray, MD, MPH, a UTMB infectious disease researcher, told NPR. "Largely, that's because our surveillance has been so poor."Most milk samples test positiveThe researchers tested 14 milk samples, 9 of which (64%) tested positive for H5N1 avian flu via polymerase chain reaction (PCR) and were also grown in culture, indicating the presence of live, infectious virus.Of 39 deep nasal swabs collected from cattle on both farms, 1 tested positive via PCR and cell culture. It was from a recuperating cow. The investigators also detected SARS-CoV-2, the virus that causes COVID-19, in a nasal swab from a sick cow. In addition, the team detected H5N1 in a great-tailed grackle found dead in an open-air dairy cattle barn.For environmental sampling, they obtained 12 bioaerosol samples from each farm, as well, to detect airborne influenza viruses but found none. They added, "A single cattle fecal slurry sample was collected on Farm B and it had molecular evidence of influenza A virus."They wrote, "Our isolates had multiple mutations associated with increased spillover potential." Our isolates had multiple mutations associated with increased spillover potential.The authors conclude, "It now seems especially prudent that we find ways to prospectively and more intensely study dairy farms to better quantify serological evidence of infections in both livestock and dairy workers. Before we can perform such important research, we need to find ways to fully protect the dairy businesses from any economic harm that might arise through such intensive study."USDA confirms H5N1 in cows in Michigan, TexasIn related news, today the USDA Animal and Plant Health Inspection Service (APHIS) confirmed 2 new H5N1 avian flu outbreaks in dairy cows, raising the national total to 175 in 13 states. The new positive samples are from Michigan, which the state announced earlier this week, plus Texas, which hasn't had an outbreak in several weeks.In addition, APHIS yesterday added three new species—deer mouse, prairie vole, and desert cottontail—all collected in Weld, County, Colorado—to its list of US mammals in which H5N1 avian flu has been confirmed. APHIS also noted other mammal detections in Colorado, including 2 domestic cats, bringing the total reported in the United States since March to 36. Related news Previous Next Studies describe deadly avian flu outbreaks among seals, terns Stephanie Soucheray Canada probes suspected avian flu infection in hospitalized teen Lisa Schnirring CDC expands avian flu testing for farm workers, notes 7% infection rate in those exposed to infected cows Lisa Schnirring Scientists track emergence of novel H5N1 flu reassortant in Cambodia Lisa Schnirring California, Washington report more suspected H5 avian flu cases Lisa Schnirring Utah reports avian flu in dairy cows as USDA announces plan for bulk milk sampling Lisa Schnirring USDA announces first H5N1 avian flu detection in US pigs Lisa Schnirring H5N1 avian flu isolate from dairy worker is transmissible, lethal in animals Lisa Schnirring This week's top reads Recent COVID-19 vaccination tied to lower risk of long COVID Overall, the risk of developing 28 out of 36 long-COVID symptoms lessened when vaccines were effective. Stephanie Soucheray California, Washington report more suspected H5 avian flu cases In related developments, the USDA reported more dairy cow and poultry outbreaks, as Los Angeles Country announced its first H5 wastewater detection. Lisa Schnirring Scientists track emergence of novel H5N1 flu reassortant in Cambodia Since a spillover in October 2023 the novel reassortment has replaced the older clade in Cambodia's poultry. Lisa Schnirring MIS-C much more common in kids not vaccinated against COVID-19, data reveal Among 12- to 17-year-olds, 90% of those with MIS-C were unvaccinated. Stephanie Soucheray CDC expands avian flu testing for farm workers, notes 7% infection rate in those exposed to infected cows The CDC now recommends testing and prophylactic Tamiflu use in asymptomatic workers exposed to sick animals. Lisa Schnirring Four cases of sexually transmitted fungal infection reported in New York The infections were caused by Trichophyton mentagrophytes type VII (TMVII), a sexually transmitted fungus that causes ringworm. Chris Dall Canada probes suspected avian flu infection in hospitalized teen The presumed positive infection comes amid a rise in poultry outbreaks in BC and US western states, likely triggered by wild bird migration. Lisa Schnirring Surveys reveal Americans' persistent mistrust in COVID vaccine science The greatest levels of trust were seen among men, those with university degrees and high median outcomes, and those who had lost someone to COVID-19. Mary Van Beusekom Trial shows safety of getting COVID, flu vaccines at same time Over half of participants (57%) reported a history of SARS-CoV-2 infection. Stephanie Soucheray Cases top 50,000 in Africa's mpox outbreak In other outbreak developments, medical groups announce a vaccine allocation plan and a vaccine trial to begin in pregnant women and in children younger than 2. Lisa Schnirring Our underwriters Unrestricted financial support provided by Principal Underwriter Leading Underwriter Major Underwriter Supporting Underwriter Become an Underwriter Help make CIDRAP's vital work possible Support Us Home Editorial policy Search news Contact Us CIDRAP - Center for Infectious Disease Research & Policy Research and Innovation Office, University of Minnesota, Minneapolis, MN Email us © 2024 Regents of the University of Minnesota. All rights Reserved. The University of Minnesota is an equal opportunity educator and employer Research and Innovation Office | Contact U of M | Privacy Policy Newsletter subscribe Get CIDRAP updates Choose newsletters Select all Daily Headlines Antimicrobial Stewardship Newsletter Chronic Wasting Disease Newsletter Flu Vaccine Roadmap Newsletter Resilient Drug Supply Newsletter Email Email Format html text News Topics & Projects Antimicrobial Resistance COVID-19 Chronic Wasting Disease Influenza Mpox All Topics A-Z Resilient Drug Supply Influenza Vaccines Roadmap CIDRAP Leadership Forum Roadmap Development Coronavirus Vaccines Roadmap . . Podcasts Antimicrobial Stewardship Chronic Wasting Disease Osterholm Update Newsletters About About CIDRAP CIDRAP in the News Our Staff Our Director Osterholm in the Press Shop Merchandise Contact Us DonateMolecular epidemiology and phylogenetic analysis of influenza viruses A (H3N2) and B/Victoria during the COVID-19 pandemic in Guangdong, China | Infectious Diseases of Poverty | Full Text Skip to main content Advertisement Search Explore journals Get published About BMC My account Search all BMC articles Search Infectious Diseases of Poverty Home About Articles Collections Submission Guidelines Submit manuscript Molecular epidemiology and phylogenetic analysis of influenza viruses A (H3N2) and B/Victoria during the COVID-19 pandemic in Guangdong, China Download PDF Download PDF Research Article Open access Published: 01 August 2024 Molecular epidemiology and phylogenetic analysis of influenza viruses A (H3N2) and B/Victoria during the COVID-19 pandemic in Guangdong, China Zhiqi Zeng1,2,6 na1, Yong Liu2,3 na1, Wenxiang Jin2,3 na1, Jingyi Liang1,4 na1, Jinbin Chen2 na1, Ruihan Chen4 na1, Qianying Li1 na1, Wenda Guan1, Lixi Liang1, Qiubao Wu1, Yuanfang Lai2, Xiaoyan Deng2 na2, Zhengshi Lin1,6 na2, Chitin Hon4,5 na2 & …Zifeng Yang1,2,5,6 na2 Show authors Infectious Diseases of Poverty volume 13, Article number: 56 (2024) Cite this article 819 Accesses 1 Citations Metrics details AbstractBackgroundNon-pharmaceutical measures and travel restrictions have halted the spread of coronavirus disease 2019 (COVID-19) and influenza. Nonetheless, with COVID-19 restrictions lifted, an unanticipated outbreak of the influenza B/Victoria virus in late 2021 and another influenza H3N2 outbreak in mid-2022 occurred in Guangdong, southern China. The mechanism underlying this phenomenon remains unknown. To better prepare for potential influenza outbreaks during COVID-19 pandemic, we studied the molecular epidemiology and phylogenetics of influenza A(H3N2) and B/Victoria that circulated during the COVID-19 pandemic in this region.MethodsFrom January 1, 2018 to December 31, 2022, we collected throat swabs from 173,401 patients in Guangdong who had acute respiratory tract infections. Influenza viruses in the samples were tested using reverse transcription-polymerase chain reaction, followed by subtype identification and sequencing of hemagglutinin (HA) and neuraminidase (NA) genes. Phylogenetic and genetic diversity analyses were performed on both genes from 403 samples. A rigorous molecular clock was aligned with the phylogenetic tree to measure the rate of viral evolution and the root-to-tip distance within strains in different years was assessed using regression curve models to determine the correlation.ResultsDuring the early period of COVID-19 control, various influenza viruses were nearly undetectable in respiratory specimens. When control measures were relaxed in January 2020, the influenza infection rate peaked at 4.94% (39/789) in December 2021, with the influenza B/Victoria accounting for 87.18% (34/39) of the total influenza cases. Six months later, the influenza infection rate again increased and peaked at 11.34% (255/2248) in June 2022; influenza A/H3N2 accounted for 94.51% (241/255) of the total influenza cases in autumn 2022. The diverse geographic distribution of HA genes of B/Victoria and A/H3N2 had drastically reduced, and most strains originated from China. The rate of B/Victoria HA evolution (3.11 × 10−3, P < 0.05) was 1.7 times faster than before the COVID-19 outbreak (1.80 × 10−3, P < 0.05). Likewise, the H3N2 HA gene’s evolution rate was 7.96 × 10−3 (P < 0.05), which is 2.1 times faster than the strains’ pre-COVID-19 evolution rate (3.81 × 10−3, P < 0.05).ConclusionsDespite the extraordinarily low detection rate of influenza infection, concealed influenza transmission may occur between individuals during strict COVID-19 control. This ultimately leads to the accumulation of viral mutations and accelerated evolution of H3N2 and B/Victoria viruses. Monitoring the evolution of influenza may provide insights and alerts regarding potential epidemics in the future. BackgroundSeasonal influenza is a serious public health issue around the world, impacting 5–15% of the population and causing roughly half a million fatalities each year [1, 2]. As a result, preventing seasonal influenza is a top worldwide health concern [3, 4]. In recent years, most cases of seasonal influenza have been caused by the simultaneous spread of influenza A and B viruses [5]. In temperate climates, influenza typically occurs once a year during the cold season; however, year-round influenza activity can be seen in tropical and subtropical areas with varied timing and duration [6]. Influenza transmission patterns in China are complex and depend on latitude, geographic region, and viral strain [7]. The intricate epidemiological nature of influenza makes it challenging to predict future influenza outbreaks in a timely manner.The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in early 2020 and rapidly spread worldwide. Non-pharmacological interventions (NPIs), which include travel restrictions, wearing masks, physical distancing, and staying at home, were implemented globally to curb SARS-CoV-2 transmission. NPIs also reduced the transmission of other respiratory viruses, such as influenza [8]. For example, influenza activity decreased substantially during March 2020 in the United States, reaching an all-time low in the summer of 2020, and the low influenza activity remained from October 2020 to May 2021 [9]. The same phenomenon was also reported in Australia, Chile, and South Africa, where influenza activity was exceptionally low during the regular influenza season in the Southern Hemisphere [9,10,11,12]. Similarly, influenza activity in China decreased significantly during the COVID-19 pandemic; however, it gradually increased in 2021, accompanied by a shift in circulating virus, from the influenza A subtype to the influenza B/Victoria subtype, and the absence of the B/Yamagata lineage [12, 13]. Currently, it remains unclear how human activity changes the regular transmission pattern of influenza virus and influences viral evolution. To answer this question, we selected Guangdong Province, which has a subtropical monsoon climate and a permanent population of 126 million as of 2021. We collected respiratory samples from patients with acute respiratory tract infections (ARTI) from 2018 to 2022 across the province. We studied the phylogenetics and genetic diversity of influenza A(H3N2) and B/Victoria. Our findings suggest that insidious influenza virus transmission and evolutionary alterations may have occurred during the COVID-19 pandemic.MethodsSample collectionThroat swabs were obtained from 173,401 patients with ARTI in Guangdong Province between January 2018 (pre-pandemic) and December 2022 (mid-pandemic). We only included samples from individuals with influenza-like symptoms (fever 37.3 ℃) accompanied by at least one respiratory symptom (sore throat, cough, coryza, or shortness of breath) and whose physician had prescribed an influenza virus laboratory test (Fig. S1). Throat swab samples were chilled at 2–8 ℃ in viral transport medium and transported to Kingmed Diagnostics (KMD) laboratory. Samples were either examined immediately or stored at − 80 ℃ until testing. KMD is a China-based accredited commercial medical laboratory.Influenza detection and Sanger sequencingViral RNA/DNA was extracted from the swabs using nucleic acid extraction kits (Shanghai Kehua Bio-Engineering Co., Ltd., Shanghai, China). TaqMan real-time polymerase chain reaction kits (ZJ Bio-Tech, Shanghai, China) were used to test the influenza A and B viruses. Influenza-positive samples were genotyped for influenza A H1/H3 and influenza B Yamagata/Victoria subtypes (test kits from Baso, Guangdong, China). Amplification conditions for the reverse transcription (RT) step were 1 cycle at 50 ℃ for 30 min and 1 cycle at 94 ℃ for 2 min, followed by 35 cycles at 94 ℃ for 30 s, 50 ℃ for 30 s and 72℃ for 1 kb/min, with a final extension step at 72℃ for 10 min. All amplifications were performed in a thermal cycler (Bio-Rad, Hercules, CA, USA). Sequences of RT-PCR primers are listed in Table S1. In total, 207 influenza A-positive samples and 196 influenza B-positive samples were sent to IGE Biotechnology, Ltd. (Guangzhou, China) for Sanger sequencing of hemagglutinin (HA) and neuraminidase (NA) genes.Bioinformatics analysisGene clustering was analyzed using CD-HIT software (http://weizhongli-lab.org/cd-hit). Identical nucleotide sequences were grouped together. For genetic diversity analysis, we downloaded the HA and NA gene sequences of H3N2 and B/Victoria influenza viruses collected in Africa, Antarctica, Asia, Europe, North America, Oceania, and South America during January 2019 to December 2022 and listed in the GISAID database (https://www.gisaid.org). Sequence multiple alignment was performed using MUSCLE software (http://www.drive5.com/muscle/manual) with default parameters. IQ-TREE (http://www.iqtree.org) software was used to build the phylogenetic tree using the maximum likelihood method. The bootstrap was set to 1000 times, and the FLU + G4 model was used for the substitution model. The ratio of the number of non-synonymous to synonymous (dN/dS) mutations was estimated using the single-likelihood ancestor counting method in DataMonkey (http://www.datamonkey.org). The mixed effects model of evolution in DataMonkey was used to identify codon sites undergoing positive selection, with a significance level of P < 0.1. The phylogenetic trees were plotted using the R version 4.2.0 (R Foundation for Statistical Computing, Vienna, Austria). Using the R “treedater” package, a strict molecular clock was matched to the phylogenetic tree to estimate the time of common ancestry and evolutionary rate.Statistical analysesWe conducted statistical analysis using R version 4.2.0 (R Foundation for Statistical Computing, Vienna, Austria). The root-to-tip distance within strains in different years was assessed using regression curve models to determine the correlation. Likelihood ratio testing was used to examine the significance of specific mutation sites under episodic diversifying positive selection. P value < 0.05 was considered significant.ResultsEpidemic of seasonal influenza in the Guangdong of China from 2020 to 2022. From January 2018 to December 2022, 173,401 throat swabs were collected from patients with ARTI. Among them 132,031 (76.14%) were outpatients from 262 hospitals or health institutions in 21 cities: Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Jiangmen, Zhaoqing, Huizhou, Shantou, Chaozhou, Jieyang, Shanwei, Zhejiang, Maoming, Yangjiang, Shaoguan, Qingyuan, Yunfu, Meizhou, and Heyuan. Distribution of samples in clinical department was displayed in Table.S2. A total of 1216 samples finally tested positive for influenza virus (Table.S3, Fig. S1). Figure 1A displays the time of changes in influenza cases during this period; control measures were collected from official websites [14,15,16,17,18]. Before the COVID-19 pandemic, there were four spikes in influenza cases: winter 2017–2018, fall 2018, winter 2018–2019, and winter 2019–2020. Influenza A/H1N1 infection was prevalent in autumn 2018, but switched to influenza B/Victoria in winter 2018–2019 (Fig. 1B, Table S2). In the following winter (2019–2020), influenza cases soared again, reaching a new high (47.67%, 123/258), with most patients infected with influenza A/H3N2. The COVID-19 pandemic began around this period. In January 2020, due to NPIs execution, including cancelling public events and restrictions on people movement and gathering, very few samples tested influenza virus positive (0.13%, 8/6256) from February 2020 to October 2021 in Guangdong Province. Regardless intermittent relaxation of the NPIs (e.g. resuming inter-provincial group tourism and restaurant dine-in services), influenza cases still remained at a very low level during the winter of 2020–2021. Nonetheless, In the winter of 2021–2022, the number of influenza cases increased gradually, peaking at 39 cases per month (4.94%, 39/789). Of the total number of influenza cases, influenza B Victoria accounted for 87.18% (34/39) of cases. During the summer of 2022, despite the prohibition on international travel, the number of influenza cases doubled (11.34%, 255/2248) compared to the previous influenza spike (4.94%, 39/789). The most common virus, influenza A H3N2, accounted for 94.51% (241/255) of the total influenza cases (Fig. 1A, B).Fig. 1Epidemiology of seasonal influenza virus between 2018 and 2022. A Monthly detection of influenza virus and SARS-CoV-2 from January 2018 to December 2022. The red line shows positive cases of influenza virus. Blue lines represent the number of new SARS-CoV-2 cases, according to statistics from the Guangdong Health Commission (http://cdcp.gd.gov.cn/); the heat map at the top right is based on the Oxford COVID-19 Government Response Tracker (OxCGRT) database, reflecting the changes in internal movement restrictions and international travel controls. Arrows highlight the COVID-19 epidemic control policy in Guangdong Province, China. Grading of restrictions on internal movement: 0-no measures; 1-recommend not traveling between regions/cities; 2-internal movement restrictions in place. Grading of international travel controls: 0-no measures; 1-screening; 2-quarantine arrivals from high-risk regions; 3-ban on arrivals from some regions. B Number of influenza virus subtypes. Commercial kits detected 1012 influenza-positive samples during 2018–2022: H1N1 (red), H3N2 (blue), Victoria (green), and Untyped (grey). “Untyped”: the test was not done because of too little remaining sampleFull size imageGenetic characterization of B/Victoria and A/H3N2 influenza virusesTo understand the changes in influenza activity amid the COVID-19 pandemic, we studied the genetic diversity in B/Victoria and A/H3N2 influenza viruses and conducted a phylogenetic analysis of the viral HA and NA genes. HA sequences of influenza B/Victoria strains from Guangdong Province were compared with those sequences from global influenza virus populations before (January to December 2019) and during the COVID-19 pandemic (January 2020 to December 2022). A phylogenetic study revealed that before the COVID-19 pandemic, the B/Victoria virus strains in Guangdong Province were closely related to lineages from diverse areas worldwide. The predominant circulating strain belonged to the V1A.3a evolutionary branch, close to the World Health Organization (WHO)-recommended vaccine strain B/Washington/02/2019 (EPI ISL 341131) for that year. During the COVID-19 pandemic, HA and NA genes of the B/Victoria virus strains evolved into new lineages (Fig. 2A, Fig. S2A). Upon comparison, these strains were close to the local strains circulating in China (e.g., Anhui, Beijing, and Fujian) and to individual lineages originating from Montana, USA, and Sydney, Australia (Fig. S2 A–D). The predominant circulating lineage belonged to the V1A.3a.2 evolutionary branch, which was similar to the WHO-recommended vaccine strains B/Washington/02/2019 (EPI ISL 341131) and B/Washington/02/2019 (21/336) (EPI ISL 7473160) in 2021–2022 (Fig. 2A, Table S4). Thus, during the COVID-19 period, the genetic diversity notably decreased among B/Victoria virus strains in Guangdong Province, with new lineages closely resembling domestic strains within China (Fig. 2B). The HA and NA proteins also underwent non-synonymous mutations (e.g., R147G, N164K, and R290K), suggesting that the B/Victoria viruses were continuously mutating (Table S5, S6).Fig. 2Phylogenic tree of the HA gene of B/Victoria influenza viruses during 2019–2022. A Phylogenetic tree of the HA gene of B/Victoria influenza viruses collected in Guangdong, China from 2019–2022. The same colors in the figure indicate strains from the same year. B Phylogenetic analysis of HA sequences of B/Victoria influenza viruses, globally and in Guangdong Province, China. In the region layer, strains from different regions are different colors. Red and blue lines show domestic pre-COVID-19 (before the COVID-19 outbreak in December 2019) and during-COVID-19 (during the COVID-19 outbreak from January 2020 to December 2022) strains in Guangdong, China, respectivelyFull size imageInfluenza A H3N2 virus exhibited a similar evolutionary trend. Before the COVID-19 pandemic (January to December 2019), three H3N2 sublineages co-circulated in Guangdong. The evolutionary relationships of the HA gene sequences of H3N2 were distributed across multiple regions internationally (e.g., Asia, Africa, Europe, and South America), forming several distinct evolutionary lineages (Fig. S4). During the COVID-19 viral circulation (January 2020 to December 2022), the HA gene of H3N2 viruses evolved into an independent evolutionary branch belonging to the 3C.2a1b.2a.1 evolutionary branch (Fig. S2B). This showed closer genetic proximity to the 2022 WHO-recommended vaccine strain A/Cambodia/e0826360/2020 (Fig. 3A, Table S4) and resembled domestic city lineages, such as those of Chongqing, Guangdong, and Guangxi. Evolutionary analysis of the HA gene suggested that the genetic diversity of influenza H3N2 viruses decreased during the COVID-19 pandemic (Fig. 3B). Although the diversity decreased, multiple mutations, including I29T, I191T, K295E, Y328N, K561N, G604S, Y632F, and I1614M for the HA protein and D1387N and N1394S for the NA protein, occurred in H3N2 viruses during the pandemic compared with those pre-COVID-19. These results indicate ongoing variations in the HA and NA genes of H3N2 influenza viruses during the COVID-19 pandemic (Table S7, S8).Fig. 3Phylogenic tree of the HA gene of H3N2 influenza viruses during 2019–2022. A Phylogenetic tree of the HA gene of H3N2 influenza viruses collected in Guangdong China during 2019–2022. The same colors in the figure indicate strains from the same year. B Phylogenetic analysis of HA sequences globally and in Guangdong, China. In the region layer, strains from different regions are different colors. Red and blue lines show domestic pre-COVID-19 and during-COVID-19 strains in Guangdong, China, respectivelyFull size imageEvolutionary rates and evolutionary selection pressure of HA and NA genes from H3N2 and B/Victoria in Guangdong, ChinaWe conducted a detailed analysis of the evolutionary rates of HA genes from H3N2 and B/Victoria in Guangdong, China during 2010–2022 to evaluate the effect of epidemic control measures on the evolution of the HA genes of these viruses. The analysis showed that the estimated HA gene evolutionary rates of H3N2 viruses before and during COVID-19 were 3.80 × 10−3 per site per year and 7.96 × 10−3 per site per year, respectively (Fig. 4A and B, Table S9); those of the B/Victoria influenza viruses before and during COVID-19 were 1.80 × 10−3 per site per year and 3.11 × 10−3 per site per year, respectively (Fig. 4C and D, Table S9). The evolutionary rates of NA genes from H3N2 and B/Victoria were shown in Table S9. Evolutionary selection pressure analysis showed that HA and NA genes from both H3N2 and B/Victoria viruses underwent purifying selection pressure (dN/dS < 1), with similar levels of selection pressure on both genes. No loci appeared to be significantly subjected to positive selection pressure acting on H3N2 influenza viruses; however, the HA gene of B/Victoria viruses showed significant positive selection pressure acting on the 264th amino acid site (P = 0.0052), suggesting that mutations at this locus may affect the transmissibility of influenza B/Victoria viruses (Table S9). However, no mutation loci for zanamivir and oseltamivir resistance were identified in the NA protein (Table S10, S11).Fig. 4Evolutionary rates of HA genes in H3N2 and B/Victoria influenza viruses before and during the COVID-19 outbreak. A–B Temporal signal in the HA gene dataset of H3N2 determined by linear regression of root-to-tip distance (y-axis) against sample collection date (x-axis). C–D Temporal signal in HA gene dataset of B/Victoria determined by linear-regression of root-to-tip distance (y-axis) against sample collection date (x-axis). Left and right represent the evolutionary rates before and during the COVID-19 pandemic, respectively. Red dots represent the evolutionary tree's tips, and black dots represent its internal nodes. The association between root-to-tip distances among strains in different years was determined using regression curve models. P value < 0.05 were considered significantFull size imageDiscussionInfluenza viruses are RNA viruses belonging to the family Orthomyxoviridae that cause a highly contagious respiratory disease in humans. Both influenza A and B viruses can cause epidemics, with influenza A/H3N2 and B/Victoria being the main strains responsible for current influenza epidemics [19]. However, the COVID-19 pandemic and subsequent implementation of NPIs disrupted the typical seasonality of common respiratory pathogens in many countries [8,9,10, 20]. This phenomenon also occurred in China, particularly with influenza viruses [21,22,23,24]. Despite the substantial decline in influenza activity in Guangdong Province, China, following the emergence of COVID-19, an occult epidemic persisted, and a large seasonal disease outbreak occurred in the summer of 2022 with uncertainty about the origin and timing of the outbreak strain. Therefore, systematic analysis and assessment of the epidemiological and evolutionary characteristics of influenza viruses in Guangdong during the COVID-19 pandemic is imperative.According to our monitoring data, influenza in Guangdong exhibited biannual peaks before the COVID-19 epidemic. Four influenza peaks occurred in winter 2017–2018, autumn 2018, winter 2018–2019, and winter 2019–2020, consistent with other local studies [25]. But in 2020, as previously reported, the influenza outbreak was effectively contained as the consequence of a significant reduction in people mobilization following the stringent implementation of COVID-19 control measures (such as border inspections, city lockdown, stay-at-home rules, closure of schools and public venues, and suspension of cafeteria dining) [26]. By the end of 2021, influenza cases involving H3N2 and B/Victoria gradually increased again, suggesting that although the influenza epidemic was suppressed for more than a year under the strict control measures, the risk of outbreaks remained even though international travel and tourism had not fully resumed [26]. Our study revealed reduced influenza viral genomic diversity after the easing of COVID-19 restrictions, but occult transmission of influenza could occur under strict NPI measures. Phylogenetic analysis showed that influenza B/Victoria was present in different lineages before the pandemic and widely distributed domestically and internationally. However, the closely related strains of B/Victoria in Guangdong in 2021 (during the COVID-19 pandemic) were mainly converged in China’s domestic branch which belonged to the evolutionary branch V1A.3a.2 and was related to the WHO-recommended vaccine strains B/Washington/02/2019 (EPI ISL 341131) and B/Washington/02/2019 (21/336) (EPI ISL 7473160). Our finding was consistent with that of Huang et al. [27]. These strains were more closely related and had identical antigenicity, suggesting that influenza vaccination may be effective. Influenza virus A/H3N2 resurged in Guangdong during the summer of 2022, had less genetic diversity than pre-COVID-19 H3N2 strains, and was closest to strains from other provinces in China during 2022. The H3N2 strains in the current epidemic in Guangdong belong to subclade 3C.2a1b.2a.1, which is on the same evolutionary branch as the 2022 WHO-recommended vaccine strain (A/Cambodia/e0826360/2020), indicating that the antigenicity of these strains is similar to the vaccine. This phenomenon of decreased genetic diversity has also occurred in countries other than China and in other respiratory viruses. Unprecedented widespread respiratory syncytial virus (RSV) outbreaks occurred in Australia during the spring of 2021. These extended into the summer across two widely separated regions, New South Wales and Australian Capital Territory, revealing a major significance in RSV genetic diversity [28].Several factors may explain the resurgence of influenza. First, seasonal influenza viruses evolve through antigenic drift to evade pre-existing immunity and gain a competitive advantage by generating new antigenic variants based on their surface protein mutations [29]. Amid the COVID-19 pandemic, HA substitutions I29T, I191T, K295E, Y328N, K561N, G604S, Y632F, and I1614M were found within the major antigenic sites of H3N2 strains, and R147G, N164K, and R290K substitutions were also present in the major antigenic sites of B/Victoria strains, compared with those of pre-epidemic B/Victoria and H3N2 strains. This suggests that the COVID-19 pandemic somehow caused antigenic drift in the H3N2 and B/Victoria strains.Our results demonstrate that after COVID-19 control measures were relaxed, the rate of B/Victoria HA evolution (3.11 × 10−3) was 1.7 times faster than before the pandemic. Likewise, the H3 gene's evolution rate was 7.96 × 10−3, which is 2.1 times faster than the strains' pre-COVID-19 evolution rate. We hypothesize that influenza viruses could still be transmitted insidiously despite NPIs being implemented. Once controls were relaxed, H3N2 and B/Victoria viruses evolved rapidly, resulting in an increase in influenza activity. However, the possibility of new introductions of influenza H3N2 and B/Victoria from external sources cannot be ruled out. Evidence suggests that immunity against influenza infection acquired through infection or vaccination wanes gradually, with circulating antibodies beginning to decline within 6 months [30, 31]. During the 3-year period encompassing the COVID-19 pandemic, the population of China lacked exposure to natural infection; therefore, influenza antibodies (either naturally acquired or vaccine-induced) may have decreased or diminished, resulting in an accumulation of susceptible individuals and potentially triggering more severe epidemics [32, 33]. Reduced administration of seasonal influenza vaccinations during the COVID-19 pandemic may have also contributed to increased susceptibility among the population [34, 35]. However, China's low influenza vaccination rates of 3.16% in 2020–2021 and 2.47% in 2021–2022 would have inevitably resulted in a new epidemic. In any case, China's vaccination rates against influenza were 3.16% in 2020–2021 and 2.47% in 2021–2022, respectively; these lower rates will inevitably cause new outbreaks in China [36].” Additionally, not to be overlooked are the decline in the proportion of mask-wearers and the deterioration of self-control consciousness [37]. All of these factors may contribute to the current seasonal influenza outbreak in Guangdong, China.This study has some limitations. Our data were restricted to virological surveillance data and may have been influenced by biases such as favorable specimen collection and case selection. Moreover, the impact of HA and NA gene mutations on the infectivity and transmissibility of these viruses remains uncertain; additional research is required to confirm their importance.To curb the COVID-19 pandemic, governments worldwide implemented strict NPIs [38]. However, NPIs do not completely inhibit the spread of influenza in a population. Once domestic and international travel resumes to pre-pandemic levels, influenza viruses will continue to spread unexpectedly [39,40,41]. Regularly monitoring the evolution of influenza viruses may provide insights and alerts us to potential epidemics in the future.ConclusionsThe COVID-19-related NPIs disrupt the transmission of seasonal influenza, which may lead to the accumulation of viral mutations and accelerated evolution of H3N2 and B/Victoria viruses. Monitoring the evolution of influenza viruses on a regular basis may provide insights and alerts regarding potential epidemics. To prevent future influenza outbreaks, global preparedness and collaboration are essential. Availability of data and materials The raw data used in this study can be obtained from the corresponding author upon reasonable request. AbbreviationsARTI: Acute respiratory tract infections COVID-19: Coronavirus disease 2019 HA: Hemagglutinin KMD: Kingmed Diagnostics laboratory NA: Neuraminidase NPIs: Non-pharmacological interventions RSV: Respiratory syncytial virus SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2 WHO: World Health Organization ReferencesIuliano AD, Roguski KM, Chang HH, Tempia S, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285–300.Article PubMed Google Scholar Russell CA, Jones TC, Barr IG, et al. The global circulation of seasonal influenza A (H3N2) viruses. Science. 2008;320(5874):340–6.Article CAS PubMed Google Scholar Paules C, Subbarao K. Influenza. Lancet. 2017;390(10095):697–708.Article PubMed Google Scholar Uyeki TM, Hui DS, Zambon M, Wentworth DE, Monto AS. Influenza. Lancet. 2022;400(10353):693–706.Article CAS PubMed PubMed Central Google Scholar Tafalla M, Buijssen M, Geets R, Vonk N-S. A comprehensive review of the epidemiology and disease burden of Influenza B in 9 European countries. Hum Vaccin Immunother. 2016;12(4):993–1002.Article PubMed PubMed Central Google Scholar Azziz Baumgartner E, Dao CN, Nasreen S, et al. Seasonality, timing, and climate drivers of influenza activity worldwide. J Infect Dis. 2012;206(6):838–46.Article PubMed Google Scholar Diamond C, Gong H, Sun FY, et al. Regional-based within-year seasonal variations in influenza-related health outcomes across mainland China: a systematic review and spatio-temporal analysis. BMC Med. 2022;20(1):58.Article PubMed PubMed Central Google Scholar Haddadin Z, Schuster JE, Spieker AJ, et al. Acute respiratory illnesses in children in the SARS-CoV-2 pandemic: prospective multicenter study. Pediatrics. 2021;148(2):e2021051462.Article PubMed Google Scholar Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020. Am J Transplant. 2020;20(12):3681–5.Article CAS PubMed PubMed Central Google Scholar Qiu Z, Cao Z, Zou M, et al. The effectiveness of governmental nonpharmaceutical interventions against COVID-19 at controlling seasonal influenza transmission: an ecological study. BMC Infect Dis. 2022;22(1):331.Article CAS PubMed PubMed Central Google Scholar Geng M-J, Zhang H-Y, Yu L-J, et al. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic. Nat Commun. 2021;12(1):6923.Article CAS PubMed PubMed Central Google Scholar Zheng L, Qi J, Wu J, Zheng M. Changes in influenza activity and circulating subtypes during the COVID-19 outbreak in China. Front Med (Lausanne). 2022;9:829799.Article PubMed Google Scholar Huang W, Cheng Y, Tan M, et al. Epidemiological and virological surveillance of influenza viruses in China during 2020–2021. Infect Dis Poverty. 2022;11(1):74.Article PubMed PubMed Central Google Scholar The Central Commission for Discipline Inspection of the Communist Party of China (CCDI): 7 more added! 24 regions initiated Level I public health emergency response. https://www.ccdi.gov.cn/yaowen/20200120200125_210339.html. 2020. Accessed 40 Apr 2024.People's Government of Guangdong Province: Guangdong enhances inbound health management, requiring quarantine for severe-area arrivals. https://www.gd.gov.cn/gdywdt/bmdt/content/post_2913089.html. 2020. Accessed 40 Apr 2024.People's Government of Guangdong Province: Implementation plan of Guangdong's COVID-19 prevention and control command for regular prevention and control measures. http://www.gd.gov.cn/gdywdt/gdyw/content/post_2993975.html. 2020. Accessed 40 Apr 2024.The State Council of the People's Republic of China: Ministry of culture and tourism notice on promoting tourism enterprises' resumption of work. https://www.gov.cn/zhengce/zhengceku/2020-07/14/content_5526872.htm. 2020. Accessed 40 Apr 2024.The People's Government of Guangzhou Municipality: Guangzhou Baiyun International Airport imposes full-process control on inbound flights to prevent overseas input. https://www.gz.gov.cn/xw/jrgz/content/post_7342219.html. 2020. Accessed 40 Apr 2024.World Health Organization. Fact Sheet Influenza (seasonal). Available from: https://www.who.intews-room/fact-sheets/detail/influenza-(seasonal). Cited 2023 Feb 3.Baker RE, Park SW, Yang W, Vecchi GA, Metcalf CJE, Grenfell BT. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci U S A. 2020;117(48):30547–53.Article CAS PubMed PubMed Central Google Scholar Chen B, Wang M, Huang X, et al. Changes in incidence of notifiable infectious diseases in China under the prevention and control measures of COVID-19. Front Public Health. 2021;9:728768.Article PubMed PubMed Central Google Scholar Itaya T, Furuse Y, Jindai K. Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020. Int J Infect Dis. 2020;97:78–80.Article CAS PubMed PubMed Central Google Scholar Feng L, Zhang T, Wang Q, et al. Impact of COVID-19 outbreaks and interventions on influenza in China and the United States. Nat Commun. 2021;12(1):3249.Article CAS PubMed PubMed Central Google Scholar Zuo Z, Yang C, Ye F, et al. Trends in respiratory diseases before and after the COVID-19 pandemic in China from 2010 to 2021. BMC Public Health. 2023;23(1):217.Article PubMed PubMed Central Google Scholar Xiaohua T, Meiyun Ye, Yali Z, et al. Seasonal epidemiological characteristics and dynamic changes of influenza viruses subtypes/lineages in Guangdong, 2014–2020. Dis surveill. 2022;37(1):108–14. Google Scholar Zeng Z, Guan W, Liu Y, et al. Different circulation pattern of multiple respiratory viruses in southern China during the COVID-19 pandemic. Front Microbiol. 2022;12:801946.Article PubMed PubMed Central Google Scholar Huang W, Li X, Tan M, et al. Epidemiological and virological surveillance of seasonal influenza viruses — China, 2020–2021. China CDC Wkly. 2021;3(44):918–22.Article PubMed PubMed Central Google Scholar Sullivan SG, Carlson S, Cheng AC, et al. Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020. Euro Surveill. 2020;25(47):2001847.Article PubMed PubMed Central Google Scholar Petrova VN, Russell CA. The evolution of seasonal influenza viruses. Nat Rev Microbiol. 2018;16(1):47–60.Article CAS PubMed Google Scholar Kissling E, Nunes B, Robertson C, et al. I-MOVE multicentre case-control study 2010/11 to 2014/15: is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination? Euro Surveill. 2016;21(16):30201.Article Google Scholar Young B, Sadarangani S, Jiang L, Wilder-Smith A, Chen MIC. Duration of influenza vaccine effectiveness: a systematic review, meta-analysis, and meta-regression of test-negative design case-control studies. J Infect Dis. 2018;217(5):731–41.Article PubMed Google Scholar Woolthuis RG, Wallinga J, van Boven M. Variation in loss of immunity shapes influenza epidemics and the impact of vaccination. BMC Infect Dis. 2017;17(1):632.Article PubMed PubMed Central Google Scholar Dhanasekaran V, Sullivan S, Edwards KM, et al. Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination. Nat Commun. 2022;13(1):1721.Article CAS PubMed PubMed Central Google Scholar Lee K, Jalal H, Raviotta JM, et al. Estimating the Impact of low influenza activity in 2020 on population immunity and future influenza seasons in the United States. Open Forum Infect Dis. 2022;9(1):ofab607.Article PubMed Google Scholar Wang Q, Xiu S, Zhao S, et al. Vaccine hesitancy: COVID-19 and influenza vaccine willingness among parents in Wuxi, China-a cross-sectional study. Vaccines (Basel). 2021;9(4):342.Article CAS PubMed Google Scholar Zhao HT, Peng ZB, Ni ZL, Yang XK, Guo QY, Zheng JD, et al. Investigation on influenza vaccination policy and vaccination situation during the influenza seasons of 2020–2021 and 2021–2022 in China. Zhonghua Yu Fang Yi Xue Za Zhi. 2022;56(11):1560–4.CAS PubMed Google Scholar Zhang S, Qi H, Shan Y, Lan H, Cao Y, Xin W, et al. An Interview study of college students’ health emergency literacy in the context of COVID-19 normalized prevention and control. Altern Ther Health Med. 2023;29(5):293–7.PubMed Google Scholar Flaxman S, Mishra S, Gandy A, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584(7820):257–61.Article CAS PubMed Google Scholar Cowling BJ, Ali ST, Ng TWY, et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020;5(5):e279–88.Article PubMed PubMed Central Google Scholar Laurie KL, Rockman S. Which influenza viruses will emerge following the SARS-CoV-2 pandemic? Influenza Other Respir Viruses. 2021;15(5):573–6.Article CAS PubMed PubMed Central Google Scholar Baker RE, Park SW, Yang W, Vecchi GA, Metcalf CJE, Grenfell BT. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci U S A. 2020;117(48):30547–53.Article CAS PubMed PubMed Central Google Scholar Download referencesAcknowledgementsWe thank all the participants in this study.FundingThis work was supported by National Key Research and Development Program of China (Grant No.2023YFC3041800), National Natural Science Foundation of China (Grant No. 82361168672); Self-supporting Program of Guangzhou Laboratory, Grant No. SRPG22-007, Major Project of Guangzhou National Laboratory, Grant No. GZNL2024A01004; Science and Technology Development Fund of Macau SAR (005/2022/ALC); Science and Technology Program of Guangzhou (No. 2022B01W0003, SL2023A04J01299); Science and Technology Development Fund of Macau SAR (0045/2021/A); Macau University of Science and Technology (FRG-20-021-MISE); Plan on enhancing scientific research in GMU.Author informationAuthor notesZhiqi Zeng, Yong Liu, Wenxiang Jin, Jingyi Liang, Jinbin Chen, Ruihan Chen and Qianying Li contributed equally to this work.Xiaoyan Deng, Zhengshi Lin, Chitin Hon and Zifeng Yang corresponding authors contributed equally to this work.Authors and AffiliationsState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510180, P.R. ChinaZhiqi Zeng, Jingyi Liang, Qianying Li, Wenda Guan, Lixi Liang, Qiubao Wu, Zhengshi Lin & Zifeng YangGuangzhou Key Laboratory for Clinical Rapid Diagnosis and Early Warning of Infectious Diseases, KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaZhiqi Zeng, Yong Liu, Wenxiang Jin, Jinbin Chen, Yuanfang Lai, Xiaoyan Deng & Zifeng YangKingmed Virology Diagnostic and Translational Center, Guangzhou Kingmed Center for Clinical Laboratory Co., Ltd., Guangzhou, ChinaYong Liu & Wenxiang JinDepartment of Engineering Science, Faculty of Innovation Engineering, Macau University of Science and Technology, Taipa, Macau, ChinaJingyi Liang, Ruihan Chen & Chitin HonGuangzhou Laboratory, Guangzhou, ChinaChitin Hon & Zifeng YangRespiratory Disease AI Laboratory on Epidemic Intelligence and Medical Big Data Instrument Applications, Faculty of Innovative Engineering, Macau University of Science and Technology, Macau SAR, ChinaZhiqi Zeng, Zhengshi Lin & Zifeng YangAuthorsZhiqi ZengView author publicationsYou can also search for this author in PubMed Google ScholarYong LiuView author publicationsYou can also search for this author in PubMed Google ScholarWenxiang JinView author publicationsYou can also search for this author in PubMed Google ScholarJingyi LiangView author publicationsYou can also search for this author in PubMed Google ScholarJinbin ChenView author publicationsYou can also search for this author in PubMed Google ScholarRuihan ChenView author publicationsYou can also search for this author in PubMed Google ScholarQianying LiView author publicationsYou can also search for this author in PubMed Google ScholarWenda GuanView author publicationsYou can also search for this author in PubMed Google ScholarLixi LiangView author publicationsYou can also search for this author in PubMed Google ScholarQiubao WuView author publicationsYou can also search for this author in PubMed Google ScholarYuanfang LaiView author publicationsYou can also search for this author in PubMed Google ScholarXiaoyan DengView author publicationsYou can also search for this author in PubMed Google ScholarZhengshi LinView author publicationsYou can also search for this author in PubMed Google ScholarChitin HonView author publicationsYou can also search for this author in PubMed Google ScholarZifeng YangView author publicationsYou can also search for this author in PubMed Google ScholarContributionsZY, XD, ZL, CH and ZZ contributed to study conception and design. LL, QW, YL contributed to data collection and analysis. ZZ, YL, WJ, JL, JC, RC, QL contributed to drafting and editing the manuscript, and they also accessed and verified the data. ZL, WG revised the manuscript. ZY, WG, ZL, YZ provided study supervision. All authors read and approved the final manuscript.Corresponding authorsCorrespondence to Xiaoyan Deng, Zhengshi Lin, Chitin Hon or Zifeng Yang.Ethics declarations Ethics approval and consent to participate The human subject protocol in this study was approved by the Ethics Committee of Guangzhou Kingmed Center for Clinical Laboratory (GZKM-MP03.10.01). All recruited participants have been exempted from informed consent. Consent for publication Not applicable. Competing interests The authors declare that there is no conflict of interest. Supplementary InformationSupplementary Material 1. Supplementary Material 2. Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. Reprints and permissionsAbout this articleCite this articleZeng, Z., Liu, Y., Jin, W. et al. Molecular epidemiology and phylogenetic analysis of influenza viruses A (H3N2) and B/Victoria during the COVID-19 pandemic in Guangdong, China. Infect Dis Poverty 13, 56 (2024). https://doi.org/10.1186/s40249-024-01218-zDownload citationReceived: 17 January 2024Accepted: 21 June 2024Published: 01 August 2024DOI: https://doi.org/10.1186/s40249-024-01218-zShare this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KeywordsInsidious transmissionInfluenzaCOVID-19 controlGenetic diversityEvolution Download PDF Advertisement Infectious Diseases of Poverty ISSN: 2049-9957 Contact us Submission enquiries: Access here and click Contact Us General enquiries: journalsubmissions@springernature.com Read more on our blogs Receive BMC newsletters Manage article alerts Language editing for authors Scientific editing for authors Policies Accessibility Press center Support and Contact Leave feedback Careers Follow BMC BMC Twitter page BMC Facebook page BMC Weibo page By using this website, you agree to our Terms and Conditions, Your US state privacy rights, Privacy statement and Cookies policy. Your privacy choices/Manage cookies we use in the preference centre. © 2024 BioMed Central Ltd unless otherwise stated. Part of Springer Nature.Valadao, Slotkin Introduce Legislation to Address Avian Influenza | U.S. Congressman David Valadao Javascript must be enabled for the correct page display Skip to Content facebook twitter Open search form Close search form search Submit SUBSCRIBE Menu Menu icon Home About Biography Committees Flood Resources Services Art Competition Community Project Funding Map Congressional App Contest Congressional Certificate Event Request Flag Request Grants Grant Letters of Support Help with a Federal Agency Internships Kids Page Meeting Request Service Academy Nominations Tour Requests Vietnam Veteran Commemoration Government Shutdown FAQ Issues Agriculture Appropriations Project Requests Water Budget Jobs and the Economy Defense and Military Immigration Energy Veterans COVID-19 Media Press Releases In the News Articles Newsletter Archive Contact Email Me E-Newsletter Sign Up Office Locations Interactive Map Text Alerts Sign Up facebook twitter search Submit Close search form Join My Email List Subscribe to receive the latest news, insights, and updates directly to your inbox. subscribe SUBSCRIBE Press Releases Valadao, Slotkin Introduce Legislation to Address Avian Influenza Share on Facebook Share on Twitter Print this Page Share by Email Washington, July 29, 2024 | Faith Mabry Tags: Agriculture Congressman David G. Valadao (CA-22) joined Congresswoman Elissa Slotkin (MI-07) to introduce the Avian Influenza Research and Response Act. The bill aims to address the ongoing detection of highly pathogenic avian flu in dairy cattle. WASHINGTON – Congressman David G. Valadao (CA-22) joined Congresswoman Elissa Slotkin (MI-07) to introduce the Avian Influenza Research and Response Act. The bill aims to address the ongoing detection of highly pathogenic avian flu in dairy cattle. “As a dairyman, I’ve been closely following this situation since the first case of avian influenza was detected in U.S. dairy cattle,” said Congressman Valadao. “While no cases have been detected in California, it’s important that we stay proactive to ensure dairy cattle and the workers who interact with these animals on a daily basis remain healthy. This bill brings avian influenza research to the forefront and better equips the industry to deal with these kinds of diseases. I’m thankful to Rep. Slotkin’s work on this critical issue for dairy farmers across the country.” “I’ve heard directly from Michigan farmers on the forefront of this outbreak of avian flu about how it’s disrupting their operations and threatening their livelihood, and this legislation is drawn directly from those conversations,” said Congresswoman Slotkin. “Food security is national security, so it’s critical that we take action to protect dairy cattle, ensure the integrity of our milk supply, and support our farmers. Accordingly, this legislation will require the Department of Agriculture to create a biosecurity education and training program for dairy producers and prioritize avian flu research, while also codifying in law compensation for dairy farmers whose milk production has suffered due to avian influenza. As we continue to combat avian flu, I’ll be working closely with state, local, and federal officials to mitigate the effects of its spread.” The Avian Influenza Research and Response Act would: Prioritize highly pathogenic avian influenza research under USDA’s Agriculture and Food Research Initiative. Codify in law recent USDA rulemaking that allows for dairy producers to be compensated for loss of milk production due to avian influenza infection. Direct the Secretary of Agriculture to establish a Dairy Biosecurity Education and Training program. Read the full text of the bill here. Related News Disaster relief needed to help ag producers October 25, 2024 | Posted in In the News Congressman Valadao Introduces Supplemental Appropriations Bill to Assist Ag Producers Impacted by Natural Disasters September 27, 2024 | Posted in Press Releases Congressman Valadao Introduces Legislation to Fix Central Valley Roads September 10, 2024 | Posted in Press Releases Congressman Valadao Statement on Confirmed Avian Flu Cases in California Dairies September 4, 2024 | Posted in Press Releases Washington, DC Office 2465 Rayburn HOB Washington, DC 20515 (202) 225-4695 Bakersfield District Office 2700 M Street Suite 250B Bakersfield, CA 93301 Phone: (661) 864-7736 Fax: (833) 284-9090 Hanford District Office 107 South Douty Street Hanford, CA 93230 Phone: (559) 460-6070 Fax: (559) 584-3564 PRIVACY Accessibility Contact house.gov facebook twitter back to top Back to topTo prevent supercharged flu virus, CDC pushes seasonal flu vaccines to farmworkers at risk of coinfection with bird flu | CNN CNN values your feedback 1. How relevant is this ad to you? 2. Did you encounter any technical issues? Video player was slow to load content Video content never loaded Ad froze or did not finish loading Video content did not start after ad Audio on ad was too loud Other issues Ad never loaded Ad prevented/slowed the page from loading Content moved around while ad loaded Ad was repetitive to ads I've seen previously Other issues Cancel Submit Thank You! Your effort and contribution in providing this feedback is much appreciated. Close Ad Feedback Close icon Health Life, But Better Fitness Food Sleep Mindfulness Relationships More Life, But Better Fitness Food Sleep Mindfulness Relationships Watch Listen Live TV Subscribe Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Live TV Listen Watch Edition US International Arabic Español Edition US International Arabic Español Life, But Better Fitness Food Sleep Mindfulness Relationships Follow CNN World Africa Americas Asia Australia China Europe India Middle East United Kingdom US Politics SCOTUS Congress Facts First 2024 Elections Business Tech Media Calculators Videos Markets Pre-markets After-Hours Fear & Greed Investing Markets Now Nightcap Health Life, But Better Fitness Food Sleep Mindfulness Relationships Entertainment Movies Television Celebrity Tech Innovate Foreseeable Future Mission: Ahead Work Transformed Innovative Cities Style Arts Design Fashion Architecture Luxury Beauty Video Travel Destinations Food & Drink Stay News Videos Sports Football Tennis Golf Motorsport US Sports Olympics Climbing Esports Hockey Watch Live TV CNN Fast Shows A-Z CNN10 CNN Max CNN TV Schedules Listen CNN 5 Things Chasing Life with Dr. Sanjay Gupta The Assignment with Audie Cornish One Thing Tug of War CNN Political Briefing The Axe Files All There Is with Anderson Cooper All CNN Audio podcasts Science Space Life Unearthed Climate Solutions Weather Features As Equals Call to Earth Freedom Project Impact Your World Inside Africa CNN Heroes Weather Video Climate Ukraine-Russia War Israel-Hamas War About CNN Photos Investigations CNN Profiles CNN Leadership CNN Newsletters Work for CNN Ad Feedback To prevent supercharged flu virus, CDC pushes seasonal flu vaccines to farmworkers at risk of coinfection with bird flu By Jen Christensen, CNN 4 minute read Updated 3:58 PM EDT, Tue July 30, 2024 Link Copied! Bird flu poses a threat to some farm workers. (Photo by Smith Collection/Gado/Getty Images). Smith Collection/Gado/Getty Images CNN — The US Centers for Disease Control and Prevention announced Tuesday a $5 million initiative to offer seasonal flu vaccines to livestock workers in order to reduce the public health concern that a new version of the influenza virus could emerge among farm workers who are at a higher risk of catching the bird flu (H5N1) virus, which has been circulating in millions of farmed and wild animals. The goal of the initiative is to protect the health and safety of livestock workers as seasonal respiratory viruses begin to circulate, Dr. Nirav Shah, principal deputy director of the CDC, said Tuesday. Avian influenza research DigicomPhoto/Science Photo Library/Getty Images Related article Colorado bird flu cases show how extreme heat may be complicating efforts to control the virus “Preventing seasonal influenza in these workers, many of whom are also potentially exposed to H5N1 viruses, may also reduce the risk of new versions of the influenza A virus emerging,” he said. If two different strains of influenza infect a person, there is always a risk they could mix together and create a completely new virus with traits from each one. A new virus could be harmless, but there is also a chance that it could be even more contagious, deadly or resistant to existing treatments. The risk of what is called genetic reassortment – when multiple viruses coinfect a cell and replicate to create a new virus – is “theoretical,” Shah said, but “because we know that it could happen, we want to take steps now to reduce that effect.” “Anything that is predictable is also something that’s preventable,” he said. Reassortment has happened with other influenza viruses. In 2009, H1N1 – which Shah described as “a close cousin” of H5N1 – was thought to have emerged because of genetic reassortment of influenza A viruses in pigs. “I’m not suggesting that it was a human-pig interaction that led to that reassortment, but it was thought to be a reassortment-type event between a novel H1 virus and a more seasonal variety,” Shah said. “This is something that has occurred, and it’s a concern for that reason. Anything we can do to reduce the likelihood that a new virus that emerges that has the transmissibility of seasonal flu with the severity of H5 is a risk that we want to reduce as much as possible.” MIAMI, FLORIDA - SEPTEMBER 10: A bottle of influenza vaccine at a CVS pharmacy and MinuteClinic on September 10, 2021 in Miami, Florida. CVS Health is offering the flu shots by appointment or walking in as health experts encourage people to get their flu shots in hopes of preventing a bad flu season. (Photo by Joe Raedle/Getty Images) Joe Raedle/Getty Images/FILE Related article The Covid-19 pandemic killed off one strain of the flu, and that will change the next vaccines The CDC said that under the new initiative, the seasonal flu vaccine will not be mandatory for farm workers. Public health officials at the state level will bring vaccines to workers at local events and to areas where they typically gather. “This is fundamentally an effort that relies upon trust, and that trust relies upon us making the case for why the vaccine is important,” Shah said. The seasonal flu vaccine does not provide protection against bird flu. The CDC says it does not think a specific bird flu vaccine is necessary, even among workers who are at a higher risk because they work with infected animals. Although there have been additional bird flu cases in humans in this outbreak, Shah said, symptoms have been mild, and the prevalence is still “extremely low” and does not warrant an H5-specific vaccination. The CDC says an additional $4 million will be sent to the National Center for Farmworker Health to help prevent more workers from getting sick with bird flu. The federal organization will use the money to partner with community-based organizations in affected states. Together, the organizations will provide training and information sessions about bird flu and expand access to testing, treatment and personal protective equipment. Get CNN Health's weekly newsletter Sign up here to get The Results Are In with Dr. Sanjay Gupta every Friday from the CNN Health team. The CDC said Tuesday that there have been nine known human cases of H5N1 among poultry workers in Colorado related to the latest outbreak. Officials previously said that the workers who got sick had been culling poultry believed to be infected at a farm in the northeast part of the state. The latest human cases are mild, mostly involving pink eye or conjunctivitis. The CDC said there are no additional tests pending, but there still could be additional cases. There have been a handful of cases in other states, including in Texas and in Michigan. All were among farm workers. The general public’s risk from bird flu still remains low, according to the CDC, but there is still a real risk for animals. The outbreak has affected millions of animals, with outbreaks in commercial poultry and in back yard flocks, cows, wild birds, wild mammals and even pets, mostly cats. Ad Feedback Ad Feedback Ad Feedback Ad Feedback Ad Feedback Ad Feedback Ad Feedback Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Live TV Listen Watch World Africa Americas Asia Australia China Europe India Middle East United Kingdom US Politics SCOTUS Congress Facts First 2024 Elections Business Tech Media Calculators Videos Markets Pre-markets After-Hours Fear & Greed Investing Markets Now Nightcap Health Life, But Better Fitness Food Sleep Mindfulness Relationships Entertainment Movies Television Celebrity Tech Innovate Foreseeable Future Mission: Ahead Work Transformed Innovative Cities Style Arts Design Fashion Architecture Luxury Beauty Video Travel Destinations Food & Drink Stay News Videos Sports Football Tennis Golf Motorsport US Sports Olympics Climbing Esports Hockey Watch Live TV CNN Fast Shows A-Z CNN10 CNN Max CNN TV Schedules Listen CNN 5 Things Chasing Life with Dr. Sanjay Gupta The Assignment with Audie Cornish One Thing Tug of War CNN Political Briefing The Axe Files All There Is with Anderson Cooper All CNN Audio podcasts Science Space Life Unearthed Climate Solutions Weather Features As Equals Call to Earth Freedom Project Impact Your World Inside Africa CNN Heroes Weather Video Climate Ukraine-Russia War Israel-Hamas War About CNN Photos Investigations CNN Profiles CNN Leadership CNN Newsletters Work for CNN Health Watch Listen Live TV Follow CNN Sign in My Account Settings Topics You Follow Sign Out Your CNN account Sign in to your CNN account Terms of Use Privacy Policy Ad Choices Accessibility & CC About Newsletters Transcripts © 2024 Cable News Network. A Warner Bros. Discovery Company. All Rights Reserved. CNN Sans ™ & © 2016 Cable News Network.Bird flu cases among farm workers may be going undetected, a study suggests : Shots - Health News : NPR Accessibility links Skip to main content Keyboard shortcuts for audio player Open Navigation Menu Newsletters NPR Shop Close Navigation Menu Home News Expand/collapse submenu for News Election 2024 National World Politics Business Health Science Climate Race Culture Expand/collapse submenu for Culture Books Movies Television Pop Culture Food Art & Design Performing Arts Life Kit Gaming Music Expand/collapse submenu for Music All Songs Considered Music Features Tiny Desk Live Sessions Podcasts & Shows Expand/collapse submenu for Podcasts & Shows Daily Morning Edition Weekend Edition Saturday Weekend Edition Sunday All Things Considered Fresh Air Up First Featured The NPR Politics Podcast Throughline Trump's Trials Wild Card with Rachel Martin More Podcasts & Shows Search Newsletters NPR Shop All Songs Considered Music Features Tiny Desk Live Sessions About NPR Diversity Support Careers Press Ethics Bird flu cases among farm workers may be going undetected, a study suggests : Shots - Health News Dairy workers in Texas show signs of prior, uncounted bird flu infections in a new study. Without better surveillance, researchers warn that health officials could be caught off guard if the virus gets more contagious. Shots Health News From NPR Your Health Treatments & Tests Health Inc. Policy-ish Public Health Twitter Shots - Health News Bird flu cases among farm workers may be going undetected, a study suggests July 31, 20242:30 PM ET From By Amy Maxmen Bird flu continues to spread among dairy cattle. And new research shows there may be more cases among farm workers than health officials have confirmed to date. Robert F. Bukaty/AP hide caption toggle caption Robert F. Bukaty/AP A new study lends weight to fears that more livestock workers have gotten the bird flu than has been reported. “I am very confident there are more people being infected than we know about,” said Gregory Gray, the infectious disease researcher at the University of Texas Medical Branch who led the study, posted online Wednesday and under review to be published in a leading infectious disease journal. “Largely, that’s because our surveillance has been so poor.” As bird flu cases go underreported, health officials risk being slow to notice if the virus were to become more contagious. A large surge of infections outside of farmworker communities would trigger the government’s flu surveillance system, but by then it might be too late to contain. Sponsor Message Shots - Health News With the U.S. bird flu outbreak uncontained, scientists see growing risks “We need to figure out what we can do to stop this thing,” Gray said. “It is not just going away.” The Centers for Disease Control and Prevention bases decisions on its surveillance. For example, the agency has bird flu vaccines on hand but has decided against offering them to farmworkers, citing a low number of cases. But testing for bird flu among farmworkers remains rare, which is why Gray’s research stands out as the first to look for signs of prior, undiagnosed infections in people who had been exposed to sick dairy cattle – and who had become ill and recovered. Gray’s team detected signs of prior bird flu infections in workers from two dairy farms that had outbreaks in Texas earlier this year. They analyzed blood samples from 14 farmworkers who had not been tested for the virus and found antibodies against it in two. This is a nearly 15% hit rate from only two dairy farms out of more than 170 with bird flu outbreaks in 13 states this year. One of the workers with antibodies had been taking medicine for a lingering cough when he agreed to allow researchers to analyze his blood in April. The other had recently recovered from a respiratory illness. She didn’t know what had caused it but told researchers that untested farmworkers around her had been sick too. Sponsor Message Richard Webby, director of the World Health Organization Collaborating Center for Influenza at St. Jude Children’s Research Hospital in Memphis, Tennessee, said the results confirmed his suspicions that the 13 human bird flu cases reported this year by the CDC were an undercount. “Maybe what we see isn’t exactly the tip of the iceberg, but it’s certainly not the whole story,” Webby said. Little testing of farm workers Although small, the study gives fresh urgency to reports of undiagnosed ailments among farmworkers and veterinarians. The CDC has warned that if people are infected by the seasonal flu and the bird flu simultaneously, the two types of viruses could swap genes in a way that allows the bird flu to spread between people as easily as seasonal varieties. No evidence suggests that’s happening now. And asymptomatic cases of the bird flu appear to be rare, according to a Michigan antibody study described by the CDC on July 19. Researchers analyzed blood samples from 35 workers from dairy farms that had outbreaks in Michigan, and none showed signs of missed infections. Unlike the study in Texas, these workers hadn’t fallen sick. Treatments A protein called Reelin keeps popping up in brains that resist aging and Alzheimer’s “It’s a small study, but a first step,” said Natasha Bagdasarian, Michigan’s chief medical executive. She said that the state was boosting outreach to test farmworkers but its efforts were complicated by systemic issues like precarious employment that renders them vulnerable to getting fired for calling out sick. Without more assistance for farmworkers, and cooperation between the government and the livestock industry, Gray said, the U.S. risks remaining in the dark about this virus. “There’s a lot of genomic studies and laboratory work, but farms are where the real action is,” Gray said, “and we’re not watching.” A researcher draws blood from a farmworker to analyze it for signs of a previous bird flu infection. Thang Nguyen/UTMB hide caption toggle caption Thang Nguyen/UTMB Communication breakdown A dairy worker in Colorado told KFF Health News that he sought medical care about a month ago for eye irritation — a common symptom of the bird flu. The doctor conducted a usual checkup, complete with a urine analysis. But the farmworker hadn’t heard of the bird flu, and the clinician didn’t mention it or test for the virus. "They told me I had nothing,” he said in Spanish, speaking on the condition of anonymity because he feared retaliation from employers. Sponsor Message This dairy worker and two in Texas said their employers have not provided goggles, N95 masks, or aprons to protect them from milk and other fluids that could be contaminated with the virus. Buying their own gear is a tall order because money is tight. As is going to the doctor. One worker in Texas said he didn’t seek care for piercing headaches and a sore throat because he doesn’t have health insurance and can’t afford the cost. He guessed the symptoms were from laboring long hours in sweltering barns with limited water. “They don’t give you water or anything,” he said. “You bring your own bottles.” But there’s no way to know the cause of symptoms — whether bird flu or something else — without testing. About a fifth of workers on livestock farms are uninsured, according to a KFF analysis, and a similar share have household incomes of less than $40,000 a year. The three farmworkers hadn’t heard of the bird flu from their employers or state health officials, never mind offers of tests. The CDC boasted in a recent update that, through its partnership with Meta, the company that owns Facebook and Instagram, bird flu posts have flickered across computer and smartphone screens more than 10 million times. Such outreach is lost on farmworkers who aren’t scrolling, don’t speak English or Spanish, or are without smartphones and internet access, said Bethany Boggess Alcauter, director of research and public health programs at the National Center for Farmworker Health. She and others said that offers of protective gear from health officials weren’t reaching farms. “We’ve heard that employers have been reticent to take them up on the offer,” said Christine Sauvé, policy and engagement manager at the Michigan Immigrant Rights Center. “If this starts to transmit more easily person to person, we’re in trouble,” she said, “because farmworker housing units are so crowded and have poor ventilation.” Sponsor Message Clinics might alert health officials if sick farmworkers seek medical care. But many farmworkers don’t because they lack health insurance and could be fired for missing work. “The biggest fear we hear about is retaliation from employers, or that someone might be blacklisted from other jobs,” Sauvé said. Flu surveillance The CDC assesses the current bird flu situation as a low public health risk because the country’s flu surveillance system hasn’t flagged troubling alerts. The system scans for abnormal increases in hospital visits. Nothing odd has turned up there. It also analyzes a subset of patient samples for unusual types of flu viruses. Since late February, the agency has assessed about 36,000 samples. No bird flu. However, Samuel Scarpino, an epidemiologist who specializes in disease surveillance, said this system would miss many emerging health threats because, by definition, they start with a relatively small number of infections. Roughly 200,000 people work on farms with livestock in the United States, according to the CDC. That’s a mere 0.1% of the country’s population. Scarpino said the CDC’s surveillance would be triggered if people start dying from the bird flu. The 13 known cases have been mild. And the system will probably pick up surges if the virus spreads beyond farmworkers and their closest contacts — but by then it may be too late to contain. “We don’t want to find ourselves in another COVID situation,” Scarpino said, recalling how schools, restaurants, and businesses needed to close because the coronavirus was too widespread to control through testing and targeted, individual isolation. “By the time we were catching cases,” he said, “there were so many that we were only left with bad options.” Troubling signs Researchers warn that the H5N1 bird flu virus has evolved to be more infectious to mammals, including humans, in the past couple of years. This drives home the need to keep an eye on what’s happening as the outbreak spreads to dairy farms across the country. Sponsor Message The bird flu virus appears be spreading mainly through milk and milking equipment. But for the first time, researchers reported in Mayand July that it spread inefficiently through the air between a few laboratory ferrets kept inches apart. And in cattle experiments, some cows were infected by breathing in virus-laden microscopic droplets — the sort of thing that could happen if an infected cow was coughing in close proximity to another. Cows do, in fact, cough. The new study from Texas notes that cattle coughed during outbreaks on the farms and showed other signs of respiratory illness. Other observations were ominous: About half of some 40 cats on one farm died suddenly at the peak of its outbreak, probably from lapping up raw milk suffused with bird flu virus. Most people diagnosed with the bird flu have been infected from animals. In his new study, Gray saw a hint that the virus may occasionally spread from person to person, but he added that this remains conjecture. One of the two people who had antibodies worked in the farm’s cafeteria adjacent to the milking parlor — alongside farmworkers but not cattle. “We need to find ways to have better surveillance,” he said, “so we can make informed decisions rather than decisions based on guesswork.” KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — an independent source for health policy research, polling, and journalism. bird flu avian influenza pandemic prevention farm workers Facebook Flipboard Email Read & Listen Home News Culture Music Podcasts & Shows Connect Newsletters Facebook Instagram Press Public Editor Corrections Contact & Help About NPR Overview Diversity NPR Network Accessibility Ethics Finances Get Involved Support Public Radio Sponsor NPR NPR Careers NPR Shop NPR Events NPR Extra Terms of Use Privacy Your Privacy Choices Text Only Sponsor MessageBecome an NPR sponsorMass vaccination with reassortment-impaired live H9N2 avian influenza vaccine | npj Vaccines Skip to main content Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement View all journals Search Log in Explore content About the journal Publish with us Sign up for alerts RSS feed nature npj vaccines articles article Mass vaccination with reassortment-impaired live H9N2 avian influenza vaccine Download PDF Download PDF Article Open access Published: 03 August 2024 Mass vaccination with reassortment-impaired live H9N2 avian influenza vaccine Flavio Cargnin Faccin ORCID: orcid.org/0000-0002-5006-51821, C. Joaquin Cáceres ORCID: orcid.org/0000-0001-8508-65921, L. Claire Gay1, Brittany Seibert ORCID: orcid.org/0000-0002-5721-53821 nAff3, Nick van Bentem ORCID: orcid.org/0009-0003-1922-85741 nAff4, Luis A. Rodriguez ORCID: orcid.org/0000-0003-0362-27561 nAff5, Ana Luiza Soares Fraiha ORCID: orcid.org/0000-0003-2100-86961 nAff6, Matias Cardenas1, Ginger Geiger ORCID: orcid.org/0000-0002-4927-80841, Lucia Ortiz1 nAff7, Silvia Carnaccini1, Darrell R. Kapczynski2, Daniela S. Rajao ORCID: orcid.org/0000-0002-0772-00651 & …Daniel R. Perez ORCID: orcid.org/0000-0002-6569-56891 Show authors npj Vaccines volume 9, Article number: 136 (2024) Cite this article 2105 Accesses 4 Altmetric Metrics details Subjects Influenza virusLive attenuated vaccines AbstractAvian influenza poses a severe threat to poultry production and global food security, prompting the development of vaccination programs in numerous countries. Modified live virus (MLV) vaccines, with their potential for mass application, offer a distinct advantage over existing options. However, concerns surrounding reversion, recombination, and unintended transmission have hindered the progress of MLV development for avian influenza in poultry. To address these concerns, we engineered reassortment-impaired, non-transmissible, safe, immunogenic, and protective MLVs through the rearrangement of internal gene segments and additional modifications to the surface gene segments HA and NA. The unique peptide marker aspartic acid-arginine-proline-alanine-valine-isoleucine-alanine-asparragine (DRPAVIAN) was incorporated into HA, while NA was modified to encode the chicken interleukin-18 (ckIL18) gene (MLV-H9N2-IL). In vitro, the MLV-H9N2 and MLV-H9N2-IL candidates demonstrated stability and virus titers comparable to the wild-type H9N2 strain. In chickens, the MLV-H9N2 and MLV-H9N2-IL candidates did not transmit via direct contact. Co-infection studies with wild-type virus confirmed that the altered HA and NA segments exhibited fitness disadvantages and did not reassort. Vaccinated chickens showed no clinical signs upon vaccination, all seroconverted, and the inclusion of ckIL18 in the MLV-H9N2-IL vaccine enhanced neutralizing antibody production. A significant decrease in viral loads post-challenge underscored the protective effect of the MLVs. The MLV-H9N2-IL vaccine, administered via drinking water, proved immunogenic in chickens in a dose-dependent manner, generating protective levels of neutralizing antibodies upon aggressive homologous virus challenge. In summary, this study lays the groundwork for safe MLVs against avian influenza suitable for mass vaccination efforts. Similar content being viewed by others Highly pathogenic avian influenza A/Guangdong/17SF003/2016 is immunogenic and induces cross-protection against antigenically divergent H7N9 viruses Article Open access 26 February 2021 Single dose of multi-clade virus-like particle vaccine protects chickens against clade 2.3.2.1 and clade 2.3.4.4 highly pathogenic avian influenza viruses Article Open access 02 July 2021 A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge Article Open access 10 February 2020 IntroductionThe global poultry industry is economically and socially vital, supplying a cost-effective protein source. High-density conditions house approximately three-quarters of the world’s poultry, making birds susceptible to infectious diseases, notably avian influenza, responsible for substantial bird losses1. Avian influenza is caused by type A influenza viruses (FLUAVs) in the Orthomyxoviridae family, characterized by enveloped, pleomorphic particles with an 8-segment negative-sense RNA genome2. FLUAVs encode core viral proteins, including hemagglutinin (HA) and neuraminidase (NA), leading to subtypes based on their HA and NA antigenic properties3.Wild aquatic birds are natural hosts for 17 HA and 9 NA subtype FLUAVs, allowing gene segment reassortment when co-infected with different FLUAVs4,5. FLUAVs are categorized as highly pathogenic avian influenza viruses (HPAIV) or low pathogenic avian influenza viruses (LPAIV), with H9N2 being a significant LPAIV in Galliformes, particularly prevalent in Asia, the Middle East, and Africa6,7,8. Recent H9N2 isolates exhibit a tri-basic cleavage site, enhancing transmission and replication in chickens9.H9N2 infections in poultry result in delayed growth, lower egg production, and poor eggshell quality, often leading to secondary infections with respiratory pathogens and substantial economic losses10,11,12. The emergence of H9N2 strains has facilitated the reassortment of additional FLUAVs, including zoonotic strains such as H5Nx HPAIVs and Asian H7N9 LPAIV/HPAIV strains13,14,15. Poultry-adapted H9N2s have acquired zoonotic potential, binding to sialic acid receptors akin to human-adapted FLUAVs, prompting the World Health Organization to consider H9N2 LPAIVs as viruses of pandemic concern, with an increasing number of human cases16,17,18,19,20.Vaccination programs against H9N2 in poultry have been implemented in Asia and the Middle East, but challenges include the magnitude of outbreaks, antigenic mismatch, and issues with vaccine potency21,22,23,24. Current vaccines, mainly whole-inactivated virus plus adjuvant (WIV-adj) and/or recombinant vector platforms, contribute to antigenic drift, necessitating individual administration and facing challenges related to prior immunity and vector issues25,26,27,28.Modified live virus (MLV) vaccines, known for their success in eradicating diseases, can induce comprehensive immune responses, offering a potential mass vaccination solution for poultry29,30. Most successful vaccine strategies for poultry are based on MLV viruses such as Newcastle disease, Gumboro disease, Infectious laryngotracheitis, and Marek’s disease. MLV vaccines can potentially work in the presence of maternal antibodies31. In the case of avian influenza, concerns of reversion, recombination, and unintended transmission have slowed MLV development for use in poultry. We used reverse genetics to generate MLV vaccines against H9N2s based on genome rearrangement and incorporation of molecular markers on the HA and NA segments. These modifications led to MLVs with drastically reduced potential for reassortment and transmission. These MLV platforms were immunogenic and protective against H9N2 virus challenge. An immunomodulator was included in the MLV platform, MLV-H9N2-IL, the chicken interleukin-18 (ckIL18) that enhanced immune responses and protection in chickens after homologous virus challenge. MLV-H9N2-IL given via drinking water induced sterilizing immunity in a vaccine dose-dependent manner in chickens. These studies show the potential of utilizing MLVs for mass vaccination strategies, a highly desired attribute for implementation by the poultry industry. An argument can be made that a successful vaccine/vaccination strategy against H9N2 LPAIV is likely going to drastically reduce the emergence of other FLUAV subtypes of animal and/or public health concerns.ResultsThe MLV-H9N2 and MLV-H9N2-IL vaccine candidates, featuring rearranged genomes and modifications in HA and NA segments, exhibit stability after serial passage in vitroThe viruses were developed based on the prototypical WF10 H9N2 strain with a rearranged genome (RAM), involving the placement of the M2 open reading frame (ORF) downstream of PB1 and the introduction of stop codons in the original M2 (Supplementary Fig. 1). In the RAM backbone, M2 is predicted to be co-translationally separated from PB1 via the action of the Thosea asigna 2 A protease (2ATav) sequence encoded between the PB1 and M2 ORFs. The MLV-H9N2 and MLV-H9N2-IL candidates carry a segment 4 (HA) encoding a 58 amino acid long sequence containing the unique DRPAVIAN peptide sequence placed downstream of the HA signal peptide sequence but upstream of the mature HA ORF (Supplementary Fig. 1). The modified HA segment was derived from the sequence of a chicken H9N2 isolate identified in Egypt in 2018 (ck/EGY). The DRPAVIAN peptide is predicted to be co-translationally removed from the HA allowing bona fide expression of HA trimers on the virus surface. The DRPAVIAN peptide sequence is unique to the MLV-H9N2 and MLV-H9N2-IL candidates and does not exist in any known sequence of any living organism available in public databases. The unique sequence is expected to reduce the HA fitness for reassortment and can be used as a differentiation method compared to wild-type HA segments.In the MLV-H9N2-IL candidate, the ckIL18 sequence was added to the C-terminus of the N2 NA, separated by a spacer released during translation via 2ATav activity (Supplementary Fig. 1). The MLV-H9N2 and MLV-H9N2-IL virus vaccine candidates were initially rescued in embryonated SPF chicken eggs and labeled as egg passage 1 (E1). The E1 MLV-H9N2 and MLV-H9N2-IL virus stocks were serially passaged five times in eggs (E5) to monitor the stability of genome modifications. RT-PCRs were performed targeting each modified segment from the E1 and E5 virus passages. The sizes of the PCR products were maintained in both E1 and E5 passages which were bigger than those obtained from the unmodified segment controls (Fig. 1a). Genome stability was further confirmed by Sanger sequencing with no discernible mutations in any of the modified segments.Fig. 1: The MLV-H9N2 and MLV-H9N2-IL vaccine candidates exhibit stability.a RT-PCR fragment profiles of MLVs before serial passages in eggs (E1) or after serial passages in eggs (E5) targeting the PB1-M2 (top), HA-DRPAVIAN (middle), and NA-IL-18 (bottom). Wild-type segments were included as positive controls to demonstrate the differences in size between modified and non-modified segments. b Chicken IL-18 expression from the MLV-H9N2-IL virus by western blot. Protein lysates of MDCK cells inoculated with MLV-H9N2 (black) or MLV-H9N2-IL (blue) at an MOI of 10 or 1 as indicated. Positive control corresponds to protein lysates of HEK293T cells transfected with the control expression plasmid pCAGGS expressing N2WF10-Furin-2A-IL-18-HIS. Negative control corresponds to non-transfected HEK293T cell lysates. The arrows indicate the predicted molecular weight of chicken IL-18 (~23 KDa) and the host cellular protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH; ~36 KDa) used as a gel loading control. Molecular weight marker (MWM) with numbers on the right in KDa of marker protein bands. Western blot images derived from the same set of protein lysates. Uncropped figures are shown in Supplementary Fig. 3.Full size imageTo demonstrate whether genome rearrangements affect virus growth, MDCK cells were infected at an MOI of 0.01 and incubated at 37 °C or 41 °C for 96 h. Compared with the H9N2 WT virus, the MLV-H9N2 and MLV-H9N2-IL viruses showed similar virus replication at 37 °C, with minor differences at 12 (hours post-infection) hpi but similar replication levels at 24, 48, 72, and 96 hpi (Supplementary Fig. 2a). At 41 °C, both MLVs showed similar virus replication compared to the H9N2 WT virus (Supplementary Fig. 2b). In contrast, the control H9N2att showed impaired replication at 41 °C but not 37 °C due to the introduction of temperature-sensitive mutations29. To further evaluate the replication of the MLVs, growth kinetics were performed in human-derived cells. Specifically, human lung carcinoma (A549) cells and immortalized human airway epithelial cells (HAE-BCi-NS1.132) grown in an air-liquid interface were infected at an MOI of 0.01 and incubated at 37 °C or 41 °C for 96 h. In A549 cells, the MLV-H9N2-IL replicated significantly less than a prototypic pandemic H1N1 virus33 (pH1N1) at all timepoints at 37 °C, demonstrating an attenuated profile (Supplementary Fig. 2c). Similar results were observed with the MLV-H9N2. Of note, both MLVs replicated less than the WT H9N2 virus. Interestingly, no statistically significant differences were observed in virus replication between the MLVs and the pH1N1 at 41 °C, but all viruses showed limited virus replication in human cells at this temperature (Supplementary Fig. 2d). Both MLV-H9N2-IL and MLV-H9N2 viruses replicated significantly less than the pH1N1 virus in HAE cells at 37 °C and 41 °C (Supplementary Fig. 2e, f), with replication levels below 3 log10 TCID50eq/ml. These MLVs also replicated less than the WT H9N2 at both temperatures. Overall, our data showed that the MLV-H9N2 and MLV-H9N2-IL are attenuated in human cell lines, exhibiting significantly lower replication levels compared to a pandemic H1N1 virus.The E4 passage virus was used to prepare an E5 stock which was used for vaccine studies. The E5 stock of the MLV-H9N2 reached titers of 3.16 × 108 EID50/ml while the MLV-H9N2-IL reached titers of 6.81 × 107 EID50/ml. Overall, these studies showed that the MLV-H9N2 and MLV-H9N2-IL viruses are stable and grow to high titers, characteristics that make them potentially suitable vaccine candidates. To demonstrate that IL-18 is being expressed from the MLV-H9N2-IL virus, MDCK cells were inoculated with the MLV-H9N2-IL and MLV-H9N2 viruses at low (1) and high (10) MOI. Cell lysates from HEK293T cells transfected with a plasmid expressing the N2WF10-Furin-2A-IL-18 product were used as positive control. IL-18 expression was detected from the MLV-H9N2-IL virus, regardless of the MOI employed (Fig. 1b and Supplementary Fig. 3a). As expected, we did not see IL-18 expression from the control MLV-H9N2 virus.Modifications made to the HA and NA segments affect their fitness for reassortment both in vitro and in vivoCo-infection studies in MDCK cells were conducted to assess the reassortment potential of the modified segments in the vaccine virus. These studies involved co-infecting cells with either the MLV-H9N2 or MLV-H9N2-IL strain and a prototypic WT H9N2 strain (ck/Tun) at a ratio of 10:1 (MLV:WT). Following two rounds of virus cloning by limiting dilution, next-generation sequencing (NGS) data revealed that the DRPAVIAN modification rendered the modified HA less fit than the WT HA from the ck/Tun strain. None of the progeny virus clones contained the DRPAVIAN-modified HA segment (Fig. 2a, b). Similarly, the ckIL18-modified NA was largely outcompeted by the WT NA from the ck/Tun strain during co-infection in vitro (Fig. 2b). In contrast, the modified PB1-M2 and M1∆M2 segments did not exhibit a significant fitness disadvantage and behaved similarly to unmodified gene segments (Fig. 2a, b). These in vitro studies indicated that the modifications introduced into the HA and NA segments, but not those in PB1 and M, affected segment fitness.Fig. 2: Reassortment data upon co-infections in vitro and in vivo.MDCK cells were infected with H9N2 WT (WT) virus and either (a) MLV-H9N2 or (b) MLV-H9N2-IL viruses. MDCK cells were coinfected with a 10:1 MLV/WT virus ratio. Supernatants collected at 72 hpi underwent two rounds of limiting dilution followed by NGS sequencing. FASTQ files were used to calculate the proportion of NGS reads that matched MLV or WT for each specific segment. Reassortment data upon co-infection of 2-week-old chickens with H9N2 WT virus and either (c) MLV-H9N2 or (d) MLV-H9N2-IL viruses at a 10MLV:1WT ratio. OP swabs collected at 5 dpi were sequenced by NGS and analyzed as the in vitro data. Data is graphed as % proportion of reads versus gene segment. WT segments (red), MLV-H9N2 segments (black), MLV-H9N2-IL segments (blue) in the progeny viruses are shown. Gray shading rectangles represent unmodified viral gene segments in WT and MLV strains. White shading rectangles represent modified viral gene segments in the MLV strains but unmodified viral gene segments in WT.Full size imageTo further evaluate reassortment potential in vivo, co-infection studies were conducted in two-week-old chickens using a 10:1 (MLV:WT) ratio to favor reassortment. Oropharyngeal (OP) swabs collected on day 5 post-inoculation (dpi) were sequenced using NGS. Consistent with the in vitro findings, both MLV-H9N2 and MLV-H9N2-IL exhibited a clear fitness disadvantage compared to the WT virus in vivo and were outcompeted (Fig. 2c, d). Importantly, reassortment between the MLV viruses and the WT virus was not observed in vivo. Interestingly, the modified PB1-M2 and M1∆M2 segments, which did not exhibit a significant fitness disadvantage in vitro, demonstrated reduced fitness in vivo, along with all other gene segments. Collectively, these data demonstrate that the MLVs are safe and possess a fitness disadvantage compared to the WT virus.MLV-H9N2 and MLV-H9N2-IL are not transmissible to direct contact chickensTo evaluate the potential for transmission of MLV-H9N2 and MLV-H9N2-IL viruses in vivo in chickens, their ability to transmit to naïve direct contact chickens was assessed. Two-week-old chickens were inoculated with either MLV-H9N2 or MLV-H9N2-IL virus via the eyes and the respiratory (nasal and tracheal), oral, and cloacal routes (EROC) at a dose of 1 × 106 EID50/chicken. Naïve direct contact chickens were introduced 24 hpi, and OP and cloacal (CL) swabs were collected from both inoculated and contact chickens daily. Viral RNA was detected in OP and CL swabs collected from directly inoculated chickens from 1 to 6 dpi, with a trend towards lower viral RNA (vRNA) levels in chickens inoculated with MLV-H9N2-IL compared to those inoculated with MLV-H9N2. Notably, none of the direct contact chickens exhibited detectable levels of vRNA in either OP or CL swabs at any timepoint (Fig. 3a,b). Additionally, serological analysis revealed no seroconversion in direct contact chickens at 14 days post-contact (Fig. 3c). These findings suggest that the replication levels of the MLVs in vivo are insufficient to allow for transmission to naïve direct contact birds.Fig. 3: MLVs transmissibility in 2-weeks-old chickens.Animals (n = 4/group) were directly inoculated with either the MLV-H9N2 (black) or MLV-H9N2-IL (blue) strains at 1 × 106 EID50/chicken. Naïve direct contacts were added 24 hpi. a OP swabs and (b) CL swabs were collected (n = 4/group/day) every day from 1 to 6 days after inoculation or after contact to analyze transmission between directly inoculated and direct contact animals. Viral loads by RT-qPCR shown as the mean ± SD Log10 TCID50 equivalent/mL, LOD 1.199 Log10 TCID50 equivalent/mL. c Blood samples were collected (n = 4/group) at 14 dpi and 14 dpc and sera prepared for HI assays to analyze seroconversion using 2-fold serum dilutions.Full size imageMLVs generate serum-neutralizing antibodies predictive of protectionTo evaluate the immunogenicity of MLV-H9N2 and MLV-H9N2-IL viruses, we employed a prime-boost vaccination strategy administered two weeks apart. Two-week-old chickens were inoculated via the EROC route with a dose of 1 × 106 EID50/chicken of either MLV-H9N2 or MLV-H9N2-IL. A control group received a subcutaneous (SC) injection of a WIVadj-H9N2 vaccine prepared in-house at a dose of 512 hemagglutinin units (HAU) per dose. A fourth group of chickens served as mock controls and were inoculated with PBS. OP and CL swabs were collected after prime vaccination to assess virus replication levels. Both MLV strains exhibited a limited window of replication, with detectable virus in both OP and CL swabs on day 3 (Fig. 4a). Notably, MLV-H9N2-IL loads were significantly less than the H9N2 WT control in OP swabs on day 3, consistent with the reduced levels of vRNA observed in the previous study (Fig. 3a, b). No MLV virus was detected after boost vaccination (data not shown).Fig. 4: MLVs are safe, generate a strong immune response, and protect chickens upon homologous challenge.a After virus inoculation, OP and CL swabs were collected (n = 6/group) at 3- and 5-dpp to establish levels of virus shedding shown as the mean ± SD Log10TCID50/mL, LOD 0.699 Log10 TCID50/mL. Virus shedding for MLV-H9N2-IL (blue), MLV-H9N2 (black), H9N2 WT virus (red) and mock inoculated controls (white) are shown. Note that the MLV-H9N2-IL (blue) replicates significantly less than the H9N2 WT virus (red). b–d Blood samples were collected (n = 8/groupimepoint) at 12 dpp and 12 dpb and sera prepared to establish levels of seroconversion from the MLV-H9N2-IL (blue), MLV-H9N2 (black), WIVadj-H9N2 (gray), and mock-vaccinated controls (mock). b HI titers expressed as 2-fold serum dilution versus timepoint of serum collection. c VNluc titers plotted as arbitrary Log10 relative light units (Log10 RLU (AU)) versus the Log2 sera dilution. Nluc activity was measured at 48 hpi. The Log2 inhibitory sera dilution 50 (Log2 ISD50) for each serum is shown. d Levels of NP antibodies as measured by a commercial ELISA and expressed as Signal-to-Noise (S/N) ratio versus timepoint of serum collection. S/N ≥ 0.6 is considered positive (e) Sinuses, trachea, lungs, pancreas, and cloaca samples (n = 4/group) were collected at 3 dpc and subjected to virus titration and shown as the mean ± SD Log10 TCID50/mL. f OP swabs and (g) CL swabs were collected (n = 6/group/day) every other day from 1 to 7 dpc. Virus shedding measured by RT-qPCR and expressed as the mean ± SD Log10 TCID50 equivalent/mL versus day post-challenge with LOD 1.199 Log10 TCID50 equivalent/mL. Data analysis and graphs were prepared using Prism v10 (GraphPad). Ordinary two-way ANOVA was performed to calculate P values followed by Tukey’s multiple comparison tests. Only statistically significant differences are shown.Full size imageSerum samples collected at 12 days post-prime (dpp) and 12 days post-boost (dpb) revealed the presence of measurable HI and virus neutralization titers (VNluc), as well as anti-NP antibodies, in all vaccinated groups except for the PBS control group. The WIVadj-H9N2 vaccine group generated the highest HI titers after prime (mean titer of 320) and after boost (mean titer of 1280). Interestingly, the inclusion of IL-18 in the MLV-H9N2-IL vaccine resulted in higher HI titers after prime (mean titer of 320 versus 80) and after boost (mean titer of 320 versus 80) compared to the vaccine candidate without IL-18 (MLV-H9N2) (Fig. 4b). To assess VNluc titers, we employed a recombinant H9N1 homologous influenza virus expressing Nanoluciferase, where titers are inversely proportional to its activity. Consistent with the HI assay, the WIVadj-H9N2 vaccine induced the highest levels of neutralizing antibodies (Log2 ISD50 of 11.77), and MLV-H9N2-IL elicited higher levels of neutralizing antibodies (Log2 ISD50 of 8.64) compared to MLV-H9N2 (Log2 ISD50 of 6.77) (Fig. 4c), suggesting that IL-18 may play a role in enhancing the host immune response following vaccination and inducing higher levels of neutralizing antibodies indicative of protection. Both MLVs induced higher levels of anti-NP antibodies after prime vaccination compared to the WIVadj-H9N2 vaccine (Fig. 4d), although all means were below the threshold for positive samples (0.6). After boost vaccination, anti-NP antibody levels increased in all groups and were comparable between the MLVs and the WIVadj-H9N2 vaccine. In conclusion, our findings demonstrate that MLVs are attenuated in vivo and induce neutralizing antibodies predictive of protection following vaccination.MLVs, but not the WIVadj-H9N2 vaccine, significantly reduce viral loads and protect chickens after a homologous challengeTo evaluate the protective efficacy of MLVs and the WIVadj-H9N2 vaccine, two weeks post-boost vaccination, chickens were challenged with a homologous virus at a dose of 1 × 108 EID50/chicken via the EROC route. CL and OP swabs were collected every other day until 7 days post-challenge (dpc), and tissues were collected at 3 dpc.In the sinuses, trachea, and cloaca, all vaccines significantly reduced viral loads compared to the mock-vaccinated challenge (Fig. 4e). In the lungs, viral replication levels were similar between the WIVadj-H9N2 vaccine and mock challenge. Interestingly, viral replication levels in the pancreas were higher in the WIVadj-H9N2 vaccine group compared to the mock challenge, although the difference was not statistically significant. Both MLVs effectively reduced viral loads and completely protected the birds against the homologous virus in all tissues examined (Fig. 4e). In OP swabs, the MLV-H9N2-IL vaccine led to significant reduction in virus shedding. At 3 dpc, the inclusion of IL-18 in the MLV-H9N2-IL vaccine significantly reduced viral loads and enhanced protection compared to the vaccine candidate without IL-18 (Fig. 4f). Importantly, in OP swabs, the WIVadj-H9N2 vaccine did not reduce virus shedding at 3 and 5 dpc compared to the mock challenge (Fig. 4f). In CL swabs, all vaccines significantly reduced viral loads and fully protected the birds against a homologous challenge compared to the mock challenge (Fig. 4g). Overall, our findings demonstrate that MLVs provide superior protection against a homologous challenge compared to the WIVadj-H9N2 vaccine.MLV-H9N2-IL is stable, shows limited replication, and is immunogenic during vaccine administration via drinking waterTo assess the feasibility of mass vaccination using the most promising vaccine candidate, MLV-H9N2-IL, two-week-old chickens were vaccinated via drinking water for 2 h with either 1 × 104 EID50/ml (low dose) or 1 × 106 EID50/ml (high dose) of MLV-H9N2-IL, employing either a prime-only or prime-boost strategy. OP and CL swabs were collected to evaluate virus replication levels following drinking water vaccination. MLV-H9N2-IL exhibited dose-dependent and limited virus replication in OP swabs on day 3 post-prime (Fig. 5a). Infectious virus was not detected in CL swabs (Fig. 5a).Fig. 5: MLV-H9N2-IL is stable and immunogenic when given via drinking water.a Chickens were vaccinated with MLV-H9N2-IL via drinking water for 2 h. Low dose: 104 EID50/mL (light blue). High dose: 106 EID50/mL (dark blue). Mock vaccinated controls included (white). OP and CL swabs were collected (n = 6/group) at 3- and 5- dpp. b MLV-H9N2-IL vaccine stability in drinking water analyzed by incubating the two vaccine doses at 25 °C, 30 °C, 40 °C, and 50 °C. Timepoints were collected at 0 h, 1 h, 2 h, and 24 h. Virus in samples were then titrated and shown as the mean ± SD Log10 TCID50/mL, LOD 0.699 Log10 TCID50/mL. Sera prepared from blood samples collected at 12 dpp (n = 6/group), 26 dpp (n = 4/group), and 12 dpb (n = 4/group) from the low dose (light blue) and high dose (dark blue) MLV-H9N2-IL vaccine groups were used to establish seroconversion. c HI titers (d), VNluc titers, and (e) NP antibody titers were established as detailed in Fig. 4.Full size imageTo assess vaccine stability in drinking water, vaccine samples were mixed with distilled water and incubated at various temperatures (25 °C, 30 °C, 40 °C, and 50 °C) for 2 h. Chickens were allowed to drink water for 2 h, and during this period, MLV-H9N2-IL was found to be stable at both low and high dose at 25 °C (Fig. 5b). Additionally, at 30 °C and 40 °C, a high dose remained stable for 2 h, while low dose appeared to decrease, with no infectious virus detected after 2 h at these temperatures. Finally, titers rapidly declined when samples were incubated at 50 °C (Fig. 5b).Blood samples were collected at 12 dpp and 12 dpb to measure HI titers, neutralizing antibodies, and anti-NP antibodies. For the prime-only groups, blood was also collected at 26 dpp, two days prior to the challenge. In the low dose group, HI titers increased from around 40 (20–80) after prime to 80 (80–160) following the boost (Fig. 5c). Similarly, HI titers increased in the high dose group after the boost (average 320, 160-640) compared to prime (average 80, 40–160). Notably, HI titers increased from 80 to 160 when comparing 12 dpp to 26 dpp in the high dose group.Consistent with the HI data, VNluc assays revealed similar and consistent results, with a prime-only (Log2 ISD50 of 8.65) or prime-boost (Log2 ISD50 of 9.01) regimen using high dose generating the highest levels of neutralizing antibodies (Fig. 5d). Anti-NP antibodies were also detected after prime vaccination and increased after boost, with comparable levels observed between the two doses tested (Fig. 5e). In summary, these findings demonstrate that MLV-H9N2-IL is stable during vaccine administration, remains attenuated when administered via drinking water, and induces neutralizing antibodies predictive of protection following vaccination.Prime-Boost with 106 EID50/ml of MLV-H9N2-IL induces sterilizing immunityTwo weeks after the boost vaccination or four weeks after the prime vaccination, chickens were challenged with a homologous virus at a dose of 1 × 108 EID50/chicken via the EROC route. OP and CL swabs were collected every other day until 5 dpc, and tissues were collected at 3 dpc.Tissue analysis revealed that all doses and vaccination strategies protected against the homologous challenge by reducing viral loads in the sinuses (Fig. 6a). Similar results were observed in the cloaca (Fig. 6a). In the trachea, a decrease in viral loads was observed compared to the mock challenge, but the difference was not statistically significant.Fig. 6: Prime-Boost with 106 EID50/ml of MLV-H9N2-IL induces sterilizing immunity.a Sinuses, trachea, and cloaca samples (n = 4/group) were collected at 3 dpc and viruses titers established as the mean ± SD Log10 TCID50/gr of tissue homogenate, LOD 0.699 Log10 TCID50/gr. b OP swabs and (c) and CL swabs were collected (n = 4/group/day) every other day from 1 to 5 dpc. Virus titers shown as the mean ± SD Log10 TCID50/mL, LOD 0.699 Log10 TCID50/mL. Data analysis and graphs performed with Prism v10 (GraphPad) using ordinary two-way ANOVA, P values calculated by Tukey’s multiple comparison tests. Only statistically significant differences are shown.Full size imageIn OP swabs, prime-only and prime-boost vaccination with high dose significantly reduced viral loads compared to the mock challenge at 1 dpc (Fig. 6b). Prime-only or prime-boost vaccination with low dose also decreased viral loads but lacked statistical significance. On 3 dpc, a boost vaccination was required to significantly reduce viral loads compared to the mock challenge, regardless of the dose (Fig. 6b). All doses and strategies significantly reduced viral loads at 5 dpc. Importantly, prime-boost vaccination with high dose completely prevented virus shedding in OP swabs on days 1, 3, and 5 dpc (Fig. 6b).In CL swabs, all vaccine doses, and strategies (low dose prime-only, high dose prime-only, low dose prime-boost, and high dose prime-boost) significantly reduced viral loads and protected the birds against the homologous virus at 1 and 3 dpc (Fig. 6c). Notably, vaccination with a prime-boost regimen at high dose completely prevented virus shedding in CL swabs after the challenge.In conclusion, prime-boost vaccination with high dose of MLV-H9N2-IL via drinking water induces sterilizing immunity in chickens, as evidenced by the absence of detectable virus replication in OP swabs, CL swabs, and the sinuses, trachea, and cloaca.DiscussionThe majority of currently approved and widely used avian influenza vaccination programs worldwide, including those in Mexico, Egypt, Pakistan, and China, rely primarily on adjuvanted inactivated whole virus vaccines34. It is well recognized that inactivated vaccines induce robust serum antibody responses but fail to elicit effective mucosal and cell-mediated immunity35. Moreover, they are incapable of activating pattern-recognition receptors on infected cells36, which play a crucial role in enhancing the production of pro-inflammatory cytokines and type I interferons, thereby initiating the local cellular innate immune response37. Another significant drawback is the potential for mismatches between circulating and vaccine strains, allowing the virus to evolve and acquire mutations that could increase its replication and transmission capabilities38. Studies have demonstrated that these vaccines fail to reduce virus shedding and do not prevent the transmission of H9N2 in chickens27, highlighting their inability to disrupt the influenza transmission cycle.MLVs hold promise for developing broader and longer-lasting effective vaccines against avian influenza due to their ability to replicate and mimic natural infection35,39. Our laboratory has successfully demonstrated that genome rearrangement is a viable, safe, and efficacious approach for MLV development40,41,42. In previous studies, our RAM vaccines effectively protected mice against clinical disease and mortality40. Additionally, the incorporation of a natural adjuvant into the HA segment enhanced the stimulation of IgG and IgA responses41.Building upon these findings, we developed two MLVs, MLV-H9N2 and MLV-H9N2-IL, based on genome rearrangement of the H9N2 subtype, the most prevalent LPAIV circulating in chickens worldwide. Utilizing the previously established RAM approach as an attenuated backbone, we incorporated additional molecular markers into the HA to prevent reassortment and an immunomodulator into the NA to further stimulate protective antibody responses.To assess the genetic stability of MLV-H9N2 and MLV-H9N2-IL viruses, we subjected them to five serial passages in eggs and evaluated their genetic integrity using RT-PCR and Sanger sequencing. The results confirmed that both viruses maintained their genetic integrity throughout the serial passages.Interestingly, both the DRPAVIAN modification and the inclusion of IL-18 in the NA resulted in a fitness disadvantage compared to the wild-type (WT) segments from the ck/Tunisia strain in vitro. In contrast, the modified PB1-M2 and M1∆M2 segments were detected in the progeny virus and exhibited similar behavior to unmodified segments in vitro. One possible explanation for the presence of these modified MLV segments in the progeny virus is the fact that MLVs were not attenuated in vitro. Despite several gene modifications, both MLVs replicated to similar levels as an H9N2 WT virus at 37 °C and 41 °C in MDCK cells. Furthermore, we also demonstrated that the MLV-H9N2 and MLV-H9N2-IL replicate significantly less than a pandemic H1N1 virus in human-derived cells. In vivo, both MLVs exhibited an attenuated profile, with virus replication levels not exceeding 3 log10 TCID50/ml and restricted to within 3 to 5 days post-prime. These low levels of virus replication in directly inoculated animals prevented the transmission of MLV-H9N2 and MLV-H9N2-IL to naïve direct contact chickens. Consistent with the attenuated profile of MLVs in vivo, our in vivo co-infection data demonstrated that both MLVs have a fitness disadvantage and all MLV segments were outcompeted by the WT virus in vivo. Additionally, we did not observe any reassortment between our MLV viruses and the WT virus in vivo. Notably, the modified PB1-M2 and M1∆M2 segments exhibited reduced fitness in vivo, further corroborating their safe profile. The observed discrepancy between in vitro and in vivo replication highlights a desirable characteristic of live attenuated vaccines. Efficient replication in cell cultures or embryonated eggs is essential for large-scale vaccine production. Conversely, attenuation in the target host is crucial for safety and efficacy. Our MLVs exhibit both of these attributes, making them promising candidates for vaccine development.However, we must exercise caution when interpreting these data, as the MLVs produced in this study contain five (MLV-H9N2) and four (MLV-H9N2-IL) WT segments that could potentially be freely exchanged. Although it was not the case, we anticipated that unmodified MLV segments (PB2, PA, NP, NS) may exhibit a fitness advantage compared to the WT ck/Tun strain, as these are also WT segments from the WF10 virus and can potentially outcompete the ck/Tun strain. Further investigations are warranted to determine whether additional modifications to each gene segment could be tolerated without compromising virus yield and protective efficacy while further minimizing reassortment potential. Such studies, however, are beyond the scope of this report.We further investigated the humoral immune responses elicited by vaccination via the EROC route. As anticipated, the WIVadj-H9N2 vaccine induced the highest levels of HI titers and neutralizing antibodies. While both MLVs generated lower HI titers, their responses were consistent with antibody levels considered protective. This aligns with our previous studies using alternative MLVs against type A and B influenza viruses and contrasts with the limited seroconversion typically associated with currently approved cold-adapted seasonal influenza vaccines for human use40,41.Despite the robust humoral responses in the WIVadj-H9N2 vaccine group, these were not sufficient to fully protect the birds against the homologous H9N2 challenge. We still detected virus in the lungs and OP swabs of birds immunized with the WIVadj-H9N2 vaccine, confirming the inability of inactivated vaccines to reduce viral loads in vaccinated birds. Notably, chickens vaccinated with the WIVadj-H9N2 vaccine exhibited significant virus replication after challenge, in samples collected from the pancreas. This unexpected finding may partially explain the ineffectiveness of inactivated vaccines in the field against H9N2 LPAIVs. Conversely, MLV-vaccinated birds, especially those receiving the MLV-H9N2-IL vaccine, exhibited almost complete protection against the challenge. This highlights the superior efficacy of MLVs in contrast to inactivated vaccines.IL-18, a proinflammatory cytokine belonging to the interleukin-1 family, was initially identified as an interferon-gamma-inducing factor43. IL-18 plays a crucial role in the host’s response to influenza A virus. Studies involving chickens immunized with a recombinant fowl pox virus expressing H9 HA and chicken IL-18 suggest that IL-18 can enhance anti-HA responses when co-expressed44. An eukaryotic expression plasmid encoding chicken IL-18 has been employed as a potential adjuvant in conjunction with an inactivated Newcastle disease vaccine, resulting in elevated antibody level responses and T and B lymphocyte proliferation compared to the group that received only the inactivated vaccine45.Consistent with these findings, our studies demonstrated that the inclusion of IL-18 elicited higher levels of HI titers and neutralizing antibodies compared to the same candidate without IL-18 (MLV-H9N2). Additionally, we observed enhanced protection in chickens vaccinated with MLV-H9N2-IL, as evidenced by reduced virus detection in OP swabs. This suggests that IL-18 may be playing a role in the host immune response, as observed for other infectious diseases45. Previous mouse studies have demonstrated that RAM and other MLV strategies induce limited virus replication and stimulate mucosal immunity. In this study focused on chickens, we concentrated exclusively on evaluating whether the vaccine elicited detectable serum HI responses indicative of protection, as these responses are more readily assessed in the field31,40,41,46.Drinking water vaccination offers several advantages, including uniform and rapid delivery, reduced costs, and the potential for extensive mass vaccination, which is highly desirable for poultry species47. Several studies have demonstrated the suitability of drinking water vaccination with MLVs, which have been successfully used and established for other important poultry diseases such as avian metapneumovirus, Fowl pox, infectious laryngotracheitis, and infectious bronchitis48,49. Live recombinant Newcastle disease vectored vaccines expressing the hemagglutinin of H9N2 and H5N1 have also been administered via drinking water vaccination and protected chickens against homologous challenges50,51.In this study, we investigated whether MLV-H9N2-IL would be immunogenic and protective in chickens when administered via drinking water using prime-only or prime-and-boost strategies. After mixing the vaccine in distilled water, we analyzed vaccine stability at different temperatures over time. MLV-H9N2-IL at 106 EID50/ml remained stable during vaccine administration at 25 °C, 30 °C, and 40 °C. This is particularly important because temperatures inside chicken houses can easily reach 40 °C, which must be considered when delivering vaccines. MLV-H9N2-IL at 104 EID50/ml was stable at 25 °C but exhibited a rapid decline in titers when incubated at 30 °C and 40 °C. Additionally, HI titers and neutralizing antibodies were readily detected after prime vaccination and increased after boost in a dose-dependent manner.Both vaccine doses and strategies reduced viral loads after the homologous challenge in CL swabs, OP swabs, sinuses, trachea, and cloaca. Importantly, a prime-and-boost regimen at 106 EID50/ml induced sterilizing immunity in chickens, as evidenced by a complete absence of virus replication in all tissues mentioned above. The ability of MLV-H9N2-IL to completely prevent virus replication and shedding after challenge is highly significant, as these birds would not transmit the virus to new hosts, effectively breaking the transmission cycle of avian influenza.This study successfully demonstrates the generation and assessment of two MLVs using genome rearrangement. MLV-H9N2 and MLV-H9N2-IL are stable, grow similarly to an H9N2 WT virus in vitro, and exhibit an attenuated profile in vivo. Co-infection studies in vivo confirmed the lack of reassortment between MLV and WT virus segments. Additional studies beyond the scope of this report will be needed to demonstrate whether unmodified segments in the MLV can reassort and perpetuate through sustained transmission. Both vaccine candidates are immunogenic and protective in chickens when administered via the EROC route. MLV-H9N2-IL administered via drinking water is also immunogenic and protective in chickens, providing an alternative to individual bird vaccination. Overall, this work provides insights into the development of vaccines against avian influenza carrying molecular markers and immunomodulators and their potential for mass vaccination applications in the field.The DIVA (Differentiating Infected from Vaccinated Animals) strategy uses vaccines that trigger a unique immune response compared to infection with the wild virus. However, most countries currently rely on traditional inactivated-adjuvanted vaccines for avian influenza, which do not inherently support DIVA. Only a few countries in Europe have recently initiated limited vaccination against highly pathogenic H5N1 viruses using recombinant vaccines and a DIVA approach52. Importantly, our focus is on a non-notifiable virus, H9N2 LPAIV, making DIVA less essential, especially where H9N2 is prevalent and poultry exports are not a major concern. Additionally, in less developed nations with limited diagnostic tools, the priority is outbreak control over distinguishing vaccinated and infected birds. It is also worth noting that the modified live virus (MLVs vaccines) created in this study contain one (HA) or two (HA and NA) instances of the Thosea asigna 2 A protease, which has an immunogenic C-terminal end53. Whether this holds true in chickens vaccinated with the rearranged MLVs requires further investigation. Future research will explore this and other MLV modifications that could enable DIVA implementation.MethodsCells and eggsMadin-Darby canine kidney (MDCK) and human embryonic kidney 293 T cells (HEK293T) were a kind gift from Robert Webster (St Jude Children’s Research Hospital, Memphis, TN, USA). Human lung carcinoma (A549) cells were purchased from ATCC (CCL-185, Manassas, VA, USA). Cells were maintained in Dulbecco’s Modified Eagles Medium (DMEM, Sigma-Aldrich, St Louis, MO, USA) containing 10% fetal bovine serum (FBS, Sigma-Aldrich), 1% antibiotic/antimycotic (AB, Sigma-Aldrich) and 1% L-Glutamine (Sigma-Aldrich). Cells were cultured at 37 °C and 5% CO2. BCi-NS1.1 immortalized human airway epithelial (HAE) cells were a kind gift from Matthew S Walters (University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA). Cells were maintained in PneumaCult-Ex Plus Basal Media (Stemcell, Vancouver, BC, Canada) containing 2% PneumaCult-Ex Plus 50X Supplement (Stemcell), 0.1% Hydrocortisone (Stemcell), 1% Penicillin/Streptomycin (Gibco, Billings, MT, USA), 0.5% Amphotericin B (Gibco), and 0.1% Gentamycin (Sigma-Aldrich) and cultured at 37 °C and 5% CO2. For differentiation of BCi-NS1.1 cells, the apical portion of 12-well ALI transwell plates (VWR, Radnor, PA, USA) were coated with 1X human collagen (Sigma-Aldrich) for 1 h. The 1X human collagen was then removed from the well, and the plates were incubated for 30 min. Then, the plates were seeded with 3 × 105 HAE cells per well with basal media in the apical portion of the well and cultured at 37 °C and 8% CO2 until reaching 100% confluency. Pneumacult ALI Base Medium (ALI Media, Stemcell) was prepared with 10% 10X Pneumacult ALI Supplement (Stemcell), 1% Pen/Strep (Gibco), 0.5% Amphotericin B (Gibco), and 0.1% Gentamycin (Sigma-Aldrich). ALI-Complete media was prepared with 1% Pneumacult ALI Maintenance Supplement (Stemcell), 0.2% Heparin Solution (Stemcell), and 0.5% Hydrocortisone (Stemcell). After cells reached 100% confluency, the basal media was removed from the basal and apical portion of the wells. ALI-Complete media was added to the basal portion of the well. Cells were cultured at 37 °C and 8% CO2 for 5 days, and media was replenished every 2–3 days. After 5 days at 8% CO2, cells were cultured at 37 °C and 5% CO2 until the cells reached 28 days in ALI-Complete media. Media was replenished every 2–3 days. Specific pathogen-free embryonated chicken eggs (ECEs) used for virus propagation and stock titration were obtained from Charles Rivers (Wilmington, MA, USA).Generation of reverse genetics plasmidsThe genome rearrangement strategies to produce MLVs have been previously described40,42. The reverse genetics backbone of the prototypical LPAIV strain A/guinea fowl/Hong Kong/WF10/1999 (H9N2) – G1/h9.4.1 lineage – has been previously described29. To generate the plasmid pDP-PB1M2WF10, the plasmid pDP-PB1WF10 was modified to preserve packaging signals in segment 254 and carrying a chimeric PB1 ORF with a C-terminal tag consisting of a glycine-glycine-glycine-glycine-serine (G4S) spacer, the Thosea asigna virus 2 A protease (2a Tav) and the M2 ORF. The pDP-M1∆M2 was generated from the plasmid pDP-MWF10 by site-directed mutagenesis to carry multiple early stop codons in the M2 ORF to prevent its expression. The pDP-DRPAVIAN-HA-ck/EGY carries a chimeric HA segment derived from the H9N2 strain A/chicken/Egypt/A15068/2018 (ck/EGY) carrying a 58 amino acids long sequence, including the unique 8 amino acid peptide sequence aspartic acid-arginine-proline-alanine-valine-isoleucine-alanine-asparragine (DRPAVIAN) placed downstream of the HA signal peptide sequence but upstream of the mature HA ORF. To generate the plasmid pDP-NAckIL18, the plasmid pDP-NAWF10 was digested with BamHI and HindIII and then a synthetic fragment encoding the mature protein sequence of chicken IL-18 (ckIL18, Genscript, Piscataway, NJ) was subcloned at the C-terminus in frame with the NA ORF. Plasmids were propagated in TOP-10 E. coli cells (ThermoFisher, Waltham, MA, USA) and purified using the QIAGEN Plasmid Maxi Kit (Qiagen, Gaithersburg, MD, USA). Plasmid sequences were confirmed by Sanger Sequencing (Psomagen, Rockville, MD, USA).Generation of MLVs by reverse geneticsRecombinant viruses were rescued by reverse genetics using the 8-plasmid system and helper plasmids in co-cultured HEK293T and MDCK cells in 6-well plates55. The MLV-H9N2 virus was generated from the combination of reverse genetics plasmids pDP-PB2WF10, pDP-PB1M2WF10, pDP-PAWF10, pDP-DRPAVIAN-HA-ck/EGY, pDP-NPWF10, pDP-NAWF10, pDP-M1∆M2WF10, pDP-NSWF10 and the protein expression helper plasmids pcDNA774-PB156 encoding the PB1 polymerase subunit from the laboratory adapted strain A/Puerto Rico/8/1934 (H1N1) (PR8) and pCAGGS-H1-HA from A/California/04/2009 (H1N1) (Ca/04)33. For the generation of MLV-H9N2-IL, the plasmid pDP-NAckIL18 was used instead of pDP-NAWF10 along with protein expression helper plasmids encoding the polymerase complex from PR8 (pcDNA762-PB2, pcDNA787-PA, pcDNA693-NP, pcDNA774-PB1)56, pCAGGS-H1-HA from Ca/04 and pCAGGS-N2-NA from Aurkey/Ohio/313053/04 (H3N2)57. On transfection day, 1 µg of each plasmid was mixed with the TransIT-LT1 transfection reagent (Mirus Bio LLC, Madison, WI, USA) in a ratio of 1 µg plasmid DNA/2 µL of transfection reagent in a final volume of 1 mL of Opti-MEM media (Fisher Scientific, Hampton, NH, USA). The mixture was incubated for 45 min and then used to overlay the 293 T/MDCK cells overnight. The next day, the transfection mixture was replaced with fresh Opti-MEM media containing 1% AB (Sigma-Aldrich). At 24 and 72 h post-transfection 1 µg/mL of tosylsulfonyl phenylalanyl chloromethyl ketone (TPCK) treated trypsin (Worthington Biochemicals, Lakewood, NJ, USA) was supplemented to the cells. Viral stocks were generated in 10-day-old specific pathogen-free (SPF) eggs. Allantoic fluids were harvested at 48 h post-infection (hpi), centrifuged, aliquoted, and stored at −80 °C. These stocks constitute the first passage in eggs (E1). Viruses were titrated by tissue culture infectious dose 50 (TCID50) and egg infectious dose 50 (EID50). Virus titers were established by the Reed and Muench method58. All viruses used in this study were confirmed by Sanger sequencing (Psomagen).Genome stability of MLVsThe MLVs were serially diluted 10-fold in phosphate-buffered saline (PBS) containing 1% AB (Sigma-Aldrich); 100 µL of 3 different dilutions were inoculated in 10-day-old SPF eggs. Eggs were incubated at 35 °C for 48 h, placed at 4 °C overnight and then allantoic fluid from each inoculated egg was collected to perform hemagglutination assays using 0,5% chicken red blood cells. For each MLV, the dilution with the highest HAU was harvested, centrifuged, aliquoted, and stored at −80 °C. Five serial passages were performed following the same procedure described above. The MLVs harvested from egg passage 5 (E5) were used to generate a viral stock. Viral RNA extraction of both MLVs (E1 and E5) was carried out using the QIAquick® Viral RNA Mini Kit (Qiagen, Germantown, MD, USA). Viral RNA was amplified by RT-PCR using SuperScript III One-Step RT-PCR Platinum Taq HiFi DNA polymerase (ThermoFisher). The PB1 segment was amplified using the forward primer PB1-2068F (5’-TTCTTGAGGATGAACAGATGTACCAGAAGTGC-3’) and reverse primer Bm-PB1-2341R-eq (5’-ATATCGTCTCGTATTAGTAGAAACAAGGCATTTTTTCATG-3’). The HA segment was amplified using the forward primer H9HA-1F (5’-CTAGCAGTTAACCGGAGTACTGG-3’) and the reverse primer H9HA657-693Rev (5’-GACAAGGGGCCTTGGCCCTATCACTGGTTTGAAGGTC-3’). The NA segment was amplified using the forward primer WF10NA118F (5’-GATTCGCGCTCTGGTTATGA-3’) and the reverse primer N2Hu_1463R (5’-AGTAGAAACAAGGAGTTTTTTC-3’). The amplicons were resolved on an agarose gel, purified using the QIAquick® Gel Extraction Kit (Qiagen), and analyzed by Sanger sequencing (Psomagen).Growth kinetics in vitroSix-well plates were seeded with 3 × 105 MDCK cells or 5 × 105 A549 cells per well the day before virus inoculation. Once HAE cells reached 28 days in ALI-Complete media, cells were washed 3 times with PBS (Life Technologies) before inoculation. Then, MDCK, A549, and HAE cells were inoculated with either H9N2 WT, MLV-H9N2, MLV-H9N2-IL, H9N2att29, or pH1N1 [A/California/04/2009 (H1N1)]33 at a multiplicity of infection (MOI) of 0.01. Upon virus inoculation, cells were incubated for 15 min at 4 °C and then for 45 min at 37 °C or 41 °C. Subsequently, A549 and MDCK cells were washed twice with 1 ml of PBS (Life Technologies) and supplemented with 2 ml of Opti-MEM (Fisher Scientific) containing TPCK-trypsin (Worthington Biochemicals, Lakewood, NJ, USA) and 1% AB (Sigma-Aldrich) and further incubated at 37 °C or 41 °C and 5% CO2 for 96 h. HAE cells were washed twice with 1 ml of PBS (Life Technologies) and fresh ALI-Complete media was added to the basal portion of the well and further incubated at 37 °C or 41 °C and 5% CO2 for 96 h. Opti-MEM (Fisher Scientific) was added to the apical portion of the well, and the cells were incubated at 37 °C or 41 °C for 10 min before collecting the supernatant. For all cells, supernatants were collected at 0, 12, 24, 48, 72, and 96 hpi and used to quantify the levels of viral replication by real-time quantitative reverse transcriptase PCR (RT-qPCR). For this purpose, viral RNA (vRNA) was extracted using the MagMAXTM-96 viral RNA Isolation kit (ThermoFisher). The quantification of vRNA was based on the Influenza A matrix gene using the forward primer M + 25 (5’-AGATGAGTCTTCTAACCGAGGTCG-3’) and the reverse primer M-124 (5’-TGCAAAAACATCTTCAAGTCTCTG-3’) along with the qPCR probe M + 64 (5’-FAM-GGCCCCCTCAAAGCCGA-TAMRA-3’). Experiments were carried out in a Quantstudio 3 (Applied Biosystem, Foster City, CA, USA) using qScript XLT One-Step RT-qPCR ToughMix Quantabio (ThermoFisher). Standard curves to correlate quantitative PCR crossing-point values with virus titers were made using a 10-fold dilution from a virus stock of known titer. Virus titers after RT-qPCR were expressed as log10 TCID50 equivalents/ml (log10 TCID50 equivalent/ml).Western blottingConfluent MDCK cells were inoculated with the MLVs (MLV-H9N2 and MLV-H9N2-IL) at an MOI of 1 or 10 for 1 h at 37 °C. Following inoculation, the inoculum was removed and replaced with fresh Opti-MEM (Fisher Scientific). Infected cells were incubated at 37 °C for 10 h. Moreover, confluent HEK293T cells were transfected with 10 µg of plasmid pCAGGS expressing N2WF10-Furin-2A-IL-18-HIS for 48 h at 37 °C. After incubation, the media was removed from the cells and cold RIPA buffer (ThermoFisher) was used to lyse the cells. Quantification of total proteins was performed using BCA protein assay kit (ThermoFisher). Then, 150 µl of supernatant was mixed with 150 µl of Laemmli buffer containing mercaptoethanol (Bio-Rad, Hercules, CA, USA), followed by boiling for 7 min, and brief sonication. Proteins were separated on a 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel and were transferred to nitrocellulose membranes (Bio-Rad) for immunoblot analysis. Membranes were blocked in 5% molecular-grade nonfat dry milk overnight on shaker at 4 °C. Then, membranes were incubated with a mouse primary antibody against chicken IL-18 (catalog number #EUS040, 1:500, Kerafast, Boston, MA, USA) or a mouse primary antibody against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (catalog number #AM4300, 1:500, Fisher Scientific) for 2 h shaking at room temperature following manufacturers’ recommendations. After washing, the membranes were incubated with the respective secondary antibodies diluted in 5% molecular-grade nonfat dry milk: goat anti-mouse secondary antibody (catalog number #31430, 1:5000, Fisher Scientific) and anti-mouse IgG-horseradish peroxidase (HRP) conjugate (catalog number #1610380, 1:5000, Fisher Scientific) for 1 h shaking at room temperature following the manufacturer’s recommendation. Finally, the membranes were washed and imaged through a chemiluminescent reaction using West Femto (ThermoFisher Scientific). The ChemiDoc MP Imaging System (Bio-Rad) was employed to visualize the membranes. The captured images in TIFF format are shown in Supplementary Fig. 3.Co-infection studies in vitroMDCK cells were seeded in 6-well plates at a ratio of 3 × 105 cells per well. The next day, cells were co-infected with a mixture of either MLV-H9N2 or MLV-H9N2-IL and A/Chicken/Tunisia/812/2012 (H9N2) (ck/Tun) at the ratio 10MLV:1WT as follows: MLV-H9N2 (MOI 0.01) + ck/Tun (MOI 0.001) and MLV-H9N2-IL (MOI 0.01) + ck/Tun (MOI 0.001). The co-infection was performed with 500 µl of each mixture for 15 min at 4 °C and then 45 min at 37 °C. Subsequently, the inoculum was removed, and cells were washed twice with 1 ml of PBS (Life Technologies). Finally, 2 ml of Opti-MEM (Fisher Scientific) supplemented with TPCK-trypsin (Worthington Biochemicals, Lakewood, NJ, USA) and 1% AB (Sigma-Aldrich, St. Louis, MO, USA) was added to the cells. Cells were incubated at 37 °C and 5% CO2. Supernatants collected at 72 hpi were used for limiting dilution assays as described elsewhere16 to isolate cloned populations. Briefly, a 96-well plate was seeded with 1.5 × 104 MDCK cells/well. Cells were infected with 8, 10-fold serial dilutions of each virus combination. After 72 h at 37 °C, supernatants were collected from wells infected with the most diluted sample displaying cytopathic effect (CPE) and then used for the second round of infection by limiting dilution. Supernatants from the second round of infection were collected at 72 h and used for sequencing.Next-Generation Sequencing (NGS)The vRNA from each sample was extracted using the MagMAX-96 viral RNA Isolation kit (ThermoFisher). Multi-Segment RT-PCR (MS-RTPCR) was performed as previously described59. Briefly, 2.5 µl of vRNA was used as a template in a 25 µl MS-RTPCR reaction (SuperScript III One-Step RT-PCR Platinum Taq HiFi DNA polymerase (ThermoFisher)) using the following primers: Opti1‐F1 5′‐GTTACGCGCCAGCAAAAGCAGG‐3′; Opti1‐F2 5′‐GTTACGCGCCAGCGAAAGCAGG‐3′; Opti1‐R1 5′‐GTTACGCGCCAGTAGAAACAAGG‐3′. The final product was analyzed in 1% agarose gel to verify whole genome amplification60. MS-RTPCR amplicons were sequenced using the Illumina platform as described elsewhere61. Briefly, products were purified using 0.45X of Agencourt AMPure XP Magnetic Beads (Beckman Coulter, Brea, CA, USA) and eluted in HyClone molecular biology water (Genesee Scientific, San Diego, CA, USA). The concentration of the samples was determined using a Qubit buffer kit (ThermoFisher, Waltham, MA, USA) in a Qubit 3.0 fluorometer (ThermoFisher) and normalized to 0.2 ng/µl. Indexes were added via tagmentation using the Nextera XT DNA library preparation kit (Illumina, San Diego, CA, USA). The reaction was set as 40% of the suggested final volume. Next, samples were purified using 0.7X of Agencourt AMPure XP Magnetic Beads and analyzed on a Bioanalyzer using a High Sensitivity DNA kit (Agilent, Santa Clara, CA, USA). Libraries were pooled and normalized to 0.5 nM. After denaturation, the final loading concentration of the pooled libraries was 14 pM. Libraries were sequenced using a MiSeq Reagent Kit V2, 300 cycles (Illumina, San Diego, CA, USA). Genome assembly was performed using a pipeline previously described62. For co-infection studies, FASTQ files generated were used to map the proportion (%) of NGS reads that matched either the MLV- or WT-specific segment. For unmodified segments (PB2, PA, NP, NS), the FASTQ file was used to map the reads to the whole WT or MLV segment, and the proportion was established based on the number of reads for the specific segment (WT or MLV) divided by the total number of reads for the given sample. To distinguish between WT or MLV-modified segments (PB1, HA, NA, and M), NGS reads were mapped to the gene segment junctions (PB1-M2; DRP-HA; NA-ckIL-18; M2esc).Preparation of WIV-adj vaccine controlReverse genetics was used to prepare a virus carrying the H9 HA of ck/EGY and the NA of the WF10 virus in the background of the laboratory-adapted strain A/Puerto Rico/08/34 (H1N1). Upon virus rescue, stocks were grown in ECE. To inactivate the virus, allantoic fluid containing the live virus was mixed with Binary Ethyleneimine 0.1 M solution and incubated at 37 °C in a T175 flask (ThermoFisher). After 13 h, this solution was added to a new T175 flask and incubated for 7 h at 37 °C. Next, 1 M sodium thiosulfate solution was added to the BEI-treated virus stock, mixed thoroughly and the pH was adjusted to 7.2. An aliquot 1:10 (500 µl out of 5 mL) of the inactivated virus was inoculated into ECE and MDCK cells to confirm the inactivation process. On the day of vaccination, the vaccine emulsions were prepared by mixing Montanide ISA71 VG (Seppic, Fairfield, NJ, USA) with the inactivated virus at a 70:30 ratio Montanide:Virus at 512 HAU per dose.Vaccine-challenge studies in chickensStudies were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Georgia (Animal Use Protocol A2022 09-001-Y1-A5) to be performed under ABSL2 conditions. SPF White Leghorn embryonated eggs (Charles River Laboratories International Inc., Wilmington, MA, USA) were hatched and chicks raised for 2 weeks. In the first experiment, 4 groups of 2-week-old chickens were established and inoculated through the eyes and the respiratory (nasal and tracheal), oral, and cloacal routes (EROC) with either 1 × 106 EID50/chicken of MLV-H9N2 (n = 30), MLV-H9N2-IL (n = 30) or control PBS (mock vaccinated group; n = 35) or via the subcutaneous route with 512 HAU/chicken of the WIVadj-H9N2 vaccine (n = 30). Chickens were boosted 2 weeks after prime with the corresponding homologous vaccine using the same routes. Two weeks after the boost, chickens were challenged with 1 × 108 EID50/chicken of the homologous virus via EROC route. The challenge virus was a recombinant virus encoding the wild-type H9 HA of ck/EGY in the background of the wild-type WF10 strain (ck/EGY/WF10). In the second experiment, 2-week-old SPF White Leghorn chickens were vaccinated via drinking water with the MLV-H9N2-IL vaccine at either the low dose of 104 EID50/ml (n = 30) or the high dose of 106 EID50/ml (n = 30) in a prime-only or prime and boost 2 weeks apart. A subset of chickens (n = 30) was administered water only. The MLV-H9N2-IL virus vaccine was diluted in distilled sterile water with Vac-Pac Plus (Best Veterinary Solutions, Columbus, GA, USA) to neutralize residual chlorine or salts in the water and stabilize the pH. Before vaccine administration, chickens were deprived of water for 6 h. Drinking water vaccination proceeded for 2 h with the MLV-H9N2-IL virus vaccine administered using bell drinkers. Two weeks after prime, half of the chickens (n = 15) in each group were boosted with the same doses as the prime. Two weeks after the boost or four weeks after prime, chickens were challenged with 1 × 108 EID50/chicken of the ck/EGY/WF10 virus via EROC route as described previously.Transmission of MLV-H9N2 and MLV-H9N2-IL viruses and reassortment in vivo in chickensChickens (2-week-old) were inoculated with 1 × 106 EID50/chicken via the EROC route with either the MLV-H9N2 (n = 4) or MLV-H9N2-IL (n = 4). At 24 hpi, directly inoculated chickens were moved into a clean isolator that contained naïve direct contact chickens (n = 4) for each respective group. Oropharyngeal (OP) and cloacal (CL) swabs were collected every day until 6 days post-inoculation (dpi) and 6 days post-contact. Viral loads were analyzed by RT-qPCR as described previously. In the fourth experiment, 2-week-old chickens were coinfected with the MLV-H9N2 (n = 4) or MLV-H9N2-IL (n = 4) at 1 × 106 EID50/chicken and Ck/Tun wild-type virus at 1 × 105 EID50/chicken (ratio 10MLV:1WT). Oropharyngeal (OP) and cloacal (CL) swabs were collected every day until 5 days days-post infection (dpi) and directly sequenced by NGS as described previously in this manuscript.Vaccine stability in drinking waterThe MLV-H9N2-IL virus vaccine diluted in sterile water with Vac-Pac Plus was incubated at different temperatures in a thermocycler: 25 °C, 30 °C, 40 °C, and 50 °C. Timepoints were collected at 0, 1, 2, and 24 h after vaccine preparation. All timepoints were titrated by TCID50, and vaccine stability expressed as the amount of infectious virus present at the specific timepoint with virus titers established by the Reed and Muench method63.Nucleoprotein enzyme-linked immunoassaysBlood was collected from a subset of chickens per group 12 days post-prime (dpp), and 12 days post-boost (dpb). The levels of nucleoprotein (NP) antibodies were determined using the IDEXX AI MultiS-Screen Avian Influenza Virus Antibody Test kit (IDEXX Laboratories Inc., Westbrook, ME, USA). The presence or absence of antibodies was determined by relating the absorbance values at 650 nm to the negative control mean. A threshold for positive samples of 0.6 was established following the manufacturer’s recommendations.Hemagglutination Inhibition (HI) assaysBlood was collected from a subset of chickens per group 12 dpp, and 12 dpb. In addition, blood was collected from a subset of chickens 26 dpp for the second experiment – drinking water vaccination – in the prime-only group. Sera samples were analyzed by hemagglutination inhibition assay as described elsewhere41 to detect the presence of neutralizing antibodies. Briefly, sera were treated twice with 50% chicken red blood cells (RBCs) and diluted 1:10 in PBS. Of this dilution, 50 μL were added to the first column of a 96-well plate and 2-fold serially diluted. Then, sera were mixed with 4 HAU/25 μL of the homologous virus. The virus/sera mixture was incubated for 30 min at room temperature and the HI activity was determined after 30 min of incubation with 0.5% of chicken RBCs. HI titers below 10 were arbitrarily assigned a value of 10.Virus neutralization assaysBlood was collected from a subset of chickens per group 12 dpp, and 12 dpb. In addition, blood was collected from a subset of chickens 26 dpp for the second experiment – drinking water vaccination – in the prime-only group. Serum samples were treated twice with 50% RBCs as described previously. Serum samples were used to perform virus neutralization assays as described elsewhere41 but modified to rely on Nanoluciferase activity (VNLuc)64. Briefly, we generated a homologous H9N1 influenza virus in the PR8 backbone carrying a Nanoluciferase gene downstream of the PB1 gene64. Sera samples were serially diluted in a 96-well plate and incubated with 100 TCID50 of the homologous virus. The serum/virus mixture was incubated for 1 h at 37 °C and then overlayed on MDCK cells for 15 min at 4 °C and 45 min at 37 °C. The mixture was removed, cells were supplemented with Opti-MEM-AB and TPCK and incubated for 48 h as described previously. VNluc titers were read out using the Nano-Glo Luciferase Assay System (Promega, Madison, WI, USA) with a Victor X3 multilabel plate reader (PerkinElmer, Waltham, MA, USA).Virus titrationOP and CL swabs were collected on 3 and 5 dpp to determine MLV and/or WT virus replication in the intestinal and respiratory tracts. In addition, OP and CL swabs were collected at 1-, 3-, 5-, and 7-days post-challenge (dpc). Briefly, swab samples were spun down, 10-fold serially diluted, and directly inoculated into a 96-well plate seeded with 1.5 × 104 MDCK cells/well. Sinuses, trachea, lungs, pancreas, and cloaca were collected on days 3 post-challenge to analyze vaccine protection after homologous challenge. Tissue homogenates were generated using the Tissue Lyzer II (Qiagen, Hilden, Germany). Briefly, 1 mL of PBS-AB was added to each sample with Tungsten carbide 3 mm beads (Qiagen, Hilden, Germany) in the tubes. Samples were homogenized for 10 min and then centrifuged at 15,000 g for 10 min Supernatants were collected, aliquoted, and directly inoculated into a 96-well plate seeded with 1.5 × 104 MDCK cells/well. All samples were titrated by TCID50 and virus titers were established by the Reed and Muench method63. Alternatively, samples were also titrated by RT-qPCR. For this purpose, vRNA was extracted using the MagMAXTM-96 viral RNA Isolation kit (ThermoFisher) and the quantification of vRNA was based on the Influenza A matrix gene as previously described in the current manuscript.Graphs/Statistical analysesAll data analyses and graphs were performed using GraphPad Prism software version 10 (GraphPad Software Inc., San Diego, CA, USA). Ordinary one-way or two-way ANOVA as needed were performed to calculate P values followed by Tukey’s multiple comparison tests. A P value below 0.05 was considered significant. Data availability All data generated, analyzed and included in this manuscript are available upon request. ReferencesCox, N. J. & Subbarao, K. Global epidemiology of influenza: past and present. Annu. Rev. Med. 51, 407–421 (2000).Article CAS PubMed Google Scholar Dadonaite, B. et al. The structure of the influenza A virus genome. Nat. Microbiol. 4, 1781–1789 (2019).Article CAS PubMed PubMed Central Google Scholar Krammer, F. et al. Influenza. Nat. Rev. Dis. Prim. 4, 3 (2018).Article PubMed Google Scholar Olsen, B. et al. Global patterns of influenza a virus in wild birds. Science 312, 384–388 (2006).Article CAS PubMed Google Scholar Liu, J. et al. Complex reassortment of polymerase genes in Asian influenza A virus H7 and H9 subtypes. Infect. Genet. Evol. 23, 203–208 (2014).Article CAS PubMed Google Scholar Suarez, D. L. & Senne, D. A. Sequence analysis of related low-pathogenic and highly pathogenic H5N2 avian influenza isolates from United States live bird markets and poultry farms from 1983 to 1989. Avian Dis. 44, 356–364 (2000).Article CAS PubMed Google Scholar Carnaccini, S. & Perez, D. R. H9 influenza viruses: an emerging challenge. Cold Spring Harb. Perspect. Med. 10, ao38588 (2019).Caceres, C. J., Rajao, D. S. & Perez, D. R. Airborne transmission of avian origin H9N2 influenza a viruses in mammals. Viruses 13, 1919 (2021).Zhang, J. et al. A risk marker of tribasic hemagglutinin cleavage site in influenza A (H9N2) virus. Commun. Biol. 4, 71 (2021).Article PubMed PubMed Central Google Scholar Bonfante, F. et al. A G1-lineage H9N2 virus with oviduct tropism causes chronic pathological changes in the infundibulum and a long-lasting drop in egg production. Vet. Res. 49, 83 (2018).Article PubMed PubMed Central Google Scholar Slemons, R. D. & Swayne, D. E. Replication of a waterfowl-origin influenza virus in the kidney and intestine of chickens. Avian Dis. 34, 277–284 (1990).Article CAS PubMed Google Scholar Qi, X. et al. Deterioration of eggshell quality in laying hens experimentally infected with H9N2 avian influenza virus. Vet. Res. 47, 35 (2016).Article PubMed PubMed Central Google Scholar Pu, J. et al. Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus. Proc. Natl Acad. Sci. USA 112, 548–553 (2015).Article CAS PubMed Google Scholar Naguib, M. M. et al. Natural reassortants of potentially zoonotic avian influenza viruses H5N1 and H9N2 from Egypt display distinct pathogenic phenotypes in experimentally infected chickens and ferrets. J. Virol. 91 10–1128 (2017).Monne, I. et al. H9N2 influenza A virus circulates in H5N1 endemically infected poultry population in Egypt. Influenza Other Respir. Viruses 7, 240–243 (2013).Article CAS PubMed Google Scholar Kimble, J. B. et al. Alternative reassortment events leading to transmissible H9N1 influenza viruses in the ferret model. J. Virol. 88, 66–71 (2014).Article PubMed PubMed Central Google Scholar Kimble, J. B., Sorrell, E., Shao, H., Martin, P. L. & Perez, D. R. Compatibility of H9N2 avian influenza surface genes and 2009 pandemic H1N1 internal genes for transmission in the ferret model. Proc. Natl Acad. Sci. USA 108, 12084–12088 (2011).Article CAS PubMed PubMed Central Google Scholar Sorrell, E. M., Wan, H., Araya, Y., Song, H. & Perez, D. R. Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc. Natl Acad. Sci. USA 106, 7565–7570 (2009).Article CAS PubMed PubMed Central Google Scholar Wan, H. et al. Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS ONE 3, e2923 (2008).Article PubMed PubMed Central Google Scholar Wan, H. & Perez, D. R. Amino acid 226 in the hemagglutinin of H9N2 influenza viruses determines cell tropism and replication in human airway epithelial cells. J. Virol. 81, 5181–5191 (2007).Article CAS PubMed PubMed Central Google Scholar Zhang, P. et al. Characterization of H9N2 influenza viruses isolated from vaccinated flocks in an integrated broiler chicken operation in eastern China during a 5 year period (1998-2002). J. Gen. Virol. 89, 3102–3112 (2008).Article CAS PubMed Google Scholar Park, K. J. et al. Rapid evolution of low-pathogenic H9N2 avian influenza viruses following poultry vaccination programmes. J. Gen. Virol. 92, 36–50 (2011).Article CAS PubMed Google Scholar Shanmuganatham, K. et al. Antigenic and molecular characterization of avian influenza A(H9N2) viruses, Bangladesh. Emerg. Infect. Dis. 19, 1393 (2013).Marinova-Petkova, A. et al. The continuing evolution of H5N1 and H9N2 influenza viruses in bangladesh between 2013 and 2014. Avian Dis. 60, 108–117 (2016).Article PubMed PubMed Central Google Scholar Rehman, S. et al. Emerging threats and vaccination strategies of H9N2 viruses in poultry in Indonesia: a review. F1000Res 11, 548 (2022).CAS PubMed PubMed Central Google Scholar Dong, J., Zhou, Y., Pu, J. & Liu, L. Status and challenges for vaccination against avian H9N2 influenza virus in China. Life 12, 1326 (2022).Article CAS PubMed PubMed Central Google Scholar Cui, H. et al. Vaccination with inactivated virus against low pathogenic avian influenza subtype H9N2 does not prevent virus transmission in chickens. J. Virus Erad. 7, 100055 (2021).Article CAS PubMed PubMed Central Google Scholar Lee, D. H., Fusaro, A., Song, C. S., Suarez, D. L. & Swayne, D. E. Poultry vaccination directed evolution of H9N2 low pathogenicity avian influenza viruses in Korea. Virology 488, 225–231 (2016).Article CAS PubMed Google Scholar Song, H., Nieto, G. R. & Perez, D. R. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J. Virol. 81, 9238–9248 (2007).Article CAS PubMed PubMed Central Google Scholar Swayne, D. E. & Kapczynski, D. Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol. Rev. 225, 314–331 (2008).Article PubMed Google Scholar Cardenas-Garcia, S. et al. Maternally-derived antibodies protect against challenge with highly pathogenic avian influenza virus of the H7N3 subtype. Vaccines. 7, 163 (2019).Walters, M. S. et al. Generation of a human airway epithelium derived basal cell line with multipotent differentiation capacity. Respir. Res. 14, 135 (2013).Article PubMed PubMed Central Google Scholar Ye, J. et al. Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype? PLoS Pathog. 6, e1001145 (2010).Article PubMed PubMed Central Google Scholar Guyonnet, V. & Peters, A. R. Are current avian influenza vaccines a solution for smallholder poultry farmers? Gates Open Res. 4, 122 (2020).Article PubMed PubMed Central Google Scholar Cox, R. J., Brokstad, K. A. & Ogra, P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand. J. Immunol. 59, 1–15 (2004).Article CAS PubMed Google Scholar Rajao, D. S. & Perez, D. R. Universal vaccines and vaccine platforms to protect against influenza viruses in humans and agriculture. Front. Microbiol. 9, 123 (2018).Article PubMed PubMed Central Google Scholar Pizzolla, A., Smith, J. M., Brooks, A. G. & Reading, P. C. Pattern recognition receptor immunomodulation of innate immunity as a strategy to limit the impact of influenza virus. J. Leukoc. Biol. 101, 851–861 (2017).Article CAS PubMed Google Scholar Chan, M. C. W. et al. Frequent genetic mismatch between vaccine strains and circulating seasonal influenza viruses, Hong Kong, China, 1996-2012. Emerg. Infect. Dis. 24, 1825–1834 (2018).Article CAS PubMed PubMed Central Google Scholar Nogales, A., DeDiego, M. L. & Martinez-Sobrido, L. Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use. Front. Cell Infect. Microbiol. 12, 954811 (2022).Article CAS PubMed PubMed Central Google Scholar Cardenas-Garcia, S. et al. FluB-RAM and FluB-RANS: genome rearrangement as safe and efficacious live attenuated Influenza B virus vaccines. Vaccines 9, 897 (2021).Caceres, C. J. et al. Development of a novel live attenuated influenza a virus vaccine encoding the iga-inducing protein. Vaccines 9, 703 (2021).Pena, L. et al. Influenza viruses with rearranged genomes as live-attenuated vaccines. J. Virol. 87, 5118–5127 (2013).Article CAS PubMed PubMed Central Google Scholar Nakamura, K., Okamura, H., Nagata, K., Komatsu, T. & Tamura, T. Purification of a factor which provides a costimulatory signal for gamma interferon production. Infect. Immun. 61, 64–70 (1993).Article CAS PubMed PubMed Central Google Scholar Chen, H. Y. et al. Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing HA of H9N2 avain influenza virus and chicken IL-18. Antivir. Res. 91, 50–56 (2011).Article CAS PubMed Google Scholar Wang, C. et al. A eukaryotic expression plasmid carrying chicken interleukin-18 enhances the response to newcastle disease virus vaccine. Clin. Vaccin. Immunol. 22, 56–64 (2015).Article CAS Google Scholar Wan, Z. et al. Alternative strategy for a quadrivalent live attenuated influenza virus vaccine. J. Virol. 92, e01025–18 (2018).Article CAS PubMed PubMed Central Google Scholar Groves, P. J. et al. Uptake and spread of infectious laryngotracheitis vaccine virus within meat chicken flocks following drinking water vaccination. Vaccine 37, 5035–5043 (2019).Article PubMed Google Scholar Ganapathy, K., Bufton, A., Pearson, A., Lemiere, S. & Jones, R. C. Vaccination of commercial broiler chicks against avian metapneumovirus infection: a comparison of drinking-water, spray and oculo-oral delivery methods. Vaccine 28, 3944–3948 (2010).Article PubMed Google Scholar Hilbink, F., Smit, T. & Yadin, H. Drinking water vaccination against infectious laryngotracheitis. Can. J. Comp. Med. 45, 120–123 (1981).CAS PubMed PubMed Central Google Scholar Lee, J. et al. Live recombinant Newcastle disease virus vectored vaccine expressing the haemagglutinin of H9N2 avian influenza virus suppresses viral replication in chickens. Avian Pathol. 52, 100–107 (2023).Article CAS PubMed Google Scholar Veits, J. et al. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. Vaccine 26, 1688–1696 (2008).Article CAS PubMed Google Scholar Niqueux, E. et al. Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks. Vaccine 41, 145–158 (2023).Article CAS PubMed Google Scholar Liu, Z. et al. Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector. Sci. Rep. 7, 2193 (2017).Article CAS PubMed PubMed Central Google Scholar Liang, Y., Huang, T., Ly, H., Parslow, T. G. & Liang, Y. Mutational analyses of packaging signals in influenza virus PA, PB1, and PB2 genomic RNA segments. J. Virol. 82, 229–236 (2008).Article CAS PubMed Google Scholar Hoffmann, E., Krauss, S., Perez, D., Webby, R. & Webster, R. G. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20, 3165–3170 (2002).Article CAS PubMed Google Scholar Perez, D. R. & Donis, R. O. The matrix 1 protein of influenza A virus inhibits the transcriptase activity of a model influenza reporter genome in vivo. Virology 249, 52–61 (1998).Article CAS PubMed Google Scholar Pena, L. et al. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J. Virol. 85, 456–469 (2011).Article CAS PubMed Google Scholar Reed, L. J. & Muench, H. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27, 493–497 (1938). Google Scholar Zhou, B. et al. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J. Virol. 83, 10309–10313 (2009).Article CAS PubMed PubMed Central Google Scholar Ferreri, L. M. et al. Improved detection of influenza A virus from blue-winged teals by sequencing directly from swab material. Ecol. Evol. 9, 6534–6546 (2019).Article PubMed PubMed Central Google Scholar Ortiz, L. et al. Blue-winged teals in guatemala and their potential role in the ecology of H14 subtype influenza a viruses. Viruses 15, 483 (2023).Article CAS PubMed PubMed Central Google Scholar Mena, I. et al. Origins of the 2009 H1N1 influenza pandemic in swine in Mexico. eLife 5, e16777 (2016).REED, L. J. & MUENCH, H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27, 493–497 (1938).Article Google Scholar Caceres, C. J., Gay, L. C., Faccin, F. C. & Perez, D. R. Use of reverse genetics for the generation of recombinant influenza viruses carrying nanoluciferase. Methods Mol. Biol. 2733, 47–74 (2024).Article CAS PubMed Google Scholar Download referencesAcknowledgementsWe would like to thank the animal resources personnel at the Poultry Diagnostic and Research Center, University of Georgia, specifically Brent Lovern, for assistance in animal studies. Funding for this work includes grants, contracts, and subawards to D.R.P. including National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture (USDA) Grant award numbers 2020-67015-31539 (with D.R.K) and 2021-67015-33406, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) Grant award number R21AI146448 and R01AI154894, Contract number 75N93021C00014 and Options 15 A, 15B and 17 A. Funds to D.R.K. also include USDA-ARS CRIS project number 6040-32000-081-00D. Funds to D.S.R include NIFA-USDA Grant award number 2020-67015-31563. L.A.R. was supported by the National Institute of General Medical Sciences, NIH under award number R25GM109435. N.v.B. was supported by funds provided by Boehringer Ingelheim Veterinary Scholars Program in association with the Georgia Veterinary Scholars Program, University of Georgia. A.L.S.F was supported with funds from the Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES). Additional funds were provided to D.R.P. by the Georgia Research Alliance and the Caswell S Eidson Chair in Poultry Medicine endowment funds.Author informationAuthor notesBrittany SeibertPresent address: W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USANick van BentemPresent address: Division of Farm Animal Health, Department Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The NetherlandsLuis A. RodriguezPresent address: Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USAAna Luiza Soares FraihaPresent address: Departamento de Medicina Veterinária Preventiva, Universidade Federal de Minas Gerais, Belo, Horizonte, Minas Gerais, BrazilLucia OrtizPresent address: Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USAAuthors and AffiliationsDepartment of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA, USAFlavio Cargnin Faccin, C. Joaquin Cáceres, L. Claire Gay, Brittany Seibert, Nick van Bentem, Luis A. Rodriguez, Ana Luiza Soares Fraiha, Matias Cardenas, Ginger Geiger, Lucia Ortiz, Silvia Carnaccini, Daniela S. Rajao & Daniel R. PerezExotic and Emerging Avian Viral Disease Research Unit, Southeast Poultry Research Laboratory, U.S. National Poultry Research Center, Agricultural Research Service, USDA, Athens, GA, USADarrell R. KapczynskiAuthorsFlavio Cargnin FaccinView author publicationsYou can also search for this author in PubMed Google ScholarC. Joaquin CáceresView author publicationsYou can also search for this author in PubMed Google ScholarL. Claire GayView author publicationsYou can also search for this author in PubMed Google ScholarBrittany SeibertView author publicationsYou can also search for this author in PubMed Google ScholarNick van BentemView author publicationsYou can also search for this author in PubMed Google ScholarLuis A. RodriguezView author publicationsYou can also search for this author in PubMed Google ScholarAna Luiza Soares FraihaView author publicationsYou can also search for this author in PubMed Google ScholarMatias CardenasView author publicationsYou can also search for this author in PubMed Google ScholarGinger GeigerView author publicationsYou can also search for this author in PubMed Google ScholarLucia OrtizView author publicationsYou can also search for this author in PubMed Google ScholarSilvia CarnacciniView author publicationsYou can also search for this author in PubMed Google ScholarDarrell R. KapczynskiView author publicationsYou can also search for this author in PubMed Google ScholarDaniela S. RajaoView author publicationsYou can also search for this author in PubMed Google ScholarDaniel R. PerezView author publicationsYou can also search for this author in PubMed Google ScholarContributionsD.R.P. and D.R.K. designed the MLV approach and overall study design. D.R.P. designed the rearrangement, the DRPAVIAN peptide and the recombinant ckIL18 strategies and plasmids. L.A.R. and B.S. performed cloning experiments. F.C.F. carried out reverse genetics, studies in vitro and in vivo, and data analyses. F.C.F., C.J.C., and D.R.P. designed the animal experiments and performed data analyses. C.J.C., L.C.G., B.S., A.L.S.F., N.v.B., M.C., G.G., L.O., and S.C. assisted in the in vitro and in vivo work and in the interpretation of results. F.C.F. and L.O. performed and analyzed NGS work. F.C.F. and D.R.P. interpreted the results, analyzed data, and wrote and edited the manuscript. D.S.R., D.R.K., and D.R.P. edited the manuscript.Corresponding authorCorrespondence to Daniel R. Perez.Ethics declarations Competing interests The authors declare no competing interests. Additional informationPublisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Supplementary informationSupplementary InformationRights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Reprints and permissionsAbout this articleCite this articleCargnin Faccin, F., Cáceres, C.J., Gay, L.C. et al. Mass vaccination with reassortment-impaired live H9N2 avian influenza vaccine. npj Vaccines 9, 136 (2024). https://doi.org/10.1038/s41541-024-00923-yDownload citationReceived: 03 January 2024Accepted: 12 July 2024Published: 03 August 2024DOI: https://doi.org/10.1038/s41541-024-00923-yShare this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative Download PDF Advertisement Explore content Research articles Reviews & Analysis News & Comment Collections Follow us on Twitter Sign up for alerts RSS feed About the journal Aims & Scope Content types Journal Information About the Editors Contact Open Access Calls for Papers Editorial policies Article Processing Charges Journal Metrics About the Partner Publish with us For Authors and Referees Language editing services Submit manuscript Search Search articles by subject, keyword or author Show results from All journals This journal Search Advanced search Quick links Explore articles by subject Find a job Guide to authors Editorial policies npj Vaccines (npj Vaccines) ISSN 2059-0105 (online) nature.com sitemap About Nature Portfolio About us Press releases Press office Contact us Discover content Journals A-Z Articles by subject protocols.io Nature Index Publishing policies Nature portfolio policies Open access Author & Researcher services Reprints & permissions Research data Language editing Scientific editing Nature Masterclasses Research Solutions Libraries & institutions Librarian service & tools Librarian portal Open research Recommend to library Advertising & partnerships Advertising Partnerships & Services Media kits Branded content Professional development Nature Careers Nature Conferences Regional websites Nature Africa Nature China Nature India Nature Italy Nature Japan Nature Middle East Privacy Policy Use of cookies Your privacy choices/Manage cookies Legal notice Accessibility statement Terms & Conditions Your US state privacy rights © 2024 Springer Nature Limited Close banner Close Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily. Email address Sign up I agree my information will be processed in accordance with the Nature and Springer Nature Limited Privacy Policy. Close banner Close Get the most important science stories of the day, free in your inbox. Sign up for Nature BriefingFlu Burden Prevented by Vaccination | Flu Burden | CDC Skip directly to site content Skip directly to search An official website of the United States government Here's how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. Flu Burden Explore Topics Search Search Clear Input Public Health About Estimated Flu Burden Why CDC Estimates the Burden of Flu Prevented by Vaccination Estimated US Flu Disease Burden Flu Burden Prevented by Vaccination View all Related Topics: Seasonal Flu | Avian Flu | Swine Flu | Flu in Animals | Flu Vaccines Work | Flu Forecasting View All search close search search Flu Burden Menu Close search Public Health About Estimated Flu Burden Why CDC Estimates the Burden of Flu Prevented by Vaccination Estimated US Flu Disease Burden Flu Burden Prevented by Vaccination View All Related Topics Seasonal Flu Avian Flu Swine Flu Flu in Animals Flu Vaccines Work Flu Forecasting View All Flu Burden About Estimated Flu Burden Why CDC Estimates the Burden of Flu Prevented by Vaccination Estimated US Flu Disease Burden Flu Burden Prevented by Vaccination View All August 2, 2024 Flu Burden Prevented by Vaccination What to know CDC estimates the impact of annual flu vaccination in the United States by calculating burden prevented by vaccination. CDC produces these estimates using a model that calculates the numbers of flu illnesses, medical visits, hospitalizations, and deaths prevented by vaccination using season-specific data on burden of disease, vaccine coverage and vaccine effectiveness (VE). Variations in these three factors can impact estimates of both the burden of disease and the burden prevented by vaccination from season to season. CDC uses the estimates of the burden of flu in the population and the impact of flu vaccination to inform policy and communications related to flu. Past seasons' burden prevented by flu vaccination Flu Burden Prevented from Vaccination 2022-2023 Flu Season CDC estimates that during the 2022-2023 season, flu vaccination prevented 6 million flu illnesses. Dec. 13, 2023 Flu Burden Prevented from Vaccination 2021-2022 Flu Season CDC estimates that during the 2021-2022 season, flu vaccination prevented 1.8 million flu illnesses. Dec. 29, 2023 Flu Burden Prevented from Vaccination 2019–2020 Flu Season CDC estimates that during the 2019-2020 season, flu vaccination prevented 7.1 million illnesses. Dec. 29, 2023 Keep Reading: *Estimates are not available for the 2020-2021 flu season due to minimal flu activity. August 2, 2024 Sources Print Share Facebook LinkedIn Twitter Syndicate Content Source: National Center for Immunization and Respiratory Diseases (NCIRD) Flu Burden Each year CDC estimates the burden of influenza in the U.S. CDC uses modeling to estimate the number of flu illnesses, medical visits, hospitalizations, and deaths related to flu that occurred in a given season. View All About Estimated Flu Burden Why CDC Estimates the Burden of Flu Prevented by Vaccination Estimated US Flu Disease Burden Flu Burden Prevented by Vaccination Sign up for Email Updates Contact Us Contact Us Call 800-232-4636 Contact CDC About CDC About CDC Organization Budget & Funding Careers & Jobs Policies Accessibility External Links Privacy Web Policies FOIA OIG No Fear Act Nondiscrimination Vulnerability Disclosure Policy Languages Languages EspaÃ±ol Language Assistance EspaÃ±ol ç¹é«ä¸­æ Tiáº¿ng Viá»t íêµ­ì´ Tagalog Ð ÑÑÑÐºÐ¸Ð¹ Ø§ÙØ¹Ø±Ø¨ÙØ© KreyÃ²l Ayisyen FranÃ§ais Polski PortuguÃªs Italiano Deutsch æ¥æ¬èª ÙØ§Ø±Ø³Û English Archive CDC Archive Public Health Publications Contact Us Contact Us Call 800-232-4636 Contact CDC About CDC Organization Budget & Funding Careers & Jobs About CDC Policies Accessibility External Links Privacy Web Policies FOIA OIG No Fear Act Nondiscrimination Vulnerability Disclosure Policy Languages Languages EspaÃ±ol Language Assistance EspaÃ±ol ç¹é«ä¸­æ Tiáº¿ng Viá»t íêµ­ì´ Tagalog Ð ÑÑÑÐºÐ¸Ð¹ Ø§ÙØ¹Ø±Ø¨ÙØ© KreyÃ²l Ayisyen FranÃ§ais Polski PortuguÃªs Italiano Deutsch æ¥æ¬èª ÙØ§Ø±Ø³Û English Archive CDC Archive Public Health Publications HHS.gov USA.govExperts consider H5N1 avian flu unknowns as state fairs loom | CIDRAP Skip to main content University of Minnesota Main navigationMain content University of Minnesotahttp:/win-cities.umn.edu/612-625-5000 Go to the U of M home page Main navigation News Antimicrobial Resistance COVID-19 Chronic Wasting Disease Influenza Mpox All Topics A-Z Resilient Drug Supply Influenza Vaccines Roadmap CIDRAP Leadership Forum Roadmap Development Coronavirus Vaccines Roadmap . . Topics & Projects Antimicrobial Stewardship Chronic Wasting Disease Osterholm Update Podcasts Newsletters About CIDRAP CIDRAP in the News Our Staff Our Director Osterholm in the Press Shop Merchandise Contact Us About Search CLOSE Search Support Menu Experts consider H5N1 avian flu unknowns as state fairs loom Stephanie Soucheray, MA Avian Influenza (Bird Flu) WeaverPhoto/iStock Share Copied to clipboard In the next 6 to 10 weeks, hundreds of state and country fairs will take place across the United States, and thousands of Americans will attend agricultural shows, walk through barns, watch dairy cattle be milked, and even observe an animal giving birth.But veterinarians, public health researchers, and scientists are unclear to what extent—if any—the recent explosion in cases of H5N1 avian influenza in dairy cattle will affect animals on exhibition or pose a threat to human health. H5N1 is deadly to poultry, but causes mild to moderate symptoms in the bovine population. So far, humans who have been infected with H5N1 via contact with infected cows have also exhibited mild illness, but case numbers in humans remain low. For decades, Andrew Bowman, DVM, PhD, from the Ohio State University, the swine-human interface has been at top of mind at county, regional, and state fairs in the United States. “What we do at fairs kind of violates every tenet of biosecurity that we preach, and we do it on public display, and we charge the public,” Bowman told CIDRAP News. “As great as fairs are for agricultural education, they create situations with multiple species from different farms housed in one spot.”Bowman likens state and county fairs to the Southeastern Asian live-animal markets, so often seen as epicenters for zoonotic spillover events. We act like that sort of thing doesn’t happen in the US.“We act like that sort of thing doesn’t happen in the US,” said Bowman. “But it does happen on a different scale, and every county across the Midwest does the same thing.”Focus on dairy cows is newBowman said that while every year poses variant flu risks linked to swine, something the Centers for Disease Control and Prevention monitors, this year will be challenging because H5N1 has now been implicated in 172 outbreaks in 13 states, with more than a dozen human cases in agricultural workers. All human cases have been mild, with case-patients recovering fully. “Are we giving the opportunity for H5 to reassort with endemic swine virus?” he asked. “We know we have fairly regular incursions of influenza in pigs and maybe it becomes a pig-adapted virus.”Moreover, the transmission dynamics of H5N1 in cattle are still not clear. “We don’t totally understand transmission at this point, and don’t have great control measures,” said Bowman. It's clear to most scientists that milk and milking equipment plays a role in the current transmission dynamics, but respiratory spread between cows could also be happening, said Bowman.Jim Lowe, DVM, the state fair veterinarian for Illinois and an associate professor at the University of Urbana-Champaign, will be watching for transmission dynamics when the Illinois state fair starts on August 5. Per protocols from the United States Department of Agriculture (USDA), all show cattle traveling interstate will be subjected to H5N1 testing 7 days before the fair starts.Lowe said they will be following that protocol but mostly watching the animals.“I don’t know what to think about it,” said Lowe. “We’re going to pay attention, and that’s a big change for us; normally you don’t do much for the dairy cows.”Milking parlors, stages, pose biggest risk Each state fair and fairgrounds has its own challenges, Lowe explained. In Illinois, beef and dairy cattle are shown days apart, and the layout of the barns has dairy cattle fairly separate from other species. But milking banks and stages, where multiple cows use the same milking equipment, are common in fairs. If transmission happens, it’s likely going to be there.Last week, the University of Minnesota Extension service released guidance on cow exhibits, which recommends that people keep lactating cows away from public events such as fairs. Because raw milk is known to have the highest concentration of H5N1 virus, the Extension program is recommending that lactating cows not attend fairs. “Milking is often done in a shared parlor and may involve shared equipment, which is an efficient way to spread H5 influenza. Although closing the parlor seems like a logical control step, that strategy will simply spread the virus source since the lactating cow must still be milked, which is now likely to be done in the cow’s stall, and the milk must still be stored and marketed or discarded,” the Extension said. The Minnesota State Fair has already announced that its late-August event will exclude cows and calves from the popular Miracle of Birth Center, where visitors watch animals being born, and will limit lactating cows based on the recommendations from the Extension program. For now, Lowe is tentatively hopeful the late-summer timing of fairs will benefit from the current outbreak. He said most of the animals shown at major state fairs are likely a previously exposed population, as they have been shown at agricultural events since March.Since 1997 avian flu has thrown us curveball after curveball.Michael Osterholm, PhD, MPH, director of the University of Minnesota's Center for Infectious Disease Research and Policy (CIDRAP), which publishes CIDRAP News, said the H5 outbreaks in dairy cattle are part of a bigger trend in flu dynamics. “We are really in a period of human animal interface with influenza unlike any I’ve ever known in my career,” Osterholm said. "Since 1997 avian flu has thrown us curveball after curveball.”Osterholm said if different fairs have different rules, it’s not out of incompetence. “It’s because people just don’t know what to do.” Related news Previous Next Studies describe deadly avian flu outbreaks among seals, terns Stephanie Soucheray Canada probes suspected avian flu infection in hospitalized teen Lisa Schnirring CDC expands avian flu testing for farm workers, notes 7% infection rate in those exposed to infected cows Lisa Schnirring Scientists track emergence of novel H5N1 flu reassortant in Cambodia Lisa Schnirring California, Washington report more suspected H5 avian flu cases Lisa Schnirring Utah reports avian flu in dairy cows as USDA announces plan for bulk milk sampling Lisa Schnirring USDA announces first H5N1 avian flu detection in US pigs Lisa Schnirring H5N1 avian flu isolate from dairy worker is transmissible, lethal in animals Lisa Schnirring This week's top reads Recent COVID-19 vaccination tied to lower risk of long COVID Overall, the risk of developing 28 out of 36 long-COVID symptoms lessened when vaccines were effective. Stephanie Soucheray California, Washington report more suspected H5 avian flu cases In related developments, the USDA reported more dairy cow and poultry outbreaks, as Los Angeles Country announced its first H5 wastewater detection. Lisa Schnirring Scientists track emergence of novel H5N1 flu reassortant in Cambodia Since a spillover in October 2023 the novel reassortment has replaced the older clade in Cambodia's poultry. Lisa Schnirring MIS-C much more common in kids not vaccinated against COVID-19, data reveal Among 12- to 17-year-olds, 90% of those with MIS-C were unvaccinated. Stephanie Soucheray CDC expands avian flu testing for farm workers, notes 7% infection rate in those exposed to infected cows The CDC now recommends testing and prophylactic Tamiflu use in asymptomatic workers exposed to sick animals. Lisa Schnirring Four cases of sexually transmitted fungal infection reported in New York The infections were caused by Trichophyton mentagrophytes type VII (TMVII), a sexually transmitted fungus that causes ringworm. Chris Dall Canada probes suspected avian flu infection in hospitalized teen The presumed positive infection comes amid a rise in poultry outbreaks in BC and US western states, likely triggered by wild bird migration. Lisa Schnirring Surveys reveal Americans' persistent mistrust in COVID vaccine science The greatest levels of trust were seen among men, those with university degrees and high median outcomes, and those who had lost someone to COVID-19. Mary Van Beusekom Trial shows safety of getting COVID, flu vaccines at same time Over half of participants (57%) reported a history of SARS-CoV-2 infection. Stephanie Soucheray Cases top 50,000 in Africa's mpox outbreak In other outbreak developments, medical groups announce a vaccine allocation plan and a vaccine trial to begin in pregnant women and in children younger than 2. Lisa Schnirring Our underwriters Unrestricted financial support provided by Principal Underwriter Leading Underwriter Major Underwriter Supporting Underwriter Become an Underwriter Help make CIDRAP's vital work possible Support Us Home Editorial policy Search news Contact Us CIDRAP - Center for Infectious Disease Research & Policy Research and Innovation Office, University of Minnesota, Minneapolis, MN Email us © 2024 Regents of the University of Minnesota. All rights Reserved. The University of Minnesota is an equal opportunity educator and employer Research and Innovation Office | Contact U of M | Privacy Policy Newsletter subscribe Get CIDRAP updates Choose newsletters Select all Daily Headlines Antimicrobial Stewardship Newsletter Chronic Wasting Disease Newsletter Flu Vaccine Roadmap Newsletter Resilient Drug Supply Newsletter Email Email Format html text News Topics & Projects Antimicrobial Resistance COVID-19 Chronic Wasting Disease Influenza Mpox All Topics A-Z Resilient Drug Supply Influenza Vaccines Roadmap CIDRAP Leadership Forum Roadmap Development Coronavirus Vaccines Roadmap . . Podcasts Antimicrobial Stewardship Chronic Wasting Disease Osterholm Update Newsletters About About CIDRAP CIDRAP in the News Our Staff Our Director Osterholm in the Press Shop Merchandise Contact Us DonateCorrection: Rapid detection of avian influenza virus based on CRISPR-Cas12a | Virology Journal | Full Text Skip to main content Advertisement Search Explore journals Get published About BMC My account Search all BMC articles Search Virology Journal Home About Articles Sections Submission Guidelines Submit manuscript Correction: Rapid detection of avian influenza virus based on CRISPR-Cas12a Download PDF Download PDF Correction Open access Published: 02 August 2024 Correction: Rapid detection of avian influenza virus based on CRISPR-Cas12a Xu Zhou1 na1, Siwen Wang1 na1, Yue Ma1, Yanbing Li1, Guohua Deng1, Jianzhong Shi1 & …Xiurong Wang1 Show authors Virology Journal volume 21, Article number: 174 (2024) Cite this article 292 Accesses Metrics details The Original Article was published on 13 November 2023 Correction: Virol J 20, 261 (2023)https://doi.org/10.1186/s12985-023-02232-7Following publication of the original article [1], the authors identified some errors in Fig. 5 (a b e) and Table 1 (line 18). The correct Fig. 5 and Table 1 is given below:Fig. 5Sensitivity analysis. a, c, e Ten-fold serial dilutions of plasmid template targeting the M gene at 2.4 × 1011 copies/µl for the sensitivity assay; b, d, f Ten-fold serial dilutions of plasmid template targeting the NP gene at 8.67 × 1011 copies/µl for the sensitivity assay; (M:11–5, 2.4 × 1011 copies/µl-2.4 × 105 copies/µl; NP:11–5, 8.67 × 1011 copies/µl-8.67 × 105 copies/µl); g, h, i, m Ten-fold serial dilutions of RNA template targeting M gene at 6.7 × 1011 copies/μL for the sensitivity assay by RT-RPA/CRISPR; i, k, l, n Ten-fold serial dilutions of RNA template targeting NP gene at 12 × 1011 copies/μL for the sensitivity assay by RT-RPA/CRISPR. (M:11–0, 6.7 × 1011 copies/µl-6.7 × 100 copies/µl; NP:11–0, 12 × 1011 copies/µl-12 × 100 copies/µl). Fluorescent signals were collected every 5 min and displayed for 2 h and 30 min, respectivelyFull size imageTable 1 Oligonucleotides used for crRNA and RT-RPA productionFull size table ReferenceZhou X, et al. Rapid detection of avian influenza virus based on CRISPR-Cas12a. Virol J. 2023;20:261. https://doi.org/10.1186/s12985-023-02232-7.Article CAS PubMed PubMed Central Google Scholar Download referencesAuthor informationAuthor notesXu Zhou and Siwen Wang are co-first authors and contributed equally to this work.Authors and AffiliationsState Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, ChinaXu Zhou, Siwen Wang, Yue Ma, Yanbing Li, Guohua Deng, Jianzhong Shi & Xiurong WangAuthorsXu ZhouView author publicationsYou can also search for this author in PubMed Google ScholarSiwen WangView author publicationsYou can also search for this author in PubMed Google ScholarYue MaView author publicationsYou can also search for this author in PubMed Google ScholarYanbing LiView author publicationsYou can also search for this author in PubMed Google ScholarGuohua DengView author publicationsYou can also search for this author in PubMed Google ScholarJianzhong ShiView author publicationsYou can also search for this author in PubMed Google ScholarXiurong WangView author publicationsYou can also search for this author in PubMed Google ScholarCorresponding authorCorrespondence to Xiurong Wang.Additional informationPublisher’s NoteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. Reprints and permissionsAbout this articleCite this articleZhou, X., Wang, S., Ma, Y. et al. Correction: Rapid detection of avian influenza virus based on CRISPR-Cas12a. Virol J 21, 174 (2024). https://doi.org/10.1186/s12985-024-02436-5Download citationPublished: 02 August 2024DOI: https://doi.org/10.1186/s12985-024-02436-5Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative Download PDF Advertisement Virology Journal ISSN: 1743-422X Contact us Submission enquiries: journalsubmissions@springernature.com Read more on our blogs Receive BMC newsletters Manage article alerts Language editing for authors Scientific editing for authors Policies Accessibility Press center Support and Contact Leave feedback Careers Follow BMC BMC Twitter page BMC Facebook page BMC Weibo page By using this website, you agree to our Terms and Conditions, Your US state privacy rights, Privacy statement and Cookies policy. Your privacy choices/Manage cookies we use in the preference centre. © 2024 BioMed Central Ltd unless otherwise stated. Part of Springer Nature.Training on Influenza Data Management and Basic Analysis: Maldives 2023 Skip to main content Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. Select language Select language English العربية 中文 Français Русский Español Português Donate Donate Home Health Topics All topicsABCDEFGHIJKLMNOPQRSTUVWXYZ Resources Fact sheets Facts in pictures Multimedia Podcasts Publications Questions and answers Tools and toolkits Popular Dengue Endometriosis Excessive heat Herpes Mental disorders Mpox Countries All countriesABCDEFGHIJKLMNOPQRSTUVWXYZ Regions Africa Americas Europe Eastern Mediterranean South-East Asia Western Pacific WHO in countries Data by country Country presence Country strengthening Country cooperation strategies Newsroom All news News releases Statements Campaigns Events Feature stories Press conferences Speeches Commentaries Photo library Headlines Emergencies Focus on Cholera Coronavirus disease (COVID-19) Greater Horn of Africa Israel and occupied Palestinian territory Mpox Sudan Ukraine Latest Disease Outbreak News Situation reports Weekly Epidemiological Record WHO in emergencies Surveillance Operations Research Funding Partners Health emergency appeal International Health Regulations Independent Oversight and Advisory Committee Data Dashboards Triple Billion Progress Health Inequality Monitor Delivery for impact COVID-19 dashboard Data collection Classifications SCORE Surveys Civil registration and vital statistics Routine health information systems Harmonized health facility assessment GIS centre for health Reports World Health Statistics UHC global monitoring report About WHO About WHO Partnerships Committees and advisory groups Collaborating centres Technical teams Organizational structure Who we are Our work Activities Initiatives General Programme of Work WHO Academy Funding Investment in WHO WHO Foundation Accountability External audit Financial statements Internal audit and investigations Programme Budget Results reports Governance Governing bodies World Health Assembly Executive Board Member States Portal Home/ Publications/ i/ item/ Training on Influenza Data Management and Basic Analysis: Maldives 2023 - Select language - العربية 中文 français русский español português Training on Influenza Data Management and Basic Analysis: Maldives 2023 Malé, Maldives, 13–15 March 2023 1 August 2024 | Meeting report Download (1.6 MB) Overview In alignment with the Global Influenza Strategy (2019–2030) and the recommendations of the 14th Bi-Regional meeting of surveillance and National Influenza Centres in WHO South-East Asia and Western Pacific regions, Maldives conducted an influenza data management workshop with WHO and the US CDC Thailand and India offices from the 13 to 15 of March 2023.To enhance the effectiveness of building stronger country capacities in data management and data reporting for evidence-based decision-making, the workshop was held immediately after the Joint National and International review of Influenza-like Illness (ILI) and Severe Acute Respiratory Infections (SARI) sentinel surveillance in Maldives.The objective of the data management component of the mission was to enhance the national capacity for influenza data management. This report presents in detail the objectives, methodology, and content of the training, the debriefing to key stakeholders including the Ministry of Health, and lists the recommendations of the joint surveillance review for operationalizing data quality improvement and data management capacity.The document will help the national programme to continue with capacity-building in data management and also assist WHO, partners, and donors in planning technical and financial support to countries to sustain progress and bolster areas that need further strengthening. WHO Team Infectious Hazard Management, SEARO Regional Office for the South East Asia (RGO) Editors WHO/SEARO/WHE/IHM Number of pages 27 Reference numbers WHO Reference Number: SEA-WHE-23 Copyright Regions Africa Americas Eastern Mediterranean Europe South-East Asia Western Pacific Policies Cybersecurity Ethics Information disclosure Permissions and licensing Preventing sexual exploitation Terms of use About us Careers Frequently asked questions Library Newsletters Procurement Publications Contact us Report misconduct Privacy policy © 2024 WHOImmunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza | npj Vaccines Skip to main content Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement View all journals Search Log in Explore content About the journal Publish with us Sign up for alerts RSS feed nature npj vaccines articles article Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza Download PDF Download PDF Article Open access Published: 03 August 2024 Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza Xiaole Cui ORCID: orcid.org/0009-0005-8747-47631, Pieter Vervaeke ORCID: orcid.org/0000-0002-1297-36301, Ya Gao2, Lisa Opsomer ORCID: orcid.org/0000-0002-3322-57461, Qing Sun1, Janne Snoeck1, Bert Devriendt ORCID: orcid.org/0000-0002-3222-87692, Zifu Zhong ORCID: orcid.org/0000-0002-5915-16183,4 & …Niek N. Sanders1,4 Show authors npj Vaccines volume 9, Article number: 138 (2024) Cite this article 3852 Accesses 2 Citations 9 Altmetric Metrics details Subjects AntibodiesLymphocyte activationRNA vaccines AbstractThis study reports on the immunogenicity and biodistribution of H5 hemagglutinin (HA)-based self-amplifying (sa) mRNA vaccines in mice. Four sa-mRNA vaccines encoding either a secreted full-length HA, a secreted HA head domain, a secreted HA stalk domain, or a full-length membrane-anchored HA were investigated. All vaccines elicited an adaptive immune response. However, the full-length HA sa-RNA vaccines demonstrated superior performance compared to head and stalk domain vaccines. The antibody titers positively correlated with the vaccine dose. Cellular immune responses and antigen-specific IgA antibodies in the lungs were also observed. The comparison of the sa-mRNA vaccines encoding the secreted and membrane-anchored full-length HA revealed that anchoring of the HA to the membrane significantly enhanced the antibody and cellular responses. In addition to the injection site, the intramuscularly injected sa-mRNA-LNPs were also detected in the draining lymph nodes, spleen, and to a lesser extent, in the lung, kidney, liver, and heart. Similar content being viewed by others Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus Article Open access 23 May 2024 An mRNA vaccine candidate encoding H5HA clade 2.3.4.4b protects mice from clade 2.3.2.1a virus infection Article Open access 14 October 2024 Self-amplifying mRNA seasonal influenza vaccines elicit mouse neutralizing antibody and cell-mediated immunity and protect ferrets Article Open access 04 October 2023 IntroductionThe risk of highly pathogenic avian influenza virus (HPAIV) to both poultry and humans is considerable due to the virus’s extensive circulation, high mortality rates, and potential for transmission between animals and humans. While inactivated virus vaccines are employed in some countries1,2,3 to vaccinate poultry, HPAIV continues to cause outbreaks. In humans, HPAIV can cause severe to deadly infections. Therefore, outbreak preparedness by developing vaccines against avian influenza is recommended. In 2022, HPAIV H5N1 causes more than 131 million domestic poultry lost due to death or culling according to WHO (World Health Organization). H5N1 strains are the dominant HPAIV subtype causing outbreaks in poultry and wild birds worldwide from 2022 October to 2023 September (www.fao.org/animal-health/situation-updates). Nowadays, disease control heavily relies on culling strategies. For poultry the European Union has approved the emergency and preventive use of influenza vaccines, often combined with the “Differentiating Infected from Vaccinated Animal” (DIVA) strategy4. The challenge of controlling this disease lies in the rapid mutation rate and antigenic shift, which diminishes vaccine effectiveness. To address this, two conferences are held every year to select new virus vaccine candidates for the upcoming next half year. However, conventional vaccines often suffer from strain mismatches due to the significant delay in response time and the complexity of the vaccine manufacturing process. Therefore, a novel platform that allows a quick and easy antigen modification is urgently needed.Since 2020, mRNA vaccines have shown remarkable potential and efficiency in preventing the coronavirus disease (COVID-19) pandemic5,6. SARS-CoV-2 mRNA vaccines have significantly reshaped the course of the global pandemic, leading to the preservation of a substantial number of lives. The COVID-19 pandemic has ignited a surge in the advancement and utilization of mRNA-based vaccines and therapies. In comparison to inactivated virus vaccines, mRNA vaccines offer several notable advantages over traditional vaccines, including a rapid design, a cell-free manufacturing and the capacity to elicit high antibody levels as well as robust cellular immune responses7,8. However, the inherent instability and the size of mRNA necessitate the use of safe and efficient delivery systems to transfer the mRNA in the cytosol of cells. Lipid nanoparticles (LNPs) have emerged as leading non-viral delivery systems for mRNA molecules, playing a crucial role in protecting the mRNA from degradation and delivering the mRNA to the cytosol. Furthermore, LNPs, like synthetic mRNA, possess inherent adjuvant properties that can synergistically enhance the efficacy of mRNA vaccines9, thereby augmenting their ability to combat viral infections10,11,12. Self-amplifying mRNA (sa-mRNA) vaccines, typically engineered from an alphavirus vector, encode a viral replicase that temporarily generates new full-length mRNA copies and many copies of a shorter subgenomic mRNA that contains the gene of interest13. Sa-mRNAs exhibit superior potential by inducing more potent and sustained mRNA expression in vivo. Consequently, sa-mRNA vaccines can achieve comparable vaccination efficacy to conventional mRNA vaccines while utilizing significantly lower doses14. Furthermore, sa-mRNA vaccines hold promise in conferring sufficient protection following a single-dose administration15.Hemagglutinin (HA) is an essential viral protein of influenza virus, characterized by a homotrimer composed of a globular head domain and a stalk domain. As the major glycoprotein on the influenza virion, HA plays a pivotal role in the immune response and serves as a preferred antigen for the development of influenza vaccine platforms16, including subunit vaccines, DNA vaccines, and mRNA vaccines17,18,19. Studies have demonstrated that immunization with soluble trimeric HA subunit vaccines induced a potent immune protection against HPAIV H5N1 in mice and chicken through the generation of high levels of neutralizing antibodies20,21.In this study, we demonstrate that LNP formulated sa-mRNA vaccines encoding HA proteins, either in full-length or truncated forms, are capable to induce durable and robust immune response, including high HAI titers, mucosal and Th1-skewed immune responses, in mice, even at a low dose of 0.25 µg. In addition, a comparative analysis of the immunogenicity between sa-mRNA-LNP vaccines encoding cell membrane anchored full-length HA and secreted full-length HA in mice showed superior efficacy of membrane anchored HA. Finally, a biodistribution study of sa-mRNA-LNPs following intramuscular immunization in mice showed high amounts and expression of the sa-mRNA at the injection site, draining lymph nodes and spleen. Our findings highlight the potential of our best-performing sa-mRNA-LNP vaccine as a candidate for combating avian influenza H5 virus infection.ResultsConstruction and verification of HA encoding sa-mRNAsA total of four sa-mRNA vaccines were created. Three sa-mRNAs encoded for respectively a secreted full-length HA (sFL-HA), secreted HA head domain (sHD-HA) and secreted stalk domain (sSD-HA). The last sa-mRNA encoded a full-length membrane anchored HA (FL-HA). All vaccines were based on the HA sequence of A/Anhui/1/2005 (H5N1) avian influenza A virus strain (Anhui 05), which belongs to clade 2.3.4. The wild-type HA (WT-HA) has 567 amino acids (aa), consisting of a signal peptide (1–16 aa), HA1 (17–338 aa) and HA2 (339–567 aa) (Fig. 1A). In order to achieve a more stable HA, the highly pathogenic multi-basic cleavage site RERRRKR (338–345 aa) was modified to IETR in all sa-mRNA vaccines except in the sHD-HA22. The sFL-HA was constructed by replacing the transmembrane domain and cytoplasmic domain of FL-HA with a leucine zipper GCN4-pII sequence23 that can form a trimeric conformation (Fig. 1A). The sHD-HA construct comprised the HA signal peptide followed by the amino acid sequence of WT-HA 59–289 aa. Based on the secreted mini H1 HA #4900, sSD-HA was engineered in which residues 52–319 aa of the head domain were replaced by a four-glycine linker and residues 422–434 aa (based on WT-HA sequence number) were substituted with a GCN4 leucine zipper sequence. Moreover, the transmembrane and cytoplasmic domain were deleted and K323C, S336K, I352T, F405Y, V408I, R410C, F412Y, R418C, T435C mutations were introduced in this sSD-HA24. To facilitate detection of the proteins, a Flag-tag was added to the C-terminal of all sa-mRNA constructs, except for FL-HA. Protein structure prediction25,26 analysis revealed that FL-HA, sFL-HA, sHD-HA and sSD-HA exhibited similar structures to the WT-HA (Fig. 1B). In vitro transcribed (IVT) and cellulose purified sa-mRNAs (Supplementary Fig. S1A, S1B) encoding FL-HA, sFL-HA, sHD-HA, sSD-HA or luciferase as control were then transfected into BHK cells, and translation of the HA antigens was detected by western blot. As expected, sFL-HA, sHD-HA, sSD-HA proteins with Flag tags were successfully detected in both the cell lysate (C) and the supernatant (S) using an anti-Flag-tag antibody (Fig. 1C). The membrane anchored FL-HA was only detected in the cell lysate (Fig. 1D) with an anti-H5 HA monoclonal antibody as FL-HA was not Flag-tagged. Based on the amino acid sequences the expected sizes of the monomeric forms of the sFL-HA, sHD-HA, sSD-HA and FL-HA antigens, which are respectively, 65 kDa, 29 kDa, 31 kDa and 63 kDa, were in agreement with the molecular weights observed on western blot (Fig. 1C and Supplementary Fig. S1C).Fig. 1: Schematic diagram of the different HA antigens, predicted protein structures, and translation verification of the sa-mRNA vaccines encoding different types of HA using either western blotting or flow cytometry.A Schematic overview of the wild type HA and the engineered HA antigens that are encoded by the sa-mRNA vaccines. The numbers within the rectangles indicate the original position of amino acids in the WT-HA sequence. The multi-basic cleavage site (RERRRKR) at the start of the fusion peptide (F) was mutated to IETR in all sa-mRNA vaccine constructs, except sHD-HA. In sFL-HA, the transmembrane domain and cytoplasmic domain were replaced by GCN4 leucine zipper (GCN4), followed by a Flag tag (Tag) sequence (DYKDDDDK). In sHD-HA, amino acids 17–58 and 290–567 were excluded and a Flag tag was added to its C-terminal. In sSD-HA, the amino acids 52–319 of the head domain were replaced by a short linker and amino acids 422–434 were substituted by GCN4. The transmembrane domain and cytoplasmic domain were replaced by a Flag tag. B The structures of the HA proteins as predicted by I-TASSER25 (available at https://zhanggroup.org/I-TASSER/), in which the fusion peptide is shown in yellow, GCN4 in green, α-helix in cyan and β sheet in purple. C, D BHK-21 cells were transfected with 1 µg sa-mRNAs encoding different types of HA using Lipofectamine® MessengerMAX™. After 24 h, the HA proteins in cell lysate (c) and supernatant (s) were analyzed by western blot. To detect the HAs, an anti-Flag tag antibody (C) or anti-H5 HA antibody (D) was used. E Flow cytometric detection of surface-exposed HA after transfection of BHK cells with sa-mRNAs encoding luciferase (control), FL-HA or sFL-HA. Surface-exposed HA was visualized 24 h after transfection using an Alexa Fluor-647 conjugated H5N1 HA antibody. The size markers can be found on the uncropped and unprocessed images (Supplementary Fig. S7) used to generate Fig. 1C, D.Full size imageFlow cytometry of BHK cells transfected with sa-mRNA encoding FL-HA, showed binding of Alexa Fluor 647 conjugated anti-H5 HA antibody, whereas no binding was observed on cells transfected with sa-mRNA encoding sFL-HA or luciferase (control) (Fig. 1E). This confirms that the membrane anchored FL-HA protein is exposed at the cell membrane after transfection with FL-HA sa-mRNA.Optimization of sa-mRNA-LNPs and dosage for intramuscular injectionWe used LNPs containing the same ionizable lipid (ALC-0315) as in the COVID-19 BNT162b2 vaccine to formulate the sa-mRNA vaccines (Supplementary Fig. S2A). In BNT162b2, a smaller non-amplifying mRNA is formulated with LNPs at an N/P (nitrogen of ionizable lipid to phosphate of mRNA) ratio of 627. However, sa-mRNA, which is much longer, may require a different N/P ratio. Therefore, to find the optimal N/P ratio for sa-mRNA, we investigated in mice (n = 4) the luciferase production after intramuscular injection of 1 µg sa-mRNA-LNPs encoding luciferase prepared at different N/P ratios (5, 10 and 15). The bioluminescent signal, an indication of luciferase expression, was quantified at different time points using an IVIS system. As shown in Fig. 2A, sa-mRNA-LNP at an N/P ratio of 10 exhibited higher luciferase expression compared to the sa-mRNA-LNPs prepared at N/P 5 or 15 as demonstrated by a significantly higher cumulative luminescence over 21 days (Fig. 2B). Subsequently, a dose-response study using 0.25 µg, 1 µg or 4 µg sa-mRNA-LNPs prepared at N/P ratio 10 showed that the highest dosage of 4 µg significantly outperformed the lower doses (1 µg and 0.25 µg) (Fig. 2C, D).Fig. 2: Optimization of sa-mRNA-LNP formulation and dosage.Balb/c mice were injected (IM) with (A and B) 1 µg luciferase encoding sa-mRNA-LNPs prepared at different N/P ratios (5, 10 or 15), or (C and D) with different doses of sa-mRNA-LNPs (0.25 µg, 1 µg or 4 µg) prepared at N/P ratio 10. The bioluminescence was monitored with an IVIS imaging system from 6 h to day 21 (A, B) or to day 14 (C, D). Total flux (photon/s) reflect the radiance integrated over the area of interest. Bar charts B and D show the area under the curve (AUC) of the curves in A and C. Each group contained 4 mice. The significance level (n = 4; *p < 0.05; **p < 0.01; ***p < 0.001) was calculated using one-way ANOVA with Tukey’s multiple comparisons test (B and D). Mean values are shown and error bars represent SD.Full size imageImmunogenicity of sa-mRNA vaccines encoding secreted HA antigensThe sa-mRNA vaccines encoding the secreted HA antigens and the control sa-mRNA, encoding luciferase, were formulated in the optimized LNPs (N/P 10) and mice were intramuscularly injected (n = 3) using a dose of 1 µg in a prime-boost schedule with an interval of three weeks. Although 4 µg sa-mRNA resulted in the highest expression (Fig. 2C, D), 1 µg was used here to obtain a better discrimination between the vaccines. Antibody levels were measured in the serum three weeks after the prime (day 21) and twelve days after the boost (day 33) (Fig. 3A). After the prime, the highest anti-H5 IgG levels, determined by ELISA and depicted as area under the absorbance curve (AUC), were found in the sFL-HA sa-mRNA vaccine group (AUC, 2.0 × 105). These anti-H5 IgG levels were approximately 1.4 times higher than those in the sHD-HA sa-mRNA vaccine group (AUC, 1.4 × 105) and 4.5 times higher than in the sSD-HA sa-mRNA vaccine group (AUC 4.4 × 104). After the boost, the anti-H5 IgG levels in the sFL-HA group showed a 20-fold increase (AUC, 4.2 × 106) and were significantly higher than the IgG levels in the other groups, which reached AUC values of 1.5 × 106 and 1.3 × 106 in the sHD-HA and sSD-HA group, respectively (Fig. 3B). The sHD-HA group induced a slightly stronger anti-H5 antibody response than sSD-HA group, with over 3 times higher anti-H5 IgG levels three weeks after the prime, but only 1.2 times higher anti-H5 IgG levels twelve days after the boost. Notably, following the boost immunization, the sSD-HA group demonstrated the highest increase in anti-H5 IgG antibody levels, achieving a 29-fold increase compared to the 20-fold and 9-fold increase in the sFL-HA and sHD-HA group, respectively (Fig. 3B). The trends and differences in antibody levels are similar when the results are reported as endpoint titers (Supplementary Fig. S2B). As expected, no detectable anti-H5 antibodies were found in the control group (Supplementary Fig. S2C).Fig. 3: Immunogenicity data of the sa-mRNA vaccines encoding secreted H5 HA antigens.A Vaccination schedule. Mice were vaccinated (IM) with 1 µg sa-mRNA-LNPs encoding sFL-HA, sHD-HA, sSD-HA or luciferase (control group) using a prime-boost schedule with a 21-day interval. Blood samples were collected three weeks after the prime (day 21) and twelve days (day 33) after the boost. Spleens were collected twelve days (day 33) after the boost. B Serum antibody levels were measured by ELISA and the data are reported as the area under the ELISA absorbance curve (AUC) for each group. No antibody titers were detected in the control group. C HAI titers in sera collected three weeks after the prime (day 21) and 12 days (day 33) after the boost. The detection limit is 8 and indicated as a dashed line, and titers below this threshold are considered as undetectable titers and shown as 1. D Spleens were harvested 12 days after the boost and stimulated with a peptide pool of a HA from a vaccine-mismatched clade (A/Indonesia/CDC835/2006(H5N1)). Subsequently, the percentage of IFN-γ positive CD3+CD8+ T cells was assessed by flow cytometry. The significance level (n = 3; *p < 0.05; **p < 0.01; ***p < 0.001) was calculated using two-way ANOVA (B and C) or one-way ANOVA (D) with Tukey’s multiple comparisons test. Bars and lines represent the geometric means (B and C) or arithmetic means. Error bars represent the SD. Figure A was created with BioRender.com.Full size imageTo evaluate the protection capacity of the elicited antibodies, hemagglutination inhibition (HAI) titers were determined using the vaccine-matched Anhui05 H5N1 virus. Mice vaccinated with the sFL-HA sa-mRNA vaccine achieved three weeks after the prime (day 21) a mean HAI titer of 13. Twelve days after the boost (day 33), the mean HAI titer in this group was 150 and significantly higher than the HAI in the other groups. Mice in the sHD-HA group failed to develop a HAI titer above the detection threshold after the prime, but after the boost reasonably high HAI titers that ranged between 32 and 64 were detected. As expected no detectable HAI titers were found in the sSD-HA group (Fig. 3C).Cellular immunity can play a vital role in conferring cross-strain protection. This prompted us to investigate HA-specific cellular responses. Due to the unavailability of a commercial peptide pool for A/Anhui/01/2005 (H5N1) HA and to demonstrate cross-clade protection of cellular immunity, we chose to employ a peptide pool derived from the vaccine unmatched strain A/Indonesia/CDC835/2006 (H5N1), which belongs to a distinct clade. HA-specific T cell responses were analyzed by intracellular staining of splenocytes isolated on day 12 after the boost vaccination. Mice in the sHD-HA group induced the highest percentage of HA specific T cells, with an average percentage of 3.1% H5 specific IFN-γ positive CD3+ CD8+ T cells, which is significantly higher than in the sFL-HA group (0.58%). No detectable T cell immunity was observed in the sSD-HA group and control group (Fig. 3D), even not after prolonging the stimulation of the splenocytes with HA peptide pool from 6 h to 48 h (Supplementary Fig. S2D).Dose-dependent and mucosal immune responsesTo further investigate a potential correlation between the vaccine dosage and the strength of the immune responses, we immunized mice (n = 12) with varying doses (0.25 µg, 1 µg and 4 µg) of the sa-mRNA-LNP vaccine encoding sFL-HA or 4 µg luciferase sa-mRNA-LNP as control, using again a prime-boost schedule with 3 weeks interval (Fig. 4A). Serum antibody (total IgG, IgG1, IgG2a) and HAI titers were determined three weeks after the prime (day 21 n = 9), and 7 (day 28 n = 4) and 14 (day 35 n = 6) days after the boost. This revealed a positive correlation between the dose and both the antibody (total IgG, IgG1, IgG2a) and HAI titers, with the 4 µg group significantly outperforming the 0.25 µg and 1 µg groups on day 28 (Fig. 4D) and day 35 (Fig. 4B and 4D, Supplementary Fig. S3A–K). Moreover, a clear effect of the boost was noticed as two weeks after the booster antibody levels increased more than 10-fold in all groups (Fig. 4B). Notably, the mean HAI titers of the mice that received the 0.25 µg dose increased after the boost to a comparable high and protective mean level of about 85 as obtained with 1 µg sa-mRNA vaccine (Fig. 4D). The ratio of IgG2a/IgG1 consistently remained above 1, suggesting the immune response induced by our sa-mRNA vaccine is skewed towards a Th1 response (Fig. 4C).Fig. 4: Dose-dependent and mucosal immune responses induced by the sFL-HA sa-mRNA-LNP vaccine.A Vaccination schedule. Mice (n = 12) were intramuscularly vaccinated with 0.25 µg, 1 µg or 4 µg of sFL-HA sa-mRNA-LNPs using a prime-boost schedule with a 21-day interval. The control mice received 4 µg of a luciferase encoding sa-mRNA-LNP. B Serum anti-H5 IgG antibody levels measured three weeks after the prime (day 21 n = 9), and one and two weeks after the boost (day 28 n = 4 and day35 n = 6). Antibody levels are shown as the area under the ELISA absorbance curve (AUC). C The IgG2a/IgG1 ratio calculated by dividing the AUC of IgG2a by the AUC of IgG1. Dashed line indicates a value of 1. D HAI titers in serum samples taken three weeks after the prime (day 21), and one (day 28) and two weeks (day 35) after the boost. The detection limit is 8 and indicated as dashed line. The value 1 indicated an undetectable titer. No antibodies were detected in the control group. E depicts the anti-H5 IgA antibodies in the bronchoalveolar lavage fluid two weeks after the boost. F and G show the elicited cellular immune responses. Spleens were collected one week after the boost and splenocytes were isolated and stimulated with the HA peptide pool from A/Indonesia/CDC835/2006(H5N1). The percentage of IFN-γ positive CD3+CD8+ T cells (F) and CD3+CD4+ T cells (G) was measured by flow cytometry. The concentrations of IL-2 (H), IFN-γ (I) and IL-10 (J) in the supernatant of stimulated splenocytes was measured by quantitative ELISA. The significance level (*p < 0.05; **p < 0.01: ***p < 0.001; ****p < 0.0001) was calculated using two way ANOVA (B and D) or one-way ANOVA (E–J) (day 21 n = 9, day 28 n = 4, day 35 n = 6) with Tukey’s multiple comparisons test. Data are represented as geometric means (B and D) or arithmetic means. Error bars represent the SD. Figure A was created with BioRender.com.Full size imageGiven the aerosol transmission route of influenza, the establishment of robust mucosal immunity is crucial in curbing the viral infection. Therefore, two weeks after the boost (day 35), HA-specific IgA levels in bronchoalveolar lavage fluid (BALF) samples were determined. All vaccinated mice (n = 6) had detectable antigen-specific IgA titers in their BALF, with the highest levels found in the 1 µg sa-mRNA-LNP vaccine group, which is significantly higher than other groups (Fig. 4E).To investigate the effect of the sa-mRNA vaccine dose on the cellular immune responses, spleens were collected 7 days after the booster vaccination, which is 5 days earlier than in Fig. 3D. H5-specific CD8+ and CD4+ T cell producing IFN-γ were detected in all vaccinated groups after 16 h of peptide pool stimulation, but not in the control group mice. The average percentage of IFN-γ producing CD8+ T cells ranged from 1.1% in the 0.25 µg group to 1.46% in the 4 µg group (Fig. 4F). A similar pattern was observed for IFN-γ producing CD4+ cells (Fig. 4G), with percentages ranging from 1.33% (0.25 µg) to 2.27% (4 µg). However, these differences in cellular immune response were not statistically significant within vaccinated groups. Antigen-specific T cells that produced IL-4 were not detected (Supplementary Fig. S3L, S3M). Moreover, we also measured multiple cytokines secreted in the supernatant of splenocytes following 16 h of stimulation with the HA peptide pool. Interestingly, the levels of IL-2 (Fig. 4H), IFN-γ (Fig. 4I), and IL-10 (Fig. 4J) increased drastically in all vaccinated mice, and again no clear dose-dependent effect was noticed. In line with the data in Supplementary Fig. S3L, S3M, IL-4 could not be detected in the supernatant of splenocytes stimulated with the HA peptide pool (Supplementary Fig. S3N).A head-to-head comparison of sa-mRNA-LNP vaccines encoding secreted or membrane anchored HAIt has been reported that genetic vaccines encoding membrane-anchored HA elicit stronger immune responses than genetic vaccines encoding secreted HA28. Therefore, we synthesized a sa-mRNA encoding a full-length membrane-anchored HA (FL-HA, Fig. 1) and compared its efficacy with the sa-mRNA encoding secreted full-length HA (sFL-HA). To that end, mice (n = 10) were intramuscularly immunized with 1 µg of LNP formulated sa-mRNA vaccines using a prime-boost schedule (Fig. 5A). In this experiment, the interval between prime and boost was 4 weeks instead of 3 weeks, as we also aimed to investigate whether a longer interval can enhance immune responses. Mice vaccinated with membrane-anchored FL-HA exhibited significantly higher anti-H5 IgG (Fig. 5B), IgG1 (Supplementary Fig. S4A) and IgG2a (Supplementary Fig. S4B) levels than mice that received the sa-mRNA encoding the secreted sFL-HA antigen (day 28 n = 6, day 35 n = 4, day 42 n = 6) after boost. The IgG2a/IgG1 ratios in both groups were above 1, which again indicates a Th1 response (Fig. 5C). Importantly, the FL-HA sa-mRNA group resulted, compared to the sFL-HA group, in significantly higher HAI titers on day 35 (Fig. 5D). Protective titers (HAI = 40) were almost obtained after the prime in the FL-HA group. The boost drastically increased the HAI titers in both groups. Seven days after the boost (day 35) the HAI titers were around 256 and 100 in the FL-HA and sFL-HA group, respectively. Two weeks after the boost, the HAI titers in both groups reached a similar level (Fig. 5D). On day 35, the BALFs were collected to measure the anti-H5 IgA level. The sa-mRNA encoding the membrane-anchored FL-HA also induced a significantly stronger mucosal immune response in the lungs, with anti-H5 IgA levels 3.5-fold higher than the sFL-HA group (Fig. 5E). One week after the boost, the percentages of HA specific IFN-γ secreting CD8+ (Fig. 5F) and CD4+ T cells (Fig. 5G) in spleen were also significantly higher in the FL-HA sa-mRNA vaccine group following 16 h of stimulation with the HA peptide pool. Finally, the cytokines secreted by splenocytes stimulated by HA peptide pool confirmed these data, showing a trend of higher IFN-γ and IL-2 secretion in the FL-HA sa-mRNA vaccine group (Supplementary Fig. S4E, F). Similar to the sFL-HA sa-mRNA vaccine, the FL-HA sa-mRNA vaccine did not induce IL-4 secretion by CD4+ and CD8+ T cells (Supplementary Fig. S4C, S4D, S4G). The differences between a 3-week and 4-week interval is discussed in the discussion section.Fig. 5: Comparison of the vaccination efficacy of sa-mRNA-LNP vaccines encoding either secreted HA or membrane anchored HA.A Vaccination schedule with 28-day (4-week) prime-boost interval. Mice (n = 10) were intramuscularly vaccinated with 1 µg sa-mRNA-LNP vaccines encoding sFL-HA or FL-HA. Mice injected with sa-mRNA-LNPs encoding luciferase served as control. B Serum anti-H5 IgG antibody levels against HA measured by ELISA 4 weeks after the prime (day 28 n = 6), one week (day 35 n = 4) and two weeks (day 42 n = 6) after the boost and shown as area under the ELISA absorbance curve (AUC). C The IgG2a/IgG1 ratios calculated by dividing the AUC of IgG2a by the AUC of IgG1. Dashed line indicates a value of 1. D HAI titers in serum samples taken four weeks after the prime (day 28), and one (day 35) and two weeks (day 42) after the boost. The detection limit is 8 and indicated as dashed line. Value sets at 1 indicate undetectable titer. E Anti-H5 IgA antibodies in BALFs collected two weeks after the boost. F and G depict the elicited cellular immune responses. Spleens were collected one week after the boost and splenocytes were isolated and stimulated with a HA peptide pool from A/Indonesia/CDC835/2006(H5N1). The percentage of IFN-γ positive CD3+CD8+ T cells (F) and CD3+CD4+ T cells (G) in the splenocytes were measured by flow cytometry. The significance levels in panels E–G (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001) were calculated by two-way ANOVA (B and D) or one-way ANOVA with Tukey’s multiple comparisons test. Data are represented as geometric means (B, D and E) or arithmetic means, Error bars represent the standard deviation. Figure A was created with BioRender.com.Full size imageBiodistribution of the sa-mRNA-LNP vaccineA sa-mRNA biodistribution analysis was conducted using real-time polymerase chain reaction(RT-qPCR)29 after intramuscular injection of 4 µg of sa-mRNA-LNP encoding sFL-HA. Tissue samples (n = 3) were collected on days 1, 3, 5 and 7 after injection, from the injection site, spleen, lung, heart, kidney, liver and brain. On day 1, sFL-HA sa-mRNA was detected in all the organs except for the brain. The highest sa-mRNA levels were observed in the intramuscular injection site, followed by the spleen, the latter having approximately 100-fold higher levels than in the liver, heart, lung and kidney (Fig. 6A). From day 3 onwards, sFL-HA sa-mRNA became undetectable in the liver, and its levels in other organs decreased compared to day 1. On day 5, HA sa-mRNA levels remained detectable in the spleens and the injection sites of all mice and in the lung of 1 mouse. By day 7, HA sa-mRNA was only detectable in the spleen and the injection site. Throughout the entire period, HA mRNA was never detected in the brain.Fig. 6: The biodistribution of the sa-mRNA-LNP vaccines in mice after intramuscular administration.A Mice were intramuscularly injected with 4 µg of LNP formulated sa-mRNA encoding sFL-HA. Subsequently at each time point, 3 mice were euthanized and the injection site, spleen, lung, heart, kidney, liver and brain were harvested. The presence of sFL-HA sa-mRNA in these organs was detected by RT-qPCR. The data are shown as the relative sa-mRNA level normalized to the reference gene GAPDH and the normalized sFL-HA sa-mRNA level in the liver on day 1 was set as 1. B Mice (n = 2) were intramuscularly injected with 4 µg of LNP formulated sa-mRNA encoding luciferase. The heart, lung, liver, spleen, kidney, and lymph nodes were harvested on day 1 and 3, and the bioluminescence was measured by the IVIS system.Full size imageTo further confirm these findings, we intramuscularly injected mice with 4 µg sa-mRNA-LNP encoding luciferase and monitored the luciferase expression by measuring the ex vivo bioluminescent signals in the major organs and popliteal draining lymph nodes. On day 1, luciferase expression was detected in the spleen, lung, kidney and the popliteal lymph nodes (Fig. 6B). On day 3, the expression was only detected in the spleen and the lymph nodes. At the injection site, the luciferase expression was present at all time points (data not shown). In addition, we monitored the weight of mice following vaccination with 0.25 µg, 1 µg, 4 µg sFL-HA sa-mRNA-LNP or 4 µg luciferase sa-mRNA-LNP, and observed no significant differences between the vaccinated groups and the non-vaccinated PBS group. This indicates that the sa-mRNA vaccines did not induce major side effects (Supplementary Fig. S5).DiscussionTo develop a potent influenza vaccine, both antigen-specific antibodies and T cell responses are essential for the vaccination effectiveness30,31,32. Furthermore, a local immune response in the lung is also warranted as influenza viruses predominantly enter the body via the respiratory tract and are primarily spread via respiratory droplets33. In this study, we engineered and investigated four sa-mRNA vaccines, of which three encoded secreted H5 HA proteins that were either in a full-length or truncated format, and a fourth encoded a full-length membrane-anchored HA. For the delivery of these sa-mRNA vaccines, we used LNPs that contained the same ionizable lipid as used in the COVID-19 BNT162b2 vaccine. As sa-mRNA is much longer than the modified mRNA in the COVID-19 BNT162b2 vaccine, we first determined the optimal N/P ratio and dose of our sa-mRNA-LNPs. Using a luciferase encoding sa-mRNA, we found that, after intramuscular administration, sa-mRNA-LNPs at an N/P ratio of 10 resulted in a higher expression than at an N/P ratios of 5 and 15 (Fig. 2A).The first sa-mRNA vaccine encoding the H5 HA stalk domain, which was designed based on the principle of the mini HA #4900 protein vaccine24, generated HA-specific antibodies but failed to trigger antigen-specific CD8+ cellular responses (Fig. 3D). Since T cell epitopes are expected to be present in the stalk34, this may indicate that the folding or stability of the stalk produced by the sa-mRNA does not favor CD8+ T cell responses. As expected, this sa-mRNA vaccine did not induce HAI titers, as antibodies against the stalk do not interfere with the hemagglutination. Nevertheless, we cannot exclude that the elicited anti-stalk antibodies can still offer protection via e.g. antibody-dependent cellular cytotoxicity35.The second sa-mRNA vaccine encoding a secreted H5 HA head domain, elicited a strong systemic response (IgG and HAI) and a highly robust T cell response (Fig. 3B–D and Supplementary Fig. S2D). This secreted H5 HA head domain is similar to the H1 head domain used in the vaccination study of Xuan et al.36, but it differs from the work of Khurana et al. and Chiu et al., who both used a complete HA1 sequences, which encodes besides the head domain also a part of the stalk domain37,38. The sa-mRNA encoding the secreted HA head domain represents a promising target to develop multivalent (sa-) mRNA vaccines, as it is less than half of the size of full-length HA protein. Indeed, Arevalo et al. evaluated a multivalent influenza vaccine by combining 20 full length HA mRNA-LNP vaccines that covered all subtypes of influenza viruses. As 2.5 µg mRNA-LNP was used for each antigen, the resulting total mRNA dose was 50 µg per mouse, which is quite high39. Especially with non-amplifying mRNA, the mRNA dosage could be halved when a mRNA sequence encoding the secreted HA head domain would be employed.The third sa-mRNA vaccine encoded the secreted full-length HA (sFL-HA) and induced higher antibody levels than other secreted HA forms. The immunogenicity and efficacy of this vaccine were studied in more detail. A dose-response study demonstrated that immunization with 4 µg of the sFL-HA sa-mRNA vaccine induced significantly higher antibody responses than 1 µg or 0.25 µg (Fig. 4B, D). Nevertheless, after the boost, the 0.25 µg dose was able to elicit HAI titers that surpassed the generally accepted correlate of protection (CoP) threshold of 40, which is the minimal requirement for a vaccine to be considered effective40. In a previous study of Vogel et al.14, 0.25 µg of a sa-mRNA encoding full-length wild-type H1 HA was not able to elicit HAI titers above the protective threshold14. This disparity is most likely attributed to the use of a potent LNP based formulation11 in our work and the utilization of cellulose purified sa-mRNA vaccines, which contain less ds-RNA byproducts (Supplementary Fig. S1B) and hence improve the vaccine efficacy41.T cells responses can be very valuable for influenza vaccines as cytotoxic CD8+ T cells can eliminate virus-infected cells. The T cell epitopes of influenza A virus, compared to its B cell epitopes, are relatively conserved, offering the potential for cross-strain protection42. We assessed antigen-specific T cell activation through flow cytometry and observed that a dose of 0.25 µg of sa-mRNA induced similar levels of antigen-specific CD4+ and CD8+ T cells compared to 4 µg sa-mRNA. It is noteworthy that the commercial HA peptides pool used in our study originated from a heterologous strain (A/Indonesia/CDC835/2006(H5N1)), which belongs to clade 2.1.3. The sa-mRNA vaccines in this work are based on the HA of a clade 2.3.4 HPAIV. Hence, our HPAIV sa-mRNA vaccines have the potential to induce cross-protection via T cell mediated immunity. There are two main subsets of CD4+ helper T cells, namely Th1 and Th2 cells, which orchestrate the immune response. Th1 cells secrete IL-2 and IFN-γ, suppressing IgG1 and IgE production, while inducing IgG2a. Conversely, Th2 cells secret IL-4 and promote IgG1 secretion43,44. Although IgG1 acts as the dominant isotype of virus-neutralizing antibodies, IgG2a antibodies play a crucial role in protection of mice against lethal infection by influenza H5N1 virus as well7,45. Our findings reveal slightly higher levels of HA-specific IgG2a than IgG1 (Figs. 4C and 5C) after primary and boost vaccination. This IgG2a isotype is highly effective in activating complement46 and facilitating antibody-dependent cellular cytotoxicity (ADCC)47. Considering the high IgG2a/IgG1 ratio (Figs. 4C and 5C) and the clear induction of HA specific T cells that produce IL-2 and IFN-γ (Fig. 4H, I and Supplementary Fig. S4E, F), we conclude that our HA sa-mRNA vaccines induced a Th1-skewed response, favoring the elimination of viral infections.The mRNA COVID-19 BNT162b1 vaccine, encoding the secreted trimerized receptor-binding domain (RBD) of SARS-CoV-2, has demonstrated the ability to elicit robust antibody and Th1 T cell responses in humans10. The antibody titer and neutralizing titer obtained with this vaccine were equivalent to the mRNA COVID-19 BNT162b2 vaccine encoding a membrane-anchored full-length spike protein6. However, our study did not find an equal performance of the membrane-anchored and secreted full-length HA. The membrane-anchored HA outperformed the secreted HA sa-mRNA vaccines in eliciting antigen-specific immune responses, including enhanced levels of HA-specific IgG, IgG1, IgG2a, IgA, HAI titers, as well as T cell responses (Fig. 5B–G and Supplementary Fig. S4A, B). Similar to our results, Freyn et al. reported that a 1-methylpseudouridine modified non-amplifying mRNA-LNP vaccine encoding the membrane-anchored full-length H1 HA elicited a stronger antibody response compared to the secreted counterpart28.In our study, the efficacy of the sFL-HA sa-mRNA-LNP vaccine was studied using both 3-week and 4-week intervals between the prime and the boost (Figs. 4 and 5). When a 3-week interval was applied, we observed that the anti-H5 IgG level did not exhibit a drastic increase 7 days after the boost (Fig. 4B), whereas the HAI titer displayed a more than 4-fold increase (Fig. 4D). Nevertheless, from 7 days to 14 days after the boost, a clear increase in IgG levels was noticed, while the HAI titer did not increase (Fig. 4B, D). Conversely, for the 4-week interval regime, a noteworthy increase in anti-H5 IgG level was observed 7 days after the boost (Fig. 5B) accompanied by a concurrent 8-fold increase in the HAI titer (Fig. 5D). However, from 7 to 14 days after the boost, neither the HAI titer nor the IgG had further increased. Overall, the 3-week and 4-week interval regimes did not generate major differences in IgG levels or HAI titers at two weeks post boost. This is in contrast with a previous report showing that a delayed-interval during vaccination with a modified non-amplifying mRNA COVID-19 vaccine enhanced humoral and T cell response48. A more in-depth study of the effect of longer prime-boost time intervals for sa-mRNA vaccines is needed.To assess the biodistribution of the sa-mRNA-LNP vaccines upon intramuscular injection in mice, we used RT-qPCR to measure HA sa-mRNA levels in different organs. As expected, massive amounts of HA sa-mRNA vaccine were detected at the injection site. However, high amounts of HA sa-mRNA were also detected in the spleens, while traces of HA sa-mRNA were also present in lungs, livers and hearts. Our results are consistent with the reported biodistribution data of the BNT162b2 COVID-19 mRNA vaccine that employs a similar LNP formulation11. In addition, intramuscular injection of luciferase sa-mRNA-LNPs corresponded to the RT-qPCR data and demonstrated protein expression in the spleen, draining lymph node, kidney and lung. No bioluminescence was detected in the heart and liver, possibly due to the lower sensitivity compared to RT-qPCR. The detection and expression of HA sa-mRNA in the spleen and lymph nodes point to a high delivery of the sa-RNA vaccine in lymphoid tissues and immune cells, which is beneficial for vaccination applications.In summary, our study provides comprehensive evidence that sa-mRNA vaccines coding a secreted HA head domain, a secreted full-length HA or a membrane-anchored full-length HA can induce strong humoral and cellular response, with HAI titers that are above 40, the minimal threshold for an efficient vaccine. Surprisingly, even when a low dose of 0.25 µg was used, protective HAI titers were obtained after a boost vaccination. The distribution of the sa-mRNA-LNPs to the lymph nodes and spleen most likely indicates, as confirmed by others49,50, that large amounts of the sa-mRNA-LNPs are internalized and expressed by immune cells, which is crucial for the efficacy of vaccines. A challenge study was not performed in this work, as mice are not sensitive to the H5N1 virus51,52. In sum, all the findings in this work highlight the potential of sa-mRNA-LNP vaccines as a promising approach for preventing influenza infections.MethodsCells and miceBHK-21 cells were cultured in Dulbecco’s Modified Eagle Medium (21885108, Gibco, Thermo Fisher, USA), supplemented with 10% fetal bovine serum (S181H-500, South American origin, VWR, USA) and 100 U/mL penicillin and 100 mg/mL streptomycin (15070-063, Gibco, Thermo Fisher). Female BALB/cJRj mice (6-7 weeks old) were purchased from Janvier (France). All the in vivo experiments were strictly reviewed and approved by the Ethics Committee of the Faculty of Veterinary Medicine, Ghent University (EC2021/63).Synthesis and purification of self-amplifying mRNAsThe hemagglutinin gene (HA) derived from A/Anhui/1/2005(H5N1) (GenBank: HM172104) was optimized for mice expression using GenScript’s OptimumGene Codon Optimization. The corresponding DNA for secreted full-length HA, head domain HA, stalk domain HA and membrane anchored HA were synthesized by Integrated DNA technology (IDT, USA). The linear DNA sequences were designed to have overlaps with pTK161 vector, for subsequent HiFi DNA assembly (E5520S, New England Biolabs, USA). The PV01 vector contains the Venezuelan Equine Encephalitis Virus strain TC-83 5’ UTR, 3’ UTR, non-structural proteins gene and luciferase gene. After HiFi cloning, the luciferase gene in the PV01 vector was replaced by an HA gene. The self-amplifying mRNA was synthesized by in vitro transcription (IVT) as previous described53. Briefly, the plasmid was linearized by digested with I-SceI homing endonuclease (R0694S, New England Biolabs) for 2 h, and completeness of cleavage was confirmed by examining the template DNA through agarose gel electrophoresis. The template was purified using silica spin columns (PCR & DNA cleanup kit, T1030S, New England Biolabs). The purified templates were then used in an IVT reaction (AM1334, Thermo fisher) with co-transcriptional capping using CleanCap technology (CleanCap AU N711410, Trilink BioTechnology, USA), following the instructions provided with the kit. The mRNA was purified using an RNA cleanup kit (T2050L, New England Biolabs) and cellulose-based purification to reduce the IFN response induced by ds-RNA as described elsewhere41. In brief, cellulose was prewashed with chromatography buffer (10 mM HEPES [pH 7.2], 0.1 mM EDTA, 125 mM NaCl, and 16% ethanol), and the sa-mRNA was added to the prewashed cellulose and incubated for 30 min with shaking. The ssRNA was collected by centrifugation with removal of dsRNA that bind to the cellulose. The mRNA was precipitated using isopropanol, dissolved in RNase-free water and stored at −80 °C for further use.mRNA-LNP formulation and characterizationSa-mRNA LNPs were formulated by rapid mixing of 3 volumes of aqueous solution containing the sa-mRNA (in sodium acetate, pH 4.5) with 1 volume of ethanolic solution (in 100% ethanol) containing the ALC-0315 lipid (HY-138170, MedChemExpress, USA), DMG-PEG2K (880151P, Avanti Polar Lipids, USA), cholesterol (700100P, Avanti Polar Lipids) and DOPE (850725 P, Avanti Polar Lipids) at a molar ratio of 50 : 1.5 : 38.5 : 10. After formulation, mRNA-LNPs were subjected to dialysis in a dialysis cassette (66003, Thermo Fisher) against DPBS (14190144, Thermo Fisher) to remove ethanol.Sa-mRNA-LNP formulations were diluted in 20 mM HEPES buffer (pH 7.4, 15630080, Thermo Fisher) and transferred into polystyrene cuvettes to measure particle size, polydispersity and zeta potential by dynamic light scattering (Zetasizer Nano-ZS, Malvern Panalytical B.V., Belgium). The diameters are reported as Z-average values. The mRNA encapsulation efficiency was measured by Quanti-it RiboGreen assay (R11490, Thermo Fisher) according to the provided instruction manual. Fluorescence emission intensity was recorded on a Cytation 5 (Agilent, USA) set at 485 nm excitation and 525 nm emission. mRNA encapsulation in LNP samples was calculated by comparing the fluorescence intensity of the mRNA-binding fluorescent dye RiboGreen® in the absence (signal from unencapsulated mRNA) and presence (signal from both encapsulated and unencapsulated) of 2% Triton X-100 (M236-10ML-5PK, VWR) to dissolve the LNP. Two-standard curves were made by using the standard sample of the kit, one curve with Triton x-100, one without Triton X-100. The encapsulation efficiency is calculated using the following equation: encapsulation efficiency (%) = ((mRNA total − mRNA unencapsulated)/mRNA total) × 100%. The most optimal N/P ratio and dose-response curve of the sa-mRNA-LNPs were determined after intramuscular injection of LNP formulated sa-mRNAs in BALB/c. The expression kinetics of the luciferase was measured after subcutaneous injection of 200 µl D-luciferin (15 mg/ml) using in vivo optical imaging with an IVIS Spectrum In Vivo Imaging System (PerkinElmer, USA).Western blotTo detect the HA protein in vitro, BHK cells were transfected with the sa-mRNA vaccines using Lipofectamine MessengerMax (LMRNA003, Invitrogen, USA). The supernatant was collected 24 h after transfection and centrifuged at 400 × g for 5 min 4 °C. The cell supernatant was concentrated using a centrifugal filter unit (Amicon Ultra-4 Centrifugal filter unit, ufc801008, Merck, USA). Simultaneously, the cells were wash twice with PBS, and 200 µL RIPA lysis buffer containing a protease inhibitor cocktail was added to the plate on ice. The plate was then shaken for 30 min. The lysate was centrifuged at 12,000 × g for 5 min at 4 °C. Subsequently, 9 µl supernatant was mixed with 1 µl glycoprotein denaturing buffer (10x) (NEB, P0704S, USA) and heated up to 100 °C for 10 min. Next, 2 µl GlycoBuffer 2 (10X), 2 µl 10% NP-40, 6 µl distilled H2O and 1 µl PNGase F (all from NEB, P0704S, USA) were added to the denatured samples and incubate at 37 °C for 1 h Finally, 4 µl Laemmli SDS sample buffer (6x) (J61337.AC, Thermo fisher) was added. Subsequently, 10 µL of the samples were loaded onto a gel (Bio-Rad 4569033) for electrophoresis. After electrophoresis, the proteins were transferred to a PVDF membrane that was subsequently blocked with 5% skim milk and incubated with HRP-conjugated anti-Flag antibody (ab49763, Abcam, USA) or anti-HA antibody (MA5-30009, Thermo fisher, USA) for 2 h. Next, the membrane incubated with anti-HA antibody was incubated with HRP-conjugated goat anti-mouse IgG(H + L) (31430, Invitrogen) for 1 h. The protein bands were visualized by adding an ECL western blotting detection kit and imaged using the ChemiDoc XRS+ system (Bio-rad).Vaccination experiments in miceAll injections of mice were administered intramuscularly into the quadriceps muscle (50 µl), and sa-mRNA encoding luciferase was used as a control. A prime-boost regime was employed for the vaccination studies with a 3 or 4-week interval.To investigate the three sa-mRNA encoding secreted HAs (sFL-HA, sHD-HA, sSD-HA), mice (n = 3) (n indicates the number of mice per group) were injected intramuscularly at day 0 with 1 µg sa-mRNA-LNP using a prime-boost schedule with a 3-week interval. Sa-mRNA encoding luciferase was used as control. The blood samples were collected from the tail vein on day 21 and day 33. Mice were euthanized by cervical dislocation and spleens were harvest for further analysis on day 33.To compare the immune response at different administered dose, four groups, each consisting of 12 mice, were intramuscularly injected with 0.25 µg, 1 µg or 4 µg sFL-HA or 4 µg of control sa-mRNA LNP, respectively, on day 0 and day 21. Blood samples were collected from random mice’s tail veins on day 21 (n = 9), 28 (n = 4) and 35 (n = 6). On day 28, spleens were collected from 6 mice in each group. On day 35, mice were euthanized by cervical dislocation, and BALF samples were collected. The BALF was collected following the method described by Lien54. Briefly, 1 ml sterile PBS was gently injected into the murine lung and then gently aspirated. The collected fluid was centrifuged at 400 × g for 5 min at 4 °C. The fluid was stored at −80 °C until further use.In the comparison experiment between sFL-HA and FL-HA, 10 mice in each group were intramuscularly administered with 1 µg sFL-HA, FL-HA or the control sa-mRNA LNP on day 0 and day 28. Blood samples were taken from random mice’s tail vein on day 28 (n = 6), day 35 (n = 4), and 42 (n = 6). On day 35, spleens were collected from 4 mice in each group. On day 42, BALF samples were collected after euthanasia.ELISAHA-specific antibody levels were determined using ELISA. Nunc MaxiSorp plates (44-2404-21, Thermo fisher) were coated with 25 ng A/Anhui/1/2005 Hemagglutinin HA Protein (11048-V08B, Sino Biological, China) overnight at 4 °C. The plate was washed three times with washing buffer (PBS with 0.05% tween-20) and then blocked with assay buffer (DS98200, Thermo fisher) for 1 h. After washing, serially diluted mouse serums were added to the plate and incubated at room temperature for 2 h. The plate was washed and the secondary HRP-conjugated goat anti mouse IgG (H + L) (31430, Invitrogen), IgG1(PA1-74421, Thermo Fisher) or IgG2a (A-10685, Thermo Fisher) antibody was added and incubated at room temperature for 45 min followed by 4-5 washes. TMB solution was then added to the plate and incubated for 15 min. The reaction was stopped by adding 100 μL of stop solution, and the absorbance at 450 nm was measured using a Cytation 5. The antibody levels were determined as the area under curves (AUC) of HA-specific antibody ELISA curves. The Cytokines from supernatant of stimulated splenocytes (as described in the Flow cytometry section) were measured using the corresponding ELISA kit, IFN-γ (88-7314, Invitrogen), IL-2 (88-7024, Invitrogen), IL-4 (88-7044, Invitrogen), IL-10 (88-7105, Invitrogen), following the provided instructions.Flow cytometrySeven or twelve days after boost immunization, spleens were collected from mice. The spleens were homogenized using a syringe plunger, and the red blood cells were lysed using ACK lysing buffer (A1049201, Thermo Fisher). A total of 106 splenocytes were stimulated with PepMix™ Influenza A (HA/Indonesia (H5N1) (PM-INFA-HAIndo, Jpt, Germany) or with cell stimulation cocktail as a positive control (00-4970, Invitrogen) for 6 or 16 h. Cytokine secretion was inhibited by a mixture of Monensin Solution (00-4505-51, Thermo Fisher) and eBioscience™ Brefeldin A Solution (00-4506-51, Thermo Fisher). After stimulation, the Fc receptors were blocked with Rat anti-mouse CD16/CD32 (553142, BD Biosciences, USA). Splenocytes were then incubated with Alexa Fluor® 488 anti-mouse CD3 antibody (100210, Biolegend, USA), PerCP/Cyanine5.5 anti-mouse CD4 Antibody (116011, Biolegend), Alexa Fluor® 700 anti-mouse CD8a Antibody (100729, Biolegend) and eBioscience Fixable Viability dye eFluor 506 (65-0866-14, Invitrogen) for 15 min. Following permeabilization, splenocytes were stained with PE anti-mouse IFN-γ Antibody (163503, Biolegend) and APC anti-mouse IL-4 Antibody (504105, Biolegend). The fluorophores were detected using a CytoFLEX flow cytometer (Beckman Coulter, USA). Gating strategy is shown in Supplementary Fig. S6.HAI assayTo determine the levels of protective anti-HA antibodies in the collected serum samples, an HAI assay was performed as described55. First, HA titration of the H5N1 virus particle (07/290, NIBSC, UK) was determined using a 0.75% turkey blood cell suspension, to quantify the virus particles needed for the hemagglutination inhibitor assay. Next 10 µL of mouse serum was mixed with 30 µL cholera filtrate (c8772, sigma) and incubated at 37 °C overnight, followed by incubation at 56 °C for 30 min to inactivate cholera filtrate. Each well of a 96 V-bottom plate was filled with 25 µL PBS. Subsequently the first wells of each row received 25 µL of serum mixture and 2-fold serial dilutions were performed. In the last wells 25 µl was discarded. The lowest dilution factor of serum is 8. Subsequently, 25 µL of the inactivated strain matched H5N1 virus containing 4 HA units was added to each well. The plate was gently tapped and incubated for 30 min at room temperature. Finally, 50 µL of 0.75% turkey blood cell suspension was added to each well and incubate for 30 min. The plate was then tilted vertically for 25 s before read out. After obtaining the results, HI titers were loaded into GraphPad Prims (version 10.1.10), and the “geometric mean with geometric SD” was selected for the analysis.mRNA biodistribution analysisBALB/c mice were intramuscularly injected with either 4 µg of sFL-HA sa-mRNA-LNP vaccine or PBS. In the HA sa-mRNA-LNP vaccine group, 3 mice were euthanized on day 1, 3, 5, and 7 post injection. Tissues including the injection site muscle, spleen, heart, liver, kidney, lung and brain were harvested, and less than 100 mg tissue was homogenized. Total mRNA was extracted using the Trizol chloroform method, and the total RNA concentration was measured using a nanodrop. For reverse transcription, 1 µg RNA was subjected to the ImProm-II™ Reverse Transcription System (A3800, Promega). After the transcription, the reaction was supplemented with 180 µl PCR-grade H2O, resulting in a final volume of 200 µL. The qPCR reaction consisted of 5 µL of KAPA SYBR® FAST qPCR master mix (2x), 0.5 µL of 10 µM forwardeverse primer, 2 µL of cDNA template, and 2 µL of PCR-grade H2O. The q-PCR procedure involved an initial step at 95 °C for 3 min, followed by 40 cycles of denaturation at 95 °C for 3 seconds and annealing/extension at 60 °C for 20 s. The reaction was then held at 25 °C. The GAPDH gene acted as a reference gene and was amplified using following primers: Forward: TGGAAAGCTGTGGCGTGAT, Reverse: ACACATTGGGGGTAGGAACAC. The HA in the sFL-HA sa-mRNA was amplified using the following primers Forward: CCAACCAGGAGGATCTTCTTATC, Reverse: TTGCTCTTCGTGGCAATCT. The relative sa-mRNA level was calculated by subtracting the HA cycle threshold (CT) value from GAPDH CT value, then calculating the average ΔCt value of the liver on day 1, and finally calculating 2 to the power of ΔΔCt (ΔCt liver -ΔCt) representing the relative mRNA expression level.For the ex vivo imaging, sa-mRNA encoding luciferase was injected into mice, and on day 1 and 3, mice were euthanized after first injecting them subcutaneously with 200 µl D-luciferin (15 mg/ml). The heart, lung, spleen, liver, kidney and draining lymph node were collected and the bioluminescence was measured in an IVIS Spectrum In Vivo Imaging System (PerkinElmer).Dot blot analysis of dsRNA contamination500 ng of mRNA in 5 µl RNase free water were loaded in duplicate onto a positively charged nylon membrane (Whatman Nytran SuPerCharge, 10416230, Sigma-Aldrich). After drying, the membrane was blocked with 5% (w/v) non-fat dried milk in TBS-T buffer (0.1% (v/v) Tween-20 in TBS) for 1 h at room temperature. After three washes with TBS-T buffer, the membrane was incubated at room temperature for 2 h with mouse J2 anti-dsRNA murine antibody (76651 L, Cell Signaling Technology) diluted 1:2000 in TBS-T buffer containing 1% (w/v) non-fat dried milk. Next, the membranes were washed three times with TBS-T buffer and incubated for 1 h at room temperature with horseradish peroxidase (HRP)-conjugated goat anti-mouse immunoglobulin G (IgG) (31430, Invitrogen) diluted 1:10,000 in TBS-T buffer containing 1% (w/v) non-fat dried milk. After washing the membranes four times with TBS-T buffer, detection of the target dsRNA on the membrane was performed using tetramethylbenzidine (TMB) solution (002023, Thermo Fisher). Data availability All data supporting the findings of this study are included in this manuscript or supplementary data. All relevant data are available from the corresponding authors upon reasonable request. ReferencesVillanueva-Cabezas, J. P., Coppo, M. J. C., Durr, P. A. & McVernon, J. Vaccine efficacy against Indonesian Highly Pathogenic Avian Influenza H5N1: systematic review and meta-analysis. Vaccine 35, 4859–4869 (2017).Article CAS PubMed Google Scholar Chen, H. & Bu, Z. Development and application of avian influenza vaccines in China. Curr. Top. Microbiol. Immunol. 333, 153–162 (2009).CAS PubMed Google Scholar Kim, S. H. Challenge for One Health: Co-Circulation of Zoonotic H5N1 and H9N2 Avian Influenza Viruses in Egypt. Viruses 10. https://doi.org/10.3390/v10030121 (2018).Pittman, M. & Laddomada, A. Legislation for the control of avian influenza in the European union. Zoonoses Public Health 55, 29–36 (2008).Article CAS PubMed Google Scholar Polack, F. P. et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N. Engl. J. Med. 383, 2603–2615 (2020).Article CAS PubMed Google Scholar Walsh, E. E. et al. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. N. Engl. J. Med. 383, 2439–2450 (2020).Article CAS PubMed Google Scholar Liu, X. et al. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Lancet 398, 856–869 (2021).Article CAS PubMed PubMed Central Google Scholar Valyi-Nagy, I. et al. Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans. Geroscience 43, 2321–2331 (2021).Article CAS PubMed PubMed Central Google Scholar Alameh, M. G. et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. Immunity 54, 2877–2892 e2877 (2021).Article CAS PubMed PubMed Central Google Scholar Sahin, U. et al. COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T cell responses. Nature 586, 594–599 (2020).Article CAS PubMed Google Scholar Li, C. et al. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine. Nat. Immunol. 23, 543–555 (2022).Article CAS PubMed PubMed Central Google Scholar Graham, M. B., Braciale, V. L. & Braciale, T. J. Influenza virus specific CD4 T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J. Exp. Med. 180, 1273–1282 (1994).Tews, B. A. & Meyers, G. Self-Replicating RNA. Methods Mol. Biol. 1499, 15–35 (2017).Article CAS PubMed Google Scholar Vogel, A. B. et al. Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses. Mol. Ther. 26, 446–455 (2018).Article CAS PubMed Google Scholar Erasmus, J. H. et al. An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates. Sci. Transl. Med. 12, https://doi.org/10.1126/scitranslmed.abc9396 (2020).Wu, N. C. & Wilson, I. A. Influenza Hemagglutinin Structures and Antibody Recognition. Cold Spring Harb. Perspect. Med. 10. https://doi.org/10.1101/cshperspect.a038778 (2020).Zhang, L. et al. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses. Hum. Vaccin Immunother. 10, 1949–1958 (2014).Article CAS PubMed PubMed Central Google Scholar Hekele, A. et al. Rapidly produced SAM((R)) vaccine against H7N9 influenza is immunogenic in mice. Emerg. Microbes Infect. 2, e52 (2013).Article PubMed PubMed Central Google Scholar Saczynska, V. Influenza virus hemagglutinin as a vaccine antigen produced in bacteria. Acta Biochim. Pol. 61, 561–572 (2014).Article PubMed Google Scholar Cornelissen, L. A. et al. A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1. PLoS One 5, e10645 (2010).Article PubMed PubMed Central Google Scholar Lin, S. C. et al. Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines. PLoS One 6, e20052 (2011).Article CAS PubMed PubMed Central Google Scholar Panaampon, J. et al. A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors. PLoS One 7, e36318 (2012).Article CAS PubMed PubMed Central Google Scholar Pekosz, A. et al. Recombinant Trimeric HA Protein Immunogenicity of H5N1 Avian Influenza Viruses and Their Combined Use with Inactivated or Adenovirus Vaccines. PLoS ONE 6. https://doi.org/10.1371/journal.pone.0020052 (2011).Impagliazzo, A. et al. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science 349, 1301–1306 (2015).Article CAS PubMed Google Scholar Yang, J. & Zhang, Y. I-TASSER server: new development for protein structure and function predictions. Nucleic Acids Res. 43, W174–W181 (2015).Article CAS PubMed PubMed Central Google Scholar Yang, J. et al. The I-TASSER Suite: protein structure and function prediction. Nat. Methods 12, 7–8 (2015).Article CAS PubMed PubMed Central Google Scholar Schoenmaker, L. et al. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. Int. J. Pharm. 601, 120586 (2021).Article CAS PubMed PubMed Central Google Scholar Freyn, A. W. et al. Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice. Mol. Ther. Methods Clin. Dev. 22, 84–95 (2021).Article CAS PubMed PubMed Central Google Scholar Vervaeke, P., Borgos, S. E., Sanders, N. N. & Combes, F. Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics. Adv. Drug Deliv. Rev. 184, 114236 (2022).Article CAS PubMed PubMed Central Google Scholar Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850–856 (2011).Article CAS PubMed Google Scholar Yap, K. L., Ada, G. L. & McKenzie, I. F. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273, 238–239 (1978).Article CAS PubMed Google Scholar Schmidt, A. & Lapuente, D. T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine. Viruses 13, https://doi.org/10.3390/v13020199 (2021).Oh, J. E. et al. Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA. Sci. Immunol. 6, eabj5129 (2021).Article CAS PubMed PubMed Central Google Scholar Bliss, C. M. et al. A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice. Mol. Ther. 30, 2024–2047 (2022).Article CAS PubMed PubMed Central Google Scholar Jacobsen, H. et al. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model. mBio 8, https://doi.org/10.1128/mBio.01463-17 (2017).Xuan, C. et al. Structural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccines. Protein Cell 2, 997–1005 (2011).Article CAS PubMed Google Scholar Khurana, S. et al. Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines. Vaccine 29, 5657–5665 (2011).Article CAS PubMed PubMed Central Google Scholar Chiu, F. F. et al. Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus. Biochem. Biophys. Res. Commun. 383, 27–31 (2009).Article CAS PubMed Google Scholar Arevalo, C. P. et al. A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes. Science 378, 899–904 (2022).Article CAS PubMed PubMed Central Google Scholar Paules, C. I., Marston, H. D., Eisinger, R. W., Baltimore, D. & Fauci, A. S. The Pathway to a Universal Influenza Vaccine. Immunity 47, 599–603 (2017).Article CAS PubMed Google Scholar Zhong, Z. et al. Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs. Mol. Ther. 29, 1370–1381 (2021).Article CAS PubMed PubMed Central Google Scholar Topham, D. J. & Doherty, P. C. Clearance of an influenza A virus by CD4(+) T cells is inefficient in the absence of B cells. J. Virol. 72, 882–885 (1998).Article CAS PubMed PubMed Central Google Scholar Snapper, C. M. & Paul, W. E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236, 944–947 (1987).Article CAS PubMed Google Scholar Mosmann, T. R. & Coffman, R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145–173 (1989).Article CAS PubMed Google Scholar Huber, V. C. et al. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin. Vaccin. Immunol. 13, 981–990 (2006).Article CAS Google Scholar Neuberger, M. S. & Rajewsky, K. Activation of mouse complement by monoclonal mouse antibodies. Eur. J. Immunol. 11, 1012–1016 (1981).Article CAS PubMed Google Scholar Unkeless, J. C. & Eisen, H. N. Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages. J. Exp. Med. 142, 1520–1533 (1975).Article CAS PubMed Google Scholar Hall, V. G. et al. Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses. Nat. Immunol. 23, 380–385 (2022).Article CAS PubMed Google Scholar Maruggi, G. et al. A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models. Mol. Ther. 30, 1897–1912 (2022).Article CAS PubMed PubMed Central Google Scholar Chen, J. et al. Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response. Proc. Natl Acad. Sci. USA 119, e2207841119 (2022).Article CAS PubMed PubMed Central Google Scholar Guan, L. et al. Highly Pathogenic H5 Influenza Viruses Isolated between 2016 and 2017 in Vietnamese Live Bird Markets. Viruses 15, https://doi.org/10.3390/v15051093 (2023).Chen, M. W. et al. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc. Natl Acad. Sci. USA 105, 13538–13543 (2008).Article CAS PubMed PubMed Central Google Scholar McCafferty, S. et al. A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity. Mol. Ther. 30, 2968–2983 (2022).Article CAS PubMed PubMed Central Google Scholar Van Hoecke, L., Job, E. R., Saelens, X. & Roose, K. Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration. J. Vis. Exp. https://doi.org/10.3791/55398 (2017).Kaufmann, L. et al. An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers. J. Vis. Exp. https://doi.org/10.3791/55833 (2017).Download referencesAcknowledgementsThe authors want to thank Kristien Van Reeth, Friso Griffioen and Ruth Mumo of the laboratory of virology (Ghent university) for providing turkey blood. Eric Cox and Simon Brabant are acknowledged for the access to gel imaging system (laboratory of veterinary immunology, Gent university). Z.Z. is supported by a postdoctoral grant from the Research Foundation—Flanders (FWO-Vlaanderen, 12K0323N). X.C. is supported by China Scholarship Council scholarship (202107650043). P.V. is supported by FWO (1172121N). This work was supported by Special Research Fund (BOF.BAS.2018.0028.01 and BOF.24Y.2020.0010.01) of Ghent University.Author informationAuthors and AffiliationsLaboratory of Gene Therapy, Faculty of Veterinary Medicine, Ghent University, B-9820, Merelbeke, BelgiumXiaole Cui, Pieter Vervaeke, Lisa Opsomer, Qing Sun, Janne Snoeck & Niek N. SandersDepartment of Translational Physiology, Infectiology and Public Health, Ghent University, B-9820, Merelbeke, BelgiumYa Gao & Bert DevriendtDepartment of Pharmaceutics, Ghent University, Ghent, BelgiumZifu ZhongCancer Research Institute (CRIG), Ghent University, 9000, Ghent, BelgiumZifu Zhong & Niek N. SandersAuthorsXiaole CuiView author publicationsYou can also search for this author in PubMed Google ScholarPieter VervaekeView author publicationsYou can also search for this author in PubMed Google ScholarYa GaoView author publicationsYou can also search for this author in PubMed Google ScholarLisa OpsomerView author publicationsYou can also search for this author in PubMed Google ScholarQing SunView author publicationsYou can also search for this author in PubMed Google ScholarJanne SnoeckView author publicationsYou can also search for this author in PubMed Google ScholarBert DevriendtView author publicationsYou can also search for this author in PubMed Google ScholarZifu ZhongView author publicationsYou can also search for this author in PubMed Google ScholarNiek N. SandersView author publicationsYou can also search for this author in PubMed Google ScholarContributionsX.C., Z.Z. and N.N.S. conceived the experiments, interpreted the results. X.C. performed the experiments and wrote the first draft of the paper. Z.Z. and N.N.S. critically revised the manuscript. P.V., J.S. and B.D. contributed to methodology. Y.G., L.O. and Q.S helped with the in vivo experiments. All authors have given approval to the final version of the manuscript.Corresponding authorsCorrespondence to Zifu Zhong or Niek N. Sanders.Ethics declarations Competing interests The authors declare no competing interests. Additional informationPublisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Supplementary informationSupplemental InformationRights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Reprints and permissionsAbout this articleCite this articleCui, X., Vervaeke, P., Gao, Y. et al. Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza. npj Vaccines 9, 138 (2024). https://doi.org/10.1038/s41541-024-00932-xDownload citationReceived: 05 December 2023Accepted: 17 July 2024Published: 03 August 2024DOI: https://doi.org/10.1038/s41541-024-00932-xShare this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative This article is cited by An mRNA vaccine candidate encoding H5HA clade 2.3.4.4b protects mice from clade 2.3.2.1a virus infection Shiho ChibaMaki KisoYoshihiro Kawaoka npj Vaccines (2024) Download PDF Advertisement Explore content Research articles Reviews & Analysis News & Comment Collections Follow us on Twitter Sign up for alerts RSS feed About the journal Aims & Scope Content types Journal Information About the Editors Contact Open Access Calls for Papers Editorial policies Article Processing Charges Journal Metrics About the Partner Publish with us For Authors and Referees Language editing services Submit manuscript Search Search articles by subject, keyword or author Show results from All journals This journal Search Advanced search Quick links Explore articles by subject Find a job Guide to authors Editorial policies npj Vaccines (npj Vaccines) ISSN 2059-0105 (online) nature.com sitemap About Nature Portfolio About us Press releases Press office Contact us Discover content Journals A-Z Articles by subject protocols.io Nature Index Publishing policies Nature portfolio policies Open access Author & Researcher services Reprints & permissions Research data Language editing Scientific editing Nature Masterclasses Research Solutions Libraries & institutions Librarian service & tools Librarian portal Open research Recommend to library Advertising & partnerships Advertising Partnerships & Services Media kits Branded content Professional development Nature Careers Nature Conferences Regional websites Nature Africa Nature China Nature India Nature Italy Nature Japan Nature Middle East Privacy Policy Use of cookies Your privacy choices/Manage cookies Legal notice Accessibility statement Terms & Conditions Your US state privacy rights © 2024 Springer Nature Limited Close banner Close Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily. Email address Sign up I agree my information will be processed in accordance with the Nature and Springer Nature Limited Privacy Policy. Close banner Close Get the most important science stories of the day, free in your inbox. Sign up for Nature BriefingStudy finds Tamiflu frequently prescribed for infants with flu | CIDRAP Skip to main content University of Minnesota Main navigationMain content University of Minnesotahttp:/win-cities.umn.edu/612-625-5000 Go to the U of M home page Main navigation News Antimicrobial Resistance COVID-19 Chronic Wasting Disease Influenza Mpox All Topics A-Z Resilient Drug Supply Influenza Vaccines Roadmap CIDRAP Leadership Forum Roadmap Development Coronavirus Vaccines Roadmap . . Topics & Projects Antimicrobial Stewardship Chronic Wasting Disease Osterholm Update Podcasts Newsletters About CIDRAP CIDRAP in the News Our Staff Our Director Osterholm in the Press Shop Merchandise Contact Us About Search CLOSE Search Support Menu Study finds Tamiflu frequently prescribed for infants with flu News brief Chris Dall, MA Topics Influenza, General Share Copied to clipboard LSOphoto / iStock A single-center study by researchers with the University of Pittsburgh School of Medicine found that adherence to national influenza antiviral treatment guidelines for children is high and has improved over time — but could be better. The findings were published yesterday in the Journal of the Pediatric Infectious Diseases Society.Using electronic health record data from the University of Pittsburgh Medical Center, the researchers reviewed how provider prescribing of the antiviral oseltamivir (Tamiflu) for infants ages 12 months and younger with influenza changed from 2012 through 2019, along with the characteristics associated with non-prescription of oseltamivir. In 2011, the Centers for Disease Control and Prevention recommended that children under the age of 2 with suspected or confirmed flu to receive antiviral treatment "as soon as possible" because of their high risk for influenza-associated complications. But few studies have specifically looked at oseltamivir prescribing for infants since those recommendations were issued.Lack of fever, more than 2 days of symptoms linked to non-prescriptionOf the 457 infants (54% male, 67.6% White) with confirmed flu over the study period, 392 (85.7%) were prescribed oseltamivir. The proportion of infants prescribed oseltamivir increased from 64.6% during the 2012-2016 flu seasons to 90.4% during the 2016-2020 seasons. "This suggests a gradual adherence to the CDC’s antiviral guidelines after they were updated in 2011 to recommend antiviral treatment be given to children < 2 years of age as soon as possible," the study authors wrote.Multivariable analysis revealed that, when adjusted for age, sex, and race, infants were more likely to not be prescribed oseltamivir if they experienced more than 2 days of influenza symptoms (odds ratio [OR], 9.4; 95% confidence interval [CI], 4.8 to 18.7), were diagnosed during the 2012-2016 influenza seasons (OR, 4.2; 95% CI: 1.8 to 9.5), tested positive for influenza via a multiplex/RT-PCR test (OR, 6.7; 95% CI, 2.7 to 16.3), or did not have a fever at point-of-care (OR, 2.3; 95% CI, 1.2 to 4.6).The authors say the findings indicate antiviral prescribing for infants with flu can still be improved in inpatient and ED setting, with rapid testing playing an important role. Review estimates impact of various vaccine strategies for flu, measles, polio, etc News brief Stephanie Soucheray, MA Topics Influenza Vaccines Misc Emerging Topics PAHO / Flickr cc The Annenberg Public Policy Center (APPC) at the University of Pennsylvania has published new data in Nature Human Behavior identifying which vaccine strategies specific countries should adopt based on their needs to increase vaccine uptake.In the past 20 years, rising vaccine hesitancy has led to suboptimal uptake of influenza, measles, polio, HPV, and other vaccines, while COVID-19 vaccines have also been met with skepticism. The recommendations are based on findings from 88 eligible randomized controlled trials testing interventions with 1,628,768 participants from 17 countries. Overall, interventions were associated with an estimated 50% higher chance of vaccination compared to "control" conditions with no intervention (odds ratio [OR], 1.5; 95% confidence interval (CI], 1.27 to 1.77).Educational campaigns have no impact In general, educational campaigns aimed at correcting vaccine misinformation had no significant impact on vaccine uptake. Instead, efforts to increase access to vaccines had the most success. Vaccination rates tripled, however, with intervention aimed at offering free transportation to vaccine sites or at bringing vaccines to nursing homes and workplaces. Some studies showed offering financial incentives had minor success in increasing vaccine uptake. Even though misinformation undermines democracy and can be far-fetched, and thus highly salient, correcting it does not ensure health behaviors like vaccination."Public health officials often say that ensuring vaccine access is the first step to promoting immunization," said Dolores Albarracin, PhD, of the APPC, in a university press release. "Our meta-analysis provides hard evidence in support of this recommendation, and indicates that this should be a special priority in under-resourced areas with limited access to health care. "By contrast, even though misinformation undermines democracy and can be far-fetched, and thus highly salient, correcting it does not ensure health behaviors like vaccination." ALL BRIEFS In case you missed it Previous Next Last patient discharged from treatment in Rwanda’s Marburg outbreak Mpox plateaus in a DR Congo hot spot, rises in other African nations Arkansas, Montana report CWD infections in deer, elk Africa CDC launches trial of smallpox drug for mpox CDC reports slight flu rise in children, first kid's flu death of season CDC tracks rise in pertussis activity Quick takes: Polio in 7 countries, lab monkey escape, pneumonic tularemia in Colorado Surveillance turns up 18 previously undetected cases of tick-borne Yezo virus in China This week's top reads Recent COVID-19 vaccination tied to lower risk of long COVID Overall, the risk of developing 28 out of 36 long-COVID symptoms lessened when vaccines were effective. Stephanie Soucheray California, Washington report more suspected H5 avian flu cases In related developments, the USDA reported more dairy cow and poultry outbreaks, as Los Angeles Country announced its first H5 wastewater detection. Lisa Schnirring Scientists track emergence of novel H5N1 flu reassortant in Cambodia Since a spillover in October 2023 the novel reassortment has replaced the older clade in Cambodia's poultry. Lisa Schnirring MIS-C much more common in kids not vaccinated against COVID-19, data reveal Among 12- to 17-year-olds, 90% of those with MIS-C were unvaccinated. Stephanie Soucheray CDC expands avian flu testing for farm workers, notes 7% infection rate in those exposed to infected cows The CDC now recommends testing and prophylactic Tamiflu use in asymptomatic workers exposed to sick animals. Lisa Schnirring Four cases of sexually transmitted fungal infection reported in New York The infections were caused by Trichophyton mentagrophytes type VII (TMVII), a sexually transmitted fungus that causes ringworm. Chris Dall Canada probes suspected avian flu infection in hospitalized teen The presumed positive infection comes amid a rise in poultry outbreaks in BC and US western states, likely triggered by wild bird migration. Lisa Schnirring Surveys reveal Americans' persistent mistrust in COVID vaccine science The greatest levels of trust were seen among men, those with university degrees and high median outcomes, and those who had lost someone to COVID-19. Mary Van Beusekom Trial shows safety of getting COVID, flu vaccines at same time Over half of participants (57%) reported a history of SARS-CoV-2 infection. Stephanie Soucheray Cases top 50,000 in Africa's mpox outbreak In other outbreak developments, medical groups announce a vaccine allocation plan and a vaccine trial to begin in pregnant women and in children younger than 2. Lisa Schnirring Our underwriters Unrestricted financial support provided by Principal Underwriter Leading Underwriter Major Underwriter Supporting Underwriter Become an Underwriter Help make CIDRAP's vital work possible Support Us Home Editorial policy Search news Contact Us CIDRAP - Center for Infectious Disease Research & Policy Research and Innovation Office, University of Minnesota, Minneapolis, MN Email us © 2024 Regents of the University of Minnesota. All rights Reserved. The University of Minnesota is an equal opportunity educator and employer Research and Innovation Office | Contact U of M | Privacy Policy Newsletter subscribe Get CIDRAP updates Choose newsletters Select all Daily Headlines Antimicrobial Stewardship Newsletter Chronic Wasting Disease Newsletter Flu Vaccine Roadmap Newsletter Resilient Drug Supply Newsletter Email Email Format html text News Topics & Projects Antimicrobial Resistance COVID-19 Chronic Wasting Disease Influenza Mpox All Topics A-Z Resilient Drug Supply Influenza Vaccines Roadmap CIDRAP Leadership Forum Roadmap Development Coronavirus Vaccines Roadmap . . Podcasts Antimicrobial Stewardship Chronic Wasting Disease Osterholm Update Newsletters About About CIDRAP CIDRAP in the News Our Staff Our Director Osterholm in the Press Shop Merchandise Contact Us DonateCDC urges livestock workers get seasonal flu vaccine to cut pandemic risk | CIDRAP Skip to main content University of Minnesota Main navigationMain content University of Minnesotahttp:/win-cities.umn.edu/612-625-5000 Go to the U of M home page Main navigation News Antimicrobial Resistance COVID-19 Chronic Wasting Disease Influenza Mpox All Topics A-Z Resilient Drug Supply Influenza Vaccines Roadmap CIDRAP Leadership Forum Roadmap Development Coronavirus Vaccines Roadmap . . Topics & Projects Antimicrobial Stewardship Chronic Wasting Disease Osterholm Update Podcasts Newsletters About CIDRAP CIDRAP in the News Our Staff Our Director Osterholm in the Press Shop Merchandise Contact Us About Search CLOSE Search Support Menu CDC urges livestock workers get seasonal flu vaccine to cut pandemic risk Lisa Schnirring Avian Influenza (Bird Flu) Igor Barilo/iStock Share Copied to clipboard A top official with the Centers for Disease Control and Prevention (CDC) today announced a $5 million plan to offer seasonal flu vaccine to livestock workers, mostly to protect their health but also to reduce the chance of human flu viruses mixing with H5N1 avian flu viruses, which would pose a new pandemic flu threat.The announcement follows a recent flurry of H5 avian flu infections in Colorado poultry cullers and sporadic infections in workers exposed to dairy cows infected with H5N1 and comes ahead of the upcoming flu season. At a Department of Health and Human Services (HHS) briefing today, Nirav Shah, MD, JD, principal deputy director for the CDC, said more human H5N1 cases are expected, but, so far, the risk remains low, except to workers exposed to sick animals.He detailed two parts of the program, one to partner with the National Center for Farmworker Health to ramp up training, as well as access to testing, personal protective equipment, and flu shots. The other is $5 million to provide states with seasonal flu vaccine targeted to farm workers. Health officials estimate that the United States has at least 200,000 livestock workers, with many other people working with animals more informally.Reassortment concerns as flu season loomsThough Shah said seasonal flu shots won't protect against H5N1, they could protect workers against coinfection with seasonal flu and reduce the chance of virus reassortment, which in theory could produce a new virus that would pose significant public health concerns.Shah acknowledged that the main role of flu shots is reducing severe disease and death, but he added that, while they don’t eliminate infection, they can reduce the risk. Though discussions are still under way on use of H5N1 vaccines, he said they aren't recommended yet because there is no person-to-person spread, no changes in the virus, and no evidence of asymptomatic spread. "For now, the seasonal flu shot is the right tool for the job," Shah said.States will craft their own vaccine plans for livestock workers, and the initial efforts will focus on hard-hit states such as Colorado and Michigan. States have already floated some idea, such as working with local health departments or offering the vaccine at gatherings frequented by livestock workers.Colorado completes poultry cullingEric Deeble, DVM, acting senior adviser for highly pathogenic avian flu at the US Department of Agriculture (USDA), said depopulation activities have been completed at two large layer farms in Weld County, Colordao. He said epidemiologic investigations are still under way into how the B3.13 genotype infecting cattle turned up on the poultry farms, but he noted that the agricultural situation is unique in Weld County. Most of the state's 105 dairy farms are concentrated in the county, and some of the poultry farms and dairy facilities are just a mile or two from each other. Related news Previous Next Studies describe deadly avian flu outbreaks among seals, terns Stephanie Soucheray Canada probes suspected avian flu infection in hospitalized teen Lisa Schnirring CDC expands avian flu testing for farm workers, notes 7% infection rate in those exposed to infected cows Lisa Schnirring Scientists track emergence of novel H5N1 flu reassortant in Cambodia Lisa Schnirring California, Washington report more suspected H5 avian flu cases Lisa Schnirring Utah reports avian flu in dairy cows as USDA announces plan for bulk milk sampling Lisa Schnirring USDA announces first H5N1 avian flu detection in US pigs Lisa Schnirring H5N1 avian flu isolate from dairy worker is transmissible, lethal in animals Lisa Schnirring This week's top reads Recent COVID-19 vaccination tied to lower risk of long COVID Overall, the risk of developing 28 out of 36 long-COVID symptoms lessened when vaccines were effective. Stephanie Soucheray California, Washington report more suspected H5 avian flu cases In related developments, the USDA reported more dairy cow and poultry outbreaks, as Los Angeles Country announced its first H5 wastewater detection. Lisa Schnirring Scientists track emergence of novel H5N1 flu reassortant in Cambodia Since a spillover in October 2023 the novel reassortment has replaced the older clade in Cambodia's poultry. Lisa Schnirring MIS-C much more common in kids not vaccinated against COVID-19, data reveal Among 12- to 17-year-olds, 90% of those with MIS-C were unvaccinated. Stephanie Soucheray CDC expands avian flu testing for farm workers, notes 7% infection rate in those exposed to infected cows The CDC now recommends testing and prophylactic Tamiflu use in asymptomatic workers exposed to sick animals. Lisa Schnirring Four cases of sexually transmitted fungal infection reported in New York The infections were caused by Trichophyton mentagrophytes type VII (TMVII), a sexually transmitted fungus that causes ringworm. Chris Dall Canada probes suspected avian flu infection in hospitalized teen The presumed positive infection comes amid a rise in poultry outbreaks in BC and US western states, likely triggered by wild bird migration. Lisa Schnirring Surveys reveal Americans' persistent mistrust in COVID vaccine science The greatest levels of trust were seen among men, those with university degrees and high median outcomes, and those who had lost someone to COVID-19. Mary Van Beusekom Trial shows safety of getting COVID, flu vaccines at same time Over half of participants (57%) reported a history of SARS-CoV-2 infection. Stephanie Soucheray Cases top 50,000 in Africa's mpox outbreak In other outbreak developments, medical groups announce a vaccine allocation plan and a vaccine trial to begin in pregnant women and in children younger than 2. Lisa Schnirring Our underwriters Unrestricted financial support provided by Principal Underwriter Leading Underwriter Major Underwriter Supporting Underwriter Become an Underwriter Help make CIDRAP's vital work possible Support Us Home Editorial policy Search news Contact Us CIDRAP - Center for Infectious Disease Research & Policy Research and Innovation Office, University of Minnesota, Minneapolis, MN Email us © 2024 Regents of the University of Minnesota. All rights Reserved. The University of Minnesota is an equal opportunity educator and employer Research and Innovation Office | Contact U of M | Privacy Policy Newsletter subscribe Get CIDRAP updates Choose newsletters Select all Daily Headlines Antimicrobial Stewardship Newsletter Chronic Wasting Disease Newsletter Flu Vaccine Roadmap Newsletter Resilient Drug Supply Newsletter Email Email Format html text News Topics & Projects Antimicrobial Resistance COVID-19 Chronic Wasting Disease Influenza Mpox All Topics A-Z Resilient Drug Supply Influenza Vaccines Roadmap CIDRAP Leadership Forum Roadmap Development Coronavirus Vaccines Roadmap . . Podcasts Antimicrobial Stewardship Chronic Wasting Disease Osterholm Update Newsletters About About CIDRAP CIDRAP in the News Our Staff Our Director Osterholm in the Press Shop Merchandise Contact Us DonateReview estimates impact of various vaccine strategies for flu, measles, polio, etc | CIDRAP Skip to main content University of Minnesota Main navigationMain content University of Minnesotahttp:/win-cities.umn.edu/612-625-5000 Go to the U of M home page Main navigation News Antimicrobial Resistance COVID-19 Chronic Wasting Disease Influenza Mpox All Topics A-Z Resilient Drug Supply Influenza Vaccines Roadmap CIDRAP Leadership Forum Roadmap Development Coronavirus Vaccines Roadmap . . Topics & Projects Antimicrobial Stewardship Chronic Wasting Disease Osterholm Update Podcasts Newsletters About CIDRAP CIDRAP in the News Our Staff Our Director Osterholm in the Press Shop Merchandise Contact Us About Search CLOSE Search Support Menu Review estimates impact of various vaccine strategies for flu, measles, polio, etc News brief Stephanie Soucheray, MA Topics Influenza Vaccines Misc Emerging Topics Share Copied to clipboard PAHO / Flickr cc The Annenberg Public Policy Center (APPC) at the University of Pennsylvania has published new data in Nature Human Behavior identifying which vaccine strategies specific countries should adopt based on their needs to increase vaccine uptake.In the past 20 years, rising vaccine hesitancy has led to suboptimal uptake of influenza, measles, polio, HPV, and other vaccines, while COVID-19 vaccines have also been met with skepticism. The recommendations are based on findings from 88 eligible randomized controlled trials testing interventions with 1,628,768 participants from 17 countries. Overall, interventions were associated with an estimated 50% higher chance of vaccination compared to "control" conditions with no intervention (odds ratio [OR], 1.5; 95% confidence interval (CI], 1.27 to 1.77).Educational campaigns have no impact In general, educational campaigns aimed at correcting vaccine misinformation had no significant impact on vaccine uptake. Instead, efforts to increase access to vaccines had the most success. Vaccination rates tripled, however, with intervention aimed at offering free transportation to vaccine sites or at bringing vaccines to nursing homes and workplaces. Some studies showed offering financial incentives had minor success in increasing vaccine uptake. Even though misinformation undermines democracy and can be far-fetched, and thus highly salient, correcting it does not ensure health behaviors like vaccination."Public health officials often say that ensuring vaccine access is the first step to promoting immunization," said Dolores Albarracin, PhD, of the APPC, in a university press release. "Our meta-analysis provides hard evidence in support of this recommendation, and indicates that this should be a special priority in under-resourced areas with limited access to health care. "By contrast, even though misinformation undermines democracy and can be far-fetched, and thus highly salient, correcting it does not ensure health behaviors like vaccination." Study finds Tamiflu frequently prescribed for infants with flu News brief Chris Dall, MA Topics Influenza, General LSOphoto / iStock A single-center study by researchers with the University of Pittsburgh School of Medicine found that adherence to national influenza antiviral treatment guidelines for children is high and has improved over time — but could be better. The findings were published yesterday in the Journal of the Pediatric Infectious Diseases Society.Using electronic health record data from the University of Pittsburgh Medical Center, the researchers reviewed how provider prescribing of the antiviral oseltamivir (Tamiflu) for infants ages 12 months and younger with influenza changed from 2012 through 2019, along with the characteristics associated with non-prescription of oseltamivir. In 2011, the Centers for Disease Control and Prevention recommended that children under the age of 2 with suspected or confirmed flu to receive antiviral treatment "as soon as possible" because of their high risk for influenza-associated complications. But few studies have specifically looked at oseltamivir prescribing for infants since those recommendations were issued.Lack of fever, more than 2 days of symptoms linked to non-prescriptionOf the 457 infants (54% male, 67.6% White) with confirmed flu over the study period, 392 (85.7%) were prescribed oseltamivir. The proportion of infants prescribed oseltamivir increased from 64.6% during the 2012-2016 flu seasons to 90.4% during the 2016-2020 seasons. "This suggests a gradual adherence to the CDC’s antiviral guidelines after they were updated in 2011 to recommend antiviral treatment be given to children < 2 years of age as soon as possible," the study authors wrote.Multivariable analysis revealed that, when adjusted for age, sex, and race, infants were more likely to not be prescribed oseltamivir if they experienced more than 2 days of influenza symptoms (odds ratio [OR], 9.4; 95% confidence interval [CI], 4.8 to 18.7), were diagnosed during the 2012-2016 influenza seasons (OR, 4.2; 95% CI: 1.8 to 9.5), tested positive for influenza via a multiplex/RT-PCR test (OR, 6.7; 95% CI, 2.7 to 16.3), or did not have a fever at point-of-care (OR, 2.3; 95% CI, 1.2 to 4.6).The authors say the findings indicate antiviral prescribing for infants with flu can still be improved in inpatient and ED setting, with rapid testing playing an important role. ALL BRIEFS In case you missed it Previous Next Last patient discharged from treatment in Rwanda’s Marburg outbreak Mpox plateaus in a DR Congo hot spot, rises in other African nations Arkansas, Montana report CWD infections in deer, elk Africa CDC launches trial of smallpox drug for mpox CDC reports slight flu rise in children, first kid's flu death of season CDC tracks rise in pertussis activity Quick takes: Polio in 7 countries, lab monkey escape, pneumonic tularemia in Colorado Surveillance turns up 18 previously undetected cases of tick-borne Yezo virus in China This week's top reads Recent COVID-19 vaccination tied to lower risk of long COVID Overall, the risk of developing 28 out of 36 long-COVID symptoms lessened when vaccines were effective. Stephanie Soucheray California, Washington report more suspected H5 avian flu cases In related developments, the USDA reported more dairy cow and poultry outbreaks, as Los Angeles Country announced its first H5 wastewater detection. Lisa Schnirring Scientists track emergence of novel H5N1 flu reassortant in Cambodia Since a spillover in October 2023 the novel reassortment has replaced the older clade in Cambodia's poultry. Lisa Schnirring MIS-C much more common in kids not vaccinated against COVID-19, data reveal Among 12- to 17-year-olds, 90% of those with MIS-C were unvaccinated. Stephanie Soucheray CDC expands avian flu testing for farm workers, notes 7% infection rate in those exposed to infected cows The CDC now recommends testing and prophylactic Tamiflu use in asymptomatic workers exposed to sick animals. Lisa Schnirring Four cases of sexually transmitted fungal infection reported in New York The infections were caused by Trichophyton mentagrophytes type VII (TMVII), a sexually transmitted fungus that causes ringworm. Chris Dall Canada probes suspected avian flu infection in hospitalized teen The presumed positive infection comes amid a rise in poultry outbreaks in BC and US western states, likely triggered by wild bird migration. Lisa Schnirring Surveys reveal Americans' persistent mistrust in COVID vaccine science The greatest levels of trust were seen among men, those with university degrees and high median outcomes, and those who had lost someone to COVID-19. Mary Van Beusekom Trial shows safety of getting COVID, flu vaccines at same time Over half of participants (57%) reported a history of SARS-CoV-2 infection. Stephanie Soucheray Cases top 50,000 in Africa's mpox outbreak In other outbreak developments, medical groups announce a vaccine allocation plan and a vaccine trial to begin in pregnant women and in children younger than 2. Lisa Schnirring Our underwriters Unrestricted financial support provided by Principal Underwriter Leading Underwriter Major Underwriter Supporting Underwriter Become an Underwriter Help make CIDRAP's vital work possible Support Us Home Editorial policy Search news Contact Us CIDRAP - Center for Infectious Disease Research & Policy Research and Innovation Office, University of Minnesota, Minneapolis, MN Email us © 2024 Regents of the University of Minnesota. All rights Reserved. The University of Minnesota is an equal opportunity educator and employer Research and Innovation Office | Contact U of M | Privacy Policy Newsletter subscribe Get CIDRAP updates Choose newsletters Select all Daily Headlines Antimicrobial Stewardship Newsletter Chronic Wasting Disease Newsletter Flu Vaccine Roadmap Newsletter Resilient Drug Supply Newsletter Email Email Format html text News Topics & Projects Antimicrobial Resistance COVID-19 Chronic Wasting Disease Influenza Mpox All Topics A-Z Resilient Drug Supply Influenza Vaccines Roadmap CIDRAP Leadership Forum Roadmap Development Coronavirus Vaccines Roadmap . . Podcasts Antimicrobial Stewardship Chronic Wasting Disease Osterholm Update Newsletters About About CIDRAP CIDRAP in the News Our Staff Our Director Osterholm in the Press Shop Merchandise Contact Us DonateQuick takes: More avian flu in Michigan cows, mRNA H5N1 vaccine initiative, reducing Salmonella in raw poultry | CIDRAP Skip to main content University of Minnesota Main navigationMain content University of Minnesotahttp:/win-cities.umn.edu/612-625-5000 Go to the U of M home page Main navigation News Antimicrobial Resistance COVID-19 Chronic Wasting Disease Influenza Mpox All Topics A-Z Resilient Drug Supply Influenza Vaccines Roadmap CIDRAP Leadership Forum Roadmap Development Coronavirus Vaccines Roadmap . . Topics & Projects Antimicrobial Stewardship Chronic Wasting Disease Osterholm Update Podcasts Newsletters About CIDRAP CIDRAP in the News Our Staff Our Director Osterholm in the Press Shop Merchandise Contact Us About Search CLOSE Search Support Menu Quick takes: More avian flu in Michigan cows, mRNA H5N1 vaccine initiative, reducing Salmonella in raw poultry News brief Lisa Schnirring Topics Avian Influenza (Bird Flu) Foodborne Disease Salmonella Share Copied to clipboard The Michigan Department of Agriculture and Rural Development (MDARD) today announced another avian influenza outbreaks at a dairy farm, its first since July 9, raising the state's total to 27. The outbreak also marks the first from Van Buren County, putting the number of affected Michigan counties at 11. MDARD said samples will be sent to the US Department of Agriculture (USDA) for confirmation. In other avian flu developments, an H5N1 outbreak has been detected in backyard poultry in Florida's Hendry County in the south central part of the state, according to the latest update from the USDA Animal and Plant Health Inspection Service (APHIS).The World Health Organization (WHO) today announced the launch of a new initiative to speed the development of and access to mRNA vaccines against H5N1 avian influenza for people in low- and middle-income countries. The project is led by Argentina-based Sinergium Biotech, which has developed candidate H5N1 vaccines, and leverages the WHO and Medicines Patent Pool mRNA technology transfer program. The company's next step is to develop a preclinical data package, which will then be shared with other manufacturing partners.The USDA Food Safety and Inspection Service (FSIS) today unveiled a proposed rule to reduce Salmonella contamination and illnesses in raw poultry, noting the plan is part of a 3-year effort to reevaluate the strategy for controlling Salmonella rate in poultry products. The proposal addresses Salmonella contamination at poultry slaughterhouses and processors. The proposal would establish product standards that would prevent raw chicken carcasses, chicken parts, ground chicken, and ground turkey from entering commerce if they contain any Salmonella above 10 colony-forming units and any detectable level for certain serotypes of public health significance. The proposal would also require establishments to develop microbial monitoring programs. Comments on the proposal are due 60 days after Federal Register publication. SARS-CoV-2 widespread in Virginia wildlife, likely from people News brief Mary Van Beusekom, MS Topics COVID-19 Sherwood411 / Flickr cc An examination of 23 common wildlife species in Virginia finds evidence of SARS-CoV-infection in 6 and antibodies indicating previous infection in 5.For the study, published today in Nature Communications, Virginia Tech researchers collected 789 nasal and oral swabs and 126 blood samples from animals live-trapped and released or being treated at wildlife rehabilitation centers in Virginia and Washington, DC, from May 2022 to September 2023.Most animal exposures near human interfacesDeer mice, opossums, raccoons, groundhogs, Eastern cottontail rabbits, and Eastern red bats had signs of infection, and isolates from an opossum showed previously unreported viral mutations closely matching the SARS-CoV-2 Omicron variant circulating in people at the time, which the authors said suggests at least seven recent human-to-animal virus transmission events. The mutations could alter the virus's effects on people.The team also identified two mice on the same day with the same variant, indicating that one mouse infected the other or that they both were infected by the same person.Further supporting human-to-animal viral spread was the finding of the highest SARS-CoV-2 antibody seroprevalence near hiking trails and other public areas. Some opossums, raccoons, Eastern gray squirrels, white-footed mice, and deer mice had SARS-CoV-2 antibodies. The virus is indifferent to whether its host walks on two legs or four. Carla Finkielstein, PhD Transmission could have taken place via wastewater, trash bins, or discarded food. There was no evidence of animal-to-human transmission."The virus can jump from humans to wildlife when we are in contact with them, like a hitchhiker switching rides to a new, more suitable host," co-senior author Carla Finkielstein, PhD, said in a Virginia Tech press release. "The virus aims to infect more humans, but vaccinations protect many humans. So, the virus turns to animals, adapting and mutating to thrive in the new hosts."SARS-CoV-2 infections have been previously identified in wildlife such as white-tailed deer and mink. "The virus is indifferent to whether its host walks on two legs or four," Finkielstein said. The study team called for more research into how SARS-CoV-2 spreads from people to wildlife, within species, and from one species to another. Most antibiotic prescriptions for kids' ear infections are too long, study finds News brief Chris Dall, MA Topics Antimicrobial Stewardship naumoid / iStock A study conducted at two large pediatric academic healthcare systems found that three-quarters of antibiotic prescriptions for children with ear infections were longer than recommended, researchers reported last week in the Journal of the Pediatric Infectious Diseases Society.Using electronic medical record (EMR) data, researchers analyzed outpatient encounters for acute otitis media (AOM) in children ages 2 to 17 years at 135 care locations affiliated with Vanderbilt University Medical Center (VUMC) and Washington University from 2019 through 2022. The primary outcome was the proportion of 5-day antibiotic prescriptions. The researchers also looked at the proportion of 7-day and 10-day prescriptions, as well as treatment failure, AOM recurrence, hospitalization, and adverse drug events.AOM accounts for roughly 25% of all antibiotics prescribed to children annually. The American Academy of Pediatrics AOM guidelines, published in 2013, recommend durations of 5 to 7 days for children ages 2 years and older with uncomplicated AOM. But previous studies have found most children receive longer durations.75% of prescriptions were for 10 daysOf the 73,198 AOM encounters included in the study, 61,612 (84%) resulted in an antibiotic prescription, and only 3,144 (5%) of those prescriptions were for 5 days; 12,060 (20%) were for 7 days and 45,689 (75%) were for 10 days. Ten-day durations were more common at Washington University than VUMC (78% vs 70%) while 7-day prescriptions were more common at VUMC (25% vs 17%). Non-first line antibiotics were prescribed in 30% of cases.Across both health systems, treatment failure, AOM recurrence, hospitalization, and mastoiditis were rare, as were office, emergency department, or urgent care visits for AOM within 30 days of the index visit.The study authors say interventions to promote more widespread use of shorter durations for AOM in pediatric outpatient settings are urgently needed."Antibiotic prescribing for AOM is an important opportunity to improve antibiotic stewardship in children," they wrote. "Shortening durations of therapy for AOM has the potential to markedly reduce antibiotic exposure among children; this may lead to important reductions in the development of antibiotic resistance, adverse events, and other unintended consequences of antibiotics." More illnesses reported in multistate Listeria outbreak linked to deli meats News brief Lisa Schnirring Topics Foodborne Disease Listeria Six more people have been sickened in a Listeria monocytogenes outbreak linked to deli meat, with one more state reporting an illness, the Centers for Disease Control and Prevention (CDC) said in a July 26 update. The new cases push the total from the outbreak, first announced on July 19, to 34 cases from 13 states. Two earlier deaths were reported. Artizone/Flickr cc Since the outbreak was first announced, interviews with sick patients suggested some had eaten deli meat sliced or prepared at delis. Labs in Maryland have identified Listeria in an unopened package of Boar's Head liverwurst as part of the outbreak investigation, which prompted a recall of that and eight other deli meats that the company produced on the same line and the same day as the liverwurst.The CDC said whole genome sequencing is underway to determine if the strain from the liverwurst sample is the same as the one making people sick. The US Department of Agriculture is conducting a traceback investigation to identify the suppliers of the deli meats bought by people sickened in the outbreak.Health officials probe connection to other deli meatsThe latest illness onset was July 12. Of information available on 33 patients, all were hospitalized. One patient got sick during pregnancy and remained pregnant after recovery. Pregnant women, seniors, and those with weakened immune systems are especially vulnerable to listeriosis complicationsThough the products were distributed to retail delis nationwide, the states reporting cases are all in roughly the eastern half of the United States, with New York the hardest hit state with 12 cases, followed by Maryland with 6.Of 24 people who were interviewed about their food exposures, 23 reported eating meats sliced at a deli. Of 23 who answered about liverwurst, 13 said they had eaten liverwurst before they became ill, and 7 reported the Boar's Head brand. "This information suggests that liverwurst is a likely source of this outbreak. CDC continues to gather information to understand which deli meats are causing illness in this outbreak," the group said. CEPI announces clinical trial of post-exposure mpox vaccine News brief Stephanie Soucheray, MA Topics Mpox The Coalition for Epidemic Preparedness Innovations (CEPI) announced over the weekend a clinical trial set to launch in the Democratic Republic of Congo (DRC) and other African countries, which will assess whether the Bavarian Nordic mpox vaccine can protect people against the disease after they have come into contact with the virus.The trial will also assess if vaccinated individuals who contract mpox have more mild courses of illness. Trial to include DRC householdsThe DRC is currently experiencing a large mpox outbreak, with more than 11,000 cases and 443 deaths reported, many in children. The trial will be conducted in households in the DRC, Uganda, and Nigeria with a laboratory-confirmed mpox infection. CEPI will enroll more than 1,500 participants over the age of 10 years.Participants will receive either an mpox vaccine or a placebo, and infections will be assessed 4 weeks later. Severity of infections, including number of lesions, will also be monitored. While healthcare workers typically vaccinate somebody before they are at risk of an infection, post-exposure-vaccinations allow for a more targeted approach, minimizing use of vaccine supply. "While healthcare workers typically vaccinate somebody before they are at risk of an infection, post-exposure-vaccinations allow for a more targeted approach, minimizing use of vaccine supply. Here, individuals in high-risk groups—such as household contacts of an index case—are vaccinated to potentially reduce the risk of infection, improve survival odds and stop onward chains of transmission," said CEPI CEO Richard Hatchett, MD, in a press release. Review and meta-analysis finds high rates of antibiotic resistance in hypervirulent Klebsiella News brief Chris Dall, MA Topics Antimicrobial Stewardship Klebsiella A systematic review and meta-analysis found high rates of resistance to older and newer antibiotics in strains of hypervirulent Klebsiella pneumoniae (hvKp), researchers reported last week in the Journal of Global Antimicrobial Resistance. NIAID Although K pneumoniae has long been recognized as an opportunistic pathogen that can cause a wide range of infections in vulnerable, immunocompromised hospital patients, hvKp strains have emerged in recent years as a new threat. In contrast to "classic" K pneumoniae strains, hvKp can cause severe infections in healthy individuals that quickly disseminate to various body sites. And while initial hvKp strains were limited to Asia and were rarely resistant to antibiotics, they've spread globally and acquired multiple antibiotic resistance genes."The convergence of hypervirulence and antibiotic resistance in these strains presents a formidable challenge as traditional treatment options have become increasingly limited," researchers from the Pasteur Institute of Iran wrote.A 'burgeoning public health challenge'In their meta-analysis of 77 studies from 17 countries across 4 continents, the researchers found high rates of resistance in hvKp to older antibiotics, including ampicillin (95%), ampicillin/sulbactam (45.1%); third-generation cephalosporins, including cefotaxime (64.2%) and ceftazidime (55.9%); and the carbapenem antibiotics imipenem (44.8%), meropenem (51.4%), and ertapenem (42.6%). Quinolones, such as ciprofloxacin and levofloxacin, exhibited resistance of 46.3% and 35.5%, respectively, while azithromycin resistance was prevalent at 76.3%. Among newer antibiotics, colistin, fosfomycin, and nitrofurantoin resistance rates were 15.3%, 51.1%, and 39.2%, respectively.The convergence of hypervirulence and antibiotic resistance in these strains presents a formidable challenge as traditional treatment options have become increasingly limited.The meta-analysis also found a trend of increasing resistance to several antibiotics over time, significant differences in resistance across countries and regions, and variabilities in testing methods and standards.The authors say global collaboration, standardized testing protocols, and tailored regional interventions will be needed effectively combat the threat of resistance in hvKp strains."This study serves as an urgent call for healthcare professionals, researchers, and policymakers to address this burgeoning public health challenge, and significantly contributes to the understanding of antibiotic resistance in hvKp strains, offering valuable insights for future research, clinical practice, and the development of public health policies," they wrote. ALL BRIEFS In case you missed it Previous Next Last patient discharged from treatment in Rwanda’s Marburg outbreak Mpox plateaus in a DR Congo hot spot, rises in other African nations Arkansas, Montana report CWD infections in deer, elk Africa CDC launches trial of smallpox drug for mpox CDC reports slight flu rise in children, first kid's flu death of season CDC tracks rise in pertussis activity Quick takes: Polio in 7 countries, lab monkey escape, pneumonic tularemia in Colorado Surveillance turns up 18 previously undetected cases of tick-borne Yezo virus in China This week's top reads Recent COVID-19 vaccination tied to lower risk of long COVID Overall, the risk of developing 28 out of 36 long-COVID symptoms lessened when vaccines were effective. Stephanie Soucheray California, Washington report more suspected H5 avian flu cases In related developments, the USDA reported more dairy cow and poultry outbreaks, as Los Angeles Country announced its first H5 wastewater detection. Lisa Schnirring Scientists track emergence of novel H5N1 flu reassortant in Cambodia Since a spillover in October 2023 the novel reassortment has replaced the older clade in Cambodia's poultry. Lisa Schnirring MIS-C much more common in kids not vaccinated against COVID-19, data reveal Among 12- to 17-year-olds, 90% of those with MIS-C were unvaccinated. Stephanie Soucheray CDC expands avian flu testing for farm workers, notes 7% infection rate in those exposed to infected cows The CDC now recommends testing and prophylactic Tamiflu use in asymptomatic workers exposed to sick animals. Lisa Schnirring Four cases of sexually transmitted fungal infection reported in New York The infections were caused by Trichophyton mentagrophytes type VII (TMVII), a sexually transmitted fungus that causes ringworm. Chris Dall Surveys reveal Americans' persistent mistrust in COVID vaccine science The greatest levels of trust were seen among men, those with university degrees and high median outcomes, and those who had lost someone to COVID-19. Mary Van Beusekom Trial shows safety of getting COVID, flu vaccines at same time Over half of participants (57%) reported a history of SARS-CoV-2 infection. Stephanie Soucheray Canada probes suspected avian flu infection in hospitalized teen The presumed positive infection comes amid a rise in poultry outbreaks in BC and US western states, likely triggered by wild bird migration. Lisa Schnirring Cases top 50,000 in Africa's mpox outbreak In other outbreak developments, medical groups announce a vaccine allocation plan and a vaccine trial to begin in pregnant women and in children younger than 2. Lisa Schnirring Our underwriters Unrestricted financial support provided by Principal Underwriter Leading Underwriter Major Underwriter Supporting Underwriter Become an Underwriter Help make CIDRAP's vital work possible Support Us Home Editorial policy Search news Contact Us CIDRAP - Center for Infectious Disease Research & Policy Research and Innovation Office, University of Minnesota, Minneapolis, MN Email us © 2024 Regents of the University of Minnesota. All rights Reserved. The University of Minnesota is an equal opportunity educator and employer Research and Innovation Office | Contact U of M | Privacy Policy Newsletter subscribe Get CIDRAP updates Choose newsletters Select all Daily Headlines Antimicrobial Stewardship Newsletter Chronic Wasting Disease Newsletter Flu Vaccine Roadmap Newsletter Resilient Drug Supply Newsletter Email Email Format html text News Topics & Projects Antimicrobial Resistance COVID-19 Chronic Wasting Disease Influenza Mpox All Topics A-Z Resilient Drug Supply Influenza Vaccines Roadmap CIDRAP Leadership Forum Roadmap Development Coronavirus Vaccines Roadmap . . Podcasts Antimicrobial Stewardship Chronic Wasting Disease Osterholm Update Newsletters About About CIDRAP CIDRAP in the News Our Staff Our Director Osterholm in the Press Shop Merchandise Contact Us DonateWHO launches effort to develop mRNA vaccine against bird flu News News CME CME Clinical Guidance Clinical Guidance Community Community Account Account Anonymous User Log In Log In Log Out Log Out News News CME CME Clinical Guidance Clinical Guidance Community Community Specialties Choose a specialty All Specialties Allergy/Asthma Cardiology Dermatology Endocrinology Gastroenterology Hematology/Oncology Hepatology Infectious Disease Nephrology Neurology Ophthalmology Optometry Orthopedics Pediatrics Primary Care Psychiatry Pulmonology Rheumatology Women's Health & OB/GYN Home Headline News Meeting News Podcasts Blogs & Columns Job Opportunities Resources Menu Close Specialties All Specialties Allergy/Asthma Cardiology Dermatology Endocrinology Gastroenterology Hematology/Oncology Hepatology Infectious Disease Nephrology Neurology Ophthalmology Optometry Orthopedics Pediatrics Primary Care Psychiatry Pulmonology Rheumatology Women's Health & OB/GYN Home Headline News Infectious Disease Subspecialties Antimicrobials Dermatology Emerging Diseases Fungal Diseases Gastrointestinal Infections Hepatitis C HIV/AIDS Influenza MRSA Nosocomial Infections Pediatric ID Practice Management Respiratory Infections STDs Vaccination Viral Hepatitis Zoonotic Infections Meeting News Podcasts Blogs & Columns Job Opportunities Resources Account Account Log In Log In Log Out Log Out Account Account Anonymous User Close Searchbar Healio News Infectious Disease Vaccination One Health Resource Center ByStephen I. Feller Fact checked byCarol L. DiBerardino, MLA, ELS Read more August 02, 2024 2 min read Save WHO launches effort to develop mRNA vaccine against bird flu ByStephen I. Feller Fact checked byCarol L. DiBerardino, MLA, ELS Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe Added to email alerts You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways:The effort will speed development of an mRNA vaccine amid an outbreak of bird flu.There have been nearly 900 human cases of bird flu, and 463 people have died globally since 1996.WHO this week announced a project to speed development of a messenger RNA vaccine against highly pathogenic avian influenza in humans.“This initiative exemplifies why WHO established the mRNA Technology Transfer Programme (TTP) — to foster greater research, development and production in low- and middle-income countries, so that when the next pandemic arrives, the world will be better prepared to mount a more effective and more equitable response,” WHO Director-General Tedros Adhanom Ghebreyesus, PhD, MSc, said in a press release. WHO announced a project to speed development of a vaccine for human H5N1 avian influenza. Image: Adobe Stock According to WHO, there have been 896 human cases and 463 deaths globally from avian influenza A(H5N1) since 2003. Variants of the H5 clade of bird flu have since 2020 killed wild birds and poultry in Africa, Asia and Europe. The virus spread to North America in 2021 and to Central and South America in 2022.In the United States, the CDC has reported 13 human cases since the start of 2024 linked to outbreaks at dairy and poultry farms. Overall, more than 100 million wild birds, poultry and backyard flocks in all 50 states have been affected, according to the CDC. More than 170 dairy herds in 13 states have also tested positive.Among the human cases, four followed exposure to dairy cows and nine followed exposure to poultry, with all of the exposures to poultry occurring in Colorado in the last several weeks. The state has tested 134 farm workers and is updating the public twice a week on new tests and confirmed cases.WHO’s mRNA TTP was developed with the Medicines Patent Pool (MPP) in July 2021 to develop candidate H5N1 vaccines and preclinical models to speed trials, manufacturing and distribution in the event of an avian influenza pandemic.“When we created the mRNA TTP with WHO, our goal was to enable low- and middle-income countries to lead development efforts, foster collaboration, share resources and disseminate knowledge,” Charles Gore, executive director of the MPP, said in the release. “This project embodies our vision and demonstrates a strong commitment to future pandemic preparedness and response.”Although the CDC continues to rate the threat of bird flu to humans to be relatively low, HHS in July gave Moderna $176 million to develop a mRNA pandemic flu vaccine, and officials have debated the usefulness of vaccinating birds and cows against the virus.WHO said it is mobilizing development of a bird flu vaccine because “avian influenza viruses are a significant public health risk due to their widespread circulation in animals and potential to cause a future pandemic.” Speeding development of a vaccine, the agency said, is necessary for “bolstering pandemic preparedness efforts.”References:CDC. H5 bird flu: Current situation. https://www.cdc.gov/bird-flu/situation-summary/index.html. Updated July 31, 2024. Accessed Aug. 1, 2024.CDC. H5N1 bird flu detections across the United States in backyard and commercial poultry. https://www.cdc.gov/bird-flu/situation-summary/data-map-commercial.html. Updated July 26, 2024. Accessed Aug. 1, 2024.Colorado department of public health & environment: Avian flu in humans. Updated July 30, 2024. Accessed Aug. 1, 2024.New initiative launched to advance mRNA vaccine development against human avian influenza (H5N1). https://www.who.intews/item/29-07-2024-new-initiative-launched-to-advance-mrna-vaccine-development-against-human-avian-influenza-(h5n1). Published July 29, 2024. Accessed Aug. 1, 2024.USDA. HPAI confirmed cases in livestock. https://www.aphis.usda.gov/livestock-poultry-disease/avian/avian-influenza/hpai-detections/hpai-confirmed-cases-livestock. Updated August 1, 2024. Accessed Aug. 8, 2024.WHO. Avian influenza A(H5N1) virus. https://www.who.inteams/global-influenza-programme/avian-influenza/avian-a-h5n1-virus. Accessed Aug. 2, 2024. Published by: Sources/DisclosuresCollapse Source: Press Release Disclosures: Gore and Tedros report no relevant financial disclosures. Read more about bird flu h5n1 bird flu virus vaccines influenza Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe Added to email alerts You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Facebook Twitter LinkedIn Email Print Comment Continue Reading Related Content Play on Healio Follow Healio Twitter Facebook Instagram Threads LinkedIn About About Healio About Healio About the Wyanoke Group About the Wyanoke Group Editorial Policy and Philosophy Editorial Policy and Philosophy Sitemap Sitemap Account Information My Account Login My Account My Account Help Help Email Subscriptions Email Subscriptions Email Subscriptions Email Subscriptions Unknown Newspaper and Journal Subscriptions Newspaper and Journal Subscriptions Contact Us Email Us Email Us Contact Newsroom Contact Newsroom Advertising Information Advertising Information Permissions and Reprints Permissions and Reprints Legal Do Not Sell My Personal Information Do Not Sell My Personal Information Terms and Conditions Terms and Conditions Medical Disclaimer Medical Disclaimer Privacy Policy Privacy Policy Sign Up for Email Get the latest news and education delivered to your inbox Email address Enter your email Update email address Specialty All Specialties Allergy & Asthma Cardiology Dermatology Endocrinology Gastroenterology/Hepatology Hematology Oncology Infectious Disease Nephrology Neurology Ophthalmology Optometry Orthopedics Pediatrics Primary Care Psychiatry Pulmonology Rheumatology Women’s Health & OB/GYN Subscribe Update email address The email address associated with your Healio account is: If you would like to edit or change the email address that your subscriptions and alerts are sent to, use the "Update email address" link. Update email address © Healio All Rights Reserved. Job board for health care professionals Job Opportunities We’re sorry, but an unexpected error has occurred. Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance. Close Would you like to receive email reminders to complete your saved activities from Healio CME? Yes No Activity saved! You'll receive reminders to complete your saved activities from Healio CME. UnsubscribeNew mRNA vaccine initiative targets avian influenza (H5N1) | TechTarget xtelligent Pharma Life Sciences Search the TechTarget Network Login Register Explore the Network TechTarget Network Healthtech Analytics Healthcare Payers Health IT HealthtechSecurity xtelligent Pharma Life Sciences Biotechnology Clinical trials & RWE Genetics & genomics Medical devices & imaging Mergers & acquisitions More Topics Pharmaceuticals Policy & regulation Research & development Other Content News Features Webinars White Papers Sponsored Sites Follow: Home Clinical trials and evidence Getty Images News New mRNA vaccine initiative targets avian influenza (H5N1) A new initiative led by WHO and MPP aims to develop mRNA vaccines for avian influenza (H5N1), boosting global pandemic preparedness. Share this item with your network: By Alivia Kaylor, MSc Published: 30 Jul 2024 The World Health Organization (WHO) and the Medicines Patent Pool (MPP) have launched a groundbreaking initiative to accelerate the development of mRNA vaccines for avian influenza (H5N1). This initiative, announced on July 29, 2024, is a significant step in enhancing global pandemic preparedness, particularly for low- and middle-income countries (LMICs). The project is spearheaded by Sinergium Biotech, an Argentinian manufacturer and a partner in the WHO–MPP mRNA Technology Transfer Program. The primary goal is to develop and make accessible mRNA vaccine candidates for H5N1, a strain of avian influenza that can potentially cause severe human illness and pandemics. The mRNA Technology Transfer Program was initiated in July 2021 to build capacity in LMICs to develop and produce mRNA-based vaccines. This program aims to democratize access to cutting-edge vaccine technology, ensuring that more regions can independently develop and produce vaccines. This capability is crucial for a swift and equitable response to future pandemics. Sinergium Biotech has already developed candidate H5N1 vaccines and is establishing proof-of-concept in preclinical models. Once this stage is completed, the technology, materials, and expertise will be shared with other manufacturing partners. This collaborative approach aims to expedite the development of H5N1 vaccine candidates and strengthen pandemic preparedness efforts globally. "This initiative exemplifies why WHO established the mRNA Technology Transfer Program to foster greater research, development, and production in low- and middle-income countries so that when the next pandemic arrives, the world will be better prepared to mount a more effective and more equitable response," said Tedros Adhanom Ghebreyesus, PhD, WHO Director-General, in the release. "When we created the mRNA Technology Transfer Program with WHO, our goal was to enable low- and middle-income countries to lead development efforts, foster collaboration, share resources, and disseminate knowledge," highlighted Charles Gore, Executive Director at MPP. “This project embodies our vision and demonstrates a strong commitment to future pandemic preparedness and response." Avian influenza viruses pose a significant public health risk due to their widespread circulation in animals and their potential to jump to humans, leading to pandemics. This initiative complements ongoing work under the Pandemic Influenza Preparedness Framework, which aims to improve and strengthen the sharing of influenza viruses with human pandemic potential and increase LMIC access to vaccines. "This announcement underscores the importance of not only geographically diversifying the innovation and production of health technologies but also the importance of early planning for access and the sharing of knowledge and technologies during the research and development processes," emphasized Jarbas Barbosa, PhD, MS, Director of the Pan American Health Organization (PAHO). In the release, Alejandro Gil, PhD, Chief Executive Officer of Sinergium, expressed enthusiasm about the initiative. "Sinergium’s enhanced capacity and readiness to apply our expertise to H5N1 will play a vital role in this effort toward global pandemic preparedness. I would also like to thank PAHO for their strong support to regional manufacturers in the Americas,” said Gil. “We are excited to tackle this public health challenge, and our R&D team will continue to work closely with the Program Partners." The mRNA Technology Transfer Program has already demonstrated success with its platform, which was used to establish the immunogenicity, efficacy, and safety of a COVID-19 vaccine candidate in preclinical animal models. Afrigen, the center where this platform was created and validated, is now transferring the technology to manufacturing partners for adaptation and enhancement for other critical disease targets. This initiative is vital to WHO and MPP’s efforts to improve the availability, access, and use of mRNA vaccines, ultimately aiming for global vaccine equity. As the world faces ongoing and future threats of pandemics, such collaborative and innovative efforts are essential to safeguard public health globally. Next Steps WHO reports increasing rates of HIV drug resistance to dolutegravirWHO Updates HPV Vaccine Guidelines: Shift Toward Single Dose SeriesNIH Researchers Begin Clinical Trials on a Universal Influenza Vaccine Dig Deeper on Clinical trials and evidence AMA updates CPT code set for avian influenza vaccines By: Jacqueline LaPointe Combined COVID-19/influenza vaccine is superior to individual vaccines By: Veronica Salib NIAID releases H5N1 research agenda with 4 primary objectives By: Veronica Salib Managing bird flu risks with advances in prevention Sponsored News Driving Digital Transformation in Healthcare –Dell Technologies It’s Restores That Matter for User Productivity –Exagrid 3 Transformative VDI Use Cases for Hybrid Work –Dell Technologies Related Content AMA updates CPT code set for avian influenza vaccines – Rev Cycle Management NIAID releases H5N1 research agenda with 4 primary ... – Pharma Life Sciences NIH Researchers Begin Clinical Trials on a Universal ... – Pharma Life Sciences Latest TechTarget resources Healthtech Analytics Healthcare Payers Health IT Healthtech Security xtelligent Healthtech Analytics Medical testing inequities contribute to racial bias in AI Inequitable lab testing to diagnose severe disease can create racial biases in the data used to train healthcare AI, potentially ... LLMs might not significantly augment diagnostic reasoning The use of GPT-4 did not necessarily enhance clinicians' diagnostic reasoning performance compared to those relying solely on ... Top data analytics tools for chronic disease management Effective chronic disease management requires healthcare stakeholders to effectively utilize data, population health management ... xtelligent Healthcare Payers ACA open enrollment for 2025: What you need to know CMS pursued proven outreach strategies for ACA open enrollment 2025, sought to lower costs for consumers, and announced that the ... HHS seeks to secure PrEP, birth control coverage A proposed rule supports birth control coverage for FDA-approved therapies and devices with no prescriptions or cost-sharing and ... Medicare Advantage growth persists ahead of open enrollment Medicare Advantage growth continues, spurred on by high quality of care, lower costs and better access to care. xtelligent Health IT and EHR How generative AI in healthcare is helping cut admin burden Over 90% of healthcare workers feel optimistic about the promise of generative AI in healthcare to alleviate administrative ... Oracle Health to release next-generation EHR in 2025 The next-generation Oracle Health EHR, which incorporates AI across 'the entire clinical workflow,' will be available to early ... EHR integration drives ambient speech purchasing decisions Healthcare organizations are prioritizing EHR integration and usability when selecting ambient speech technology, with top picks ... xtelligent Healthtech Security Kaiser Permanente reports email data breach Recent healthcare cybersecurity incidents include an email data breach that affected Kaiser Permanente and a ransomware attack ... Using psychology to defend against phishing attacks A healthy dose of judicious skepticism is crucial to preventing phishing attacks, said David Fine, supervisory special agent at ... Understanding new NY hospital cybersecurity regulations Recently enacted New York State general hospital cybersecurity requirements could be a sign of what's to come for the healthcare ... About Us Editorial Ethics Policy Meet The Editors Contact Us Privacy Policy Advertisers Business Partners Media Kit Corporate Site Contributors Reprints Answers Features News All Rights Reserved, Copyright 2024 - 2024, TechTarget Privacy Policy Cookie Preferences Cookie Preferences Do Not Sell or Share My Personal Information CloseIn Bird Flu Fight, CDC Plans Seasonal Flu Shot Push for Farmworkers | MedPage Today CME Healthcare Jobs Synopsi Edit Profile Manage Subscriptions CME Tracker Log Out Login Sign Up Specialties Back Allergy & Immunology Anesthesiology Cardiology Critical Care Dermatology Emergency Medicine Endocrinology Gastroenterology Genetics Geriatrics HIV / AIDS Hospital-Based Medicine Infectious Disease Nephrology Neurology Nursing OB / GYN Oncology / Hematology Ophthalmology Orthopedics Pain Management Pathology Pediatrics Pharmacy Primary Care Psychiatry Pulmonology Radiology Rheumatology Surgery Transplantation Urology Perspectives Health Policy Meetings Special Reports Break Room Conditions Back Condition Centers DocAudio Making the Rounds Medical Journeys Society Partners Back AAD Reading Room ACR Reading Room AGA Reading Room ASCO Reading Room Endocrine Society Reading Room IDSA Reading Room OMA Reading Room Infectious Disease > Flu & URI In Bird Flu Fight, CDC Plans Seasonal Flu Shot Push for Farmworkers — Co-infection with seasonal influenza, H5N1 raises concerns about human adaptation, CDC says by Katherine Kahn, Staff Writer, MedPage Today July 30, 2024 MedpageToday Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window email article The CDC is investing $10 million in a major push to get livestock workers vaccinated for seasonal influenza before the upcoming respiratory season, the agency announced on Tuesday. Of the $10 million allocated to the effort, $5 million will be used for seasonal flu vaccines for livestock workers and another $5 million will go to the National Center for Farmworkers Health and partner organizations to focus on outreach and education efforts. The CDC is working with states to develop ways to get the vaccine to approximately 200,000 livestock workers in the U.S. Although the seasonal flu vaccine will not prevent infection from H5N1 bird flu, getting livestock workers vaccinated for seasonal flu can potentially reduce the rare risk of co-infection with the two viruses, Nirav Shah, MD, JD, the CDC's principal deputy director, said on a call with reporters. Since March of this year, H5N1 has spread to at least 171 dairy herds across 13 states. To date there have been a total of nine cases of H5N1 in poultry workers in Colorado, three of which the CDC confirmed last week. All of those cases have been mild, with conjunctivitis as the predominant symptom. Farmworkers who are involved with culling H5N1-infected poultry are at heightened risk for the disease. Dual infections with both seasonal flu and H5N1 could potentially result in an exchange of genetic material between the two different influenza viruses in a process known as reassortment. "In theory, reassortment could lead to a new influenza virus that could pose a significant public health concern -- a virus that has the transmissibility of seasonal influenza with the severity of H5N1," Shah explained. "We want to do everything we can to reduce the risk that the virus may change because of this coinfection and reassortment," he emphasized. "Widespread seasonal influenza vaccine among livestock workers helps reduce this risk." During the 2022 flu season, the seasonal flu vaccine prevented 6 million illnesses, averted 65,000 hospitalizations, and prevented 3,700 deaths in the U.S. alone, Shah said. In addition to warding off the risk of seasonal flu-H5N1 dual infections, protecting farm workers from seasonal flu is also critical because many live communally in rural areas where access to healthcare may be limited. Healthcare systems in rural areas can easily be overwhelmed even during a regular flu season, let alone a severe one, Shah commented. "Vaccination against seasonal flu helps reduce the strain on hospitals in the fall and winter when influenza is circulating and thus helps protect the broader community as a whole," Shah added. Some of the money allocated to the National Center for Farmworker Health will be used to provide training and information sessions about H5N1 and also to collaborate with key partners in states to increase access to H5N1 testing, treatment, and personal protective equipment. Shah reiterated that the CDC's overall assessment of the risk to the general population from H5N1 remains low. Katherine Kahn is a staff writer at MedPage Today, covering the infectious diseases beat. She has been a medical writer for over 15 years. Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window email article Comment Please enable JavaScript to view the comments powered by Disqus. Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or window Visit us on TikTok. Opens in a new tab or window Visit us on YouTube. Opens in a new tab or window Subscribe for Free About Help Center Terms of Use Privacy Policy Do Not Sell My Personal Information Advertise With Us AdChoices Accessibility Statement visit everydayhealthgroup.com visit healthecareers.com/ visit medpagetoday.com visit primeinc.org The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. © 2005–2024 MedPage Today, LLC, a Ziff Davis company. All rights reserved. MedPage Today is among the federally registered trademarks of MedPage Today, LLC and may not be used by third parties without explicit permission.Optimizing flu protection in older adults: Enhanced vs. standard-dose vaccines News News CME CME Clinical Guidance Clinical Guidance Community Community Account Account Anonymous User Log In Log In Log Out Log Out News News CME CME Clinical Guidance Clinical Guidance Community Community Specialties Choose a specialty All Specialties Allergy/Asthma Cardiology Dermatology Endocrinology Gastroenterology Hematology/Oncology Hepatology Infectious Disease Nephrology Neurology Ophthalmology Optometry Orthopedics Pediatrics Primary Care Psychiatry Pulmonology Rheumatology Women's Health & OB/GYN Home Headline News Meeting News Podcasts Blogs & Columns Job Opportunities Resources Menu Close Specialties All Specialties Allergy/Asthma Cardiology Dermatology Endocrinology Gastroenterology Hematology/Oncology Hepatology Infectious Disease Nephrology Neurology Ophthalmology Optometry Orthopedics Pediatrics Primary Care Psychiatry Pulmonology Rheumatology Women's Health & OB/GYN Home Headline News Infectious Disease Subspecialties Antimicrobials Dermatology Emerging Diseases Fungal Diseases Gastrointestinal Infections Hepatitis C HIV/AIDS Influenza MRSA Nosocomial Infections Pediatric ID Practice Management Respiratory Infections STDs Vaccination Viral Hepatitis Zoonotic Infections Meeting News Podcasts Blogs & Columns Job Opportunities Resources Account Account Log In Log In Log Out Log Out Account Account Anonymous User Close Searchbar Healio News Infectious Disease Influenza ByCaitlin Hart, PharmD ByKati Shihadeh, PharmD, BCIDP Fact checked byCarol L. DiBerardino, MLA, ELS Read more July 31, 2024 4 min read Save Optimizing flu protection in older adults: Enhanced vs. standard-dose vaccines ByCaitlin Hart, PharmD ByKati Shihadeh, PharmD, BCIDP Fact checked byCarol L. DiBerardino, MLA, ELS Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe Added to email alerts You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Influenza is responsible for significant mortality and hospitalization rates in the United States, ranging from 4,900 to 51,000 deaths and 100,000 to 710,000 hospitalizations annually between 2010 and 2023, according to the CDC. A and B viruses are the predominant influenza types that circulate during influenza seasons, which typically begin in October, peak between December and February, but can last longer than that. Data derived from the CDC. People aged 65 years or older are at a particularly high risk for severe complications from influenza, accounting for 70% to 85% of annual influenza-related deaths and 50% to 70% of influenza-related hospitalizations. Given the substantial disease burden, special consideration is necessary to mitigate morbidity and mortality in this population, namely through annual influenza vaccination.Recommended vaccinesThere are several FDA-approved methods to administer influenza vaccines, including intramuscular injection, nasal spray and jet injector. This year, the U.S. switched to trivalent formulations for all influenza vaccines, removing the influenza B/Yamagata strain, which has not caused a confirmed infection since March 2020 and is believed to have disappeared from circulation.Since 2022, the CDC has recommended three enhanced influenza vaccines for people aged 65 years or older over standard-dose vaccines that are widely used across all age groups: a high-dose vaccine, a recombinant vaccine and an adjuvanted vaccine. A clinical trial that included more than 30,000 patients aged 65 years or older demonstrated a 24% reduction in influenza infections among patients who received the high-dose vaccine compared with a standard dose vaccine. Additionally, those who received the high-dose vaccine had significantly higher rates of seropositivity and hemagglutination inhibition titers. According to Grohskopf and colleagues, there are some observational studies have shown a benefit in taking one of these enhanced vaccines over a standard-dose vaccine, “particularly in prevention of influenza-associated hospitalizations.”“The size of this relative benefit has varied from season to season and is not observed in all studies in all seasons, making it difficult to generalize the findings to all or most seasons,” they wrote last year in MMWR. “Studies directly comparing [the three enhanced vaccines] with one another are few and do not support a conclusion that any one of these vaccines is consistently superior to the others across seasons.”If none of the three enhanced vaccines are available, the CDC recommends that older adults receive any other age-appropriate vaccine. The agency advises against using the nasal spray formulation for this age group, recommending the vaccine be given via intramuscular injection to achieve adequate protection.The optimal time frame for influenza vaccination is September to October, but unvaccinated people should get vaccinated as long as influenza is circulating, according to the CDC. Early vaccination in July or August is discouraged for older adults because of concerns about immunogenicity peaking prematurely and protection potentially waning over the course of the influenza season. Studies have shown varying durations of immunity conferred by influenza vaccines across different influenza seasons. A study by Petrie and colleagues found that antibody titers to influenza hemagglutinin and neuraminidase decreased slowly over 18 months, with a twofold decrease estimated to take more than 600 days. Conversely, a study by Belongia and colleagues found a significant association between vaccination interval and infection, with the mean interval from vaccination to influenza infection onset being 101.7 days.Coadministration with other vaccinesThe approval of vaccines against COVID-19 and respiratory syncytial virus raised questions about the timing and safety of administering these vaccines alongside an influenza vaccine.According to the CDC, coadministration of COVID-19, RSV and influenza vaccines is safe, although patients may be more likely to experience mild side effects like fatigue, headache or injection site reactions. However, patients are not required to receive all three vaccines at the same visit, and there is no required minimum wait time between administering the vaccines, allowing flexibility for patients to receive them concurrently or separately throughout the fall and winter seasons, according to the CDC.Ultimately, the crucial message is to ensure annual influenza vaccinations for people aged 65 years or older, ideally with the high-dose or other enhanced vaccines between September and October. Patients who are willing and able can consider receiving the influenza, COVID-19 and RSV vaccines together or separately, based on their preferences and scheduling convenience.References: Belongia EA, et al. Vaccine. 2015;doi:10.1016/j.vaccine.2014.06.052CDC. Disease burden of flu. https://www.cdc.gov/flu/about/burden/index.html. Last reviewed Feb. 28, 2024. Accessed July 10, 2024.CDC. Flu & people 65 years and older. https://www.cdc.gov/flu/highrisk/65over.htm. Last reviewed March 21, 2024. Accessed July 29, 2024.CDC. Getting a flu vaccine and other recommended vaccines at the same time. Available at: https://www.cdc.gov/flu/prevent/coadministration.htm. Last reviewed Dec. 8, 2023. Accessed July 12, 2024.CDC. Influenza vaccination: A summary for clinicians. https://www.cdc.gov/flu/professionals/vaccination/vax-summary.htm. Last reviewed March 21, 2024. Accessed July 29, 2024.CDC. Information for the 2024-2025 flu season. https://www.cdc.gov/flu/season/faq-flu-season-2024-2025.htm. Last reviewed March 14, 2024. Accessed July 29, 2024.CDC. Trivalent influenza vaccines. https://www.cdc.gov/flu/preventrivalent.htm. Last updated March 14, 2024. Accessed July 29, 2024. Grohskopf LA, et al. MMWR Morb Mortal Wkly Rep. 2022;doi:10.15585/mmwr.rr7202a1. Kuehn BM. JAMA. 2022; doi:10.1001/jama.2022.12520. Petrie JG, et al. J Infect Dis. 2015;doi:10.1093/infdis/jiv313.For more information: Caitlin Hart, PharmD, is a PGY2 infectious disease pharmacy resident at Denver Health Medical Center. Kati Shihadeh, PharmD, BCIDP, is a clinical pharmacy specialist in infectious diseases at Denver Health Medical Center. Shihadeh can be reached at katherine.shihadeh@dhha.org. Published by: Sources/DisclosuresCollapse Source: Expert Submission Disclosures: Hart and Shihadeh report no relevant financial disclosures. Read more about influenza infections vaccination Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe Added to email alerts You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Facebook Twitter LinkedIn Email Print Comment Continue Reading Related Content Play on Healio Follow Healio Twitter Facebook Instagram Threads LinkedIn About About Healio About Healio About the Wyanoke Group About the Wyanoke Group Editorial Policy and Philosophy Editorial Policy and Philosophy Sitemap Sitemap Account Information My Account Login My Account My Account Help Help Email Subscriptions Email Subscriptions Email Subscriptions Email Subscriptions Unknown Newspaper and Journal Subscriptions Newspaper and Journal Subscriptions Contact Us Email Us Email Us Contact Newsroom Contact Newsroom Advertising Information Advertising Information Permissions and Reprints Permissions and Reprints Legal Do Not Sell My Personal Information Do Not Sell My Personal Information Terms and Conditions Terms and Conditions Medical Disclaimer Medical Disclaimer Privacy Policy Privacy Policy Sign Up for Email Get the latest news and education delivered to your inbox Email address Enter your email Update email address Specialty All Specialties Allergy & Asthma Cardiology Dermatology Endocrinology Gastroenterology/Hepatology Hematology Oncology Infectious Disease Nephrology Neurology Ophthalmology Optometry Orthopedics Pediatrics Primary Care Psychiatry Pulmonology Rheumatology Women’s Health & OB/GYN Subscribe Update email address The email address associated with your Healio account is: If you would like to edit or change the email address that your subscriptions and alerts are sent to, use the "Update email address" link. Update email address © Healio All Rights Reserved. Job board for health care professionals Job Opportunities We’re sorry, but an unexpected error has occurred. Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance. Close Would you like to receive email reminders to complete your saved activities from Healio CME? Yes No Activity saved! You'll receive reminders to complete your saved activities from Healio CME. UnsubscribeOHSU scientists get closer to developing a universal flu vaccine - OPB Nov. 12, 2024contribute nowElection results and analysisStay updated as votes are counted and trends emergeThink Out LoudOHSU scientists get closer to developing a universal flu vaccineBy Sheraz Sadiq (OPB)July 30, 2024 5:31 p.m.Broadcast: Tuesday, July 30Your browser does not support the audio element.When autumn arrives, reminders typically start going out for people to get their annual flu shot. The vaccine changes each year based on what strain of influenza is likely to be circulating then. Sometimes, it’s a good match, and other times, it’s not so good. But what if you could get one vaccine that would confer lifetime protection against the flu and its ever-changing strains?THANKS TO OUR SPONSOR:Become a SponsorScientists at Oregon Health & Science University are working on advancing that goal by developing a new way to deliver vaccines against flu viruses. The vaccines are delivered through a harmless virus that most people are exposed to at some point in their lives. The technology stimulates the body to release cells that attack the internal machinery of the harmful virus instead of its outer surface which can evolve to slip past immune defenses. Joining us to talk about this research is Jonah Sacha, a professor at OHSU and the chief of pathobiology at the Oregon National Primate Research Center.The following transcript was created by a computer and edited by a volunteer:Dave Miller: This is Think Out Loud on OPB. I’m Dave Miller. In just a few months, many of us are going to be getting reminders to get our annual flu shot. The flu vaccine changes each year based on what strain or strains of influenza are most likely to be circulating. Sometimes it’s a good match, other times less so. But what if you could get a single dose that conferred a lifetime of protection against ever changing strains? That is what scientists at OHSU are hoping to create. And according to a recent paper, they are getting closer.Jonah Sacha is a professor at OHSU and the chief of pathobiology at the Oregon National Primate Research Center. He joins us now. Welcome back to the show.Jonah Sacha: Thank you for having me.Miller: Can you explain the current model – how annual vaccines for flu are put together?Sacha: Currently, we receive a vaccine that’s updated every year. And it’s sort of a best estimate by professionals who study the influenza viruses that are circulating within the animal pools that we know of. So within birds and pigs. It’s an educated guess of what’s going to be circulating in humans later in the year. And so they build this tailored vaccine every year based upon what they estimate is going to jump into humans from those animals.Miller: And how does that vaccine work in our body? What does our body do in response?Sacha: So when you receive one of these vaccines, it is essentially a killed or inactivated influenza virus. And what it does is to alert your body to, this as a pathogen that you want to remember. Our body is fantastic about recognizing foreign invaders and remembering them for later. The issue with influenza is that it’s not just one singular virus. It’s actually a large swarm of closely related yet genetically distinct viruses that are slightly different from each other.Miller: But the model is to actually take an actual influenza virus and then inactivate it, or take a part of it, or a dead version of it, and use that to train our body then to make antibodies against it?Sacha: Correct. So then your body sees this and it makes these small Y-shaped molecules called antibodies. And what they do is they physically attach to the outside of the virus and they prevent it from attaching to your cells and infecting you. And that’s how they protect you from getting sick with influenza.Miller: And how effective are they?Sacha: It really depends. They can range from as little as 30%, up to 75% or 80%. And it really depends on how closely what the vaccine is based on, to what virus actually emerges and then infects people in that influenza season. You can see something similar now happening with the SARS-CoV-2 or COVID vaccines, where it’s sort of a guess of what’s going to happen. And really the efficacy of the vaccine depends on how closely that vaccine strain matches what you actually get infected with later on.Miller: In fact, it seems like we’re due for a new COVID-19 vaccine?Sacha: That’s right. Interestingly, SARS-CoV-2 or COVID-19 vaccines are going to become sort of like an annual influenza vaccine. They’re going to follow that model. So we’ll be receiving annual influenza vaccines and then likely also annual COVID vaccines.Miller: But you’re working on something to actually upend that model. What’s different about the vaccine model that you’re working on?Sacha: As I mentioned, most of our historically successful vaccines work upon this idea that you can show the body a virus, the body will recognize it, remember it, make these Y-shaped molecules. Then when your body re-encounters that same virus later on, those Y-shaped molecules will attack that virus and prevent it from making you sick. The issue is that those sorts of vaccine approaches don’t work great when there’s a lot of diversity in the virus. And we see that with influenza. And we see that with SARS-CoV-2, the causative agent of COVID-19.So the vaccine that we’re actually making has its origins in a vaccine approach that we were making for HIV. I came to OHSU 13 years ago to work on this exact vaccine vector. It’s based on another virus called cytomegalovirus or CMV, which is a quite innocuous virus that most people in the world are infected with. This virus is unique because, instead of making these Y-shaped antibodies, it actually trains your body to make a different type of immune response, one that is based on T-cells. You may have heard of them as killer T-cells. And these are immune system cells that will go around and recognize small pieces inside of the virus and then kill the cells that are infected with it. So our vaccine, based on CMV or cytomegalovirus, doesn’t use antibodies. Instead, it relies on these killer T-cells to do the work.Miller: What’s different about attacking the inside of the virus as opposed to using antibodies to go for the outside?Sacha: Yes, that’s a great question. And I bring this back to HIV because it’s sort of where all this started. But with HIV, with influenza, and with SARS-CoV-2, the theme is the same – these viruses are not just one single virus, but they’re rather diverse swarms. And they’re really adept at changing the outside of themselves. And when they do that, the body has difficulty recognizing that. So when you target the inside of a virus, it’s very difficult for these viruses to change the essential building blocks that allow them to form the virus particles.A good analogy is that we train, with vaccines, our immune system to remember the color of the shirt of the bank robber. So if the bank robber comes in wearing a red shirt, your body is always going to say, “aha,” using antibodies, “I see that red shirt. I know that’s a bank robber. I will attack it.” However, these bank robbers, like the viruses, are smart. They change their shirts. And so now if the bank robber comes in with a blue shirt, your antibodies are no longer gonna work. But if you can train the T-cells to ignore the shirt, and focus on the fact that this person has glasses and a beard, then your body can recognize that bank robber much better.Miller: This model is, as you noted, already being tested by your colleagues for HIV and for tuberculosis as well. How did you get the idea to try it for influenza?Sacha: It’s a funny story that actually, ironically, harkens back to almost 10 years ago to the day. Ten years ago I was attending a conference called the International Aids Society meeting, which I just got back from last week in Germany. And 10 years ago, that meeting was in Melbourne, Australia. But when I came home, I didn’t realize that I was infected with H1N1 swine flu. And I wound up passing that virus to everyone in my household, including my wife and my son who, at the time, was three years old. He got rather sick and wound up in the hospital at OHSU.In that moment, I remember thinking this is really unfortunate because we all took our annual influenza vaccines, but yet they didn’t protect us. And while I was thinking about why it didn’t work, I realized the CMV vaccine vector that we’re using for HIV actually parallels a lot of the same problems that we have with influenza vaccines. And that’s where the idea came out of – a very personal up-close experience with influenza in my household.THANKS TO OUR SPONSOR:Become a SponsorMiller: So to construct this new vaccine, my understanding is you put in pieces of the 1918 influenza virus, which was responsible for killing an estimated 50 million people around the world. Why choose this 106-year-old virus?Sacha: So that is the oldest isolate that we have of influenza. I think it’s actually one of the oldest isolates we have of any virus. And we chose it, very specifically, because we wanted to make the test of our vaccine as rigorous as possible. So we picked the oldest possible isolate to vaccinate against. And then we came back and we challenged, with a virus, an avian influenza that was isolated in the early 2000′s. So that’s nearly 100 years of natural influenza evolution between the strain that we used to vaccinate with and the one that we used to challenge with. [Because] nearly 100 years of evolution would capture all of this sequence diversity or change within the virus, it would therefore be a very stringent test of our vaccine. And that’s actually why we chose it.Miller: Is the thinking that if you had used, as the basis for the vaccine, a virus from five years ago, that you would actually confer even more benefit and it would let the body identify it with even more accuracy?Sacha: That is exactly correct. So we chose the oldest strain we could to make it as difficult as possible. And that is where, actually, we want to go next, to then make the vaccine sequence that we use more optimal so that you get better coverage and make the healthy immune system recognize influenza even better – more accurately, as you put it.Miller: Six of the 11 vaccinated nonhuman primates that were exposed to the H5N1 survived.I think that was the language in the press release. Does that mean that five of them didn’t?Sacha: That is correct. Again, this is due to our deliberate choice of this virus. So the H5N1 avian influenza isolate that we selected is incredibly pathogenic. It is uniformly lethal in these animals. In humans that have been infected with this, the mortality rate is around 60%. This is one of the most pathogenic viruses that we know of. Again, we chose this deliberately to make the test as difficult as possible for our vaccine.Miller: I saw those numbers and it just made me wonder if a 55% survival rate, post-vaccination, is something to celebrate. Celebration is the wrong word, but it still is good news, given just how dangerous this virus is?Sacha: Yes, that is one component. It’s good news given how dangerous this virus is, given the huge hurdle that we set up to make for the vaccine strain that we use coming from 100 years previously. We set the vaccine at the biggest disadvantage that we could to test the proof of concept because no one had ever really tried to make a T-cell based vaccine for primates before.As I mentioned, the current vaccine approach is all based on antibodies, which is very powerful, but necessitates the vaccine having to change every year. So we’re pivoting away from that and deliberately trying a completely new approach to try and achieve a universal influenza vaccine.Miller: Just stepping aside from this science for a second, what kinds of security and safety protocols do you have in place? As you said, this is a devastatingly effective virus that kills unvaccinated monkeys. But it would also kill many, many thousands or millions of humans, if it were to escape. And it’s not that far from the major population center of our state. How do you keep it in the confines of the Center?Sacha: I’ll say three things. This challenge work was actually not done here but was done at the University of Pittsburgh in Pittsburgh. But that doesn’t change the fact that it’s still a population center. But we, as scientists in the United States, are under extremely strict regulations from multiple levels. And this is all done in what we call a Level 3 facility which has multiple checks and balances so that it would be very difficult for this to ever get out.Secondly, I will say that this H5N1, if you zoom out and look at the United States or in the world, this virus is currently in our dairy population. So even if there were to be “a leak,” the virus is already out there in dairy cows already.Miller: And it’s the same virus?Sacha: It’s not the exact same virus. It’s H5N1, but is a different isolate than this one. But nevertheless, there is H5N1 that is out there circulating in animals and currently in our dairy cows.Miller: So to go back to the possibility of this going from basic research to an actual vaccine people could take – what are the steps that have to happen before that?Sacha: It’s a great question. So we sit at the interface of preclinical and clinical research. So with this result, this now gives us the ability to have the justification to proceed into clinical trials. Now, if we were starting from scratch, it would be years because the first thing has to happen is a phase-1 clinical trial which is to establish the safety of any such approach. Luckily, we are following in the footsteps of my colleagues who have been working on this vaccine for decades now.This work was, like I said, why I came here to Oregon 13 years ago. This vaccine vector for CMV is now in clinical trials for HIV. And clinical trials for tuberculosis are starting soon. And because all of that work has already been done, the trail has already been blazed, so to say, our pathway forward is much quicker and much easier now because of that work.Miller: Meaning … what’s a potential time frame?Sacha: It’s difficult to say because a lot of this is out of my control. But if the HIV vaccine trials and the tuberculosis trials are successful, I could see this going into trials with people and potentially being tested for efficacy within five to 10 years. Again, there are a lot of factors that go into that. What’s unique about influenza is that you can run clinical trials where you can vaccinate people and then experimentally infect them. There are centers to test exactly this setup within the United States. So this could actually go quite quickly once the clinical vaccine is made to test.Miller: Is there any reason this same model couldn’t be used for coronavirus as well, like the one that causes COVID-19?Sacha: That’s an absolutely fantastic question. And as you can see, we’re facing similar issues here with SARS-CoV-2, with the COVID vaccine needing to change every year. And I would posit that, rather than us constantly trying to chase these viruses as they evolve and putting our vaccines where we think the virus is going to go, or where it just was, we aim at these conserved segments of the virus where we know it can’t move, and base vaccines off of that. Soyes, I think that this approach could be used and ideally should be used for these highly variable viruses like HIV influenza and SARS-CoV-2.Miller: Just finally, if the brilliant nugget here is to go after the unchanging part of these viruses opposed to the quickly mutating parts, if these are “clever” evolutionarily pressured beings, what’s to say that they won’t mutate in some other way, given the new pressure that you’re gonna be putting on them?Sacha: It’s a great question. Of course, they can. Viruses will always change and find a way. But what we’ve learned though is that when you target not one but multiple conserved regions of a virus, it’s very difficult, if not impossible, for a virus to escape those multi-pressures. The best analogy is the antiretroviral therapy drugs that we use for HIV. If you use one of them in isolation, the virus will simply mutate, sort of laugh at you and then keep replicating. But if you use two or three in combination, they can’t, and it simply can’t escape all three, and it stops the virus dead in its tracks. So with the vaccine, it would be similar to that. We have to take multiple targets at multiple conserved areas of the virus.Miller: Jonah Sacha, thanks very much.Sacha: Thank you for having me.Miller: Jonah Sacha is a professor at Oregon Health and Science University and chief of pathobiology at the Oregon National Primate Research Center.Contact “Think Out Loud®”If you’d like to comment on any of the topics in this show or suggest a topic of your own, please get in touch with us on Facebook, send an email to thinkoutloud@opb.org, or you can leave a voicemail for us at 503-293-1983. The call-in phone number during the noon hour is 888-665-5865.THANKS TO OUR SPONSOR:Become a SponsorTHANKS TO OUR SPONSOR:Become a Sponsor📨 Stay informed after Election DayLearn what the election results will mean for the Pacific Northwest. Subscribe to our “First Look” newsletter for a daily roundup of the biggest stories shaping the region.EmailPlease leave this field blankSign upTags: Think Out Loud, Health, Medicine, Research, OhsuOPB’s critical reporting and inspiring programs are made possible by the power of member support.Become a Sustainer nowTV & Radio SchedulesSponsorshipHelp CenterManage My MembershipContact UsNotificationsPrivacy PolicyFCC Public FilesFCC ApplicationsTerms of UseEditorial PolicySMS T&CContest RulesAccessibilityListen to the OPB News live stream (opens new window)Streaming NowLatino USAShow switch stream buttonsSwitch Stream:OPB NewsListen to the OPB News live stream (opens new window)KMHDListen to the KMHD live stream (opens new window)OHSU-led research fuels hope for a universal flu vaccine - OPB Nov. 12, 2024contribute nowElection results and analysisStay updated as votes are counted and trends emergeOHSU-led research fuels hope for a universal flu vaccineBy Ben Botkin (Oregon Capital Chronicle)July 31, 2024 4:56 p.m.They say the new approach could lead to the development of a “one and done” shot to cover all flu variants in five yearsJonah Sacha, an Oregon Health & Science University researcher and senior co-author of a new study, says new research could lead to a universal influenza vaccine within five years.Courtesy of Christine Torres Hicks / Oregon Health & Science UniversityOregon Health & Science University researchers say they have a promising new approach to developing a universal influenza vaccine — potentially within five years.THANKS TO OUR SPONSOR:Become a SponsorSuch a vaccine — a “one and done” dose — would provide a person with lifetime immunity against a rapidly evolving influenza virus and help safeguard against a pandemic like the recent one that also caused a respiratory illness. Flu strains have triggered six major epidemics in the past century and a half, with the worst in 1918 when millions of people died worldwide.Flu vaccines — and COVID shots — are based on targeting a particular strain that’s circulating. A universal flu shot would have to work against all strains of the virus, which mutates over time. So researchers adopted a new, OHSU-developed approach, according to the study, which was published this month in the journal Nature Communications.Researchers started by inoculating 11 monkeys with the 1918 flu virus. They then were exposed to an avian H5N1 influenza virus from 2005, an viral infection that originated with birds but is highly infectious for humans. Six of the 11 monkeys survived the exposure to H5N1.Related: Oregon lags behind goal of high flu vaccination rate for health care workersThat’s a good outcome for the experiment considering the strength of the H5N1 virus, said senior author Jonah Sacha, professor and chief of the Division of Pathobiology at OHSU’s Oregon National Primate Research Center.“We did that because we wanted to make it a really difficult test, so that if we saw any kind of signal, we could be confident that what we were seeing was real,” Sacha said in an interview.A control group of six primates did not receive the vaccine and also was exposed to the H5N1 virus. They all died.Sacha said the method used to deliver the vaccine could potentially help other mutating viruses like SARS-CoV-2, the virus that causes COVID-19.THANKS TO OUR SPONSOR:Become a Sponsor“It’s a very viable approach,” he said. “For viruses of pandemic potential, it’s critical to have something like this. We set out to test influenza, but we don’t know what’s going to come next.”Different approachThe key to the vaccine’s success was its method of delivery, called a platform. The one used in the flu vaccine trials was also developed by OHSU and is in clinical trials for HIV vaccines.The approach involves putting small amounts of the vaccine into a common herpes virus cytomegalovirus, or CMV, which infects people but usually produces no symptoms. Nevertheless, CMV prompts an immune response which trains the immune system to fight the flu strains in the vaccine.This is different from typical vaccines, including the existing flu vaccines, which rely upon an antibody response that targets the latest version of the virus.By using an old version of the influenza virus, it was effective despite all the mutations of the past century.“It worked because the interior protein of the virus was so well preserved,” Sacha said. “So much so, that even after almost 100 years of evolution, the virus can’t change those critically important parts of itself.”Related: Flu infections in Southern Oregon are the highest in the state this seasonThe OHSU researchers worked within a secure laboratory at the University of Pittsburgh, where they exposed the vaccinated primates to small particle aerosols containing the avian H5N1 influenza virus. That virus is currently infecting dairy cows. If that virus started a pandemic, a quick response would be necessary, researchers said.“Should a deadly virus such as H5N1 infect a human and ignite a pandemic, we need to quickly validate and deploy a new vaccine,” co-author Douglas Reed, associate professor of immunology at the University of Pittsburgh Center for Vaccine Research, said in a statement.Besides OHSU and the University of Pittsburgh, other involved institutions included the Tulane National Primate Research Center in Louisiana, the University of Washington, and the Washington National Primate Research Center at the University of Washington.Oregon Capital Chronicle is part of States Newsroom, a network of news bureaus supported by grants and a coalition of donors as a 501(c)(3) public charity. Oregon Capital Chronicle maintains editorial independence. Contact Editor Lynne Terry for questions: info@oregoncapitalchronicle.com. Follow Oregon Capital Chronicle on Facebook and X.THANKS TO OUR SPONSOR:Become a SponsorTHANKS TO OUR SPONSOR:Become a Sponsor📨 Stay informed after Election DayLearn what the election results will mean for the Pacific Northwest. Subscribe to our “First Look” newsletter for a daily roundup of the biggest stories shaping the region.EmailPlease leave this field blankSign upTags: Oregon Health & Science University, Research, Flu, VaccinesOPB’s critical reporting and inspiring programs are made possible by the power of member support.Become a Sustainer nowTV & Radio SchedulesSponsorshipHelp CenterManage My MembershipContact UsNotificationsPrivacy PolicyFCC Public FilesFCC ApplicationsTerms of UseEditorial PolicySMS T&CContest RulesAccessibilityListen to the OPB News live stream (opens new window)Streaming NowLatino USAShow switch stream buttonsSwitch Stream:OPB NewsListen to the OPB News live stream (opens new window)KMHDListen to the KMHD live stream (opens new window)June and July 2024 see surge in influenza deals for pandemic prep Skip to content Search for: Suggested Topics: Categories Browse by resource or article categoryResourcesReportsBiotech funding trackerBiotech deals trackerList of biotech eventsList of biotech grants List of biotech associationsCategoriesNews and TrendsIn-depthBest in BiotechPodcastsOpinionExpert AdviceSponsored The biggest private biotech investments in August 2024 Long non-coding RNAs: what’s behind the growing “dark genome” buzz? Sectors Browse by sectorApproachesAntibodyArtificial IntelligenceCAR-TCell TherapyCRISPRGene editingGene therapyGenomicsMicrobiomemRNA TechnologyT-cellsTherapeutic areasAgingAlzheimer'sCancerDiabetesMental health Grab your free report on 3D organoids and explore their future potential Six biotech companies that could revolutionize obesity treatments Drug Development Stay informed on the latest drug development updatesR&DResearchDrug DiscoveryClinical trialsRegulatory approvalBDFundingPartnershipsM&ATop biotech startupsWorld biotech leadersUSAU.K.FranceGermany Connect with decision-makers and researchers worldwide for collaborative opportunities More Learn more about LabiotechCompanyAbout UsOur Editorial CalendarCareersAbout our parent company InpartJoin UsContact Us Subscribe to our newsletter Advertise with us Subscribe Search for: Top Topics Cancer Gene therapy Artificial intelligence mRNA technology CRISPR CAR-T Categories Resources Reports Biotech funding tracker Biotech deals tracker List of biotech events List of biotech grants List of biotech associations Categories News and Trends In-depth Best in Biotech Podcasts Opinion Expert Advice Sponsored The biggest private biotech investments in August 2024 Long non-coding RNAs: what’s behind the growing “dark genome” buzz? Sectors Approaches Antibody Artificial Intelligence CAR-T Cell Therapy CRISPR Gene editing Gene therapy Genomics Microbiome mRNA Technology T-cells Therapeutic areas Aging Alzheimer's Cancer Diabetes Mental health Grab your free report on 3D organoids and explore their future potential Six biotech companies that could revolutionize obesity treatments Drug Development R&D Research Drug Discovery Clinical trials Regulatory approval BD Funding Partnerships M&A Top biotech startups World biotech leaders USA U.K. France Germany Connect with decision-makers and researchers worldwide for collaborative opportunities More Company About Us Our Editorial Calendar Careers About our parent company Inpart Join Us Contact Us Subscribe to our newsletter Advertise with us Podcast Reports Home News and Trends Influenza solution deals pile up as pandemic preparedness increases Influenza solution deals pile up as pandemic preparedness increases By Jules Adam 6 minutesmins July 29, 2024 6 minutesmins Share WhatsApp Twitter Linkedin Email The last few weeks have seen a drive in deals either focused on influenza solutions or with assets in this field. Advanced technologies, particularly mRNA and RNAi, are at the forefront of this investment boom. According to CSL Seqirus, exploring platforms like self-amplifying mRNA and leveraging proven technologies such as cell-based manufacturing is crucial to identifying new influenza prevention and treatment solutions.The historical precedence of influenza pandemics and the potential threat of viruses like H5N1 are significant drivers behind this increased investment. As governments and health organizations worldwide recognize the need for robust preparedness strategies, the role of advanced technologies in transforming influenza vaccine development becomes increasingly important.We reached out to some of the players involved in the recent surge in investment toward influenza solutions to better understand the trend.Table of contentsOverview of recent influenza dealsGSK and CureVac’s €1.45 billion ($1.57 billion) collaboration on mRNA vaccinesOn July 3, 2024, it was announced that GSK and CureVac have restructured their existing partnership, culminating in a €1.45 billion ($1.57 billion) deal. “Under the new licensing agreement, GSK has acquired full control over the development, manufacturing, and global commercialization of mRNA vaccines for flu and COVID, including the seasonal and avian flu program and flu/COVID combination vaccines, utilizing CureVac’s technology. This is a very strong validation of our technology,” said Alexander Zehnder, chief executive officer of CureVac.The collaboration allows CureVac to focus on building a robust research and development (R&D) pipeline while leveraging GSK’s global capabilities to advance critical programs such as the avian flu vaccine, a potential future pandemic threat. This deal aims to ensure preparedness for potential pandemics by advancing mRNA technology​.CSL Seqirus’ contract with HERA for pre-pandemic bird flu vaccines On June 11, 2024, it was announced that CSL Seqirus has been awarded a contract by the European Commission’s Health Emergency Preparedness and Response Authority (HERA) to supply 665,000 doses of pre-pandemic bird flu vaccine to 15 European countries, with the option to purchase up to 40 million more doses over four years. This deal aims to enhance Europe’s pandemic preparedness by stockpiling vaccines tailored to the current avian influenza strain. The press release takes note of an outbreak of highly pathogenic avian influenza viruses in birds and poultry reported in Europe. “CSL Seqirus is well-prepared with its existing egg-based and cell-based platforms to tackle the threat of influenza, including from this current outbreak. We are also actively exploring all of our platforms to find new solutions and improvements. This includes self-amplifying mRNA and our other proven technologies, cell-based manufacturing, and our MF59 adjuvant,” the company told us.Tiba Biotech’s BARDA contract for RNAi-based flu therapeuticsIn July 2024, it was also announced that Tiba Biotech secured a $749,999 contract with the Biomedical Advanced Research and Development Authority (BARDA) to develop RNAi-based flu therapeutics. This initiative, part of BARDA’s FASTx program, focuses on creating adaptable treatment platforms for public health emergencies. Tiba’s synthetic, biodegradable nanoparticle platform promises higher payload capacity and reduced toxicity compared to traditional lipid nanoparticles, representing a significant advancement in RNA-based therapies​.Suggested Articles AI program finds multiple influenza drug targets AAHI bags $9.9M to develop nasal spray influenza RNA vaccine Eight biotech companies advancing the field of siRNA The ABC of biotech partnerships Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR What are the drivers of this investment trend in influenza treatments?The repeated occurrence of influenza pandemics, such as the notable outbreaks in 1918, 1957, 1968, and 2009, are obvious reminders of the importance of being vigilant and prepared. This historical context drives continuous investment in research and development to improve responses to potential future pandemics.“Pandemics, as natural phenomena, present unpredictable and severe threats to global health, reinforcing the necessity for robust preparedness strategies. Governments and health organizations worldwide recognize this, and that responding to outbreaks of virus strains with pandemic potential, such as the currently circulating H5N1 virus, requires immediate and effective action. This includes comprehensive surveillance, testing, monitoring, and vaccination efforts, all of which are pillars of good preparedness and crucial in mitigating the impacts of potential pandemics,” indicated a CSL Seqirus spokesperson.Zehnder confirmed the global recognition of the influenza threat is the main driver of the surge in investment. “Avian flu is considered a potential future pandemic threat, and which has sporadically crossed species from its original bird host to other animal hosts and humans. While as of today, there is no known case of human-to-human transmission of avian flu, being prepared for a potential next evolution step of this virus is an important part of pandemic preparedness.”The success of mRNA vaccines during the COVID-19 pandemic has served this investment trend well as it has demonstrated the technology’s potential for creating effective and adaptable vaccines. This success has led to increased confidence and investment in mRNA technology for influenza vaccines. “We are also actively exploring all of our platforms to find new solutions and improvements. This includes self-amplifying mRNA and our other proven technologies, cell-based manufacturing, and our MF59 adjuvant,” said CSL Seqirus’ spokesperson.What will the fight against influenza look like?When it comes to influenza, we are dealing with pandemic risks and, very much like they did during COVID-19, players of the biotech industry will have to collaborate. “Pandemics require a response that transcends national boundaries, making collaboration with governmental health agencies essential for effective preparedness and response. Collaborations with governmental health agencies and public health bodies are integral to our strategic planning at CSL Seqirus. These partnerships reinforce our commitment to public health and pandemic preparedness, enabling us to align our resources and capabilities with national and global health objectives effectively,” explained CSL Seqirus’ spokesperson.CSL Seqirus also believes we shouldn’t stop at the solutions that have been proven effective. “The current trend of increased investment in influenza virus research and development in established and novel vaccine technologies reflects a proactive approach by governments and non-government organizations to enhance preparedness and increase the global capacity to respond to seasonal influenza, outbreaks, and pandemics. While traditional egg-based methods and more recent cell-based vaccines are pivotal for both seasonal and pandemic preparedness, exploring other technologies such as next-generation mRNA is important to identify potential new approaches,” said the spokesperson.And Tiba Biotech is a good example of the potential of next-generation RNA technology in influenza. Tiba Biotech’s RNAi-based therapeutics utilize a synthetic, biodegradable nanoparticle platform designed to deliver RNA-based therapies more effectively than traditional lipid nanoparticles. This platform promises higher payload capacity and reduced toxicity, making it a significant advancement in the field of RNA-based treatments. The recent agreement with BARDA is bound to tap into the potential of this technology to serve pandemic preparedness. COVID-19 has left scars, not all bad. As the CSL Seqirus spokesperson highlighted, there is an ongoing evolution of advanced disease surveillance and collaboration. “Surveillance is critical to identify and monitor the emergence of novel pathogens, such as new or re-emerging avian influenza strains of pandemic potential. This also enables the ongoing build of a library of candidate vaccine viruses and technical work to explore their characteristics and potential for vaccine production.” New technologies related to influenza:Viral-Based Cancer Gene Therapy and Treatment of Influenza Infection Through Induction of Cell Death – Fox Chase Cancer CenterLive Attenuated Viral Vaccines – University of Minnesota Mild and Uniform Infectious Bronchitis Vaccine for Newly Hatched Chicks – Auburn University Explore other topics: influenzainvestmentVaccines ADVERTISEMENT Newsletter Signup - Under Article / In Page"*" indicates required fieldsSubscribe to our newsletter to get the latest biotech news!Consent* I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.*Business email* CommentsThis field is for validation purposes and should be left unchanged. Latest Articles Gene editing sector investment struggles: What’s driving the slowdown? How to negotiate your job offer in biotech How to succeed as a woman in biotech The biggest private biotech investments in October 2024 ADVERTISEMENT Suggested Articles AI program finds multiple influenza drug targets AAHI bags $9.9M to develop nasal spray influenza RNA vaccine Eight biotech companies advancing the field of siRNA The ABC of biotech partnerships Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPRLatest Articles Gene editing sector investment struggles: What’s driving the slowdown? How to negotiate your job offer in biotech How to succeed as a woman in biotech The biggest private biotech investments in October 2024 Subscribe to our newsletter to get the latest biotech news! Signup now Explore Labiotech Biotech news by sectorBiotech news by regionBiotech news by companyNews and TrendsIn DepthBest in BiotechReportsPodcastSite Map About Labiotech Advertise with Labiotech.euSubscribeContactEditorial calendar Our Other Brands Inpart Follow Us Instagram Twitter Linkedin Google News Youtube RSS Feed Newsletter Signup - Footer"*" indicates required fieldsSubscribe to our newsletter to get the latest biotech news!Business email* Consent* I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.CommentsThis field is for validation purposes and should be left unchanged. Made with - Labiotech UG, All Rights Reserved -ImprintPrivacy PolicyThe Bird Flu Threat Keeps Growing | WIREDSkip to main contentOpen Navigation MenuMenuThe Bird Flu Threat Keeps GrowingSecurityPoliticsGearThe Big StoryBusinessScienceCultureIdeasMerch2024 ElectionMoreChevronSearchSearchSecurityPoliticsGearThe Big StoryBusinessScienceCultureIdeasMerch2024 ElectionPodcastsVideoNewslettersMagazineTravelSteven Levy's Plaintext ColumnWIRED Classics from the ArchiveEventsWIRED InsiderWIRED ConsultingJobsCouponsEmily MullinScienceJul 29, 2024 3:18 PMThe Bird Flu Threat Keeps GrowingHuman cases keep ticking up, are very likely to be underreported, and offer the virus the opportunity to learn how to spread from person to person.Photograph: Nathan Howard/Getty ImagesSave this storySaveSave this storySaveOngoing outbreaks of avian influenza have decimated poultry flocks and wild birds across the United States and worldwide. The virus, known as H5N1, is also increasingly adapting to mammals and has been found in cats, goats, and raccoons. In the US, it has spread to at least 170 dairy herds across 13 states. And in April, health officials confirmed that a dairy worker had caught the virus from an infected cow. This was the first time the virus made the jump from a mammal to a human.Now, the number of people becoming infected with bird flu is ticking upward. On July 25, the US Centers for Disease Control and Prevention confirmed an additional three human cases, bringing the total number of US cases to 13 since April. The infections occurred in people who were working directly with infected poultry at an egg farm in Colorado that had reported an outbreak of H5N1 among its birds. All three people have mild symptoms and have been offered Tamiflu, an antiviral drug. The CDC says the risk of H5N1 infection in the general public remains low.“These cases are not entirely surprising given that these people were working with infected poultry,” says Stephen Morse, an epidemiologist at Columbia University in New York. “The good news is that so far, there’s no evidence that this has spread from person to person. At that point, we’d really have to ramp up the concern to the level of red alert.”The CDC is looking into whether the workers in Colorado were wearing personal protective equipment, or PPE, such as gloves, coveralls, footwear, masks, and goggles. Historically, most human cases of bird flu infection have happened in people who were not wearing recommended PPE, according to the agency.The new cases come shortly after another cluster of human infections was identified this month. On July 19, the CDC confirmed six human cases of bird flu among poultry workers at a different facility in Colorado. Those cases were in workers who were involved in the culling of birds infected with H5N1. Once the virus is found on a farm, poultry producers must cull entire flocks. With the latest three infections, Colorado now has nine confirmed cases of bird flu.The other four cases—one in Texas, two in Michigan, and one in Colorado—have been linked to exposure to infected dairy cows. The virus likely spread to the workers through raw milk. A study published in May found that the virus can remain stable on milking equipment for at least an hour, increasing its potential to infect people and other animals. Pasteurizing milk, however, kills the H5N1 virus.Most PopularSecurityThe AI Machine Gun of the Future Is Already HereBy Jared KellerCultureTaylor Swift Fans Are Leaving X for Bluesky After Trump’s ElectionBy Vittoria ElliottGearI Went Birding With the World’s First AI-Powered BinocularsBy Lola MéndezScienceThe Incredible Power of Quantum MemoryBy Lakshmi ChandrasekaranSo far, all the US cases this year have resulted in mild symptoms, but in the past, H5N1 has had a lethality rate of around 50 percent. From 2003 to 2023, a total of 878 people tested positive for the virus, and 458 deaths were reported.The last time H5N1 caused a major outbreak among US poultry flocks was in 2015, when it wiped out 50.5 million birds. It wasn’t until April 2022 that the US saw its first reported human case of bird flu, in a poultry worker in Colorado. No further cases were reported until this year. “Something has changed,” says Anice Lowen, a flu researcher at Emory University in Atlanta, Georgia. “Whether it’s due to changes in the virus or changes in the circumstances of exposure is hard to know without more information.”The CDC’s sequencing of the virus from the sixth human case reported from Colorado shows that it is related to the viruses detected in recent poultry outbreaks and infected dairy cattle herds. It contains a marker of mammalian adaptation that has been identified in more than 99 percent of dairy cow sequences, as well as in the first Michigan human case.It’s possible there are more human infections that are going undetected. The US has tested only around 200 individuals for the virus, while more than 4,100 people are being monitored. Lowen says ideally everyone working with infected animals should be tested. “It’s really important that we know the extent of spillover,” she says. “I think this country certainly has the resources to be doing more testing.”Matthew Miller, codirector of the Canadian Pandemic Preparedness Hub at McMaster University in Ontario, says proper PPE is critically important for groups at high risk of exposure. “Giving the virus an opportunity to infect humans is giving it an opportunity to learn how to transmit between humans,” he says. Flu viruses undergo constant changes in a host as they replicate, and it’s possible that H5N1 could eventually develop mutations that would make human transmission more likely.In the case of the first Colorado facility, US health officials acknowledged that high summer temperatures may have played a role in those six infections. “At the time transmission is thought to have occurred, Colorado was experiencing 104-plus-degree heat,” said Nirav Shah, principal deputy director of the CDC, in a press conference on July 16. “The barns in which culling operations occur were no doubt even hotter. All of this makes PPE use a challenge.” There were also large industrial fans in the barns, which could have blown virus particles through the air, increasing the risk of infection.Most PopularSecurityThe AI Machine Gun of the Future Is Already HereBy Jared KellerCultureTaylor Swift Fans Are Leaving X for Bluesky After Trump’s ElectionBy Vittoria ElliottGearI Went Birding With the World’s First AI-Powered BinocularsBy Lola MéndezScienceThe Incredible Power of Quantum MemoryBy Lakshmi ChandrasekaranAlongside rising cases in people, the virus has also spread to dozens of mammal species. A study published in Nature on July 25 found that the spillover of avian flu from birds to dairy cattle led to mammal-to-mammal transmission—between cows, and from cows to cats and a raccoon—raising concerns that H5N1 could eventually adapt to spread among people.As H5N1 spreads to more species, scientists are worried about its potential to spark a pandemic. Some countries have tried vaccinating poultry against avian flu, but Morse says the problem is making enough doses at scale. Commercially raised chickens have short lives, and in the US, facilities may raise thousands of birds. “A lot of animals would need to be vaccinated, and in practical terms, it’s very hard to do,” Morse says.Finland has started vaccinating high-risk workers at fur and poultry farms, and Morse thinks the US should follow suit. Several H5N1 vaccines have been licensed and the US has stockpiled a supply of these, but because the virus has a high mutation rate, it’s not known whether those vaccines would be effective against the currently circulating virus. The US recently awarded Moderna $176 million to develop an mRNA vaccine against H5N1. The company, which made one of the Covid-19 mRNA vaccines, is currently testing its bird flu vaccine in an early-stage trial.You Might Also Like …In your inbox: Our biggest stories, handpicked for you each dayElection reaction: The manosphere wonThe Big Story: California will keep moving the world forwardTrump's failed attempt to overthrow Venezuela's presidentEvent: Join us for The Big Interview on December 3 in San FranciscoEmily Mullin is a staff writer at WIRED, covering biotechnology. Previously, she was an MIT Knight Science Journalism project fellow and a staff writer covering biotechnology at Medium's OneZero. Before that, she served as an associate editor at MIT Technology Review, where she wrote about biomedicine. Her stories have also... Read moreStaff WriterXTopicsscienceanimalsbirdsinfectious diseasehealthcoloradobird fluRead MoreAfter Hurricane Milton, Get Ready for MoldThousands may now be at risk of mold-related illnesses following this year's hurricanes in the American South.Emily MullinA Neuralink Rival Says Its Eye Implant Restored Vision in Blind PeopleScience Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize faces.Emily MullinCells From Different Species Can Exchange ‘Text Messages’ Using RNALong known as a messenger within cells, RNA is increasingly seen as life’s molecular communication system—even between organisms widely separated by evolution.Annie MelchorThe US Has a Cloned Sheep Contraband ProblemAfter a Montana man illegally cloned and bred an endangered giant sheep species, government agencies must now contend with the illicit offspring.Matt ReynoldsRFK Jr. Wants to Reshape US Health Policy. Good Luck With ThatRobert F. Kennedy Jr. says he’ll make big changes in the US government if Donald Trump is elected. He may find them hard to pull off, no matter what position he’s appointed to.Emily MullinMicroplastics Could Be Making the Weather WorseMicroplastics cause clouds to form in places where they wouldn't otherwise, which is likely to have knock-on effects on the weather and climate.Miriam FreedmanMilton Disrupted the Flow of Drinking Water—so Florida Deployed a Machine to Harvest It From AirA Tampa-based company that makes atmospheric water generators and the state of Florida were able to supply one to a hospital shortly after Milton made landfall.Emily MullinThe Secret Electrostatic World of InsectsInvisibly to us, insects and other tiny creatures use static electricity to travel, avoid predators, collect pollen, and more. New experiments explore how evolution may have influenced this phenomenon.Max G. LevyThe Doctor Behind the ‘Suicide Pod’ Wants AI to Assist at the End of LifeThe death of an American woman inside Philip Nitschke’s latest invention reveals the next frontier in the right-to-die debate.Morgan MeakerThese Smart Glasses Will Read Your Emotions and Watch What You EatA new type of smart glasses from Emteq Labs have cameras pointed inwards, aiming to track your life and quantify how you’re feeling—and what you’re eating.Boone AshworthThe EU Is Investigating Temu for Illegal Products and Addictive DesignToys, pharmaceuticals, and cosmetics are suspected to be among the noncompliant products available to the Chinese shopping platform’s 90 million European users.Morgan MeakerThe Untold Story of Trump's Failed Attempt to Overthrow Venezuela's PresidentA successful CIA hack of Venezuela's military payroll system, insider fights for spy agency resources, and messy opposition politics: A WIRED investigation reveals a secret Trump-era attempt to oust autocratic ruler Nicolás Maduro.Zach DorfmanWIRED is where tomorrow is realized. It is the essential source of information and ideas that make sense of a world in constant transformation. The WIRED conversation illuminates how technology is changing every aspect of our lives—from culture to business, science to design. The breakthroughs and innovations that we uncover lead to new ways of thinking, new connections, and new industries.More From WIREDSubscribeNewslettersFAQWIRED StaffEditorial StandardsArchiveRSSAccessibility HelpReviews and GuidesReviewsBuying GuidesMattressesElectric BikesSoundbarsStreaming GuidesWearablesTVsCouponsCode GuaranteeGift GuidesAdvertiseContact UsManage AccountJobsPress CenterCondé Nast StoreUser AgreementPrivacy PolicyYour California Privacy Rights© 2024 Condé Nast. All rights reserved. WIRED may earn a portion of sales from products that are purchased through our site as part of our Affiliate Partnerships with retailers. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Condé Nast. Ad ChoicesSelect international siteUnited StatesLargeChevronItaliaJapónCzech Republic & SlovakiaFacebookXPinterestYouTubeInstagramTiktokGetting ahead of H5N1 bird flu | CEPICEPIAbout CEPIWhat we doPartner with usNews & storiesContact usMenuCEPISearchSearchBlogGetting ahead of H5N1 bird fluKate Kelland2nd August 2024ShareFacebookLinkedInXThe potential human epidemic threat posed by the outbreak of H5N1 bird flu among dairy cattle in the United States is âincreasing dailyâ, says influenza expert Dr Rick Bright, and should prompt global health security and research organisations to take âconcrete stepsâ to get ahead.Speaking at the Global Pandemic Preparedness Summit in Rio de Janeiro, Brazil, Dr Brightâwho was formerly head of the U.S. Biomedical Advanced Research and Development Authority and is currently working with CEPIâs preparedness and response expertsâdescribed the H5N1 outbreak in domesticated mammals and poultry as âunprecedentedâ.âThe alarm bells are going off,â he said. âAnd some people want to hit snooze, but others want to take concrete actions to be ready to make sure that we can respond in an equitable way when this takes off.âH5N1 is a Type A influenza virus from the Orthomyxovirus family. It has circulated in wild birds across the world for several decades and during that time has also caused outbreaks on poultry farms and sporadic human infections.H5N1 can infect people who come into contact with diseased birds. According to the World Health Organization, some 50 percent of the more than 900 people that have been infected with H5N1 since 2003 have died. The virus has so far shown little ability to spread person-to-person, but in recent years has spilled over from birds into mammals â a development many scientists say is a concern. Since late 2023, it has been spreading among dairy cattle on farms in the United States where it has also caused several worrying cases of spillover infection in peopleâall of them farm workers in close contact with cattle. Latest data on the U.S. H5N1 outbreak shows the virus has caused at least 10 confirmed human cases of infection across three states and been detected in 169 dairy herds across 13 states. It has also infected an estimated 100 million poultry chickens and more than 9,500 wild birds.âThe problem with this situation is that there are a lot of people that work daily in constant interaction with these animals,â said Bright. âThe chance for infection via spillover into people is a daily risk. And itâs increasing.ââThe more people infected, the more chance for mutation and the more chance that this will change very rapidly and get out of control.âIn May, CEPI convened a cross-departmental group of its outbreak response experts to keep closer track of the H5N1 outbreak and take some initial âno-regretâ steps designed to put the world ahead of the virus if it were to become a greater human threat.Those steps include exploring potential H5N1 vaccine development using computer-assisted design of H5N1 antigensâsubstances that trigger an immune response.âThereâs been a ton of new science about how to design better antigens â particularly computationally-assisted or artificial intelligence-assisted antigens,â said Dr Nicole Lurie, CEPIâs Executive Director for Preparedness and Response. âSo weâve put together a consortium to try to design and then test novel antigens with the goal of taking the best candidates at least through Phase I (clinical trials) in humans.âCEPI is also looking at the potential role of mRNAâthe technology behind some of the life-saving COVID-19 vaccines that were developed and authorised in under a year.The coalition is also working with partners across the pandemic preparedness and response ecosystem, including national governments and global health partners such as the WHO, Gavi and others to think about how we can best collaborate to improve H5N1 preparedness. And it is talking to its recently-launched network of vaccine manufacturers in the Global South to better understand and then navigate the potential barriers that might stand in the way of scaling up production of new H5N1 vaccines if they were needed.While the virus is still primarily a flu that infects and affects bird populations, it has also spread to a wide range of mammals in recent years and is now changing in ways scientists donât immediately understand. Itâs also coming into contact with a lot more people. Lurie warned that further unknowns will emerge in the northern hemisphere autumn and winter as wild birds migrate and the virus starts co-circulating with seasonal influenza strains. Those unknowns need very close monitoring, she said âbecause we can never make up for lost time.âBoth Lurie and Bright strongly reiterated the need to put equity at the centre of the global health security systemâs response. Through its partnerships across research and policy, CEPI is using its voice to advocate for equitable access to bird flu vaccines. Millions of doses of H5N1 vaccines are already being bought up by the United States and other high-income countries, posing a risk that low- and middle-income countries could be left behind in the event of a widespread avian flu outbreak. âOur (CEPIâs) philosophy is that when we are worried enough about something, we want to get ready. We want to lean forward. And we want to take some early no-regret actions,â Lurie told delegates at the Summit. âWe figure that we can always stop (if the threat recedes), but â¦. If the worst happens, weâre going to be way ahead of the game.âThe Global Pandemic Preparedness Summit 2024: Outcomes ReportRead moreNavigating Existential Risks: Insights from Dr. Richard HatchettRead moreThe quest to detect the next pandemic threatRead moreWhere to go nextThe OrthomyxovirusesRead moreCEPI steps up H5N1 preparedness as outbreak in cattle persistsRead moreCEPIAboutWhat we doPartner with usNews & storiesLegalSocialAboutOur approachCEPI 2.0 and the 100 Days MissionEquitable accessThe CEPI teamBoard members & committeesInvestorsJoint Coordination GroupScientific Advisory CommitteePortfolio Strategy & Management BoardWhy we existDocuments libraryCareersWhat we doResearch & developmentEnabling scienceVaccine technologyManufacturing and supply chainPriority pathogensChikungunyaCoronavirusesDisease XEbolaLassaNipahRift Valley FeverOur portfolioOur impactPartner with usSupport CEPICalls for proposalsProcurement tendersOur coalitionNews & storiesNewsStoriesHow climate change increases pandemic riskThe Viral Most WantedMedia resourcesGlobal Pandemic Preparedness Summit 2024LegalCookie PolicyData Protection and Privacy PolicyExternal Privacy NoticeModern Slavery, Human Trafficking and Human Rights StatementReporting concernTackling RacismSocialXFacebookLinkedinÂ©2024 CEPI. All rights reservedQuick takes: H5N1 in US dairy cattle, human H5N1 case in Cambodia, polio in 4 countries | CIDRAP Skip to main content University of Minnesota Main navigationMain content University of Minnesotahttp:/win-cities.umn.edu/612-625-5000 Go to the U of M home page Main navigation News Antimicrobial Resistance COVID-19 Chronic Wasting Disease Influenza Mpox All Topics A-Z Resilient Drug Supply Influenza Vaccines Roadmap CIDRAP Leadership Forum Roadmap Development Coronavirus Vaccines Roadmap . . Topics & Projects Antimicrobial Stewardship Chronic Wasting Disease Osterholm Update Podcasts Newsletters About CIDRAP CIDRAP in the News Our Staff Our Director Osterholm in the Press Shop Merchandise Contact Us About Search CLOSE Search Support Menu Quick takes: H5N1 in US dairy cattle, human H5N1 case in Cambodia, polio in 4 countries News brief Chris Dall, MA Topics Avian Influenza (Bird Flu) Polio Share Copied to clipboard The US Department of Agriculture's Animal and Plant Inspection Service has confirmed three more H5N1 avian flu outbreaks in dairy cattle, bringing the national total of infected herds to 178 in 13 states. The new positive samples are from a herd in Colorado, which has now confirmed 25 outbreaks over the last 30 days, and two herds in South Dakota.Cambodia's Ministry of Health yesterday reported the country's eighth human case of H5N1 of 2024, according to Avian Flu Diary. The case is in a 4-year-old boy from Svay Rieng Province who had touched dead chickens about 12 days before the onset of his illness. The boy is currently hospitalized. It’s the 14th human H5n1 case reported in Cambodia over the last 18 months. All of the cases reported in the country have belonged to the 2.3.2.1c clade of H5N1.Four countries this week reported cases of vaccine-derived polio, according to the latest update from the Global Polio Eradication Initiative. Nigeria reported six cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) in Kano Province, raising the country's 2024 total to 37 cases. Chad, Guinea, and Yemen each reported one cVDPV2 cases, bringing their 2024 totals to 6, 5, and 33 cases, respectively. Washington state confirms first CWD case News brief Chris Dall, MA Topics Chronic Wasting Disease Joan D Squared / iStock Chronic wasting disease (CWD) was confirmed yesterday in an adult female white-tailed deer found dead in Spokane, Washington. It's the state's first case of CWD.Washington Department of Fish & Wildlife (WDFW) said the confirmation was made by the Washington Animal Disease Laboratory at Washington State University, which tested lymph nodes from the deer submitted in July with a batch of other samples for testing. WDFW said it's still working on details of the case and will hold a press briefing next week to provide more information.Case found through proactive surveillanceWashington is now the 35th state with documented CWD in wild or captive cervids. It's also been found in four Canadian provinces.CWD is a neurologic disease caused by misfolded proteins called prions and is fatal in infected deer. It poses an ongoing threat to cervids such as deer, elk, moose, and reindeer because it can spread from animal-to-animal and through environmental contamination. The disease isn't known to infect humans, but officials recommend not eating meat from a sick animal and using precautions when field-dressing or butchering cervids.WDFW said it's been testing for CWD since 1995 and has increased those efforts in eastern Washington since 2021 due to proximity to known cases in western Montana. "With the spread of CWD across the country and recent detections in adjacent states and provinces, WDFW has proactively conducted surveillance in this area since 2021," Eric Gardner, WDFW’s Wildlife Program Director, said in a press release. "We detected this case because of the surveillance program, and we are immediately reviewing our Management Plan and the circumstances of this detection."WDFW said staff members are preparing to collect tissue samples from deer, elk, and moose within the initial response area to understand more about the outbreak, and that it's working with land owners, land management agencies, state and local governments, tribal partners, and sportspeople and conservation groups in the affected area in an attempt to reduce spread of the disease. ALL BRIEFS In case you missed it Previous Next Last patient discharged from treatment in Rwanda’s Marburg outbreak Mpox plateaus in a DR Congo hot spot, rises in other African nations Arkansas, Montana report CWD infections in deer, elk Africa CDC launches trial of smallpox drug for mpox CDC reports slight flu rise in children, first kid's flu death of season CDC tracks rise in pertussis activity Quick takes: Polio in 7 countries, lab monkey escape, pneumonic tularemia in Colorado Surveillance turns up 18 previously undetected cases of tick-borne Yezo virus in China This week's top reads Recent COVID-19 vaccination tied to lower risk of long COVID Overall, the risk of developing 28 out of 36 long-COVID symptoms lessened when vaccines were effective. Stephanie Soucheray California, Washington report more suspected H5 avian flu cases In related developments, the USDA reported more dairy cow and poultry outbreaks, as Los Angeles Country announced its first H5 wastewater detection. Lisa Schnirring Scientists track emergence of novel H5N1 flu reassortant in Cambodia Since a spillover in October 2023 the novel reassortment has replaced the older clade in Cambodia's poultry. Lisa Schnirring MIS-C much more common in kids not vaccinated against COVID-19, data reveal Among 12- to 17-year-olds, 90% of those with MIS-C were unvaccinated. Stephanie Soucheray CDC expands avian flu testing for farm workers, notes 7% infection rate in those exposed to infected cows The CDC now recommends testing and prophylactic Tamiflu use in asymptomatic workers exposed to sick animals. Lisa Schnirring Four cases of sexually transmitted fungal infection reported in New York The infections were caused by Trichophyton mentagrophytes type VII (TMVII), a sexually transmitted fungus that causes ringworm. Chris Dall Canada probes suspected avian flu infection in hospitalized teen The presumed positive infection comes amid a rise in poultry outbreaks in BC and US western states, likely triggered by wild bird migration. Lisa Schnirring Surveys reveal Americans' persistent mistrust in COVID vaccine science The greatest levels of trust were seen among men, those with university degrees and high median outcomes, and those who had lost someone to COVID-19. Mary Van Beusekom Trial shows safety of getting COVID, flu vaccines at same time Over half of participants (57%) reported a history of SARS-CoV-2 infection. Stephanie Soucheray Cases top 50,000 in Africa's mpox outbreak In other outbreak developments, medical groups announce a vaccine allocation plan and a vaccine trial to begin in pregnant women and in children younger than 2. Lisa Schnirring Our underwriters Unrestricted financial support provided by Principal Underwriter Leading Underwriter Major Underwriter Supporting Underwriter Become an Underwriter Help make CIDRAP's vital work possible Support Us Home Editorial policy Search news Contact Us CIDRAP - Center for Infectious Disease Research & Policy Research and Innovation Office, University of Minnesota, Minneapolis, MN Email us © 2024 Regents of the University of Minnesota. All rights Reserved. The University of Minnesota is an equal opportunity educator and employer Research and Innovation Office | Contact U of M | Privacy Policy Newsletter subscribe Get CIDRAP updates Choose newsletters Select all Daily Headlines Antimicrobial Stewardship Newsletter Chronic Wasting Disease Newsletter Flu Vaccine Roadmap Newsletter Resilient Drug Supply Newsletter Email Email Format html text News Topics & Projects Antimicrobial Resistance COVID-19 Chronic Wasting Disease Influenza Mpox All Topics A-Z Resilient Drug Supply Influenza Vaccines Roadmap CIDRAP Leadership Forum Roadmap Development Coronavirus Vaccines Roadmap . . Podcasts Antimicrobial Stewardship Chronic Wasting Disease Osterholm Update Newsletters About About CIDRAP CIDRAP in the News Our Staff Our Director Osterholm in the Press Shop Merchandise Contact Us DonateNew initiative launched by WHO to develop mRNA bird flu vaccines - ABC News ABC NewsVideoLiveShowsElections538ShopStream onLive resultsUpdated: Nov. 12, 12:07 AM ETNational Election Results: presidential Projection: Trump is President-elect226312226312Harris71,781,346270 to winTrump74,987,170Expected vote reporting: 95%Recent ProjectionsAriz. Dist. 1Projected WinnerDavid Schweikert•R2 hours agoAriz.SenateProjected WinnerRuben Gallego•D2 hours agoNational Election Results: house206215206215Dem.214 up for electionLost: 1218 for controlestimateRep.221 up for electionGained: 1Undecided races of the 2024 election: Live results and analysisLive resultsUpdated: Nov. 12, 12:18 AM ET12:15 AMDemocrats projected to win Arizona’s Senate seat4:53 PMRep. Stefanik’s U.N. appointment to trigger special election in New YorkNew initiative launched by WHO to develop mRNA bird flu vaccinesThe initiative is being led by Argentinian manufacturer Sinergium Biotech.ByMary KekatosJuly 29, 2024, 7:20 PM5:01Yellow and red particles of avian influenza A H5N1 virus particles.CDC & NIAIDThe World Health Organization announced Monday that it has launched an initiative to help accelerate the development of a human bird flu vaccine using messenger RNA (mRNA) technology.The project, which will be led by Argentinian pharmaceutical company Sinergium Biotech, will aim to identify vaccine candidates for manufacturers in low- and middle-income countries, the WHO said.The Centers for Disease Control and Prevention (CDC) has previously said the risk of bird flu, also known as avian influenza, to the general public is low and there is currently no evidence of human-to-human transmission. Federal health officials have also prepared millions of vials of an available non-mRNA bird flu vaccine as a precautionary measure, just in case it becomes necessary.MORE: 4th human case of bird flu linked to dairy cow outbreak: CDCmRNA technology is the same type that was used in the development of COVID vaccines. Most vaccines use a weakened or inactive virus to stimulate an immune response, but mRNA vaccines teach the body how to make proteins that can trigger an immune response and fight off an infection.Researchers can often design mRNA vaccines more quickly than they can produce the live or weakened pathogens needed for a traditional vaccine.Yellow and red particles of avian influenza A H5N1 virus particles.CDC & NIAIDThe initiative is part of the WHO's mRNA Technology Transfer Program, which has a goal of building capacity in low- and middle-income countries to produce mRNA vaccines.Sinergium Biotech has already developed candidates for H5N1 vaccines, according to the WHO. The company is looking to perform proof-of-concept studies, in which researchers decide whether to continue studying the product based on its efficacy.If the proof-of-concept study is successful, Sinergium said it plans to share the "technology, materials and expertise" with other manufacturing partners so they can develop the vaccine themselves."This initiative exemplifies why WHO established the mRNA Technology Transfer Programme -- to foster greater research, development and production in low- and middle-income countries, so that when the next pandemic arrives, the world will be better prepared to mount a more effective and more equitable response," WHO Director-General Dr. Tedros Adhanom Ghebreyesus said in a statement.The WHO says that avian influenza viruses are a "significant public health risk" because they spread widely in animals and have the potential to cause a future pandemic. However, the global health agency indicated that its preparedness efforts are an example of being proactive, rather than reactive, by increasing access to vaccines.MORE: CDC preparing for 'possibility of increased risk to human health' from bird fluIn the United States, there have been 13 human cases of bird flu since April of this year, according to an update last week from the CDC. All the human patients either came into contact with sick dairy cows or infected poultry, according to the CDC.The U.S. government has also awarded Moderna $176 million to develop and test an mRNA vaccine that could be used for bird flu, Reuters reported in early July.Related TopicsBird FluPopular ReadsTrump's plan for education in his second termNov 11, 4:56 PMSotomayor has no plans to resign: SourcesNov 10, 4:27 PMArrest in fatal shooting at Tuskegee UniversityNov 10, 6:35 PMMissing American tourist in Hungary killed: PoliceNov 9, 1:36 PM538's final forecasts for the 2024 electionNov 5, 7:49 AMABC News Live24/7 coverage of breaking news and live eventsABC News NetworkAbout Nielsen MeasurementChildren's Online Privacy PolicyContact UsDo Not Sell or Share My Personal InformationInterest-Based AdsPrivacy PolicyTerms of UseYour US State Privacy Rights © 2024 ABC NewsFlu shots for farm workers latest CDC initiative on bird flu outbreak Skip to Main Content Election 2024 FDA Congress Newsletters Log In My Account Subscribe Now My Account Settings Billing Log Out Reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now BiotechPharmaPublic HealthHealth TechPolicyScienceFirst OpinionSTAT+STAT Events Search Log In Try STAT+ My Account Home News Latest Business Biotech Pharma Health Tech Health Insurance Hospitals Medical Devices Washington Policy FDA CDC NIH Science CRISPR Gene Therapy Research Neuroscience Public Health H5N1 Bird Flu Addiction Covid-19 Abortion Health Disparities Infectious Disease Mental Health Disease Cancer Cardiovascular Disease Chronic Disease Diabetes Alzheimer's Obesity Features Coercive Care The Obesity Revolution The War on Recovery Newsletters Opinion Columns Adam Feuerstein Matthew Herper Ed Silverman Reports E-books Podcasts Tools & Trackers CRISPR Tracker Breakthrough Device Tracker Generative AI Tracker Obesity Drug Tracker Events Upcoming Events Summits 2025 Breakthrough East 2025 Breakthrough West Community STAT Wunderkinds '24 STAT Madness Video Advertise STAT Brand Studio Don't miss out Subscribe to STAT+ today, for the best life sciences journalism in the industry Learn more HealthCDC will offer seasonal flu shots to farmworkers to lower bird flu risk By Helen Branswell July 30, 2024 Reprints Cows at a dairy in California. Rich Pedroncelli/AP The Centers for Disease Control and Prevention announced Tuesday that it is funding a $5 million program to vaccinate livestock industry workers against seasonal flu in a bid to reduce the pandemic risk posed by the ongoing H5N1 bird flu outbreak in cattle. The voluntary program, which will be administered by state and local public health workers, is aimed at getting seasonal flu shots into as many people as possible who are working in proximity to animals — poultry, cows, or other livestock — that could be infected with H5N1. Nirav Shah, the CDC’s principal deputy director, said there are an estimated 200,000 people officially working in this sector nationwide, though he acknowledged that number doesn’t encompass all people working with these animals.advertisement H5N1 could evolve to become a pandemic flu strain one of two ways, by gradually acquiring mutations that give it the ability to easily infect and spread among people, or by swapping genetic material with other flu viruses, such as H3N2 or H1N1, the influenza A viruses that circulate and cause illness during the flu season. That gene swapping, a process called reassortment, can occur when an animal or a person is infected at the same time with two or more flu A viruses. The rationale for the CDC program is to lower the risk that farmworkers will be infected with human flu strains during the coming flu season and, if they go to work sick, transmit human flu viruses to cows or other mammals already infected with H5N1, or themselves become co-infected with the bird flu virus. Newsletters Sign up for Morning Rounds Understand how science, health policy, and medicine shape the world every day Please enter a valid email address. Privacy Policy “In theory, reassortment could lead to a new influenza virus that could pose a significant public health concern. A virus that has the transmissibility of seasonal influenza and the severity of H5N1,” Shah, the CDC’s principal deputy director, said during a press conference featuring the CDC and officials of the U.S. Department of Agriculture. “We want to do everything we can to reduce the risk that the virus may change because of co-infection and reassortment.”advertisement For the time being, though, “everything” stops short of offering these same workers H5N1 vaccine from the U.S. National Pre-pandemic Influenza Vaccine Stockpile. Finland is vaccinating mink farm workers against H5N1, which has caused outbreaks in these animals. But the U.S. government has said at this point it doesn’t see a value in following suit. “Given the low rates of [human H5N1] infection overall, the mild symptoms, the lack of person-to-person [transmission], I don’t think the question is: Why not do it? I think the question is: Why do it?” Shah said. Related: Could cow vaccines help halt the spread of bird flu in U.S. herds? Experts are divided Shah said there are ongoing discussions among U.S. officials about whether to offer H5N1 vaccine to farmworkers, but “for right now, the seasonal flu shot is the right tool for the job.” The CDC will spend up to $2 million on the flu shots, with the remaining $3 million going to finance on-the-ground efforts to get the vaccine to farmworkers, Shah said. Implementation will look different from location to location, he noted, and may involve bringing vaccine doses to farms, or setting up vaccination booths at public events that are frequented by farmworkers. Since the outbreak of bird flu in cows was first recognized in late March, 13 workers have been diagnosed with H5N1. All the cases to date have been mild. Four of the cases were farmworkers infected while working with dairy cattle; the other nine were people who were infected while culling chickens when the virus from cows spilled over into two large poultry operations in Colorado. Related: USDA maintains bird flu can be eliminated from dairy cows, even as doubts mount among experts Since the outbreak was first recognized, the USDA has confirmed infections in 172 herds in 13 states. Eric Deeble, USDA’s point person for H5N1 in dairy cows, said the department continues to believe the outbreak can be contained. “Given that we have seen a real increase in awareness of producers and an increase in biosecurity, we believe that we can arrest the spread of this disease and ultimately eradicate it in dairy cattle on the farms,” he said. Another USDA official, Michael Pruitt, indicated that the department has been studying viruses from the outbreak on an ongoing basis and is not seeing evidence that the virus has been evolving in cows, calling it “very stable up to this point.” About the Author Reprints Helen Branswell Senior Writer, Infectious Diseases Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. @HelenBranswell linkedin.com/in/helen-branswell-22ab936/ Tags H5N1 Bird Flu infectious disease public health To submit a correction request, please visit our Contact Us page. Trending Compounding group sues FDA for removing Lilly’s obesity drug… Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list White House should declare national emergency over IV fluid… White House should declare national emergency over IV fluid shortages caused by Helene, says hospital group With boost from RFK Jr. and Tucker Carlson, two… With boost from RFK Jr. and Tucker Carlson, two chronic disease entrepreneurs vault into Trump’s orbit Recommended A STAT Investigation: Pain, loss, and coercive care A STAT Investigation: Pain, loss, and coercive care Cardiovascular health disparities persist in puzzling ways, studies find Cardiovascular health disparities persist in puzzling ways, studies find What the Trump administration could mean for the health… What the Trump administration could mean for the health care industry, from hospitals to pharma Recommended Stories Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more Biotech Elaine Chen STAT Plus: Schizophrenia drug AbbVie picked up in $9 billion acquisition fails in key trials advertisement Who to Know Isabella Cueto STAT Plus: ‘MAHA’ is moving into Trump’s White House. Here’s who RFK Jr. could bring along for the ride Politics Lizzy Lawrence STAT Plus: What letting RFK Jr. ‘go wild’ might mean for Trump’s FDA Matt's Take Matthew Herper STAT Plus: How will Trump’s election change the FDA? History yields some clues Reporting from the frontiers of health and medicine Back to top Company About Our Team Contact Us Careers Diversity & Inclusion Our Awards Advertise With Us STAT Brand Studio Supporters Licensing Stories Account STAT+ Group Subscriptions FAQ My Account Log In Subscribe More Events Newsletters Reports App Podcasts Community Privacy Comment Policy Terms Do Not Sell My Data ©2024 STATU.S. will buy regular flu shots for farmworkers to prevent bird flu from getting more dangerous | PBS News Full Episode Monday, Nov 11 Close Menu PBS NewsHour Episodes Podcasts Newsletters The Latest Politics Brooks and Capehart Politics Monday Supreme Court Arts CANVAS Poetry Now Read This Nation Supreme Court Race Matters Essays Brief But Spectacular World Agents for Change Economy Making Sen$e Paul Solman Science The Leading Edge ScienceScope Basic Research Innovation and Invention Health Long-Term Care Education Teachers' Lounge Student Reporting Labs For Teachers Newshour Classroom NewsHour Shop About Feedback Funders Support Jobs Close Menu Give to PBS News Hour now while all gifts are MATCHED! Double your support for intelligent, in-depth, trustworthy journalism. Donate now Close Popup PBS News Menu Notifications Get news alerts from PBS News Turn on desktop notifications? Yes Not now Full Episodes Podcasts Newsletters Live By — Mike Stobbe, Associated Press Mike Stobbe, Associated Press Leave your feedback Share Copy URL https://www.pbs.orgewshour/health/u-s-will-buy-regular-flu-shots-for-farmworkers-to-prevent-bird-flu-from-getting-more-dangerous Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter U.S. will buy regular flu shots for farmworkers to prevent bird flu from getting more dangerous Health Jul 30, 2024 4:57 PM EST NEW YORK (AP) — The U.S. will pay for flu shots for farmworkers this year, a strategy to prevent bird flu from changing into something more dangerous. Dairy and poultry farms are dealing with outbreaks of bird flu, and 13 workers have picked up infections. All cases are mild and are believed to have spread directly from infected animals to people. But health officials are worried about what might happen if people are infected with bird flu and seasonal flu at the same time. It’s possible the viruses could swap gene segments, in a process that scientists call reassortment. Bird flu, for example, could gain the ability to spread as easily among people as seasonal flu does. To prevent coinfections, the Centers for Disease Control and Prevention on Tuesday said it will spend $5 million to buy seasonal flu shots and get livestock workers vaccinated this fall, working with state and local officials. Another $5 million will be spent to promote the shots. “We want to do everything we can to reduce the risk that the virus may change,” said the CDC’s Dr. Nirav Shah. Seasonal flu shots do not protect against bird flu. But they might reduce coinfections, he said. The CDC is also discussing the possibility of offering some farmworkers the antiviral medication Tamiflu to prevent getting the flu, Shah said. U.S. officials say there are at least 200,000 livestock workers in the country. According to the National Center for Farmworker Health, about a quarter of livestock workers typically get a seasonal flu shot. Production of a limited amount of bird flu vaccine for people is underway, but the government is not recommending it for farmworkers. There isn’t the kind of person-to-person spread that would trigger that kind of vaccination campaign, Shah said. A bird flu virus has been spreading since 2020 among mammals — including dogs, cats, skunks, bears and even seals and porpoises — in scores of countries. Earlier this year, the virus known as H5N1 was detected in U.S. livestock. AP health writer JoNel Aleccia contributed to this report. Left: A warning sign is placed at a dairy farm in Martin, Michigan, on June 6, 2024. Photo by Tom Polansek/ Ruters Related Colorado dairy worker infected with bird flu in 4th human case linked to U.S. outbreak By JoNel Aleccia, Associated Press U.S. government will pay Moderna $176 million to develop an mRNA bird flu pandemic vaccine By Associated Press Why is bird flu highly lethal to some animals, but not others? Scientists are trying to find out By Mike Stobbe, Associated Press Bird flu outbreak at dairy farms continue to raise concerns about virus spreading By William Brangham, Jackson Hudgins Michigan reports another person working with cows got bird flu, the third U.S. case this year By Mike Stobbe, JoNel Aleccia, Associated Press How bird flu puts workers on farms and in food processing plants at higher risk By Laura Santhanam Raw milk sales spike despite CDC’s warnings of risk associated with bird flu By JoNel Aleccia, Associated Press U.S. pledges money and other aid to help track and contain bird flu on dairy farms By JoNel Aleccia, Mike Stobbe, Associated Press Bird flu has spread to more farm animals. Here’s what to know about food safety By JoNel Aleccia, Associated Press Largest U.S. fresh egg producer detects bird flu in chickens, halts production By Ken Miller, Associated Press Go Deeper agriculture bird flu farming farmworkers influenza By — Mike Stobbe, Associated Press Mike Stobbe, Associated Press Support Provided By: Learn more Support PBS News: Educate your inbox Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else. Enter your email address Subscribe Form error message goes here. Thank you. Please check your inbox to confirm. Full Episode Monday, Nov 11 PBS News © 1996 - 2024 NewsHour Productions LLC. All Rights Reserved. PBS is a 501(c)(3) not-for-profit organization. Sections The Latest Politics Arts Nation World Economy Science Health Education About About Us TV Schedule Press Feedback Funders Support Newsletters Podcasts Jobs Privacy Terms of Use Stay Connected Facebook YouTube Instagram X TikTok Threads RSS Subscribe to Here's the Deal with Lisa Desjardins Enter your email address Subscribe Form error message goes here. Thank you. Please check your inbox to confirm. Support our journalism Learn more about Friends of the News Hour. Support for News Hour Provided ByAvian Flu Could Pose Significant Threat to Georgia’s Poultry Farms | News Center Skip to main navigation Skip to main content MENU News Center Main navigation Calendar Categories Business and Economic Development Campus and Community Earth and Environment Health and Medicine Science and Technology Society and Culture Daily Digest Whistle Whistle Whistle archives Features Features Features Archive Subscribe and Follow Media-Ready Experts Contact Us Search Search Breadcrumb Home Avian Flu Could Pose Significant Threat to Georgia’s Poultry Farms Georgia Tech expert Wendy White warns of contagion risk in the poultry industry Aug 01, 2024 The recent outbreak of the highly pathogenic avian influenza (HPAI H5N1) virus has raised concerns among poultry producers and food safety experts. The virus is highly contagious among birds and poses a significant risk despite stringent biosecurity measures, according to Georgia Tech food safety and agriculture expert Wendy White. “In states that are a major poultry producer, like Georgia, backyard flocks are also extremely common, and we've seen outbreaks spread from the home to larger commercial flocks in this manner,” said White. She emphasized that while the Centers for Disease Control and Prevention (CDC) has categorized the risk of HPAI H5N1 to the human population as low, it remains crucial for poultry farms to implement critical biosecurity practices. These include restricting access of flocks to wild birds by confining them to chicken houses and covered coops, limiting visitors, and implementing strict hygiene protocols for employees and equipment. “American poultry farms have already implemented several of the CDC-recommended biosecurity measures to stop and prevent the spread of aviation influenza,” White said. “Visiting commercial chicken houses is often more involved than visiting someone in the ICU. Visitors and employees are required to don personal protective equipment, such as boots and jumpsuits, that are dedicated to that farm.” Regarding Georgia’s preparedness to handle a significant H5N1 outbreak, White expressed confidence but acknowledged the need for ongoing vigilance and improvements. “Georgia is among the top five chicken producers in the country and home to a diverse population of wild birds, so there is a significant risk that sporadic cases of highly pathogenic avian influenza could spread and cause a major outbreak,” White stated. “Federal and state agencies, and Georgia poultry producers are working closely together to identify any cases and take swift action to stop the spread of any aviation influenza.” With such collaborative efforts, White added, Georgia aims to maintain rigorous measures to protect its poultry industry and ensure public safety. Advancements in food processing and handling also play a vital role in mitigating the risks of HPAI H5N1 contamination in the poultry supply chain. “The USDA has stated that poultry, eggs, and other foods that are properly prepared and cooked are safe to eat,” White noted. “Laboratory studies have shown that normal cooking practices for meat and eggs, and pasteurization for dairy products, are sufficient to kill this virus.” Surveillance is also key in managing HPAI H5N1 outbreaks. USDA inspectors carefully monitor animal health on farms and regularly test food products to ensure a safe food supply. “Advancements in testing have enabled food companies to run more tests, and whole genome sequencing allows epidemiologists to link animal and human cases to control outbreaks quicker,” White explained. White also added that regulatory policies and guidelines are essential for controlling the spread of HPAI H5N1 in the poultry industry. Both the USDA and poultry companies conduct vigilant inspections and testing to quickly identify and mitigate sources of the virus. Few cases among humans have been reported elsewhere, underscoring the importance of ongoing vigilance. “The USDA is also conducting surveillance testing on wild birds to understand and prevent the spread of aviation influenza through migratory birds,” White said. Contact Siobhan RodriguezInstitute Communications Email sar30@gatech.edu Resources Georgia Tech Resources Offices and Departments News Center Campus Calendar Special Events GreenBuzz Institute Communications Visitor Resources Campus Visits Directions to Campus Visitor Parking Information GT visitor Wireless Network Information Georgia Tech Global Learning Center Georgia Tech Hotel and Conference Center Barnes and Noble at Georgia Tech Ferst Center for the Arts Robert C. Williams Paper Museum Colleges, Instructional Sites and Research Colleges College of Computing College of Design College of Engineering College of Lifetime Learning College of Sciences Ivan Allen College of Liberal Arts Scheller College of Business Instructional Sites Georgia Tech-Europe Georgia Tech-Shenzhen Georgia Tech Online Professional Education The Language Institute Global Footprint Global Engagement Research Georgia Tech Research Institute Research at Georgia Tech Executive Vice President for Research Student and Parent Resources Student Resources Apply BuzzPort Buzzcard Career Center Commencement Graduate and Postdoctoral Education Undergraduate Education Library Student Life Student Entrepreneurship Education Abroad Canvas Parent Resources Parent and Family Programs Division of Student Life Scholarships and Financial Aid Employee, Alumni, and Other Resources Employees Administration and Finance Advising and Teaching Faculty Affairs Faculty Hiring Postdoctoral Services Human Resources Staff Council TechWorks Alumni and Foundation Alumni Association Alumni Career Services Foundation Giving Back to Tech Outreach Startup Companies Economic Development Industry Engagement Institute Relations Professional Education Georgia Institute of Technology North AvenueAtlanta, GA 30332 +1 404.894.2000 Campus Map General Directory Employment Emergency Information Legal Equal Opportunity, Nondiscrimination, and Anti-Harassment Policy Legal & Privacy Information Human Trafficking Notice Title IX/Sexual Misconduct Hazing Public Disclosures Accessibility Accountability Accreditation Report Free Speech and Censorship Concern © 2024 Georgia Institute of Technology GT LOGINInfluenza Viruses May Have an Alternate Route Into Cells | Microbiology toggle navigation Loading... Loading... LEADERBOARD Login here Register Free LOGIN REGISTER FREE Home Virtual Events Upcoming On-Demand Companies Posters Categories See More See More See More See More Health & Medicine Clinical & Molecular DX Immunology Cardiology Cancer Cell & Molecular Biology Genetics & Genomics Microbiology Neuroscience Plants & Animals Earth & The Environment Chemistry & Physics Technology Cannabis Sciences Drug Discovery & Development Webinars Upcoming On-Demand Categories See More See More Health & Medicine Clinical & Molecular DX Immunology Cardiology Cancer Cell & Molecular Biology Genetics & Genomics Microbiology Neuroscience Plants & Animals Earth & The Environment Chemistry & Physics Technology Cannabis Sciences Drug Discovery & Development Trending News Most Recent What's Hot Categories Multimedia See More See More Health & Medicine Clinical & Molecular DX Immunology Cardiology Cancer Cell & Molecular Biology Genetics & Genomics Microbiology Neuroscience Drug Discovery & Development Plants & Animals Cannabis Sciences Earth & The Environment Space & Astronomy Chemistry & Physics Technology Sponsored Content Infographics Videos eBooks See More Scientific Products Categories Companies New Popular Antibodies Immunity, Immunoassay, Immunotherapy Assay Kits Detection, Quantification Biomolecules Proteins Cell Biology Cell function Cell-Based Assays Cell viability Cell/Tissue Culture Cell lines, Cell growth, Cell differentiation Chemicals and Reagents Reagent kits, Laboratory chemicals Drug Discovery and Development Target identification, High-throughput screening Flow Cytometry Immunophenotyping, Cell cycle analysis Genomics Genome sequencing, Transcriptomics Imaging (Bio-Imaging / Microscopy) Fluorescence imaging Lab Automation High-throughput screening, Robotics, Liquid handling systems Lab Equipment Incubators Life Sciences Biological research, Biotechnology Molecular Biology DNA replication, Gene expression, PCR Next Gen Sequencing DNA sequencing, High-throughput sequencing, NGS platforms Quality Control and Validation QC standards, Quality assurance Single Cell Analysis Transcriptomics Technology Biotechnology, Instrumentation, Data analysis See More See More See More Companies See More Science Store Men's T-Shirts Women's T-Shirts Accessories Gift Cards Gift Card Balance See More See More See More Gift Card $25 Gift Card $50 Gift Card $75 Gift Card $100 See More Labroots Store Gift Card Balance Check Balance $0.00 Balance Gift Card Number: No gift card matches the entered value. Continuing Education More Virtual Events All Virtual Events Upcoming On-Demand Posters Companies Health & Medicine Clinical & Molecular DX Immunology Cardiology Cancer Cell & Molecular Biology Genetics & Genomics Microbiology Neuroscience Plants & Animals Earth & The Environment Chemistry & Physics Technology Cannabis Sciences Drug Discovery & Development Webinars All Webinars Upcoming On-Demand Health & Medicine Clinical & Molecular DX Immunology Cardiology Cancer Cell & Molecular Biology Genetics & Genomics Microbiology Neuroscience Plants & Animals Earth & The Environment Chemistry & Physics Technology Cannabis Sciences Drug Discovery & Development Trending News Most Recent What's Hot Health & Medicine Clinical & Molecular DX Immunology Cardiology Cancer Cell & Molecular Biology Genetics & Genomics Microbiology Neuroscience Drug Discovery & Development Plants & Animals Cannabis Sciences Earth & The Environment Space & Astronomy Chemistry & Physics Technology Multimedia Sponsored Content Infographics Videos eBooks Scientific Products Companies Science Store Men's T-Shirts Women's T-Shirts Accessories Gift Cards Gift Card Balance Continuing Education Company About Us The Team Careers Press Room Social Media Press Releases Editorial & Writing Team Blog Scholarships RSS Contact Us Continuing Education Leaderboard Advertise Media Kit Custom Virtual Events Virtual Event Series Hybrid Events Digital Advertising Webinars Rate Card Editorial Calendar Posters Case Studies Testimonials Request Demo Forms Audience Selection Form Social Media Preference Forms Custom Virtual Event Email Form Sponsored Content Selection Form Legal Terms and Conditions Privacy Policy Order Policy Shipping Policy Copyrights User Agreement User Data Request Support Company About Us The Team Careers Press Room Social Media Press Releases Editorial & Writing Team Media Partnerships Blog Scholarships Continuing Education Leaderboard Contact Us Advertise Media Kit Custom Virtual Events Virtual Event Series Hybrid Events Digital Advertising Webinars Rate Card Editorial Calendar Posters Case Studies Testimonials Request Demo Forms Audience Selection Form Social Media Preference Forms Custom Virtual Event Email Form Sponsored Content Selection Form Legal Terms and Conditions Privacy Policy Order Policy Shipping Policy Copyrights User Agreement User Data Request Learn More Custom virtual eventsuccess stories,view Labroots' Case Studies Learn More Win a gift card to theLabroots' Store! Learn More Register for the nextLabroots' Virtual Event, Clinical Diagnostics & Research Virtual Event Series 2024 Learn More Call for Posters!Submit a poster to any Labroots event Have questions? Visit our Support pages Login here Register Free Trending / Microbiology / Influenza Viruses May Have an Alternate Route Into Cells JUL 29, 2024 8:08 AM PDT Share Influenza Viruses May Have an Alternate Route Into Cells WRITTEN BY: Carmen Leitch 3 H5N1 avian influenza is highly pathogenic and has been devastating bird populations worldwide. It continues to do so, and is also moving into new animals, like skunks, bears, raccoons, cats, and dairy cows. Since impacting agriculture, the virus has also infected a number of exposed agricultural workers. Poultry and dairy workers in the US have recently reported infections. There have also been H5N1 cases in several other countries including Vietnam and Australia. Other strains of avian influenza have also recently sickened people, like H5N2 in Mexico and H9N2 in Vietnam and China. The severity of these cases has ranged widely. In recent months, some experts have not been particularly concerned about the threat this virus might pose to humans, because the avian flu uses a pathway into cells that can't be used in humans. It's been thought that the infection mechanism would have to do change dramatically and significantly before it could begin to affect many people. But those changes are not impossible. And as more and more animals have become infected, more experts are beginning to sound the alarm - they are concerned that if we don't stop the virus now in animals, it will affect us in unpredictable ways in the future. Now a new report has shown that while influenza viruses use well known and characterized pathways to infect cells, some viruses can find another way in. Reporting in Nature Microbiology, researchers have idenitified a novel infection mechanism in which the flu virus uses a human immune protein complex to get inside of cells. This approach can help the virus infect new species, and potentially, humans. Flu viruses usually use envelope proteins that surround the virus to enter cells; these proteins erupt from the flu's structure like spikes. A viral protein called hemagglutinin binds to a molecule called sialic acid on the surface of animal and human cells to infect them. But hemagglutinin can also bind to protein complexes on some human immune and respiratory cells called MHC class II complexes. These usually help the body tell the difference between foreign cells and cell of the self. But the virus can use this as an alternate pathway into cells. "We found that MHC class II complexes in humans, pigs, ducks, swans and chickens allow viruses to enter cells, but not those in bats," said senior study author Professor Silke Stertz of the Institute of Medical Virology at the University of Zurich (UZH). Related: Evidence Emerges that Avian Flu is Transmitting From One Mammal to Another In cells grown in culture, the virus was able to infect cells in both the usual way, and through MHC class II complexes. The structural compatibility between the virus and cell surface structures can have a critical influence on which species are ultimately infected, including humans, and how severe the infections become. "Our finding shows that influenza viruses can adapt to use different entry pathways. This might influence their ability to infect different species and potentially jump between animals and humans," noted Stertz. The threat of a human flu pandemic may be greater than appreciated. Sources: University of Zurich, Nature Microbiology Share About the Author Carmen Leitch Bachelor's (BA/BS/Other) Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling. You May Also Like JUL 12, 2024 Technology AI Model Estimates Lung Function from Chest X-Rays How can artificial intelligence (AI) contribute to the healthcare industry? This is what a recent study published in The ... Written By: Laurence Tognetti, MSc 4 JUL 25, 2024 Genetics & Genomics A New Method to Decipher the Secrets of the Gut Microbiome There are around a trillion microbes in the human gastrointestinal system. This community of microbes, known as the gut ... Written By: Carmen Leitch 4 JUL 26, 2024 Space & Astronomy Importance of Understanding Microgravity's Impact on Muscles How can microgravity influence muscle regeneration and overall muscle loss in astronauts? This is what a recent study pu ... Written By: Laurence Tognetti, MSc 3 SEP 10, 2024 Microbiology Scientists Explore the Microbiomes of Foods Microorganisms are everywhere, even inside of our guts. The microbes we interact with can sometimes have a huge influenc ... Written By: Carmen Leitch 4 SEP 19, 2024 Health & Medicine Lab-Generated Antibodies Prevent Antimicrobial Resistance Our immune systems generate antibodies that neutralize and help eliminate foreign pathogens. These antibodies or protein ... Written By: Brian G. Morreale 3 OCT 01, 2024 Microbiology Marburg Outbreak in Rwanda Causes 8 Deaths In recent weeks, 27 cases of Marburg disease have been reported in the Republic of Rwanda, and nine patients have now di ... Written By: Carmen Leitch 3 Loading Comments... Content Tags Molecular Biology Major Histocompatibility Complex (MHC) Immunology Zoonotic Disease Zoonosis Virus Virology Research Public Health Protein Biochemistry Protein Binding Molecular Pathology Molecular Microbiology Animals Medicine Influenza Infectious Disease Infection Health Cellular Pathology Cellular Mechanism Cell Surface Receptors Cell Culture Cell Biology Biochemistry Avian See more See less Multimedia Sponsored Content Infographics Videos eBooks Neuroscience Alcohol Use Worsens Symptoms of Bipolar Disorder Cell & Molecular Biology Scientists Reveal How Gluten Can Damage the Intestine in Celiac Let's Talk Science. Let's Talk Medicine. The leading scientific social networking website and producer of educational virtual events and webinars. About Us The Team Contact Us Careers Media Kit Virtual Events Posters Multimedia Blog Press Room Science Store Gift Card Balance Continuing Education Scholarships Leaderboard Order Policy Shipping Policy Privacy Policy Terms and Conditions User Agreement User Data Request Copyrights Support Chati © 2008-2024 Labroots Inc. Opens in a new window Opens an external site Opens an external site in a new window × Modal titleMaternal immune response to flu linked to fetal brain changes Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About COVID-19 News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge Newsletters Health & Personal Care eBooks Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Cold, Flu & Cough Eating Disorders Eye Health Gastrointestinal Health Heart Disease High Blood Pressure Lung Cancer Mental Health Mpox Pregnancy Type 1 Diabetes Type 2 Diabetes Sexual Health Sleep View Health A-Z ×Top Health Categories Coronavirus Disease COVID-19 Heart Disease Diet & Nutrition High Blood Pressure Artificial Intelligence Lung Cancer Allergies Mental Health Alzheimer's & Dementia Mpox Arthritis & Rheumatology Pregnancy Breast Cancer Type 1 Diabetes Cold, Flu & Cough Type 2 Diabetes Eating Disorders Sexual Health Eye Health Sleep Gastrointestinal Health View Health A-Z Medical Home Life Sciences Home About News Life Sciences A-Z White Papers Lab Equipment Interviews Newsletters Webinars More... eBooks Contact Meet the Team Advertise Search Become a Member White Papers MediKnowledge Newsletters Health & Personal Care eBooks Contact Meet the Team Advertise Search Become a Member Webinars eBooks Contact Meet the Team Advertise Search Become a Member Maternal immune response to flu linked to fetal brain changes Download PDF Copy Reviewed University of Illinois College of Agricultural, Consumer and Environmental SciencesJul 29 2024 A bad case of the flu during pregnancy can increase the risk for fetal neurodevelopmental disorders such as schizophrenia and autism spectrum disorder. But it's not the virus itself doing the damage; it's the mother's immune response. New University of Illinois Urbana-Champaign research using live mouse-adapted influenza virus improves upon previous mouse experiments to explain the process on a cellular and molecular level. It also indicates fetal brain changes are more likely once the severity of the mother's infection meets a specific threshold. Our data provide really compelling evidence for an infection severity threshold, which mimics what we see in humans. There are only a subset of maternal infections that are going to be severe enough to cause concerns like this. That said, pregnant people should definitely get the flu vaccine to reduce their risk." Adrienne Antonson, senior study author, assistant professor in the Department of Animal Sciences, College of Agricultural, Consumer and Environmental Sciences at Illinois The study is one of only a handful to investigate maternal infection in mice using live influenza virus at doses that replicate seasonal flu outbreaks in humans. "That means our results are more relevant to human pathological infection," said lead study author Ashley Otero, a doctoral student in the Neuroscience Program at Illinois. Antonson's team infected pregnant mice with live influenza A virus, rather than a viral mimic -; an inert molecule that mimics viral behavior -; used by most research groups in recent decades. The viral mimic elicits the innate immune response, broadly categorized as non-specific inflammation, that occurs within 24 to 48 hours of infection. These studies have provided important clues about which inflammatory proteins are made by the mother and how they interact with the fetal brain. But Otero says viral mimics may prompt slightly different immune responses than the live virus in both mother and fetus, and they fail to capture what happens during the mother's adaptive immune response, which occurs later and helps an animal "remember" past infections. To address these issues, the team subjected the mice to one of two doses of the virus -; representing a moderate or severe infection -; at the moment in gestation closest to the end of the first trimester in humans. Then, at two and seven days post-infection, they tracked how the infection progressed in the lungs and intestines of the mother, as well as how products from the mother's immune response interacted with the fetal brain. They also measured the physical properties of fetal brains, including the thickness of the cortex, which has been linked to neurodevelopmental disorders in humans. Several important viral mimic studies in mice have implicated an immune protein called interleukin-17 -; primarily manufactured by T helper (Th)-17 cells in the mother's intestinal tract -; in changes to the fetal brain and neurodevelopmental disorder-like behaviors after birth. But the live virus didn't activate that protein. Related StoriesUsing a molecular testing technology for faster and comprehensive diagnosis of brain tumorsBrain cells form multiple coordinate systems to guide behavioral actionsPolyphenol-rich Mediterranean diets could help keep the brain younger"At first, when I saw that interleukin-17 was not elevated in our moms from influenza infection, I was convinced we wouldn't see any changes in the developing fetal brain," Otero said. "But interestingly, we did see very similar responses in the developing neocortex, including dramatic reductions in the upper neuronal layers in fetuses from moms who had the higher-dose infection." Otero further explains that postmortem human studies have documented smaller cortical structures in people with schizophrenia and autism spectrum disorder. "So, our results were really in line with what we see in human brains." Antonson added, "We don't think it's ever going to be just one inflammatory molecule that's causing all these different things. But this is the first time this pathway has been thoroughly investigated and compared against models that, thus far, have demonstrated that interleukin-17 is really involved. That's why it's important to move beyond viral mimic models to the true live virus." Having ruled out interleukin-17, at least at the time points they studied, the team tracked immune cells in the fetal brain. Microglia, which infiltrate the brain and interact with developing neurons, had signatures of increased inflammatory activity in fetuses from high-dose flu-infected mothers. Fetal border-associated macrophages (BAMs), which border the brain's surfaces and provide constant immune surveillance, were also more active and abundant. Both cell types normally aid in healthy brain development, but Otero and Antonson think that when they're spurred into an overactive state, they could attack instead of support healthy developing neurons. Viral mimic studies have also implicated overactive microglia in causing fetal brain deformities, but BAM activity is vastly understudied. Otero plans to follow up with more research to understand the role of BAMs in prenatal influenza infection. Antonson emphasizes that maternal infection is only one of many risk factors for neurodevelopmental disorders. "These disorders are caused by a multitude of elements, including environmental factors, genetics, pharmacological exposures, and more. We're focusing on just this in-utero period, but the early postnatal period is important, and adolescence is important. It's just one slice of a very complicated pie." Source:University of Illinois College of Agricultural, Consumer and Environmental SciencesJournal reference:Otero, A. M., et al. (2024). Influenza A virus during pregnancy disrupts maternal intestinal immunity and fetal cortical development in a dose- and time-dependent manner. Molecular Psychiatry. doi.org/10.1038/s41380-024-02648-9. Posted in: Child Health News | Medical Research News | Women's Health News | Disease/Infection News Tags: Autism, Brain, Cell, Cortex, Flu, Genetics, Genomic, Immune Response, immunity, Inflammation, Influenza, Interleukin, Lungs, Microglia, Molecule, Neocortex, Neurons, Neuroscience, Pregnancy, Prenatal, Protein, Psychiatry, Research, Schizophrenia, Vaccine, Virus Comments (0) Download PDF Copy Suggested Reading Disruptions in liver and brain clocks contribute to unhealthy eating patternsStudy reveals how COVID-19 affected the spread and evolution of seasonal influenzaStudy reveals liver-brain communication as key to managing circadian eating patterns and obesityUT Dallas researchers awarded $3.7 million NIH grant for brain aging studyNoninvasive brain stimulation shows promise for enhancing navigation skills in cognitive impairmentNew model sheds light on APOE4's role in Alzheimer's pathologyDoes more education reshape your brain?Healthy lifestyle choices can offset genetic risk for brain diseases Comments The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical. Cancel reply to comment Post a new comment Login (Logout) Quirky Comment Title Post TrendingStories LatestInterviews Top HealthArticles Traditional Chinese herb shows promise against Alzheimer’s and Parkinson’sBreakthrough research reveals how to target malignant DNA in aggressive cancersAncient herb shows promise in fighting dementiaLink between COVID-19 and long-term risk of autoimmune and autoinflammatory connective tissue disordersCDC updates pain care guidelines for clinicians Exploring the G:Box and for high-quality imaging Dr Martin Biggs In this interview, News Medical speaks with Dr Martin Biggs from Synoptics about Syngene's G:Box, a high-quality imaging and gel documentation system. Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024 Carolyn Marks and Joel Svensson In this interview, conducted at SfN 2024 in Chicago, News Medical speaks with Joel Svensson and Carolyn Marks of Atlas Antibodies, about their new launch, the MolBoolean™, as well as how conferences like SfN are helping shape the future of neuroscience research. How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics Susan Magsamen The intersection of arts and neuroscience reveals transformative effects on health and learning, as discussed by Susan Magsamen in her neuroaesthetics research. Why You Might Feel Tired After Drinking CoffeeMythbusting: The 10,000 Steps Per Day TrendCan Magnesium Supplements Help You Sleep Better?Challenges in the Global ADHD Medication Supply ChainHow Does Semaglutide Work to Lose Weight? Latest NewsMethylGPT unlocks DNA secrets for age and disease predictionAI-based ultrasound software guides childbirth decisions with high accuracyRevolutionary AI predicts aging and disease from DNA patternsCannabinol enhances sleep in rats, study showsOvertreatment of older men with prostate cancer raises concerns Newsletters you may be interested in Schizophrenia (Subscribe or Preview) Psychiatry (Subscribe or Preview) Pregnancy / Maternal Health (Subscribe or Preview) See all Newsletters » High Credibility: This website adheres to all nine standards of credibility and transparency. Medical Links Medical Home COVID-19 News Health A-Z White Papers Thought Leaders Insights MediKnowledge Series Health & Personal Care Medical Devices Drugs eBooks Life Sciences Links Life Sciences Home News Lab Instruments & Equipment Life Sciences A-Z White Papers Thought Leaders Insights Webinars eBooks Other Useful Links About Meet the Team Search Newsletters Sitemap Advertise Contact Terms & Conditions Privacy & Cookie Policy Content Policy Ownership & Funding Information Other AZoNetwork Sites AZoM AZoNano AZoCleantech AZoOptics AZoRobotics AZoSensors AZoMining AZoQuantum AZoBuild AZoLifeSciences AZoAi Facebook Twitter LinkedIn News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Update Your Privacy Preferences Last Updated: Tuesday 12 Nov 2024 News-Medical.net - An AZoNetwork Site Owned and operated by AZoNetwork, © 2000-2024 Azthena logo with the word Azthena Maximise chat window Hide chat window Your AI Powered Scientific Assistant Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. To start a conversation, please log into your AZoProfile account first, or create a new account. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. Log in A few things you need to know before we start. Please read and accept to continue. Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI. Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy. Large Language Models can make mistakes. Consider checking important information. I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements. Please check the box above to proceed. Start Chat Great. Ask your question. Clear Chat Clear Chat Brief Moderate Detailed Azthena may occasionally provide inaccurate responses. Read the full terms. Terms While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information. Read the full Terms & Conditions. Provide Feedback Submit Cancel You might also like... × Traumatic brain injury should be recognized as a chronic condition, experts sayStudy reveals new H5N1 variants evade human antibodies more effectively Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About COVID-19 News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge Newsletters Health & Personal Care eBooks Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Cold, Flu & Cough Eating Disorders Eye Health Gastrointestinal Health Heart Disease High Blood Pressure Lung Cancer Mental Health Mpox Pregnancy Type 1 Diabetes Type 2 Diabetes Sexual Health Sleep View Health A-Z ×Top Health Categories Coronavirus Disease COVID-19 Heart Disease Diet & Nutrition High Blood Pressure Artificial Intelligence Lung Cancer Allergies Mental Health Alzheimer's & Dementia Mpox Arthritis & Rheumatology Pregnancy Breast Cancer Type 1 Diabetes Cold, Flu & Cough Type 2 Diabetes Eating Disorders Sexual Health Eye Health Sleep Gastrointestinal Health View Health A-Z Medical Home Life Sciences Home About News Life Sciences A-Z White Papers Lab Equipment Interviews Newsletters Webinars More... eBooks Contact Meet the Team Advertise Search Become a Member White Papers MediKnowledge Newsletters Health & Personal Care eBooks Contact Meet the Team Advertise Search Become a Member Webinars eBooks Contact Meet the Team Advertise Search Become a Member Study reveals new H5N1 variants evade human antibodies more effectively Download PDF Copy Reviewed University of North Carolina at CharlotteAug 2 2024 In a new study led by UNC Charlotte researchers from the Center for Computational Intelligence to Predict Health and Environmental Risks (CIPHER) and the North Carolina Research Campus at Kannapolis, University scholars have found evidence that the latest variants of H5N1 influenza -; commonly known as avian or bird flu -; are better at evading antibodies, including those of humans, than previous iterations of the virus. The study is currently published as a preprint on the online bioRxiv preprint server for biology research and is awaiting peer-review. In June 2024, the U.S. Department of Agriculture reported that over 300 mammals had been found to have been infected with the H5N1 virus between 2022 and 2024. The World Health Organization recently reported that approximately five humans have been infected with H5N1 in 2024 alone, "but the broader potential impact to human health remains unclear," the UNC Charlotte researchers wrote. Using advanced AI and physics-based modeling techniques made possible by UNC Charlotte and the North Carolina General Assembly investments in high-performance computing research and artificial intelligence-assisted computational analysis, University researchers have made strides in understanding the specific interactions between H5N1 virus proteins and antibodies, with the goal that these findings will inform the design of stronger, more effective vaccines for the virus. This project was led by first author Colby T. Ford, a CIPHER visiting scholar in data science and founder of Charlotte-based startup, Tuple, LLC, along with recent College of Computing and Informatics students Shirish Yasa, Khaled Obeid and Sayal Guirales-Medrano, as well as Department of Bioinformatics and Genomics professors Richard Allen White III and Daniel Janies. Tuple, LLC was also a partner in this project. Historically, our ability to answer biological questions was limited to the throughput of our traditional lab-based processes. Today, however, through the seemingly limitless scale of high-performance and cloud computing, we employ AI and other modeling tools to answer such questions computationally. In this study, our aim is to be more forward looking to predict the potential health impacts of H5N1 influenza before a major event catches us off guard." Colby T. Ford, First Author Building off of CIPHER's previous SARS-CoV-2 research on coronavirus variants and their ability to evade antibodies, this study is based on data pulled from 1,804 computational experiments as well as an in-depth phylogenetic analysis of 18,508 protein sequences of H5N1 collected between 1959 and 2024. CIPHER scholars also visualized the geographic and host shifts found throughout H5N1's history. According to the study, virus mutations related to "host-shifts" from birds to mammals had a statistically significant negative impact on the ability of antibodies to bind to and fight off H5N1. Researchers also found that based on the wide variety of host species and geographic locations in which H5N1 was observed to have been transmitted from birds to mammals, there does not appear to be a single central reservoir host species or location associated with H5N1's spread. This indicates that the virus is well on its way to moving from epidemic to pandemic status in the near future. Related StoriesH5N1 avian flu found in Texas dairy cattle and milk, sparking concerns about underreported infectionsBlowflies linked to bird flu spread in southern JapanGlobal experts gather in Brisbane for scientific meeting dedicated to influenzaThis study is the latest example of UNC Charlotte's groundbreaking efforts to put advanced computational research methods to use toward better understanding and fighting infectious diseases across the globe. "We are entering a whole new era of molecular epidemiology in which we provide a functional insight above and beyond disease surveillance." said Janies, CIPHER co-director and the Carol Grotnes Belk Distinguished Professor in Bioinformatics and Genomics. "We demonstrate that large data sets can be analyzed rapidly with high-performance computing and artificial intelligence to assess our preparedness for important problems such as H5N1, which is spreading rapidly to new hosts and regions including American cattle and farmworkers." "H5 related avian influenza A is an emerging pathogen in humans while being an ongoing pandemic in wildlife for over two years," said White, Assistant Professor of Bioinformatics. "Our predictive study provides a window to the future of using AI in the arms race against emerging pathogens." Source:University of North Carolina at CharlotteJournal reference:Ford, C. T., et al. (2024). Large-Scale Computational Modeling of H5 Influenza Variants Against HA1-Neutralizing Antibodies. bioRxiv preprint. https://www.biorxiv.org/content/10.1101/2024.07.14.603367 Posted in: Medical Research News | Disease/Infection News Tags: Agriculture, Antibodies, Artificial Intelligence, Avian Influenza, Bioinformatics, Bird Flu, Computational Modeling, Coronavirus, Epidemiology, Flu, Genomics, H5N1, Infectious Diseases, Influenza, Pandemic, Pathogen, Protein, Research, SARS, SARS-CoV-2, students, Virus Comments (0) Download PDF Copy Suggested Reading New CDC report highlights disparities in flu hospitalization and vaccinationPasteurization effectively reduces H5N1 virus in milk but further testing is essentialStudy reveals how COVID-19 affected the spread and evolution of seasonal influenzaResearch identifies respiratory transmission potential of H5N1 virusMaternal immune response to flu linked to fetal brain changesInnovative nasal spray and vaccine for respiratory virus protectionStudy reveals high effectiveness of flu vaccines in children but highlights challenges with certain subtypesH5N1 bird flu is mutating fast and jumping to mammals - could the next pandemic be here? Comments The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical. Cancel reply to comment Post a new comment Login (Logout) Quirky Comment Title Post TrendingStories LatestInterviews Top HealthArticles Traditional Chinese herb shows promise against Alzheimer’s and Parkinson’sBreakthrough research reveals how to target malignant DNA in aggressive cancersAncient herb shows promise in fighting dementiaLink between COVID-19 and long-term risk of autoimmune and autoinflammatory connective tissue disordersCDC updates pain care guidelines for clinicians Exploring the G:Box and for high-quality imaging Dr Martin Biggs In this interview, News Medical speaks with Dr Martin Biggs from Synoptics about Syngene's G:Box, a high-quality imaging and gel documentation system. Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024 Carolyn Marks and Joel Svensson In this interview, conducted at SfN 2024 in Chicago, News Medical speaks with Joel Svensson and Carolyn Marks of Atlas Antibodies, about their new launch, the MolBoolean™, as well as how conferences like SfN are helping shape the future of neuroscience research. How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics Susan Magsamen The intersection of arts and neuroscience reveals transformative effects on health and learning, as discussed by Susan Magsamen in her neuroaesthetics research. Why You Might Feel Tired After Drinking CoffeeMythbusting: The 10,000 Steps Per Day TrendCan Magnesium Supplements Help You Sleep Better?Challenges in the Global ADHD Medication Supply ChainHow Does Semaglutide Work to Lose Weight? Latest NewsMethylGPT unlocks DNA secrets for age and disease predictionAI-based ultrasound software guides childbirth decisions with high accuracyRevolutionary AI predicts aging and disease from DNA patternsCannabinol enhances sleep in rats, study showsOvertreatment of older men with prostate cancer raises concerns Newsletters you may be interested in Infectious Diseases (Subscribe or Preview) COVID-19 (Subscribe or Preview) Genetics (Subscribe or Preview) See all Newsletters » High Credibility: This website adheres to all nine standards of credibility and transparency. Medical Links Medical Home COVID-19 News Health A-Z White Papers Thought Leaders Insights MediKnowledge Series Health & Personal Care Medical Devices Drugs eBooks Life Sciences Links Life Sciences Home News Lab Instruments & Equipment Life Sciences A-Z White Papers Thought Leaders Insights Webinars eBooks Other Useful Links About Meet the Team Search Newsletters Sitemap Advertise Contact Terms & Conditions Privacy & Cookie Policy Content Policy Ownership & Funding Information Other AZoNetwork Sites AZoM AZoNano AZoCleantech AZoOptics AZoRobotics AZoSensors AZoMining AZoQuantum AZoBuild AZoLifeSciences AZoAi Facebook Twitter LinkedIn News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Update Your Privacy Preferences Last Updated: Tuesday 12 Nov 2024 News-Medical.net - An AZoNetwork Site Owned and operated by AZoNetwork, © 2000-2024 Azthena logo with the word Azthena Maximise chat window Hide chat window Your AI Powered Scientific Assistant Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. To start a conversation, please log into your AZoProfile account first, or create a new account. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. Log in A few things you need to know before we start. Please read and accept to continue. Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI. Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy. Large Language Models can make mistakes. Consider checking important information. I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements. Please check the box above to proceed. Start Chat Great. Ask your question. Clear Chat Clear Chat Brief Moderate Detailed Azthena may occasionally provide inaccurate responses. Read the full terms. Terms While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information. Read the full Terms & Conditions. Provide Feedback Submit Cancel You might also like... × Exclusive: Emails reveal how health departments struggle to track human cases of bird fluBluebottle flies identified as carriers of Avian Influenza virus Mexico Brazil Arabic Global South Cone Andean Region Spain Indonesia Search Register Login Search TECHNICAL ARTICLES MONOGRAPHICS Species REPORTAGE INTERVIEWS SECTORIAL NEWS Authors BUSINESS DIRECTORY PRODUCT GUIDES REGISTRATION/LOGIN AVINEWS MAGAZINE PRINTED SUBSCRIPTION AGRIFM - PODCAST AGRI - CALENDAR AGRINEWS CAMPUS REGIONS Spain Mexico Brazil Arabic Global South Cone Andean Region Indonesia Magazine Feeding and nutrition of layers Themes Species Interviews Sectorial Authors Companies Product Events RECOMMENDED Alternative production Animal Nutrition AviNews aviNews Biosecurity Equipment Events Genetics 2024 PSA Annual Meeting 41st Saudi Agriculture 2024 Additives aditives alpacas Alphitobius diaperinus Amino acids aMPV Animal welfare Antibiotic-free poultry Artificial Intelligence Ascaridia galli READ SUMMARY SUBSCRIBE RECEIVE IN PAPER OTHER EDITIONS 02 Aug 2024 Bluebottle flies identified as carriers of Avian Influenza virus Avian influenza, commonly known as bird flu, has been a persistent global health concern. While the primary mode of transmission is through direct contact between birds, a recent study conducted by researchers at Kyushu University has revealed an unexpected vector: bluebottle flies (Calliphora nigribarbis). PDF FILE Avian influenza, commonly known as bird flu, has been a persistent global health concern. While the primary mode of transmission is through direct contact between birds, a recent study conducted by researchers at Kyushu University has revealed an unexpected vector: bluebottle flies (Calliphora nigribarbis). These flies, typically associated with decaying flesh and feces, have been found to carry the avian influenza virus in southern Japan. The avian influenza crisis Since 2020, avian influenza outbreaks have wreaked havoc on bird populations worldwide. Millions of wild birds have succumbed to the disease, and over 500 million farm birds have been culled. Japan, where even a single infection case on a poultry farm triggers the culling of all livestock, faced a staggering 326 outbreaks during the 2022-2023 winter season. This led to the sacrifice of 17.7 million birds. Additionally, some avian influenza strains have crossed over to mammals, including cows, goats, dogs, cats, and, more recently, poultry and dairy workers. The latter cases have been associated with alarmingly high mortality rates. Investigating bluebottle flies Professor Ryosuke Fujita and his team focused their research on a population of wild cranes in Izumi City, Kagoshima Prefecture, southern Japan. During the winter, thousands of cranes migrate to this area, making them susceptible to infection. In the winter of 2022-2023, 1,600 cranes from a colony of 10,000 died due to avian influenza. The researchers set traps across Izumi City to capture bluebottle flies, particularly Calliphora nigribarbis. Unlike other fly species, these flies remain active during winter, coinciding with the peak avian influenza season. Their attraction to animal flesh and feces made them prime suspects for virus transmission. The researchers collected 648 bluebottles and found that 14 of them carried the avian influenza virus. Most of the bluebottles that tested positive for the virus were collected at the sampling site closest to the crane colony.Continue after advertising. Unexpected vectors The team’s findings, published in Scientific Reports, highlight a potential new avenue for avian influenza spread. Bluebottle flies, drawn to carrion and waste, play an unexpected role in transmitting the virus. Understanding these vectors is crucial for safeguarding both wildlife and humans working closely with livestock. As we continue to combat avian influenza, researchers will explore additional pathways to prevent further outbreaks and protect global poultry populations. In conclusion, bluebottle flies, drawn to carrion and waste, play an unexpected role in avian influenza transmission. Understanding these vectors is crucial for safeguarding both wildlife and humans working closely with livestock. As we continue to combat avian influenza, researchers will explore additional pathways to prevent further outbreaks and protect global poultry populations. Sources: Available upon request PDF FILE Related to Biosecurity 04 Nov Backyard pig infected with H5N1 virus in the U.S. 30 Oct France is scared by Salmonella and recalls 3 million eggs 10 Sep AI H5N1 in the U.S.: 13 human cases in poultry workers since April 04 Sep Biosecurity Compliance: The Balance Between Culture, Personality, Experience, Education and Technology 30 Aug SENASICA successfully eradicates H5N1 AI outbreak in Mexico MAGAZINE AVINEWS INTERNATIONAL Subscribe now to the poultry technical magazine OTHER EDITIONS READ SUMMARY SUBSCRIBE RECEIVE IN PAPER AUTHORS Zoetis Technical Team FOLLOW H&N Technical Team FOLLOW Brian Fairchild FOLLOW Dr. Edgar O. Oviedo-Rondon FOLLOW Gracieli Araujo Specialist in Animal Welfare - Cobb LatCan FOLLOW Guillermo Tellez FOLLOW Ken Bafundo FOLLOW Güner GÖVENÇ FOLLOW Nestor Ledesma Martínez FOLLOW Dra. Elein Hernández FOLLOW Talha Siddique FOLLOW EDITION AviNews International September 2024 In ovo vaccination with Embrex® technology helps support earlier, more robust immune response in chicks Zoetis Technical Team Egg Size H&N Technical Team Brian Fairchild Interview Brian Fairchild High Oleic Soybeans and their Impact on Egg and Poultry Meat Quality Dr. Edgar O. Oviedo-Rondon Metapneumovirus Epidemiology and Seasonality Dr. Edgar O. Oviedo-Rondon Controlling Insects in Poultry Production Gracieli Araujo Specialist in Animal Welfare - Cobb LatCan Effects of Chronic Stress and Intestinal Inflammation on Commercial Poultry Health and Performance: Part I Guillermo Tellez Applications of Saponins in Poultry Production Ken Bafundo The Quality Parameters of Soybean and Alternative Protein Feedstuffs in Poultry Nutrition Güner GÖVENÇ Pathology of the Immune System in the Diagnosis of Immunosuppression in Poultry Nestor Ledesma Martínez Animal Welfare and Artificial Intelligence: A Combination of the Poultry Present or Future? Dra. Elein Hernández Advancing Poultry Health: The Role of Predictive Analytics in Disease Prevention Talha Siddique Biosecurity Compliance: The Balance Between Culture, Personality, Experience, Education and Technology Dr. Edgar O. Oviedo-Rondon SUMMARY Subscribe now to aviNews magazine SEE MORE OTHER EDITIONS JOIN OUR POULTRY COMMUNITY Access the PDF articles Keep up to date with our newsletters Receive the magazine for free in digital version REGISTER DISCOVER LEGAL Privacy policy Cookies policy Más información sobre las cookies OUR MEDIA aviNews Magazine Other Media JOIN Online Register Printed subscriptions Advertise Publish with us Contact FOLLOW US 2024 Copyright Grupo de Comunicación agriNews, SL. All rights reserved. Reproduction of the content of this page in any format or communication, electronic or printed, without express authorization is prohibited.Request authorization. Agencia de Marketing GanaderoHealth officials report more Colorado workers infected with bird flu - Roll Call Skip to content Politics Campaigns Congress White House Policy Defense Energy/Environment Fintech Health Care Technology Transportation All Policy Heard on the Hill Podcasts CQ Budget Equal Time Fintech Beat Political Theater Oversight Factba.se Kamala Harris Joe Biden Donald Trump White House Calendar White House Releases Press Seating Chart Donald Trump Twitter Correspondents Dinner Blog Visuals More Newsletters Capitol Ink Roll Call e-Edition Opinion Events Classifieds RollCall logo Search RollCall.com RollCall logo Politics Campaigns Congress White House Policy Defense Energy/Environment Fintech Health Care Technology Transportation All Policy Heard on the Hill Podcasts CQ Budget Equal Time Fintech Beat Political Theater Oversight Factba.se Kamala Harris Joe Biden Donald Trump White House Calendar White House Releases Press Seating Chart Donald Trump Twitter Correspondents Dinner Blog Visuals More Newsletters Capitol Ink Roll Call e-Edition Opinion Events Classifieds Search RollCall.com Policy Health officials report more Colorado workers infected with bird flu CDC announced plans for flu vaccinations for workers to help ward off H5N1 virus Jon Arizti Sanz works in a Massachusetts lab on May 14 testing milk purchased at area grocery stores for the presence of bird flu. (David L. Ryan/The Boston Globe via Getty Images) By Olivia M. Bridges Posted July 30, 2024 at 5:46pm Facebook Twitter Email Reddit The number of bird flu infections among Colorado poultry workers increased to nine, the Centers for Disease Control and Prevention told reporters Tuesday, for a total of 14 cases nationwide from exposure to poultry and dairy cattle since 2022. The cases in Colorado come out of two farms located in Weld County, which is northeast of the Denver metro area. The workers experienced mild symptoms, including conjunctivitis. The CDC assessment of the risk to the public remains low, but poultry workers tasked with culling infected birds are at a heightened risk of infection. The CDC and Agriculture Department said in a call with reporters that the heat and challenges using personal protective equipment, or PPE, may have contributed to the cases. “It is just a challenge to wear PPE at all times in a place in which there is high volume fans moving a lot of air, as well as the type of depopulation exercise that was used here,” Eric Deeble, the USDA’s acting senior adviser for H5N1 response, said. The USDA reported that one of the facilities used CO2 carts to cull the infected birds — a method that required the workers to directly place the chicken in the cart. Deeble added that a “less than perfect adoption of PPE by the workers” could have contributed to the human cases. But he said the workers are not to blame, and the USDA hasn’t changed its recommendations for the use of PPE. During the call, the CDC announced that it is providing $5 million to vaccinate livestock workers against the seasonal flu on a voluntary basis amid the growing outbreak. States will submit a plan to implement a vaccination campaign to the CDC, and so the ground-level effort will vary from state to state. The CDC said that $3 million of the funds is earmarked to go to states to carry out their plans. “Preventing seasonal influenza in these workers, many of whom are also potentially exposed to H5N1 viruses, may also reduce the risk of new versions of the influenza A virus emerging,” Nirav Shah, principal deputy director of the CDC, said. “The seasonal flu vaccine can potentially reduce the risk of co-infection with seasonal and H5N1 influenza viruses.” The CDC said that it’s already requested states to begin working on its plan for the vaccination campaign, and the effort will kick off in the fall and winter, following the timeline people typically receive the flu vaccine. The seasonal flu vaccine won’t protect from H5N1, and at this time, CDC does not recommend administering an H5N1 vaccine. “This is because of the lack of severe illness that we’ve seen thus far, the absence of person to person transmission, the absence of any changes to the virus, and reassuringly, the absence of asymptomatic infection,” Shah said. The CDC also announced that it would invest $5 million for farm worker health and safety outreach and education efforts. Of that amount, $4 million would go to the National Center for Farmworker Health to partner with community based organizations in states with infections to provide training and information sessions. The center also would work with key partners in states to increase access to testing, treatment, PPE and the seasonal flu shot. Recent Stories Legal questions surround Trump’s talk of political prosecutions Trump can make immigration moves on his first day back in office How RFK Jr.’s health proposals would stack up in practice High hopes for bald eagle bill in the lame duck Here’s a look at who’s in — and possibly in — Trump’s second administration Trump administration faces antitrust enforcement dilemma The Source for news on Capitol Hill since 1955 About Contact Us Advertise Events Privacy RC Jobs Newsletters The Staff Subscriptions CQ and Roll Call are part of FiscalNote, a leading provider of political and business risk solutions. Copyright 2024 CQ and Roll Call. All rights reserved. X XI feel sick. How do I know if I have the flu, COVID, RSV or something else? Menu Close Home Edition Africa Australia Brasil Canada Canada (français) España Europe France Global Indonesia New Zealand United Kingdom United States Edition: Available editions Global Africa Australia Brasil Canada Canada (français) España Europe France Indonesia New Zealand United Kingdom United States Get newsletter Become an author Sign up as a reader Sign in Search Academic rigour, journalistic flair Andrea Piacquadio/Pexels I feel sick. How do I know if I have the flu, COVID, RSV or something else? Published: July 30, 2024 9.24pm BST Natasha Yates, Bond University Author Natasha Yates General Practitioner, PhD Candidate, Bond University Disclosure statement Natasha Yates does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment. Partners Bond University provides funding as a member of The Conversation AU. View all partners Languages Portuguese English Email X (Twitter) Facebook LinkedIn WhatsApp Messenger You wake with a sore throat and realise you are sick. Is this going to be a two-day or a two-week illness? Should you go to a doctor or just go to bed? Most respiratory illnesses have very similar symptoms at the start: sore throat, congested or runny nose, headache, fatigue and fever. This may progress to a dry cough. Best case scenario is that you have “a cold” (which can be any one of hundreds of viruses, most commonly rhinovirus), which is short-lived and self-limiting. But some respiratory illnesses can be much more serious. Here is a brief guide to some important bugs to know about that are circulating this winter, and how to work out which one you have. Respiratory syncytial virus (RSV) For most people an RSV infection will feel like “a cold” – annoying, but only lasting a few days. However, for babies, older adults and people with immune issues, it can lead to bronchiolitis or pneumonia, and even become life-threatening. RSV isn’t seasonal, which means you are just as likely to get it in summer as in winter. However, it is highly contagious so we noticed it disappearing almost completely during COVID lockdowns. There is now a rapid-antigen test (RAT) for RSV which also checks for influenza and COVID, and is the best way of finding out if RSV is what is causing symptoms. Recently, a preventative immune therapy has become available for high risk babies (nirsevimab) and there are also vaccines for higher risk adults. Nirsevimab is also available to all babies for free in Western Australia and Queensland. A preventative immune therapymmune therapy is available for at-risk babies (and in some states, all babies). polkadot_photo/Shutterstock But there are no specific treatments. Adults who get it simply have to ride it out (using whatever you need to manage symptoms). Babies and higher risk patients need to present to an emergency department if they test positive for RSV and are also looking or feeling very unwell (this might mean rapid shallow breathing, fevers not coming down with paracetamol or ibuprofen, a baby not feeding, mottled-looking skin, or going blue around the mouth). If a patient has developed a bronchiolitis or pneumonia, they may need to be hospitalised. Influenza Once you have had the “true flu” (influenza), you will find it frustrating when people call their sniffly cold-like symptoms a “flu”. Influenza infections generally start with a sore throat and headache which quickly turns into high fevers, generalised aches and excessive fatigue. You feel like you have been hit by a truck and may struggle to get out of bed. This can last a week or more, even in people who are generally fit and healthy. Influenza is a major public health issue internationally, with 3–5 million cases of severe illness and 290,000 to 650,000 respiratory deaths annually. People who are at greater risk of complications from influenza include pregnant women, children under five, adults aged 65 and over, First Nations peoples, and people with chronic or immunosuppressive medical conditions. For this reason, annual vaccination is recommended and funded for vulnerable people. Vaccination is also readily available for all Australians who want it, through pharmacies as well as medical clinics, usually at a cost of less than A$30. In some states, it’s free for all residents. Vaccination usually costs less than $30 or is free for at-risk groups. 89stocker/Shutterstock Influenza is seasonal, with definite peaks in the winter months. This is why vaccines are offered from early autumn. If you think you may have influenza, there are now home-testing RATs: all current influenza RATs are in combination with COVID RATs, as the symptoms overlap. Treatment for most people is to manage symptoms and try to avoid spreading it around. Doctors can also prescribe antivirals to vulnerable patients; these work best if started within 48 hours of symptoms. COVID It has been less than five years since COVID-19, caused by SARS-CoV-2, started to spread around the world in pandemic proportions. Although COVID is no longer a public health emergency, it still causes more deaths than influenza and RSV combined. Unlike RSV and influenza, only those aged over 70 are in a high-risk age group for COVID. Other factors besides age may put you at higher risk of becoming very unwell when infected by this virus. This includes having other respiratory diseases (such as asthma or chronic obstructive pulmonary disease, also known as COPD), diabetes, cancer, kidney disease, obesity or heart disease. Unlike most respiratory viruses, SARS-CoV-2 tends to set off inflammation beyond the respiratory system. This can involve a range of other organs including the heart, kidneys and blood vessels. Although most people are back to their usual work or study after a week or two, a significant proportion go on to experience extended symptoms such as fatigue, breathlessness, brain fog and mood changes. When these last more than 12 weeks, without any other explanation for symptoms, it’s called long COVID. Some people experience symptoms for weeks or months. Gorodenkoff/Shutterstock COVID vaccines can prevent serious illness and have been monitored for several years now for their safety and effectiveness. Current vaccination recommendations are based on age and immune status. It’s worth discussing them with your doctor if you are unsure whether you would benefit or not. Antivirals can treat COVID in higher-risk people who contract it, whether vaccinated or not. Specific advice about what to do if you test positive on a RAT will vary according to your current state guidelines and workplace, however the general principles are always: avoid spreading the virus to others, and give yourself time to rest and recover. What if it’s not one of those? So you’ve done your combined RSV/flu/COVID RAT and the result is negative. But you still have symptoms. What else could it be? More than 200 different viruses can cause cold and flu symptoms, including rhinovirus (mentioned above), adenovirus and sometimes even undefined pathogens. If an illness progresses to a cough which will not go away, and/or you start coughing up sputum, this could be a bacterial infection, such as pertussis (whooping cough), streptococcus pneumoniae, haemophilus influenzae or moraxella catarrhalis. So it’s worth getting assessed by a GP who may do a chest Xray and/or test your sputum, particularly if they suspect pneumonia. You also may also start out with what is clearly a viral infection but then get a secondary bacterial infection later. So if you are getting more unwell over time, it’s worth getting tested, in case antibiotics will help. However, taking antibiotics for a purely viral illness will not only be useless, it can contribute to harmful antibiotic resistance and give you unwanted side effects. Influenza Flu Health RSV Winter health Consumer health COVID-19 Events More events Jobs Lecturer / Senior Lecturer in Indigenous Knowledges Investigator, Student Academic Misconduct (Multiple Positions Available) Commissioning Editor Nigeria Professor in Physiotherapy Postdoctoral Research Associate More jobs Editorial Policies Community standards Republishing guidelines Analytics Our feeds Get newsletter Who we are Our charter Our team Partners and funders Resource for media Contact us ​ ​ ​ Privacy policy Terms and conditions Corrections Copyright © 2010–2024, The ConversationWorried about bird flu mutation, feds seek livestock worker vaccinations • South Dakota Searchlight HOME NEWS Government Environment Economy Health Justice Education Decision 2024 Commentary ABOUT SUBSCRIBE DONATE Part of States Newsroom Government Environment Economy Health Justice Education Decision 2024 10:01 News Story EconomyHealth Worried about bird flu mutation, feds seek livestock worker vaccinations By: Jared Strong, Iowa Capital Dispatch - July 31, 2024 10:01 am Dairy cows in Iowa. (Photo courtesy of Iowa State Dairy Association) Federal health officials are encouraging farm workers who tend livestock and poultry to get vaccinated for seasonal influenza to help prevent a bird flu mutation that might spark a pandemic in people. The U.S. Centers for Disease Control and Prevention said Tuesday it would devote up to $5 million to pay for the vaccinations, and that it will rely on states to implement the initiative. There are 14 known human infections of highly pathogenic avian influenza that resulted from contact with infected dairy cattle and poultry in the United States, and all but one has happened in the past four months. Fourth human case of bird flu diagnosed in Colorado dairy farm worker The virus has been circulated by wild birds for more than two years and has sporadically transmitted to domestic birds. A variation of the virus has been infecting U.S. dairy cattle since December, and four people who worked closely with infected cattle also became ill. In recent weeks, nine people in Colorado who were tasked with culling infected poultry contracted the virus. The CDC has maintained that the virus’ risk to humans is low — those who have been infected so far had minor symptoms of respiratory illness or pinkeye, or both. It has not been shown to transmit between people, but the virus has the potential to rapidly gain that ability if it infects someone who also has a seasonal flu virus. “Such dual infections, while rare, could potentially result in an exchange of genetic material between two different influenza viruses,” Dr. Nirav Shah, principal deputy director for the CDC, said in a call with reporters Tuesday. Shah said that “reassortment” process could pose a “significant public health concern” if bird flu gains the ability to spread person-to-person the way seasonal flu does, potentially resulting in a virus that spreads easily and causes severe symptoms. A new vaccination campaign Shah said the CDC will devote up to $10 million for farm workers’ health related to avian flu. Half will be spent educating and training farm workers about how to avoid being infected. The other half will pay for seasonal flu vaccines for an estimated 200,000 farm workers who tend livestock and poultry. The CDC hopes to vaccinate all of them but acknowledges that less than half of the general population typically gets a flu shot. How the voluntary vaccination effort will proceed is unclear. State health officials are expected to implement them, most immediately in the 13 states that have confirmed infections among cows. That includes Iowa, where 13 dairy herds have been infected. However, no new infections have been reported in the state in the past month. A spokesperson for the Iowa Department of Health and Human Services — which presumably would coordinate with the CDC — did not immediately respond to a request to comment for this article. The vaccine will not protect the workers from contracting bird flu, Shah said, nor will it guarantee they won’t be infected by seasonal flu. But he said it’s an important component of the public health response to the new virus’ threat. “The risk here is a theoretical but important risk,” Shah said. Colorado has most recent infections The confirmations of new bird flu infections among cattle have waned significantly in most states, except for in Colorado. In the past 30 days, two-thirds of the nation’s 32 newly infected herds were in that state, according to U.S. Department of Agriculture data. Some of that might be due to Colorado’s robust testing protocols, but it’s also “a quirk of history and geography,” said Eric Deeble, deputy under secretary for marketing and regulatory programs for the USDA. The state has far fewer dairy farms than the leading milk-producing states, but most of them are concentrated in one county. “They are all in very close proximity to one another, and so there is a lot of sharing of equipment, a lot of sharing of personnel and a lot of movement on and off farms to adjacent farms,” Deeble said. The USDA has identified the movement of equipment and people between dairy farms as a primary vector for virus transmissions from herd to herd and from herd to flock. The virus has been identified in 172 dairy herds in the United States this year. Fifty of them are in Colorado. In Texas, where the infections originated, the virus was confirmed in 22 herds, although there were many that went untested because they recovered before bird flu was identified as the culprit. Iowa Capital Dispatch is part of States Newsroom, a nonprofit news network supported by grants and a coalition of donors as a 501c(3) public charity. Iowa Capital Dispatch maintains editorial independence. Contact Editor Kathie Obradovich for questions: [email protected]. Follow Iowa Capital Dispatch on Facebook and X. XWorried about bird flu mutation, feds seek livestock worker vaccinations by Jared Strong, Iowa Capital Dispatch, South Dakota Searchlight July 31, 2024 Worried about bird flu mutation, feds seek livestock worker vaccinations by Jared Strong, Iowa Capital Dispatch, South Dakota Searchlight July 31, 2024 Federal health officials are encouraging farm workers who tend livestock and poultry to get vaccinated for seasonal influenza to help prevent a bird flu mutation that might spark a pandemic in people. The U.S. Centers for Disease Control and Prevention said Tuesday it would devote up to $5 million to pay for the vaccinations, and that it will rely on states to implement the initiative. There are 14 known human infections of highly pathogenic avian influenza that resulted from contact with infected dairy cattle and poultry in the United States, and all but one has happened in the past four months. Fourth human case of bird flu diagnosed in Colorado dairy farm worker The virus has been circulated by wild birds for more than two years and has sporadically transmitted to domestic birds. A variation of the virus has been infecting U.S. dairy cattle since December, and four people who worked closely with infected cattle also became ill. In recent weeks, nine people in Colorado who were tasked with culling infected poultry contracted the virus. The CDC has maintained that the virus’ risk to humans is low — those who have been infected so far had minor symptoms of respiratory illness or pinkeye, or both. It has not been shown to transmit between people, but the virus has the potential to rapidly gain that ability if it infects someone who also has a seasonal flu virus. “Such dual infections, while rare, could potentially result in an exchange of genetic material between two different influenza viruses,” Dr. Nirav Shah, principal deputy director for the CDC, said in a call with reporters Tuesday. Shah said that “reassortment” process could pose a “significant public health concern” if bird flu gains the ability to spread person-to-person the way seasonal flu does, potentially resulting in a virus that spreads easily and causes severe symptoms. A new vaccination campaign Shah said the CDC will devote up to $10 million for farm workers’ health related to avian flu. Half will be spent educating and training farm workers about how to avoid being infected. The other half will pay for seasonal flu vaccines for an estimated 200,000 farm workers who tend livestock and poultry. The CDC hopes to vaccinate all of them but acknowledges that less than half of the general population typically gets a flu shot. How the voluntary vaccination effort will proceed is unclear. State health officials are expected to implement them, most immediately in the 13 states that have confirmed infections among cows. That includes Iowa, where 13 dairy herds have been infected. However, no new infections have been reported in the state in the past month. A spokesperson for the Iowa Department of Health and Human Services — which presumably would coordinate with the CDC — did not immediately respond to a request to comment for this article. The vaccine will not protect the workers from contracting bird flu, Shah said, nor will it guarantee they won’t be infected by seasonal flu. But he said it’s an important component of the public health response to the new virus’ threat. “The risk here is a theoretical but important risk,” Shah said. Colorado has most recent infections The confirmations of new bird flu infections among cattle have waned significantly in most states, except for in Colorado. In the past 30 days, two-thirds of the nation’s 32 newly infected herds were in that state, according to U.S. Department of Agriculture data. Some of that might be due to Colorado’s robust testing protocols, but it’s also “a quirk of history and geography,” said Eric Deeble, deputy under secretary for marketing and regulatory programs for the USDA. The state has far fewer dairy farms than the leading milk-producing states, but most of them are concentrated in one county. “They are all in very close proximity to one another, and so there is a lot of sharing of equipment, a lot of sharing of personnel and a lot of movement on and off farms to adjacent farms,” Deeble said. The USDA has identified the movement of equipment and people between dairy farms as a primary vector for virus transmissions from herd to herd and from herd to flock. The virus has been identified in 172 dairy herds in the United States this year. Fifty of them are in Colorado. In Texas, where the infections originated, the virus was confirmed in 22 herds, although there were many that went untested because they recovered before bird flu was identified as the culprit. Iowa Capital Dispatch is part of States Newsroom, a nonprofit news network supported by grants and a coalition of donors as a 501c(3) public charity. Iowa Capital Dispatch maintains editorial independence. Contact Editor Kathie Obradovich for questions: info@iowacapitaldispatch.com. Follow Iowa Capital Dispatch on Facebook and X. South Dakota Searchlight is part of States Newsroom, a nonprofit news network supported by grants and a coalition of donors as a 501c(3) public charity. South Dakota Searchlight maintains editorial independence. Contact Editor Seth Tupper for questions: info@southdakotasearchlight.com. Follow South Dakota Searchlight on Facebook and X. View Republishing Guidelines Copy to clipboard 1Republish Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our website. AP and Getty images may not be republished. Please see our republishing guidelines for use of any other photos and graphics. Jared Strong, Iowa Capital DispatchJared Strong is the senior reporter for the Iowa Capital Dispatch. He has written about Iowans and the important issues that affect them for more than 15 years, previously for the Carroll Times Herald and the Des Moines Register. His investigative work exposing police misconduct has notched several state and national awards. He is a longtime trustee of the Iowa Freedom of Information Council, which fights for open records and open government. He is a lifelong Iowan and has lived mostly in rural western parts of the state.MORE FROM AUTHOR Related News Health experts outline how Trump administration could affect…by Jennifer ShuttNovember 8, 2024 Rape, incest and ‘health of the mother’: Abortion reform…by Makenzie HuberNovember 6, 2024 South Dakotans approve consideration of Medicaid expansion…by Seth Tupper, Makenzie Huber and John HultNovember 6, 2024 Shining a light on South Dakota Democracy Toolkit // How to vote | Where to vote | Early voting | State lawmakers | Federal lawmakers DEMOCRACY TOOLKIT How to voteWhere to voteEarly votingState lawmakersFederal lawmakers © South Dakota Searchlight, 2024 v1.59.8 ABOUT US South Dakota Searchlight provides free news and commentary on critical issues facing the state. We seek to serve the public interest with accuracy, fairness, insight and civility. We’re part of States Newsroom, the nation’s largest state-focused nonprofit news organization. DEIJ Policy | Ethics Policy | Privacy Policy Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our website. (See full republishing guidelines.) DEIJ Policy | Ethics Policy | Privacy Policy © South Dakota Searchlight, 2024 v1.59.8 States Newsroom Fair. Fearless. Free.CDC Allocates $10 Million for Flu Shots to Combat Avian Influenza | Food Processing WebinarsPodcastsTechnical ResourcesTop 100©Subscribe Food SafetyWorkforceSupply ChainProduct DevelopmentPlant OpsBusiness StrategiesMergers & AcquisitionsLegal IssuesFood SafetyCDC Allocates $10 Million for Flu Shots to Combat Avian InfluenzaJuly 31, 2024While the seasonal flu vaccine does not directly protect against bird flu, it would defend against double-infections and prevent the bird flu virus from mutating.Dave Fusaro In an effort to stop the ongoing avian influenza (bird flu) outbreak from becoming widespread and serious, the Centers for Disease Control and Prevention (CDC) this week earmarked $10 million to more aggressively get farm workers to receive the annual flu vaccine, hoping that would prevent more serious illnesses from both seasonal flu and bird flu and the avian influenza virus from mutating. “The allocation includes $5 million earmarked for seasonal flu vaccines and another $5 million for educational and training programs aimed at protecting farm workers from bird flu,” the agency wrote. The program apparently means free flu vaccines for qualified farm workers. “While the seasonal flu vaccine does not directly protect against bird flu, vaccinating farm workers is a strategic move to prevent co-infection with both seasonal flu and bird flu.” And preventing seasonal flu among farm workers could reduce the likelihood of new influenza strains emerging through mutation. This week’s initiative comes after three more farm workers in a Colorado county contracted the virus after culling infected chickens. While their symptoms were mild and they are recovering, the disease is spreading among poultry and dairy cows, and now at least 13 farm workers -- nine in July alone -- have contracted the virus. About the Author Dave Fusaro | Editor in ChiefDave Fusaro has served as editor in chief of Food Processing magazine since 2003. Dave has 30 years experience in food & beverage industry journalism and has won several national ASBPE writing awards for his Food Processing stories. Dave has been interviewed on CNN, quoted in national newspapers and he authored a 200-page market research report on the milk industry. Formerly an award-winning newspaper reporter who specialized in business writing, he holds a BA in journalism from Marquette University. Prior to joining Food Processing, Dave was Editor-In-Chief of Dairy Foods and was Managing Editor of Prepared Foods.Continue ReadingA Case Study In Remote Alarm Notification SoftwareHow to Save Energy on PumpsSponsored Recommendations4 shipping challenges that a dedicated carrier can solveNavigating the logistics industry is challenging. Find out how a dedicated transportation solution can solve some of the most common shipping challenges.Recipe for successful growth: Schneider’s dedicated fleet services helps bakery riseLearn how a large bakery company complimented their private fleet with Schneider Dedicated freight services to increase freight capacity, amplify visibility & reduce costs.Produce grower optimizes network and delivery consistencyAn organic produce grower's fractured transportation model resulted in a lot of empty miles and brokered freight for a producer. Learn how they were able to optimize their transportatio...Schneider Dedicated grows refrigerated transportation for organic grocerAn organic grocery retailer with locations nationwide needed a shipper that could match its reach and volume. Schneider created a custom refrigerated transportation solution to...Latest from Food SafetyCourtesy of UpSnack Brands Snack FoodsPipcorn, Spudsy Snack Brands Combine to Form UpSnack BrandsAndy HanacekLocomotive74 EnvironmentalFresh Del Monte Produce Hits Scope 1 and 2 GHG Goals Seven Years EarlyAndy HanacekMost ReadWhat Will Trump 2.0 Mean for Food & Beverage?2024 Processor of the Year: Keurig Dr Pepper: EnergizedHow Will Food Manufacturing Look in 2025?Sponsored4 shipping challenges that a dedicated carrier can solveRecipe for successful growth: Schneider’s dedicated fleet services helps bakery riseProduce grower optimizes network and delivery consistency Load More Content https://www.facebook.com/foodprocessing http:/witter.com/foodprocessing https://www.linkedin.com/company/food-processing-magazine https://www.youtube.com/user/FoodProcessingMag Contact UsAdvertiseDo Not Sell or SharePrivacy PolicyTerms & Conditions © 2024 Endeavor Business Media, LLC. All rights reserved.FAO warns of rising avian flu threat in Asia-Pacific region | WATTPoultry.comMarket InformationTop Poultry CompaniesExpert InsightsBlogsRegionsMagazinesSign InPoultry MeatEggPoultry HealthSustainabilityPoultry FutureTopicsPoultry MeatEggPoultry HealthSustainabilityPoultry FutureRegionsMarket InformationTop Poultry CompaniesTop Feed CompaniesAgriculture ProductsDirectory of SuppliersEvent CalendarExpert InsightsWebinarsBrand InsightsPodcastsWhite PapersWATT Poultry ChatTop Companies Data DownloadsMagazinesMoreSign InSubscribeAdvertiseAbout UsContact UsFollow WATTPoultry.comFacebook iconLinkedIn iconYouTube iconSign InFollow WATTPoultry.comFacebook iconLinkedIn iconYouTube iconPoultry MeatEggPoultry HealthSustainabilityPoultry FutureMarket InformationTop Poultry CompaniesExpert InsightsBlogsRegionsMagazinesSubscribeAdvertiseBroilers & TurkeysDiseases & HealthAvian InfluenzaFAO warns of rising avian flu threat in Asia-Pacific regionThe United Nations’ agency sees potential for the current situation in the region to develop into a full-blown pandemic.Jackie LindenJuly 29, 2024designersart | BigStockPhoto.comConcerned about a recent jump in human infections with influenza viruses of avian origin in the region, the United Nations’ Food and Agriculture Organization (FAO) is calling for urgent action in the Asia-Pacific area in order to create a holistic approach to disease management.Stressing the need for a united response, it wants to see surveillance systems implemented, capacity building in diagnostics, and full and timely data sharing between sectors. In particular, the agency is looking for full genome sequencing in order to monitor the spread of the virus, and its evolution.“Governments, international organizations, and the private sector must collaborate and share information transparently and in a timely manner to devise effective containment strategies,” FAO said.Specifically for the regional poultry sector, the agency described strengthening of biosecurity measures as “imperative,” along with effective vaccination strategy.It also called for awareness to be created among health providers and the general public in its 13 member nations in the Asia-Pacific regarding the human health risks from sick and dead poultry. Human cases spike in Asia-PacificIn recent years, few infections in people were reported in this region, according to the FAO.However, over the past few months, 13 cases have been recorded in Cambodia, and others in China and Vietnam. This is a cause for concern for the FAO, along with the emergence of a new strain of avian influenza(A) virus.“Since late 2023, we have observed a rise in human cases and the virus spreading to new animal species,” said Kachen Wongsathapornchai, who is Regional Manager of FAO Emergency Centre for Transboundary Animal Diseases (ECTAD). “The emergence of novel A/H5N1 strains, which are more easily transmissible, increases the pandemic threat.”For the FAO, the threat is exacerbated by the ever wider geographical spread of the H5N1 highly pathogenic avian influenza (HPAI) virus serotype, and its ability to infect new species of wild and domestic animals. Furthermore, there are particular additional risks in some regions, including generally low levels of biosecurity in the Greater Mekong sub-region, Indonesia, and the Philippines. While some other nations may be insufficiently prepared for the return of avian influenza, others — including Bangladesh, India, and Nepal — are already battling to control outbreaks, says the FAO.Kachen called for the region to take immediate coordinated preventative measures.Supporting this call for action is the latest news from the World Health Organization. Its latest report on the avian influenza (A) situation in the Western Pacific Region includes a further human case in China reported in the period July 19-25. A 70-year-old woman in Anhui province who became unwell in mid-June tested positive for the H5N6 virus variant. She died in early July. This patient was the 93rd confirmed infection with this particular virus type in the region since 2014, and the 57th to die. Update on HPAI situation in the region’s poultryLatest report from the dedicated Australian government website confirms a total of 16 HPAI outbreaks in poultry linked to viruses of the H7 family. The first cases were confirmed in mid-May, and no new cases have been confirmed over the past week.Of these outbreaks, eight occurred at premises in the state of Victoria, six in New South Wales, and two in the Australian Capital Territory (ACT). All premises have been depopulated.According to earlier notifications to the World Organisation for Animal Health (WOAH), four of the flocks were described as backyard or hobby flocks, and tested positive for the H7N8 virus variant — as have those at four commercial farms. At another seven farms, presence of the H7N3 virus was confirmed, while the H7N9 serotype was found at just one farm.Total number of poultry impacted by the ongoing disease waves in Australia has just passed 1.8 million.In the Philippines, there has also been no change in the HPAI situation, according to the latest update from the Department of Agriculture (DA) Bureau of Animal Industry. As of July 19, there are just three ongoing outbreaks in the country. All involve the H5N1 virus serotype, and are affecting three poultry farms in the province of Pampanga in the Central Luzon region. View our continuing coverage of the global avian influenza situation in poultry, and on disease developments in the U.S.RecommendedHatchersGiordano HatchCargoSystem ProLifeLatest NewsNational Turkey Federation offering 'Thanksgiving 101' tips and recipesRelated StoriesAvian InfluenzaAnother Weld County, Colorado, farm hit with avian fluAvian InfluenzaMore H5N1 cases reported in Colorado poultry, peopleAvian InfluenzaWOAH: H5N1 situation in Mexican poultry is resolvedAvian InfluenzaAvian influenza recurs in poultry in Bhutan, CambodiaMore in Avian InfluenzaAvian InfluenzaAvian flu confirmed in poultry flocks in 13 European countriesThe H5N5 variant has been confirmed for the first time at a European poultry farm.Brand InsightsVaccination success depends on crew trainingZoetisContinuous evaluation and training are critical to improving pullet vaccination accuracy.Avian Influenza8 more British Columbia flocks struck by avian fluSo far in 2024, the province has had 22 commercial poultry flocks affected by the virus.Avian InfluenzaLatest Canadian HPAI infections involved variety of speciesOne more flock infection has been reported in Abbotsford, British Columbia.Avian InfluenzaHPAI hits 5 flocks in British Columbia, 1 in CaliforniaAPHIS provides additional information concerning two broiler flocks previously reported as confirmed cases.Avian InfluenzaAustralia commits more funds to H5N1 preparednessAustralian authorities add additional funds to surveillance, biosecurity, vaccines and communications in the face of possible H5N1 incursion.Avian InfluenzaAPHIS updates report on California HPAI casesFlock size numbers for two of four affected operations have been disclosed.Avian InfluenzaMore HPAI reported in California, British Columbia poultryBoth the state and the province have confirmed cases in two commercial flocks.Avian InfluenzaFirst avian flu outbreaks of the season in East AsiaHPAI cases have been reported in poultry and wild birds across Asia from Israel to Japan and South Korea.Avian InfluenzaAvian influenza strikes two California broiler flocksThe number of chickens involved has not yet been disclosed.North AmericaAvian flu infections continue to hit British ColumbiaThe province has had six commercial poultry flocks affected by the virus since October 21.Avian InfluenzaFrance confirms avian flu in vaccinated flocksDucks were found to be positive for the HPAI virus following routine testing, despite them showing no symptoms of the disease.Avian InfluenzaAvian flu hits second broiler flock in California countyThe latest flock infection in Tulare County involved 6,000 broilers.Page 1 of 182Next PageNews and analysis for the global poultry industryFollow WATTPoultry.comFacebook iconLinkedIn iconYouTube iconDelete My DataTopicsPoultry MeatEggPoultry HealthSustainabilityPoultry FutureMoreWebinarsBrand InsightsPodcastsWhite PapersWATT Poultry ChatTop Companies Data DownloadsMagazinesSubscribeAdvertiseAbout UsContact UsMedia RequestPrivacy PolicySite Map© 2024 All rights reserved.The blowfly, a potential means [IMAGE] | EurekAlert! Science News Releases Advanced Search Home News Releases Multimedia Meetings Login Register The blowfly, a potential means of bird flu transmission (IMAGE) Kyushu University Caption Blowflies, a family of flies strongly attracted to decaying flesh and feces, are carrying the bird flu virus in southern Japan, highlighting a potential new route of bird flu transmission. Image captured from Kyushu University’s Biodiversity Conservation Zone. Credit Ryosuke Fujita, Kyushu University Usage Restrictions Only for media and non-commercial use. License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system. Media Contact Danielle Ellenby Kyushu University sysintlkh@jimu.kyushu-u.ac.jp Office: 928022138 More on this News Release Tiny flyers with large impact: Blowflies carry bird flu virus Kyushu University Journal Scientific Reports Funder Japan Society for the Promotion of Science DOI 10.1038/s41598-024-61026-1 Keywords /Health and medicine/Diseases and disorders/Infectious diseases/Influenza/Avian influenza /Health and medicine/Diseases and disorders/Infectious diseases/Influenza /Health and medicine/Diseases and disorders/Infectious diseases /Health and medicine/Diseases and disorders/Epidemics /Health and medicine/Human health/Public health /Life sciences/Organismal biology/Animals/Invertebrates/Arthropods/Insects /Health and medicine/Epidemiology/Infectious disease transmission /Health and medicine/Epidemiology/Infectious disease transmission/Disease vectors /Health and medicine/Epidemiology/Disease outbreaks /Health and medicine/Epidemiology /Health and medicine Additional Multimedia The blowfly, a potential means of bird flu transmission Original Source https://www.kyushu-u.ac.jp/enesearches/view/296 Copyright © 2024 by the American Association for the Advancement of Science (AAAS) facebook.com/EurekAlert @EurekAlert youtube.com/EurekAlert Help / FAQ Services Eligibility Guidelines Contact EurekAlert! Terms & Conditions DMCA Privacy Policy Disclaimer Copyright © 2024 by the American Association for the Advancement of Science (AAAS)Prince Albert Victor: The Fascinating Story of Britain's 'Lost' King | HistoryExtraSubscribeNewsletter sign upDownload appJoin our AcademyThe official website for BBC History MagazinePeriodBack to Main menuAncient EgyptRomanVikingAnglo-SaxonMedievalTudorElizabethanGeorgianVictorianSecond World WarBack to PeriodBrowse all periodsPeopleBack to Main menuTutankhamunRichard IIIHenry VIIIElizabeth IQueen VictoriaWinston ChurchillCleopatraNapoleon BonaparteBack to PeopleBrowse all peopleTopicsBack to Main menuKings and queensWeird and wonderfulSex and loveSocial historyReligious historyWomen's historyHistorical Q&AsHeritage visitsHistory heroHistorical recipesTurning points in British HistoryBack to TopicsBrowse all topicsVideoPodcastBack to Main menuPodcast seriesQuizzesMembershipBack to Main menuMembership areaBack to MembershipMember discountsJoin HistoryExtraBBC History MagAcademyBack to MembershipVictorian Life with Ruth GoodmanLate-medieval England courseRoman Britain courseD-Day courseWitchcraft courseElizabethans courseVikings courseRegency courseSubscribeNewsletter sign upDownload appJoin our AcademySearchHomePeriodVictorianPrince Albert Victor, aka Eddy: the fascinating story of Britain’s ‘lost’ kingPrince Albert Victor, aka Eddy: the fascinating story of Britain’s ‘lost’ kingQueen Victoria’s grandson and heir to the British throne, the handsome Prince Albert Victor – or ‘Eddy’ – had an illustrious future ahead of him. Yet by the time of his premature death in 1892, he had disappointed his family and been linked to a sexual scandal. In the 1970s, it was even suggested that the prince was the notorious Whitechapel killer, Jack the Ripper. Here, Alan Robert Clark explores the life of Prince Eddy and the many questions the royal still raises…Published: July 30, 2024 at 2:28 PMThe gifting season is soon upon us! Treat a loved one, or yourself, to a BBC History Magazine subscription AND receive a hardback and signed book - includes FREE HistoryExtra Membership.SaveShare on facebookShare on twitterShare on whatsappEmail to a friendThe execution of the Romanovs by the Bolsheviks was one of the most haunting footnotes of the First World War. But for the Empress Alexandra at least, destiny could have been very different. Instead of dying in the blood-soaked cellar at Ekaterinberg – the fate which met Tsar Nicholas II, his wife and their five children – she might easily have lived a long, contented life in the splendour of Buckingham Palace and Windsor Castle.AdvertisementThe future tsar was not the first man who wanted Alicky of Hesse (as she was known as a girl) to become his wife. That distinction belongs to another young and handsome prince, a prince who is now largely forgotten.His formal name was Prince Albert Victor, later the Duke of Clarence, but he was always called ‘Eddy’ by his family.Who was Prince Albert Victor?Born in 1864, Albert Victor (called Eddy by his family) was the elder son of Edward (Bertie), Prince of Wales and the future King Edward VII, and his wife Alexandra of Denmark. Albert Victor was the grandson to the ruling Queen Victoria, and therefore heir presumptive to the crown of the United Kingdom.Edward, Prince of Wales (the future King Edward VII) and his wife Alexandra of Denmark, photographed with his mother Queen Victoria. (Photo by Hulton Archive/Getty Images)At this time, the British empire was at its spectacular zenith and the British ruled in territories across the world; Prince Eddy’s future was beyond dazzling. He was tall, dark and handsome as well as reportedly kind and good-natured.Many, including his grandmother Queen Victoria, prayed that Eddy and his cousin, Alicky, would marry. But Alicky turned Prince Eddy down, flatly rejecting what the queen – her nose out of joint – called “the greatest prize there is”. Why on earth would the ungrateful girl do that? What, exactly, was wrong with Eddy?Read more | The marriages of Queen Victoria’s grandchildren: how the dynasty shaped EuropeTo the royal family, Alicky’s refusal was unwelcome confirmation of their own secret fears that there was indeed quite a lot ‘wrong’ with Eddy.Despite his positive characteristics, the prince was exceptionally languid and lethargic, showing precious little interest in anything at all, beyond shooting birds out of the sky. The prince's childhood tutor had despaired of being able to educate Eddy to the standard necessary for his position in life. When Eddy and his younger brother George were sent as midshipmen on a three-year voyage round the world to broaden their horizons, both literally and metaphorically, there seemed to be little effect on sleepy Eddy.George, their father Edward’s clear favourite, had found himself in the role of ‘carer’ to his elder brother. The Prince of Wales, increasingly irritated and concerned by his older son’s apathy, chaffed him mercilessly. Even the doting Alexandra – who infantilised all her five surviving children, still calling them by childish names when they were full-grown adults – began to worry, though she put his lethargy down to having grown too tall too fast.But the unspoken consensus gradually took hold that the heir presumptive just wasn’t up to the mark and hopelessly unworthy of the stratospheric position he must one day hold.This is all the more tragic because, in the light of modern knowledge, it is most likely that Prince Eddy simply had learning difficulties; one historian believes that he may also have suffered from a mild form of childhood epilepsy which would explain his apathy and problems with concentration. Sadly, Eddy himself probably intuited the general view of his inadequacies. So, as he grew towards adulthood, a boy who was destined to be one of the most famous people in the world had little sense of self-esteem.It was decided that Eddy should go to university, though it was wisely decreed he would not have to sit any examinations.His time at Trinity College, Cambridge, was among the happiest of his life. Freed from the claustrophobic royal cocoon, he began to blossom. His new tutor was James Kenneth 'Jem' Stephen, a charismatic academic and poet, just a few years older than Eddy himself. Stephen seems to have realised very quickly that the prince was far from stupid, and that his fine human qualities of kindness and empathy for others were strong foundations for a successful constitutional monarch. The young tutor worked hard to nurture Eddy’s potential, stretching his mind through literature and poetry and, above all, by simply soaking up the company of clever people, who were far removed from the philistine, ‘hunting and shooting’ milieu the prince had inhabited until then.Great reputations Member exclusive | In our podcast series, expert historians discuss the contested reputations of key historical figures, charting the lives and afterlives of Cleopatra, Napoleon Bonaparte, Emmeline Pankhurst and more… Listen to all episodes now Prince Albert Victor's sexualityFor the first time, Eddy was encouraged to see some value in himself and to get his first hazy impressions of his own identity. It was an intense friendship; whether or not it ever became a physical relationship can’t be known, but there were certainly quite a few gay men in the sophisticated, liberal circles in which Eddy now found himself.By this point, the prince had grown into an extremely handsome young man. Luckily for him, he had inherited the looks of his beautiful mother rather than the bulbous-features of his father’s family. He had a long swan-like neck, a full-lipped mouth, and was what we’d now call a fashion victim. For Eddy, with his fragile sense of self-worth, this was yet another way of validating himself – and he seems to have embraced it vigorously.Prince Albert Victor was, in today's parlance, a fashion victim. (Photo by Hulton Archive/Getty Images)Modern historians have been divided on Eddy’s sexuality. Some maintain there is no concrete proof that the prince was anything other than heterosexual.Whilst this can’t be denied, there is much to suggest that he was at least bisexual. What are referred to, delicately and vaguely, by earlier authors as Eddy’s "dissipations" must have been something far more scandalous from the usual vices of the young men of his class; drink, gambling and heterosexual sex. Nobody, least of all his own licentious father, would have raised an eyebrow at a few mistresses or visits to prostitutes.Read more | King Edward VII’s love chair: how did Dirty Bertie’s siège d’amour actually work?Yet it was Bertie himself who, at his wits’ end over what to do about his wayward heir, at one point insisted Eddy should go on a long tour of the more remote colonies and certainly nowhere near the sybaritic capitals of Europe. What exactly was so shocking about Eddy’s shenanigans that put the jaded Bertie into such a panic? Even Queen Victoria herself seems somehow to have caught wind of her grandson’s peccadilloes. “I ask again,” bleated her private secretary. “Who is it tells the Queen these things?”Edward, Prince of Wales (and future Edward VII) and his wife Alexandra, Princess of Wales (third from left) and their five children. From left: Albert Victor, Duke of Clarence; Maud, Queen of Norway; Louise, the Princess Royal, Duchess of Fife. Front, Prince George (future George V) and Princess Victoria. (Photo by Hulton Archive/Getty Images)The trouble with Eddy came to a head with the Cleveland Street Scandal of 1889, in which the existence of a male brothel in London frequented by the aristocracy exploded in the press. Eddy was rumoured to have been one of its clients.Down the decades, forests of newsprint have been devoured by writers competing to prove that either there was some sort of establishment cover-up over Eddy’s presence or, conversely, that he never went there at all. From our enlightened viewpoint in the 21st century, it is difficult to care either way but, as the saying goes, the past is a foreign country where they do things differently. Though Eddy’s name was kept out of the British press, the scandal was serious enough for the New York Times to opine that the dissolute Prince Albert Victor would never be permitted to ascend the British throne.Was Prince Albert Victor Jack the Ripper?It was Prince Albert Victor's louche reputation which, ludicrously, put him at the centre of the obsession with the identity and motivation of the Victorian killer dubbed ‘Jack The Ripper’ during the 1970s. As a tall ‘toff’ had been seen in the vicinity of one of the murders, might it have been Eddy? This theory was floated despite the provable fact he had been at Balmoral on the night in question.Yet another theory suggested that the prince had impregnated one of the murder victims, that she was going to spill the beans and that the establishment, in order to protect the monarchy, ordered her killing and that of all the other women in whom she had confided.Read more | 5 theories about Jack the Ripper's identityPoor Eddy; the relatively few people who know his name today probably only do so in relation to these ‘penny-dreadful’ tales. He is the ‘black sheep’ prince. A sad epitaph for a reportedly kind, considerate young man who, whatever his faults, was still loved by his family and liked by nearly everyone who knew him.Prince Albert Victor's engagementAfter Alicky had spurned him, Prince Albert Victor had fallen in love with Princess Hélène of Orléans, whose father was a pretender to the French throne. But her Catholicism put paid to the match and Eddy had reverted to his ‘tomcat’ ways. Meanwhile, his so-called career as an army officer had been lacklustre and his parents had no idea what to do with him.In late 1891, they more or less ordered him to marry Mary of Teck, a minor princess within the British royal family whom he scarcely knew. The reserved, bookish ‘May’, as she was known, seemed an unlikely spouse but, in the queen’s view, she was just the right girl to steady Eddy. To everyone’s surprise, they appeared to hit it off and the wedding was planned for February 1892. In those same weeks, the government suggested that he should become Viceroy of Ireland, which was a purely ceremonial role, but a goodwill gesture to attempt to cool the tensions in the area.All at once, Eddy was to have a new bride and a new purpose in life. His father had arranged a meeting with the relevant politicians for the third week of January 1892 to discuss the plan further. But by that time Eddy would be dead.What did Prince Albert Victor die of?On 7 January 1892, the day before his 28th birthday, Prince Albert Victor caught a cold which turned into flu, and Eddy missed his own birthday party. The flu turned in pneumonia and, to the horror of his family, he was dead within the week – just one victim of the influenza outbreak that killed many thousands that terrible winter.Albert Victor, Duke Of Clarence (left) pictured with his brother, the future George V, c1885. After Albert's death, George married Albert Victor's fiancée Mary of Teck and became heir apparent to the throne. (Photo by W. & D. Downey/Getty Images) (Photo by W&D Downey/Hulton Archive/Getty Images)Bertie, Prince of Wales – the father who had teased him so mercilessly – reportedly wept throughout the funeral, and it’s said that he kept Eddy’s picture above his bed for the rest of his life.Following the morbid example of Queen Victoria, his clinging mother Alexandra kept the room in which he died as a permanent shrine; his hairbrushes and shaving things all ready, a fire burning in the grate. His fiancée Princess May became a ‘widow’ before she had become a wife (though, after a decent interval, she was ‘passed on’ to his younger brother George and became the austere, iconic Queen Mary).And the great mass of the people, shocked and saddened at a young life cut short, mourned their lost prince. Bells tolled across Britain. Shops and theatres closed. The expected tributes were paid. But the view of many in the establishment (and the view that history has endorsed) is that the death of Prince Eddy was a lucky break that paved the way for the younger brother, who was perhaps gruff and uninspiring but a far safer pair of hands.Where is Albert Victor buried?It is difficult to think of any other royal of recent times whose reputation has been so comprehensively and unfairly ‘trashed’ as that of Prince Albert Victor, grandson of Queen Victoria. Whatever files are kept on him in the Royal Archives, a private family resource, appear to be firmly closed to most researchers.Even in death, he somehow seems a man apart; his tomb in St George’s Chapel, Windsor, splendid though it is, lies in a space to the rear of the main church, separate from where the rest of his family lies. Few of the tourists who shuffle past it probably have any idea who he was.The Albert Memorial Chapel Windsor during the funeral of Prince Albert Victor. (Photo by Print Collector/ Getty Images)Obviously we can never know what sort of monarch that Eddy might have been. Yet his own father, who came to the throne in 1901 with the lowest of expectations, turned out to be the highly successful King Edward VII.Might not Eddy, far from being a 'waste of space’, have repeated that pattern? In an age when the personalities of monarchs mattered more than they do now, who’s to say what emollient effect his decent, good-hearted character might have had on the international stage in the tense years leading up to the Great War? It’s certainly hard to imagine that he would ever have turned his back on the plight of the Romanovs, as his brother King George V arguably did. And Alicky, the girl Eddy had once yearned to marry, might well have died an old lady in the peaceful safety of some English country house.Like all ‘lost’ princes, Eddy is one of the fascinating ‘what if's of history. But instead of the tired old trope of ‘what a blessing’ that he never lived to sit upon the British throne, perhaps history should rather be saying ‘what a shame’.Read more | Could George V have saved the Romanovs?AdvertisementAlan Robert Clark is the author of the historical novel The Prince of Mirrors (Fairlight Books, 2018)AdvertisementAdvertisementThe gifting season is soon upon us! Treat a loved one, or yourself, to a BBC History Magazine subscription AND receive a hardback and signed book - include FREE HistoryExtra Membership. See booksAdvertisementSign up for the weekly HistoryExtra newsletterSign up to receive our newsletter!Email addressSign UpBy entering your details, you are agreeing to our terms and conditions and privacy policy. You can unsubscribe at any time.Save 53% + a hardback and signed bookGive a gift or treat yourselfSee booksUSA Subscription offer!Save 76% on the shop price when you subscribe today - Get 13 issues for just $45 + FREE access to HistoryExtra.comSubscribe nowHistoryExtra podcastListen to the latest episodes nowListen hereVisit us on FacebookVisit us on TwitterVisit us on InstagramVisit us on YoutubeVisit us on RssAbout UsTerms & ConditionsPrivacy PolicyCookie PolicyCode of ConductHistory Magazine SubscriptionsFAQContact UsVacanciesLicensingFind UsManage Privacy SettingsHistory Extra is owned and published by Immediate Media Company Limited. BBC History Magazine and BBC History Revealed are published by Immediate Media Company Limited under licence from BBC Studios Distribution.© Immediate Media Company Ltd. 2024Cornellâs Animal Diagnostic Center testing limit avian flu Open in Our App Get the best experience and stay connected to your community with our Spectrum News app. Learn More Open in Spectrum News App Continue in Browser Toggle navigation Central NY EDIT Watch Live | Recent Activity Log Out Recent Activity Log In LATEST NEWS Headlines Business & Growth Around the State Education Good News Health The Big Deal with Errol Louis Pursuit Unlimited Everyday Heroes Lottery Seen On WEATHER & TRAFFIC Today's Forecast 7 Day Forecast Interactive Radar Current Conditions Satellite & Radar Weather Blog Travel Weather Watches & Warnings Closings & Delays Sign Up For Weather Alerts Traffic Map Traffic News Gas Prices Storm Season POLITICS Election Results Political News New York State of Politics Capital Tonight 2024 Elections Washington, D.C. Bureau In Focus AROUND SYRACUSE Things to Do Community Calendar Submit an Event SPORTS Sports Headlines Orange Empire PUBLIC SAFETY Public Safety News Podcasts All Podcasts Buffalo End Zone What Could Be OUR JOURNALISTS ACCOUNT Sign Out Recent Activity ACCOUNT Sign In Recent Activity LATEST NEWS Headlines Business & Growth Around the State Education Good News Health The Big Deal with Errol Louis Pursuit Unlimited Everyday Heroes Lottery Seen On WEATHER & TRAFFIC Today's Forecast 7 Day Forecast Interactive Radar Current Conditions Satellite & Radar Weather Blog Travel Weather Watches & Warnings Closings & Delays Sign Up For Weather Alerts Traffic Map Traffic News Gas Prices Storm Season POLITICS Election Results Political News New York State of Politics Capital Tonight 2024 Elections Washington, D.C. Bureau In Focus AROUND SYRACUSE Things to Do Community Calendar Submit an Event SPORTS Sports Headlines Orange Empire PUBLIC SAFETY Public Safety News Podcasts All Podcasts Buffalo End Zone What Could Be OUR JOURNALISTS × Set Weather Location Get hyperlocal forecasts, radar and weather alerts. Please enter a valid zipcode. Save Confirm Your News Market We automatically picked the Spectrum News market we think is most relevant to you. New York City News and information that matter to your community. Local weather forecasts. Confirm Change News Market You can change your news market at any time. State of PoliticsRead up on New York politics with our Capital Tonight team. WEATHER ALERTSView full list of weather alerts. Closings and DelaysCheck the latest closings and delays for schools, business, and churches around CNY and the Mohawk Valley. The Animal Health Diagnostic Center is located at Cornell University in Ithaca. (Emily Kenny/Spectrum News 1) New York state provides Cornell lab $19.5M to control avian flu in dairy industry By Emily Kenny, Report for America corps member Central NY PUBLISHED 6:00 PM ET Jul. 29, 2024 PUBLISHED 6:00 PM EDT Jul. 29, 2024 SHARE While there are no confirmed cases of avian flu among New Yorkâs dairy cattle, researchers at Cornell University will utilize state funds on the frontlines to help fight the outbreak. New York legislators gave $19.5 million on Monday to expand the Animal Health Diagnostic Center at Cornell University, just months after avian influenza was confirmed to be spreading to dairy cattle. âThe need to grow this facility and to be able to handle all the needs that theyâre dealing with today with HPAI and everything else, was apparent,â said New York Commissioner of Agriculture Richard Ball. In March, it was confirmed by the Animal Health Diagnostic Center that a dairy herd in Texas tested positive for the highly pathogenic avian influenza. âWe have this new phenomenon to think about with dairy herds coming down with HPAI, which we thought was restricted to the poultry industry. The need and demands on the diagnostic lab to help with that understanding [is important],â Ball said. New York has not had any positive cases of HPAI among dairy cattle, but 13 other states have, which concerns the commissioner. âLactating dairy animals moving between states need to be tested before they can do that movement, so weâre watching that very closely. Weâve been focusing on biosecurity with our dairy industry in a very big way,â Ball said. Pasteurization of milk is vital to killing the virus in milk. âWe tested and tested nationally and in the state. These people here did a lot of that testing, so weâre good. We have a safe milk supply, but we still need to understand more about how this is moving around,â Ball said. Diego Diel, director of virology laboratory at the Animal Health Diagnostic Center, was one of the first to confirm the mammal-to-mammal spread of HPAI after receiving samples of milk from farms in Texas. âWe tested those samples when they first arrived, targeting the normal pathogens that cause respiratory diseases in cattle, but the sequences came back all negative. So then we decided to run next generation sequencing on those samples, and thatâs how we detected avian influenza sequences,â Diel said. While researchers donât know exactly how the virus spreads from cow to cow, Diel suspects it could be through aerosols created during the milking process as cattle shed a high level of the virus in milk. âThat is one of the ways that influenza could transmit. The other possibility could just be mechanical transmission through milking,â Diel said. When infected cows are milked, the milking machine goes to the next animal, potentially infecting them, causing a drop in milk production. Diel said to his knowledge, there have been no confirmed cases among beef cattle. âI think they would probably be less susceptible because of the tropism of the virus for the mammary glands. Potentially, lactating beef cows could be susceptible and transmit the virus, but I think it would be more limited because of that difference,â Diel said. His research found that domesticated cats and raccoons also tested positive for the virus. New York requires lactating dairy cattle attending county and state fairs to have a negative HPAI test within seven days. Many of these tests will come through the Animal Health Diagnostic Center. âLetâs not contribute to making something worse,â Ball said. âItâs a totally understandable, and several states have adopted the same policies.â Poultry going to fairs also will have regulations in place, and while cattle can survive the HPAI, birds cannot. âFor our cows, itâs a challenge, but for our poultry, itâs life and death and the only remedy is depopulation,â Ball said. Spectrum News Contact About RSS Sitemap FAQ ADVERTISE WITH US CAREERS TERMS Your Privacy Rights California Consumer Privacy Rights California Consumer Limit the Use of My Sensitive Personal Information Do Not Sell or Share My Personal Information/Opt-Out of Targeted Advertising CERTIFICATIONS Â© 2024, Charter Communications, all rights reserved.Tiny flyers with large impact: Blowflies carr | EurekAlert! Advanced Search Home News Releases Multimedia Meetings Login Register News Release 1-Aug-2024 Tiny flyers with large impact: Blowflies carry bird flu virus A new study from a wild bird colony in southern Japan reveals that blowflies are a potential means of bird flu transmission. Peer-Reviewed Publication Kyushu University image: In winter, thousands of cranes migrate to Izumi city in Southern Japan. During winter 2022-2023, 1600 cranes out of colony of 10000 cranes died from bird flu. view more Credit: Ryosuke Fujita, Kyushu University Fukuoka, Japan – Researchers from Kyushu University have discovered that blowflies, a family of flies strongly attracted to decaying flesh and feces, are carrying the bird flu virus in southern Japan. Their findings, published in Scientific Reports, introduce a potential new route of transmission for bird flu and highlight the need to develop new countermeasures to prevent and control the disease in poultry farms. Since 2020, bird flu has been spreading rapidly around the globe, leading to the death of millions of wild birds and the culling of more than half a billion farmed birds worldwide. In Japan, where a single case of infection on a poultry farm mandates the culling of the entire stock, the 2022-2023 winter season saw a record-high of 326 outbreaks of bird flu, resulting in the sacrifice of 17.7 million birds. Some strains of bird flu have also jumped to mammals, including cows, goats, dogs, cats, and since March, an uptick of cases in poultry and dairy workers, with a high fatality rate, has raised significant concern. "Bird flu has been causing substantial damage to wildlife and the poultry industry, and also holds great risk for humans who work closely with livestock. It’s therefore vital to understand how the virus spreads and its potential routes of transmission to control and prevent outbreaks," explains first author Associate Professor Ryosuke Fujita of Kyushu University’s Faculty of Agriculture. In this research, the scientists studied a wild crane colony in Izumi city, Kagoshima Prefecture, in southern Japan. In winter, the prime season for bird flu, thousands of cranes migrate to this area, with their dense numbers making them vulnerable to infection. During winter 2022-2023, 1600 cranes out of colony of 10000 cranes died from bird flu. "We were notified about the cranes being infected and we had to act quickly,” says Fujita. Along with his colleagues, he set traps at different locations around Izumi city to collect blowflies. "We were particularly interested in one species of blowfly, Calliphora nigribarbis, as unlike other fly species, they are active in winter, coinciding with the peak season of bird flu. This, along with their attraction to the flesh and feces of animals, makes them a prime suspect for spreading the virus," adds Fujita. The researchers collected 648 blowflies and discovered that 14 blowflies were carrying the bird flu virus. The majority of virus-positive blowflies were collected from the sample site closest to the crane colony. "While 14 blowflies may seem like a low number, this represents a prevalence in blowflies of 2.2%, which is a huge percentage compared to other diseases spread by insects,” explains Fujita. The research team also used genetic testing to confirm that the blowflies were carrying the same virus strain that has been infecting the crane colony. Unlike birds and mammals which the virus infects and replicates inside, blowflies instead ingest the virus from infected dead birds or their waste, with the virus maintaining infectivity for up to two days. Blowflies are capable of flying at least 2 kms per day, so the researchers estimate that is it feasible for them to reach nearby poultry farms or other wild bird populations within a 4 km range. The researchers believe that as the blowfly moves from place to place, it could contaminate surfaces, food sources and water sources, with healthy birds becoming infected through direct contact with these contaminated sources, or by ingesting adult or larval blowflies. In Japan, where farmers often use closed farming systems instead of open spaces to control infections and maximize production, countermeasures aimed at eliminating blowflies could be implemented fairly easily, helping to protect farmers from severe financial damage. "By keeping areas clean and using fly control methods, such as fine nets or insecticides, we can reduce the risk of virus spread to indoor poultry farms. However, in outdoor farms in other countries, and in wild bird populations, controlling blowflies may be logistically impossible,” says Fujita. Having identified that blowflies carry the virus, Fujita and his colleagues are now collaborating with the government to capture blowflies in quarantined sites around infected poultry farms, hoping to find definitive evidence that blowflies are causing these outbreaks. Fujita and his colleagues are also developing new tools that use artificial intelligence to assess and predict the potential risks of vector insects. "By using advanced technologies alongside on-the-ground research, we can better understand and control the spread of bird flu and other insect-borne diseases, ultimately safeguarding both animal and human health,” concludes Fujita. Written by Negar Khalili ### For more information about this research, see Fujita, R., Tachi, T., Hino, M. et al. Blowflies are potential vector for avian influenza virus at enzootic area in Japan. Sci Rep 14, 10285 (2024). https://doi.org/10.1038/s41598-024-61026-1 About Kyushu University Founded in 1911, Kyushu University is one of Japan's leading research-oriented institutes of higher education, consistently ranking as one of the top ten Japanese universities in the Times Higher Education World University Rankings and the QS World Rankings. The university is one of the seven national universities in Japan, located in Fukuoka, on the island of Kyushu—the most southwestern of Japan’s four main islands with a population and land size slightly larger than Belgium. Kyushu U’s multiple campuses—home to around 19,000 students and 8000 faculty and staff—are located around Fukuoka City, a coastal metropolis that is frequently ranked among the world's most livable cities and historically known as Japan's gateway to Asia. Through its VISION 2030, Kyushu U will “drive social change with integrative knowledge.” By fusing the spectrum of knowledge, from the humanities and arts to engineering and medical sciences, Kyushu U will strengthen its research in the key areas of decarbonization, medicine and health, and environment and food, to tackle society’s most pressing issues. Journal Scientific Reports DOI 10.1038/s41598-024-61026-1 Method of Research Experimental study Subject of Research Animals Article Title Blowflies are potential vector for avian influenza virus at enzootic area in Japan Article Publication Date 4-May-2024 COI Statement The authors declare no competing interests. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system. Media Contact Danielle Ellenby Kyushu University sysintlkh@jimu.kyushu-u.ac.jp Office: 928022138 More on this News Release Tiny flyers with large impact: Blowflies carry bird flu virus Kyushu University Journal Scientific Reports Funder Japan Society for the Promotion of Science DOI 10.1038/s41598-024-61026-1 Keywords /Health and medicine/Diseases and disorders/Infectious diseases/Influenza/Avian influenza /Health and medicine/Diseases and disorders/Infectious diseases/Influenza /Health and medicine/Diseases and disorders/Infectious diseases /Health and medicine/Diseases and disorders/Epidemics /Health and medicine/Human health/Public health /Life sciences/Organismal biology/Animals/Invertebrates/Arthropods/Insects /Health and medicine/Epidemiology/Infectious disease transmission /Health and medicine/Epidemiology/Infectious disease transmission/Disease vectors /Health and medicine/Epidemiology/Disease outbreaks /Health and medicine/Epidemiology /Health and medicine Additional Multimedia The blowfly, a potential means of bird flu transmission Original Source https://www.kyushu-u.ac.jp/enesearches/view/296 Copyright © 2024 by the American Association for the Advancement of Science (AAAS) facebook.com/EurekAlert @EurekAlert youtube.com/EurekAlert Help / FAQ Services Eligibility Guidelines Contact EurekAlert! Terms & Conditions DMCA Privacy Policy Disclaimer Copyright © 2024 by the American Association for the Advancement of Science (AAAS)Stem cell therapy advances: MSCs show potential in managing COVID-19 and influenza infections Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About COVID-19 News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge Newsletters Health & Personal Care eBooks Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Cold, Flu & Cough Eating Disorders Eye Health Gastrointestinal Health Heart Disease High Blood Pressure Lung Cancer Mental Health Mpox Pregnancy Type 1 Diabetes Type 2 Diabetes Sexual Health Sleep View Health A-Z ×Top Health Categories Coronavirus Disease COVID-19 Heart Disease Diet & Nutrition High Blood Pressure Artificial Intelligence Lung Cancer Allergies Mental Health Alzheimer's & Dementia Mpox Arthritis & Rheumatology Pregnancy Breast Cancer Type 1 Diabetes Cold, Flu & Cough Type 2 Diabetes Eating Disorders Sexual Health Eye Health Sleep Gastrointestinal Health View Health A-Z Medical Home Life Sciences Home About News Life Sciences A-Z White Papers Lab Equipment Interviews Newsletters Webinars More... eBooks Contact Meet the Team Advertise Search Become a Member White Papers MediKnowledge Newsletters Health & Personal Care eBooks Contact Meet the Team Advertise Search Become a Member Webinars eBooks Contact Meet the Team Advertise Search Become a Member Stem cell therapy advances: MSCs show potential in managing COVID-19 and influenza infections Download PDF Copy Reviewed Compuscript LtdJul 31 2024 Announcing a new article publication for BIO Integration journal. The emergence of infectious diseases, including viral zoonoses, has allowed intensive research into novel therapeutic approaches. Stem cell therapy, mostly using mesenchymal stem cells (MSCs), has garnered significant attention due to the immunomodulatory properties and tissue repair capabilities. MSCs have demonstrated promise in treating severe COVID-19 cases and several clinical trials have revealed that MSC therapy improves 28-day survival rates, reduces mortality, and accelerates recovery. These cells effectively mitigate a cytokine storm, relieve pulmonary symptoms, and positively influence organ recovery, including the liver and kidneys. Bioanalytical readings return to normal following MSC administration, emphasizing the potential in managing COVID-19-induced complications. MSC therapy offers a potential solution for infection with the influenza virus, which is responsible for historical pandemics and epidemics, and remains a global health concern. MSCs inhibit immune cell-mediated responses and reduce lung damage in animal models, and despite antiviral drugs, influenza-induced manifestations persist. MSCs, with an ability to counteract inflammation and promote lung tissue repair, hold promise for managing influenza infection While MSCs offer therapeutic benefits, certain challenges remain. Specifically, ethical considerations, regulatory hurdles, and scalability are some of the challenges that hinder widespread adoption. However, ongoing systematic reviews and meta-analyses provide real-time insight that support the security and effectiveness of MSC therapy. Source:Compuscript LtdJournal reference:Datta, N., (2024) Stem Cell Therapy for SARS-CoV-2 and Influenza Virus Infections. BIO Integration. DOI:10.15212/bioi-2024-0016. Posted in: Medical Research News | Disease/Infection News Tags: Cell, covid-19, Cytokine, Drugs, Global Health, Immunomodulatory, Infectious Diseases, Inflammation, Influenza, Language, Liver, Medicine, Mesenchymal Stem Cells, Mortality, Research, SARS, SARS-CoV-2, Stem Cells, Virus Comments (0) Download PDF Copy Suggested Reading Space-grown stem cells show promise for accelerating biotherapiesCurcumin compound reactivates Epstein–Barr virus, offering safer cancer therapyKey kinase involved in cell division linked to abnormal blood vessel growth in genetic disorderUnraveling the mechanism of Shufeng Jiedu Capsules in influenza treatmentSARS-CoV-2 hijacks host proteins to escape immune clearanceSeasonal influenza adapted and evolved during the COVID-19 pandemicGroundbreaking study sheds light on stem cell dynamics post-transplantElevated antibody responses to Epstein-Barr virus linked to increased risk of multiple sclerosis Comments The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical. Cancel reply to comment Post a new comment Login (Logout) Quirky Comment Title Post TrendingStories LatestInterviews Top HealthArticles Traditional Chinese herb shows promise against Alzheimer’s and Parkinson’sBreakthrough research reveals how to target malignant DNA in aggressive cancersAncient herb shows promise in fighting dementiaLink between COVID-19 and long-term risk of autoimmune and autoinflammatory connective tissue disordersCDC updates pain care guidelines for clinicians Exploring the G:Box and for high-quality imaging Dr Martin Biggs In this interview, News Medical speaks with Dr Martin Biggs from Synoptics about Syngene's G:Box, a high-quality imaging and gel documentation system. Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024 Carolyn Marks and Joel Svensson In this interview, conducted at SfN 2024 in Chicago, News Medical speaks with Joel Svensson and Carolyn Marks of Atlas Antibodies, about their new launch, the MolBoolean™, as well as how conferences like SfN are helping shape the future of neuroscience research. How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics Susan Magsamen The intersection of arts and neuroscience reveals transformative effects on health and learning, as discussed by Susan Magsamen in her neuroaesthetics research. Why You Might Feel Tired After Drinking CoffeeMythbusting: The 10,000 Steps Per Day TrendCan Magnesium Supplements Help You Sleep Better?Challenges in the Global ADHD Medication Supply ChainHow Does Semaglutide Work to Lose Weight? Latest NewsMethylGPT unlocks DNA secrets for age and disease predictionAI-based ultrasound software guides childbirth decisions with high accuracyRevolutionary AI predicts aging and disease from DNA patternsCannabinol enhances sleep in rats, study showsOvertreatment of older men with prostate cancer raises concerns Newsletters you may be interested in Infectious Diseases (Subscribe or Preview) COVID-19 (Subscribe or Preview) Bipolar Disorder (Subscribe or Preview) See all Newsletters » High Credibility: This website adheres to all nine standards of credibility and transparency. Medical Links Medical Home COVID-19 News Health A-Z White Papers Thought Leaders Insights MediKnowledge Series Health & Personal Care Medical Devices Drugs eBooks Life Sciences Links Life Sciences Home News Lab Instruments & Equipment Life Sciences A-Z White Papers Thought Leaders Insights Webinars eBooks Other Useful Links About Meet the Team Search Newsletters Sitemap Advertise Contact Terms & Conditions Privacy & Cookie Policy Content Policy Ownership & Funding Information Other AZoNetwork Sites AZoM AZoNano AZoCleantech AZoOptics AZoRobotics AZoSensors AZoMining AZoQuantum AZoBuild AZoLifeSciences AZoAi Facebook Twitter LinkedIn News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Update Your Privacy Preferences Last Updated: Tuesday 12 Nov 2024 News-Medical.net - An AZoNetwork Site Owned and operated by AZoNetwork, © 2000-2024 Azthena logo with the word Azthena Maximise chat window Hide chat window Your AI Powered Scientific Assistant Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. To start a conversation, please log into your AZoProfile account first, or create a new account. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. Log in A few things you need to know before we start. Please read and accept to continue. Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI. Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy. Large Language Models can make mistakes. Consider checking important information. I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements. Please check the box above to proceed. Start Chat Great. Ask your question. Clear Chat Clear Chat Brief Moderate Detailed Azthena may occasionally provide inaccurate responses. Read the full terms. Terms While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information. Read the full Terms & Conditions. Provide Feedback Submit Cancel You might also like... × Leritrelvir shows high efficacy against SARS-CoV-2 protease mutationsAvian Influenza Confirmed In Neighboring States | Daily Dodge Skip to content Home 1430 ESPN 95.3 WBEV Contact Us Menu News Sports Weather and Closings Agriculture Obituaries Audio Daily Dodge TV Help Wanted Events Contests Pet of the Week Dodge County Most Wanted Diario Dodge ABC News Radiothon Digital Marketing Pack Attack Party Uncle Bill Avian Influenza Confirmed In Neighboring States July 28, 2024 by Daily Dodge (Wisconsin) The U.S. Department of Agriculture National Veterinary Services Laboratories says over the past 30 days a highly infectious avian influenza was confirmed in 43 dairy herds in six states including Iowa, Michigan, and Minnesota. Wisconsin’s Department of Agriculture, Trade and Consumer Protection state order requiring a negative test for Influenza A for lactating dairy cattle prior to moving to fairs or exhibitions is still in effect. No cases of cattle, poultry, or wildlife have been reported in Wisconsin. Nine human cases have been reported in the U.S. since 2022. The Food and Drug Administration and USDA emphasize that the commercial milk supply is safe, and the USDA is confident that the meat supply is safe. Categories News Tags Avian Influenza Listeria Outbreak Reported In WisconsinAlliant Energy Crews Return Home After Helping In Illinois Submit a News Tip Want to have your photos featured in our new website design? Send us your local photos for consideration! Click to Submit Your Photos Submit a Job Posting GOOD KARMA BROADCASTING100 Bill McCollum Way, Beaver Dam, WI 53916 920-885-4442 feedback@goodkarmabrands.com ESPN Daily Dodge ESPN | WBEV Daily Dodge ESPN | WBEV © 2024 Daily Dodge • Built with GeneratePress × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × × Submit Your Photo Want to have your photos featured in our new website design? Upload your local photos here for consideration! Name(Required) First Last Email(Required) Photo Upload(Required) Drop files here or Select files Accepted file types: jpg, gif, png, Max. file size: 5 MB, Max. files: 5. Photo Details(Required)Consent(Required) I consent to my photos being used on dailydodge.comCommentsThis field is for validation purposes and should be left unchanged. × News Title* Location Description*Name First Last Email CAPTCHA CLOSE Senior's Name* Which Type of Senior?*College SeniorHigh School SeniorSchool Graduating From* HiddenSchool Graduating From*Upload Image*Accepted file types: jpg, jpeg, png, gif.Video Share Link Please copy and paste your YouTube or Vimeo, etc. share link here.CAPTCHANameThis field is for validation purposes and should be left unchanged. CLOSEBird flu making a comeback in the N.C. agriculture industry Open in Our App Get the best experience and stay connected to your community with our Spectrum News app. Learn More Open in Spectrum News App Continue in Browser Toggle navigation Charlotte EDIT Watch Live | Recent Activity Log Out Recent Activity Log In Latest News Spectrum News App Seen on Spectrum Headlines Public Safety Education Back to School Health Exploring Your Health Coronavirus Business Employment Lottery Pursuit Unlimited Veterans Month Weather Interactive Radar Today's Forecast 7-Day Forecast Watches & Warnings Closings & Delays Weather Blog Climate Change Project Weather Storm Season Traffic Interactive Traffic Map Submit a Traffic Issue Transportation News Track Gas Prices Near You Around Charlotte Community Calendar Submit An Event Things to Do Eating N.C. Tar Heel Treasures The Little Things Matter Feel Good Friday Everyday Heroes High School Scholars Back to School Politics 2024 Election Election Results Political News Washington D.C. Bureau Capital Tonight In Focus Front Porch Politics Tying It Together Podcast Sports Sports News Carolina Panthers Podcasts Tying It Together with Tim Boyum Our Journalists ACCOUNT Sign Out Recent Activity ACCOUNT Sign In Recent Activity Latest News Spectrum News App Seen on Spectrum Headlines Public Safety Education Back to School Health Exploring Your Health Coronavirus Business Employment Lottery Pursuit Unlimited Veterans Month Weather Interactive Radar Today's Forecast 7-Day Forecast Watches & Warnings Closings & Delays Weather Blog Climate Change Project Weather Storm Season Traffic Interactive Traffic Map Submit a Traffic Issue Transportation News Track Gas Prices Near You Around Charlotte Community Calendar Submit An Event Things to Do Eating N.C. Tar Heel Treasures The Little Things Matter Feel Good Friday Everyday Heroes High School Scholars Back to School Politics 2024 Election Election Results Political News Washington D.C. Bureau Capital Tonight In Focus Front Porch Politics Tying It Together Podcast Sports Sports News Carolina Panthers Podcasts Tying It Together with Tim Boyum Our Journalists × Set Weather Location Get hyperlocal forecasts, radar and weather alerts. Please enter a valid zipcode. Save Confirm Your News Market We automatically picked the Spectrum News market we think is most relevant to you. New York City News and information that matter to your community. Local weather forecasts. Confirm Change News Market You can change your news market at any time. GAS PRICESFind the lowest prices in the Charlotte area NEW PODCAST EPISODEDecision 2024: North Carolina's post-election results COMMUNITY CALENDARAdd an event to our calendar WEATHER ALERTFull list of active watches and warnings CLOSINGS ALERTFull list of active closings and delays Bird flu making a comeback in the N.C. agriculture industry By Jatrissa Wooten Chapel Hill PUBLISHED 9:00 AM ET Jul. 31, 2024 PUBLISHED 9:00 AM EDT Jul. 31, 2024 SHARE CHAPEL HILL, N.C. â The bird flu is showing up again in North Carolina's agriclture industry, and health officials are advising on how to handle the rise in cases. As of April 2024, there have been 24 confirmed cases of highly pathogenic avian influenza, otherwise known as HPAI, in wild birds in North Carolina. Itâs something state agriculturalists say they continue to watch closely. What You Need To Know Symptoms in livestock of the new strain of bird flu include not eating, less milk production and abnormal appearance in their milk Symptoms in chicken include sudden death, lack of energy, appetite and coordination problems as well as reduced egg production The North Carolina Department of Health and Human Services is providing an online toolkit to help identify these symptoms The North Carolina Wildlife Resources also recently confirmed a single case in a black bear in Hyde County. Scientists at UNC Chapel Hill said this disease mostly transfers to livestock, including birds and cows. Humans can get infected through direct or indirect contact with infected birds or their droppings, but itâs rare â especially for those who do not live or work on a farm. Mark Heise is a virologist at UNC School of Medicine. Heise and some of his students study viruses in a lab, develop anti-viral drugs, and will work in a cell culture room. âItâs where we grow the cell that we use to work with the viruses,â Heise said. Having graduated from UNC in 1997, Heise has devoted over 30 years to studying viruses. Heâs been doing this a long time, so when they find a virus like the new strain of avian influenza, Heise said it peaked his interest. Heise said this new strain of bird flu is highly contagious among birds and though it can infect humans, it's unlikely. He added the public should know the potential threat posed by the virus but also said not to panic. âThe greatest risk right now is really to the U.S. agricultural industry,â Heise explained. At the moment, researchers are monitoring the spread, but they do not consider food to be in danger. However, agricultural animals may experience significant impacts. Symptoms in livestock of the new strain of bird flu include not eating, less milk production and abnormal appearance in their milk. Symptoms in chicken include sudden death, lack of energy, appetite and coordination problems as well as reduced egg production, according to the American Veterinary Medical Association. Though most birds will die from it, dairy cattle recover with treatment. The North Carolina Department of Health and Human Services is providing a toolkit online to help identify these symptoms âI do think itâs important,â Heise said. âThough, from a public health standpoint that we continue to prepare for the possibility that these viruses could make the jump or be a problem in the future.â Thatâs a challenge he and his students are willing to take on. Spectrum News Contact About Spectrum News App RSS SITEMAP Certifications ADVERTISE Careers TERMS Your Privacy Rights California Consumer Privacy Rights California Consumer Limit the Use of My Sensitive Personal Information Do Not Sell or Share My Personal Information/Opt-Out of Targeted Advertising Â© 2024, Charter Communications, all rights reserved.CDC pushes farmworkers to get seasonal flu vaccine to combat bird fluSkip to main content HomeNewsStateMidwestNational CDC pushes farmworkers to get seasonal flu vaccine to prevent 'reassortment' with bird fluThe CDC aims to vaccinate 200,000 farmworkers against the seasonal flu in hopes preventing "reassortment" with bird flu.Colleen Kottke Wisconsin State FarmerThe U.S. Centers for Disease Control and Prevention announced Tuesday a $10 million initiative to vaccinate livestock industry workers against seasonal flu in hopes of protecting workers and reducing the risk of a new version of bird flu from emerging.As of July 30, 2024, the U.S. Department of Agriculture has detected the bird flu virus (H5N1) in poultry flocks in nearly every state since 2022. The virus has also been found in over 170 dairy herds in 13 states since March when it was first found in a dairy herd in Texas.Farm workers having daily contact with poultry and dairy cows are especially at risk for contracting the virus. Workers culling nearly 2 million laying hens at two poultry farms in Weld County, Colorado, were exposed to the virus, with nine testing positive. Four dairy farm workers contracted the virus in Texas, Michigan and Colorado.Despite increased outbreaks, CDC officials say all cases of human infection so far have been mild and are believed to have been spread from direct contact with infected chickens and cows."These infections do not change CDC's overall assessment of the risk to the general population from H5N1," the CDC's principal director Dr. Nirav Shah told reporters.Why the season flu vaccine and not the bird flu vaccine?With flu season on the horizon, CDC officials want to be proactive in preventing the virus from mutating into something more dangerous. Because livestock workers are at risk of becoming infected with bird flu due to their exposure to animals, they are also at risk of contracting the seasonal flu just like anyone else."It's possible that they could be co-infected with both seasonal influenza viruses that they pick up from the community, and each dual infection, while rare, could potentially result in an exchange of genetic material between the two viruses in a process known as reassortment," Shah said. "It could lead to a new influenza virus that could pose a significant public health concern."A virus that has the transmissibility of seasonal influenza and the severity of H5 is a risk the CDC wants to reduce as much as possible, Shah said.While the seasonal flu shot offers no cross-protection against bird flu, Shah said the vaccination boosts the body's immune system, fighting off the seasonal flu virus before the virus can take hold."Therefore we can at least reduce the chance of this co-infection from happening," Shah said. "It doesn't eliminate it, but it does reduce it. And in public health, that's the name of the game."CDC officials have not seen evidence that the bird flu virus has changed to produce a more severe disease, nor have they seen any person-to-person transmission, warranting the use of a H5N1 vaccine."When we think about the right tool for this moment, the seasonal vaccine has all of the benefits we're looking for," Shah said.How will health workers get the message out to farmworkers?As part of the initiative, the CDC will allocate $5 million to partner organizations, including the National Center for Farmworker Health, to focus on outreach and education efforts to train workers to protect themselves. Groups will work with key partners and states to increase access to testing, treatment, personal protective equipment and the seasonal flu shot.CDC will invest another $5 million to vaccinate livestock workers for seasonal influenza in affected states before this fall. The vaccines are not mandatory. Shah said local and state health departments will have the onus of submitting a plan to the CDC for getting the shots out to workers."We are starting initial discussions with states where there have been the highest number of infections among livestock herds and flocks," Shah said. "We are going to keep this program open for all states that want to participate, but we've got to start somewhere."According to government data, Shah said there's an estimated 200,000 livestock workers in the U.S., which includes veterinarians and other service personnel coming in close contact with animals."We know there is also a high number of unofficial workers in this sector," Shah said.Eric Deeble, deputy undersecretary for marketing and regulatory programs at USDA, said many agricultural and livestock workers come from countries where vaccinations are commonplace and well accepted. However, he says flu shot rates for U.S. farmworkers are much lower than the average population which is 47%."I think the low numbers in the U.S. were not due to reticence, but rather access to the vaccines in the past," Deeble said.Shah said the effort to curb the spread of bird flu hinges on the trust of farmworkers."That trust relies on us to make the case of why the vaccine is important," Shah said. "When livestock workers are vaccinated against the seasonal flu, they are protected as well as their co-workers, family members and the community as a whole."Contact Colleen Kottke at 920-517-2653 or ckottke@gannett.com. Follow her on X (formerly Twitter) at @ColleenKottke. Facebook Twitter EmailHelpTerms of ServiceSubscription Terms & ConditionsPrivacy PolicySite MapAccessibilityOur Ethical PrinciplesResponsible DisclosureYour Privacy Choices © Copyright Gannett 2024What the dairy industry can learn from poultry’s HPAI response | WATTPoultry.comMarket InformationTop Poultry CompaniesExpert InsightsBlogsRegionsMagazinesSign InPoultry MeatEggPoultry HealthSustainabilityPoultry FutureTopicsPoultry MeatEggPoultry HealthSustainabilityPoultry FutureRegionsMarket InformationTop Poultry CompaniesTop Feed CompaniesAgriculture ProductsDirectory of SuppliersEvent CalendarExpert InsightsWebinarsBrand InsightsPodcastsWhite PapersWATT Poultry ChatTop Companies Data DownloadsMagazinesMoreSign InSubscribeAdvertiseAbout UsContact UsFollow WATTPoultry.comFacebook iconLinkedIn iconYouTube iconSign InFollow WATTPoultry.comFacebook iconLinkedIn iconYouTube iconPoultry MeatEggPoultry HealthSustainabilityPoultry FutureMarket InformationTop Poultry CompaniesExpert InsightsBlogsRegionsMagazinesSubscribeAdvertiseBroilers & TurkeysDiseases & HealthAvian InfluenzaWhat the dairy industry can learn from poultry’s HPAI responseInformation sharing and collaboration will be crucial to stopping disease threat.Denise HeardAugust 1, 2024Subscribe to MagazineVladimir Zapletin | iStock.comAvian influenza, or "bird flu," is a contagious viral disease of domestic and wild birds. The disease is caused by influenza type A viruses and varies in severity depending on the strain and species affected. Highly pathogenic avian influenza (HPAI) strains are fatal for domestic poultry and can wipe out entire flocks within days. It is a major threat to the poultry industry, animal health, trade and the economy worldwide. Since January 2022, highly pathogenic avian influenza H5N1 has affected more than 97 million birds across 48 states. Dairy cases reportedIn March 2024, HPAI H5N1, also called H5N1 bovine influenza, was confirmed on dairy premises. Since the initial confirmation, the virus has spread to more than 145 dairy herds across 12 states and the cases continue to rise. Infected dairy cattle present with different clinical signs and symptoms than poultry, such as a decrease in milk production, drop in feed consumption, and thickened or clotted milk. Dairy cattle typically recover from clinical signs after approximately two weeks and most can go back into milk production. A United States Department of Agriculture (USDA) national epidemiological survey of affected dairy premises indicated that enhanced biosecurity measures are needed to decrease the spread of the virus. Factors that appear to be of greatest risk for introduction into dairy premises may be mitigated through enhanced biosecurity, increased animal testing and potentially through within-state animal movement restrictions, if they can be implemented without impacting animal welfare.Whole genome sequencing (WGS) of viruses from positive dairy and poultry premises identified Eurasian lineage goose/Guangdong clade 2.3.4.4b, genotype B3.13 on both premises. Because some HPAI-affected dairy cattle were undetected and nonclinical at the time of movement and had been shipped to a dairy near a later affected poultry flock, it suggested indirect transfer of the virus from the dairy to the poultry premises.Time to work togetherThe poultry industry has battled HPAI for many years now, which has led to a significant amount of research in areas such as enhanced biosecurity methods, viral transmission, pathogenesis, surveillance, environmental sampling, depopulation and repopulation, disposal, cleaning and disinfection and other areas. There are valuable lessons that have been learned through battling with HPAI in poultry that may assist the dairy industry in controlling and eliminating the disease. Further, due to the nature of how the virus mutates and transmits, there have been human cases reported and other events in a multitude of mammals. Information sharing and collaboration are needed to ensure the sustainability of dairy products, poultry and eggs. It is crucial that all animal agriculture sectors get involved and proactively work together to combat this national agricultural threat. Subscribe to MagazineRecommendedHatchersGiordano HatchCargoSystem ProLifeLatest NewsNational Turkey Federation offering 'Thanksgiving 101' tips and recipesRelated StoriesAvian InfluenzaFAO warns of rising avian flu threat in Asia-Pacific regionAvian InfluenzaAnother Weld County, Colorado, farm hit with avian fluAvian InfluenzaMore H5N1 cases reported in Colorado poultry, peopleAvian InfluenzaWOAH: H5N1 situation in Mexican poultry is resolvedMore in Avian InfluenzaAvian InfluenzaAvian flu confirmed in poultry flocks in 13 European countriesThe H5N5 variant has been confirmed for the first time at a European poultry farm.Brand InsightsThink strategically in developing IBDV vaccination programsZoetisDeveloping vaccination programs for IBDV requires strategic use of several vaccine types.Avian Influenza8 more British Columbia flocks struck by avian fluSo far in 2024, the province has had 22 commercial poultry flocks affected by the virus.Avian InfluenzaLatest Canadian HPAI infections involved variety of speciesOne more flock infection has been reported in Abbotsford, British Columbia.Avian InfluenzaHPAI hits 5 flocks in British Columbia, 1 in CaliforniaAPHIS provides additional information concerning two broiler flocks previously reported as confirmed cases.Avian InfluenzaAustralia commits more funds to H5N1 preparednessAustralian authorities add additional funds to surveillance, biosecurity, vaccines and communications in the face of possible H5N1 incursion.Avian InfluenzaAPHIS updates report on California HPAI casesFlock size numbers for two of four affected operations have been disclosed.Avian InfluenzaMore HPAI reported in California, British Columbia poultryBoth the state and the province have confirmed cases in two commercial flocks.Avian InfluenzaFirst avian flu outbreaks of the season in East AsiaHPAI cases have been reported in poultry and wild birds across Asia from Israel to Japan and South Korea.Avian InfluenzaAvian influenza strikes two California broiler flocksThe number of chickens involved has not yet been disclosed.North AmericaAvian flu infections continue to hit British ColumbiaThe province has had six commercial poultry flocks affected by the virus since October 21.Avian InfluenzaFrance confirms avian flu in vaccinated flocksDucks were found to be positive for the HPAI virus following routine testing, despite them showing no symptoms of the disease.Avian InfluenzaAvian flu hits second broiler flock in California countyThe latest flock infection in Tulare County involved 6,000 broilers.Page 1 of 182Next PageNews and analysis for the global poultry industryFollow WATTPoultry.comFacebook iconLinkedIn iconYouTube iconDelete My DataTopicsPoultry MeatEggPoultry HealthSustainabilityPoultry FutureMoreWebinarsBrand InsightsPodcastsWhite PapersWATT Poultry ChatTop Companies Data DownloadsMagazinesSubscribeAdvertiseAbout UsContact UsMedia RequestPrivacy PolicySite Map© 2024 All rights reserved.The vanishing flu strain: Why Canada’s seasonal vaccine is changing - National | Globalnews.ca SKIP TO MAIN CONTENT In the news Remembrance Day Counterfeit Coins University Shooting Cuba Earthquake Global News Home Subscribe Site theme toggle. Switch between light or dark mode Light Dark Live Search Site theme toggle. Switch between light or dark mode Light Dark GlobalNews home WatchWorldCanadaLocalPoliticsMoneyHealthEntertainmentLifestylePerspectivesSportsShoppingCommentaryContestsPodcastsU.S. News The vanishing flu strain: Why Canada’s seasonal vaccine is changing Click to return to homepage Leave a comment Share this item on Facebook Share this item via WhatsApp Share this item on Twitter Send this page to someone via email See more sharing options Full Menu Search Menu Home Trending Watch Local Menu Menu Close Submit Search Topics WatchWorldCanadaLocalChange locationPoliticsMoneyHealthEntertainmentLifestylePerspectivesSportsShoppingCommentaryContestsPodcastsU.S. News TV Programs Global NationalWest BlockThe Morning ShowVideo CentreMore… Connect Email alertsAlexaBreaking News Alerts from Global NewsLicense ContentContact Us National Change Close Change Close BarrieBCCalgaryDurhamEdmontonGuelphHalifaxHamiltonKingstonKitchenerLethbridgeLondonMontrealNew BrunswickOkanaganOttawaPeterboroughReginaSaskatoonTorontoWinnipeg Global News Facebook Pages Global News Twitter Accounts Global News Youtube Channel Global News on Instagram Global News on LinkedIn Global News on TikTok Global News on Telegram Go Back Close Local your local region National BarrieBCCalgaryDurhamEdmontonGuelphHalifaxHamiltonKingstonKitchenerLethbridgeLondonMontrealNew BrunswickOkanaganOttawaPeterboroughReginaSaskatoonTorontoWinnipeg Share Close Share this item on Facebook facebook Share this item on Twitter twitter Send this page to someone via email email Share this item via WhatsApp whatsapp Share this item on Pocket pocket Share this item via Telegram telegram Share this item on Reddit reddit Copy article link Copy link Calendar Close Calendar Close All event types Comedy Festival Food Health Music Sports Theatre Virtual Other Search Close Submit search Quick Search Trending Now Add Global News to Home Screen Close Instructions: Press the share icon on your browser Select Add to Home Screen Press Add Comments Close comments menu Want to discuss? Please read our Commenting Policy first. Video link Headline link Advertisement Close X Click to scroll back to top of the page Backto top Health The vanishing flu strain: Why Canada’s seasonal vaccine is changing By Katie Dangerfield Global News Posted July 29, 2024 2:24 pm Updated July 30, 2024 11:29 am 5 min read If you get Global News from Instagram or Facebook - that will be changing. Find out how you can still connect with us. Hide message bar 1:21 NACI announces changes to the flu vaccine after strain disappears WATCH: Health officials in Canada are changing plans for the annual flu vaccine after new research found a strain of seasonal influenza has completely vanished across the globe. Katherine Ward has this story and more in Health Matters for July 30, 2024 – Jul 30, 2024 Leave a comment Share this item on Facebook Share this item via WhatsApp Share this item on Twitter Send this page to someone via email See more sharing options Share Close Share this item on Facebook facebook Share this item on Twitter twitter Send this page to someone via email email Share this item via WhatsApp whatsapp Share this item on Pocket pocket Share this item via Telegram telegram Share this item on Reddit reddit Copy article link Copy link Descrease article font size Increase article font size A strain of seasonal influenza has completely vanished globally since March 2020, and due to its disappearance, health officials in Canada are changing up the annual flu vaccine. The B/Yamagata influenza strain, once a dominant force among influenza B viruses, may have vanished entirely due to the stringent measures imposed during the COVID-19 pandemic, according to the National Advisory Committee on Immunization (NACI). No cases have been confirmed across the globe since March 2020.Due to the strain’s disappearance, NACI announced on July 26 that expert groups have endorsed removing the B/Yamagata component from influenza vaccine formulations. As a result, Canada’s flu vaccine will shift from a quadrivalent to a trivalent formula.“As of March 2020, following the onset of the COVID-19 pandemic and implementation of measures to reduce the transmission of SARS-CoV-2, there have been no confirmed detections of naturally circulating B/Yamagata lineage viruses worldwide, including in Canada,” NACI said in the statement. Story continues below advertisement “Based on current epidemiological data, there is global expert consensus that B/Yamagata virus strains should be removed from influenza vaccine formulations and that manufacturing should transition to trivalent vaccines exclusively,” it added.Before the strains disappeared, there were four strains of seasonal influenza circulating: two from influenza A (H1N1 and H3N2) and two from influenza B (B/Victoria and B/Yamagata). 4:35 Respiratory illness back-to-school concerns Since the 2014 to 2015 flu season, Canada has used quadrivalent influenza vaccines containing strains from both influenza B lineages (B/Victoria and B/Yamagata) to offer protection against circulating influenza B viruses.Although influenza A is usually the dominant strain, both influenza A and B contribute to seasonal epidemics. Despite its lower overall prevalence, influenza B can still pose a significant burden in Canada, accounting for up to 44 per cent of reported laboratory detections in some seasons, according to NACI. Story continues below advertisement “In November, December and into January, we mostly see influenza A. And then in the latter part of the season, January, February and tailing off through March, we’ll see a little bit more influenza B,” explained infectious diseases specialist Dr. Isaac Bogoch.“If you look at the absolute number of cases, we usually have way more influenza A compared to influenza B, but B starts to show up a little bit later on in the season.”He said that while the diagnosis, prevention, and treatment of influenza A and B are the same, what differs is their epidemiology. This difference in epidemiology might explain why B/Yamagata disappeared while other strains persisted. How did B/Yamagata vanish? The B/Yamagata strain was first discovered in Japan in the late 1980s. It began spreading globally and became a predominant influenza strain in North America by the early 2000s. Story continues below advertisement By the 2014 to 2015 flu season, Canada had added the B/Yamagata strain to its seasonal flu vaccine, making it a quadrivalent formula to protect against more influenza types. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy. In Canada and globally, between 2012 and 2017, B/Yamagata viruses caused a larger proportion of influenza B infections than B/Victoria, NACI said. However, two years before the COVID-19 pandemic, the B/Yamagata lineage started becoming dominant.Then, in March 2020, it seemingly vanished.“During the darkest days of COVID, we stopped detecting one of the two influenza B strains and that was B/Yamagata,” Bogoch said. “Was it hiding out somewhere or was it just circulating in lower levels? Was it going to somehow emerge later on? Those are questions that were asked at that time. But, it didn’t seem to come back.”Although it has disappeared, Bogoch emphasized that this does not mean the strain is eradicated, as eliminating any virus is extremely challenging.But there are theories about what happened to it.The first theory relates to the public health measures implemented at the start of the pandemic. 2:26 Influenza cases have declined while RSV and COVID are up, according to Interior Health A 2022 study published in Nature, argued that since April 2020, many countries have seen historically low seasonal influenza virus circulation, attributable to quarantines, social distancing, school and workplace closures, mask-wearing, surface disinfection and enhanced hand hygiene. Story continues below advertisement Bogoch suggested that another factor contributing to the B/Yamagata strain’s disappearance could be the “massive drop in human mobility” during the pandemic. Trending Now First B.C., now Montreal: What a pair of port shutdowns means for Canada 1.4M Honda vehicles may see engines fail, prompting U.S. probe “If you look at international travel, passenger volumes and human mobility patterns during that time, they were a tiny fraction of what they are normally” he explained.“And when you look at how seasonal influenza is transmitted, it goes from the southern hemisphere and then it works up its way into the northern hemisphere during our winter months, and then back to the southern hemisphere during their winter months and ping-pongs back and forth.”He believes that the near standstill in travel during the pandemic, along with tighter border restrictions, may have contributed to the decline of the strain.Another reason could be “viral interference,” he said, meaning the COVID-19 strain may have helped suppress a weaker strain of influenza.However, he stressed that these are all theories, and a combination of these factors may have contributed to the disappearance of the B/Yamagata strain. When will the new vaccine be available? These are just the early stages of transitioning from a quadrivalent to a trivalent seasonal influenza vaccine, so the new formula will not be available for the 2024 to 2025 flu season, according to NACI. Story continues below advertisement “For the 2024-2025 influenza season in Canada, vaccine availability is anticipated to remain unchanged. Quadrivalent formulations will continue to be supplied for public programs. No trivalent formulations will be available for standard dose or high dose inactivated influenza vaccines,” it stated.NACI anticipates a gradual transition to trivalent influenza vaccines, acknowledging significant logistical challenges and potential regulatory complexities. More details about trivalent influenza vaccines will be included in the 2025 to 2026 Influenza Seasonal Statement.Both quadrivalent and trivalent influenza vaccine formulations are clinically safe and effective, according to NACI. 2:31 How COVID-19 pandemic precautions crushed the flu season While the updated vaccine may not be available in Canada this upcoming flu season, the U.S. has already adopted the trivalent formulation for the 2024 to 2025 season.The Centers for Disease Control and Prevention (CDC) has announced that flu vaccines will be trivalent in the United States for the 2024-2025 season. Story continues below advertisement “Because influenza B/Yamagata lineage viruses have not been detected after March 2020, the World Health Organization (WHO) and FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended that the influenza B/Yamagata lineage vaccine virus component be excluded from flu vaccines as soon as possible,” the CDC website states.Since there’s no evidence that B/Yamagata is completely eradicated, NACI said it will continue to monitor each flu season.“Continued epidemiological and virological monitoring of influenza virus, investigation of any reports of B/Yamagata detection, and continued assessment of programmatic factors remains important, as does clear and transparent communication of updated recommendations,” it said. More on Health More videos From 300 lbs to 100K races: How this mom of 4 took up ultramarathons With B.C. teen sick in hospital with suspected bird flu, what should parents know? Veteran mental health highlighted on Remembrance Day: ‘It’s hard to say I’m not OK’ Bird flu: What we know about Canada’s 1st human case detected in B.C. H5 avian influenza: B.C. reports 1st suspected human case of bird flu Should parents be concerned about avian flu in B.C. schools? Health Matters: Asthma linked to memory deficits in children Health Canada talks Radon Action Month Journalistic standards Comment Report an error © 2024 Global News, a division of Corus Entertainment Inc. Sponsored content More from Global News Veteran mental health highlighted on Remembrance Day: ‘It’s hard to say I’m not OK’ With B.C. teen sick in hospital with suspected bird flu, what should parents know? Advertisement Stay in the loop The latest health and medical news emailed to you every Sunday. Sign up for Health IQ newsletter Sign Up Trending From 300 lbs to 100K races: How this mom of 4 took up ultramarathons 1,123 Read How Canadian consumers can spot counterfeit $2 coins 746 Read RCMP report reveals new details on GTA man and his ‘camel-toe’ fake toonies 655 Read First B.C., now Montreal: What a pair of port shutdowns means for Canada 532 Read With B.C. teen sick in hospital with suspected bird flu, what should parents know? 457 Read 1.4M Honda vehicles may see engines fail, prompting U.S. probe 408 Read Top Videos From overweight to ultramarathoner: How an Alberta woman transformed her life 60 Viewed RCMP report reveals new details on GTA man and his fake toonies 42 Viewed 26,000+ fake toonies seized in CBSA bust 37 Viewed Quebec man who imported 26K fake toonies gets jail time 34 Viewed H5 avian influenza: B.C. reports 1st suspected human case of bird flu 29 Viewed Should parents be concerned about avian flu in B.C. schools? 25 Viewed More Videos Stay in the loop The latest health and medical news emailed to you every Sunday. Sign up for Health IQ newsletter Sign Up Advertisement Report an Error Subscribe here AdChoices Global News Facebook Pages Global News Twitter Accounts Global News Youtube Channel Global News on Instagram Global News on LinkedIn Global News on TikTok Global News on Telegram AboutPrinciples & PracticesBranded ContentContact usRSSNewslettersNotificationsSmart homeAdvertisers Election RegistryGlobal News Licensing RequestsCookie consent ©2024 Global News, a division of Corus Entertainment Inc. Corus News. All rights reserved. Privacy PolicyCopyrightTerms of UseAdvertiseAdvertising Standards TermsCorus EntertainmentAccessibility AdvertisementChina standardizes diagnosis, treatment of measles, dengue fever, avian influenza - Chinadaily.com.cn Search HOME CHINA WORLD BUSINESS LIFESTYLE CULTURE TRAVEL VIDEO SPORTS OPINION REGIONAL FORUM NEWSPAPER MOBILE Global EditionASIA 中文双语Français HOME CHINA WORLD BUSINESS LIFESTYLE CULTURE TRAVEL VIDEO SPORTS OPINION REGIONAL FORUM NEWSPAPER China Daily PDF China Daily E-paper MOBILE China News Society Innovation HK/Macao Cross-Strait Cover Story Photo Environment Health Military Video Home / China / Society Home China Society China standardizes diagnosis, treatment of measles, dengue fever, avian influenza Xinhua | Updated: 2024-07-30 10:09 Share Share - WeChat CLOSE BEIJING -- China has released protocols for measles, dengue fever, and human infection with the avian influenza virus as part of its efforts to standardize the diagnosis and treatment of infectious diseases, the National Health Commission said Monday. The documents address etiology, epidemiology, pathological changes, clinical symptoms, complications, laboratory testing, identification and diagnosis, as well as treatment and prevention of the three infections. One protocol said all groups are susceptible to the measles virus, with the apparent infection rate above 90 percent among those without immunity following exposure. The new protocol for dengue fever emphasizes the importance of early identification and timely treatment of severe cases. Measures should be taken to isolate patients from mosquitoes, and the isolation can be lifted if the course of the disease exceeds five days and the body temperature of patients naturally drops to normal for more than 24 hours, according to the protocol. The protocol for avian influenza advises avoiding contact with sick or dead animals and maintaining healthy dietary habits to prevent infection. "If symptoms such as fever occur, one should seek medical attention promptly and inform the physician about any recent contact with birds or visits to poultry markets." China is beefing up its public health service capabilities. Pilot programs are being implemented to improve collaboration and integration between hospitals and disease prevention and control institutions. There are also initiatives to install disease control supervisors at medical institutions and grant prescription rights to public health physicians. Photo China's first reusable satellite returns to Earth with payloads Posters: Celebrating China's mighty achievements Ten photos from across China: Oct 4 - 10 Posters: China's achievements in elderly care services Migratory birds flock to Jilin's wetland haven Art opens up creativity of Tibetan kids Latest PLA Navy fleet conducts realistic training in East China Sea China's first reusable satellite returns to Earth with payloads Policies set to boost graduate job market in Wuhan Feature: Service station on Yangtze River achieves carbon neutrality Beijing launches supporting services for elderly aged 80 and above Retrial begins for high-profile child trafficking case State Council News China ready to join Singapore for modernization - Chinese premier Li urges EU to adopt objective, rational policy toward China Xi meets foreign guests attending China International Friendship Conference Exclusive Posters: Celebrating China's mighty achievements Posters: China's achievements in elderly care services China records strong tourism numbers during holiday Newsmaker Health worker awarded for improving lives in county Journey to Joy: A unique career path for a chef's dream Ten photos you don't wanna miss Ten photos from across China: Oct 4 - 10 Special Coverage 75 years on Third Plenary Session of the 20th CPC Central Committee Top BACK TO THE TOP English 中文 HOME CHINA WORLD BUSINESS LIFESTYLE CULTURE TRAVEL VIDEO SPORTS OPINION REGIONAL FORUM NEWSPAPER China Daily PDF China Daily E-paper MOBILE Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site. License for publishing multimedia online 0108263 Registration Number: 130349 About China Daily Advertise on Site Contact Us Job Offer Expat Employment FOLLOW US Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form.Dairy shows remain 'status quo' at Wisconsin State Fair despite additional hurdles of avian flu - WPR Skip to Audio Player Menu Close Toggle Site Mobile Navigation Home News Shows Culture Music ABOUT Who We Are Events Careers / Volunteer LISTEN Stations & Schedules Music Playlists Ways to Listen SUPPORT Ways to Give Membership FAQ Funding Information CONTACT Get in Touch Help / FAQ Newsletters POLICIES Ethical Guidelines Policies and Reports Privacy Policy News Shows Culture Music Wisconsin Public Radio Homepage Wisconsin Public Radio (WPR) Logo Wisconsin Public Radio (WPR) Logo Donate Icon Donate Search wpr.org Search Icon Agriculture, Dairy, News Dairy shows remain ‘status quo’ at Wisconsin State Fair despite additional hurdles of avian flu Veterinary leader says additional testing hasn't deterred fair participants. But some farms are choosing not to test for the virus. By Hope Kirwan July 30, 2024 Updated July 30, 2024 at 9:34 am Download Connor Larson, a member of Lafayette County 4-H, moves his Jersey cow at the Wisconsin State Fair on Thursday, Aug. 4, 2022, in West Allis, Wis. Angela Major/WPR A team of around 10 veterinarians will help check-in the cattle and other show animals coming to the Wisconsin State Fair this week. Veterinary superintendent Dr. Tia Kastenson said the process will look mostly the same as it does every year, with animals coming off trailers and being settled into barns before the West Allis fairground fills with hundreds of thousands of people. But this week, the team of animal doctors will be paying much closer attention to the dairy cows as avian flu continues to affect herds across the country. Stay informed on the latest news Sign up for WPR’s email newsletter. Email PhoneThis field is for validation purposes and should be left unchanged. Wisconsin has not had a case of the highly-contagious influenza virus since it was first reported in dairy cows in March. But new cases of the disease continue to surface and have been found in 13 states. Lactating cows, or those currently producing milk, are required to have proof they’ve tested negative for influenza in the week before arriving at a fair or exhibition, thanks to a state order issued by the state Department of Agriculture, Trade and Consumer Protection in June. Kastenson said it will likely take a little longer for the veterinary team to check the extra paperwork. “They’ll collect the papers, make sure all the cows that are lactating have their (test) dates in check, and then they’re gonna monitor as those cows come off the trailer,” she said. “If there’s anything questionable, they’re gonna pull (the cows) before they go into the barn.” She said the fair also has vets available throughout the 11-day event who can help watch for signs of illness in the barns. A man leads a cow in a cattle barn at the Arkansas State Fair in Little Rock, Ark., Friday, Oct. 10, 2014. The fair runs through Oct. 19. AP Photo/Danny Johnston Kastenson said the State Fair hasn’t seen a drop in the number of people bringing dairy cattle to the Junior Show, they’ll start arriving on Tuesday. She said numbers for the open shows later in the fair have not been finalized, but she doesn’t anticipate lower participation. “I don’t expect (fair attendees) to notice any difference,” she said. “The number of cows are the same, the shows are going to be run the same. Once they’re in the barn, it’s going to be pretty much status quo.” County fairs around the state have already gone through the additional testing requirements for avian flu this summer. The Wisconsin Veterinary Diagnostic Laboratory has received nearly 400 samples every week since June, according to director Keith Poulsen. Poulsen said they could accommodate more tests, but there hasn’t been the demand. “We’re seeing much smaller lactating cow groups at our fairs or fairs have just canceled the lactating cow classes,” he said. “I live in Lodi. We only had one lactating cow (at the fair) and that was just sad because there’s a lot of farms and kids that are prepping those cows to show for so long.” Poulsen said many dairy farms have been reluctant to test their cows because of concerns about what a positive result would mean for their ability to sell milk. Federal ag officials have tried to encourage more voluntary testing on farms to get a better understanding of where the virus is and how it’s spreading from farm to farm. But Poulsen said these efforts haven’t caught on. Research by Poulsen and other scientists has shown that exposure to the milk from an infected cow is likely how the infection is spreading within a herd. But he said that doesn’t explain every new case. Poulsen said the additional testing generated by fairs and exhibitions has been a positive, but only goes so far. “It increases awareness and it does give us some information. But if we’re not doing herd level aggregate testing, we don’t have a complete picture of what’s going on,” he said. Wisconsin Public Radio, © Copyright 2024, Board of Regents of the University of Wisconsin System and Wisconsin Educational Communications Board. Related Stories The show goes on at World Dairy Expo despite threat of avian flu State officials urge public to protect against bird flu at county fairs, petting zoos Wisconsin fairs required to check cows for avian flu this summer Wisconsin study supports belief that milk pasteurization kills avian flu virus Fear over avian flu has died down for Wisconsin dairy farms. But experts warn of continued threat. Footer Partner Navigation Wisconsin Public Radio Homepage Wisconsin Public Radio (WPR) Logo Wisconsin Public Radio (WPR) Logo Educational Communications Board University of Wisconsin-Madison NPR PBS Wisconsin Footer Site Navigation ABOUT Who We Are Events Careers / Volunteer LISTEN Stations & Schedules Music Playlists Ways to Listen SUPPORT Ways to Give Support FAQ Funding Information CONTACT Get in Touch Help / FAQ Newsletters POLICIES Ethical Guidelines Policies, Public Files and Reports Privacy Policy © 2024 by Wisconsin Public Radio, a service of the Wisconsin Educational Communications Board and the University of Wisconsin-Madison Social Networks Navigation FacebookInstagramBlowflies are potential vector for avian influenza virus at enzootic area in Japan | Infectious Diseases 2024 | Infectious diseases | Poultrymed ×¢××¨××ª Contact Us Publications|Atlases|Infectious diseases|What's new ?|Vaccines|Management|Various|Events|Legislation|Glossary|Links|Sponsors Infectious Diseases 2024 Home>Infectious diseases>Infectious Diseases 2024>Blowflies are potential vector for avian influenza virus at enzootic area in Japan Blowflies are potential vector for avian influenza virus at enzootic area in Japan 3 August, 2024 Researchers from Kyushu University have discovered that blowflies, a family of flies strongly attracted to decaying flesh and feces, are carrying the bird flu virus in southern Japan. Their findings, published in Scientific Reports, introduce a potential new route of transmission for bird flu and highlight the need to develop new countermeasures to prevent and control the disease in poultry farms. In this research, the scientists studied a wild crane colony in Izumi city, Kagoshima Prefecture, in southern Japan. In winter, the prime season for avian influenza, thousands of cranes migrate to this area, with their dense numbers making them vulnerable to infection. During winter 2022-2023, 1,600 cranes out of colony of 10,000 cranes died from bird flu. The researchers collected 648 blowflies and discovered that 14 blowflies were carrying the bird flu virus. The majority of virus-positive blowflies were collected from the sample site closest to the crane colony. The research team also used genetic testing to confirm that the blowflies were carrying the same virus strain that has been infecting the crane colony. Unlike birds and mammals which the virus infects and replicates inside, blowflies instead ingest the virus from infected dead birds or their waste, with the virus maintaining infectivity for up to two days. Blowflies are capable of flying at least 2 kms per day, so the researchers estimate that is it feasible for them to reach nearby poultry farms or other wild bird populations within a 4 km range. The researchers believe that as the blowfly moves from place to place, it could contaminate surfaces, food sources and water sources, with healthy birds becoming infected through direct contact with these contaminated sources, or by ingesting adult or larval blowflies. Infectious Diseases 2024 Infectious Diseases 2023 Infectious Diseases 2022 Infectious Diseases 2021 Read More Infectious Diseases 2020 Infectious Diseases 2019 Infectious Diseases 2018 Infectious Diseases 2017 Infectious Diseases 2016 Infectious Diseases 2015 Infectious Diseases 2014 Infectious Diseases 2013 Infectious Diseases 2012 Infectious Diseases 2011 Infectious Diseases 2010 Infectious Diseases 2009 Infectious Diseases 2008 Infectious Diseases 2007 Infectious Diseases 2006 Infectious Diseases 2005 Infectious Diseases 2004 Huvepharma Poulpharm Specialized in offering high quality research activities, both on a diagnostic level and when prforming clinical studies. Vetworks Event Vetworks Selected poultry consultants trained to provide independent advice according to your companyâs needs. our Partners Print page Send page Copyright Â© 2000-2024,Dr. Nati Elkin.All Rights Reserved. Infectious Disease TopicsHatching Ideas: Ilaria capuaVaccinesKnowledgeFocus OnDrugsPoultry MarketEggsAbout usContact usTerms and ConditionsRSS Follow Us:Fewer Australians are getting their annual influenza vaccine, national data shows - ABC NewsSkip to main contentABC NewsJust InFor YouPoliticsUS ElectionWorldBusinessAnalysisSportLifestyleEntertainmentMoreSearch the news, stories & peopleLog inNews HomeJust InFor YouAnalysisRuralWatch LiveHealthIndigenousPoliticsUS ElectionScienceElectionsWorldEnvironmentInvestigationsBusinessFact CheckLocal newsSportAFLNRLFootballTennisCricketNetballLifestyleWellbeingRelationships & FamilyFood & RecipesPersonal FinanceHome & GardenEntertainmentTV & MoviesBooksMusicPop CultureArtsYour ABC AccountPersonalise the news andstay in the knowLog in to personaliseFacebookYouTubeInstagramTwitterEmergencyBackstoryNewsletters中文新闻BERITA BAHASA INDONESIATOK PISINABCABC iViewABC ListenTriple JABC KidsABC NewsABC News News HomeFewer Australians are getting their annual influenza vaccine, national data showsShare Fewer Australians are getting their annual influenza vaccine, national data showsBy Andi YuBy Madi ChwastaTopic:HealthSun 28 JulSunday 28 JulySun 28 Jul 2024 at 11:22pmThe uptake of flu vaccinations has dropped nationally. (AAP: David Crosling)In short: It's peak influenza season but about 540,000 fewer Australians have had a flu shot compared to this time last year. A national survey conducted to find out why people were choosing not to get an influenza jab found some thought the flu vaccine would give them the flu, or that it wouldn't work at all. What's next?Doctors and epidemiologists say the vaccine is well worth getting because it reduces flu severity and protects people from pneumonia and other illnesses.abc.net.auews/australia-influenza-vaccination-uptake-decrease-flu-peak/104130284Link copiedShareShare articleIt's peak flu season in Australia but fewer people are opting to get vaccinated against influenza.Compared with this time last year, about 540,000 fewer Australians have had a flu shot.The yearly count is at its lowest since 2020, when vaccination data was made available.The drop is most significant for people aged between 5 and 64 — more than 440,000 people in this age category chose not to get a vaccination this year compared with last year.Vaccination rates are also lower for under 5s and over 65s.Federal government data for the first two weeks of July indicates more respiratory illness this year than last year. The latest Australian Respiratory Surveillance Report said influenza cases have risen steeply since late April 2024, peaking earlier this month. The age group most represented in influenza case numbers were children aged 0-9.Survey reveals why people aren't getting flu jabNational Centre for Immunisation Research and Surveillance (NCIRS) associate director Frank Beard said flu vaccine uptake this year was about 2 or 3 per cent lower than last year, and up to 10 per cent lower than rates in 2022.Interim findings from a national survey by the NCIRS identified people's main reasons for not vaccinating against flu were that they didn't think influenza was serious, the vaccine would give them the flu, or it wouldn't work."Those are incorrect but certainly, they're all out there," Professor Beard said."Since the COVID pandemic there seems to be vaccine fatigue, with all the focus on COVID vaccination."Also, with the current cost of living issues, people are busy and so they're not prioritising influenza vaccination as much as they should."Frank Beard says people seem to have "vaccine fatigue" since the COVID-19 pandemic. (Supplied)He said the survey also showed that people thought it was hard to get the vaccine and that cost was a barrier.But Professor Beard said it was easier than ever to get a flu shot."Pharmacists in all states and territories can now give influenza vaccination," he said."Most of them give it to anyone five years and over. Higher risk groups get it for free."Experts say this year's flu season is a big one. (ABC News: Kym Agius)Professor Beard encouraged all people to get their flu shot to prevent the illness aggravating other medical conditions."Every year it causes thousands of hospitalisations in Australia and hundreds of deaths," he said.Doctors seeing more flu cases in hospital emergency departmentAt the Royal Melbourne Hospital (RMH) the emergency department has recorded 120 cases of influenza in the past two weeks. "Even at this time of the year, that's a large number," RMH respiratory physician Lou Irving said."There's clearly a lot of influenza in the community."The numbers will eventually show that this is a big [flu] season."Professor Irving doesn't work in the emergency department himself, but sees inpatients with respiratory illness, of which a higher number have been influenza recently. "Of the five patients admitted to us overnight, four of them were flu positive," he said. Lou Irving has noticed a higher number of flu cases at the Royal Melbourne Hospital in recent weeks. (ABC News: Jessica Longbottom)Professor Irving said while vaccination rates nationally were waning, it was still worth having the flu shot to prevent the chance of serious illness.In his job, he said, he'd been witnessing an increase in community-acquired pneumonia, of which a predisposing factor was seasonal influenza."Some people think of the flu as just a transient two to three days of aches and pains and fever, but unfortunately that infection then lowers the immune defences to other illnesses," he said. "Although the vaccine is not 100 per cent effective, it does lessen the severity."Catherine Bennett says the effects of lower vaccine uptake are being seen now while the flu season is peaking.Lower vaccine uptake makes a greater impact in flu seasonDeakin University chair in epidemiology Catherine Bennett said two issues feeding into the current flu peak — fewer people getting yearly flu shots, and a large population of people who hadn't contracted flu in a long time due to pandemic lockdowns so their general immunity was low."That's the concern, that with lower vaccine uptake we are seeing impact now that the flu season is now at its peak," Professor Bennett said."People just get frustrated with having to think about things like vaccines. "There is that vaccine fatigue for some people, but also it's less clear when it's a problem because we've been hearing about flu and RSV and COVID right through the year."She said the flu vaccine is not perfect, but it's worth taking because it reduces the risk of infection."If you're taking [the flu shot] at the time that it's on offer — from April each year now — that's to coincide with our flu season and that is when the vaccine is most effective." Posted Sun 28 Jul 2024 at 11:22pmSunday 28 Jul 2024 at 11:22pmSun 28 Jul 2024 at 11:22pm, updated Mon 29 Jul 2024 at 2:02amMonday 29 Jul 2024 at 2:02amMon 29 Jul 2024 at 2:02amShare optionsCopy linkFacebookX (formerly Twitter)Top StoriesFamily shares tribute for Eleanor Bryant, teacher's aide killed when truck crashed into preschoolTopic:Road Accidents and IncidentsPhoto shows Eleanor Bryant, who was killed when a truck crashed into a Victorian preschool, pictured smiling at the races.Early election speculation reaches a fever pitch as Albanese announces two candidates in two hoursTopic:ElectionsPhoto shows A man in a black suit and a yellow tie stands at a podium, addressing the press and gesturing to the crowd.Donald Trump and the one big threat to Australia's almost $4 trillion superannuation systemDAnalysis by David TaylorPhoto shows SuperannuationUnder proposed laws the truth about COVID-19 could have been struck from the internetTopic:Social MediaPhoto shows A row of people looking at their phones with one set of hands and phone in focus. Police had warnings about Bondi Junction killer's behaviour before mass stabbing, court toldTopic:CrimePhoto shows Bondi Junction Stabbing RampageRelated storiesBetween the flu, COVID and RSV, we have 'so many things circulating simultaneously'. Here's what the data saysTopic:HealthPhoto shows A woman in a blue top blowing her nose using a tissueRelated topicsAdelaideAustraliaBrisbaneDarwinHealthHealth PolicyHobartInfluenzaMelbournePerthSydneyVaccines and ImmunityTop StoriesFamily shares tribute for Eleanor Bryant, teacher's aide killed when truck crashed into preschoolTopic:Road Accidents and IncidentsPhoto shows Eleanor Bryant, who was killed when a truck crashed into a Victorian preschool, pictured smiling at the races.Early election speculation reaches a fever pitch as Albanese announces two candidates in two hoursTopic:ElectionsDonald Trump and the one big threat to Australia's almost $4 trillion superannuation systemDAnalysis by David TaylorUnder proposed laws the truth about COVID-19 could have been struck from the internetTopic:Social MediaPolice had warnings about Bondi Junction killer's behaviour before mass stabbing, court toldTopic:CrimeJust InScrap metal pile next to a back road reveals ghosts of lithium past, present and futureTopic:Mining and Metals Industry10m ago10 minutes agoTue 12 Nov 2024 at 6:10amThe elusive, smelly 'corpse flower' is delighting crowds in once-in-a-decade bloomTopic:Botanical Gardens14m ago14 minutes agoTue 12 Nov 2024 at 6:06amJohn ran 100km after just three months of training, with a community supporting him throughTopic:Mental Health28m ago28 minutes agoTue 12 Nov 2024 at 5:52amAustralian aviation pioneer Lawrence Hargrave celebrated 130 years after first heavier-than-air flightTopic:Aerospace and Defence Equipment Manufacturing22m ago22 minutes agoTue 12 Nov 2024 at 5:58amMore Just InBack to topFooterABC News homepageMore From ABC NEWSWe acknowledge Aboriginal and Torres Strait Islander peoples as the First Australians and Traditional Custodians of the lands where we live, learn, and work.SectionsABC NEWSJust InWatch LivePoliticsWorldBusinessAnalysisSportScienceHealthEntertainmentLifestyleFact CheckOtherNews in language中文Berita Bahasa IndonesiaTok PisinConnect with ABC NewsFacebookInstagramYouTubeApple NewsX (formerly Twitter)More from ABC NewsContact ABC NEWSThis service may include material from Agence France-Presse (AFP), APTN, Reuters, AAP, CNN and the BBC World Service which is copyright and cannot be reproduced.AEST = Australian Eastern Standard Time which is 10 hours ahead of GMT (Greenwich Mean Time)Editorial PoliciesAccessibilityHelpContact UsAbout the ABCPrivacy PolicyTerms of Use© 2024 ABCNew push for mRNA bird flu vaccine development: WHO - The Hindu India World Movies Technology e-Paper Menu Science Data Health Opinion SEARCH FREE TRIALGIFT a Subscription Subscribe LOGIN ACCOUNT PREMIUM Open in The Hindu AppFREE TRIALLOGINGIFT a Subscription ACCOUNT PREMIUM Subscribe Science Data Health Opinion SEARCH India World Movies Technology e-Paper Science Data Health Opinion SEARCH News Business Entertainment Life & Style Society Technology Videos Sport Cities States Science Show More Chennai Delhi Bengaluru Hyderabad Movies Food Children Data Kochi Books Education Podcast Brandhub To enjoy additional benefitsFREE TRIALGIFT a Subscription Subscribe LOGIN ACCOUNT PREMIUM ShowcaseSubscribe to NewslettersCrossword+CONNECT WITH US Home Sci-Tech Health New push for mRNA bird flu vaccine development: WHO Under the initiative led by Argentinian manufacturer Sinergium Biotech, technology, materials, and expertise will be shared with a network of manufacturers in poorer countries, allowing them to accelerate their own vaccine development and productionUpdated - July 29, 2024 06:23 pm IST - Geneva, Switzerland AFP Copy link Email Facebook Twitter Telegram LinkedIn WhatsApp Reddit READ LATER Remove SEE ALL PRINT An employee dilutes poultry serum samples for an ELISA test for the detection of antibodies to the avian influenza virus at the Reference Laboratory of the World Organization for Animal Health in Campinas, Brazil. File photograph used for representational purposes only | Photo Credit: REUTERS The World Health Organisation (WHO) announced Monday, July 29, 2024, a new project to accelerate the development in poorer countries, of vaccines for human bird flu infections, using cutting-edge messenger RNA technology. The WHO said Argentinian manufacturer Sinergium Biotech would lead the effort and had already begun developing candidate H5N1 vaccines. The bird flu H5N1 first emerged in 1996, but since 2020 an exponential growth in outbreaks in birds has occurred in parallel with the virus increasingly jumping to mammals, including cattle in US farms and a few humans. This has prompted fears the virus could spark a future pandemic. Does H5N1 pose a threat for humans? | ExplainedSinergium is aiming to establish proof-of-concept in preclinical models for its candidate vaccines, the WHO said. Once the preclinical data is ready, the technology, materials, and expertise will be shared with a network of manufacturers in poorer countries, allowing them to accelerate their own development and production. The UN health agency said the project would be rolled out through the mRNA technology transfer programme it established with the UN-backed Medicines Patent Pool(MPP) in 2021, at the height of the Covid-19 crisis. That programme was aimed to help low- and middle-income countries, which found themselves dramatically underserved during the pandemic, to develop and produce their own vaccines using mRNA. The technology instructs the body to produce a unique protein that stimulates an immune response, teaching it to defend against the infection. Does India need to be concerned about the avian flu outbreak? | In Focus podcastVaccine equitySwiftly developed mRNA Covid vaccines were game-changers during the pandemic, but they also exposed glaring global vaccine inequity and demands for a fairer distribution amid efforts to use the technology against other diseases. “This initiative exemplifies why WHO established the mRNA Technology Transfer Programme,” the agency’s chief Tedros Adhanom Ghebreyesus said in a statement. That programme, which counts 15 manufacturing partners in countries ranging from South Africa to Ukraine to Vietnam, was aimed “to foster greater research, development and production in low- and middle-income countries”, he said. That way, “when the next pandemic arrives, the world will be better prepared to mount a more effective and more equitable response”. Does bird flu have the potential to turn into the next pandemic?Avian influenza viruses are among those considered to carry the potential of sparking a future pandemic. The WHO has said there are a range of traditional influenza vaccines already licensed for pandemic use that could potentially be tailored to combat H5N1 if it begins spreading among people. But Martin Friede, who heads the WHO’s vaccine research unit, said focusing on developing mRNA-based vaccines was particularly interesting when seeking to establish sustainable production capacity. Previous efforts to boost influenza vaccine production in developing countries had often faltered, with facilities narrowly focused on egg-based pandemic influenza jabs shutting after the threat dissipated and governments stopped procuring the doses. “The advantage of mRNA is that, in theory, we can make a Covid vaccine, we can make H5N1 vaccines, but also many other vaccines and importantly also therapeutics,”Friede told reporters. If the need for H5N1 vaccines or other jabs fades, instead of shutting down production, “we hope that all of the partners will be able to produce something else”, he said. He said half of the manufacturers in the programme had already begun installing necessary equipment to develop and produce mRNA-based vaccines, meaning they will be able to act far more swiftly if disaster strikes again. Published - July 29, 2024 05:07 pm IST Read Comments Copy link Email Facebook Twitter Telegram LinkedIn WhatsApp Reddit READ LATER Remove SEE ALL PRINT Related Topics health / Avian Influenza Outbreak / World / India / vaccines / medical research Top News Today0 / 0 Read in App The Hindu About Us Code of Editorial Values News Archive Sitemap Print Subscription Digital Subscription Subscribe to Newsletters Rss Feeds Readers Editor-Terms of Reference Authors & Contributors Frame Front page Contact us Contact Us Social Media Advertise With Us Group News Sites Business Line BL on Campus Sportstar Frontline இந்து தமிழ் திசை The Hindu Centre Young World Club The Hindu ePaper Business Line ePaper Crossword + Free Games Other Products RoofandFloor STEP Images Classifieds - Print Bookstore & Special Publications Popular Sections Elections Israeli–Palestinian conflict 2023 Latest News National News International News Videos Life & Style Food Podcast Showcase Opinion Editorial Columns Comment Cartoon Letters Interview Lead Business Agri-Business Industry Economy Markets Budget Sport Cricket Football Hockey Tennis Athletics Motorsport Races Other Sports Sci-Tech Science Technology Health Agriculture Environment Gadgets Internet States Andhra Pradesh Karnataka Kerala Tamil Nadu Telangana Cities Bengaluru Chennai Coimbatore Delhi Hyderabad Kochi Kolkata Kozhikode Madurai Mangaluru Mumbai Puducherry Thiruvananthapuram Tiruchirapalli Vijayawada Visakhapatnam Trending on The Hindu India News Kolkatta doctor rape murder case SC hearing LIVE (Sep 9) India News News PM Modi Brunei visit Coast guard crash New Zealand fata fog Intel’s Core Ultra 200V series processors Tesla China Sales Queen Elizabeth schools in India Trending on Group sites Stock Market Live Updates Stocks to buy today IND vs SL, 1st ODI Mogun Bagan Paralympics 2024 Gold Rate Today Silver Rate Today Explore Frontline Packages Centre is diluting federalism Frontline Current Issue Terms of Use Privacy Policy Copyright© 2024, THG PUBLISHING PVT LTD. or its affiliated companies. All rights reserved. BACK TO TOPSign in to unlock member-only benefits!Access 10 free stories every monthSave stories to read laterAccess to comment on every storySign-up/manage your newsletter subscriptions with a single clickGet notified by email for early access to discounts & offers on our products✕Looks like you are already logged in from more than 3 devices!To continue logging in, remove at least one device from the below listLog outLog Out from all devicesTerms & conditions | Institutional SubscriberCommentsComments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments. We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.Evidence Emerges that Avian Flu is Transmitting From One Mammal to Another | Microbiology toggle navigation Loading... Loading... LEADERBOARD Login here Register Free LOGIN REGISTER FREE Home Virtual Events Upcoming On-Demand Companies Posters Categories See More See More See More See More Health & Medicine Clinical & Molecular DX Immunology Cardiology Cancer Cell & Molecular Biology Genetics & Genomics Microbiology Neuroscience Plants & Animals Earth & The Environment Chemistry & Physics Technology Cannabis Sciences Drug Discovery & Development Webinars Upcoming On-Demand Categories See More See More Health & Medicine Clinical & Molecular DX Immunology Cardiology Cancer Cell & Molecular Biology Genetics & Genomics Microbiology Neuroscience Plants & Animals Earth & The Environment Chemistry & Physics Technology Cannabis Sciences Drug Discovery & Development Trending News Most Recent What's Hot Categories Multimedia See More See More Health & Medicine Clinical & Molecular DX Immunology Cardiology Cancer Cell & Molecular Biology Genetics & Genomics Microbiology Neuroscience Drug Discovery & Development Plants & Animals Cannabis Sciences Earth & The Environment Space & Astronomy Chemistry & Physics Technology Sponsored Content Infographics Videos eBooks See More Scientific Products Categories Companies New Popular Antibodies Immunity, Immunoassay, Immunotherapy Assay Kits Detection, Quantification Biomolecules Proteins Cell Biology Cell function Cell-Based Assays Cell viability Cell/Tissue Culture Cell lines, Cell growth, Cell differentiation Chemicals and Reagents Reagent kits, Laboratory chemicals Drug Discovery and Development Target identification, High-throughput screening Flow Cytometry Immunophenotyping, Cell cycle analysis Genomics Genome sequencing, Transcriptomics Imaging (Bio-Imaging / Microscopy) Fluorescence imaging Lab Automation High-throughput screening, Robotics, Liquid handling systems Lab Equipment Incubators Life Sciences Biological research, Biotechnology Molecular Biology DNA replication, Gene expression, PCR Next Gen Sequencing DNA sequencing, High-throughput sequencing, NGS platforms Quality Control and Validation QC standards, Quality assurance Single Cell Analysis Transcriptomics Technology Biotechnology, Instrumentation, Data analysis See More See More See More Companies See More Science Store Men's T-Shirts Women's T-Shirts Accessories Gift Cards Gift Card Balance See More See More See More Gift Card $25 Gift Card $50 Gift Card $75 Gift Card $100 See More Labroots Store Gift Card Balance Check Balance $0.00 Balance Gift Card Number: No gift card matches the entered value. Continuing Education More Virtual Events All Virtual Events Upcoming On-Demand Posters Companies Health & Medicine Clinical & Molecular DX Immunology Cardiology Cancer Cell & Molecular Biology Genetics & Genomics Microbiology Neuroscience Plants & Animals Earth & The Environment Chemistry & Physics Technology Cannabis Sciences Drug Discovery & Development Webinars All Webinars Upcoming On-Demand Health & Medicine Clinical & Molecular DX Immunology Cardiology Cancer Cell & Molecular Biology Genetics & Genomics Microbiology Neuroscience Plants & Animals Earth & The Environment Chemistry & Physics Technology Cannabis Sciences Drug Discovery & Development Trending News Most Recent What's Hot Health & Medicine Clinical & Molecular DX Immunology Cardiology Cancer Cell & Molecular Biology Genetics & Genomics Microbiology Neuroscience Drug Discovery & Development Plants & Animals Cannabis Sciences Earth & The Environment Space & Astronomy Chemistry & Physics Technology Multimedia Sponsored Content Infographics Videos eBooks Scientific Products Companies Science Store Men's T-Shirts Women's T-Shirts Accessories Gift Cards Gift Card Balance Continuing Education Company About Us The Team Careers Press Room Social Media Press Releases Editorial & Writing Team Blog Scholarships RSS Contact Us Continuing Education Leaderboard Advertise Media Kit Custom Virtual Events Virtual Event Series Hybrid Events Digital Advertising Webinars Rate Card Editorial Calendar Posters Case Studies Testimonials Request Demo Forms Audience Selection Form Social Media Preference Forms Custom Virtual Event Email Form Sponsored Content Selection Form Legal Terms and Conditions Privacy Policy Order Policy Shipping Policy Copyrights User Agreement User Data Request Support Company About Us The Team Careers Press Room Social Media Press Releases Editorial & Writing Team Media Partnerships Blog Scholarships Continuing Education Leaderboard Contact Us Advertise Media Kit Custom Virtual Events Virtual Event Series Hybrid Events Digital Advertising Webinars Rate Card Editorial Calendar Posters Case Studies Testimonials Request Demo Forms Audience Selection Form Social Media Preference Forms Custom Virtual Event Email Form Sponsored Content Selection Form Legal Terms and Conditions Privacy Policy Order Policy Shipping Policy Copyrights User Agreement User Data Request Learn More Custom virtual eventsuccess stories,view Labroots' Case Studies Learn More Win a gift card to theLabroots' Store! Learn More Register for the nextLabroots' Virtual Event, Clinical Diagnostics & Research Virtual Event Series 2024 Learn More Call for Posters!Submit a poster to any Labroots event Have questions? Visit our Support pages Login here Register Free Trending / Microbiology / Evidence Emerges that Avian Flu is Transmitting From One Mammal to Another JUL 28, 2024 8:29 AM PDT Share Evidence Emerges that Avian Flu is Transmitting From One Mammal to Another WRITTEN BY: Carmen Leitch 3 Around 1995, a form of highly pathogenic avian influenza known as H5N1 emerged in waterfowl in China. About a decade later, it began to infect more wild birds, and spread around the world. While it wreaked havoc in a variety of wild bird populations, it also started to affect farms where poultry was raised. Millions of birds died or had to be culled. For a time, other flu viruses became far more dominant. But by 2021, a new genetic form or clade of H5N1 was detected in wild birds around the world. Poultry farms were again affected. By 2022, over 50 million birds had died or been culled because of the virus. The number has only risen since then. While there are some vaccines available, there are many challenges to applying them effectively. Though there were some efforts to use such vaccines, H5N1 continued to spread, and started to show up in other animals. Scientists have documented H5N1 infections in a huge number of wild animals. Some experts are growing increasingly concerned that so many infected animals are giving the virus untold chances to mutate into new forms, some of which may threaten people. It's long been assumed that this virus did not pose a major threat to the public, because people have to be infected after contact with an infected bird. Even when they are infected, there has not been any evidence that one person can spread H5N1 to another. But some researchers are still sounding the alarm, and have suggested that we both do more to stop this virus from continuing to spread, and also that we start to develop vaccines for this strain of the flu. Right now, there are promising candidates for human H5N1 vaccines. There is also new evidence that the concern is warranted. For the first time, researchers have determined that avian influenza is now moving, in some cases, from one infected mammal to another. The report, which was published in Nature, has shown that H5N1 infected cows, then spread to other cows, and then cats, and finally, a raccoon. "This is one of the first times that we are seeing evidence of efficient and sustained mammalian-to-mammalian transmission of highly pathogenic avian influenza H5N1," said study co-author Diego Diel, associate professor of virology at Cornell University, among other appointments. In this work, the investigators assessed samples of the virus that had been isolated from infected animals. This effort did not reveal any genetic mutations that are thought to promote the transmission of the virus in people. The researchers did find that some viral samples could move from one mammal to another, which means it may adapt even more in mammals. Dairy cows that are infected with H5N1 probably first got it from wild birds. There are high viral levels in milk from infected cows, though it is thought that when applied correctly, pasteurization kills the virus in milk. Related: Influenza Viruses May Have an Alternate Route Into Cells This study also used whole genome sequencing to demonstrate that the virus moved from cow to cow after infected cows were moved from Texas to a farm in Ohio. After that, it moved to cats. The cats were likely drinking raw milk from the infected cows. A raccoon and wild birds also tested positive for the virus on the Ohio farm. There have been eleven confirmed cases of H5N1 in people in the United States, and each individual only experienced mild symptoms. These cases were in agricultural workers who either helped to cull herds or worked with dairy cows. Four recent cases in Colorado are thought to be linked to the same county. While people can be infected, the efficiency of viral replication is still low in humans. But the virus will keep changing. "The concern is that potential mutations could arise that could lead adaptation to mammals, spillover into humans and potential efficient transmission in humans in the future," Diel said. Right now, we must keep monitoring animals, and potentially infected humans, noted Diel. There are testing programs now available at no cost from the U.S. Department of Agriculture. We must make an effort to contain the virus and stop further spread, added Diel. Sources: Cornell University, Nature Share About the Author Carmen Leitch Bachelor's (BA/BS/Other) Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling. You May Also Like JUL 05, 2024 Microbiology Invasive Brown Widow Spiders Carry Chlamydia-Related Bacteria The invasive brown widow spider, Latrodectus geometricus, is native to South Africa, but has moved to several places aro ... Written By: Carmen Leitch 3 JUL 15, 2024 Microbiology Chickenpox Virus Gets an Unusual Boost From the Immune System Many of us experienced chickenpox as kids. The virus has a few sneaky ways to cause illness, and hang around in the body ... Written By: Carmen Leitch 5 AUG 22, 2024 Earth & The Environment Multiple Methane-Generating Microbes are Discovered Archaea are a major branch of life, but we still have a lot to learn about these microbes, which were only discovered in ... Written By: Carmen Leitch 4 SEP 01, 2024 Microbiology An Evolutionary Journey From Ancient Asgardians to Human Immunity Microbes have been engaged in an arms race with one another that goes back for millennia. While we have been able to rev ... Written By: Carmen Leitch 4 SEP 29, 2024 Microbiology Gum Disease Bacteria Affect Head & Neck Cancer Risk There are different communities of microbes, or microbiomes, in and on various parts of the human body like the skin, gu ... Written By: Carmen Leitch 4 OCT 16, 2024 Microbiology When Did Ants Start Farming? 66 Million Years Ago Humans began to farm about 11,000 years ago, when temperatures around the planet warmed, and people could settle down an ... Written By: Carmen Leitch 2 Loading Comments... Content Tags Medicine Zoonotic Disease Zoonosis Virus Virology Viral Genomics Viral Genetics Sequencing Public Health Molecular Microbiology Molecular Epidemiology Molecular Biology Microbiology Agricultural Biology Influenza Infectious Disease Infection Health Field epidemiology Epidemiology Data Science Data Mining Avian Animals Agricultural Sciences See more See less Multimedia Sponsored Content Infographics Videos eBooks Earth & The Environment A Shocking Source of Oxygen: Deep-Sea Minerals That Generate Electricity Technology 3-D printing artificial blood vessels to improve bypass procedures Let's Talk Science. Let's Talk Medicine. The leading scientific social networking website and producer of educational virtual events and webinars. About Us The Team Contact Us Careers Media Kit Virtual Events Posters Multimedia Blog Press Room Science Store Gift Card Balance Continuing Education Scholarships Leaderboard Order Policy Shipping Policy Privacy Policy Terms and Conditions User Agreement User Data Request Copyrights Support Chati © 2008-2024 Labroots Inc. Opens in a new window Opens an external site Opens an external site in a new window × Modal titleFlu vaccine will curb bird flu risk for US farm workers, CDC deputy director says | US news | The Guardian Skip to main contentSkip to navigationClose dialogue1/2Next imagePrevious imageToggle captionSkip to navigationPrint subscriptionsSearch jobs Sign inIntInternational editionUK editionUS editionAustralia editionEurope editionThe Guardian - Back to homeThe GuardianNewsOpinionSportCultureLifestyleShow moreHide expanded menuNewsView all NewsWorld newsUS elections 2024UK newsClimate crisisUkraineEnvironmentScienceGlobal developmentFootballTechBusinessObituariesOpinionView all OpinionThe Guardian viewColumnistsCartoonsOpinion videosLettersSportView all SportFootballCricketRugby unionTennisCyclingF1GolfUS sportsCultureView all CultureBooksMusicTV & radioArt & designFilmGamesClassicalStageLifestyleView all LifestyleFashionFoodRecipesLove & sexHealth & fitnessHome & gardenWomenMenFamilyTravelMoneySearch input google-search SearchSupport usPrint subscriptionsSearch jobsHolidaysDigital ArchiveGuardian LicensingAbout UsThe Guardian appVideoPodcastsPicturesNewslettersToday's paperInside the GuardianThe ObserverGuardian WeeklyCrosswordsWordiplyCorrectionsSearch input google-search SearchSearch jobsHolidaysDigital ArchiveGuardian LicensingAbout UsWorldEuropeUSAmericasAsiaAustraliaMiddle EastAfricaInequalityGlobal development Though US officials don’t recommend the bird flu vaccine for people yet, they believe that flu shots could help mitigate the consequences of H5N1 spread. Photograph: Brandon Bell/Getty ImagesView image in fullscreenThough US officials don’t recommend the bird flu vaccine for people yet, they believe that flu shots could help mitigate the consequences of H5N1 spread. Photograph: Brandon Bell/Getty ImagesUS news This article is more than 3 months oldFlu vaccine will curb bird flu risk for US farm workers, CDC deputy director saysThis article is more than 3 months oldUS launches major vaccination campaign in a bid to prevent healthcare strain and potential mutations of H5N1 virusMelody SchreiberFri 2 Aug 2024 17.00 BSTLast modified on Fri 2 Aug 2024 17.03 BSTShareIn the face of serious concerns over the spreading bird flu virus in US agriculture, the US Centers for Disease Control and Prevention (CDC) is pushing a major flu vaccination campaign among farm workers in a bid to prevent healthcare strain and combat potential mutations from the highly pathogenic bird virus.Part of the campaign will seek to combat disinformation about vaccines, which has hampered previous efforts.There are approximately 200,000 livestock workers in the United States, although the tally likely leaves out unofficial workers. It’s not clear what vaccination rates look like in the livestock industry. On average, only 47% of Americans get the flu shot each year.US supreme court rulings will affect response to threats like bird flu – expertsRead moreNirav Shah, principal deputy director of the CDC, said he was optimistic the vaccine campaign will be successful.“Many agricultural and livestock workers come from countries where vaccination is very commonplace, well-accepted and rates are very high,” he said. If farm workers do have low rates of vaccination, “the reason is access, not reticence”, he added.The new $5m campaign will bring seasonal flu shots to farm workers and another $5m will go toward strengthening healthcare for them, including improved access to testing, treatment and personal protective equipment.The campaign will distribute the seasonal flu shot, but not an H5N1-specific vaccine for bird flu, among communities that may have limited access to health care.The US ordered 4.8m doses of an H5N1 vaccine in May, and vials are now coming off the production line. The US has also entered into an agreement with Moderna to produce an mRNA vaccine for bird flu, expected to begin trials in 2025.The new vaccines have not yet been approved by the Food and Drug Administration (FDA), though there are options to use medications before clinical trials are complete through the FDA’s expanded access program for people at high risk of severe illness or death.Officials maintain the bird flu vaccines are not recommended for anyone at this time, while acknowledging the higher risk for farm workers compared to the general public.For farm workers and close contacts of people who test positive, the CDC is instead recommending flu antivirals: preapproved drugs that may work better to block transmission than flu vaccines typically do. Antivirals may be used before or after a person is exposed to a virus.The seasonal flu vaccine is being offered to protect the health of farm workers as well as the functionality of health systems, said Shah.View image in fullscreenNirav Shah speaks at a news conference in April 2020 in Augusta, Maine. Photograph: Robert F Bukaty/AP“Healthcare systems in rural areas can easily be overwhelmed – that’s true even in regular flu season,” he said. “Vaccination against seasonal flu helps reduce the strain on hospitals.”In the 2022, the flu shot prevented 6m illnesses, 65,000 hospitalizations and 3,700 deaths, according to the CDC.Officials also hope the seasonal flu vaccine will reduce the chance of co-infection – when someone gets sick with multiple strains of the flu at the same time. While the flu shot doesn’t prevent all infections, it can lower the risks.The seasonal flu shot could thus help prevent reassortment, where a worker might get bird flu and human flu at the same time and mix them to make an even worse variant.“In theory, reassortment could lead to a new influenza virus that could pose a significant public health concern: a virus that has the transmissibility of seasonal influenza and the severity of H5N1,” Shah said.The new campaign will focus on increasing access, but strategies will likely differ depending on the state, Shah said. States may work with local health care providers and county health departments, they could go directly to farms and they could set up clinics and vaccination tents at social gatherings, churches, fairs and community centers.There are a few reasons US officials don’t recommend the bird flu vaccine for people yet, Shah said. So far, no one in the US has been hospitalized or died from H5N1, despite a global 50% mortality rate from this strain. The main symptom has been conjunctivitis, or pink eye, though some patients have developed more typical flu symptoms like coughing and sore throat.The virus also isn’t showing mutations to become more transmissible among people, and there isn’t evidence that the virus is spreading from person to person, though testing remains very limited.Health officials seem to see the US outbreak as a series of anomalies: no one has gotten very sick yet; they believe they can arrest the spread in livestock. A recent spate of cases among poultry workers in Colorado, where nine people tested positive, may be attributed to unusually high heat, making personal protective gear less effective, they say.skip past newsletter promotionSign up to Headlines USFree newsletterGet the most important US headlines and highlights emailed direct to you every morningEnter your email address Sign upPrivacy Notice: Newsletters may contain info about charities, online ads, and content funded by outside parties. For more information see our Privacy Policy. We use Google reCaptcha to protect our website and the Google Privacy Policy and Terms of Service apply.after newsletter promotionThey weigh these concerns, which they see as relatively unusual, against longer-term issues like the spread of misinformation that may result in vaccine hesitancy.“Anything that happens following vaccination, whether caused by the vaccine or not, would and could be attributed to the vaccine, at least in the minds of the public,” Shah said. “And that could destroy confidence in that vaccine. It could destroy confidence in all vaccines for a number of years.”Extreme heat may be crucial factor in human spread of bird fluRead moreIn 1976, for example, an outbreak of a pandemic-potential swine flu led to a widespread vaccination campaign that was soon engulfed in misinformation. An extremely rare side effect known as Guillain-Barré syndrome emerged – but that’s not what engendered skepticism, Shah says.Several people had heart attacks after getting their vaccines in the same location. An investigation later ruled out a connection to the vaccine – “people have heart attacks,” Shah said – but the association was already set among the public.Similar anti-vaccine sentiment exploded from the fringes into the mainstream during the Covid pandemic. Some misinformation campaigns falsely attributed illness and death to vaccines.“What’s different here is that this would be a new vaccine, and with anything new – Covid vaccines, a new drug, a new surgical procedure – all eyes are on that,” Shah said. “Do the benefits outweigh the risks?”It’s a question health officials will weigh as the bird flu outbreak continues.In the meantime, farm workers and others in close contact with animals continue to face elevated risks of bird flu.The CDC recently changed its procedures to make flu antivirals like Tamiflu easier to access.“Tamiflu is a very viable option before we get to this point of vaccination, and we are embracing it,” Shah said. “On any kind of farm setting where any worker has been exposed, we have recommended it.”Antivirals help reduce severity of illness, and they can also keep viruses from being transmitted by suppressing the amount of virus a person has in their body.Workers could also take the medicine before they’re exposed, in order to prevent infection entirely.“We’re discussing that, too,” Shah said. “It raises some tough questions, though. How long should they be taking it? What about the side effects?”But short-term use of the medication could be especially helpful for workers who are culling infected poultry and milking infected cows, particularly since the high-heat conditions implicated in the Colorado outbreak are expected to continue in many places.Explore more on these topicsUS newsBird fluVaccines and immunisationHealthFluFarmingnewsShareReuse this contentMost viewedMost viewedWorldEuropeUSAmericasAsiaAustraliaMiddle EastAfricaInequalityGlobal developmentNewsOpinionSportCultureLifestyleOriginal reporting and incisive analysis, direct from the Guardian every morningSign up for our emailHelpComplaints & correctionsSecureDropWork for us Privacy policyCookie policyTerms & conditionsContact usAll topicsAll writersDigital newspaper archiveTax strategyFacebookYouTubeInstagramLinkedInXNewslettersAdvertise with usSearch UK jobsBack to top© 2024 Guardian News & Media Limited or its affiliated companies. All rights reserved. (dcr)Bird flu vaccine for cows is gaining interest Skip to Main Content Election 2024 FDA Congress Newsletters Log In My Account Subscribe Now My Account Settings Billing Log Out Reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now BiotechPharmaPublic HealthHealth TechPolicyScienceFirst OpinionSTAT+STAT Events Search Log In Try STAT+ My Account Home News Latest Business Biotech Pharma Health Tech Health Insurance Hospitals Medical Devices Washington Policy FDA CDC NIH Science CRISPR Gene Therapy Research Neuroscience Public Health H5N1 Bird Flu Addiction Covid-19 Abortion Health Disparities Infectious Disease Mental Health Disease Cancer Cardiovascular Disease Chronic Disease Diabetes Alzheimer's Obesity Features Coercive Care The Obesity Revolution The War on Recovery Newsletters Opinion Columns Adam Feuerstein Matthew Herper Ed Silverman Reports E-books Podcasts Tools & Trackers CRISPR Tracker Breakthrough Device Tracker Generative AI Tracker Obesity Drug Tracker Events Upcoming Events Summits 2025 Breakthrough East 2025 Breakthrough West Community STAT Wunderkinds '24 STAT Madness Video Advertise STAT Brand Studio Don't miss out Subscribe to STAT+ today, for the best life sciences journalism in the industry Learn more HealthCould cow vaccines help halt the spread of bird flu in U.S. herds? Experts are divided By Helen Branswell July 29, 2024 Reprints Illustration: Christine Kao/STAT; Photos: Adobe With the number of U.S. dairy herds infected with H5N1 bird flu rising almost daily, fears are growing that the dangerous virus cannot be driven out of this species. That belief is amplifying calls for the development of flu shots for cows. Multiple animal vaccine manufacturers are reportedly at work trying to develop such products. And the U.S. Department of Agriculture is eagerly encouraging the effort, detailing in a notice last week what kinds of evidence would be needed to win licensing approval for cow vaccines.advertisement But a number of scientists question whether investing too heavily in this strategy is a wise approach at this point, given that there remain many outstanding questions about whether vaccinating cows would be an effective way of stopping spread of the virus in cattle in the first place. Some wonder whether farmers will be willing to absorb the costs of vaccines to prevent an infection they don’t currently view as a serious threat to their operations, or whether they would agree to the stringent post-vaccination surveillance that must go hand-in-glove with any attempt to use vaccines to solve this vexing problem. To date dairy farmers have, in large measure, refused to cooperate with efforts to chart how deeply the virus has infiltrated U.S. herds, seeing the possible stigma of admitting they have H5N1-infected cows as a greater risk than the virus itself. “Despite the USDA’s program to compensate farmers for production losses and their and other agencies’ efforts to incentivize more testing of cows and people at-risk, distribute [personal protective equipment], etc., there doesn’t seem to be widespread enthusiasm,” said Angela Rasmussen, a virologist at the University of Saskatchewan’s Vaccine and Infectious Disease Organization in Saskatoon, Canada. “That makes me wonder how willing producers would be to vaccinate their entire herds even if a vaccine were available, especially if it costs them any money at all. For large herds, this could mean a substantial investment.”advertisement Related: Despite bird flu anxiety in the dairy barn, a yearly tradition carries on at an Iowa county fair Rasmussen is one of a number of experts STAT spoke to who are not convinced cow flu shots are the answer to this dilemma. The need to stop transmission of the virus in cows is pressing — more, really, for us than for the animals themselves. The longer it transmits among mammals, the better adapted to mammalian species it will become. The changes it will acquire in that process could make it better equipped to transmit to and among people. Many scientists watching the U.S. situation unfold believe traditional containment measures, strictly applied, could drive the virus from cows. More limits on movement of cows. Aggressive testing of herds, possibly through the sampling of bulk tanks on farms. More stringent biosecurity. To be clear, the USDA also contends the spread of H5N1 in dairy cattle can be stopped through traditional containment measures. “Enhanced biosecurity [within the industry] should get us to a point where we can arrest the spread,” Eric Deeble, USDA’s acting senior adviser for the H5N1 response, reiterated earlier this month at a press conference. In a previous news conference, Deeble said vaccines for cows would take some time to develop, and containment should be achievable before they are ready. “We hope that through enhanced biosecurity and additional testing that … we will be able to eliminate this disease from the dairy herd in the absence of a vaccine, although we believe that they may be helpful down the line,” he said, adding the USDA hopes its programs to help pay for measures aimed at reducing the spread of H5N1, and to compensate for lost milk production, will entice dairy farmers to take the steps needed to lower the risk of transmission. The department’s production loss compensation program requires positive test results to make a claim, which could make more visible the actual scope of the problem, if farmers apply for it. In the nearly one month since the program was launched, 12 applications have been submitted, Marissa Perry, USDA’s deputy director of communications, told STAT in an email. Newsletters Sign up for Daily Recap All the health and medical news you need today, in one email Please enter a valid email address. Privacy Policy That’s out of 172 herds with confirmed bird flu infections, and the untold others where the virus has infected cows but farmers — some of whom view bird flu as just one more health problem cows occasionally develop — haven’t bothered to test. Some may have done what a canny Oklahoma farmer did in mid-April when faced with the possibility of H5N1-infected cows: Collected swabs and stored them, only submitting them for testing after the USDA’s milk compensation program went into effect. (They were positive.) Under a federal regulation that came into effect at the end of April, all positive H5 tests must be reported to the USDA. Florian Krammer, an influenza virologist at Mount Sinai’s Icahn School of Medicine in New York who has worked on developing human vaccines, is hopeful about the prospect of administering flu shots to cows. In fact, earlier in this outbreak Krammer raised the possibility of giving stockpiled H5N1 vaccines made for people to cows to try to quell spread of the virus. Experts who are more skeptical of the utility of vaccinating cows counter that human flu vaccines produce underwhelming results when used in people, and may not do what we need them to do in cattle. In people, they do reduce the risk of serious infection requiring hospitalization and of death, but have much more modest impact — if any — on preventing infection or blunting onward transmission, said Michael Osterholm, director of the University of Minnesota’s Center for Infectious Disease Research and Policy. CIDRAP has studied the real-world effectiveness of flu vaccines in depth. Krammer doesn’t necessarily see that as a problem when it comes to cows. In people, flu vaccines, which are injected into the arm, don’t trigger production of antibodies that can neutralize virus in the upper respiratory tract, where infection occurs. Cows’ udders, where H5N1 infection is believed to take hold in most cases, produce high levels of this kind of antibody, known as IgG. Related: USDA maintains bird flu can be eliminated from dairy cows, even as doubts mount among experts “We’re talking about an anatomic site that has tons of IgG. That’s exactly the antibodies that you would get with intramuscular vaccination,” he said. “It’s not clear if this is going to be 100% effective in stopping transmission. It’s unlikely. But if you combine that with other measures, it could be used as a tool to cut down on transmission.” Thijs Kuiken, a Dutch pathologist who has studied H5N1 for two decades, thinks the U.S. needs to mount a broad response to solve its H5-in-cows problem. But, like Krammer, he also believes cow vaccines could help. “It would most likely reduce infection, reduce secretion [of virus], therefore slow down transmission, and therefore help to stop an epidemic,” said Kuiken, a professor in the department of viroscience at Erasmus Medical Center in Rotterdam. Other experts question whether enough is known about what we actually need cow flu vaccines to do to start designing these products. Osterholm has led efforts to develop what are known as “target product profiles” for other vaccines, including one for a universal flu vaccine for people. A TPP is effectively the list of criteria a vaccine should meet to be effective. Knowing how a virus spreads within the population you are trying to protect — be it human or bovine — is a prerequisite to figuring out how to design these vaccines, Osterholm noted. Rasmussen agrees there are important gaps in our understanding of how H5N1 is moving from cow to cow and herd to herd. In her view, it’s unclear whether vaccines would solve or potentially exacerbate the spread of H5 in cows. “Would an intramuscular or intranasal vaccine work to prevent infection via the mammary gland? Would intra-mammary vaccination protect against infection by the respiratory route? How well would any of these vaccination approaches work to prevent disease and what impact would this have on milk production?” she asked. Related: Bird flu that infected 6 Colorado poultry workers is closely related to the virus in cows Since the very beginning of the outbreak, the USDA has said that it believes that, in the main, individual cows are becoming infected when they come in contact with contaminated milk that pools in milking machines as cows are led in and out in succession. It also believes the virus is spreading from herd to herd through other human-mediated means — the movement of cows from infected herds within and across state lines, the trucks and other equipment that transport animals and supplies from farm to farm, and on the clothing of workers who pull shifts on more than one farm. But once the virus is in a herd, does respiratory transmission occur? That, after all, is the way humans infect one another with flu. Results of efforts to get to the bottom of this question have been mixed to date. A preprint — a scientific paper that hasn’t yet been through peer review — posted online by scientists from USDA’s National Veterinary Services Laboratories in Ames, Iowa, reported on the experimental infection of heifers and lactating cows. They found respiratory transmission can occur, though hypothesized that infection in the mammary gland likely lasts longer. And a study published this week in Nature that is based on an analysis of spread of the virus through nine farms across four states also pointed to respiratory transmission playing some role in transmission of the virus. But Jürgen Richt, a veterinarian and director of the Center of Excellence for Emerging and Zoonotic Animal Diseases at Kansas State University’s College of Veterinary Medicine, conducted experimental infections of cows and did not see evidence of spread of the virus via the respiratory tract. “My conclusion from my studies is … the respiratory route is not the major route of transmission,” Richt told STAT. “But will there be instances where it could happen? Most likely. If you have thousands of animals. Some are sick. They have bacterial infections on top [of flu]. Crowding. These are conditions we cannot replicate. Our [lab] animals are housed in, like, a five-star hotel.” Does it matter? In a word, yes. If a vaccine protects udders but does not protect respiratory tracts, the most obvious signs that this virus is spreading in a herd — reduced milk production and thickened, discolored milk — could disappear, making a currently hard-to-detect problem virtually invisible. There is already evidence that respiratory infection in cows is more subtle than infection in the udder. The preprint on the experimental infection work conducted by the USDA’s scientists notes that signs of clinical disease “may not be recognized under field conditions, particularly from a respiratory route of exposure.” If cow vaccines could induce what’s called sterilizing immunity — immunity that prevents infection, not just lessening the illness that infection causes — flu virologist Thomas Peacock said he’d be more enthusiastic about the idea. But flu vaccines as we know them don’t do that, said Peacock, an expert at Britain’s Pirbright Institute, which focuses on controlling viral illnesses in animals. Peacock suggested he’s left with the sense that cow vaccines are a fallback solution, an easier out than putting in place policies that the industry doesn’t want to have to adopt. Related: Preparing schools for the H5N1 bird flu they’re likely to face “At the moment it just feels like, well, we have to do something, but we don’t want to do the expensive, disruptive thing, and therefore we’re going to do the cheap, good-sounding thing,” Peacock said. “It really feels like a last resort that we shouldn’t have to be going to.” He and Kuiken likened going the vaccine route to admitting defeat — an acknowledgement that the dairy industry cannot be cajoled, enticed, or even coerced into taking the steps needed to stop spread within U.S. herds. “My feeling is that if vaccination started to be used for cattle, that would be a huge admission of failure,” Peacock said. If cow vaccines are used, they will have to be deployed as part of a series of measures, the most important of which would be surveillance, said Marion Koopmans, who heads the viroscience department at Erasmus Medical Center. The aim would be to detect transmission that the use of vaccines might mask. “The full blocking or elimination of virus is unlikely. So you will need to make sure you have ways of picking up circulation that might have become silent, because vaccination is more likely to suppress the symptoms,” she said. David Swayne, an avian influenza expert who worked for the USDA for nearly 30 years and is now a private consultant, agreed that vaccination of cows would have to be done as part of a more multifaceted response. “It’s not just about injecting a vaccine,” he said. “You need to then follow up to look serologically, and then you also need to follow up to make sure there’s no virus by testing, let’s say, bulk milk or something like that. Surveillance is really a critical part of any kind of vaccination program for a severe disease like [highly pathogenic avian influenza.]” Swayne acknowledged the concerns about the unanswered questions about how H5N1 is spreading in cows, but he said vaccine manufacturers should be working on vaccines while researchers are seeking those answers. Vaccines may be a necessary tool for controlling this disease in the future. “Instead of waiting until you answer all the questions on pathogenesis, it’s good to go ahead and start working on those vaccines now, so that when you get to the end, and you have all your answers, you’ve got the vaccines ready for that final step,” he said. About the Author Reprints Helen Branswell Senior Writer, Infectious Diseases Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. @HelenBranswell linkedin.com/in/helen-branswell-22ab936/ Tags H5N1 Bird Flu infectious disease public health STAT+ To submit a correction request, please visit our Contact Us page. Trending Compounding group sues FDA for removing Lilly’s obesity drug… Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list White House should declare national emergency over IV fluid… White House should declare national emergency over IV fluid shortages caused by Helene, says hospital group With boost from RFK Jr. and Tucker Carlson, two… With boost from RFK Jr. and Tucker Carlson, two chronic disease entrepreneurs vault into Trump’s orbit Recommended Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie… Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more Schizophrenia drug AbbVie picked up in $9 billion acquisition… Schizophrenia drug AbbVie picked up in $9 billion acquisition fails in key trials A STAT Investigation: Pain, loss, and coercive care A STAT Investigation: Pain, loss, and coercive care Recommended Stories Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more Biotech Elaine Chen STAT Plus: Schizophrenia drug AbbVie picked up in $9 billion acquisition fails in key trials advertisement Who to Know Isabella Cueto STAT Plus: ‘MAHA’ is moving into Trump’s White House. Here’s who RFK Jr. could bring along for the ride Politics Lizzy Lawrence STAT Plus: What letting RFK Jr. ‘go wild’ might mean for Trump’s FDA Matt's Take Matthew Herper STAT Plus: How will Trump’s election change the FDA? History yields some clues Reporting from the frontiers of health and medicine Back to top Company About Our Team Contact Us Careers Diversity & Inclusion Our Awards Advertise With Us STAT Brand Studio Supporters Licensing Stories Account STAT+ Group Subscriptions FAQ My Account Log In Subscribe More Events Newsletters Reports App Podcasts Community Privacy Comment Policy Terms Do Not Sell My Data ©2024 STATBlowflies linked to bird flu spread in southern Japan Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About COVID-19 News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge Newsletters Health & Personal Care eBooks Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Cold, Flu & Cough Eating Disorders Eye Health Gastrointestinal Health Heart Disease High Blood Pressure Lung Cancer Mental Health Mpox Pregnancy Type 1 Diabetes Type 2 Diabetes Sexual Health Sleep View Health A-Z ×Top Health Categories Coronavirus Disease COVID-19 Heart Disease Diet & Nutrition High Blood Pressure Artificial Intelligence Lung Cancer Allergies Mental Health Alzheimer's & Dementia Mpox Arthritis & Rheumatology Pregnancy Breast Cancer Type 1 Diabetes Cold, Flu & Cough Type 2 Diabetes Eating Disorders Sexual Health Eye Health Sleep Gastrointestinal Health View Health A-Z Medical Home Life Sciences Home About News Life Sciences A-Z White Papers Lab Equipment Interviews Newsletters Webinars More... eBooks Contact Meet the Team Advertise Search Become a Member White Papers MediKnowledge Newsletters Health & Personal Care eBooks Contact Meet the Team Advertise Search Become a Member Webinars eBooks Contact Meet the Team Advertise Search Become a Member Blowflies linked to bird flu spread in southern Japan Download PDF Copy Reviewed Kyushu UniversityAug 1 2024 Researchers from Kyushu University have discovered that blowflies, a family of flies strongly attracted to decaying flesh and feces, are carrying the bird flu virus in southern Japan. Their findings, published in Scientific Reports, introduce a potential new route of transmission for bird flu and highlight the need to develop new countermeasures to prevent and control the disease in poultry farms. Since 2020, bird flu has been spreading rapidly around the globe, leading to the death of millions of wild birds and the culling of more than half a billion farmed birds worldwide. In Japan, where a single case of infection on a poultry farm mandates the culling of the entire stock, the 2022-2023 winter season saw a record-high of 326 outbreaks of bird flu, resulting in the sacrifice of 17.7 million birds. Some strains of bird flu have also jumped to mammals, including cows, goats, dogs, cats, and since March, an uptick of cases in poultry and dairy workers, with a high fatality rate, has raised significant concern. Bird flu has been causing substantial damage to wildlife and the poultry industry, and also holds great risk for humans who work closely with livestock. It's therefore vital to understand how the virus spreads and its potential routes of transmission to control and prevent outbreaks." Ryosuke Fujita, First Author, Associate Professor, Kyushu University's Faculty of Agriculture In this research, the scientists studied a wild crane colony in Izumi city, Kagoshima Prefecture, in southern Japan. In winter, the prime season for bird flu, thousands of cranes migrate to this area, with their dense numbers making them vulnerable to infection. During winter 2022-2023, 1600 cranes out of colony of 10000 cranes died from bird flu. "We were notified about the cranes being infected and we had to act quickly," says Fujita. Along with his colleagues, he set traps at different locations around Izumi city to collect blowflies. "We were particularly interested in one species of blowfly, Calliphora nigribarbis, as unlike other fly species, they are active in winter, coinciding with the peak season of bird flu. This, along with their attraction to the flesh and feces of animals, makes them a prime suspect for spreading the virus," adds Fujita. Related StoriesPasteurization effectively reduces H5N1 virus in milk but further testing is essentialStudy reveals how COVID-19 affected the spread and evolution of seasonal influenzaH5N1 bird flu is mutating fast and jumping to mammals - could the next pandemic be here?The researchers collected 648 blowflies and discovered that 14 blowflies were carrying the bird flu virus. The majority of virus-positive blowflies were collected from the sample site closest to the crane colony. "While 14 blowflies may seem like a low number, this represents a prevalence in blowflies of 2.2%, which is a huge percentage compared to other diseases spread by insects," explains Fujita. The research team also used genetic testing to confirm that the blowflies were carrying the same virus strain that has been infecting the crane colony. Unlike birds and mammals which the virus infects and replicates inside, blowflies instead ingest the virus from infected dead birds or their waste, with the virus maintaining infectivity for up to two days. Blowflies are capable of flying at least 2 kms per day, so the researchers estimate that is it feasible for them to reach nearby poultry farms or other wild bird populations within a 4 km range. The researchers believe that as the blowfly moves from place to place, it could contaminate surfaces, food sources and water sources, with healthy birds becoming infected through direct contact with these contaminated sources, or by ingesting adult or larval blowflies. In Japan, where farmers often use closed farming systems instead of open spaces to control infections and maximize production, countermeasures aimed at eliminating blowflies could be implemented fairly easily, helping to protect farmers from severe financial damage. "By keeping areas clean and using fly control methods, such as fine nets or insecticides, we can reduce the risk of virus spread to indoor poultry farms. However, in outdoor farms in other countries, and in wild bird populations, controlling blowflies may be logistically impossible," says Fujita. Having identified that blowflies carry the virus, Fujita and his colleagues are now collaborating with the government to capture blowflies in quarantined sites around infected poultry farms, hoping to find definitive evidence that blowflies are causing these outbreaks. Fujita and his colleagues are also developing new tools that use artificial intelligence to assess and predict the potential risks of vector insects. "By using advanced technologies alongside on-the-ground research, we can better understand and control the spread of bird flu and other insect-borne diseases, ultimately safeguarding both animal and human health," concludes Fujita. Source:Kyushu UniversityJournal reference:Fujita, R., et al. (2024). Blowflies are potential vector for avian influenza virus at enzootic area in Japan. Scientific Reports. doi.org/10.1038/s41598-024-61026-1 Posted in: Medical Research News | Disease/Infection News Tags: Agriculture, Artificial Intelligence, Avian Influenza, Bird Flu, Education, Flu, Food, Genetic, Influenza, Medicine, Research, students, Virus Comments (0) Download PDF Copy Suggested Reading Study reveals high effectiveness of flu vaccines in children but highlights challenges with certain subtypesCDC identifies new Oropouche virus cases in U.S. travelers, raising public health concernsScientists detect replication-competent Oropouche virus in semen of traveler, sparking transmission fearsCurcumin compound reactivates Epstein–Barr virus, offering safer cancer therapyExclusive: Emails reveal how health departments struggle to track human cases of bird fluElevated antibody responses to Epstein-Barr virus linked to increased risk of multiple sclerosisGlobal experts gather in Brisbane for scientific meeting dedicated to influenzaNew CDC report highlights disparities in flu hospitalization and vaccination Comments The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical. Cancel reply to comment Post a new comment Login (Logout) Quirky Comment Title Post TrendingStories LatestInterviews Top HealthArticles Traditional Chinese herb shows promise against Alzheimer’s and Parkinson’sBreakthrough research reveals how to target malignant DNA in aggressive cancersAncient herb shows promise in fighting dementiaLink between COVID-19 and long-term risk of autoimmune and autoinflammatory connective tissue disordersCDC updates pain care guidelines for clinicians Exploring the G:Box and for high-quality imaging Dr Martin Biggs In this interview, News Medical speaks with Dr Martin Biggs from Synoptics about Syngene's G:Box, a high-quality imaging and gel documentation system. Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024 Carolyn Marks and Joel Svensson In this interview, conducted at SfN 2024 in Chicago, News Medical speaks with Joel Svensson and Carolyn Marks of Atlas Antibodies, about their new launch, the MolBoolean™, as well as how conferences like SfN are helping shape the future of neuroscience research. How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics Susan Magsamen The intersection of arts and neuroscience reveals transformative effects on health and learning, as discussed by Susan Magsamen in her neuroaesthetics research. Why You Might Feel Tired After Drinking CoffeeMythbusting: The 10,000 Steps Per Day TrendCan Magnesium Supplements Help You Sleep Better?Challenges in the Global ADHD Medication Supply ChainHow Does Semaglutide Work to Lose Weight? Latest NewsMethylGPT unlocks DNA secrets for age and disease predictionAI-based ultrasound software guides childbirth decisions with high accuracyRevolutionary AI predicts aging and disease from DNA patternsCannabinol enhances sleep in rats, study showsOvertreatment of older men with prostate cancer raises concerns Newsletters you may be interested in Genetics (Subscribe or Preview) Bowel Cancer (Subscribe or Preview) MedTech (Subscribe or Preview) See all Newsletters » High Credibility: This website adheres to all nine standards of credibility and transparency. Medical Links Medical Home COVID-19 News Health A-Z White Papers Thought Leaders Insights MediKnowledge Series Health & Personal Care Medical Devices Drugs eBooks Life Sciences Links Life Sciences Home News Lab Instruments & Equipment Life Sciences A-Z White Papers Thought Leaders Insights Webinars eBooks Other Useful Links About Meet the Team Search Newsletters Sitemap Advertise Contact Terms & Conditions Privacy & Cookie Policy Content Policy Ownership & Funding Information Other AZoNetwork Sites AZoM AZoNano AZoCleantech AZoOptics AZoRobotics AZoSensors AZoMining AZoQuantum AZoBuild AZoLifeSciences AZoAi Facebook Twitter LinkedIn News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Update Your Privacy Preferences Last Updated: Tuesday 12 Nov 2024 News-Medical.net - An AZoNetwork Site Owned and operated by AZoNetwork, © 2000-2024 Azthena logo with the word Azthena Maximise chat window Hide chat window Your AI Powered Scientific Assistant Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. To start a conversation, please log into your AZoProfile account first, or create a new account. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content. Log in A few things you need to know before we start. Please read and accept to continue. Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI. Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy. Large Language Models can make mistakes. Consider checking important information. I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements. Please check the box above to proceed. Start Chat Great. Ask your question. Clear Chat Clear Chat Brief Moderate Detailed Azthena may occasionally provide inaccurate responses. Read the full terms. Terms While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information. Read the full Terms & Conditions. Provide Feedback Submit Cancel You might also like... × Oropouche virus spreads in South America as scientists warn of potential outbreaks in the U.S.New research sheds light on mortality rate disparities in Alaska during the 1918 flu pandemic - OsloMet OsloMet - Home Search Menu About OsloMet Study at OsloMet Our research Work for us Alumni University Library Contact us Featured research New research sheds light on mortality rate disparities in Alaska during the 1918 flu pandemic Exposure to earlier illness likely holds the key to understanding why some groups in Alaska suffered disproportionately high death rates in the 1918 influenza pandemic, OsloMet researchers have found. A research article from: Centre for Welfare and Labour Research Published: 29/07/2024 Last updated: 30/07/2024 Text: Matthew Davidson Photo: Heritage / Scanpix From understanding who is most at risk of illness to preparing for the next pandemic, there is a great deal to be learned from hundred-year-old death certificates.One of the enduring questions of the 1918-20 influenza pandemic is why Indigenous populations in remote areas were more vulnerable than non-Indigenous people living in cities. Limited access to healthcare is a factor, but it doesn’t satisfyingly explain why the death rates in these populations was as much as eight times higher than non-indigenous ones. Now, thanks to recently obtained data analysed by OsloMet Professor Svenn-Erik Mamelund, University of Missouri Professor Lisa Sattenspiel, and their team, we have clearer evidence that one of the key explanations is that remoteness limits exposure to earlier diseases.The 1918 flu was especially deadlyThe 1918 flu stands out as one of the deadliest influenza pandemics in history. Between two and five percent of the world’s population died in just a few years. As Mamelund puts it, "studying this historical event goes beyond scientific curiosity. It’s important to know how pandemics behaved in the past in order to understand what could happen in the future and prepare for it."Mamelund says pandemics are connected across time. We need to know what to expect and how well earlier policy actions worked so that we can take a proactive stance toward the next pandemic.The 1918 flu pandemic was difficult to manage in part because it didn’t affect the expected populations. We usually expect to see elderly people and young children hit hardest but in most places this wasn’t the case. Instead, researchers have found that across Europe and North America it disproportionately affected young adults.However, Mamelund and Sattenspiel say that this was only true in cities. In indigenous populations in remote areas, the deaths are more evenly distributed and the elderly do make up a large portion of the deaths. The big question they are trying to answer is "why were Indigenous people across the world so much more vulnerable than people in cities?". Studying this historical event goes beyond scientific curiosity. It’s important to know how pandemics behaved in the past in order to understand what could happen in the future and prepare for it. – Svenn-Erik Mamelund Remoteness is a risk factorThere are many studies of disease, from even before 1918 through to the present day, that try to identify risk factors. Medical conditions - like heart disease, or tuberculosis, and even age - make someone much more likely to get seriously ill. We also know that lower social-economic status, substandard housing, and lower income lead to higher risk. What we don’t know is how remoteness influences disease mortality. Across the world, indigenous people - from Sami, to Pacific Islanders, to Alaska Natives - suffer many times more deaths from pandemics than non-Indigenous people living in cities. While this is well known among researchers, the reason for this discrepancy is still unclear. Mamelund and Sattenspiel think they’ve found the answer in records from the 1918-20 influenza pandemic.Based on their new research, Mamelund and Sattenspiel hypothesize that the remote settings protect against the spread of viruses. According to Mamelund, “people living in urban societies are likely to encounter waves of various pathogens, but limited contact with outsiders means that people living in remote areas are less likely to encounter these pathogens. Even when a pathogen does reach them, the small communities (often home to less than 100 people) cannot sustain the spread of disease.”While remoteness makes it less likely for diseases to arrive, when they do it can be absolutely devastating. Mamelund and Sattenspiel suspect that high death rates during the 1918-20 influenza pandemic may be a result of many remote Indigenous populations not having experience with earlier versions of the disease and therefore possess lower levels of immunity against the pandemic. Tough life, fertile ground for researchThe Alaska territory in the early 1900s was a strange and difficult place. Around 27,000 of the territory’s 57,000 inhabitants were Alaska Natives. The other 30,000 were non-Indigenous, drawn to the area by gold, furs, and the canning industry. The non-Indigenous were mostly in their 20s to 40s, nearly all of them were men (around this time, the ratio of men to women in Alaska was 258 to 1), and over half of them returned to their home cities in the colder months.These factors make the region great for studying pandemics. Both the Indigenous and non-Indigenous people in Alaska inhabited equally remote locations, faced a harsh climate, and had similar access to care. And yet, Alaskan Natives still experienced eight times higher mortality from the 1918-20 flu pandemic and had disproportionately high mortality among the elderly. Professor Svenn-Erik Mamelund. Seeking goldIt is this age discrepancy that Mamelund and Sattenspiel believe holds the key. They are the first to seriously mine Alaskan death certificates from the time period for answers. “People look at cities at the expense of remote places like Alaska. Data on these communities is hard to find, so many people think the data doesn’t exist”, he explains. The death certificate data confirms the disparity in mortality rates that the team previously estimated from their work comparing anecdotes, various local reports, doctor notes, and diaries. To unravel the mystery of why Indigenous populations in remote areas were more susceptible to the 1918-20 pandemic, the researchers calculated mortality over time and age, focusing on age-specific mortality. It was difficult to identify deaths from flu because they could be listed as “flu”, or “pneumonia”, or several other complications. Instead, they looked at “excess mortality”, the number of deaths during the pandemic over an expected baseline number. This is the same method public health officials use today to tease out the number of deaths from COVID. Mamelund found that both groups encountered virus in the same remote and cold setting. The higher mortality among elderly Indigenous people was the key finding. “Remoteness gave less exposure to flu in the past and that gives less immunity compared to people who have been living in cities or less remote areas”, he explains, “the non-Indigenous Alaskans must have encountered the virus in a different way in their origin cities in the past and brought their immunities with them”. Remoteness gave less exposure to flu in the past and that gives less immunity compared to people who have been living in cities or less remote areas. – Svenn-Erik Mamelund Lessons for the futureThe cyclical nature of pandemics means that these lessons from history still apply today.In the 2009 swine flu pandemic, for example, Indigenous people in North America, Oceania, and the Pacific again had three to eight times higher pandemic mortality than other populations. Part of this difference is likely due to higher prevalence of medical risk factors for severe influenza outcomes among Indigenous people like diabetes and asthma, by higher risks of infection due to socioeconomic factors, and differences in access to health care. However, the fact that Indigenous populations have lived, and often still live, in isolated places means that their inexperience with influenza almost certainly affects their immunity as well.Mamelund and Sattenspiel's findings show us how we can protect these risk groups from the next pandemic. “This idea of remoteness, less exposure and less immunity, is key to understanding mortality differences between remote indigenous and non-indigenous people in cities” says Mamelund. Armed with this understanding, Mamelund suggests public health officials should make it part of their pandemic response plan. “When you know that indigenous people are at risk you should prepare for this to happen again, maybe they should be prioritized for vaccines”. He encourages public health officials to consider this and include education and outreach programs to ensure that Indigenous groups accept vaccines when they are available. These well-administered vaccination programs will be the key to protecting vulnerable Indigenous populations from future pandemics.Learn moreLisa Sattenspiel, Svenn-Erik Mamelund, Sushma Dahal, Amanda Wissler, Gerardo Chowell, Emma Tinker-Fortel, Death on the permafrost: Revisiting the 1918-20 influenza pandemic in Alaska using death certificates, American Journal of Epidemiology, 2024;, kwae173 (academic.oup.com).Centre for Research on Pandemics & Society (PANSOC) Contact Loading ... Featured research Working life, society and welfare Effective pandemic planning must take social inequalities seriously Researchers at PANSOC have been studying pandemic planning for decades. COVID-19 has thrust their work into the spotlight. Working life, society and welfare Norwegian study looks at how the Coronavirus pandemic is affecting people’s health and careers The coronavirus pandemic is affecting the majority of employed adults in Norway, but in different ways. Working life, society and welfare To end a pandemic, consider socioeconomics Norway is starting its vaccination programme and people facing high medical risk are first in line. But medical conditions aren’t the only factors to consider when protecting people from a deadly virus. More featured research A research article from: Centre for Welfare and Labour Research Published: 29/07/2024 Last updated: 30/07/2024 Text: Matthew Davidson Photo: Heritage / Scanpix P.O. Box 4, St. Olavs plass NO-0130 Oslo Norway Tel.: +47 67 23 50 00 Contact us Norwegian Accessibility statement Cookies policy Employee directory Employee website Student website Upcoming events Work for us Admin Facebook X (Twitter) LinkedIn InstagramBird flu has been detected in Van Buren County, marking it as the 27 dairy herd infection | WKAR Public Media Search Query Show Search Live TV Home WKAR News All News ArtPath Profiles Inside the Arts Noticias En Español PODCAST: ¿Qué Onda Michigan? WKAR Sports All News ArtPath Profiles Inside the Arts Noticias En Español PODCAST: ¿Qué Onda Michigan? WKAR Sports Radio Ways to Listen to WKAR Radio Reading Service Playlist: 90.5 WKAR Schedule: 90.5 WKAR Schedule: NewsTalk AM 870 | 102.3 Schedule: Classical 24/7 Schedule: Jazz 24/7 Schedule: WKAR Radio Reading Service 90.5 Classical Music Latinx Programming | WKAR Radio 90.5 Classical with Linda Kernohan 90.5 Classical with Jody Knol 90.5 Classical with Jamie Paisley Folk with Matt Watroba The Fugue Great Lakes Concerts A Groove Supreme Michigan Minute MSU In Concert MSU Today with Russ White Showtunes Across the Mitten Ways to Listen to WKAR Radio Reading Service Playlist: 90.5 WKAR Schedule: 90.5 WKAR Schedule: NewsTalk AM 870 | 102.3 Schedule: Classical 24/7 Schedule: Jazz 24/7 Schedule: WKAR Radio Reading Service 90.5 Classical Music Latinx Programming | WKAR Radio 90.5 Classical with Linda Kernohan 90.5 Classical with Jody Knol 90.5 Classical with Jamie Paisley Folk with Matt Watroba The Fugue Great Lakes Concerts A Groove Supreme Michigan Minute MSU In Concert MSU Today with Russ White Showtunes Across the Mitten TV TV Schedule WATCH Live TV WATCH PBS KIDS LIVE WATCH PBS KIDS VIDEO WATCH at PBS VIDEO Michigan Learning Channel BackStage Pass Beyond the Score with Al Martin Binary Minds Curious Crew Curious About Careers Decoding Disinformation: AI and the Threat to Democracy Food Over 50 MSU Commencements MSU Video Music for Social Justice Off the Record Serving Up Science State of the State Support Line: America and the Track to Ukraine WKAR TV Specials TV Schedule WATCH Live TV WATCH PBS KIDS LIVE WATCH PBS KIDS VIDEO WATCH at PBS VIDEO Michigan Learning Channel BackStage Pass Beyond the Score with Al Martin Binary Minds Curious Crew Curious About Careers Decoding Disinformation: AI and the Threat to Democracy Food Over 50 MSU Commencements MSU Video Music for Social Justice Off the Record Serving Up Science State of the State Support Line: America and the Track to Ukraine WKAR TV Specials Education WKAR Family PBS KIDS Michigan Learning Channel Mrs. Pizzo's Workshop | FAQs PBS Learning Media WKAR Family PBS KIDS Michigan Learning Channel Mrs. Pizzo's Workshop | FAQs PBS Learning Media Community Calendar View All Events Submit An Event WKAR Events In Your Community View All Events Submit An Event WKAR Events In Your Community Info About Us A Century of Service Contact Us Notes from Shawn Turner Staff Student Internships Station News The Mid WKAR Awards WKAR StayTuned Update TechNotes Community Guidelines About Us A Century of Service Contact Us Notes from Shawn Turner Staff Student Internships Station News The Mid WKAR Awards WKAR StayTuned Update TechNotes Community Guidelines Give to WKAR Get Passport Donate Your Car Leave a Legacy Major Gifts Corporate Support Stakeholder Report Donor Login Get NPR+ Podcast Bundle Get Passport Donate Your Car Leave a Legacy Major Gifts Corporate Support Stakeholder Report Donor Login Get NPR+ Podcast Bundle DONOR LOGIN © 2024 Michigan State University Board of Trustees Menu Public Media from Michigan State University Show Search Search Query Live TV DONATE Play Live Radio Next Up: 0:00 0:00 0:00 0:00 Available On Air Stations On Air Now Playing 90.5 WKAR On Air Now Playing WKAR NewsTalk - AM 870 | 102.3 FM On Air Now Playing WKAR Classical 24/7 On Air Now Playing WKAR Jazz 24/7 On Air Now Playing WKAR Radio Reading Service All Streams Home WKAR News All News ArtPath Profiles Inside the Arts Noticias En Español PODCAST: ¿Qué Onda Michigan? WKAR Sports All News ArtPath Profiles Inside the Arts Noticias En Español PODCAST: ¿Qué Onda Michigan? WKAR Sports Radio Ways to Listen to WKAR Radio Reading Service Playlist: 90.5 WKAR Schedule: 90.5 WKAR Schedule: NewsTalk AM 870 | 102.3 Schedule: Classical 24/7 Schedule: Jazz 24/7 Schedule: WKAR Radio Reading Service 90.5 Classical Music Latinx Programming | WKAR Radio 90.5 Classical with Linda Kernohan 90.5 Classical with Jody Knol 90.5 Classical with Jamie Paisley Folk with Matt Watroba The Fugue Great Lakes Concerts A Groove Supreme Michigan Minute MSU In Concert MSU Today with Russ White Showtunes Across the Mitten Ways to Listen to WKAR Radio Reading Service Playlist: 90.5 WKAR Schedule: 90.5 WKAR Schedule: NewsTalk AM 870 | 102.3 Schedule: Classical 24/7 Schedule: Jazz 24/7 Schedule: WKAR Radio Reading Service 90.5 Classical Music Latinx Programming | WKAR Radio 90.5 Classical with Linda Kernohan 90.5 Classical with Jody Knol 90.5 Classical with Jamie Paisley Folk with Matt Watroba The Fugue Great Lakes Concerts A Groove Supreme Michigan Minute MSU In Concert MSU Today with Russ White Showtunes Across the Mitten TV TV Schedule WATCH Live TV WATCH PBS KIDS LIVE WATCH PBS KIDS VIDEO WATCH at PBS VIDEO Michigan Learning Channel BackStage Pass Beyond the Score with Al Martin Binary Minds Curious Crew Curious About Careers Decoding Disinformation: AI and the Threat to Democracy Food Over 50 MSU Commencements MSU Video Music for Social Justice Off the Record Serving Up Science State of the State Support Line: America and the Track to Ukraine WKAR TV Specials TV Schedule WATCH Live TV WATCH PBS KIDS LIVE WATCH PBS KIDS VIDEO WATCH at PBS VIDEO Michigan Learning Channel BackStage Pass Beyond the Score with Al Martin Binary Minds Curious Crew Curious About Careers Decoding Disinformation: AI and the Threat to Democracy Food Over 50 MSU Commencements MSU Video Music for Social Justice Off the Record Serving Up Science State of the State Support Line: America and the Track to Ukraine WKAR TV Specials Education WKAR Family PBS KIDS Michigan Learning Channel Mrs. Pizzo's Workshop | FAQs PBS Learning Media WKAR Family PBS KIDS Michigan Learning Channel Mrs. Pizzo's Workshop | FAQs PBS Learning Media Community Calendar View All Events Submit An Event WKAR Events In Your Community View All Events Submit An Event WKAR Events In Your Community Info About Us A Century of Service Contact Us Notes from Shawn Turner Staff Student Internships Station News The Mid WKAR Awards WKAR StayTuned Update TechNotes Community Guidelines About Us A Century of Service Contact Us Notes from Shawn Turner Staff Student Internships Station News The Mid WKAR Awards WKAR StayTuned Update TechNotes Community Guidelines Give to WKAR Get Passport Donate Your Car Leave a Legacy Major Gifts Corporate Support Stakeholder Report Donor Login Get NPR+ Podcast Bundle Get Passport Donate Your Car Leave a Legacy Major Gifts Corporate Support Stakeholder Report Donor Login Get NPR+ Podcast Bundle DONOR LOGIN WKAR News Bird flu has been detected in Van Buren County, marking it as the 27 dairy herd infection WKAR Public Media | By Michelle Jokisch Polo Published July 30, 2024 at 8:25 AM EDT Facebook LinkedIn Email Rodrigo Abd/AP / APFILE - Dairy cattle feed at a farm on March 31, 2017, near Vado, N.M. Another Michigan dairy worker has been diagnosed with bird flu, the third human case associated with an outbreak in U.S. dairy cows, health officials said Thursday, May 30, 2024. (AP Photo/Rodrigo Abd, File) The highly pathogenic avian influenza has been confirmed at a dairy farm in Van Buren County. The dairy herd of 35 cattle tested positive on Friday according to the Michigan Department of Agriculture and Rural Development.The new case brings the total number of dairy herds impacted in the bird flu outbreak in cattle to 27.State officials issued an emergency order in May requiring dairy and poultry farms to enhance biosecurity measures to prevent further spread of the virus.The order has impacted Michigan’s summer fair season as it prohibits the exhibition of lactating dairy cattle and those in the last two months of pregnancy until there have been no positive cases for sixty days.So far, bird flu has been reported in two Michigan farmworkers and more than six million birds. The number of cases has prompted legislators to seek solutions to address the outbreak.Last week, U.S. Representative Elissa Slotkin (Democrat) for Michigan’s 7th district introduced a new bipartisan bill to research and address avian flu.“I’ve heard directly from Michigan farmers on the forefront of this outbreak of avian flu about how it’s disrupting their operations and threatening their livelihood, and this legislation is drawn directly from those conversations,” said Slotkin in a press release.The Avian Influenza Research and Response Act would create a biosecurity education and training program for dairy producers, prioritize avian flu research and codify into law compensation for farmers whose milk production has been affected by the virus. WKAR News Facebook LinkedIn Email Michelle Jokisch Polo As WKAR's Bilingual Latinx Stories Reporter, Michelle reports in both English and Spanish on stories affecting Michigan's Latinx community. See stories by Michelle Jokisch Polo WKAR is supported by You might be interested WKAR is supported by WKAR is supported by WKAR is supported by Help WKAR continue delivering essential reporting and programming to mid-Michigan by making your Giving Tuesday gift. We're aiming for 300 donations by December 3rd, and each early gift will strengthen your community resource and support the programs you love. Support your community public media station today. DONATE © 2024 Michigan State University Board of Trustees Contact Us Directions and Map Employment Privacy Policy Notice of Nondiscrimination Public File FCC ApplicationsCanine respiratory illness impacting Delaware - 47abc SectionsNews 2024 Election Hurricane Helene Good Morning Delmarva Crime The Bright Side Good News 47 National/World Politics Foodie Friday Weather Closings and Delays Interactive Radar Skycams Junior Storm Team Weather Blog Weather Tidbits WeatherWise Podcast Sports Delmarva Sports Insider After the Whistle Watch Live … Discover Delmarva Tourism Apps and Podcasts Community Calendar Fugitive Friday LinksContests Jobs Pets What’s On Marquee Backstage Social Media 47abc Search News 2024 Election Hurricane Helene Good Morning Delmarva Crime The Bright Side Good News 47 National/World Politics Foodie Friday Weather Closings and Delays Interactive Radar Skycams Junior Storm Team Weather Blog Weather Tidbits WeatherWise Podcast Sports Delmarva Sports Insider After the Whistle Watch Live … Discover Delmarva Tourism Apps and Podcasts Community Calendar Fugitive Friday Contests Jobs Pets What’s On Marquee Backstage 1 / 0 Canine respiratory illness impacting Delaware July 30, 2024 Sarah Ash, DELAWARE – The First State is seeing an outbreak of a canine respiratory illness, known as Canine Infectious Respiratory Disease Complex. Due to the outbreak, the Delaware Department of Agriculture issued a restriction order on July 12th, prohibiting the transport of dogs in or out of the state for 30 days. The order can be extended beyond the initial 30 days if necessary. Officials say the most common symptoms of this illness include coughing, sneezing, lethargy, low energy, and fever. Sara Smith, Senior Director of Marketing and Communications with the Brandywine Valley SPCA, says they haven’t seen any extreme issues with this illness so far in their shelter, but because they are the largest animal welfare organization in the state, she says it was important to take all necessary steps to protect their population and the community. “We took drastic measures immediately to vaccinate all of our dogs in all of our locations, all of the dogs in our foster homes, any dog in our population, and also any dog that was coming in as a stray,” Smith said. The Brandywine Valley SPCA is now offering free canine influenza vaccines to the community. Registration is open now for the two-dose vaccination; more information can be found here. If your pup starts showing signs of this respiratory illness, experts say you should reach out to your veterinarian immediately. Categories: Local News, Pet Tips, Top Stories Tags: brandywine valley spca, canine infectious respiratory disease complex, pet tips, pets, sara smith, vaccines FacebookTwitter Related Posts: Elderly homeless population are on the rise in Maryland and officials are starting to get concerned Wicomico County students train to become firefighters Salisbury University community members take a stand against recent violence Because Local Matters Most Popular 2024 Election totals across Maryland & DelawareUPDATE: Police make additional arrests in alleged Salisbury hate crimeUPDATE: Police investigating a fatal two vehicle crashMilton man charged with home improvement fraudChase leads to arrest warrant for Ellendale woman PromotionsBig Deal Contests Job Openings Pets NewsTop Stories Good Morning Delmarva 2024 Election Hurricane Helene The Bright Side Emerging Leaders GMD Cooking Crime National/World Politics Noticias Fugitive Friday Homeless Sex Offenders WeatherWeather Interactive Radar Skycams Weather Blog Weather Wise Podcast Junior Storm Team Weather Tidbits Closings and Delays Dog Walking Forecast SportsSports Delmarva Sports Insider High School College Professional After the Whistle About 47abcAbout Us Meet The Team Advertise With Us Contact Us Job Openings What’s On Connect With UsSubmit a Photo Submit a Story Newsletter Facebook Twitter Instagram YouTube CommunityPets Foodie Friday Viewer Photos Community Calendar Contests Big Deals Obituaries © 2024 47abc. Marquee Broadcasting Inc. © 2024 47abc Privacy Policy | Terms Of Service | FCC Public File | FCC Applications | Closed Captioning Close Share Toggle Fullscreen Zoom in/out Previous NextOHSU study shows 'promising' step toward flu shot with lifetime immunity Skip to content KOIN.com Portland 49° Sign Up Portland 49° Sponsored By Toggle Menu Open Navigation Close Navigation Search Please enter a search term. Primary Menu News Fentanyl Crisis Wildfires Eye on NW Politics Your Local Election Headquarters Oregon Washington Crime National Special Reports Entertainment Positive Vibes Where We Live Northwest Grown Washington DC Politics from The Hill BestReviews BestReviews Daily Deals Automotive News Press Releases Top Stories ‘It’s been wild’: Wet weather wreaking havoc on Portland … 8 mins ago Albany classes canceled as teacher strike looms 7 mins ago Video Newsletters Weather Air Quality Weather Alerts Closings and Delays Weather Radar Pet Walk Forecast Weather Photos Oregon and Washington Weather Webcams Eye on Climate Earthquakes Ski Conditions KOIN 6 Weather Kids Traffic Traffic Cams Video KOIN 6 Newscasts KOIN Live Stream Events CBSN CBS Shows TV Listings Sports High School Spotlight George Fox University Pacific University AM Extra Move it Monday Mayor Monday Tech Tuesday Wallet Wednesday Foodie Friday More Portland’s CW Marketplace Epic Discounts Find a Job Post a Job Work for Us Everyday Northwest Be Our Guest Everyday Northwest Eat and Drink Everyday Northwest Entertainment Everyday Northwest Events Everyday Northwest Family Everyday Northwest Fashion and Beauty Everyday Northwest Featured Guests Everyday Northwest Health and Wellness Everyday Northwest Home and Garden Everyday Northwest Local Business Spotlight More Portland’s CW Community Write From the Start St. Jude Children’s Research Hospital Kids Speak Out Oregon Boys and Girls Clubs of Portland Union Gospel Mission Sunshine Division Giving Contests Choose Local Eye on the Northwest SOLVE Local Events About Us Portland’s CW Meet the Team Regional News Partners Work for Us Advertise with Us Contact Us ReportIt KOIN 6 News Mobile Apps Newsletters KOIN 6 Text Alerts KOIN, KRCW EEO Public File Report About BestReviews Search Please enter a search term. Health OHSU makes progress toward flu vaccine with lifetime immunity by: Michaela Bourgeois Posted: Aug 1, 2024 / 01:16 PM PDT Updated: Aug 2, 2024 / 04:55 PM PDT by: Michaela Bourgeois Posted: Aug 1, 2024 / 01:16 PM PDT Updated: Aug 2, 2024 / 04:55 PM PDT SHARE PORTLAND, Ore. (KOIN) – New research led by Oregon Health & Science University found a “promising approach” for a universal flu vaccine that could provide lifetime immunity. With help from a century-old virus, researchers said a “one-and-done” flu shot could be coming soon. “It’s exciting because in most cases, this kind of basic science research advances the science very gradually; in 20 years, it might become something,” said the study’s lead author, Jonah Sacha, Ph.D., professor and chief of the Division of Pathobiology at OHSU’s Oregon National Primate Research Center. “This could actually become a vaccine in five years or less.” Portland one step closer to capping I-5, reconnecting historic neighborhood During the study, researchers tested an OHSU-developed vaccine platform against the virus most likely to cause the next pandemic: the avian H5N1 influenza virus, also known as bird flu. The study found the vaccine created a robust immune response in monkeys that were exposed to the bird flu virus, OHSU said. Researchers noted the vaccine was not based on the contemporary bird flu virus. Instead, the monkeys were vaccinated against the influenza virus of 1918 — which killed millions of people around the world. Multnomah County, AMR reach agreement to fix long ambulance response times The study found six out of eleven monkeys vaccinated against the 1918 virus survived exposure to bird flu, which OHSU said is one of the deadliest viruses today. A control group of six unvaccinated monkeys exposed to bird flu died from the disease, OHSU said. According to Sacha, OHSU’s vaccine platform could be helpful against other mutating viruses such as SARS-CoV-2 — or coronavirus. Oregon coast state park reopening includes a ‘noticeable change’ “It’s a very viable approach,” Sacha said. “For viruses of pandemic potential, it’s critical to have something like this. We set out to test influenza, but we don’t know what’s going to come next.” “Should a deadly virus such as H5N1 infect a human and ignite a pandemic, we need to quickly validate and deploy a new vaccine,” said co-corresponding author Douglas Reed, Ph.D., associate professor of immunology at the University of Pittsburgh Center for Vaccine Research. During the study, researchers used a platform OHSU previously developed to fight HIV and tuberculosis and is currently in a clinical trial against HIV. DATA: New mapping tool shows Portland’s richest and poorest neighborhoods The method includes inserting small pieces of pathogens into the common herpes virus, cytomegalovirus, or CMV, which infects most people in their lifetimes with mild or no symptoms, OHSU explained. The virus is designed to then create an immune response from the body’s T cells. According to OHSU, this approach differs from other vaccines, which are designed to create an antibody response that targets the most recent evolution of the virus. Owner of North Portland newspaper charged with making threats in Alabama “The problem with influenza is that it’s not just one virus,” Sacha said. “Like the SARS-CoV-2 virus, it’s always evolving the next variant and we’re always left to chase where the virus was, not where it’s going to be.” OHSU said the study shows the potential for creating a vaccine against bird flu in humans. “Inhalation of aerosolized H5N1 influenza virus causes a cascade of events that can trigger respiratory failure,” said co-senior author Simon Barratt-Boyes, Ph.D., professor of infectious diseases, microbiology and immunology at University of Pittsburgh. “The immunity induced by the vaccine was sufficient to limit virus infection and lung damage, protecting the monkeys from this very serious infection.” UW debunks Elon Musk’s claim that brain implant will ‘exceed normal human vision’ The study also shows CMV vaccines could generate a long-lasting immune response against an array of new variants, OHSU explained. “I think it means within five to 10 years, a one-and-done shot for influenza is realistic,” Sacha said. “It’s a massive sea change within our lifetimes,” he added. “There is no question we are on the cusp of the next generation of how we address infectious disease.” Copyright 2024 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. ✕ Read next > Read next > Next ✕ ✕ Read next > Next story in Cancel Read next > Next story in Cancel Wayfair’s Black Friday Sneak Peek has deals up to … Holiday / 10 hours ago BestReviews rounded up the best Wayfair Black Friday deals on furniture, kitchenware, appliances and pet products. Walmart’s early Black Friday sale is starting today Holiday / 6 hours ago BestReviews picked the top early Black Friday deals on bestselling electronics, home appliances, kitchenware and more. The best early Black Friday gifts under $50 Holiday / 9 hours ago BestReviews has assembled a collection of top-quality gifts priced under $50, currently available at discounts of up to 60% off. View All BestReviews Top Stories Wet weather wreaking havoc on Portland roads Albany classes canceled as teacher strike looms Winter Weather Advisory issued for Oregon Cascades Watch: Veterans Voices 2024 Olympian reveals interesting tidbit about bronze … Top Stories More Stories World leaders descend on Azerbaijan’s capital Baku … Azerbaijan accused of ramping up repression of critics … Democrat Ruben Gallego wins Arizona US Senate race … Judge set to rule on whether to scrap Trump’s conviction … Why AP called the Arizona Senate race for Ruben Gallego Congress returns to unfinished business and a new … A pair of Trump officials have defended family separation … Pentagon secrets leaker Jack Teixeira set to be sentenced, … More Stories KOIN.com Video Portland’s historic Peacock Lane releases 2024 holiday … 3 hours ago ‘Life can change in an instant’: Family remembers … 5 hours ago Suspect killed by deputy after Waldport disturbance 5 hours ago Son arrested after father found dead in Clackamas … 5 hours ago Portland celebrates Veterans Day with parades, ceremonies … 6 hours ago Watch: Veterans Voices 2024 6 hours ago OPENING DAY: Mt. Hood Meadows resort announces earliest … 6 hours ago Terminal Gravity Brewing wants you to think hoppy … 9 hours ago Clackamas County Hiker found dead in Mt. Hood National … 10 hours ago Oregon, Washington communities celebrate Veterans … 10 hours ago Northwest Battle Buddies wants veterans to have a … 11 hours ago We can help you cook at an Epic Discount 11 hours ago More Videos More from KOIN.com Family remembers father found dead on Mt. Hood Tommy Wiseau coming to Portland for movie screenings Hillsboro voters turn down measure to fluoridate … Mt. Hood Meadows announces earliest opening in 15 … OSU grad student employees vote to strike Portland’s most popular pet names of 2024 Man found dead in Clackamas County, son arrested King tides, 28-foot waves to swamp the Oregon Coast More from KOIN.com Current 49° Mostly Cloudy Tonight 48° Showers Precip: 42% Tomorrow 53° Rain Precip: 86% Trending Stories King tides, 28-foot waves to swamp the Oregon Coast Family remembers father found dead on Mt. Hood Wet weather wreaking havoc on Portland roads Winter Weather Advisory issued for Oregon Cascades Hiker found dead in Mt. Hood National Forest ID’d BestReviews.com - Top picks to make everyone happy The best early Black Friday gifts under $50 Holiday / 9 hours ago The best early Best Buy Black Friday deals Holiday / 9 hours ago Wayfair’s Black Friday Sneak Peek has deals up to … Holiday / 10 hours ago Walmart’s early Black Friday sale is starting today Holiday / 6 hours ago All the best Veterans Day freebies and deals Holiday / 12 hours ago The best Black Friday deals at PetSmart Holiday / 3 days ago View All BestReviews Picks Reporting Portland and Vancouver area breaking news and weather stories to make Oregon and Southwest Washington a better place to live News Weather Newsletters Video AM Extra Sports Everyday Northwest Community About Us KOIN: FCC Public File KRCW: FCC Public File KOIN: FCC EEO Report 2023-2024 KRCW: FCC EEO Report 2023-2024 Nexstar CC Certification Contact Us Advertise with Us Get News App Get the iOS app Get the Android app from Google Play Get Weather App Get the iOS Weather app Get the Android Weather app from Google Play Stay Connected Haystack Privacy Policy 06/27/2024 Terms Of Use FCC Applications Public File Assistance Contact The Hill NewsNation BestReviews Content Licensing Nexstar Digital Journalistic Integrity Sitemap Do Not Sell or Share My Personal Information © 1998 - 2024 Nexstar Media Inc. | All Rights Reserved. ✕FAO Calls For More Efforts To Combat Avian Flu As Cases Rise Worldwide - Health Policy Watch Skip to content menu Home About Us Search for: Search for: Antimicrobial Resistance Infectious Diseases Pandemics & Emergencies Non-Communicable Diseases Health, Climate & SDGs Search for: Search for: FAO Calls for More Efforts to Combat Avian Flu as Cases Rise Worldwide Outbreaks 01/08/2024 • Zuzanna Stawiska Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to print (Opens in new window) Exposure to infected poultry is among the main sources of avian flu infections As more avian flu cases are detected across the Asia-Pacific region, the Food and Agriculture Organization (FAO) is calling for “regional efforts to combat a rise” of the disease. Over the past year, highly pathogenic avian influenza clades, especially H5N1, have gained ground globally, infecting an increasing number of species, including poultry, dairy cows, and domestic animals. As of July 31, one single avian flu variant of H5N1 had infected 172 dairy herds and 13 farm workers in the United States and continues to spread further, raising questions about the country’s ability to curb the transmissions. In the Asia-Pacific region, there have been 13 human H5N1 avian flu cases since late 2023, six of which were reported in Cambodia this year. The newly-reported cases point to a trend of more human infections from the virus. And in the Asian-Pacific, at least one other avian flu variant is circulating along with the H5N1 type, clade 2.3.4.4b, prevalent in the US. “All these cases involved direct contact with poultry or wild birds, and so far, no human-to-human transmission has been observed,” confirmed Filip Claes, FAO’s Asia-Pacific Regional Laboratory Coordinator in an email response to Health Policy Watch. 🚨 BREAKING: @FAO calls for urgent action as new #avianinfluenza variants threaten Asia and the Pacific. "Immediate, coordinated preventive measures are essential for Member Nations," says @DrKachen. Read the news and action points 🗞️ https:/.co/1K7ELizAOu#ECTAD #OneHealth pic.twitter.com/MmKE4aTrZB — FAO Asia Pacific (@FAOAsiaPacific) July 25, 2024 “The primary threat is that HPAI continues to circulate in poultry causing economic losses. Additionally, it provides an opportunity [for the virus] to continuously adapt, and spill over to additional species, including humans,” he added. He called for building diagnostics capacity and more data sharing, along with strengthening farming biosecurity and biosafety measures. Avian influenza has even reached the arctic and Antarctic regions, infecting scavenger species, marine mammals, carnivorous domestic pets, and mammals farmed for fur, and dairy cattle. Since last year, there have been human cases in Australia, India, the US, Mexico, Vietnam, China, and Cambodia. Of the 886 human infections reported from 2003 to May 2024, more than half were fatal. Alhough the World Health Organization continues to assess H5N1-related risks to the public as low (and low-to-moderate for farm workers), the emergence of new, more easily transmissible strains “increases the pandemic threat,” warned Kachen Wongsathapornchai, Regional Manager of FAO Emergency Centre for Transboundary Animal Diseases earlier this week. Calling the recent bird flu surge “deeply concerning” the FAO official appealed for “immediate action.” Insufficient outbreak response Avian flu H5N1 situation update as of 31 July 2024 – all reports since outbreak began in March. “Strengthening and integrating surveillance systems is crucial,” Claes said, enumerating measures South-East Asian countries should implement to fight the outbreaks. “Countries should invest in advanced diagnostic infrastructure and training for laboratory personnel,” as well as enhance international and inter-agency collaboration, prepare biosecurity protocols for farms and consider vaccination campaigns. In the US, where the virus has infected an expanding circle of dairy cattle herds since first reports emerged in March, the country response is insufficient, US experts have long maintained. There is, for instance, too little data and research that would ensure better understanding of the virus and the ways in which it transmits – not only through the mammary glands during milking, as was previously thought, new research seems to suggest. Farmers reluctant to have herds and workers tested Modes of infection with avian flu from poultry – a likely transmission path for some of the human cases There is not enough testing infrastructure either. And farmers and their employees are reluctant to get themselves or their cattle tested, posing yet another problem in the US where there is no legal framework for mandatory animal tests. Similarly, for farm workers, testing and even wearing personal protective equipment is neither compulsory nor popular due to a general mistrust towards the official agencies, fear of lost revenue or, in the case of the workers, lack of a healthcare insurance. Meanwhile, lax sanitation procedures in large dairy operations are big enablers of virus transmission, allowing cow-to-cow transmission when milking machines are not cleaned between every individual animal. “Much more extensive follow up, serology studies and close monitoring of ‘mixing vessel animal species’, for instance pigs,” which can more easily incubate and transmit viruses to humans is needed, said Michael Osterholm, director of the University of Minnesota-based Centre for Infectious Disease Research and Policy (CIDRAP), in earlier comments to Health Policy Watch. Overall, a more coherent plan of response is urgently needed in the Americas as well as Asia, Claes emphasized. In creating a plan, communication about the risk “with all stakeholders, from national governments to grassroots levels, is crucial to develop awareness and community engagement in tackling and controlling avian influenza.” Image Credits: Pickpik, USDA, CDC. Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to print (Opens in new window) Combat the infodemic in health information and support health policy reporting from the global South. Our growing network of journalists in Africa, Asia, Geneva and New York connect the dots between regional realities and the big global debates, with evidence-based, open access news and analysis. To make a personal or organisational contribution click here on PayPal. Posted in Content type, Disease Surveillance, FAO, Health & Environment, Infectious Diseases, Institutions, News, North America, One Health, Outbreaks, Pandemics & Emergencies, Regional Policy, Sanitation & Hygiene, South-East Asia, Western Pacific, World Health Organization Related WHO Appeals to Israel: Reverse Decision Closing Headquarters of UN Palestinian Refugee Agency Emergency Response 01/11/2024 WHO: Final Phase of Gaza Polio Vaccine Campaign Postponed as Conflict Escalates Humanitarian Crises 23/10/2024 Human Behaviour Drives Pandemics – And Rebuilding Trust is Essential Pandemics & Emergencies 14/10/2024 Do you really care about access and equity in global health? Your contributions are urgently needed to support our mission in open access global health journalism and our network of correspondents in Africa, Asia, New York and Geneva. Their reporting connects the dots between the regional realities and the big global debates. Every contribution - big or small - helps us sustain our reporting for the benefit of all. Related WHO Appeals to Israel: Reverse Decision Closing Headquarters of UN Palestinian Refugee Agency Emergency Response 01/11/2024 WHO: Final Phase of Gaza Polio Vaccine Campaign Postponed as Conflict Escalates Humanitarian Crises 23/10/2024 Human Behaviour Drives Pandemics – And Rebuilding Trust is Essential Pandemics & Emergencies 14/10/2024 Do you really care about access and equity in global health? Your contributions are urgently needed to support our mission in open access global health journalism and our network of correspondents in Africa, Asia, New York and Geneva. Their reporting connects the dots between the regional realities and the big global debates. Every contribution - big or small - helps us sustain our reporting for the benefit of all. This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Sign up for free news alerts Signup Link Contact Us info@healthpolicy-watch.org 1-5 Route des Morillions CP 2100 Geneva 1211, Switzerland +41 22 791 67 28 About Privacy Policy Archives Staff Access Log in Entries RSS Comments RSS Wordpress.org Supported by Sponsors Copyright c 2020 Global Policy Reporting Loading Comments... You must be logged in to post a comment.BLACKPINK’s Jisoo wraps up new zombie thriller Influenza filming with Park Jung Min; thanks cast, crew in new PIC | PINKVILLA: Korean Latest Videos Entertainment Bollywood Hollywood TV South Anime Box Office Collection Exclusives Movie Reviews Explore All Lifestyle Love & Relationships People Explore All Korean Music TV Series News Explore All Fashion Celebrity Style Explore All Health Weight Loss Diet Fitness Explore All Beauty Hair Care Hair Styles Makeup Skin Care Explore All Privacy Policy Terms of use About Us Contact Us Affiliate Disclosure Product Research Image Usage Policy Editorial Guidelines Cookie Policy Press Room Awards/Badges JOIN OUR WHATSAPP CHANNEL Latest Videos Entertainment Bollywood Hollywood TV South Anime Box Office Collection Exclusives Movie Reviews Explore All Explore All Entertainment Categories Oprah Winfrey Denies USD 1 Million Payment For Hosting Kamala Harris Town Hall: ‘Was Paid Nothing’ Harry Potter TV Series Chooses THIS Actor As Its Top Choice For Dumbledore; Deets Queen Elizabeth’s Final Diary Entry REVEALED: Check Out the Five-Word Sentence She Wrote Two Days Before Her Passing Ali Fazal is ‘thrilled’ to star with Phoebe Waller-Bridge in Hollywood film Rule Breakers; calls her ‘powerhouse of talent’ Sai Pallavi reveals she had an emotional breakdown on sets of Shyam Singha Roy for THIS reason; shares how producer reacted to her day off plea Shah Rukh Khan Threat Case: Mumbai police arrests accused from Chhattisgarh Keke Palmer Opens Up About Racially Charged Moment With Scream Queens Costar And Conflict With Ryan Murphy On Set WATCH: Bipasha Basu-Karan Singh Grover’s daughter Devi turns 2; little munchkin singing is cutest thing on internet today Bigg Boss Tamil 8 nominations: Who among 13 nominated contestants will exit Vijay Sethupathi-hosted reality TV show this week? Lifestyle Love & Relationships People Explore All Explore All Lifestyle Categories Virgo to Leo: 4 Zodiac Signs Who Prioritize Short-term Spending Over Long-term Savings Aries to Libra: 4 Zodiac Signs Who Set High Standards And Self-evaluate Their Work 50 Anniversary Gifts for Girlfriend That Will Warm Her Heart Gemini to Libra: 4 Zodiac Signs Whose Timidity Is Mistaken for Conceit Gemini to Capricorn: 4 Zodiac Signs Who See Gratitude as a Magnet for Prosperity Cancer to Scorpio: 4 Zodiac Signs Who Unwind Best by Swaying to Music Sagittarius to Pisces: 4 Zodiac Signs Who Teach Their Kids Lovely Table Manners 30+ Exciting 30th Birthday Trip Ideas to Indulge Yourself How Do I Know If I Have a Crush? Here Are 20 Telltale Signs Korean Music TV Series News Explore All Explore All Korean Categories Byeon Woo Seok to perform Lovely Runner OST Sudden Shower at 2024 MAMA Awards’ Japan ceremony on November 23 The Trunk main trailer OUT: Gong Yoo and Seo Hyun Jin's fake marriage blossoms into reality; SEE official poster inside When Business Proposal’s Kim Se Jeong and ASTRO’s Cha Eun Woo lit up stage with TWICE’s Cheer Up dance BTS' V sparks speculation about potential A24 movie debut with recent social media activity; DEETS inside 8 TV shows with Choi Ji Woo that define her stellar acting career and legacy 'How much are you paying me?': When BTS’ Jungkook switched on his business mode after Jimin asked him to collaborate IU’s agency updates on legal proceedings against 180 individuals for slander, deepfake content creation; shares details of plagiarism case Min Hee Jin faces 100 million KRW property seizure order over defamation and unfair labour case by former ADOR employee Bromance unlocked: Jung Hae In sends coffee truck to 88-liner bestie Im Siwan’s filming set for Mantis; PICS Fashion Celebrity Style Explore All Explore All Fashion Categories Move over sequins, Tamannaah Bhatia’s corset-inspired denim dress worth Rs 31,952 is the new party staple Sara Ali Khan in an LBD with cape is perfect inspo on how to dress for bachelorette party like a celebrity Karisma Kapoor's black sequin saree with cape is ultimate staple for your next cocktail night Tamannaah Bhatia’s look in black with Serpentine bustier by Gaurav Gupta screams BOLD, proving she’s beyond the ordinary Sara Tendulkar’s blue and silver embroidered suit is a royal treat for this wedding season Sonam Kapoor channels retro charm in polka dot dress paired with a Dior bag worth Rs 2 Lacs Mira Rajput masters Sunday style in a comfy gray floral suit; perfect for a laid-back day Malaika Arora steps out in quirky denim Bermuda and jacket, but it’s the waistband that gives the main character energy Mrunal Thakur serves desi diva energy in two stunning sharara sets and they are just in time to steal the spotlight this wedding season Health Weight Loss Diet Fitness Explore All Explore All Health Categories Scarlett Johansson’s Workout Routine: How She Stays Fit At 39 David Beckham’s Workout Routine And Diet Plan: Fitness Secrets Revealed Christina Aguilera’s Weight Loss: Ozempic Rumors, Diet And More Fat Joe Weight Loss of 200 Pounds with Ozempic And a Low-carb Diet Jenna Jameson’s Weight Loss: How She Lost 80 Lbs with Keto And Intermittent Fasting Gwen Stefani’s Diet And Workout Plan to Stay Fit And Healthy Kate Hudson’s Workout Routine And Diet (Pilates, Yoga, Salads, Etc.) Ariel Winter’s Weight Loss: How the “Modern Family” Star Lost 30 lbs Gal Gadot’s Workout Regime for “Wonder Woman” (Plus Diet, Etc.) Beauty Hair Care Hair Styles Makeup Skin Care Explore All Explore All Beauty Categories Salma Hayek’s Plastic Surgery Rumors: Nose Job And Other Beauty Secrets Eva Mendes' Plastic Surgery: Did She Go Under the Knife? Ben Affleck’s Plastic Surgery Rumors: Botox, Face Lift, And More Tired of dandruff? Here are the top 7 most effective anti-dandruff solutions you need to try Anne Hathaway’s Plastic Surgery Rumors: Nose Job, Facelift, And More Sharon Osbourne’s Plastic Surgery, Anti-aging, Weight Loss, And More Katy Perry’s Plastic Surgery: Did the “Roar” Singer Get Any Cosmetic Procedures? Ryan Gosling’s Plastic Surgery Rumors for His New Film “The Fall Guy” Demi Moore’s Plastic Surgery: Decoding Her Secrets of Ageless Glow Our Sister site Latest Videos Exclusives Entertainment Lifestyle Box office Movie Reviews Korean Fashion About Us Image Usage Policy Privacy Policy Contact Us Editorial Guidelines Affiliate Disclosure Product Research Cookie Policy Press Room Awards/Badges Terms & Conditions Copyright © 2007 - 2024 Pinkvilla Media Private Limited. All rights reserved. Click here for additional information Advertisement Advertisement Home / Korean / TV Series BLACKPINK’s Jisoo wraps up new zombie thriller Influenza filming with Park Jung Min; thanks cast, crew in new PIC BLACKPINK’s Jisoo has wrapped up filming for Influenza marking the day with a cheerful Instagram story update. See here. By Tanya Saxena Updated on Aug 01, 2024 | 11:12 AM IST | 218.9K BLACKPINK’s Jisoo wraps up new zombie thriller Influenza filming with Park Jung Min; thanks cast, crew in new PIC follow us share BLACKPINK's Jisoo; Image: YG Entertainment, Jisoo's Instagram In this Article BLACKPINK’s Jisoo shares new Instagram story marking warp up of Influenza filmingKnow more about Jisoo of BLACKPINK BLACKPINK’s Jisoo, who was last seen in the romantic K-drama Snowdrop will be returning with a new K-drama soon alongside Park Jung Min. In new developments, Jisoo shared a new Instagram story announcing that she has completed filming for her forthcoming zombie thriller K-drama Influenza. BLACKPINK’s Jisoo shares new Instagram story marking warp up of Influenza filming On July 22, 2024, Jisoo surprised fans with a new update about her upcoming zombie thriller K-drama Influenza filming. Jisoo shared on her Instagram story that she has wrapped up Influenza filming with Park Jung Min. She further thanked the cast and crew of Influenza in the story by saying “Thank you all for your hard work”. Check out BLACKPINK’s Jisoo’s Instagram story celebrating the wrap-up of Influenza here: Meanwhile, Influenza is an upcoming zombie-thriller K-drama led by BLACKPINK’s Jisoo who will play Kang Young Joo, and Park Jung Min who will portray Lee Jae Yoon. Influenza will be set in an air defense unit in Seoul and follow the story of a recently broke-up couple, soldier Lee Jae Yoon and Kang Young Joo. As they are reeling from this news, a zombie apocalypse breaks out and they are stuck there. As they try to make their way to each other once again, they are faced with dangerous zombies on their way who they must kill and survive. The story depicts the gradual progress of Kang Young Joo (Jisoo) and Lee Jae Yoon’s (Park Jung Min) characters as they become better and stronger versions of themselves while fighting zombies. Advertisement Additionally, Influenza is based on a novel of the same name by Han Sang Woon. Further, the drama is penned by Parasite writer Han Ji Won and hailed by Time to Hunt director Yoon Sung Hyun. Know more about Jisoo of BLACKPINK Jisoo also known by her full name Kim Jisoo is a famous South Korean singer and actress. She is also a member of the iconic K-pop girl group BLACKPINK with whom she debuted in August 2016. Jisoo made her acting debut with a small cameo in the K-drama Kim Soo Hyun’s The Producers. She finally played a lead role in the romantic and action K-drama Snowdrop alongside Jung Hae In. ALSO READ: PICS: BLACKPINK’s Jisoo brings glitz and glamor to Dior show in Paris, figure skater Kim Yuna looks breathtaking Pinkvilla Pulse Subscribe to our newsletter for entertainment exclusives, star interviews, and the latest lifestyle trends. Look No Further! Subscribe About The Author Tanya Saxena Tanya, on this side of the screen, probably with a Bangtan Bomb and my K-pop playlist on the play. ... Tanya, on this side of the screen, probably with a Bangtan Bomb and my K-pop playlist on the play. She is an English Literature postgraduate with a knack for K-dramas and K-pop, Novels, and Manga. Her to-watch list is slipping out of her hands, but she has not lost hope. One day, she says, she will watch it all. Always prefers animals to humans, if she sees your pet there’s a big chance, she might try to pet them. Read more Credits: Jisoo's Instagram, YG Entertainment Advertisement You May Like This 1 entertainment Oprah Winfrey Denies USD 1 Million Payment For Hosting Kamala Harris Town Hall Was Paid Nothing 2 entertainment Harry Potter TV Series Chooses THIS Actor As Its Top Choice For Dumbledore Deets 3 entertainment Queen Elizabeths Final Diary Entry REVEALED Check Out the FiveWord Sentence She Wrote Two Days Before Her Pass... 4 entertainment Ali Fazal is thrilled to star with Phoebe WallerBridge in Hollywood film Rule Breakers calls her powerhouse of... Latest Articles korean Byeon Woo Seok to perform Lovely Runner OST Sudden Shower at 2024 MAMA Awards’ Japan ceremony on November 23 korean BTS' V sparks speculation about potential A24 movie debut with recent social media activity; DEETS inside korean 8 TV shows with Choi Ji Woo that define her stellar acting career and legacy korean 'How much are you paying me?': When BTS’ Jungkook switched on his business mode after Jimin asked him to colla... Advertisement You May Like This entertainment Sai Pallavi reveals she had an emotional breakdown on sets of Shyam Singha Roy for THIS reason; shares how pro... entertainment Shah Rukh Khan Threat Case: Mumbai police arrests accused from Chhattisgarh entertainment Keke Palmer Opens Up About Racially Charged Moment With Scream Queens Costar And Conflict With Ryan Murphy On ... entertainment WATCH: Bipasha Basu-Karan Singh Grover’s daughter Devi turns 2; little munchkin singing is cutest thing on int... entertainment Bigg Boss Tamil 8 nominations: Who among 13 nominated contestants will exit Vijay Sethupathi-hosted reality TV... entertainment Amaran Box Office Collections: Blockbuster run continues for Siva Karthikeyan film on second Monday entertainment ‘Not Only Do You..’ Selena Gomez Pens Sweet Note To Boyfriend Benny Blanco As He Lands In Sexiest Man Alive Is... entertainment Angry Allu Arjun fans attack a YouTube channel office over objectionable content of Pushpa 2 star and his wife... Advertisement Advertisement Advertisement Subscribe to our Newsletter By providing this information, you agree that we may process your personal data in accordance with our Privacy Statement Pinkvilla Style Icons Download app FOLLOW US ON Company About Us Image Usage Policy Privacy Policy Contact Us Editorial Guidlines Affiliate Disclosure Product Research Cookie Policy Press Room Awards/Badges Terms & Conditions POPULAR CATEGORIES Latest Videos Exclusives Entertainment Lifestyle Box office Movie Reviews Korean Fashion HOT TOPICS Ajay Devgn Rohit Shetty Ranveer Singh Golmaal 5 Kareena Kapoor Singham Again Drishyam 3 Salman Khan Ajay Devgn and Akshay Kumar All The Best 2 TRENDING ON THE WEB Deepika Padukone Megan Fox Bigg Boss 18 Maa Nanna Superhero 2.5 Dimensional Seduction Kim Se Jeong The Buckingham Murders Rupali Ganguly Suriya BTS' V Anthony Mackie BOX OFFICE BUZZ Highest Grossing Indian films on Diwali Bhool Bhulaiyaa 3 Box Office Collections Singham Again Box Office Collections Amaran 2nd Monday Tamil Nadu Box Office Highest Hindi Movie Grossers Overseas Kartik Aaryan Hit Flop Movie List Venom The Last Dance Copyright © 2007 - 2024 Pinkvilla Media Private Limited. All rights reserved. Click here for additional information AdvertisementNew global initiative to advance mRNA vaccine development against human avian influenza (H5N1) Connect with us : Digital Edition Welcome Guest Subscribe Login/Sign Up Tuesday, 12 November 2024 Editorial Calendar 2024 Newsletter Infographics Media Kit INR Toggle navigation Home News Policy & Regulatory Bio Money World Science Supplier People Academics Opinion Pharma BioPharma Biotechnology BioServices Special Bio Special Union Budget 22 Health science earning Survey Union Budget 2023-24 Bioservices- June 2022 Survey Bioincubators- June 2022 Survey Biopharma- May 2022 Survey Diagnostic/ Medtech- April 2022 Survey Industrial enzymes- Feb 2022 Survey Biosuppliers- Jan 2022 Survey Job Seeker's Behaviour Survey Healthcare Digital Healthcare Artificial Intelligence Start-ups Bio-Med MedTech Medical Tools & Device Medical Diagnostic Bio Interactions Premium Article White paper Industry Report Webinars Blogs E- magazine Video blogs Text blogs Awards News World New global initiative to advance mRNA vaccine development against human avian influenza (H5N1) New global initiative to advance mRNA vaccine development against human avian influenza (H5N1) 30 July 2024 | News This development supplements ongoing work under the Pandemic Influenza Preparedness Framework image credit- shutterstock A new project aiming to accelerate the development and accessibility of human avian influenza (H5N1) messenger RNA (mRNA) vaccine candidates for manufacturers in low- and middle-income countries has been launched. The Argentinian manufacturer Sinergium Biotech will lead this effort leveraging the World Health Organization (WHO) and the Medicines Patent Pool (MPP) mRNA Technology Transfer Programme. Sinergium Biotech has developed candidate H5N1 vaccines and aims to establish proof-of-concept in preclinical models. Once the preclinical data package is concluded, the technology, materials, and expertise will be shared with other manufacturing partners, aiding the acceleration of the development of H5N1 vaccine candidates, and bolstering pandemic preparedness efforts. "This initiative exemplifies why WHO established the mRNA Technology Transfer Programme – to foster greater research, development and production in low- and middle-income countries, so that when the next pandemic arrives, the world will be better prepared to mount a more effective and more equitable response," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. Comments × Thank You Your comment has been submitted for approval. Please note that comments are moderated and are generally published if they are on-topic and not abusive. Comment × Your session has been expired. Please click here to Sign-in or Sign-up Log In To Comment New User? Create Account Other Topics India Pharma manufacturing Covid19 Indian Biotech Cell & Gene theraphy Cancer Rare Disease Generics Patients Care Medtech Drugs innovations BioSupplier Biotech HealthCare IT Bio Start Ups Bio Asia Vaccines Leadership Will Boosting Biofoundries Tra... “To achieve our ‘Skilled India... “A network of Biofoundries, wi... Targeted Transformation of Dia... How Seed Funding is Driving In... How AI is Propelling Radiology... TRENDING TOPICS Early Diabetic Retinopathy Det Impact of Digital Transformati Govt announces launch of 4 CoE PM inaugurates Lyfius Pharma’s Most read NPPA revises ceiling prices of eigh Govt to establish 5 Centres of Exce Experts highlight urgency to expand PM inaugurates state-of-the-art R J Survey Box Will Boosting Biofoundries Transform India's Biomanufacturing Landscape? Yes No May be × Please select an option to participate in the poll. Vote View poll results More polls × You have successfully cast your vote. {{ optionDetail.option }}{{ optionDetail.percentage }}% {{ optionDetail.percentage }}% Complete More polls Subscribe to BioSpectrum India Enquiry Thanks for contacting us! We will get in touch with you shortly. Please fill the all fields. Name Email Enter a valid email address. Phone Message Send message Contact Us Ashirwad Bungalow, First floor,36/A/2, S.No. 270, Pallod Farms, Near Bank of Baroda, Baner Road, Pune, Maharashtra, India 411045Mob : +91-9579069369 Email : communications@mmactiv.com **Disclaimer Visit Our Digital Magazine : BioSpectrum Asia NuFFooDS Spectrum Sitemap © 2024 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer Web Interface Conceived and Powered By : SCI Knowledge Interlinks Have an Account? Login Create Account Forgot Password Login Email id Password Sign In Create Account City First Name Last Name Email ID Password Confirm Password Newsletter E-magazine Biospectrum Infomercial Bio Resource I accept the terms & condition & Privacy policy Sign Up Forgot Password Email id Submit Close × Subscribe To Our Newsletter Email ID I accept the terms & condition & Privacy policy SUBSCRIBE! CloseWHO to accelerate bird flu vaccine development - Taipei Times Front Page Taiwan News Business Editorial & Opinion Sports World News Features Bilingual Pages SearchSearch All Front Page Taiwan News Business Editorial & Opinion Sports World News Features Bilingual Pages GO Home World News Tue, Jul 30, 2024 page5 WHO to accelerate bird flu vaccine development AFP, GENEVA, Switzerland The WHO yesterday announced a new project to accelerate the development in poorer nations of vaccines for human avian influenza infections using cutting-edge messenger ribonucleic acid (mRNA) technology.The WHO said Argentine manufacturer Sinergium Biotech would lead the effort and had already begun developing candidate H5N1 vaccines.Bird flu H5N1 first emerged in 1996, but since 2020 an exponential growth in outbreaks in birds has occurred in parallel with the virus increasingly jumping to mammals, including cattle in US farms and a few humans. Former UN secretary-general Ban Ki-moon, left, and WHO Director-General Tedros Adhanom Ghebreyesus take part in the Olympic village torch relay at the Olympic Village in Paris on Friday last week. Photo: AFP This has prompted fears the virus could spark a future pandemic.Sinergium is aiming to establish proof-of-concept in preclinical models for its candidate vaccines, the WHO said. Once the preclinical data is ready, the technology, materials and expertise would be shared with a network of manufacturers in poorer nations, allowing them to accelerate their own development and production.The UN health agency said the project would be rolled out through the mRNA technology transfer program it established with the UN-backed Medicines Patent Pool in 2021, at the height of the COVID-19 pandemic.That program was aimed to help low and middle-income nations, which found themselves dramatically underserved during the pandemic, to develop and produce their own vaccines using mRNA.The technology instructs the body to produce a unique protein that stimulates an immune response, teaching it to defend against the infection.Swiftly developed mRNA COVID-19 vaccines were game-changers during the pandemic, but they also exposed glaring global vaccine inequity.“This initiative exemplifies why WHO established the mRNA Technology Transfer Programme,” WHO Director-General Tedros Adhanom Ghebreyesus said in a statement.That program, which counts 15 manufacturing partners in nations ranging from South Africa to Ukraine to Vietnam, was aimed “to foster greater research, development and production in low and middle-income countries,” he said.That way, “when the next pandemic arrives, the world will be better prepared to mount a more effective and more equitable response,” he added.The WHO has said there are a range of traditional influenza vaccines already licensed for pandemic use that could potentially be tailored to combat H5N1 if it begins spreading among people, but Martin Friede, who heads the WHO’s vaccine research unit, said focusing on developing mRNA-based vaccines was particularly interesting when seeking to establish sustainable production capacity.Previous efforts to boost influenza vaccine production in developing nations had often faltered, with facilities narrowly focused on egg-based pandemic influenza jabs shutting after the threat dissipated and governments stopped procuring doses.“The advantage of mRNA is that, in theory, we can make a COVID vaccine, we can make H5N1 vaccines, but also many other vaccines and importantly also therapeutics,” Friede told reporters.If the need for H5N1 vaccines or other jabs fades, instead of shutting down production, “we hope that all of the partners will be able to produce something else,” he said. Most Popular 1TSMC cannot make 2nm chips abroad now: MOEA 2SpaceX asks Taiwanese firms to move 3Videos about Taiwan upset China: source 4Taiwan in Time: The rise and fall of Taipei’s sky bridges 5Taiwan sees ‘more pros than cons’ if Trump wins back presidency You might also like Philippine Coast Guard to acquire 40 patrol craft 2024-11-08 The Philippines yesterday said its coast guard would acquire 40 fast patrol craft from France, with plans to deploy some of them in disputed areas of the South China Sea. The deal is the “largest so far single purchase” in Manila’s ongoing effort to modernize its coast guard, with deliveries set to start in four years, Philippine Coast Guard Commandant Admiral Ronnie Gil Gavan told a news conference. He declined to provide specifications for the vessels, which Manila said would cost 25.8 billion pesos (US$440 million), to be funded by development aid from the French government. He said some of the vessels would West suspects Russia in airplane plots 2024-11-07 CARGO PLANE VECTOR: Officials said they believe that attacks involving incendiary devices on planes was the work of Russia’s military intelligence agency the GRU Western security officials suspect Russian intelligence was behind a plot to put incendiary devices in packages on cargo planes headed to North America, including one that caught fire at a courier hub in Germany and another that ignited in a warehouse in England. Poland last month said that it had arrested four people suspected to be linked to a foreign intelligence operation that carried out sabotage and was searching for two others. Lithuania’s prosecutor general Nida Grunskiene on Tuesday said that there were an unspecified number of people detained in several countries, offering no elaboration. The events come as Western officials say Fans attacked in Amsterdam return to Israel 2024-11-10 A plane bringing Israeli soccer supporters home from Amsterdam landed at Israel’s Ben Gurion airport on Friday after a night of violence that Israeli and Dutch officials condemned as “anti-Semitic.” Dutch police said 62 arrests were made in connection with the violence, which erupted after a UEFA Europa League soccer tie between Amsterdam club Ajax and Maccabi Tel Aviv. Israeli flag carrier El Al said it was sending six planes to the Netherlands to bring the fans home, after the first flight carrying evacuees landed on Friday afternoon, the Israeli Airports Authority said. Israeli Prime Minister Benjamin Netanyahu also ordered Biden should have quit sooner, Nancy Pelosi says 2024-11-10 Former US House of Representatives speaker Nancy Pelosi said if US President Joe Biden had ended his re-election bid sooner, the Democratic Party could have held a competitive nominating process to choose his replacement. “Had the president gotten out sooner, there may have been other candidates in the race,” Pelosi said in an interview on Thursday published by the New York Times the next day. “The anticipation was that, if the president were to step aside, that there would be an open primary,” she said. Pelosi said she thought the Democratic candidate, US Vice President Kamala Harris, “would have done Front Page Taiwan News Business Editorial & Opinion Sports World News Features Bilingual Pages About Us Employment Contact Us RSS Copyright © 1999-2024 The Taipei Times. All rights reserved.WHO Reaches Deal With Argentinian MRNA Vaccine Developer To Produce A Low-Cost Avian Flu Jab - Health Policy Watch Skip to content menu Home About Us Search for: Search for: Antimicrobial Resistance Infectious Diseases Pandemics & Emergencies Non-Communicable Diseases Health, Climate & SDGs Search for: Search for: WHO Reaches Deal with Argentinian mRNA Vaccine Developer to Produce a Low-Cost Avian Flu Jab Intellectual Property 29/07/2024 • Elaine Ruth Fletcher Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to print (Opens in new window) Lab technician at Afrigen, the Cape Town-based firm hosting the WHO co-sponsored Vaccine Technology Transfer Hub. The Argentina-based biotech firm, Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered know-how to the hub, which was founded by WHO in 2021 together with the Medicines Patent Pool, and is hosted by the South African firm Afrigen, based in Cape Town. Sinergium “has developed candidate H5N1 vaccines and aims to establish proof-of-concept in preclinical models. Once the preclinical data package is concluded, the technology, materials, and expertise will be shared with other manufacturing partners, aiding the acceleration of the development of H5N1 vaccine candidates, and bolstering pandemic preparedness efforts.” said WHO in a statement. “This initiative exemplifies why WHO established the mRNA Technology Transfer Programme – to foster greater research, development and production in low- and middle-income countries, so that when the next pandemic arrives, the world will be better prepared to mount a more effective and more equitable response,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. H5N1 is first vaccine target for the hub since COVID-19 Colorized transmission electron micrograph of Avian influenza A H5N1 viruses (seen in gold) grown in MDCK cells (seen in green). Following it’s launch, the Afrigen mRNA Technology Transfer Programme focused mostly on testing and developing an mRNA COVID-19 vaccine candidate. Progress, however, was slow because the major mRNA vaccine manufacturers, Moderna and Pfizer, refused to share their know-how on the WHO-sponsored platform – opting to sign licencing agreements to manufacture COVID vaccines under their brand identities with other manufacturers elsewhere in Africa. So the agreement by Sinergium to share its IP and partner directly with the WHO co-hosted hub is a breakthrough for the global health agency – which has long sought a role in the emerging mRNA vaccine market – to reduce costs and make vaccines more accessible in low- and middle-income countries. The new agreement signed with a Latin-American based firm also takes a small, but meaningful, step towards the ‘regionalization’ of vaccine markets, WHO officials said on Monday. “This announcement underscores the importance of not only geographically diversifying the innovation and production of health technologies including and recognizing the capacities in Latin American and the Caribbean, but also the importance of early planning for access and the sharing of knowledge and technologies during the research and development processes,” said Dr Jarbas Barbosa, Director of the Pan American Health Organization (PAHO), WHO’s Regional Office for the Americas. Dr Alejandro Gil, Chief Executive Officer of Sinergium, credited PAHO’s “strong support it offers to regional manufacturers in the Americas” with playing an instrumental role in the deal. “Sinergium’s enhanced capacity and readiness to apply our expertise to H5N1 will play a vital role in this effort towards global pandemic preparedness. …We are excited to tackle this public health challenge and our R&D team will continue to work closely with the Programme Partners.” Along with the base at Afrigen, WHO’s mRNA technology transfer hub programme includes Institut Pasteur in Senegal – and is planned to eventually includes manufacturers in over a dozen other low- and middle-income countries around the world. Moderna also advancing a candidate vaccine with US government help 172 dairy herds in 13 states have so far been affected by the spread of avian flu in dairy cattle since the outbreak was reported in late March. Moderna is reportedly at a more advanced stage in the process of developing and mRNA vaccine for the virus, which is spreading rapidly amongst dairy cattle herds in the United States. In early July, the US government awarded the Cambridge-based firm $176 million to advance development of “an mRNA-based pandemic influenza vaccine.” “We have successfully taken lessons learned during the COVID-19 pandemic and used them to better prepare for future public health crises. As part of that, we continue to develop new vaccines and other tools to help address influenza and bolster our pandemic response capabilities,” said HHS Secretary Xavier Becerra, at the time of the announcement. While WHO has so far assured that the risks to humans of avian flu remain low, as long as human-to-human transmission is not occurring, the ever-widening transmission of the deadly virus amongst different animal species increases the risks that it may one day soon mutate in a way that it can more easily infect, and be transmitted, amongst humans. And in the absence of effective vaccines, which are also widely available, that could unleash yet another pandemic on the world. Image Credits: Afrigen, CDC/ Courtesy of Cynthia Goldsmith, CDC. Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to print (Opens in new window) Combat the infodemic in health information and support health policy reporting from the global South. Our growing network of journalists in Africa, Asia, Geneva and New York connect the dots between regional realities and the big global debates, with evidence-based, open access news and analysis. To make a personal or organisational contribution click here on PayPal. Posted in Africa, Briefs, Content type, Drug & Diagnostics Development, Institutions, Intellectual Property, Latin America & Caribbean, Medical Innovation, Medicines & Vaccines, Regional Policy, World Health Organization Related Nations Deadlocked Over Health-Biodiversity Framework at COP16 Health & Environment 26/10/2024 Africa CDC Accuses US Government of Creating Panic in Travel Advisory Over Rwanda Marburg Outbreak Outbreaks 10/10/2024 WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children Medicines & Vaccines 02/10/2024 Do you really care about access and equity in global health? Your contributions are urgently needed to support our mission in open access global health journalism and our network of correspondents in Africa, Asia, New York and Geneva. Their reporting connects the dots between the regional realities and the big global debates. Every contribution - big or small - helps us sustain our reporting for the benefit of all. Related Nations Deadlocked Over Health-Biodiversity Framework at COP16 Health & Environment 26/10/2024 Africa CDC Accuses US Government of Creating Panic in Travel Advisory Over Rwanda Marburg Outbreak Outbreaks 10/10/2024 WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children Medicines & Vaccines 02/10/2024 Do you really care about access and equity in global health? Your contributions are urgently needed to support our mission in open access global health journalism and our network of correspondents in Africa, Asia, New York and Geneva. Their reporting connects the dots between the regional realities and the big global debates. Every contribution - big or small - helps us sustain our reporting for the benefit of all. This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Sign up for free news alerts Signup Link Contact Us info@healthpolicy-watch.org 1-5 Route des Morillions CP 2100 Geneva 1211, Switzerland +41 22 791 67 28 About Privacy Policy Archives Staff Access Log in Entries RSS Comments RSS Wordpress.org Supported by Sponsors Copyright c 2020 Global Policy Reporting Loading Comments... You must be logged in to post a comment.Punjab, Gujarat, Haryana top the list with H1N1 deaths - The Hindu India World Elections Technology e-Paper Menu Science Data Opinion SEARCH FREE TRIALGIFT a Subscription Subscribe LOGIN ACCOUNT PREMIUM Open in The Hindu AppFREE TRIALLOGINGIFT a Subscription ACCOUNT PREMIUM Subscribe Science Data Opinion SEARCH India World Elections Technology e-Paper Science Data Opinion SEARCH News Business Entertainment Life & Style Society Technology Videos Sport Cities States Science Show More Chennai Delhi Bengaluru Hyderabad Movies Food Children Data Kochi Books Education Podcast Brandhub To enjoy additional benefitsFREE TRIALGIFT a Subscription Subscribe LOGIN ACCOUNT PREMIUM ShowcaseSubscribe to NewslettersCrossword+CONNECT WITH US Home Sci-Tech Health Punjab, Gujarat, Haryana top the list with H1N1 deaths The country has recorded over 7,000 cases so far, of which Punjab, Gujarat, and Haryana have registered the largest number of deathsUpdated - July 31, 2024 12:44 pm IST - NEW DELHIBindu Shajan Perappadan Copy link Email Facebook Twitter Telegram LinkedIn WhatsApp Reddit READ LATER Remove SEE ALL PRINT Punjab (41), Gujarat (27) and Haryana (26) have registered the largest number till end of June. File | Photo Credit: Getty Images/iStockphoto Of the 150 recorded Influenza A (H1N1) deaths across India - Punjab (41), Gujarat (27) and Haryana (26) have registered the largest number till end of June as per Health Ministry data while Delhi (1,563), Gujarat (1,049), and Rajasthan (1,008) have the largest number of cases. The country has recorded over 7,000 cases so far, as per the record. 3,544 cases of H1N1 in 2023 was the highest in 14 years in T.N.The Health Ministry has provided guidelines on screening and categorisation of patients, laboratory diagnosis, infection control, home care, and clinical management. States have been advised to increase awareness among public for adopting simple public health measures such as hand washing, covering the mouth while coughing, sneezing, and avoiding crowded places.According to the World Health Organization seasonal influenza spreads easily, with rapid transmission in crowded areas including schools and nursing homes. When an infected person coughs or sneezes, droplets containing viruses (infectious droplets) are dispersed into the air and can infect persons in close proximity. The virus can also be spread by hands contaminated with influenza viruses. To prevent transmission, people should cover their mouth and nose with a tissue when coughing, and wash their hands regularly. Spurt in H1N1 cases in AlappuzhaIn temperate climates, seasonal epidemics occur mainly during winter, while in tropical regions, influenza may occur throughout the year, causing outbreaks more irregularly. The time from infection to illness, known as the incubation period, is about two days, but ranges from one to four days. There are around a billion cases of seasonal influenza annually, including three to five million cases of severe illness, and it causes 2,90,000 to 6,50,000 respiratory deaths annually. Developing countries comprise of nearly 99% of deaths from influenza-related lower respiratory tract infections in children under five years of age. Symptoms begin one to four days after infection and usually last around a week.Experts note that vaccination is the best way to prevent influenza and though this may be less effective in older people. It will, however, make the illness less severe and reduces the chance of complications and death. Published - July 30, 2024 09:50 pm IST Read Comments Copy link Email Facebook Twitter Telegram LinkedIn WhatsApp Reddit READ LATER Remove SEE ALL PRINT Related Topics health / Gujarat / Haryana Top News Today0 / 0 Read in App The Hindu About Us Code of Editorial Values News Archive Sitemap Print Subscription Digital Subscription Subscribe to Newsletters Rss Feeds Readers Editor-Terms of Reference Authors & Contributors Frame Front page Contact us Contact Us Social Media Advertise With Us Group News Sites Business Line BL on Campus Sportstar Frontline இந்து தமிழ் திசை The Hindu Centre Young World Club The Hindu ePaper Business Line ePaper Crossword + Free Games Other Products RoofandFloor STEP Images Classifieds - Print Bookstore & Special Publications Popular Sections Elections Israeli–Palestinian conflict 2023 Latest News National News International News Videos Life & Style Food Podcast Showcase Opinion Editorial Columns Comment Cartoon Letters Interview Lead Business Agri-Business Industry Economy Markets Budget Sport Cricket Football Hockey Tennis Athletics Motorsport Races Other Sports Sci-Tech Science Technology Health Agriculture Environment Gadgets Internet States Andhra Pradesh Karnataka Kerala Tamil Nadu Telangana Cities Bengaluru Chennai Coimbatore Delhi Hyderabad Kochi Kolkata Kozhikode Madurai Mangaluru Mumbai Puducherry Thiruvananthapuram Tiruchirapalli Vijayawada Visakhapatnam Trending on The Hindu News Hamas Chief Yahya Sinwar killing LIVE Full list of Haryana ministers Kolkatan who returns to Durga Puja after 20 years EC to announce schedule for Maharashtra, Jharkhand polls Waqf row Did not want to blow up India ties: Justin Trudeau RSS, Togadia decide to work together to ‘unite’ Hindus Five Eyes support Canada India Canada row Trending on Group sites Stock Market Live Updates Stocks to buy today Hockey Mogun Bagan Paralympics 2024 Gold Rate Today Silver Rate Today Sexual Harassment in Telugu Film Industry Mango: The Michael Jackson of Fruits Frontline Current Issue Terms of Use Privacy Policy Copyright© 2024, THG PUBLISHING PVT LTD. or its affiliated companies. All rights reserved. BACK TO TOPSign in to unlock member-only benefits!Access 10 free stories every monthSave stories to read laterAccess to comment on every storySign-up/manage your newsletter subscriptions with a single clickGet notified by email for early access to discounts & offers on our products✕Looks like you are already logged in from more than 3 devices!To continue logging in, remove at least one device from the below listLog outLog Out from all devicesTerms & conditions | Institutional SubscriberCommentsComments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments. We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.How flu vaccines are monitored for safety | InSight+ News Views Polls Current Issue Previous Issues MJA MJA Podcasts MJA Jobs Board Write for us Subscribe search more_vert Home News Views Polls Current Issue Previous Issues MJA MJA Podcasts MJA Jobs Board Write for us search × InSight+ Issue 29 / 29 July 2024 How flu vaccines are monitored for safety Authored by Annika Howells Related Links Queensland GP elected new AMA President InSight+ What GPs need to know about iron deficiency in women InSight+ How can we improve health literacy in Australia? InSight+ ‘I keep away from people’ – combined vision and hearing loss is isolating more and more older Australians InSight+ RHD deaths in Doomadgee: Four Corners, the coronial inquest and Aboriginal community control InSight+ InSight+ Issue 29 / 29 July 2024 With millions of flu vaccines administered every year, monitoring their safety is crucial. As misinformation about the safety of vaccines continues to spread online, many people may be unaware that Australia has a robust process of vaccine pharmacovigilance, which monitors vaccine safety to detect any adverse events following immunisation (AEFI). In a perspective published in the Medical Journal of Australia, researchers from the Therapeutic Goods Administration (TGA), the National Centre for Immunisation Research and Surveillance, and the Telethon Kids Institute, have outlined the processes used to monitor seasonal influenza vaccines for safety. “This article aims to support the seasonal influenza vaccine program by providing confidence in the robust national pharmacovigilance processes for seasonal influenza vaccines in Australia,” the authors wrote. Annual influenza vaccination is recommended for all people aged six months and over, and is available free for many people. Approximately 9 million influenza vaccines were administered in Australia in 2023 — a significant drop from the 11 million vaccines administered in 2022. Due to the widespread distribution of flu vaccines, it is imperative that pharmacovigilance systems are quick to respond to any AEFI. “The purpose of these pharmacovigilance systems is to monitor for unexpected types and rates of AEFI, including rare and population-specific events,” the authors wrote. “The identification and investigation of potential safety concerns is a key function of these systems, with the TGA also focused on ensuring that vaccines registered for use in Australia maintain a favourable benefit–risk profile.” Approximately 9 million influenza vaccines were administered in Australia in 2023 (BaLL LunLa/Shutterstock). Multiple methods of surveillance Vaccine pharmacovigilance is a collaborative process between the TGA, the nationally funded surveillance initiative AusVaxSafety, and state and territory health departments. The TGA receives reports of any AEFI submitted by health care professionals, pharmaceutical companies, state and territory health departments, and the public, and these reports are entered into a national database. Vaccines are also monitored through other national and international data, data mining algorithms, and, in the case of seasonal influenza vaccines, monthly safety surveillance reports throughout the influenza season. Serious adverse events that would warrant further investigation include any events that cause fatal or life-threatening conditions, new or prolonged hospitalisation, persistent or significant disability, birth defects, or any medical event that requires intervention to prevent serious adverse events. “The TGA identifies and reviews cases of regulatory significance, including serious AEFI reports of concern, and may consider convening the Vaccine Safety Investigation Group when an AEFI of concern is identified that has the potential to change the favourable benefit–risk balance of a vaccine, or affect public confidence in vaccine safety,” the authors wrote. “The outcomes from the Vaccine Safety Investigation Group are publicly available and serve to inform regulatory action and the vaccine program.” AusVaxSafety has also actively monitored influenza vaccine safety since 2014 using surveys, which are sent to vaccine recipients via SMS or email three days after vaccination. The survey results are reported to the TGA, the Department of Health and Aged Care, and state and territory jurisdictions. The challenges of monitoring flu vaccine safety Despite comprehensive surveillance programs, the authors note there are ongoing challenges when it comes to monitoring adverse effects from influenza vaccines. Under-reporting and incomplete reports can undermine data in the system, especially in the case of patient self-reporting. “The quality of information provided in these self-reports and the presence of missing data may have an impact on safety signal detection and investigation,” the authors wrote. “Reporters are encouraged to provide as much information as possible either at the time of reporting an adverse event, or when further information is sought.” Long term and late onset reactions to vaccines are also difficult to capture in surveillance surveys, and clinicians are encouraged to be aware of late-onset conditions and report any such incidents to the TGA. To maintain ongoing improvements in pharmacovigilance systems, the TGA is currently working on improvements to AEFI data quality, as well as functionality of the database system itself. They are also developing educational models to support health practitioners in engaging with adverse event reporting. “The TGA and AusVaxSafety recognise the importance of providing timely and transparent information on seasonal influenza vaccine safety to the Australian public,” the authors wrote. “Close collaboration between national pharmacovigilance systems continues to support the health and safety of Australians through close monitoring of seasonal influenza vaccines and rapid communication of any emerging safety signals.” Read the perspective in the Medical Journal of Australia. Subscribe to the free InSight+ weekly newsletter here. It is available to all readers, not just registered medical practitioners. Leave a ReplyYour email address will not be published. Required fields are marked *Comment * Name * Comment anonymously (name will be hidden, email is always hidden). Email * Tweets by @theMJA Most popular posts Concerns over international doctor fast-track pathway Views:2,820 Date: 2024-10-28 Bullying in medical academia: time to enforce the policies Views:2,276 Date: 2024-10-21 New guidelines for ADHD prescribing Views:2,230 Date: 2024-10-14 Poor nutrition and misleading marketing: the truth about commercial baby foods in Australia Views:1,987 Date: 2024-11-04 Scope of Practice Review comes under fire Views:1,796 Date: 2024-11-11 ADVERTISE CONTACT US PRIVACY POLICY TERMS OF USE DISCLAIMERBlackpink's Jisoo Starrer Influenza Is Now Newtopia, Makers Release New Stills Of Zombie Drama | Park Jung Min | Times NowOpen PopupTimes NowTN NavbharatZoomET NowET Now SwadeshTimes DriveHealth and MeDigitMarathiTeluguTamilBengaliKannadaThemePowered by Entertainment Bollywood Box Office Reviews TV Web Series Hollywood Korean Telugu Tamil Kannada Malayalam Movies Veteran Bengali Actor Manoj Mitra Dies At 85 In Kolkata When Janhvi Kapoor Visited Tirupati With Shikhar Pahariya On Mom Sridevi's Birth Anniversary Children's Day 2024: When Alia Bhatt Recalled Raha's First Kick, Said She Wouldn't Let Her Move Out At A Young Age Shah Rukh Khan Death Threat Case: Cops Grill Suspect From Chhattisgarh Kevin Feige Says MCU Still ‘Committed’ To Blade With Mahershala AliSuman Indori: Python Spotted On Set Of Ashnoor Kaur’s Show, Zain Imam Gets NostalgicAmjad Khan Birth Anniversary: How Gabbar Singh Was Culmination Of 10 Years Of Actor's StruggleMukesh Khanna To Return As Shaktimaan, Fans Disappointed: All Set To Ruin Our ChildhoodAamir Khan Says 'Young Actors Must Have Got Really Upset' With Shah Rukh-Salman's Post-Credit Scene In PathaanRupali Ganguly Issues Defamation Notice To Stepdaughter Esha Verma, Demands Rs 50 Crore - Details InsideCitadel Honey Bunny Actress Simran Bagga Feels Makers Could Have Done More With Her Role: It Had Lot Of Potential | EXCLLady Singham Solo Film Happening! Rohit Shetty CONFIRMS Deepika Padukone Will Return In Spin-OffVikrant Massey Explains What Secularism Means To Him Ahead Of The Sabarmati Report Release: I Am Still A LiberalRidley Scott's Gladiator II FIRST Reviews Out: Critics Call Pedro Pascal, Paul Mescal Film A 'Thrilling Spectacle'Director Krish Jagarlamudi And Priti Challa Tie The Knot Bollywood Veteran Bengali Actor Manoj Mitra Dies At 85 In Kolkata When Janhvi Kapoor Visited Tirupati With Shikhar Pahariya On Mom Sridevi's Birth Anniversary Amjad Khan Birth Anniversary: How Gabbar Singh Was Culmination Of 10 Years Of Actor's Struggle Mukesh Khanna To Return As Shaktimaan, Fans Disappointed: All Set To Ruin Our Childhood Shah Rukh Khan Death Threat Case: Cops Grill Suspect From ChhattisgarhAamir Khan Says 'Young Actors Must Have Got Really Upset' With Shah Rukh-Salman's Post-Credit Scene In PathaanLady Singham Solo Film Happening! Rohit Shetty CONFIRMS Deepika Padukone Will Return In Spin-OffVikrant Massey Explains What Secularism Means To Him Ahead Of The Sabarmati Report Release: I Am Still A LiberalChildren's Day 2024: When Alia Bhatt Recalled Raha's First Kick, Said She Wouldn't Let Her Move Out At A Young AgeRohit Shetty REACTS To People Calling Cirkus End Of His Career: Koi Farq Nahi Padha Tha Aur Ab Bhi Nahi Padh Raha | EXCLUSIVESharda Sinha's Last Video Singing Chhath Geet In Hospital Leaves Fans Teary-Eyed. WatchAmitabh Bachchan Writes Letters Of Appreciation To EveryoneVikrant Massey TROLLED For 'So-Called Azaadi' Comment Ahead Of The Sabarmati Report: Promotions Ke Liye Kuch BhiRohit Shetty Says Singham Again Not Made For Critical Acclaim: Can't Cry Over It, Our Target Audience Enjoys... | EXCLRohit Shetty On 33 Years Of Friendship With Ajay Devgn: Whatever I Am Today, Is Because Of Him | Exclusive Box Office Bhool Bhulaiyaa 3 Vs Singham Again Movie Collection Day 11: It's A Low Monday For Kartik Aaryan, Ajay Devgn At Box Office Paddington In Peru Sees BIGGEST UK Box Office Opening For British Film Since No Time To Die Singham Again Box Office Collection Day 11: Ajay Devgn's Film Survives Monday Test Despite Hitting Lowest Number Bhool Bhulaiyaa 3 Box Office Collection Day 11: Horror Comedy Becomes Kartik Aaryan's FIRST Rs 200 Crore Film Ajay Devgn's Singham Again To Become 3rd Highest Hindi Grosser Of The Year, All Set To Beat Hrithik Roshan's FighterBhool Bhulaiyaa 3 Vs Singham Again Movie Collection 2nd Sunday: Kartik Aaryan Starrer Set To Surpass Ajay Devgn Film At Box Office​Singham Again Box Office Collection Day 10: Ajay Devgn, Rohit Shetty's Cop Drama Surpasses Rs 200 CroreBhool Bhulaiyaa 3 Vs Singham Again Movie Collection 2nd Saturday: Margin Between Kartik, Ajay's Films Less Than Rs 10 Crore At Box OfficeSingham Again Box Office Collection Day 9: Ajay Devgn, Rohit Shetty Film Inches Closer To Rs 200 Crore MarkBhool Bhulaiyaa 3 Box Office Collection Day 9: Kartik Aaryan's Horror-Comedy Kicks Off 2nd Weekend With Double DigitsBhool Bhulaiyaa 3 Vs Singham Again Movie Collections Day 8: Kartik Aaryan Begins 2nd Week On Better Note Than Ajay DevgnSingham Again Box Office Collection Day 8: Ajay Devgn, Rohit Shetty's Cop Thriller Maintains Steady PaceBhool Bhulaiyaa 3 Box Office Collection Day 8: Kartik Aaryan's Horror Comedy Earns MORE Than Singham AgainBhool Bhulaiyaa 3 Vs Singham Again Box Office Collection Week 1: Ajay Devgn Cop Movie DEFEATS Kartik Aaryan Horror ComedySingham Again Box Office Collection Day 7: Ajay Devgn's Cop Drama Ends Double-Digit Streak As It Dips Again Reviews Khwaabon Ka Jhamela Movie Review: Sayani-Prateik's Unexpected Journey Of Self-Discovery Leaves A Smile The Great Indian Kapil Show Season 2 Episode 8 Review: Narayan-Sudha Murthy, Deepinder Goyal's Sweetness Fails To Raise The Bar Oru Anweshanathinte Thudakkam: A Satisfactory Watch Despite Its Long-Wound Story-telling Behind The Scenes Movie Review: All That Glitters Is Not Gold, An Anthology Showcases Harsh Realities Of ‘Silver Screen’ Saga Vijay 69 Movie Review: Anupam Kher's Slice-Of-Life Sports Drama Is Cheesy But HeartwarmingJitender Reddy Review: A partly engaging political thrillerElla Movie Review: Isha Talwar Film Is A Thrilling Journey of Mystery, Crime And SupernaturalHere Movie Review: Tom Hanks' Multi-Generational Tale Explores Time, Love And LossAnora Movie Review: Mikey Madison Is A Gutsy Modern Cinderella In This Boisterous FairytaleI Am Kathalan Review: An Entertaining Watch That Is Let Down By An Oversimplified NarrativeOuter Banks Season 4 Part 2 Review: Predictable Yet Fun, The Pogues Give Us Thrilling RideCitadel Honey Bunny Review: Varun Dhawan, Samantha's Prequel Spy Saga Packs A Solid PunchThe Great Indian Kapil Show Season 2 Episode 7 Review: Kartik, Vidya, Triptii Bring In Diwali DhamakaMithya The Dark Chapter Review: Even Huma Qureshi Cannot Save This Not-So-Dark SequelSingham Again Movie Review: Rohit Shetty Cooks Up Family-Sized Entertainer With Mix Of Action, Drama, Comedy TV Sana Sultan Shares First Statement After Marriage, Reveals Sheru Was Gifted By Husband Mohammad Wazid Suman Indori: Python Spotted On Set Of Ashnoor Kaur’s Show, Zain Imam Gets Nostalgic Bigg Boss 18 Nomination Task: Tajinder Bagga, Kashish Kapoor And 5 Others Get Nominated Shama Sikander Mourns The Loss Of Her Father Sikander Ali Gesawat Rupali Ganguly-Esha Verma Defamation Row: Sana Raees Khan Reveals Anupamaa Star Had Traumatic Experience - ExclusiveRupali Ganguly Issues Defamation Notice To Stepdaughter Esha Verma, Demands Rs 50 Crore - Details InsideAvneet Kaur Meets Tom Cruise On Mission Impossible Sets, Varun Dhawan Can't Keep CalmHeavily Pregnant Shraddha Arya Dances Her Heart Out, Says 'One Last Party Before...'Bigg Boss 17 Fame Arun Mashettey To Make Acting Debut With Salman Khan's SikandarBigg Boss 18: Vivian Dsena Turns Postman For Nomination TaskRohit Shetty Says 'Television Audience Has Made Me A Brand' - ExclusiveSmriti Irani-Ekta Kapoor To Drashti Dhami-Sanaya Irani: TV Stars Who Are Real-Life BFF'sAnupamaa Star Sagar Parekh To Make TV Comeback With THIS ShowTV Actor Amit Tandon CONFESSES: I Cheated On My Wife With Multiple WomenSreejita De-Michael Blohm-Pape's Haldi Pics Is All About Love And Happiness Web Series Citadel Honey Bunny Actress Simran Bagga Feels Makers Could Have Done More With Her Role: It Had Lot Of Potential | EXCL How Sidhant Gupta Agreed To Play Nehru In Freedom At Midnight: Saying Yes Was A Journey | Exclusive Bhagyashree's Daughter Avantika Dassani On Being Critical Of Her Performance In Mithya 2: I'm Hungry For Growth - EXCL Sikandar Ka Muqaddar Trailer: Avinash Tiwary, Tamannaah's Heist Film Builds Suspense. Watch HBO Teases 2025 With First Looks At Hacks, The White Lotus, The Last Of Us And A Knight Of The Seven Kingdoms. WatchThe Penguin Season Finale Twists EXPLAINED By Creator Lauren Le FrancNavjot Singh Sidhu Returns To Kapil Sharma's Show After Getting Sacked 5 Years AgoMeet Sidhant Gupta: Actor Who Plays Jawaharlal Nehru In Freedom At MidnightManik Papneja Calls His Character Watson To Adah Sharma's Sherlock Holmes In Reeta Sanyal | ExclusiveParis Has Fallen Finale EXPLAINED: How Tewfik Jallab, Ritu Arya Spinoff Series Saves French CapitalCate Blanchett Unpacks Disclaimer's Shocking Finale, Her Character's Big Reveal: Wanted To Get It...Vijay Varma Shares Light-Hearted BTS Look From IC 814: The Kandahar Hijack. See PicsARM: Tovino Thomas Does A SS RajamouliAndor Season 2: Star Wars Prequel Series With Diego Luna To Release On THIS DateEuphoria Season 3: HBO Refutes Reports Of Series Cancellation, States 'Nothing Has Changed' Hollywood Kevin Feige Says MCU Still ‘Committed’ To Blade With Mahershala Ali Ridley Scott's Gladiator II FIRST Reviews Out: Critics Call Pedro Pascal, Paul Mescal Film A 'Thrilling Spectacle' Mission: Impossible – The Final Reckoning Teaser Trailer: Is Tom Cruise's Franchise Coming To An End? Beyoncé's Oscar Looks Over The Years Demi Moore's Style Shines With Effortless GlamThe 4:30 Movie - When Single Theatres Made Your Senses TingleLeonardo DiCaprio Turns 50: Why Titanic Star Was Glad He Didn't Win An Oscar At 19MTV EMAs Full Winners List Out! Taylor Swift Tops With Maximum NodsLeonardo DiCaprio's History Of Dating Young Girls, Full ListLast Week Tonight Host John Oliver Calls Donald Trump's US Presidential Win 'F***ing Crazy'Critics Choice Documentary Awards 2024 Full Winners List OUT: Super/Man, Will And Harper Tie For Best FeatureWhen Demi Moore Spoke About Posing Naked For Magazine Cover: Thank Goodness People Remember...'Zendaya's Audacious Clicks To Leave You STUNNEDJennifer Lopez Talks About 'Challenging Relationships' While Promoting New Film Unstoppable Amid Divorce With Ben AffleckLiam Payne Death: 31-Year-Old One Direction Singer DID NOT Die By Suicide, Confirms Argentine Authorities Korean BLACKPINK Tops November Brand Rankings: See the Top 10 Korean Girl Groups Min Hee-Jin To Lose House, At Risk Of Facing 100 Million Won Worth Property Seizure Amid HYBE Vs ADOR Case BTS' Jimin Wins Best K-Pop Award At MTV EMAs 2024, Here's What Blackpink's Lisa Won Blackpink Lisa's FIRST Look In The White Lotus Season 3 Teaser Out! Fans Say, 'We Are Seated' Lisa To Stray Kids: K-Pop Artists Who Presented Their Creations For Grammys 2025GOT7 Leader JAY B To Drop His First Full Length Solo Album Road Runner On THIS DayDid BTS' Jungkook, V, Suga Dance On Shah Rukh Khan's Marjaani? Watch Viral VideoTell Me That You Love Me Actors Jung Woo Sung, Shin Hyun Bin Reject DATING RumoursHYBE Insider Reveals Shocking Details About Employee Dying From 'Overwork', ADOR CEO Claimed Death By Personal IllnessGrammys 2025 Nominations Snub BTS, Blackpink, Stray Kids, SEVENTEEN, K-Pop Fans Call Awards 'Rigged, Racist'Blackpink's Jisoo NOT Making Solo Comeback, Would Rather Focus On Acting. Deets About Her Upcoming K-Dramas, FilmBTS Jungkook's I AM STILL Gets OTT Series Version. Here's When And Where It'll Start StreamingBTS' V Announces New Song White Christmas With Late Bing Crosby. ARMY Begins Release Countdown - 'Best News...'Blackpink Jisoo, GOT7 Jinyoung Support NCT Doyoung's New Single The Story, 'Inkigayo Siblings' Leave Fans In MeltdownBTS' Jimin's Handwritten Letters, Lyric Notebooks And More To Be Put On Display At Los Angeles Exhibition Telugu Director Krish Jagarlamudi And Priti Challa Tie The Knot 22 Years Of Prabhas: First Pan India Superstar And Undisputed Box Office Phenomenon Prabhas's Film 'Kalki 2898 AD' To Release In Japan On January 3, 2025 For Shogatsu Allu Arjun's 'Pushpa 2: The Rule' Trailer To Be Launched In Patna On November 17 Kalki 2898 AD Director Nag Ashwin To Direct Alia Bhatt? Here’s The Truth‘Epic’ Is The Theme Of Vijay Deverakonda’s New KFC CommercialGame Changer Teaser Clocks 70 Million Hits; Ram Charan’s Film Generates Great BuzzRashmika Mandanna Radiates Warmth In Kubera New Poster! Movie's First Glimpse To Be Out SoonDirector Krish To Get Married To Dr Priti Challa; Wedding To Be Held In Hyderabad On November 11Hollywood Star Don Lee Shares 'Salaar Part 2' Poster, Fans Speculate His Role In The SequelIts Official: The Ravishing Sreeleela Is Set To Light Up The Screen In A Special Number With Allu Arjun In Pushpa 2: The RuleRashmika Mandanna Gifts Allu Arjun With Silver 'Good Luck’ Gift Ahead Of ‘Pushpa 2: The Rule’ ReleaseMatka Is Not A Socio-Political But A Commercial Mass Film: Varun TejRam Charan Attends 'Game Changer' Teaser Event In Lucknow 'Barefoot'Shoot Of Prabhas-Starrer 'Salaar Part 2: Shouryanga Parvam' Begins Tamil Did Nimrat Kaur Just REACT To Dating Rumours With Abhishek Bachchan? Latest Reel On 'Pakki Friendship' Goes Viral Kanguva Advance Bookings Are Promising! Suriya’s Film To Post Strong Numbers On Day 1 Kamal Haasan Requests Fans Not To Call Him Ulaganayagan Anymore, Decides To Drop All Honorary Titles Delhi Ganesh Last Rites: Indian Air Force Pays Tribute To Tamil Star And Former Officer. Watch Epic Trailer Of Suriya's Kanguva Raises The Hype!Delhi Ganesh Passes Away: PM Modi Fondly Remembers 'Illustrious Film Personality', Offers CondolencesKanguva Is A Remarkable Blend Of Prehistoric And Science Fiction: Producer K.E Gnanavel RajaKarthi, Sivakumar Among Other Celebs Pay Last Respects To Veteran Actor Delhi GaneshTamil Actor Delhi Ganesh Passed Away At 80; Family Shared An Official Statement About His DeathDhanush Directorial Idli Kadai Gets A Release DateWatch: Mannippu Song from Suriya's Kanguva Released!‘Thug Life’ First Look, Teaser Unveiled On Kamal Haasan‘s Birthday; Film To Release On June 5, 2025Happy Birthday Kamal Haasan: Shruti Haasan Pens Sweet Note For 'Appa', Calls Him 'Rare Diamond''Life Of Investigative Journalists Is Very Difficult,' Says Raashii Khanna As She Opens Up About Her Character In The Sabarmati ReportSuriya Says He's 'Manifesting' About Reuniting On-Screen With Wife Jyotika Kannada Bangalore Based Carnatic Singer-Flautist Varijashree Venugopal Bags Grammy Nomination Gumti Trailer Out: A Film Celebrating The Culture And Traditions Of The Kudubi Tribe Bagheera Box Office: Srii Murali Starrer Action Drama Poised To Become Top-Grossing Kannada Film In 2024 So Far Everybody Calls Her Lady Superstar: Real Star Upendra On Nayanthara In Netflix Documentary 'Nayanthara: Beyond The Fairytale' Maryade Prashne Film Team Celebrates Shankar Nag’s Anniversary As Chalakarana DinaacharaneRemembering The Maverick Genius Shankar Nag On His Birth AnniversaryJai Hanuman: Rana Daggubati Joins Rishab Shetty In Prasanth Varma's HanuMan SequelPrabhas, Hombale Films Sign Three-Film Deal Starting With Salaar: Part 2Kannada Star Shivarajkumar Confirms He Is In Treatment For Health Issues But Assures Fans He Is Fine‘Navagraha’ Experience Was Overwhelming, Both On And Off Screen: Sharmiela Mandre - EXCLUSIVESharmiela Mandre’s Latest Production ‘Adhirshtasaali’ Starring Madhavan To Hit Screens Soon - EXCLUSIVEI Am Finally Eating All That I Missed During The Making Of Bagheera: Srii MuraliI Will Definitely Work On The Sequel To Bagheera And This Time Will Wrap It Up In One Year: Director Dr Suri'Lining Up Celebs Will Not Help You...': Ricky Kej Shares 'Lesson' From US Election ResultsRishi-Starrer 'Rudhra Garuda Purana' Unveils New Song ‘Kann Munde Bandu’; Film Set For December 27 Release Malayalam Indrajith Sukumaran's Njan Kandatha Sare Cleared For Release With U/A Certificate Watch: Theliyaathe Nee From Naslen's I Am Kathalan Released Vineeth Kumar Is Playing Shajahan In Aashiq Abu's Rifle Club, Character Poster Released Sunny Wayne And Lukman Avaran's Turkish Tharkkam Gets A Release Date! Asif Ali's Kishkindha Kaandam OTT Release Date Announced!Suresh Gopi Shares Announcement On Ottakomban Amidst Speculation On His Acting CareerKanakarajyam On OTT! Where To Watch This Indrans-Murali Gopy FilmVishnu Agasthya Is Playing Godjo In Aashiq Abu's Rifle Club; Character Poster ReleasedSamadhana Pusthakam On OTT! Where To Watch This Comedy Drama FilmWatch: High Energy First Single From Basil Joseph-Nazriya's Sookshmadarshini is Out!With An Impressive Cast Line Up, Lijin Jose Directorial 'Her' Gears Up For Its OTT PremiereSecond Look of Suresh Gopi-Anupama Parameswaran'S JSK Released!Kansoochi Thumbaal Song From Sthanarthi Sreekuttan Is A Song About The Innocence Of Childhood LoveWatch: Music Video Of Kannale Song From Oshana ReleasedWatch: Mohini Music Video From Gaganachari Is Out! Movies Amaran The Sabarmati Report Venom: The Last Dance Joker: Folie à Deux Raid 2Metro.... In DinoDevaGame ChangerLucky BaskharBaby JohnJolly LLB 3KingDhadak 2Housefull 5Devara Movie Review: Jr NTR And Saif Ali Khan's Action Thriller Is Not Engaging EnoughTrending:ICC Champions TrophyReliance Investment in APAir India Vistara FlightSuryakumar YadavDelhi AQIDonald TrumpBengaluru Hotel Bomb11:11 Manifestation PowerMaharashtra Election Candidates ListProperty Market Value CalculatornewsentertainmentkoreanBlackpink's Jisoo Starrer Influenza Is Now NEWTOPIA, Makers Release New Stills Of Zombie DramaBlackpink member Jisoo is returning to acting with the upcoming K-drama Newtopia. The Korean show, which was previously titled Influenza, is set to release in 2025. The makers revealed details about its plot along with new stills of Jisoo, and her co-star Park Jung Min known for Hellbound and Smugglers.Authored by: Mimansa ShekharUpdated Aug 1, 2024, 18:16 ISTJisoo plays an engineer in Newtopia. (Image Credit: Coupang Play)Blackpink's Jisoo starrer Influenza, is now Newtopia! The actor-singer's upcoming zombie apocalypse series has been renamed, its makers announced on Thursday through a press release. They also released the new stills from the project, which was wrapped up recently.Coupang Play confirmed the cast and title 'Newtopia', apart from its ensemble starcast. The images feature Jisoo and her co-star Park Jung Min of Hellbound and Smugglers fame in fresh looks.ALSO READ: Blackpink's Concert Film BORN PINK In Cinemas To Release In India On THIS DayNewtopia Wrapped-UpThe cast and crew of the much-awaited project celebrated its wrap-up during a special dinner on July 25. The team also shared pics from the K-drama's wrap-up party. In a blurry picture, Jisoo was seen holding a mic, seemingly giving a speech. This was days after the Blackpink star dropped a snap from the show's sets with the caption, "I finished filming. Thank you all for your hard work."Newtopia is directed by Yoon Sung-hyun, known for helming Bleak Night and Time to Hunt. The project marks his TV directorial debut.About NewtopiaJointly written by Han Jin-won (Parasite) and Ji Ho-jin (A Shop for Killers), Newtopia is set in the aftermath of a viral outbreak that transforms infected individuals into zombies. Jisoo and Jung Min play lovers who navigating a zombie-infested Seoul.While Jung Min encounters a zombie outbreak during his mandatory military service, Jisoo plays an engineer awaiting his release. Separately, the two cross the city desperately searching for each other amidst the chaos of downtown Seoul.Newtopia is expected to release in 2025.ALSO READ: Blackpink's Jisoo, Rowoon Make Special Appearance At Lovely Runner Star Kim Hye-Yoon's Fan Meeting. WATCHMore about JisooTaking a break from singing and her Blackpink activities, Jisoo is returning to acting with Newtopia. She is also set to make her big screen debut with Omniscient Reader's Viewpoint. The movie also stars Lee Min-ho, Chae Soo-bin and Ahn Hyo-seop.Get Latest News Live on Times Now along with Breaking News and Top Headlines from Korean, Entertainment News and around the world. Latest News Trending:Tom CruiseMission ImpossibleRupali Ganguly Defamation CaseBigg Boss 18Bhool Bhulaiyaa 3 Box OfficeSingham Again Box OfficeMimansa Shekhar authorA cinema nerd appreciating everything old school, Mimansa loves exploring behind-the-scenes world of movies and its histrionics, be it the black n whi...View MoreEnd of ArticleSubscribe to our daily Entertainment Newsletter!SubmitRelated News Sana Sultan Shares First Statement After Marriage, Reveals Sheru Was Gifted By Husband Mohammad WazidVeteran Bengali Actor Manoj Mitra Dies At 85 In KolkataWhen Janhvi Kapoor Visited Tirupati With Shikhar Pahariya On Mom Sridevi's Birth AnniversaryChildren's Day 2024: When Alia Bhatt Recalled Raha's First Kick, Said She Wouldn't Let Her Move Out At A Young AgeShah Rukh Khan Death Threat Case: Cops Grill Suspect From ChhattisgarhFollow us :Download AppTop TrendsChennai School HolidayDelhi Air QualitySuryakumar YadavAir India Vistara FlightReliance in Andhra PradeshICC Champions TrophySilver Price TodaySports NewsWorld NewsDelhi NewsTop SearchesHolidays in IndiaFestivalsGold Price TodayAadhaar CardPAN CardDriving LicenceVoter IDFuel Price in IndiaLiquor Age in IndiaChennai RainsEntertainmentBhool Bhulaiyaa 3 Vs Singham AgainBigg Boss 18Ranbir KapoorParineeti ChopraIndia's Best Dancer 4 WinnerLifestyle11:11 Manifestation PowerKartik Purnima 2024Mrunal ThakurMasterChef Sarah ToddBaby NamesCompanyAbout UsContact UsAdvertise with usRegulatoryTerms & ConditionsPrivacy PolicyDisclaimerComplaint RedressalSyndication And Partnerships© 2024 Bennett, Coleman & Company LimitedSwine flu toll 150 till June, up from 2023 tally of 129 | India News - Times of IndiaEditionININUSSign InTOIindiaSaving Our StripesTimes EvokeMaharashtraDelhiKarnatakaTamil NaduTelanganaUttar PradeshWest BengalGujaratMadhya PradeshBiharChandigarhRajasthanArunachal PradeshAndhra PradeshAssamChhattisgarhGoaHaryanaHimachal PradeshJammu KashmirJharkhandKeralaManipurMeghalayaMizoramNagalandOdishaPunjabSikkimTripuraUttarakhandAndaman Nicobar IslandsDadra Nagar HaveliDaman DiuLakshadweepPondicherryWeb StoriesToday's ePaperNewsIndia NewsSwine flu toll 150 till June, up from 2023 tally of 129TrendingIsrael Hezbollah WarTelangana School HolidayMark ZuckerbergHaryana Election ResultWomen T20 Match Dream11 PredictionDr Javed Akhtar MurderUGC Net ResultHaryana Assembly ElectionIsrael Hezbollah WarTelangana School HolidayMark ZuckerbergHaryana Election ResultWomen T20 Match Dream11 PredictionDr Javed Akhtar MurderUGC Net ResultHaryana Assembly ElectionIsrael Hezbollah WarTelangana School HolidayMark ZuckerbergHaryana Election ResultWomen T20 Match Dream11 PredictionDr Javed Akhtar MurderUGC Net ResultHaryana Assembly ElectionSwine flu toll 150 till June, up from 2023 tally of 129Durgesh Nandan Jha / TNN / Updated: Aug 1, 2024, 02:43 ISTShareAA+Text SizeSmallMediumLargeFollow us As of June 30, nearly 150 deaths due to seasonal influenza A (H1N1), also known as swine flu, were reported across India. Punjab, Gujarat, Haryana, and Maharashtra had the highest fatalities. Delhi reported 1,563 cases but no deaths this year. Surveillance continues to monitor potential virus mutations, according to Dr Neeraj Nischal of AIIMS Delhi. Swine flu toll 150 till June, up from 2023 tally of 129 NEW DELHI: As of June 30, nearly 150 people have died due to seasonal influenza A (H1N1), also known as swine flu, across India, according to data from the National Centre for Disease Control. Punjab reported 41 deaths, followed by Gujarat (27), Haryana (26) and Maharashtra (16). Delhi did not report any deaths this year, but did record 1,563 cases.Govt data recorded 7,215 cases of swine flu across India as of June 30.India reported 129 H1N1 deaths and 8,125 cases last year. In 2022, 410 deaths and 13,202 cases were reported.Swine flu is a contagious respiratory disease, transmitted through inhalation of contaminated droplets or is transferred from a contaminated surface to the eyes, nose or mouth of a person."Surveillance continues to spot any potential clustering of illness and unusual symptoms that may be caused by mutation in the virus causing the illness," said Dr Neeraj Nischal of AIIMS Delhi.End of ArticleFOLLOW US ON SOCIAL MEDIA Visual Stories Previous9 things that make Areca Palm the perfect indoor plantLifestyleSoaked moong dal benefits: 10 benefits for eating this energy powerhouse for breakfastLifestyleHow to make South Indian stye Paneer Dosa at homeFoodThe 8 perfect steps to grow âDhaniyaâ in the kitchen gardenLifestyle10 baby girl names that sound royalLifestyle15 Indian states and their famous state animalstravel10 delicious Indian dishes that can be made with raw bananaFoodHow to make protein-rich Lahori Paneer KormaFood8 fruits and veggies that can help get rid of eye glassesLifestyle10 green vegetables that have highest protein contentLifestyle Next123 Photostories â10 most educated countries of the worldâThe Great Indian Kapil Show 2:From high-end car collection to net worth, lavish apartment, farmhouse and more: Luxurious life of Kapil SharmaAnimal Park, Dhoom 4, Ramayana: 5 upcoming blockbuster movies of Ranbir Kapoor5 signs you are unknowingly being toxic to yourself, as per psychologyExclusive - Karan Veer Mehra on Asim Riaz's fight on Khatron Ke Khiladi 14: Not everyone can handle success; kitne Asim aaye chale gaye life khatam...From their moving-in together plans to Krishna Mukherjee hinting at the Bigg Boss couple'swedding next year; A look at Jasmine Bhasin and Aly Goni's emotional reunionWhere the zodiac signs would prefer to liveFrom being 3 months pregnant while sitting on the hotseat to her son calling Amitabh Bachchan 'dadu'; Shruthy Daga opens up about her 'arranged marriage', KBC14 Journey and moreBigg Boss Kannada 11: Full and final list of contestants5 traditional Indian hair oils for hair growth5 types of people one should completely avoid for peace in life, as per psychologyLaughter Chefs: From Bharti Singh- Krushna Abhishek getting emotional to Nia Sharma getting teary eyed on missing Sudesh Lehri: Top moments from the recent episode123Hot PicksIsrael Iran War LiveTom BradyHashem SafieddineTirupati Laddu Case HearingZoho CEOTaylor SwiftSean CombsTOP TRENDINGDeputy Speaker Narhari ZirwalPawan KalyanTamil Nadu School Bomb ThreatKing CharlesElon MuskHashem SafieddineHydrogen TrainFD RatesPM ModiPrince HarryTrending StoriesIn IndiaEntire WebsiteWho is Shailaja Paik, the Dalit Professor from the University of Cincinnati Recognized as a MacArthur Fellow?After 22-year wait, 30-year-old mows down father's murdererConpur: 'Time machine' offer makes Rs 35 crore vanish'Indian cricket ki dhaak ban chuki hai': Pakistan great admitsThree banks revise FD rates in October 2024: Get up to 8.05% interest on fixed deposits - check latest rates'Was screaming, hitting him': 5-year-old Florida boy suffers cardiac arrest on Disney rollercoaster rideVirat Kohli says rivalry against Australia was intense at the start, but now it has...King Charles misses 'darling boy' Harry but it is William who...WWE Stars Who Left Wrestling to Pursue a Completely Different Career: Batista, AJ Lee and more'I have lost this matchâ¦': When Sachin Tendulkar was 'weeping like a school boy' after India lost to PakistanWill Liz Cheney be Kamala's trump card?BJP eyes hat-trick, Congress a comeback as Haryana votes todayWhy this plot in Mumbai is expected to fetch â¹2,000 croreWill not allow anti-India acts on our soil: Sri Lanka presidentCriticism of government no ground for criminal case against scribe: SC'Today 5 people will die,' posted 'killer' before wiping out familyNew injection to cut cholesterol by up to 50% and other tips for healthy heartAmazon could cut 14,000 managerial roles'Disappointing but not ... ': India on fugitive Zakir Naik's Pakistan visitTop court declines to halt demolitions near SomnathAbout usCreate Your Own AdTerms of Use and Grievance Redressal Policy Privacy policyAdvertise with usRSSNewsletterFeedbackePaperSitemapArchivesFOLLOW US ONOther Times Group News SitesThe Economic TimesHindi Economic TimesNavbharat TimesMaharashtra TimesVijaya KarnatakaTelugu SamayamTamil SamayamMalayalam SamayamI am GujaratTimesPointsIndiatimesBrand CapitalEducation TimesTimes FoodMumbai MirrorBangalore MirrorMX PlayerHindi PodcastPopular CategoriesHeadlinesSports NewsBusiness NewsIndia NewsWorld NewsBollywood NewsHealth+ TipsIndian TV ShowsCelebrity PhotosTechnology NewsHot on the WebNavratri ColorsTriptii DimriAnanya PandayAnar BenefitsArjun KapoorVitamin B12Viral NewsGenelia DâSouzaAamir KhanShah Rukh KhanTop TrendsIND vs NZ Live ScoreBengaluru Collages Bomb ThreatSteve SmithNEET PG SC HearingMohammad KaifShailaja PaikHaryana Election ResultUGC NET ResultRishabh PantNima Hospital Doctor MurderTaylor SwiftThe RockWomen's T20 World CupTop MBA Colleges of IndiaT20 WC ScheduleWomen T20 World Cup Points TableLive Cricket ScoreTrending TopicsSamantha Ruth PrabhuNavratri Colours 2024Navratri Day 2 ColourTMKOC New SonuNaga ChaitanyaDevara CollectionGOAT OTT ReleaseRajinikanthDeepika PadukoneGovindaDevaraGovinda NewsDevara Movie ReviewHealthy RaitasSwatantrya Veer SavarkarColdplay India tour 2025Maa Durga 108 NamesNavratri JewellerySony Bravia 55 inch 4k Ultra HD TVWordle AnswerLiving and entertainmentETimesTravel DestinationsCricbuzz.comTVLifestyleNewspaper SubscriptionFood NewsTimes PrimeWhats HotServicesCouponDuniaTechGigTimesJobsBollywood NewsTimes MobileGadgetsCareersColombiaLatest NewsKolkataâs Ganga ghats transform into a hub of rituals with the arrival of DurgaNavratri Will Be Luckiest for These Signs5 corporate employees share their workplace horror storiesISL: Borjaâs left foot to Goaâs rescueNeelam Kothari speaks out against ageism says 'aunties' label is uncoolWill join NCP (SP) with supporters, says BJP leader Harshvardhan PatilManju Pavagada gets engaged in a close affair; pictures go viral on social mediaCommunity Connect: Hungry for connectionInsider Claims Nick Sirianni Plays 'Madden' with Eagles, While AJ Brown Is Celebrated as Jalen Hurts' SaviorKolkata shoppers flood markets ahead of Durga Puja weekend rushWWE Throwback: Shawn Michaels retires with a heartfelt speech after losing the âCareer vs Streakâ matchMysuru all set for a glittering DasaraSupreme Court dismisses pleas seeking review of sub-classifications in SC reservation judgment'Disappointing, condemnable but not ... ': India on fugitive Zakir Naik's Pakistan visitTechnological advancements have revolutionized cancer treatment, say doctorsPakistan seals off capital, suspends internet ahead of rally by Imran Khan's supporters'Brand of ISPL is growing': League's head of selection Jatin Paranjape"That was legit a thank you" WWE superstar reveals jaw-dropping gesture for AEW fans after historic returnCopyright Â© 2024 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication ServiceMSNStudy Shows Human Sickness Risk From Bird Flu-Tainted Raw Milk; Virus Is Infectious In Unpasteurized Milk For Five Weeks - The Japan News Please disable the ad blocking feature. To use this site, please disable the ad blocking feature and reload the page. This website uses cookies to collect information about your visit for purposes such as showing you personalized ads and content, and analyzing our website traffic. By clicking “Accept all,” you will allow the use of these cookies. Accept all Reject all Users accessing this site from EEA countries and UK are unable to view this site without your consent. We apologize for any inconvenience caused. Japanese SUBSCRIBE SIGN UP SUBSCRIBE SIGN UP Home Page Latest News Politics. Politics & Government Defense & Security Elections Political Series G7 Summit Society. General News Crime & Courts Imperial Family Obituaries Social Series Coronavirus Noto Peninsula Earthquake Business. Economy Companies Markets Business Series YIES World. US Presidential Election Asia - Pacific US & Canada Europe Russia Wider World Global News Services. Washington Post Associated Press Reuters AFP - Jiji Editorial & Columns. Yomiuri Editorial Political Pulse Insights into the World Cultural Viewpoints Outside Contributors Sports. Baseball Soccer Basketball Rugby Golf Tennis Sumo Figure Skating Other Sports Soccer World Cup Olympics & Paralympics Science & Nature. Science Technology Environment Climate Change Culture. Manga & Anime Film & TV Kabuki / Noh / Rakugo Performing Arts Art Fashion Music Books & Literature Museums JN Specialties. Perspectives Donald Keene’s Legacy Ramen of Japan Delicious Beautiful Spectacular JAPAN Decommissioning Fukushima Weekly Edition Vantage Point Video Features. Delicious Japan in Focus Travel Spots Troubleshooter Neko Pitcher Political Cartoons LOGIN SUBSCRIBE LOGIN SIGN UP MY ACCOUNT SUBSCRIBE MY ACCOUNT SIGN UP Latest News Politics Politics & Government Defense & Security Elections Political Series G7 Summit Society General News Crime & Courts Imperial Family Obituaries Social Series Coronavirus Noto Peninsula Earthquake Business Economy Companies Markets Business Series YIES World US Presidential Election Asia - Pacific US & Canada Europe Russia Wider World Global News Services Washington Post Associated Press Reuters AFP - Jiji Editorial & Columns Yomiuri Editorial Political Pulse Insights into the World Cultural Viewpoints Outside Contributors Sports Baseball Soccer Basketball Rugby Golf Tennis Sumo Figure Skating Other Sports Soccer World Cup Olympics & Paralympics Science & Nature Science Technology Environment Climate Change Culture Manga & Anime Film & TV Kabuki / Noh / Rakugo Performing Arts Art Fashion Music Books & Literature Museums JN Specialties Perspectives Donald Keene’s Legacy Ramen of Japan Delicious Beautiful Spectacular JAPAN Decommissioning Fukushima Weekly Edition Vantage Point Video Features Delicious Japan in Focus Travel Spots Troubleshooter Neko Pitcher Political Cartoons Home>Science & Nature>Science Science Study Shows Human Sickness Risk From Bird Flu-Tainted Raw Milk; Virus Is Infectious In Unpasteurized Milk For Five Weeks Post Share Post Yomiuri Shimbun file photoUniversity of Tokyo The Yomiuri Shimbun 12:20 JST, August 1, 2024 A study using mice suggests that consuming raw milk from cows infected with avian influenza poses an infection risk for humans. According to a team of researchers from the University of Tokyo and other institutions, milk from cows infected with the H5N1 strain of bird flu contained high levels of the virus, and mice that were fed the milk subsequently became infected. The team’s work was published in the U.S. medical journal The New England Journal of Medicine on May 24. In the United States, cows infected with the virus have been reported in nine states since March; some cases of infection in humans have also been confirmed. The research team examined milk from infected cows in the United States and found that the milk contained over 10 million particles of the virus per milliliter. Mice to which the milk was administered showed viral multiplication in organs throughout their bodies. The team heated one set of samples of the infected milk at 63C for 30 minutes and another set at 72C for 15 seconds. In both sets, the virus declined to less than 1/30,000 of its previous level. In unpasteurized milk from infected cows, the virus was found to remain infectious for five weeks, according to the team. “Humans could be infected with avian influenza after consuming unpasteurized milk,” said Yoshihiro Kawaoka, director of the University of Tokyo Pandemic Preparedness, Infection, and Advanced Research Center. “This is important information that all those concerned have been paying attention to,” said Yoshihiro Sakoda, professor of virology at Hokkaido University. “Pasteurized milk poses virtually no infection risk to consumers. But dairy farmers and people dealing with unpasteurized milk products need to take precautions.” Add TheJapanNews to your Google News feed. Science Latest Articles Scientists Rebuild the Face of 400-year-old Polish ‘Vampire’ Research: Phasing out Teen Smoking Could Save 1.2 Million Lives Back from Edge of Extinction, Frogs Begin Journey Home Oldest Tadpole from Dinosaur Times Found in Southern Argentina Latest Articles 2nd Ishiba Cabinet: How Long Will This Unstable Administration Co... Shohei Ohtani, Aaron Judge Headline List of MVP Finalists Typhoon Usagi Likely to Approach Okinawa on Sunday Shigeru Ishiba May Have Dozed Off During Diet Vote for Prime Mini... Popular Articles Streaming Services Boost Anime Popularity Overseas; Former 'Geeky... Japan’s Major Carmakers to Review Production Bases After Trump Wi... ‘Women Over 30 Would Have Uteruses Removed’; Remarks of CPJ Leade... Fed’s Rate Cut: With Future Uncertain, Vigilance Must Not Wane Japanese Companies Sprucing Up Employee Dorms to Attract New Work... Japan Patent Office Mulls Revising Laws to Cope With Digital Tech... ‘Zero Day,’ Drama Depicting China’s ‘invasion of Taiwan,’ Rings A... Why is an exit from deflation needed amid inflation? "Science & Nature" POPULAR ARTICLE Polish Families Pick through Debris after Floods Wash Away Homes Parkinson’s Patients to Receive Gut Bacteria Transplants, in Clinical 1st for Japan Ukraine’s Forests Devastated in Hellscape of War CO2 Capture Technologies Advancing with Eye on Climate Change; New Technologies Include Absorption Coating Compound for Concrete Osaka-Kansai Expo: Robot Avatars to be Operated by Online Visitors; Hopes to Show Barrier-free Future in Japan JN ACCESS RANKING Streaming Services Boost Anime Popularity Overseas; Former ‘Geeky’ Interest More Beloved Among Gen Z than 3 Major U.S. Sports JICA Employee Suspected of Leaking Info on ODA Project in Manila; Bidding for Railway Renovation May Have Been Impacted G20 Sees Soft Landing for Global Economy; Leaders Pledge to Resist Protectionism as Trump Calls for Imported Goods Flat Tariff Japanese Automakers Team Up on Software Development; Aim to Compete with U.S., China in SDV Market 2024 POLLS: Ruling Camp Likely to Win Lower House Majority The Japan News / Weekly Edition Our weekly ePaper presents the most noteworthy recent topics in an exciting, readable fomat. Read more eng jp Subscription of Newspaper Politics Society Business World News Services Editorial & Columns Sports Science & Nature Culture JN Specialties Features Video About us Membership Terms & Conditions Website Policies FAQ Advertise © 2024 The Japan News - by The Yomiuri ShimbunWellington nurse Maria Packe-Leonard’s funeral after flu death on hold as husband fights for life - NZ Herald MenuSearchSubscribeSign InHomeLatest newsVideoNew ZealandSportUS ElectionBusinessEntertainmentPodcasts & audioQuizzesOpinionLifestyleTravelVivaWeather forecastsSearchSubscriptionsHerald PremiumViva PremiumThe ListenerBusinessDeskSectionsLatest newsNew ZealandAll New ZealandCrimePoliticsEducationOpen JusticeScam UpdateWorldAll WorldAustraliaAsiaUKUnited StatesMiddle EastEuropePacificBusinessAll BusinessMarketsSharesCurrencyCommoditiesStock TakesCryptoMarkets with MadisonMedia InsiderBusiness analysisPersonal financeKiwiSaverInterest ratesTaxInvestmentEconomyInflationGDPOfficial cash rateEmploymentSmall businessBusiness reportsMood of the BoardroomProject AucklandSustainable business and financeCapital markets reportAgribusiness reportInfrastructure reportCompaniesAged CareAgribusinessAirlinesBanking and financeConstructionEnergyFreight and logisticsHealthcareManufacturingMedia and MarketingRetailTelecommunicationsTourismDeloitte Top 200 AwardsOpinionAll OpinionAnalysisEditorialsBusiness analysisPremium opinionLetters to the editorSportAll SportOlympicsParalympicsRugbySuper RugbyNPCAll BlacksBlack FernsRugby sevensSchool rugbyCricketBlack CapsWhite FernsRacingNetballSilver FernsLeagueWarriorsNRLFootballWellington PhoenixAuckland FCAll WhitesFootball FernsEnglish Premier LeagueGolfMotorsportFormula 1BoxingUFCBasketballNBABreakersTall BlacksTall FernsTennisCyclingAthleticsSailingAmerica's CupSailGPLifestyleAll LifestyleViva - Food, fashion & beautySociety InsiderRoyalsSex & relationshipsFood & drinkRecipesRecipe collectionsRestaurant reviewsRestaurant bookingsHealth & wellbeingFashion & beautyPets & animalsThe Selection - Shop the trendsShop fashionShop beautyShop entertainmentShop giftsShop home & livingMilford's Investing PlaceEntertainmentAll EntertainmentTVMoviesMovie reviewsMusicMusic reviewsBooksBook reviewsCultureReviewsBook reviewsMovie reviewsMusic reviewsRestaurant reviewsTravelAll TravelNewsNew ZealandNorthlandAucklandWellingtonCanterburyOtago / QueenstownNelson-TasmanBest NZ beachesInternational travelAustraliaPacific IslandsEuropeUKUSAAfricaAsiaRail holidaysCruise holidaysSki holidaysLuxury travelAdventure travelKāhu Māori newsEnvironmentAll EnvironmentOur Green FutureTalanoa Pacific newsPropertyAll PropertyProperty InsiderInterest rates trackerResidential property listingsCommercial property listingsHealthTechnologyAll TechnologyAISocial mediaRuralAll RuralDairy farmingSheep & beef farmingHorticultureAnimal healthRural businessRural lifeRural technologyOpinionAudio & podcastsWeather forecastsAll Weather forecastsKaitaiaWhangāreiDargavilleAucklandThamesTaurangaHamiltonWhakatāneRotoruaTokoroaTe KuitiTaumaranuiTaupōGisborneNew PlymouthNapierHastingsDannevirkeWhanganuiPalmerston NorthLevinParaparaumuMastertonWellingtonMotuekaNelsonBlenheimWestportReeftonKaikōuraGreymouthHokitikaChristchurchAshburtonTimaruWānakaOamaruQueenstownDunedinGoreInvercargillMeet the journalistsPromotions & competitionsOne Roof property listingsDriven car newsPuzzles & QuizzesPuzzlesAll PuzzlesSudokuCode CrackerCrosswordsCryptic crosswordWordsearchQuizzesAll QuizzesMorning quizAfternoon quizSports quizRegionsNorthlandAll NorthlandFar NorthKaitaiaKerikeriKaikoheBay of IslandsWhangareiDargavilleKaiparaMangawhaiAucklandWaikatoAll WaikatoHamiltonCoromandel & HaurakiMatamata & PiakoCambridgeTe AwamutuTokoroa & South WaikatoTaupō & TūrangiBay of PlentyAll Bay of PlentyKatikatiTaurangaMount MaunganuiPāpāmoaTe PukeWhakatāneRotoruaTairāwhiti / East CoastAll Tairāwhiti / East CoastGisborneWairoaHawke's BayAll Hawke's BayNapierHastingsHavelock NorthCentral Hawke's BayTaranakiAll TaranakiStratfordNew PlymouthHāweraManawatū - WhanganuiAll Manawatū - WhanganuiWhanganuiPalmerston NorthManawatūTararuaHorowhenuaWellingtonAll WellingtonKapitiWairarapaUpper HuttLower HuttNelson & TasmanAll Nelson & TasmanMotuekaNelsonTasmanMarlboroughWest CoastCanterburyAll CanterburyKaikōuraChristchurchAshburtonTimaruOtagoAll OtagoOamaruDunedinBalcluthaAlexandraQueenstownWanakaSouthlandAll SouthlandInvercargillGoreStewart IslandMediaVideoAll VideoNZ news videoBusiness news videoPolitics news videoSport videoWorld news videoLifestyle videoEntertainment videoTravel videoMarkets with MadisonKea Kids newsPodcasts & audioAll Podcasts & audioThe Front PageOn the TilesAsk me AnythingThe Little ThingsCooking the BooksCartoonsPhoto galleriesToday's Paper - E-editionsPhoto salesClassifiedsNZME NetworkAdvertise with NZMEOneRoofDriven Car GuideBusinessDeskNewstalk ZBWhat the ActualSunliveGisborne HeraldZMThe HitsCoastRadio HaurakiThe Alternative Commentary CollectiveGoldFlavaiHeart RadioHokonuiRestaurant HubNZME EventsSign InSubscribeAdvertisementAdvertise with NZME.Home / New ZealandWellington nurse Maria Packe-Leonard’s funeral after flu death on hold as husband fights for lifeBy Melissa NightingaleSenior Reporter, NZ Herald - Wellington·NZ Herald·30 Jul, 2024 11:52 PM4 mins to readSaveShareShare this articleCopy LinkEmailFacebookTwitter/XLinkedInRedditThe Black Ferns women's sevens side has struck gold in Paris, and an autopsy is underway on the remains of who police believe is Yanfei Bao. Video / NZ Herald / GettyWellington nurse Maria Packe-Leonard has died after catching influenza type A, though little more is known about why the virus turned deadlyHer husband, John Leonard, remains in an induced coma in the ICU as his body fights pneumonia and a blood infection caused by the illnessA funeral for Packe-Leonard is on hold while family wait to see if her husband will pull throughA Wellington nurse’s funeral after her death from the flu is on hold in hopes her critically ill husband will get well enough to attend with their two children.John Leonard is in an induced coma in Wellington Hospital’s ICU battling pneumonia and a blood infection, but brother-in-law Darrell Packe said there was a glimmer of hope as Leonard slowly became more stable.“The doctors have gone from talking in hours to talking in days, which is a good thing,” he told the Herald.Leonard’s wife, 53-year-old Maria Packe-Leonard, died on July 21, 10 days after developing influenza type A symptoms.AdvertisementAdvertise with NZME.AdvertisementAdvertise with NZME.A Givealittle page has been set up to support the family as they wait to see whether Leonard will pull through, and while they grieve Packe-Leonard.The otherwise fit and healthy nurse had gone to the hospital ED the day before her death and was checked over and discharged. The next day she was “a little bit better” in the morning, but went quickly downhill and succumbed to her illness.Packe said there was a preliminary report into her death but it said “bugger all” and did not shed any light on why the virus had hit her so hard.Shortly after Packe-Leonard’s death, her husband started deteriorating as well, Packe said.AdvertisementAdvertise with NZME.“We took him to the GP on Thursday... he left the GP with medication then on Friday his health had declined considerably so his youngest son phoned me and said we’ve got to get him to the hospital or a doctor or something. We got people to come and get him from the house and drive him down there quickly.”Leonard’s condition has been touch and go since then.“I guess with all these things when someone’s on life support... it’s all in balance, you know? Things change in hours, not days, so a state of flux, really.”Packe said the health staff used the term “unstably stable” previously, but things were becoming slightly more settled now.“His vitals are remaining in an acceptable range for longer periods of time. We are dealing with little bumps at the moment, little downs, not big downs.”Packe has been calling the ICU with the phone on speaker so the couple’s two sons, aged 14 and 15, can ask questions about their father’s condition.In a photo posted on Givealittle is Maria Packe-Leonard, 55, who died after a battle with flu. She is pictured with her two sons, who are now aged 14 and 15, and husband John. “I think with Maria passing, while he’s alive, there’s hope.”The family have put Packe-Leonard’s funeral on hold while they watch Leonard’s recovery.“What we’re hoping for is that he pulls through, gets well again, strong enough to attend a funeral with his boys.”Packe said the family was doing “pretty well, considering”.AdvertisementAdvertise with NZME.“We’re just having to deal with some hard stuff. Like everyone would be, we’re going through highs and lows.”The boys have been doing “very well” and Packe said the family were making sure to talk to them openly and encourage them to do what feels right, whether that meant going to school or staying at home in bed.“If they want to cry, that’s fine, if they want to laugh, that’s fine.“It’s been quite a journey with the boys. They are very special kids.”John Leonard is in the ICU at Wellington Regional Hospital. Photo / Mark MitchellPacke wanted people to know the boys had been watching the Givealittle page and were reading every comment that came in.“We’re watching that and it’s quite humbling. You see people put 100 bucks in and you see people put 5 bucks in. It all means the same to us.”AdvertisementAdvertise with NZME.The boys “get a buzz out of how many people are supporting them”.Packe also wanted to thank the community for the support they had received.“It’s been fantastic how the community has been around all this, I just want to reiterate all that.”Te Whatu Ora Capital, Coast and Hutt Valley group director operations Jamie Duncan said Packe-Leonard would be “deeply missed” as a nurse for the Lower Hutt area.“Maria was a popular and highly-valued member of our Capital, Coast and Hutt Valley whānau.”Duncan said they were supporting those who worked with Packe-Leonard closely.AdvertisementAdvertise with NZME.Melissa Nightingale is a Wellington-based reporter who covers crime, justice and news in the capital. She joined the Herald in 2016 and has worked as a journalist for 10 years.SaveShareShare this articleCopy LinkEmailFacebookTwitter/XLinkedInRedditLatest from New ZealandNew ZealandUpdated'Deliberate disruption': Auckland motorists fume ahead of rush hour hīkoi protest over harbour bridge12 Nov 06:11 AMNew ZealandGang patches in public places will not be tolerated when new laws begin, police say12 Nov 05:41 AMNew ZealandCeremony marks opening of 11 relocatable homes at Ōmāhu Marae12 Nov 05:30 AMSponsored: Make sure your valuables are coveredsponsoredAdvertisementAdvertise with NZME.Latest from New Zealand'Deliberate disruption': Auckland motorists fume ahead of rush hour hīkoi protest over harbour bridge12 Nov 06:11 AMHundreds of protesters have gathered on North Shore tonight ahead of tomorrow's march.Gang patches in public places will not be tolerated when new laws begin, police say12 Nov 05:41 AMCeremony marks opening of 11 relocatable homes at Ōmāhu Marae12 Nov 05:30 AMEmergency services responding to fire in Auckland suburb of Ōtara12 Nov 05:26 AMsponsoredOtago pinot leads NZ wine resurgenceNZ HeraldAbout NZ HeraldMeet the journalistsNewslettersClassifiedsHelp & supportContact usHouse rulesPrivacy PolicyTerms of useCompetition terms & conditionsOur use of AISubscriber ServicesNZ Herald e-editionsDaily puzzles & quizzesManage your digital subscriptionManage your print subscriptionSubscribe to the NZ Herald newspaperSubscribe to Herald PremiumGift a subscriptionSubscriber FAQsSubscription terms & conditionsPromotions and subscriber benefitsNZME NetworkThe New Zealand HeraldThe Northland AgeThe Northern AdvocateWaikato HeraldBay of Plenty TimesRotorua Daily PostHawke's Bay TodayWhanganui ChronicleVivaNZ ListenerWhat the ActualNewstalk ZBBusinessDeskOneRoofDriven CarGuideiHeart RadioRestaurant HubNZMEAbout NZMENZME careersAdvertise with NZMEDigital self-service advertisingBook your classified adPhoto salesNZME Events© Copyright 2024 NZME Publishing LimitedTOPAuthorities race to combat the threat of bird flu | The Saturday Paper The Saturday Paper The Monthly Australian Foreign Affairs SEARCH Subscribe LOG IN My Account Help Centre New Newsletter Preferences Font size Dark / light mode Log out Back ✓ YOUR ACCOUNT Latest Edition All Editions News Latest Politics Immigration Indigenous Affairs Economy Education Media Law & Crime Defence Religion Comment Latest Comment Paul Bongiorno Editorial Cartoon Letters Poem Culture Latest Profile Review Fiction Books Music Film Television Theatre Art Games Dance Poetry Life Latest Travel Technology Science Fashion Gardening Architecture Education Food Sport Puzzles Post Newsletters Podcasts More from The Monthly Australian Foreign Affairs</a> Schwartz Shop For subscription enquiries call 1800 077 514 or email [email protected]. Connect with us on News Comment Culture Life Sport Food Puzzles Newsletters Podcasts Editions SEARCH Log in August 3 – 9, 2024 | No. 511 August 3 – 9, 2024 | No. 511 News Comment Culture Life Food Puzzles Sport Newsletters Podcasts Editions August 3 – 9, 2024 | No. 511 News As Australian authorities battle to contain an outbreak of avian influenza, they are braced for the possible arrival of a subtype that is devastating bird and mammal populations overseas. By Bianca Nogrady. Authorities race to combat the threat of bird flu A pelican suspected to have died from H5N1 avian influenza on a beach in Lima. Credit: Ernesto Benavides / AFP SHARE Copy Link Facebook X Email LinkedIn The beaches of South America’s south-eastern and western coastlines are breeding grounds for sea lions. Every year, hundreds of thousands of these marine mammals converge in riotous crowds along the sandy and rocky beaches that stretch from Lima and Rio de Janeiro down to the southern-most tip of the continent. In early 2023, something went catastrophically wrong. Scientists visiting areas that should have been full of noisy, stinking sea lions and elephant seals found instead silent beaches. “Almost 20,000 animals that should be there were not there,” says virus ecologist Michelle Wille, a senior research fellow at Peter Doherty Institute for Infection and Immunity in Melbourne. “They just found carcasses and carcasses and carcasses on the beach.” Scientists report that at least 24,000 sea lions died in the region in the first few months of 2023. The culprit is avian influenza – also known as bird flu – and specifically, a deadly new strain called highly pathogenic avian influenza A(H5N1) lineage 2.3.4.4b. As well as decimating wild bird populations around the world, including tens of thousands of pelicans and hundreds of thousands of cormorants, the virus has jumped into mammals. Species ranging from foxes and cats to cows and polar bears are succumbing, from the Arctic to Antarctica. The H5N1 strain of bird flu has been around since 1959, when it was first detected in chickens in Scotland, and since then has caused many outbreaks in birds, and even human fatalities. This latest strain is unique, however, says virologist Kirsty Short, an associate professor at the University of Queensland. “It’s doing things that we have not previously seen avian influenza do before,” Short says. The virus has spread to both South America and Antarctica for the first time, suggesting it is highly transmissible among wild birds. https://youtu.be/il4wVh7ebX0 The spillover into mammals is also much more widespread. “In the US, where we’re getting spillover into dairy cattle, and now from the infection into dairy cattle we’re getting onward transmission to poultry but also to mammals on the farm,” Short says. “There’s been examples of cats on the farm being infected because they drank the infected milk from dairy cattle.” The virus has also infected a small number of humans, but there is no evidence of human-to-human transmission. There is, however, growing evidence to suggest it can spread between mammals. The one place H5N1 hasn’t yet reared its head is Australia. That might come as a surprise, given recent headlines about bird flu outbreaks in poultry farms in Victoria, New South Wales and the Australian Capital Territory. But there’s a very important difference between those two scenarios. The Australian bird flu outbreaks are caused by another group of avian influenza strains – the H7 subtype. Avian influenza H7 is a different beast to H5N1 – it has been lurking in Australian wild birds for at least half a century in a low-pathogenic form, causing little harm to wildlife. The only time it appears on the radar is when there is a crossover into chickens. For as-yet-unknown reasons, the low pathogenic H7 subtype in wild birds can mutate into a high-pathogenic subtype in chickens and this can trigger an outbreak among commercial poultry flocks. Outbreaks of highly pathogenic H7 bird flu have happened eight times in Australia since 1976. In many ways the latest outbreak, which began in May 2024 and has been caused by three H7 strains, is no different, says Brant Smith, national animal disease preparedness coordinator at the federal Department of Agriculture, Fisheries and Forestry in Canberra. “There’s only so many of us that work in this space ... it’s actually extremely important for the public to report any sick or dead birds that they see.” “It’s the biggest H7 outbreak we’ve had, and it certainly had an impact on egg supply and export because our threat- and disease-free status obviously changed,” Smith says. The timing of this H7 outbreak, appearing at the same time as H5N1 rampages around the world, is pure coincidence. H7 outbreaks tend to occur after periods of high rainfall – such as the recent run of La Niña-driven wet summers on Australia’s east coast – which lead to a boom in wild bird populations and create the right conditions for high levels of circulating low pathogenic H7 in native birds. The rise of free-range poultry farming is also a contributing factor, says Michelle Wille. “Free-range is not great for biosecurity,” she says. “You have your birds outside, how are you going to do biosecurity?” While it’s deadly in chickens, H7 doesn’t pose a threat to native birds, mammals or humans. Food Standards Australia New Zealand has reassured the public that eggs and cooked chicken meat are safe to handle and consume. The response strategy for this latest H7 avian influenza outbreak, developed by federal and state and territory governments and industry bodies, appears to be working. Affected farms have been quarantined and cleaned, flocks have been culled, and no new infections have been reported since July 10, Smith says, though “you can’t discount the fact that it can happen again, so it’s more of a ‘cautiously optimistic’ on that front”. What’s keeping Wille, Smith and many others up at night is the prospect of H5N1 2.3.4.4b arriving in this country. The news from conservation colleagues overseas is devastating, and “if this virus arrives here, it is unlikely to do anything different compared to what it’s been doing everywhere else,” Wille says. If the virus does come to Australia, it’s most likely to be brought by an infected migratory bird, says veterinary scientist Tiggy Grillo, national coordinator and chief operating officer of Wildlife Health Australia. Australia is an important destination for many migratory birds, some of which fly here from as far away as Alaska. However, that transmission to these shores is not as straightforward as it sounds. “Not only does the bird get infected, it needs to stay healthy to fly with the virus,” Grillo says. And not all migratory species are at risk. “The bird has to go through a location where the virus is currently active, so if they’re coming from a location in North Asia or from Alaska, and the virus isn’t active there at the minute, then they’re not being exposed.” With spring migrations just around the corner, Australia is on high alert for any signs of H5N1 in wild birds. Scientists such as Wille have been working to predict the most likely routes the virus would take to Australia, which helps to identify high-risk areas, and doing regular field testing of native birds to look for the virus. Wildlife Health Australia, a non-government agency that collaborates with government departments on wildlife health issues, has also produced toolkits to help groups working in the sector, such as wildlife managers, veterinarians and wildlife carers. The organisation also undertakes regular surveys of wild birds, in addition to the government’s own National Avian Influenza Wild Bird Surveillance Program. One of the most important elements in this surveillance is the general public. “There’s only so many of us that work in this space, but there are so many people that are out there bushwalking and enjoying the environment,” Wille says. The national emergency animal disease hotline – 1800 675 888 – is for public use, and “it’s actually extremely important for the public to report any sick or dead birds that they see”, she says. If H5N1 does get into Australia, it’s a much greater challenge to contain than H7 has been, because, unlike farmed chickens, wild birds can fly wherever they like. Biosecurity measures for potentially vulnerable areas will be important. “Someone might move it by walking around in one bird colony where they they’re not aware yet that it’s infected, and then they take their boots to another place,” Grillo says. Some affected regions overseas have restricted access to national parks in an effort to reduce the spread. It’s also important to reduce other stressors that can affect wild bird health, such as the risk of invasive predators, Grillo says. Other measures might include removing the carcasses of birds and animals that have died from the virus, to reduce exposure to other animals, but in a country the size of Australia, that could be logistically challenging. There is an animal vaccine against H5N1 but, again, the challenges of vaccinating wild birds mean that approach has only been used so far with extremely endangered species, such as the California condor and a trial on five New Zealand birds, including the kākāpō and takahē. As the United States’ experience has shown, H5N1 is a threat also to dairy cows, with 171 dairy herds affected so far. The good news, says Smith, is H5N1 symptoms in cows are generally mild and it doesn’t spread rapidly. He says it’s not going to lead to the nightmare scenarios seen with infections such as foot-and-mouth disease, “where you shut down the whole industry for a period of time”. For humans, this particular strain of H5N1 also appears to cause relatively mild symptoms, such as conjunctivitis. There have been 28 cases of human infection reported globally since 2021, most of which were not serious. Australia’s federal government also has a stockpile of vaccines and antiviral medication as part of its preparedness for possible spillover of H5N1 to the human population, and is currently updating national public health guidelines for the management of human cases associated with outbreaks of avian influenza. While the prospect of ecological devastation of Australia’s unique wildlife is terrifying, Grillo says Australia has a well-oiled mechanism for outbreak response. It’s not a certainty that H5N1 will make its way here, but authorities are bracing for it. “We could be really fortunate and miss this happening, but we still need to prepare.” This article was first published in the print edition of The Saturday Paper on August 3, 2024 as "Flight risk". For almost a decade, The Saturday Paper has published Australia’s leading writers and thinkers. We have pursued stories that are ignored elsewhere, covering them with sensitivity and depth. We have done this on refugee policy, on government integrity, on robo-debt, on aged care, on climate change, on the pandemic. All our journalism is fiercely independent. It relies on the support of readers. By subscribing to The Saturday Paper, you are ensuring that we can continue to produce essential, issue-defining coverage, to dig out stories that take time, to doggedly hold to account politicians and the political class. There are very few titles that have the freedom and the space to produce journalism like this. In a country with a concentration of media ownership unlike anything else in the world, it is vitally important. Your subscription helps make it possible. Subscribe Subscriber exclusive Send this article to a friend for free. Share this subscriber exclusive article with a friend or family member using share credits. Give this article Used 1 of ... credits use share credits to share this article with friend or family. You’ve shared all of your credits for this month. They will refresh on December 1. If you would like to share more, you can buy a gift subscription for a friend. SHARE WITH A FRIEND? CREDITS REMAIN SHARE WITH A SUBSCRIBERUNLIMITED Loading... SHARE COPY LINK EMAIL LINK USES 1 SHARE CREDIT CREATE SHARING LINK SHARE COPY LINK EMAIL LINK Share credits renew each month and allow a non-subscriber to read a full article. RELATED READING News Bird flu threatens Philip Island’s penguin colony Kate Holden An outbreak of bird flu threatens to reach the little penguin population on Phillip Island, as thousands of short-tailed shearwaters begin their migration to lay eggs. A plan is being made to protect the penguins, although it is currently secret. Bianca Nogrady is a science journalist and the author of Climate Change: How We Can Get to Carbon Zero. August 3, 2024 Give this article Used 1 of ... credits use share credits to share this article with friend or family. You’ve shared all of your credits for this month. They will refresh on December 1. If you would like to share more, you can buy a gift subscription for a friend. SHARE WITH A FRIEND? CREDITS REMAIN SHARE WITH A SUBSCRIBERUNLIMITED Loading... SHARE COPY LINK EMAIL LINK USES 1 SHARE CREDIT CREATE SHARING LINK SHARE COPY LINK EMAIL LINK Share credits renew each month and allow a non-subscriber to read a full article. SHARE Copy Link Facebook X Email LinkedIn Get the news you need to your inbox. SIGN UP Post Your daily source of news. 7am weekdays. The Saturday Briefing Editor's picks from The Saturday Paper. Every Saturday. 7AM Highlights The best of our daily news podcast, 7am. Selection once a fortnight. PREVIOUS ARTICLE TABLE OF CONTENTS NEXT ARTICLE August 3 – 9, 2024 | No. 511 Edition August 3 – 9, 2024 Edition No. 511 News Teals at risk in Goldstein, Kooyong, Mackellar and Curtin Jason Koutsoukis Exclusive: Border Force drones retired over security concerns Karen Barlow Making meaning of the reading wars Martin McKenzie-Murray Authorities race to combat the threat of bird flu Bianca Nogrady The lucrative business of trusts Mike Seccombe The community-led program that’s aiming to improve refugee settlement Cheyne Anderson Navigating a broken employment services system Rick Morton Hamas vows retaliation against assassination Jonathan Pearlman Comment The fledgling promise of Albanese’s Garma reset John Hewson Inflation scares and Albanese’s reshuffle Paul Bongiorno There are no more safe seats Richard Denniss Letters & Editorial JON KUDELKA CARTOON, AUGUST 3, 2024 Jon Kudelka Labor’s maybe Broader understanding Culture United Visual Artists founder Matt Clark Neha Kale STC’s Cost of Living Fiona Murphy The Bear’s season 3 Sarah Krasnostein Kerrie Poliness’s Non-Objective Wildflowers Carolyn Barnes HBO’s House of the Dragon Anthony Carew Freedom Catherine McKinnon Books Tintinnabulum Andy Jackson Bird Maria Takolander Slick: Australia’s toxic relationship with Big Oil Kurt Johnson Life Beef and seaweed soup O Tama Carey Reading and reckoning with Alice Munro Romy Ash The 2024 Paris Olympics so far Martin McKenzie-Murray The Cryptic Cryptic Crossword No. 511 Liam Runnalls The Quiz The Ariarne Titmus Competition Pool is located in which Australian city? Cindy MacDonald More from Author Bianca Nogrady is a science journalist and the author of Climate Change: How We Can Get to Carbon Zero. health November 2, 2024 Covid-19 inquiry finds key failings in pandemic response Bianca Nogrady A lack of planning for the worst led to Australia’s uncoordinated response to Covid-19, with a report recommending nine key pillars for an effective pandemic response. health August 24, 2024 Dispatch from the long Covid frontline Bianca Nogrady The acute phase of the Covid-19 pandemic might be over, but a lack of resources and knowledge continues to make the treatment of long Covid difficult. environment June 1, 2024 Fossil fuels are unreliable backstops in the energy transition Bianca Nogrady The decision to extend the life of Eraring’s power station is a sign of desperation as ageing fossil fuel plants contribute to gaps in supply amid a shortage of renewables. health September 2, 2023 The science on Covid boosters Bianca Nogrady As Covid-19 variants continue to outpace vaccines, and the risks of long Covid remain, the government needs to be prepared to act rapidly and at scale. health July 8, 2023 Pharmacy Guild’s bid to block prescriptions reform Bianca Nogrady The government’s reforms to raise dispensing limits on prescription drugs are aimed at making them more accessible and affordable – changes the Pharmacy Guild strongly opposes as a threat to their revenues. Editions View all editions Take a stand while sitting down. Subscribe to The Saturday Paper for less than $2.20 a week. SUBSCRIBE NOW Get the news you needto your inbox. SIGN UP Post Your daily source of news. 7am weekdays. The Saturday Briefing Editor's picks from The Saturday Paper. Every Saturday. 7AM Highlights The best of our daily news podcast, 7am. Selection once a fortnight. Account and Preferences Hello Reader You're not logged in. LOG IN Or subscribe here. Text size Dark and light mode Help Centre Manage Subscriptions Newsletter preferences Log out Add to homescreen Install app CLOSE Back to top Subscribe newsletters News Comment Culture Life Food Puzzles Sport Post Podcasts Editions SWIPE FOR MORE The Saturday Paper About Contact Advertise Editorial Guidelines Subscribe Forgot Password Help Centre Terms & Conditions Privacy Policy Career Find a Stockist Feedback More from Schwartz Media Read The Monthly Australian Foreign Affairs Listen 7am Podcast Read This Connect Get the news you need to your inbox. The Saturday Paper is a weekly newspaper, published 50 times a year by Schwartz Media. Subscriptions Phone 1800 077 514 Email [email protected] Editorial Email [email protected] © 2024 The Saturday Paper. All rights reserved.'Flunami' erupts in Queensland as hospitalisations soar and doctors hold crisis meetings | Daily Mail Online Home News Royals U.S. Sport TV Showbiz Femail Health Science Money Travel Podcasts Shopping Best Buys Discounts Black Friday My Profile Logout Login Breaking News Australia Video University Guide China Debate Meghan Markle Prince Harry King Charles III Weather Most read My Profile Logout Login Privacy Policy Feedback Tuesday, Nov 12th 2024 3PM 17°C 6PM 13°C 5-Day Forecast Advertisement I didn't think there was ANY problem carrying suitcases from Mexico for two guys I barely knew... they said it was just $250,000 in cash. I'm STUNNED it was actually £15m of cocaine - it's so unfair I face 60 years in US jail, says Brit beautician Revealed - Putin 'was so close to launching a nuke in Ukraine that British officials started preparing for the UK to be hit by the deadly fallout': Shock news comes as Russia 'plans to up drone attacks in coming days following US election' The Church of England's most prolific abuser John Smyth beat scores of boys till they bled. GUY ADAMS asks... why did no one in authority tell the police about the abuse by top barrister who exchanged Christmas cards with Justin Welby for years? EDEN CONFIDENTIAL: What made Harry Styles flee chef Jamie Oliver's £15m home? New 'gold' pill that could spell the end of hangovers: It sounds too good to be true, but scientists may have finally uncovered a way to enjoy alcohol without ANY harmful side-effects How a £400 brain zapper finally helped me conquer my depression: ANNE ATKINS suffered for 30 years and nothing worked - until she tried the headset now being rolled out on the NHS Two mothers who 'refused to quarantine' in hotels after flying to Dubai to get boob jobs face prison sentence after losing Irish court battle against Covid pandemic policy Phil Foden's party-loving mother blasted by neighbours for 'deafening Disneyland two-hour fireworks display' at her £3.5m Cheshire mansion 'that left pets and children in immense distress' Founder of world's oldest breastfeeding charity QUITS in protest at inclusion of transgender women - saying it has become 'a travesty' that 'indulges the fantasies of adults' Even the nepo babies are flocking to Australia! The celeb offspring who are joining exodus of Brits who prefer life Down Under Truth about your chances of surviving if you fall ill on a plane: A thousand people a year die due to medical emergencies on flights - and you might be alarmed at how little medical training most cabin crew have... ALAN MENDOZA: If Starmer really wants to stop illegal migrants, he should encourage the rest of the EU to follow Germany and bring back borders Parents' fury after school tries to 'ban' Christmas references from its festive pantomime so it can be 'inclusive' for children of all faiths Archbishop Justin Welby must quit after 'ignoring' child sex abuse by Church of England's most prolific attacker, say clergy and victims Kate's chic tweaks to refashion old looks: From velvet bows to hemlines and even a disappearing sari, how she makes recycled style look fresh off the catwalk NADINE DORRIES: Boris is the ONLY man who can help Labour work with Trump Plane passenger sparks fierce debate after sitting in between couple on three-hour flight Premier League footballer probed over rape claims after previously being arrested in February last year Ring-free Jessica Simpson hints Eric Johnson marriage is OVER as she says she 'put up' with things she 'did not deserve' The Skegness property gold rush: It's rated the world's worst holiday resort, but 'Skeggy' is now creating a new seaside millionaires' row to rival Sandbanks STEPHEN GLOVER: I believe Welby is a good man. But what kind of person rails against slavery while staying silent about a monstrous abuser? ROSS CLARK: This Net Zero crusade makes Britain a world beater - in pure lunacy Middle class misery SPREADS! After pan-demonium over Le Creuset sale, now Britain is running out of taramasalata! Here are the number of sit-ups experts say you should be able to do for your age Previous Next 'Flunami' erupts in Queensland as hospitalisations soar and doctors hold crisis meetingsAustralia is being slammed by a wave of illness It is affecting hospital bed availability READ MORE: Urgent warnings over 'super cold' striking Australia as disease expert Professor Peter Collignon says latest Covid strain may be a 'beat up' By PADRAIG COLLINS FOR DAILY MAIL AUSTRALIA Published: 04:07 GMT, 31 July 2024 | Updated: 23:39 GMT, 31 July 2024 e-mail 100 shares 263 View comments Queensland is in the midst of a 'flunami' as influenza cases place a strain on the health system as the authorities deny they have held crisis talks over a hospital beds shortage. The number of residents being hospitalised for the flu surpassed the number of patients being admitted with Covid for the first time this year. Queensland Health figures show that 257 people were hospitalised for flu as of last Sunday, five more than those with Covid, and more than 80 per cent of hospital admissions for flu are patients who have not been vaccinated. In the last week, 5,674 people were diagnosed with flu compared to 1,603 Covid cases, and there have been 37 deaths from flu already this winter.Of the flu cases, 1,521 were in school children, 630 cases in preschool and 644 cases for those aged over 65.Infectious diseases expert Dr Paul Griffin said the number of flu cases was straining the healthcare system.Queensland Chief Health Officer Dr Catherine McDougall, though, said 'While hospitals in south-east Queensland are under pressure from respiratory illness admissions, anyone presenting to our hospitals will receive care.'Our hospitals have well-established measures in place to manage surges in respiratory illnesses to ensure beds are available and patients continue to receive high quality care. Queensland is in the midst of a 'flunami' as influenza cases place a strain on the health system and authorities launch crisis talks over a hospital beds shortage (pictured, Surfers Paradise)'As is standard practice, meetings occur daily to safely and effectively manage any increases in patient demand.'Dr Griffin told Daily Mail Australia 'It is one of our lowest years of (flu) vaccine uptake, which, is a little disappointing. 'We lobbied very hard to get the the vaccine funded ahead of time for everyone, and the government, to their credit, did do that.'So in Queensland at the moment, it's free for everyone who's eligible. But despite that, we've actually seen fairly low uptake.'And in the context of the numbers (of people with flu) we're seeing at the moment and the impact on the healthcare system, that is quite disappointing,' he said. Dr Griffin said the lower than expected vaccine numbers have been caused by a few different factors. 'We've focused so much on Covid over the last few years - we've also asked a lot of people to to try and mitigate the the spread of Covid - and I think there's an element of fatigue and frustration with a lot of those measures.'He said that some people have lost sight of the significance of the flu.'We've been hearing so much about Covid numbers and the impact of Covid that people may have forgotten that the flu is around and is a very significant viral infection in its own right.'Misinformation about vaccination and its benefits and its safety has also transcended to other vaccines outside of Covid.Dr Griffin said people are thinking: 'What's the point? I wouldn't get that vaccine. It doesn't stop you getting it anyway.'But he said that is the wrong way to look at it. 'We know that the vaccine is not perfect. It doesn't necessarily absolutely stop you getting the flu,' he said.'But what it does do is significantly alter your trajectory and reduce the probability of getting more severe disease and requiring hospitalisation, for example. Dr Griffin said the lower than expected vaccine numbers have been caused by a few different factors (pictured, Aussie healthcare worker dressed in PPE)'We know the vaccine does do a great job of that.' He added that 'if our vaccine rates are low, then we have a population that's more susceptible to progressing to those more significant manifestations, requiring hospitalisation and potentially even not surviving'. All of the extra hospitalisations of people who did not get vaccinated is putting huge pressure on the health system.'The challenge is that our healthcare system essentially operates at capacity at baseline, so you add any additional challenges to that, and it does make it difficult,' Dr Griffin said. 'And at the moment, with high numbers of influenza hospitalisations (and) significant numbers of people in hospital with Covid and some other unique challenges, it has put a significant strain on our healthcare system ... 'There's essentially no (hospital) beds anywhere in south-east Queensland.'Epidemiologist Catherine Bennett also told Daily Mail Australia that 'it is a concern that we have seen a drop in flu vaccines'.She said part of the slow uptake of vaccines is because 'There were warnings early on that it wasn't quite as severe as people perhaps were expecting. 'So if that's usually a prompt for people to think about going and getting a vaccine back in April or May, maybe they've left it a bit late this year.'But we might be paying the price for that. It has played out as quite a nasty flu season across the country.' Share or comment on this article: 'Flunami' erupts in Queensland as hospitalisations soar and doctors hold crisis meetings e-mail 100 shares Bing Site Web Enter search term: Search DON'T MISS I'm A Celebrity 2024 lineup is CONFIRMED! Coleen Rooney and ab-flashing Tulisa get a jungle makeover in first look snaps Megan Fox is PREGNANT: Star expecting first child with Machine Gun Kelly as she debuts bump She's expecting Ariana Grande looks painfully thin in plunging dress at Wicked premiere after sparking concern over her dramatic weight loss EXCLUSIVECher: As I swore at the driver of a white convertible who had cut me up, I realised it was Warren Beatty. 'Do you want to come to my place?' he asked. I was 15... Iron Maiden star Paul Di'Anno's cause of death revealed after married father-of-six heavy metal singer passed away aged 66 Laundry legend or sock-shrinking disaster? Share this quiz with your loved ones so they can identify their bad household habits - and change them for good! Ad Feature I'm A Celeb's Coleen Rooney reveals vast list of instructions to look after her four children on two HUGE boards during her jungle stint Kate's chic tweaks to refashion old looks: From velvet bows to hemlines and even a sari, how she makes recycled look fresh Britney Spears reunites with son Jayden, 18, after years of estrangement and move to Hawaii Reestablishing their bond EXCLUSIVESuper soft hair in three easy steps: Simple routine provides up to 7x* more moisture for up to 72 hours** Ad Feature Revealed - six of the top-seven favourites to replace Gary Lineker on Match of the Day are women as BBC looks to reboot the show EDEN CONFIDENTIAL: What made Harry Styles flee chef Jamie Oliver's £15m home? Bizarre Liam Payne's $9,500-a-month mansion he moved into with girlfriend Kate Cassidy weeks before his death is back on the rental market Angelina Jolie looks chic in trench coat and black dress at Director's Guild in NYC as her biopic Maria garners Oscar buzz Find your inner glow: We asked one beauty writer to trial a new range of gentle skincare - here's how she got on Ad Feature Ben Affleck's son Samuel, 12, is the perfect mini-me of his movie-star mom Jennifer Garner Fans have been commenting on the likeness Nicole Kidman brings back her iconic curls as she leads the stars at the New York premiere of her new animated movie Spellbound Alec Baldwin and wife Hilaria bring six of their children to the Spellbound premiere in New York City Family posed on the red carpet Gary Lineker has been spotted for the first time since 'quitting Match of The Day': BBC star seen having a meal with family How understanding your glucose levels can help you feel less tired after meals Ad Feature EXCLUSIVEAerial photos show Leonardo DiCaprio's stunning eco-friendly compound is completed just in time for his 50th birthday Jennifer Lopez shares sweet snap with child Emme, 16, from Wicked premiere Megan Fox's miscarriage comments resurface after rainbow baby announcement with Machine Gun Kelly Maura Higgins enjoys final date night with new flame Pete Wicks before she heads to Australia for I'm A Celeb as a latecomer Looking to refresh your space before winter? Transform your home and interiors with these 10 top must-know brands Ad Feature Busta Rhymes praises 'superstar' Benny Hill as US rapper reveals he's a VERY unlikely fan of the saucy British comedian - after discovering him during childhood holidays in Morecambe Ralph Fiennes looks unrecognizable as he reunites with his The English Patient co-star Juliette Binoche for upcoming epic The Return Even the nepo babies are flocking to Australia! Celeb offspring join the exodus of Brits who prefer life Down Under EXCLUSIVETHE DUCHESS OF YORK: I'm on a mission to rid nappies of plastic - with my fifth grandchild on the way Damaged hair? Don't despair! With 1 billion bonds packed in every bottle, the NEW bond-building wonder product is here to help Ad Feature EXCLUSIVEPhil Foden's party-loving mother blasted by neighbours for 'deafening Disneyland two-hour fireworks display' Only Fools And Horses star Sir David Jason, 84, reveals he struggles to get parts because of his age Difficulties Her Majesty The Queen: Behind Closed Doors review: Camilla's personality shone, writes CHRISTOPHER STEVENS Martin Scorsese, 81, provides hilarious director's commentary on daughter Francesca's TikTok Riviera glamour, Ibiza nightlife and the most stylish ships at sea: Why THIS is the ultimate cruise for your adults-only Mediterranean escape Ad Feature Selena Gomez shares sweet reaction to boyfriend Benny Blanco making the Sexiest Man Alive list as she gushes about his 'unconditional' love Ariana Grande and Ethan Slater attend Wicked Q&A after it was revealed bosses hid romance over box office fears Gary Lineker 'will QUIT Match of the Day at the end of the season' after 26 years presenting the show EXCLUSIVEMelvin Odoom is the SEVENTH star to land in Brisbane ahead of I'm A Celeb - as jungle-bound DJ shares first impression of Australian weather Struggling to maintain your weight during menopause? You're not alone - here's why this happens and what you can do about it Ad Feature Nicolas Cage looks mysterious while dressed in character as he shoots upcoming Spider-Noir series on location in Los Angeles Coleen Nolan's son Jake Roche, 32, reveals he's going to be a dad in days as singer is forced to reschedule upcoming shows Chris Pratt and wife Katherine Schwarzenegger welcome their third child together and name has nod to JFK Pet Shop Boys star Neil Tennant slams current popular music as 'narcissistic and processed' as he throws shade at Oasis BUSTED! The career-myths that are holding you back from success Advertising Coleen Rooney wears £1,060 silk pyjamas to jet out of UK airport for I'm A Celeb as she makes the most of luxury items Aussie actress slams Rebel Wilson's 'absurd' claims she was sexually harassed by a producer on set of new film The Deb Popular British comedian and TV star shocks fans as he announces he's quitting Twitter for good Stepping back Kyle Richards 'terrified' to discuss 'evolving sexuality' with her kids amid Morgan Wade romance rumors EXCLUSIVEGive the gift of curiosity! Discover why the What on Earth! Magazine is the ultimate Christmas present for kids who love learning (and we have an offer) SHOPPING Khloe Kardashian shows off her 27inch waistline in see-through nude lingerie as she announces new brand Trim physique Inside Keith Urban's incredible $6.5m luxury car collection as his wife Nicole Kidman reveals the vehicle she likes to drive Austin Barnes and Matt Smith are surrounded by New York Mets fans on Caught Stealing set Channing Tatum enjoys a romantic stroll with co-star Kirsten Dunst on set of their upcoming film Roofman Benny Blanco sparks internet frenzy as he makes Sexiest Man Alive list amid Selena Gomez romance: 'He's redefining sexy!' Megan Fox fans notice very specific astrological detail about her pregnancy announcement post with MGK EPHRAIM HARDCASTLE: Why did the late Queen miss out on a Nobel Peace Prize for transforming the Commonwealth? Bad Sisters star Sharon Horgan says she is glad the show made women feel like they weren't 'f***ing crazy' EXCLUSIVEMariah Carey's 5.5 inch custom sandals were designed to dazzle with over 10,000 hand-applied crystals Nicole Scherzinger pictured wearing Kamala Harris shirt before 'coming out as a Trump supporter' Awkward MAFS UK's Polly Sellman and Adam Nightingale 'SPLIT' after explosive row as groom is branded a 'f*****g narcissist' Machine Gun Kelly's turbulent dating history laid bare as he prepares to welcome first child with Megan Fox Checkered past Bradley Cooper looks loved-up with Gigi Hadid in NYC after sparking shock with 'unrecognizable' face Smitten Who left the Big Brother house? Baked Potato is brutally sent home through the back door just days ahead of final Happy Monday's star Bez rocked out 'until 4am' after the MTV EMAs and 'showed Maya Jama how to party' Queen Camilla appears emotional as she speaks to domestic violence survivor in new documentary Powerful topic Keke Palmer claims costar made a racist remark to her on Ryan Murphy's Scream Queens series Allegations Coleen Rooney insists small food portions won't bother her on I'm A Celeb as she often 'misses a meal' and 'never gets hangry' Sting says Diddy allegations don't 'taint' Every Breath You Take - after disgraced rapper sampled song Nonplussed Kristin Chenoweth addresses Sean 'Diddy' Combs sex trafficking allegations with unusual response Rapper is under arrest The inventive way Megan Fox hid her baby bump at Halloween bash before pregnancy reveal with MGK Secret Yellowstone stars 'still processing' popular show's devastating ending - after bombshell season return Jane Moore shares the poignant reason she finally decided to say yes to I'm A Celebrity - and reveals her TWO big phobias The REAL reason Chris Martin kisses the tarmac before he flies after Coldplay frontman was seen planting his lips to the ground Leonardo DiCaprio rings in 50th birthday with Vittoria Ceretti, 26, at second star-studded dinner party Night out Loose Women icon 'set to reprise legendary role in Waterloo Road' as she returns to her soap roots Returning to the show Cast of iconic kids' TV show send fans wild with 'nostalgia overload' as they reunite 25 years after first episode Legendary Jeopardy! host Ken Jennings reveals major show update in off-camera admission He made an off-camera admission David Duchovny reveals 'failure of friendship' with The X-Files co-star Gillian Anderson amid tension on hit show Queen Camilla praised for 'moving' and 'powerful' ITV documentary on domestic abuse Positive response Legendary rocker hits back at John Farnham claim their former manager 'drugged me for years' Not happy EXCLUSIVEBrian Austin Green's surprising reaction to ex-wife Megan Fox's pregnancy with Machine Gun Kelly Unexpected Leggy Millie Mackintosh stuns in a black chic minidress as she joins husband Hugo Taylor at book launch As stylish as always Line Of Duty star Adrian Dunbar 'CONFIRMS' show's return: 'When they announce it, it's going to burn up the internet!' EXCLUSIVEWhat's really going with Euphoria? Cancelation rumors spark after Zendaya is cast in Christopher Nolan film Megan Fox and Machine Gun Kelly's ROLLERCOASTER romance timeline: From pregnancy to drinking each other's blood LL Cool J 'chased Monty Don to ask for a selfie as rapper reveals himself to be a VERY unlikely fan of the BBC horticulturist' GK Barry spills the beans on Ant McPartlin and Declan Donnelly's awkward Instagram gaffe - as she prepares for I'm A Celeb Cat Deeley is criticised by viewers after unfortunate gaffe during Remembrance Day segment on This Morning I'm A Celebrity's Tulisa admits she 'doesn't want to draw attention' in jungle by recreating Myleene Klass' bikini moment EXCLUSIVEThe real reason Ben Affleck always looks 'miserable' The actor always manages to look downcast Emily Watson catches the eye in a graphic gown as she joins chic co-star Olivia Williams at VIP screening of DUNE: Prophecy Megan Fox and MGK fans react to pregnancy reveal eight months after pair ENDED engagement Delighted How England Lioness Chloe Kelly went from goofy teen to glamorous red carpet regular - and the £350 beauty treatment she swears by Travis Kelce and Taylor Swift joined by surprise sports superstar in Chiefs VIP suite as new images emerge EXCLUSIVEColeen Rooney to be greeted by her four sons on the I'm A Celebrity bridge after husband Wayne is forced to stay behind Jessica Simpson hints Eric Johnson marriage is OVER as she admits she 'put up' with things she 'did not deserve' Lizzie Cundy, 56, puts on a leggy display as she follows in Jennifer Lopez's footsteps and undergoes a HydraFacial EXCLUSIVEBBC axes Paddy McGuinness comedy about his life and divorce amid concerns it would be 'insensitive' to his former wife Stephen Fry and Sophie Winkleman join host of celebs sending letter to Sadiq Khan demanding he change Tube's 5G advertising Luann de Lesseps, 59, reveals which A-List actor she made out with and how she is a member of the Mile High Club I'm A Celeb star Oti Mabuse reveals she is taking part on the gruelling ITV show to 'catch up on sleep' after giving birth to her first child last year Timothee Chalamet reveals the feature he was told would prevent him from succeeding in Hollywood Huge star The View panel fiercely defend Nicole Scherzinger over Russell Brand's election hat Speaking out Queen Silvia of Sweden stuns in deep purple ensemble as she joins King Carl XVI Gustaf for award ceremony in Stockholm Coleen Rooney gives a subtle nod to her Wagatha Christie trial against Rebekah Vardy as she prepares for I'm A Celebrity Strictly sends viewers wild as it reveals comedian ie FIRST confirmed for festive special as he jokes he's about to 'ruin Christmas' EXCLUSIVEColeen's one last night with Wayne! Rooney insisted on taking the last possible flight to Australia ahead of her I'm A Celeb stint Travis Kelce's ex Kayla Nicole makes wild accusation against Taylor Swift Nicole dated Kelce on and off for five years before his romance with Swift James McAvoy is seen for the first time on the Glasgow set of his new film California Schemin' about hoax rappers Silibil N' Brains EXCLUSIVEMadonna quietly splits from toyboy Akeem Morris It looks like Madonna is no longer crazy for her recent toyboy Demi Moore, 62, shows off her bikini body as she wishes 2lb dog Pilaf a happy birthday Kevin Costner breaks silence on Yellowstone's John Dutton being killed off in Season 5 part two premiere Cash-strapped Diddy is renting out his private jet for $432k-a-flight as sex trial looms Troubled rapper is trying to generate cash Benny Blanco dishes on VERY romantic mornings with Selena Gomez as he makes People's Sexiest Man Alive issue Katy Perry brutally trolled after sharing her pick for the year's best film Got more than she bargained for Prince Harry pens heartfelt message of 'admiration and appreciation' for his 'fellow veterans' on Remembrance Day Charles grins as he welcomes King of Bahrain to Windsor Castle with a warm hug Charles is hosting Hamad Bin Isa Al Khalifa As Philip Schofield lays his 'extraordinary loyal' mother Pat to rest, friends tell how she became his rock after his TV downfall, reveals KATIE HIND BBC drops first trailer for Return to Paradise and finally confirms release date for Death in Paradise spin-off series Coming soon The Wheel fans blast mortified Helen Flanagan for getting 'very simple' question wrong - but do you know the answer? Dexys Midnight Runners original member dead: Andy Leek passes away aged 66 following long battle with Parkinson's disease just days after tying the knot Shirtless Romeo Beckham shows off his ripped physique as he enjoys getaway with pals - after confirming romance with Gray Sorrenti Cher: The night I took a drunken John Lennon to the Playboy mansion - and he stripped stark naked in front of me in the infamous secret Grotto Barry McGuigan is the SIXTH star to touch down in Australia ahead of his I'm A Celeb stint and jokes he's 'there to sign his next big fighter' Ex Big Brother star Narinder Kaur faces furious backlash for saying Kate Middleton has 'aged so much' as princess returns to royal duties Gary Barlow is dwarfed by best friend musician Eliot Kennedy as the pair share a boozy bath on the Take That star's wine tour series Eamonn Holmes takes shocking swipe at GB News co-star's appearance as sexism debate takes personal turn - and she warns 'back off!' Laverne Cox breaks silence on whether she'll leave US after Trump's election win Opened up about the possibility of leaving Kourtney Kardashian and Travis Barker transform into Morticia and Gomez Addams for new Halloween posts Getting into character Damian Lewis is criticised for his conduct during Wolf Hall interview after he confessed the role has 'worn him down' Mission Impossible 8 FIRST LOOK: Tom Cruise's Ethan Hunt dangles from a glider in trailer as title for long-delayed conclusion is finally revealed Cruz Beckham, 19, and girlfriend Jackie Apostel, 29, enjoy another public display of affection as they share a passionate kiss Netflix fans rave over 'gripping' crime thriller based on true story 'full of twists and turns' - praising 'excellent acting and an unpredictable ending' Gladiator II review: This sequel falls short of its masterpiece predecessor but is still heaps of farfetched and ferocious fun Deal Or No Deal fans blast ITV bosses for 'killing' the show with big change to Stephen Mulhern's reboot Not happy Chappell Roan has shock four word response to report about her split from management Speaking out EXCLUSIVEPregnant Charlotte Dawson details how she's learning to forgive fiancé Matthew Sarsfield's sexting scandal as she insists that it would have been 'easier to walk away' Kristin Cavallari's ex Mark Estes 'proposes' to Love Island star after hanging out with former girlfriend Marriage plans Chris Evans continues to wow with bookish new look as he promotes Red One in NYC Looking good Yellowstone fans confused after Kevin Costner appears in credits for season five part two despite departure Melissa Suffield jiggles around in a pink bikini as she hits back at cruel trolls and urges to acknowledge the 'reality of everyday bodies' Kyle Richards gives BFF Teddi Mellencamp divorce advice amid Edwin Arroyave split At different stages in their divorces Paul Mescal reveals his 'heartbeat is going through the f***ing roof' as he arrives at the Gladiator II premiere in his hometown Dublin with his family Jennifer Meyer, 47, flashes her $500K diamond engagement ring from billionaire Geoffrey Ogunlesi, 33 Pricey Moment Laurence Fox rescued his fiancee's dog Rocky after pet Jack Russell got trapped in hole underground EXCLUSIVEI'm A Celebrity contestants are set to be battered by freak storms and torrential rain as bad weather threatens to 'ruin' the series Katie Price appears to reignite bitter feud with Emily Atack as she makes snide 'fishy' dig AGAIN in front of huge audience at The Clapham Grand The Day Of The Jackal star Ursula Corbero star sends fans wild with her racy social media snaps after revealing she was 'confused' by her 'weak' role Livid Loose Women fans urge James Martin to 'move with the times' after 'daft, money-wasting' cooking confession on ITV show Moment country star SCREAMS as she falls and takes out her guitarist mid-show Performing in Helotes, Texas on Friday Diana Vickers sets pulses racing in a skimpy gold bikini as she soaks up the sun on lavish Ibiza getaway Sofia Richie is 17 years YOUNGER than sister Nicole Richie but they look the same age in rare photo Raye and LL Cool J look all partied out as they leave Manchester after MTV EMAs - where the British singer was named Best UK & Ireland artist Michelle Keegan and Mark Wright enjoy Majorca getaway with Olly Murs after admitting they're in the 'boring phase of their relationship' Taylor Swift fans furious over savage Jeopardy! clue about Travis Kelce On the program's official Instagram account Iskra Lawrence is praised for sharing footage of her homebirth after welcoming baby daughter 'P. P' Wolf Hall leaves viewers 'traumatised' with 'brutal' execution scene just minutes into BBC premiere as they beg 'please don't show that again!' Rebekah Vardy sets tongues wagging as she packs for mystery trip abroad and posts a teasing emoji - as nemesis WAG Coleen Rooney jets off to Australia for I'm A Celeb Antiques Roadshow guest gasps 'I could cry!' as he learns staggering value of sculpture he bought for just £50 and was using as a DOORSTOP How Alison Hammond's turbulent love life influenced her debut novel, from cheating scandals to surprise encounters at a massage parlour Coleen Rooney jets to Australia ahead of I'm A Celeb stint and reveals nod to her family - as she prepares to join the five celebs who have already landed Brooklyn Beckham reveals his tattoo tribute to Quincy Jones and says he 'misses him more than he can imagine' after the legendary producer's death aged 91 Has Leonardo DiCaprio finally found love with Vittoria Ceretti and ditched his golden rule? A look at the star's relationships as he turns 50 The truth about how accurate that shocking Wolf Hall scene showing Anne Boleyn's execution really was Idina Menzel and Taye Diggs' son, 15, is nearly as tall as his mother as mother-son duo attend Wicked premiere Legendary Chicago singer-songwriter Ella Jenkins dead at 100 Mariah Carey will be 'quizzed under oath' over claims estranged brother sold drugs despite star still reeling from losing mom and sister on the same day Quincy Jones is laid to rest at private family funeral in Los Angeles a week after his death at age 91 Netflix fans furious as three whole episodes of blockbuster series are uploaded with no sound in 'crippling' blunder - raging 'I thought I was going mad!' Linda Lusardi gets £3.8k non-surgical face lift and says she feels '10 years younger' - after becoming 'depressed about her jowls' James Norton reveals he has put off having children 'because it wouldn't be fair to have them right now' as he details split from fiancée Imogen Poots Dwayne 'The Rock' Johnson finally addresses on set behavior controversy including 'peeing in bottles' Charli XCX leads the nominees at the Rolling Stone UK Awards with three nods as Raye and Dua Lipa are also honoured Movie director Cameron Crowe, 67, welcomes his 3rd child with publicist Anais Smith, 40 Liam Payne's 'drug dealer' speaks for first time: Argentinian waiter probed over One Direction star's death tells how singer took cocaine with him Robbie Williams announces three huge UK stadium shows as part of mammoth Live 25 tour Damian Lewis slams Donald Trump by comparing him to his Wolf Hall alter-ego Henry VIII as he claims he's become 'disillusioned to the people around him' Tulisa unveils club-themed home makeover complete with huge dressing room, home gym, a bridge that leads to nowhere Gayle King fans warn her to be 'careful' after CBS host admits 'stepping out' of her comfort zone with Shaboozey Yellowstone star Cole Hauser says it would be a 'shame to stop' telling the Dutton family story Ellie Goulding shares a rare snap of son Arthur, 4, and kisses him on the cheek as they adorably dress in matching Spider-Man costumes Sunday Brunch viewers bombard show with complaints just minutes into episode - sinking claws into 'boring and unfunny' Channel 4 scenes Ben Affleck is only 'one errant remark' away from being cancelled and believes the 'phone could stop ringing' despite his success Eddie Redmayne and Úrsula Corberó put on a steamy display as husband and wife in scenes from Sky TV's The Day Of The Jackal Jamie Oliver enjoys Coldplay concert with a female friend in Sydney - after he pulled his children's book from the shelves Mike Tyson has ditched veganism, is on a sex and cannabis ban and training six hours a day to prepare to fight 27-year-old Jake Paul Your turn next? Fans go wild for adorable photo of 'auntie' Taylor Swift posing with fellow Chiefs WAG's baby 'I thought to myself, what if it had been my daughter?' Queen Camilla praises mother of woman killed by her ex - and admits she wouldn't be as 'dignified' in the same position Friends fans complain of 'plot hole' in well-known episode which still 'drives them wild' 26 years later Strictly's Nancy Xu says she is 'gutted' that she and Shayne Ward will miss out on Blackpool and that she finds it 'unfair' that he was 'criticised' Geri Horner pulls series of animated facial expressions as she wraps up warm in stylish white outfit for autumn walk Ant McPartlin looks exhausted as he works up a sweat during gruelling workout ahead of I'm A Celebrity Ali Larter, 48, came to fame for her whipped cream bikini in Varsity Blues - see her now The truth behind Ben Shephard's This Morning absence revealed as ITV star fronts new project worlds away from daytime hit James Norton's surprising health battle - fans shocked to learn newly single Happy Valley hunk lives with deadly illness Lauren Pope kicks off festive season a little too early putting up her Christmas tree as she reveals she had anxiety about last year due to being a single mother Advertisement Follow DailyMail Subscribe Daily Mail Follow @dailymail Follow DailyMail Follow MailOnline Follow Daily Mail MORE DON'T MISS Radio 1 DJ Dean McCullough is the FOURTH star to arrive in Australia ahead of this year's I'm a Celebrity... Get Me Out of Here! How Sophie has become Kate's closest ally: 'Maternal' Duchess is a huge support to Princess of Wales - and it's come about because of void left by Meghan Furious Autumnwatch fans rage 'it's appalling and an insult to viewers!' as they skewer BBC for 'dumbing down' beloved nature show with complete overhaul Coleen Rooney reveals the secret to making her marriage with Wayne work as she confesses there were times she thought they wouldn't make it Emily Atack claims her party trick is 'worse than a one night stand' as she recalls the 'embarrassing' and 'horrendous' drunken night out Liam Payne larks about with close pal Rita Ora in unearthed video of them as the heartbroken singer pays tribute at the MTV EMAs Lorde shares a photo of a table littered with drugs and alcohol after celebrating her birthday Partied hard after celebrating with friends Keely Hodgkinson sparks concern as she displays her very sunburnt chest while posing in a tiny crop top during lavish holiday in Hawaii Tulisa reveals she'll QUIT showbusiness in the next two years despite wanting to relaunch solo career after I'm A Celebrity stint Major EastEnders 'Christmas spoiler REVEALED as actress accidentally leaves top secret script on train' Nightmare MTV VMAs worst dressed: Flamboyant outfits that fell flat as A-listers swarmed the red carpet in Manchester Olivia Rodrigo announced as fourth headliner for BST Hyde Park - as her support act is confirmed Kate's meaningful messages: How Princess of Wales used her outfits to pay tribute to Diana, the late Queen and her great-grandmother during Remembrance events BBC Breakfast in ANOTHER hosting shake-up as Jon Kay disappears from show without explanation The Penguin fans hail season one ending as 'the best thing DC has made' as Colin Farrell gives six-word response to calls for a second series Dancing On Ice's Vanessa Bauer says the show's new 24-hour bullying hotline is 'very necessary' ahead of its return in 2025 Viewers defend Boots' 'fabulous' Christmas advert starring Bridgerton's Adjoa Andoh after 'snowflake' critics blasted 'woke' plot Leomie Anderson ditches her gown for a VERY skimpy nude co-ord as she joins Love Island's Indiyah Polack and Maya Jama at MTV EMAs after party Shirtless Mark Wahlberg, 53, orders a trolley full of ice on room service as he continues his wacky health regime Sophie's been supportive from the start! Duchess helped an 11-year-old Princess Beatrice as she fainted on the balcony on Remembrance Sunday Listen as Katie Price performs her 2017 song I Got U at The Clapham Grand - so do you think her vocals make the cut? Strictly fans are left FUMING as they accuse Shirley Ballas of being 'biased' for sending home Shayne Ward in nail biting dance off Rita Ora breaks down in tears as she pays moving tribute to close friend Liam Payne at the MTV EMAs Emotional moment Kristina Rihanoff poses for incontinence pad campaign after she and husband Ben Cohen put their £1.75m home up for sale amid financial woes James Argent shares passionate kiss with new girlfriend Nicoline Artursson as besotted couple pack on the PDA for romantic Bonfire Night date Victoria Beckham displays incredibly toned figure as she poses for a mirror selfie - after husband David gave her new beauty product rave reviews Ice Spice flashes her abs in a cropped varsity top and low-rise pleated skirt as she steps out for dinner in Paris after performing her Y2K! World Tour Rita Ora leads the red carpet glamour in a pink feathered gown as she joins glamorous Maya Jama, Vick Hope and Raye at the MTV EMAs Bonnie Blue issues defiant message after her Australian visa was torn up - but there's a glaring problem with her new X-rated plan EXCLUSIVEKate Middleton's Remembrance Day pain: Emotional Princess of Wales appeared 'sad but regal' at Cenotaph, says body language expert Paddy McGuinness reveals he got 'choked up' over the huge support he's had for his 300 mile charity cycle challenge after feeling 'down and dejected' Rita Ora flaunts her jaw-dropping figure in ELEVEN incredible looks as she makes history as host of the MTV EMAs Raye leaves fans speechless with her vocals as she takes to the stage alongside Tyla and Shawn Mendes at the MTV EMAs Charli XCX is snubbed at MTV EMAs despite five nominations while Chappell Roan also leaves empty handed Ben Affleck looks miserable as 'spectacular' Jennifer Lopez shows him what he's missing on red carpet Sabrina Carpenter fan urinates all over the concert floor in San Francisco Ben Affleck treats his son Samuel, 12, to courtside seats at star-studded Lakers vs. Raptors game in LA Ariana Grande and Cynthia Erivo offer apologies for crying so much during Wicked promotion Kate wears Diana's ring in public for the first time since Christmas: Sapphire engagement ring is back after Princess opted to wear eternity bands during treatment Art Garfunkel recalls recent tearful reunion with Paul Simon after 'not seeing each other' for many years Margot Robbie shows off her midriff in a crop top less than a month after giving birth as she steps out in LA SPOILER ALERT: The real reason Yellowstone bosses sealed Kevin Costner's fate in first 30 seconds of bombshell season return Wolf Hall: The Mirror And The Light review: Cromwell's so menacing his glare could split a skull, writes CHRISTOPHER STEVENS MTV EMAs WINNERS FULL LIST: Taylor Swift dominates with FOUR gongs including Best Artist... while Raye and Tyla also win The White Lotus season 3 teaser shows first look at Blackpink's Lisa as hospitality host Keith Urban scrapes $600K Rolls Royce after dropping nepo baby Sunday Rose off at Billie Eilish concert Gavin Rossdale looks loved up with his Gwen Stefani lookalike girlfriend Xhoana X at MTV EMAs Happy Monday's star Bez causes CHAOS as he REFUSES to let go of the mic from Rita Ora in hilarious moment at MTV EMAs Nicola Peltz Beckham says her 'heart is shattered' in emotional tribute to Quincy Jones as she promises to look after his daughter Camila Mendes debuts bold new look as she gears up to film live-action remake of Masters Of The Universe Emmerdale's James Moore reveals future family plans after marrying partner Sophie Edwards as bride recalls their first date N-Dubz singer Tulisa Contostavlos is the third star to arrive in Brisbane ahead of this year's I'm a Celebrity... Get Me Out of Here! Coleen Rooney will NOT be reunited with Wayne after her I'm A Celeb ordeal' as football fixtures leave him grounded EXCLUSIVEColdplay frontman Chris Martin's bizarre act before boarding a plane out of Australia bound for New Zealand Who left Strictly Come Dancing? Shayne Ward's dancing journey is over after receiving the lowest results and landing in the dance-off against Wynne Evans Strictly Come Dancing RECAP as Shayne Ward is eliminated in week eight after losing dance off to Wynne Evans Nicole Kidman looks elegant in a black coat and dress as she heads out in New York City s EXCLUSIVEViewers insist star of Lidl's Christmas advert is the 'double' of Princess Charlotte - so, who is the royal lookalike? Felicity Jones cuts a chic figure in a black blazer and jeans as she addresses the audience at a screening for her new film The Brutalist Shawn Mendes dons smart suit at MTV EMAs in first red carpet appearance since addressing sexuality Zoe Saldana and Kerry Washington glow in silky tops as they lead the stars at ACLU Bill of Rights Awards Christina Ricci oozes business chic in blazer dress at book signing in LA for her new tarot deck and guidebook Fans inundate Bruce Willis's wife with messages of support after she shares 'heartbreaking' video Right behind her Pregnant Gisele Bundchen puts on a leggy display in tiny shorts as she leaves her old house in Miami Beach with a large box Bradley Cooper's unrecognizable face in snap with Gigi Hadid sparks social media confusion: 'Is that AI Bradley?' SPOILER ALERT: Yellowstone femme fatale Sarah Atwood's involvement in John Dutton's brutal death is revealed in Season 5 Part 2 premiere Joker 2 star says it is the 'worst film ever made' and that he and his co-stars knew it was 'going to bomb' while filming Michelle Keegan and Mark Wright show off VERY lavish Christmas lights and decorations at £3.5m Essex mansion Georgia Toffolo stuns in a sheer gown as she celebrates 30th birthday and proposal from James Watt with personalised beer Kim Kardashian embraces on-screen mother Glenn Close as they film Ryan Murpjy's new Hulu series All's Fair Ariana Grande fans point out NSFW error on Mattel's Wicked doll packaging - as collection risks mass recall Surfing royals: How Princess Diana sparked her sons' love for the ocean after Prince Harry recently rode waves in California and Prince William surfed chilly Scottish waters Rihanna looks totally at ease as she sits in front of her own Fenty Beauty ad at a bus stop in humorous post Halsey and fiancé Avan Jogia look loved-up at Lakers vs. Raptors NBA game in LA Prince Edward remembers 'all who have made the ultimate sacrifice' as he lays Remembrance Sunday wreath Big Brother viewers SLAM show's 'totally unfair' final twist just days ahead of grand finale: 'Sack whoever came up with this idea!' ROBERT HARDMAN: Courage of the Princess of Wales on parade - in a sign of what matters MOST to the royals Big target Khloe Kardashian throws niece Dream a soccer-themed 8th birthday bash No expense spared Jedward put on a VERY animated display in matching sequinned suits as they lark about on the red carpet at the MTV EMAs Rita Ora's proud mum Vera, 60, wears a chic black suit as she supports her daughter on the MTV EMAs red carpet Halsey and new fiancé Avan Jogia look loved up while enjoying a romantic lunch in NYC Yellowstone's surprising connection to Australia... and it's not actress Jacki Weaver Amelia Gray Hamlin puts on an edgy Y2K display in low-waisted jeans and busty tank top in Milan Elon Musk slams Dana Carvey's impression of him on post-election SNL and says show's been 'dying for years' Air Bud's Kevin DiCicco says he's homeless and dealing with major health problems James Bond fans have revealed the very unlikely Aussie who should play the next 007 Interesting choice Tulisa Contostavlos 'set to use I'm A Celebrity as launchpad for new solo career' as N-Dubz singer becomes third star to arrive EXCLUSIVEShe's the seductive 60s TV actress who was called the 'feline devil' by an iconic vigilante superhero - can you guess who? Bella Hadid flashes her incredible abs in tiny bikinis in racy photo dump from her recent trip to Dubai Looking good Adam Brody and Kristen Bell show off undeniable chemistry as they support Netflix's Nobody Wants This in LA Sam Thompson says he 'might get another bridge reunion' with Pete Wicks if he gets the axe from Strictly Come Dancing Kim Kardashian sports edgy black trench coat as she visits skin care clinic in Beverly Hills Jodie Turner-Smith sets pulses racing as she swaps her regal red carpet gown for skintight black PVC dress at the MTV EMAs Jada Pinkett Smith sparks health concern following rare date night with husband Will Smith The future's orange! Lorraine Kelly takes her adorable granddaughter to her first Dundee United game Proud granny Make breakfast TV great again! Eammon Holmes looks unrecognisable as he transforms into perma-tanned Donald Trump What Kate said to Sophie: Lip reader reveals conversation between Princess of Wales and Duchess of Edinburgh at Cenotaph Katherine Ryan, 41, puts on a busty display as she makes rare red carpet appearance with daughter Violet, 15, at the MTV EMAs Maya Jama channels Elizabeth Hurley as she slips into THAT career-making Versace safety pin gown to attend the MTV European Music Awards Lioness Chloe Kelly looks incredible in a cropped bandeau top and thigh-high boots on the red carpet at MTV EMAS What Taylor Swift told security guard: Pop star's cutting remark to her entourage during wild arrival to watch Travis Kelce Rita Ora shares a red carpet kiss with husband Taika Waititi ahead of her history-making THIRD hosting gig at the MTV EMAs Mariah Carey and son Moroccan dress up as Alvin and the Chipmunks for Halloween in rare family snap Venom 3 stays strong at the box office for third week in a row but new holiday film emerges to challenge it Gemma Atkinson turns heads in a busty leather dress as she poses on the MTV European Music Awards red carpet Travis Kelce sends girlfriend Taylor Swift wild as breaks Kansas City Chiefs history with another touchdown Jodie Turner-Smith puts on a show-stopping display in royal blue gown with a train and fascinator at the 2024 MTV EMAs SPOILER ALERT: Yellowstone fans furious over fate of Kevin Costner's John Dutton in Season 5 part two premiere Jeremy Clarkson WILL join protesting farmers at rally in Westminster this week after fears of 'police ban' Pregnant Charlotte Crosby shows off her baby bump alongside fiancé Jake Ankers at MTV EMAs in Manchester Mabel, 28, rocks a quirky checked dress as she joins her chic mum Neneh Cherry, 60, at the MTV European Music Awards Brooklyn Beckham goes for a spin in his classic Mustang in Los Angeles after adding another car to his impressive collection Emily Ratajkowski flashes leg in glam red coat as she walks her dog in New York City She looked super chic as she stepped out Vick Hope puts on a VERY leggy display in a racy thigh-high split skirt and sculpted bodice at the star-studded MTV EMAs James Norton admits split from ex-fiancée Imogen Poots was not his decision as he reveals heartbreaking reason they broke up Katie McGlynn puts on a VERY leggy display in a skimpy silver mini dress as she joins busty Liberty Poole at the MTV EMAs Aaron Taylor-Johnson cuts a debonair figure in a burgundy suit as he graces the red carpet at 2024 MTV EMAs Holly Hagan puts on a VERY busty display in a plunging gown as she cosies up to pregnant co-star Charlotte Crosby at MTV EMAs Tony Hinchcliffe breaks his silence on Trump election win after calling Puerto Rico a 'floating island of garbage' How to watch Yellowstone Season 5 Part 2 premiere in Australia as show begins new frontier without Kevin Costner . Brianna Chickenfry reveals why she won't get Zach Bryan lyric tattoo removed amid ugly split Interview Britney Spears claims was censored in 2016 is finally published Discussing her conservatorship EXCLUSIVEI'm A Celeb welcomes its first arrival! McFly star Danny Jones touches down at Brisbane Airport Taylor Swift's entourage get into heated altercation as she arrives to watch Travis Kelce and Chiefs Drama Leomie Anderson flaunts her jaw-dropping figure in a VERY skimpy tasselled gown as she poses up a storm on the MTV EMAs red carpet Netflix fans gripped by 'best show they've ever watched' - raving that crime thriller 'had them hooked just a few minutes in' EXCLUSIVEKelly Brook and her husband Jeremy Parisi land major ITV show deal after winning over viewers on BBC's Race Across the World Mel B shares a glimpse of her VERY organised shoe collection - after branding fellow Spice Girls 'd***heads' Raye puts on a very animated display as she stuns in a quirky bejewelled gown ahead of her performance at the MTV EMA's Pamela Anderson's secrets to embracing her natural beauty at 57: From sunrise walks to her no makeup rule and the one thing she avoids 'at all costs' Georgia Kousoulou shows off her bump in skintight dress as she celebrates her daughter's birth with 'dream baby shower' Gigi Hadid and Bradley Cooper enjoy date night as they watch Alyssa Milano performing on Broadway Molly Marsh dazzles as she shows off her enviable figure in sparkly burgundy dress at the MTV European Music Awards Katie Price jumps on stage during London drag competition and belts out her 2017 track I Got U - as she reignites celebrity feud Coleen Rooney suffers major blow ahead of I'm A Celebrity appearance as the first stars touch down in Australia EXCLUSIVEI'm A Celeb's Sam Thompson reveals he made emotional phone call to best pal Pete Wicks during thunderstorm-hit flight to Australia Chappell Roan 'parts ways' with her management team amid skyrocketing career Split Susan Sarandon admits she'll never work in Hollywood again and reflects on being dropped by her agent after Palestine remarks Pregnant Lottie Tomlinson cradles her bump in a stunning white dress as she celebrates her baby shower with twin sisters Phoebe and Daisy Noel Gallagher is 'working on a new album' with 'six tracks already in the bag' - but brother Liam is yet to contribute I was on The Undateables - the amount we actually got paid and how long it took to film a single date left me completely stunned . The Duchess of Edinburgh, 59, stepped into 'maternal' role at Cenotaph to help 'stoic' Kate Middleton - offering a supportive touch, says body language expert Leonardo DiCaprio ditches the models to party with his peers as he celebrates 50th birthday with Brad Pitt, 60, Paris Hilton, 43, Katy Perry, 40 and his long-time buddies Emmerdale's James Moore ties the knot with partner Sophie Edwards in emotional lakeside ceremony as bride reveals the soap star's heartfelt speech Kaia Gerber oozes glamour in Marc Jacobs gowns and opens up about her intellect being underestimated as she graces Vogue's December cover VERY dramatic exits! From Olivia Rodrigo disappearing through a hole to Gemma Collins' viral mishap - on-stage tumbles that will make you wince English acting legend is approached to be face of Marks & Spencer as bosses keen to sign 'chic, high calibre and sophisticated' star to evolve brand GMA host looks just like his famous father as he shares romantic proposal photos Will Reeve has made a made a big step in his life EXCLUSIVEZara McDermott will NOT be joining boyfriend Sam Thompson in Australia as he films I'm A Celebrity spin-off show Today's headlines Most Read I didn't think there was ANY problem carrying suitcases from Mexico for two guys I barely knew... they said... Putin was so close to launching a nuke in Ukraine that Britain was preparing for the fallout... as... The Church of England's most prolific abuser John Smyth beat scores of boys till they bled. GUY ADAMS... One of the founders of world's oldest Breastfeeding support charity QUITS in protest at inclusion of... New 'gold' pill that could spell the end of hangovers: It sounds too good to be true, but scientists may... How a £400 brain zapper finally helped me conquer my depression: ANNE ATKINS suffered for 30 years and... Two mothers who 'refused to quarantine' in hotels after claiming they flew to Dubai to get boob jobs could... Phil Foden's party-loving mother blasted by neighbours for 'deafening Disneyland two-hour fireworks display'... EDEN CONFIDENTIAL: What made Harry Styles flee chef Jamie Oliver's £15m home? Even the nepo babies are flocking to Australia! Celeb offspring join the exodus of Brits who prefer life... Truth about your chances of surviving if you fall ill on a plane: A thousand people a year die due to... ALAN MENDOZA: If Starmer really wants to stop illegal migrants, he should encourage the rest of the EU to... Parents' fury after school tries to 'ban' Christmas references from its festive pantomime so it can be... Middle class misery SPREADS! After pan-demonium over Le Creuset sale, now Britain is running out of... Kate's chic tweaks to refashion old looks: From velvet bows to hemlines and even a disappearing sari, how... NADINE DORRIES: Boris is the ONLY man who can help Labour work with Trump Plane passenger sparks fierce debate after sitting in between couple on three-hour flight Premier League footballer probed over rape claims after previously being arrested in February last year Jessica Simpson hints Eric Johnson marriage is OVER as she admits she 'put up' with things she 'did not... Strongman filmed lifting a Ford Transit van and pulled tractor with his bare hands while claiming car crash... STEPHEN GLOVER: I believe Welby is a good man. But what kind of person rails against slavery while staying... ROSS CLARK: This Net Zero crusade makes Britain a world beater - in pure lunacy World's oldest joke shop which supplied fake moustaches, magic wands and whoopee cushions to generations of... Here are the number of sit-ups experts say you should be able to do for your age The Skegness property gold rush: It's rated the world's worst holiday resort, but 'Skeggy' is now creating a... Terrified friends burned to death 'trapped inside crashed Tesla after its electronic doors failed' Apple quietly discontinuing flagship device due to lackluster sales More than 16,000 people object to 'outrageous' plans for Norfolk 'mega-farm' housing 870,000 chickens and... Daily guide to what the stars have in store for YOU - November 12, 2024 Revealed - six of the top-seven favourites to replace Gary Lineker on Match of the Day are women as BBC... Cher: As I swore at the driver of a white convertible who had cut me up, I realised it was Warren Beatty.... Mattel pulls hotly anticipated Wicked dolls from the shelves over X-rated error - and calls on fans to... Gary Lineker has shaped the football conversation for 25 years but his controversies got too much for the... Why Cadbury's Chocolate Fingers are changing hands in France for more than TWENTY times their retail price Stephen Fry and Sophie Winkleman join host of celebs sending bizarre letter to Sadiq Khan demanding he... I went to the Le Creuset sale and it was HELL, it was absolute chaos and organisers completely... OLIVIA DEAN: Why young Gen Z fans like me are swooning over Le Creuset? Hospice nurse reveals grim reality of what happens to human body minutes, hours and days after death Fury in Sweden at video of Syrian asylum seeker pushing a 91-year-old widow down stairs before violently... How England can fix their blitz to escape a Springbok onslaught after Australia exposed Steve Borthwick's... I'm A Celebrity's 2024 lineup is CONFIRMED! Coleen Rooney and ab-flashing Tulisa get a jungle makeover in... Melvin Odoom is the SEVENTH star to land in Brisbane ahead of I'm A Celeb - as jungle-bound DJ shares his... Maura Higgins enjoys final date night with new flame Pete Wicks before she heads to Australia for I'm A... I'm A Celeb's Coleen Rooney reveals vast list of instructions to look after her four children on two HUGE... Shock over woman with 'blackface' make up and cotton stuck to her at German carnival Why it's so dangerous for doctors to dismiss heavy periods as 'normal': They could be a sign of a more... Donald Trump to name Marco Rubio as Secretary of State Why a second Trump term will push America toward authoritarianism - and Ukraine may be the biggest casualty... Oprah Winfrey breaks silence on 'being paid $1million to support Kamala Harris' campaign Melania Trump snubs Jill Biden: First Lady makes revealing first move by skipping traditional White House... MORE HEADLINES Kate Middleton supporters slam TV presenter for 'disgusting' remark about Princess of Wales' appearance as she returns to royal duties after cancer treatment Liam Payne's 'drug dealer' speaks for first time and shares unseen photo: Argentinian waiter probed over One Direction star's death discloses new details about singer's last days and insists he did nothing wrong Fury in Sweden at video of Syrian asylum seeker pushing a 91-year-old widow down stairs before violently mugging her as she visits husband's grave The truth about how accurate that shocking Wolf Hall scene showing Anne Boleyn's execution really was Family of pharmacy student, 21, who killed herself after being wrongly told she had failed an exam hit out at university after 'totally unnecessary tragedy' Terrified friends burned to death 'trapped inside crashed Tesla after its electronic doors failed' PAN-demonium! Le Creuset sale sparks four-hour queue and police operation as hundreds of shoppers descend on warehouse to bag high-end luxury pot at cut price 'I have no regrets': Defiant council worker who was sacked for 'AdultHumanMale' instead of he/him tells how he's been forced to use his retirement savings to pay legal bill More than 3,000 privately-educated pupils applied to join state schools between June and September as Labour's VAT tax raid forces parents to pay extra £2,000 on fees I didn't think there was ANY problem carrying suitcases from Mexico for two guys I barely knew... they said it was just $250,000 in cash. I'm STUNNED it was actually £15m of cocaine - it's so unfair I face 60 years in US jail, says British beautician, 28 Jill Biden gives Kamala Harris the cold shoulder after husband Joe was forced out of race the VP lost to Trump Mother is torn apart by pack of wild dogs on her walk to work after making desperate last phone call begging for help One of the founders of world's oldest Breastfeeding support charity QUITS in protest at inclusion of transgender women - and says organisation has 'become a travesty of my original intent' Moment 'six-foot black cat stalks through UK field hunting prey' as locals reveal fears a 'panther' is on the loose BBC axes Paddy McGuinness comedy about his life and divorce amid concerns it would be 'insensitive' to his former wife Christine after their break-up Artisan potter wins bitter £300k four-year battle with painter neighbour over ownership of 4ft-wide stream dividing their gardens Trump border czar Tom Homan has a blunt message for his critics as he defends his mass deportation plan Football's shame as Remembrance Sunday silence is scrapped after nine seconds when Celtic football fans chant pro-IRA songs through it Why IS Starmer attending COP29 summit? PM faces demands for UK to pay into $1TRILLION climate fund as he heads to Azerbaijan despite leaders from US, Germany, EU, China and India staying away Woman loses £20,000 in fake TV licensing scam after conman fooled her into using WhatsApp screen sharing so he could see what was on her phone Donald Trump Jr suggests his President-elect father will cut off aid to Ukraine with meme telling Zelensky 'you're 38 days from losing your allowance' Primary school teacher, 57, took fatal overdose after being urged to 'find a new hobby' by her GP to battle her depression, inquest hears Keir Starmer and Emmanuel Macron's crisis summit on how to deal with Trump: PM and French leader plan for US trade war, the end of Pentagon defence handouts and Ukraine peace deal Trump announces his new 'border czar' Tom Homan to lead the biggest mass deportation in U.S. history Putin was so close to launching a nuke in Ukraine that Britain was preparing for the fallout... as intelligence sources say Russia is likely to up drone attacks in coming days following US election Mother, 54, who bled to death during botched gastric stomach operation in Turkey had turned to surgery because she could not buy another course of Ozempic, inquest hears Bonnie Blue issues defiant message after Australian authorities tore up her visa How undercover cops posing as lorry drivers pulled off Britain's biggest drugs bust EVER after finding two tonnes of cocaine worth £186m hidden in cargo of bananas from Colombia Pictured: Schoolgirl, 12, who tragically died after being hit by falling tree branch as devastated family pay tribute to 'shining light' Justin Welby 'has lost confidence of the clergy': Archbishop of Canterbury facing mounting pressure to quit for 'ignoring' sex abuse by Church of England's most prolific abuser School Head of English wants Shakespeare axed for GCSEs because it 'sends pupils and teachers to sleep' and TikTok and Instagram posts studied instead Moment girl wearing headphones is run over by a train while crossing tracks - and somehow survives with minor injuries Spirit Airlines flight forced to divert after being shot at while trying to land MOST READ IN DETAIL Advertisement NEW ARTICLESHomeTop Share Back to top Home News Royals U.S. Sport TV Showbiz Femail Health Science Money Travel Podcasts Shopping Sitemap Archive Video Archive Authors Topics Index Mobile Apps Screensaver RSS Text-based site Reader Prints Our Papers Top of page Daily Mail Mail on Sunday This is Money Metro Jobsite Mail Travel Published by Associated Newspapers Ltd Part of the Daily Mail, The Mail on Sunday & Metro Media Group dmg media Contact us How to complain Leadership Team Advertise with us Contributors Terms Subscription Terms & Conditions Do not sell or share my personal information About MailOnline Privacy Settings Privacy policy & cookies Advertisement AdvertisementTiny flyers with large impact: Blowflies carry bird flu virus | Research Results | KYUSHU UNIVERSITY Support Kyushu U 日本語 ENGLISH Prospective students Current students Companies & researchers Alumni Crisis Management News Events About Office of the President University Overview Kyushu U Connect Fast Facts Public Relations Featured Academics Schools & Centers The Global University Project Alumni Resources Donation Activities and Initiatives Future Plans University Facilities Academics Faculty of Arts and Science Schools Distinctive Education Programs Double Degree Programs Student Exchange Programs Short-term Study Programs The 3 Policies: Diploma, Curriculum, and Admissions Course Registration Academic Calendar Admissions Undergraduate Admissions Graduate Admissions Tuition, Fees & Scholarships Information for International Students Campus Life Facilities and Healthcare Extracurricular / Student-Led Activities Careers & Employment Procedures Contact Information for Consultations Research Research at Kyushu University Academic Staff Educational and Research Activities Database Research Activity Support Industry-University -Government Collaboration Support Research Centers and Projects Framework to Support Collaborated Research Research Integrity 日本語 ENGLISH News Topics Features Discover the Research Research Close-Up Notices Important Research Results Humanities & Social Sciences Art & Design Life & Health Math & Data Physics & Chemistry Materials Technology Environment & Sustainability Events Event Calendar Categories Public Seminar Lecture, etc. Exhibition Other Place Ito Campus Hakozaki Satellite Hospital Campus Chikushi Campus Ohashi Campus Beppu Campus Off Campus About Office of the President Message from the President Kyushu University VISION 2030 Biography Honorary Doctorates History of the Presidency Kyushu U Connect University Overview Organization Charter Presidential Selection Regulations and Policies History Future Plans Mid-Term Objectives and Plans Public Relations Publications Press Releases Promotional Videos University logomark List of Social Media Accounts Virtual Backgrounds Virtual Backgrounds (Archive) Featured Academics Campus Relocation Ceremony to Commemorate Completion of Ito Campus University Facilities Alumni Resources Alumni Associations Donation Donations to Schools, Graduate Schools, and Researchers, etc. Activities and Initiatives Promoting Diversity, Equity, and Inclusion QS-APPLE 2019 Response to the 2016 Kumamoto Earthquake Schools & Centers Research Institutes Centers for Common Education and Research Organizations and Offices Hospitals Libraries Museums Others Academics Faculty of Arts and Science Schools Educational and Research Course The 3 Policies Academic Calendar Course Registration Curriculum Registration / Syllabuses Distinctive Education Programs Program for Leading Graduate Schools Admissions Undergraduate Admissions Enrolling in Undergraduate School Applicants with Disabilities Graduate Admissions Applicants with Disabilities Enrolling as a Research Student Tuition, Fees, & Scholarships Tuition and Fees Enrollment Fee Exemption/Deferment and Tuition Fee Exemption for Newly-enrolled Students Scholarships Payment of tuition Tuition Fee Exemption, Enrollment Fee Exemption/Deferment Financial Aid Double Degree Programs Student Exchange Programs Campus Life Facilities and Healthcare Student Facilities Dormitories Healthcare Personal Accident Insurance for Students/ Liability Insurance Careers & Employment New Information How to use Job and Career Support System Career Consulting Job Hunting Support for International Students Recruitment of International Students Extracurricular / Student-Led Activities Procedures Certificates National Pension System for Students Contact Information for Consultations One-Stop Consultation Service Research Research at Kyushu University Humanities and Social Sciences Art and Design Life and Health Math and Data Physics and Chemistry Materials Technology Discover the Research Environment and Sustainability Research Close-Up Research Centers and Projects Next-Generation Fuel Cell Research Center (NEXT-FC) Research Activity Support On-campus Consultation Research Strategy Promotion Support for Research Funding and Grants Support for Other Research Activities Industry - University - Government Collaboration Support Technological Consultation Intellectual Property Management and Use Joint Research/Sponsored Research Comprehensive Collaboration Joint Research Department Research Integrity Framework to Support Collaborative Research International ･Prospective students ･Current students ･Companies & researchers ･Alumni ･Support Kyushu U Crisis Management ･Contact Us ･Visit ･Career ･Disclaimer & Copyright ･Privacy Policy ･Sitemap 研究成果 Research Results TOP News Research Results Tiny flyers with large impact: Blowflies carry bird flu virus Tiny flyers with large impact: Blowflies carry bird flu virus A new study from a wild bird colony in southern Japan reveals that blowflies are a potential means of bird flu transmission. Associate Professor Ryosuke Fujita Faculty of Agriculture 2024.08.01 Research ResultsLife & Health Fukuoka, Japan – Researchers from Kyushu University have discovered that blowflies, a family of flies strongly attracted to decaying flesh and feces, are carrying the bird flu virus in southern Japan. Their findings, published in Scientific Reports, introduce a potential new route of transmission for bird flu and highlight the need to develop new countermeasures to prevent and control the disease in poultry farms. Since 2020, bird flu has been spreading rapidly around the globe, leading to the death of millions of wild birds and the culling of more than half a billion farmed birds worldwide. In Japan, where a single case of infection on a poultry farm mandates the culling of the entire stock, the 2022-2023 winter season saw a record-high of 326 outbreaks of bird flu, resulting in the sacrifice of 17.7 million birds. Some strains of bird flu have also jumped to mammals, including cows, goats, dogs, cats, and since March, an uptick of cases in poultry and dairy workers, with a high fatality rate, has raised significant concern. "Bird flu has been causing substantial damage to wildlife and the poultry industry, and also holds great risk for humans who work closely with livestock. It’s therefore vital to understand how the virus spreads and its potential routes of transmission to control and prevent outbreaks," explains first author Associate Professor Ryosuke Fujita of Kyushu University’s Faculty of Agriculture. In this research, the scientists studied a wild crane colony in Izumi city, Kagoshima Prefecture, in southern Japan. In winter, the prime season for bird flu, thousands of cranes migrate to this area, with their dense numbers making them vulnerable to infection. During winter 2022-2023, 1600 cranes out of colony of 10000 cranes died from bird flu. Fig. 1. Transmission of bird flu from infected wild birds to other wild birds or poultry via blowflies. "We were notified about the cranes being infected and we had to act quickly,” says Fujita. Along with his colleagues, he set traps at different locations around Izumi city to collect blowflies. "We were particularly interested in one species of blowfly, Calliphora nigribarbis, as unlike other fly species, they are active in winter, coinciding with the peak season of bird flu. This, along with their attraction to the flesh and feces of animals, makes them a prime suspect for spreading the virus," adds Fujita. The researchers collected 648 blowflies and discovered that 14 blowflies were carrying the bird flu virus. The majority of virus-positive blowflies were collected from the sample site closest to the crane colony. "While 14 blowflies may seem like a low number, this represents a prevalence in blowflies of 2.2%, which is a huge percentage compared to other diseases spread by insects,” explains Fujita. The research team also used genetic testing to confirm that the blowflies were carrying the same virus strain that has been infecting the crane colony. Unlike birds and mammals which the virus infects and replicates inside, blowflies instead ingest the virus from infected dead birds or their waste, with the virus maintaining infectivity for up to two days. Blowflies are capable of flying at least 2 kms per day, so the researchers estimate that is it feasible for them to reach nearby poultry farms or other wild bird populations within a 4 km range. The researchers believe that as the blowfly moves from place to place, it could contaminate surfaces, food sources and water sources, with healthy birds becoming infected through direct contact with these contaminated sources, or by ingesting adult or larval blowflies. Fig. 2. Wild crane colony in Izumi City, Kagoshima, Japan. (Ryosuke Fujita, Kyushu University) In Japan, where farmers often use closed farming systems instead of open spaces to control infections and maximize production, countermeasures aimed at eliminating blowflies could be implemented fairly easily, helping to protect farmers from severe financial damage. "By keeping areas clean and using fly control methods, such as fine nets or insecticides, we can reduce the risk of virus spread to indoor poultry farms. However, in outdoor farms in other countries, and in wild bird populations, controlling blowflies may be logistically impossible,” says Fujita. Fig. 3. The blowfly, a potential means of bird flu transmission. (Ryosuke Fujita, Kyushu University) Having identified that blowflies carry the virus, Fujita and his colleagues are now collaborating with the government to capture blowflies in quarantined sites around infected poultry farms, hoping to find definitive evidence that blowflies are causing these outbreaks. Fujita and his colleagues are also developing new tools that use artificial intelligence to assess and predict the potential risks of vector insects. "By using advanced technologies alongside on-the-ground research, we can better understand and control the spread of bird flu and other insect-borne diseases, ultimately safeguarding both animal and human health,” concludes Fujita. (By Negar Khalili) ### For more information about this research, see Fujita, R., Tachi, T., Hino, M. et al. Blowflies are potential vector for avian influenza virus at enzootic area in Japan. Sci Rep 14, 10285 (2024). https://doi.org/10.1038/s41598-024-61026-1 Research-related inquiries Ryosuke Fujita, Associate ProfessorFaculty of AgricultureContact information can also be found in the full release. Kyushu U Connect Tweet Back to the list TOP News Research Results Tiny flyers with large impact: Blowflies carry bird flu virus Research Results Humanities & Social Sciences Art & Design Life & Health Math & Data Physics & Chemistry Materials Technology Environment & Sustainability Year 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 九州大学Kyushu University744 Motooka Nishi-ku Fukuoka 819-0395 Contact Us | Visit Career Academics Disclaimer & Copyright Admissions News Privacy Policy Research Events Sitemap Campus Life About COPYRIGHT © KYUSHU UNIVERSITY. ALL RIGHTS RESERVED.Flu Facts: How to protect yourself and your family from influenza - Sinar Daily Please Log In Focus National Politics World Money Deep Dive Politically Frank Exclusives Sports Special Reports Culture Personality Islamic Viral Entertainment Opinions Commentary Columnists Letters On The Ground Videos Podcast For You Contact Us Log In Sign Up Search Sinar Harian Sinar Plus Sinar Bestari Sinar Islam GE15 PRU Opinions Flu Facts: How to protect yourself and your family from influenza In countries with cold climates, such as those experiencing autumn, winter, and spring, influenza types A and B frequently cause seasonal epidemics. In contrast, in Malaysia's tropical climate, influenza can occur throughout the year. By AINUR FADLINA MOHD NADZIR 02 Aug 2024 04:40pm Source: 123rf A- A A+ Follow us on Instagram and Twitter for the latest updates. Subscribe to our YouTube Channel for more videos. INFLUENZA, commonly known as the flu, is a respiratory infection typically caused by influenza A, B, or C viruses. These viruses come in various subvariants, which is due to their continuous evolution. In countries with cold climates, such as those experiencing autumn, winter, and spring, influenza types A and B frequently cause seasonal epidemics. In contrast, in Malaysia's tropical climate, influenza can occur throughout the year. The flu virus spreads when an infected person coughs or sneezes, releasing droplets that others can inhale. It can also spread through contact with surfaces contaminated by the influenza virus. Symptoms and complications of influenza infection Anyone, including healthy individuals, can become infected with the influenza virus. However, studies show that certain groups are at higher risk for severe illness. These groups include older adults (over 65 years old), pregnant women, people with chronic conditions such as asthma, diabetes, and high blood pressure, as well as children under the age of five. Influenza symptoms often resemble those of a common cold. Typical influenza symptoms include fever, cough, sore throat, headache, muscle aches, and fatigue, which usually appear within one to four days of infection. Most people recover within a week, but some symptoms, such as cough and fatigue, can persist for more than two weeks. In high-risk patients, more severe symptoms may also occur. Influenza can also lead to serious complications, such as infections of the nose and ears. More severe complications can include pneumonia (lung infection), myocarditis (inflammation of the heart), encephalitis (inflammation of the brain), and kidney failure. Prevention of influenza Several preventive measures can help curb the spread of influenza. One key measure is the influenza vaccine, which aims to protect at-risk groups from infection. The vaccine works by stimulating the production of antibodies by the body to fight the virus. There are two main types of flu vaccines: the quadrivalent vaccine, which targets four virus subvariants, and the trivalent vaccine, which targets three virus subvariants. These vaccines are available at private clinics and hospitals. Since influenza viruses constantly evolve, an annual influenza vaccination is essential. Each year, the vaccine's composition is updated to protect against the latest and most common strains. Annual immunization not only reduces the risk of infection but also helps prevent severe illness and complications. Studies show that vaccination can lower the risk of illness by 40-60 per cent when the vaccine matches the prevalent strains. This is especially important for high-risk groups such as the elderly, young children, pregnant women, and people with chronic conditions. In addition to vaccination, maintaining good personal hygiene is crucial. The public should wash their hands thoroughly with soap and water or use hand sanitizer. Those who are symptomatic should wear a face mask in public and practice proper coughing and sneezing etiquette. Treatment of influenza In general, there is no specific treatment for influenza. Most treatments focus on alleviating the symptoms. For example, patients may receive antipyretics or painkillers to relieve fever and body aches, and antihistamines for cold symptoms. It is also recommended that patients drink plenty of fluids to prevent dehydration. If symptoms do not improve or worsen, patients should seek further treatment at the nearest medical facility. High-risk patients with severe flu symptoms may be treated with antiviral medicines to prevent complications. Antiviral medicines such as oseltamivir and zanamivir are used to treat the virus infection in high-risk patients. These drugs should be taken twice daily for five to ten days. Possible side effects of oseltamivir include nausea, vomiting, headaches, and stomach pain. Every individual can help prevent the spread of influenza In summary, influenza can be prevented through vaccination and other recommended preventive measures. Individuals showing symptoms should consult a doctor for further evaluation. If antiviral medicine is prescribed, patients should take it as directed. If there are any inquiries regarding medicines, please call the National Pharmacy Call Centre (NPCC) at the toll-free number 1-800-88-6722 during weekdays from 8am to 5pm, except on public holidays. Ainur Fadlina Mohd Nadzir is a pharmacist at Hospital Sultan Idris Shah, Serdang. The views expressed in this article are the author's own and do not necessarily reflect those of Sinar Daily. Follow us on Instagram and Twitter for the latest updates. Subscribe to our YouTube Channel for more videos. Prevention treatment influenza treatment of influenza protect yourself protect yourself and your family Flu Facts More Like This BRICS countries LETTERS Malaysia and BRICS: Balancing Global Opportunities and Challenges By PAUL ANTHONY MARIADAS AND UMA MURTHY 04 Nov 2024 12:13pm This could give Malaysia more autonomy in its foreign policy, allowing it to navigate between competing global powers more effectively. FILE PIX - The armed forces, police and other agencies scrambled to save those who were still trapped in their homes back in December 2021. (PHOTO BY XINHUA) LETTERS Northeast Monsoon is coming, are we prepared for it? By CHIA CHU HANG 04 Nov 2024 09:15am The government has approved multiple flood mitigation projects costing over RM10 billion that needs to be closely monitored to prevent corruption and ensure effectiveness. LETTERS The Travesty of Deferring the Social Work Profession Bill - A Plea to the Prime Minister of Malaysia We have been waiting for 14 long years for this Bill to be tabled. Not one year, or five or even 10 years, but 14 years. Illustration by Sinar Daily LETTERS Empowering Entrepreneurs: RM50 million Digital Matching Grant and new SME financing in Budget 2025 By SHERMAINE WONG 18 Oct 2024 08:54pm The RM50 million Digital Matching Grant and BSN’s Digital Grant aligns with the needs of modern-day content-preneurs. Read Full Article NEW Photo for illustration purposes only. Evolving reading habits call for blending digital and traditional library resources Defence Minister Datuk Seri Mohamed Khaled Nordin said the Investigation Board had completed its probe into the case, and the punishment for the cadet would be decided today. Photo by Bernama Cadet charged with injuring junior with steam iron faces expulsion from UPNM His Majesty Sultan Ibrahim, King of Malaysia, has urged the Defence Ministry to seriously address bullying cases at the Military Training Academy (ALK) of Universiti Pertahanan Nasional Malaysia (UPNM). - Photo by Bernama King wants defence ministry to address bullying cases seriously Mattel’s new 'Wicked' dolls have stirred controversy after a printing error on the toy packaging mistakenly directed customers to a pornographic website instead of the intended promotional page for the highly anticipated 'Wicked' movie. Photo: X Mattel recalls ‘Wicked’ dolls after packaging links to porn site Photo for illustration purposes only. - BERNAMA FILE PIX Challenges persist in elevating Orang Asli education amid isolation, limited support Most Read The alleged actions of seniors bullying juniors at UPNM have been considered a culture, under the justification of testing mental and physical resilience. Cadets turned blind eye to abuse - Former UPNM cadet Photo for illustration purposes only. Teenage Chinese national found dead in private school's carpark Photo for illustration purpose only. - File photo by AFP Neymar says Saudi Arabia can host exceptional FIFA World Cup in 2034 Syed Saddiq - File photo by Bernama Syed Saddiq gets temporary release of passport to attend forums in Jakarta Photo for illustration purposes only. - BERNAMA FILE PIX Challenges persist in elevating Orang Asli education amid isolation, limited support Contact Us Advertising Privacy Policy © 2024 Sinar Karangkraf All Rights ReservedAgriculture Victoria continues responding to avian influenza | Wyndham Home News Sport Lifestyle Galleries In Business More Star Weekly Find My Newspaper Brimbank & North West Maribyrnong & Hobsons Bay Melton & Moorabool Northern Sunbury & Macedon Ranges Wyndham Competitions Women’s Health Subscribe Digital Editions Classifieds View Search Photos Kids Advertise Contact Our Community Search Support quality local journalism Make a contribution Wyndham Subscribe Digital Editions Classifieds View Search Photos Kids Advertise Contact Our Community Home News Sport Lifestyle Galleries In Business More Star Weekly Find My Newspaper Brimbank & North West Maribyrnong & Hobsons Bay Melton & Moorabool Northern Sunbury & Macedon Ranges Wyndham Competitions Women’s Health WYNDHAM Home News Agriculture Victoria continues responding to avian influenza News Agriculture Victoria continues responding to avian influenza 03/08/2024 Facebook Twitter Email Agriculture Victoria is continuing to respond to the detection of high pathogenicity avian influenza at eight poultry farms in the state. (Unsplash). Agriculture Victoria is continuing to respond to the detection of high pathogenicity avian influenza at eight poultry farms in the state, with no new infected properties identified since 24 June. State government staff have completed more than 5000 surveillance activities, including property visits, phone calls and dead bird collections, and have tested over 16,300 samples. Agriculture Victoria staff are continuing to work with affected properties supporting decontamination, egg and litter disposal activities. A comprehensive surveillance program of all of the commercial poultry farms in the area is also underway. To manage the affected areas, a housing requirement is also in place, meaning all birds in the restricted area or control area near the infected properties must remain in their enclosures, to prevent contact with wild birds. State chief veterinary officer Dr Graeme Cooke said that bird owners provide essential support in preventing further outbreaks. “We appreciate that in these areas it’s not always easy to have your birds housed and we thank bird owners for their essential support to prevent the spread of this disease, as the risk of the disease remains,” Dr Graeme Cooke said. “I’d also like to acknowledge the poultry industry for their ongoing assistance as we work to eradicate avian influenza from Victoria,” he said. Infected properties continue to be decontaminated and the risk of infection removed, as Agriculture Victoria works towards achieving freedom of avian influenza for Victoria’s poultry industry. Agriculture Victoria has urged poultry farmers, backyard flock and bird owners to report any cases of unexplained bird deaths to the VicEmergency Hotline on 1800 226 226. While cases among humans in direct contact with animals infected with highly pathogenic avian influenza viruses are possible, the current risk to the public remains low. If you have had contact with birds on an affected property and you are experiencing cold or flu symptoms, call your doctor or the Department of Health. Details: agriculture.vic.gov.au/avianinfluenza. TAGSNews Facebook Twitter Email Previous articleLocals picked for combinesNext articleHelp fundraise for Red Nose Australia jimjin Digital Editions Latest Come catch a carp! 12/11/2024 Catch a Carp Day will be returning to Manor Lakes Reserve on Saturday, November 30, in a bid to tackle an invasive species. Hosted... WRA cleans up at awards 12/11/2024 Getting on the road with L2P 12/11/2024 Marcus out after 19 years 11/11/2024 Werribee pays its respects 11/11/2024 Subscribe Digital Editions Classifieds View Search Photos Advertise Contact About Our Community Home News Sport LifestyleGalleries Competitions Privacy Statement Privacy Policy Editorial Complaints Terms and Conditions © 2024 MMP Star Pty Ltd. All rights reserved Edit with Live CSS Save Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.H5N1 Insights IAS Brochure | OUR CENTERS Bangalore Delhi Lucknow Srinagar Dharwad HyderabadCall us @ 08069405205 Search Here Search Search Here SearchCall us @ 08069405205 Blog MENUMENUHomeAbout UPSCAn Introduction to the CSE ExamPrelimsMainsPersonality TestSyllabusAnnual Calendar by UPSC-2025BooklistsCommon Myths about the ExamFAQsWho We AreAbout Insights IASOur Mission, Vision & ValuesDirector's DeskBrochureMeet Our TeamOur BranchesCareers at Insights IASFree ResourcesCurrent AffairsDaily Current Affairs+PIB SummaryInsights into EditorialsSansad TVMindmapsInsta Revision Modules for PrelimsQuizzes(Prelims)Current Affairs QuizStatic QuizQUEDCurrent Affairs RTMInsta-DART(CSAT)Insta 75 Days Revision Tests for Prelims 2024MainsSecure (Mains Answer writing)Secure SynopsisEthics Case StudiesInsta EthicsWeekly Essay ChallengeInsta Revision Modules-MainsInsta 75 Days Revision Tests for MainsSecure (Archive)Analyticas: Optional SubjectsSociologyAnthropologyPSIRLaw OptionalKannada LiteraturePublic AdministrationGeographyPsychologyPhilosophyEconomicsHistoryEnglish LiteratureManagementMedical ScienceMathematicsCommerce & AccountancyCoursesDownloadsCurrent AffairsMonthly Magazine: CURRENT AFFAIRS 30Content for Mains Enrichment (CME)InstaMaps: Important Places in NewsWeekly CA MagazineThe PRIME MagazineInsights into EditorialsSansad TVMindmapsYojanaInsta Revision Modules-PrelimsInsta Revision Modules-MainsQuizzesCurrent Affairs QuizStatic QuizRTM QuizQUED QuizInsta-DART(CSAT) QuizInsta 75 days Revision Tests for Prelims 2022MainsInsights SECURE(Mains Answer Writing)Insta 75 Days Revision Tests for MainsInterviewInterview TranscriptsQuestions Papers & SyllabusPrevious Years' Question Papers-PrelimsAnswer Keys for Prelims PYQsSolve Prelims PYQsPrevious Years' Question Papers-MainsUPSC CSE SyllabusBooklistFAQsToppersToppers from Insights IASTestimonialsFelicitationUPSC ResultsInstapediaGeneral Studies – 1Indian Heritage & CultureAncient Indian HistoryMedieval Indian HistoryModern Indian HistoryWorld HistoryWorld GeographyIndian GeographyIndian SocietyGeneral Studies – 2PolityGovernanceSocial JusticeInternational RelationsGeneral Studies – 3EconomyAgricultureEnvironment & EcologyDisaster ManagementScience & TechnologySecurity IssuesGeneral Studies – 4Ethics, Integrity and AptitudeGalleryBlogOUR CENTERSBangaloreDelhiLucknowSrinagarDharwadHyderabadInsights IAS Brochure Facebook Instagram Telegram Youtube Twitter Podcast Posted on August 2, 2024 by Insights Editor mRNA vaccine development against human avian influenza (H5N1) Source: WHO Context: A new initiative to develop and distribute mRNA vaccines for human avian influenza (H5N1) in low- and middle-income countries (LMICs), in collaboration with the World Health Organization (WHO) and the Medicines Patent Pool (MPP). The project is part of the mRNA Technology Transfer Programme, established in 2021 to enhance vaccine production capacity in LMICs.Once successful, the knowledge and materials will be shared with other manufacturers to expedite vaccine development and strengthen pandemic preparedness.The initiative aligns with ongoing efforts to improve the sharing of influenza viruses and vaccine access under the Pandemic Influenza Preparedness Framework. The mRNA Technology Transfer Programme has already developed a platform for COVID-19 vaccine candidates, which is now being adapted for other diseases, enhancing global vaccine equity. H5N1 CategoriesINSIGHTS, Today's Article TagsGS3, mRNA vaccine development against human avian influenza (H5N1), SCIENCERelated Posts TagsGS3, mRNA vaccine development against human avian influenza (H5N1), SCIENCE Post navigationPrevious PostPrevious Nano-MIND technologyNext PostNext Krishna Raja Sagar (KRS) dam Insights IAS - Branches Bangalore ×3rd Floor, Nanda Ashirwad Building, Chandra Layout Main Rd, Maruthi Nagar, Attiguppe, Bengaluru, Karnataka 560040Google Map+ Delhi ×#B-10, 3rd Floor, Bada Bazar Rd, Old Rajinder Nagar, New Delhi, Delhi 110060Google Map+ Srinagar ×3rd Floor, Opposite Hotel Solar Residency, Aramwari, Pathanbagh, Rajbagh, Srinagar-190008Google Map+ Hyderabad ×1-10-209/1 Kamala towers , 1st floor above Punjab National Bank , Ashoknagar X roads, Ashoknagar Hyderabad 500020. Davanagere ×#1092 Jadhav Complex, Ring Road, Nijilingappa Layout, opposite to EDU ASIA School Davangere, Karnataka 577004About UsInsights IAS: Simplifying UPSC IAS Exam Preparation.InsightsIAS has redefined, revolutionized and simplified the way aspirants prepare for UPSC IAS Civil Services Exam. Today, it’s India’s top website and institution when it comes to imparting quality content, guidance and teaching for the IAS Exam. Popular CoursesFoundation Program: OGP (Offline & Online Guidance Program) Prelims Test SeriesIntegrated Prelims-cum-Mains (IPM) Test SeriesMains Test SeriesOptional Subjects Contact Us: Call us at 080 69405205 (toll-free)support@insightsias.comWant to work with us? Write to us atcareers@insightsias.com Copyright © Insights Active Learning HomeAbout UPSCAn Introduction to the CSE ExamPrelimsMainsPersonality TestSyllabusAnnual Calendar by UPSC-2025BooklistsCommon Myths about the ExamFAQsWho We AreAbout Insights IASOur Mission, Vision & ValuesDirector’s DeskBrochureMeet Our TeamOur BranchesCareers at Insights IASFree ResourcesCurrent AffairsDaily Current Affairs+PIB SummaryInsights into EditorialsSansad TVMindmapsInsta Revision Modules for PrelimsQuizzes(Prelims)Current Affairs QuizStatic QuizQUEDCurrent Affairs RTMInsta-DART(CSAT)Insta 75 Days Revision Tests for Prelims 2024MainsSecure (Mains Answer writing)Secure SynopsisEthics Case StudiesInsta EthicsWeekly Essay ChallengeInsta Revision Modules-MainsInsta 75 Days Revision Tests for MainsSecure (Archive)Analyticas: Optional SubjectsSociologyAnthropologyPSIRLaw OptionalKannada LiteraturePublic AdministrationGeographyPsychologyPhilosophyEconomicsHistoryEnglish LiteratureManagementMedical ScienceMathematicsCommerce & AccountancyCoursesDownloadsCurrent AffairsMonthly Magazine: CURRENT AFFAIRS 30Content for Mains Enrichment (CME)InstaMaps: Important Places in NewsWeekly CA MagazineThe PRIME MagazineInsights into EditorialsSansad TVMindmapsYojanaInsta Revision Modules-PrelimsInsta Revision Modules-MainsQuizzesCurrent Affairs QuizStatic QuizRTM QuizQUED QuizInsta-DART(CSAT) QuizInsta 75 days Revision Tests for Prelims 2022MainsInsights SECURE(Mains Answer Writing)Insta 75 Days Revision Tests for MainsInterviewInterview TranscriptsQuestions Papers & SyllabusPrevious Years’ Question Papers-PrelimsAnswer Keys for Prelims PYQsSolve Prelims PYQsPrevious Years’ Question Papers-MainsUPSC CSE SyllabusBooklistFAQsToppersToppers from Insights IASTestimonialsFelicitationUPSC ResultsInstapediaGeneral Studies – 1Indian Heritage & CultureAncient Indian HistoryMedieval Indian HistoryModern Indian HistoryWorld HistoryWorld GeographyIndian GeographyIndian SocietyGeneral Studies – 2PolityGovernanceSocial JusticeInternational RelationsGeneral Studies – 3EconomyAgricultureEnvironment & EcologyDisaster ManagementScience & TechnologySecurity IssuesGeneral Studies – 4Ethics, Integrity and AptitudeGalleryBlogOUR CENTERSBangaloreDelhiLucknowSrinagarDharwadHyderabadInsights IAS Brochure HomeAbout UPSCAn Introduction to the CSE ExamPrelimsMainsPersonality TestSyllabusAnnual Calendar by UPSC-2025BooklistsCommon Myths about the ExamFAQsWho We AreAbout Insights IASOur Mission, Vision & ValuesDirector’s DeskBrochureMeet Our TeamOur BranchesCareers at Insights IASFree ResourcesCurrent AffairsDaily Current Affairs+PIB SummaryInsights into EditorialsSansad TVMindmapsInsta Revision Modules for PrelimsQuizzes(Prelims)Current Affairs QuizStatic QuizQUEDCurrent Affairs RTMInsta-DART(CSAT)Insta 75 Days Revision Tests for Prelims 2024MainsSecure (Mains Answer writing)Secure SynopsisEthics Case StudiesInsta EthicsWeekly Essay ChallengeInsta Revision Modules-MainsInsta 75 Days Revision Tests for MainsSecure (Archive)Analyticas: Optional SubjectsSociologyAnthropologyPSIRLaw OptionalKannada LiteraturePublic AdministrationGeographyPsychologyPhilosophyEconomicsHistoryEnglish LiteratureManagementMedical ScienceMathematicsCommerce & AccountancyCoursesDownloadsCurrent AffairsMonthly Magazine: CURRENT AFFAIRS 30Content for Mains Enrichment (CME)InstaMaps: Important Places in NewsWeekly CA MagazineThe PRIME MagazineInsights into EditorialsSansad TVMindmapsYojanaInsta Revision Modules-PrelimsInsta Revision Modules-MainsQuizzesCurrent Affairs QuizStatic QuizRTM QuizQUED QuizInsta-DART(CSAT) QuizInsta 75 days Revision Tests for Prelims 2022MainsInsights SECURE(Mains Answer Writing)Insta 75 Days Revision Tests for MainsInterviewInterview TranscriptsQuestions Papers & SyllabusPrevious Years’ Question Papers-PrelimsAnswer Keys for Prelims PYQsSolve Prelims PYQsPrevious Years’ Question Papers-MainsUPSC CSE SyllabusBooklistFAQsToppersToppers from Insights IASTestimonialsFelicitationUPSC ResultsInstapediaGeneral Studies – 1Indian Heritage & CultureAncient Indian HistoryMedieval Indian HistoryModern Indian HistoryWorld HistoryWorld GeographyIndian GeographyIndian SocietyGeneral Studies – 2PolityGovernanceSocial JusticeInternational RelationsGeneral Studies – 3EconomyAgricultureEnvironment & EcologyDisaster ManagementScience & TechnologySecurity IssuesGeneral Studies – 4Ethics, Integrity and AptitudeGalleryBlogOUR CENTERSBangaloreDelhiLucknowSrinagarDharwadHyderabadInsights IAS BrochureSri Lanka seeing influenza spread among children: Doctor | EconomyNext An Echelon Media Company Tuesday November 12th, 2024 All Sections All Stories Brand Voice Video Economy Fiscal Trade Monetary General Economy Opinion Bellwether Op-ed/Special Reports Finance Banking Insurance Markets Bonds & Forex Commodities Stocks & Companies Politics Political News Defence legal Logistics Shipping Ground Aviation Energy Petroleum Power tech ICT Environment Science world International news South asia culture People Lifestyle Sports video & infographics Video Info graphics Slideshows miscellaneous Offbeat Namal Suvendra business Apparel Construction and Real Estate Fisheries Tea Tourism Education General Industry Agriculture General Services | Home All Stories Economy Opinion Finance Markets Politics Business Video Brand Voice Health Sri Lanka seeing influenza spread among children: Doctor Tuesday July 30, 2024 12:40 pm Tuesday July 30, 2024 12:40 pm ECONOMYNEXT – A pediatric specialist at the Lady Ridgeway Children’s Hospital in Colombo has warned that influenza types A and B and an upper respiratory viral fever are spreading among children in Sri Lanka. Pediatrician Dr Deepal Perera has urged parents to be aware of flu like symptoms, including fever with headache, cough, cold, sneezing, body aches, difficulty in breathing and vomiting. “If such symptoms spread quickly in classes and day care centers and homes, this could be a viral disease of the upper respiratory tract or influenza,” Dr Perera said. A sputum test can check for influenza and if so anti-virals will be administered, he was quoted as saying in a government statement. “Antibiotics are not necessary as this is a viral infection and if the cough persists, it may lead to childhood asthma, so proper treatment should be given.” The pediatrician said those with symptoms should wear face masks and that children with symptoms should be kept at home. More natural liquid food, lots of rest, an recommended dosage of paracetamol should be given to sick children, he said. Children under 2 years, adults over 65 years, people with chronic respiratory diseases, immunocompromised people and pregnant mothers, could develop complications he warned. (Colombo/Jul30/2024) Leave a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Save my name, email, and website in this browser for the next time I comment. Δ Leave a Comment Leave a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Save my name, email, and website in this browser for the next time I comment. Δ Most viewed 1 Sri Lanka President promises to unify nation, build a country without war 2 Sri Lanka’s BRICS membership not rejected, FM, Russian Embassy clarify 3 Sri Lanka pharmaceutical sector beginning to grow after crisis 4 Sri Lanka private credit up Rs89bn in September, government down 5 Sri Lanka banks, SMEs meet at Presidents office to discuss parate law, loans Economy IMF mission in Sri Lanka next week to begin review, budget in Feb Tuesday November 12, 2024 11:08 am Tuesday November 12, 2024 11:08 am ECONOMYNEXT – An International Monetary Fund team will visit Sri Lanka next week, the agency said, while President Anura Dissanayake said he expected a budget to be presented and passed in parliament by February. “An IMF team led by Peter Breuer, senior mission chief for Sri Lanka, is expected to visit Colombo next week to conduct the third review for Sri Lanka’s economic reform program supported by the IMF’s Extended Fund Facility,” a spokesperson said. President Anura Dissanayake said at his last campaign rally that the mission would arrive soon after the election to conduct the third review of the program. “We will finish the review by end January/early February,” he said. “Then we can achieve considerable stability in the economy.” For an IMF program review to pass, a staff level agreement has to be crafted with fiscal and monetary targets for the next year. For that a budget in line with program parameters is required. A budget is planned for February, President Dissanayake said. Until then a vote-on-account will be presented. “Because we are setting up new ministries we cannot do a budget in a hurry,” President Dissanayake said. “In December we will do a 4-month vote on account. But we do not want to wait for 4 months. By end February we hope to approve a budget. It will have benefits for the people.” He said a 3,000 rupee allowance has already been given to pensioners. “There are people who deserve Aswesuma but they have been missed,” he said. “We will review and give to those people as well. We will reduce the PAYE tax to a reasonable level. Then VAT on food taxes will be removed. We will give a payment for children to buy school items.” A state worker salary hike will be made, he said. Debt restructuring is expected to be completed by December and debt repayments will begin from 2028, he said. “We have calculated how much we have to pay in 2028,” he said. “We have a strong belief that the NPP can build an economy that will be bigger than the debt repayment share.” (Colombo/Nov12/2024) Continue Reading Markets Sri Lanka rupee trading at 292.65/75 to dollar, bond yields down Tuesday November 12, 2024 11:06 am Tuesday November 12, 2024 11:06 am ECONOMYNEXT – Sri Lanka’s rupee was trading weaker at 292.65/75 to the US dollar Tuesday from 292.55/75 to the US dollar on Monday, dealers said, while bond yields were down. A bond maturing on 01.05.2027 was quoted at 11.12/18 percent. A bond maturing on 01.05.2028 was quoted at 11.58/60 percent. A bond maturing on 15.06.2029 was quoted at 11.95/12.00 percent. An auction of 85,000 million rupees of treasury Bonds was ongoing. In equities, Colombo’s All Share Price Index was trading up 0.45 percent, or 58.58 points higher at 12,933.90, while the S&P SL20 of more liquid stocks was up 0.72 percent or 27.89 points higher at 3,882. The market turnover was 699 million rupees. (Colombo/Nov12/2024) Continue Reading Markets Fonterra says gets meaningful buyer interest for Sri Lanka unit, consumer division Tuesday November 12, 2024 10:38 am Tuesday November 12, 2024 10:38 am ECONOMYNEXT – New Zealand-based Fonterra said it has received meaningful buyer interest in initial exploration to sell off its global consumer division and integrated units in Sri Lanka and Oceania. Earlier this year Fonterra said that it was planning to exit consumer (retail) business and focus on ingredients and food service distribution channels. “We have received meaningful buyer interest in the businesses in scope for divestment, which is testament to their strength and potential,” Chief Executive Miles Hurrell said in a statement. “Through the scoping phase, we have assessed both a trade sale and IPO as attractive divestment options and will now prepare for a sale process which will pursue both options.” Advisors are working on the divestment. “We will thoroughly test the terms and value of both a trade sale and IPO with the market before seeking support from farmer shareholders for a divestment option through a vote,” Hurrell said. “A final decision on which divestment pathway to pursue will be based on several factors, including which option will result in optimal long-term value for the Co-op.” Continue Reading Subscribe to notifications Your'e subscribed to notifications Our Site Uses Cookies We use cookies to help us improve and customize your experience. Learn more about how we use cookies in our cookie policy. Granular Cookie Control Functional Preferences Analytics Marketing OK Economy FISCAL trade monetary GENERAL ECONOMY Opinion bellwhether Op-ed/Special Reports Finance banking insurance Markets BOND AND FOREX COMMODITIES stocks and companies Politics political news defence legal Logistics shipping ground aviation Energy petroleum power tech ict environment science world international news south asia culture people life style sports video & infographics video infographics slideshows miscellaneous offbeat namal suvendra business apparel construction and real estate fisheries tea tourism education general industry agriculture general service about en ABOUT CONTACT ADVERTISE TERMS PRIVACY FOLLOW US Facebook Instagram Twitter Linkedin Youtube Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement (updated 1/1/20) and Privacy Policy and Cookie Statement (updated 1/1/20). Your California Privacy Rights. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Condé Nast. Ad Choices. DAILY NEWSLETTER Signup Gain clarity on the biggest stories of the day with our daily newsletter, Morning Briefing ABOUT CONTACT ADVERTISE TERMS PRIVACY daily newsletter sign up © 2023 Echelon Media (PVT) Ltd. All Rights Reserved daily newsletter sign up